Citrus Sinensis ID: 014527

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420---
Protein Sequence
MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSWMPL
Secondary Structure (PSIPRED)
cccEEccEEEEEEEEcccccEEEEEEEEEccccEEEEcccccccccccHHHHHHHHHHHcccccccEEEEcccccccEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEEccccccEEEEEEcccccEEEccccccccccccccccEEEcccHHHcccccccccccHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccHHHHHcccHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEcccEEEEEEEEEEccEEEEEEEEccccEEEEEEEEEcccccccHHHHHHHHHHHccccccccEEEEEEEccEEEEEEEccccEHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccHHHcccEEEccccccEEcEccccccEccccEccccccccccccHHHHHcEcccHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccHHHHccccccHHHHHHHHHHHccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHcHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MERIIGVKYKlgrkigsgsfGEIFLASHVDTNEIVAVKIensgtkhpqlLYEAKVYKILqggsgipnikwygvdgednVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHsrgflhrdikpdnflmglgrkanQVYIIDFGLakkyrdpttnrhipyrenknltgtaRYASCNTHLGIEQSRRDDLESLGYVLLYFLRgslpwqglKAATKKQKYDKICekkvstpievlckshpaefasYFHYCQsltfdqrpdygFLKRLFHDLfsregydfdfvfDWTILKYQQTqktksqdllpasrvtnsrvmpmrtdklkgvndascsAEVLEcrgsynrtrpdadmqhrpsvaekmssdhhfgkhsmgnasipsasfvlpstfnrnfqkpegpdeaanigrghgnktgassswmpl
Flexible Loop (DISEMBL)
meriigvkyklgrkigsgSFGEIFLASHVDTNEIVAVKIensgtkhpqLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGlakkyrdpttnrhipyrenknltgtARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQqtqktksqdllpasrvtnsrvmpmrtdklkgvndascsaEVLECRgsynrtrpdadmQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPdeaanigrghgnktgassswmpl
Low Complexity Region (SEG)
MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSWMPL
Disordered region (IsUnstruct)
***IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQ*******************************************************************************************************************************
Disordered Region (DISOPRED)
MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAV**********QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT************************************************************************************************************************************
Disordered Region (DISEMBL)
MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG**********DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHG************
Disordered Region (DISPRO)
*ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT*****************************************************************************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSWMPL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	423	2.2.26 [Sep-21-2011]
P42158	450	Casein kinase I isoform d	no	no	0.737	0.693	0.735	1e-143
Q6P647	415	Casein kinase I isoform d	yes	no	0.926	0.944	0.559	1e-129
Q5BP74	415	Casein kinase I isoform d	N/A	no	0.926	0.944	0.559	1e-129
Q5ZLL1	416	Casein kinase I isoform e	no	no	0.721	0.733	0.681	1e-128
P49674	416	Casein kinase I isoform e	yes	no	0.721	0.733	0.678	1e-128
Q9JMK2	416	Casein kinase I isoform e	yes	no	0.721	0.733	0.678	1e-128
Q7T2E3	403	Casein kinase I isoform d	no	no	0.697	0.732	0.701	1e-128
Q06486	415	Casein kinase I isoform d	no	no	0.697	0.710	0.694	1e-128
Q9DC28	415	Casein kinase I isoform d	no	no	0.697	0.710	0.694	1e-128
Q6P3K7	409	Casein kinase I isoform d	no	no	0.697	0.721	0.698	1e-128

>sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2

 Score =  509 bits (1311), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 233/317 (73%), Positives = 277/317 (87%), Gaps = 5/317 (1%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN  TKHPQLLYE+K+Y+ILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct: 61  GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG+ FD+VFDWTILKYQQ+Q 
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query: 301 TKSQDLLPASRVTNSRV 317
           T      P SR  N  V
Sbjct: 301 TA-----PPSRALNPAV 312

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1

 Score =  463 bits (1191), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 232/415 (55%), Positives = 306/415 (73%), Gaps = 23/415 (5%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY----- 295
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+     
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGANRA 300

Query: 296 ---QQTQKTKSQDLLPASRVTNSRVMP-MRTDKLKGVNDASCSAEVLECRGSYNRT-RPD 350
               + ++ + ++ L   R   +R +P   + +L+G  + + S  +     + N + RP 
Sbjct: 301 AEDAERERREREERLRHPRNPAARGLPSTASGRLRGTQEVTPSTPLTPTSHTANTSPRPV 360

Query: 351 ADMQHRPSVAEKM--------SSDHHFGKHS---MGNASIPS--ASFVLPSTFNR 392
           + M+    V+ ++        SS    G+     M  + IPS  AS  LPST +R
Sbjct: 361 SGMERERKVSMRLHRGAPVNVSSSDLTGRQETSRMSTSQIPSRVASSGLPSTVHR 415

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling.

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2

 Score =  461 bits (1187), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 232/415 (55%), Positives = 306/415 (73%), Gaps = 23/415 (5%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +  +E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT-- 298
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+  +  
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRA 300

Query: 299 ------QKTKSQDLLPASRVTNSRVMP-MRTDKLKGVNDASCSAEVLECRGSYNRT-RPD 350
                 ++ + ++ L  +R    R +P   + +L+G  + + S  +     + N + RP 
Sbjct: 301 AEDAERERREREERLRHTRNPAVRGLPSTASGRLRGTQEVTPSTPLTPTSHTANTSPRPV 360

Query: 351 ADMQ---------HRPSVAEKMSSDHHFGKHS--MGNASIPS--ASFVLPSTFNR 392
           + M+         HR +     SSD    + +  M  + IPS   S  LPST +R
Sbjct: 361 SGMERERKVSMRLHRGAPVNVSSSDLTSRQDTSRMSTSQIPSRVTSSGLPSTVHR 415

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2

 Score =  459 bits (1182), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 208/305 (68%), Positives = 261/305 (85%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G KY+LGRKIGSGSFG+I+L +++ T E VA+K+E   TKHPQL  E+K YK++Q
Sbjct: 1   MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+   + 
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300

Query: 301 TKSQD 305
            +  D
Sbjct: 301 PEDMD 305

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1

 Score =  458 bits (1178), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 207/305 (67%), Positives = 261/305 (85%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E   TKHPQL  E+K YK++Q
Sbjct: 1   MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+   + 
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300

Query: 301 TKSQD 305
            +  D
Sbjct: 301 PEDVD 305

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2

 Score =  458 bits (1178), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 207/305 (67%), Positives = 261/305 (85%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E   TKHPQL  E+K YK++Q
Sbjct: 1   MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+   + 
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300

Query: 301 TKSQD 305
            +  D
Sbjct: 301 PEDVD 305

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1

 Score =  457 bits (1177), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 207/295 (70%), Positives = 257/295 (87%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + + T E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2

 Score =  457 bits (1176), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 205/295 (69%), Positives = 256/295 (86%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

>sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2

 Score =  457 bits (1176), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 205/295 (69%), Positives = 256/295 (86%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

>sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1

 Score =  457 bits (1176), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 206/295 (69%), Positives = 256/295 (86%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	423
224092300	431	predicted protein [Populus trichocarpa]	0.995	0.976	0.778	0.0
359484562	433	PREDICTED: casein kinase I isoform delta	0.995	0.972	0.747	0.0
356523722	430	PREDICTED: casein kinase I isoform delta	0.990	0.974	0.746	0.0
388495184	431	unknown [Lotus japonicus]	0.988	0.969	0.740	0.0
356513159	430	PREDICTED: casein kinase I isoform delta	0.990	0.974	0.748	1e-180
224142173	424	predicted protein [Populus trichocarpa]	0.978	0.976	0.733	1e-178
356531301	426	PREDICTED: casein kinase I isoform delta	0.978	0.971	0.737	1e-177
357500563	424	Casein kinase I isoform delta-like prote	0.976	0.974	0.728	1e-175
356495220	662	PREDICTED: casein kinase I isoform delta	0.959	0.613	0.742	1e-175
449530861	433	PREDICTED: casein kinase I isoform delta	0.995	0.972	0.704	1e-173

>gi|224092300|ref|XP_002309549.1| predicted protein [Populus trichocarpa] gi|222855525|gb|EEE93072.1| predicted protein [Populus trichocarpa]

 Score =  680 bits (1755), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/425 (77%), Positives = 364/425 (85%), Gaps = 4/425 (0%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERIIG KYKLGRKIGSGSFGEIFLA+H+ + EIVAVKIEN  TKHPQLLYEAK+YKIL 
Sbjct: 1   MERIIGEKYKLGRKIGSGSFGEIFLATHIHSGEIVAVKIENRSTKHPQLLYEAKLYKILG 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGI NIKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQMIARIEY+H
Sbjct: 61  GGSGIANIKWCGVDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMIARIEYMH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
            +GFLHRDIKPDNFLMGLGRKA+QVY+IDFGLAK+YRDPTT++HI YRENKNLTGTARYA
Sbjct: 121 VKGFLHRDIKPDNFLMGLGRKASQVYVIDFGLAKRYRDPTTHQHITYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLES+GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESIGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG++FDFVFDWTILKY+QTQ+
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGFEFDFVFDWTILKYKQTQR 300

Query: 301 TKSQ----DLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHR 356
            K Q    DL P SRVT+SR M M  +K KGVN AS SAEV + RGS    RPD  MQ  
Sbjct: 301 PKPQPQSSDLQPNSRVTSSRAMAMDLNKDKGVNGASYSAEVADHRGSNKVARPDTHMQLG 360

Query: 357 PSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGA 416
            S +  +++D+   KH+M NAS+PS SFV PS   R+F K +G  +A NIGRG GN+ GA
Sbjct: 361 SSFSRNVTADNPLDKHNMNNASMPSTSFVPPSASRRDFMKLDGSTDAVNIGRGLGNRAGA 420

Query: 417 SSSWM 421
           SS  M
Sbjct: 421 SSRLM 425

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484562|ref|XP_002284044.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297738784|emb|CBI28029.3| unnamed protein product [Vitis vinifera]

 Score =  645 bits (1664), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/423 (74%), Positives = 349/423 (82%), Gaps = 2/423 (0%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERI+G KYKLGRKIGSGSFGEI+LA+HVDT EIVAVKIENS TKHPQLLYEAK+Y +LQ
Sbjct: 1   MERIVGGKYKLGRKIGSGSFGEIYLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYNLLQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIP I+W G+DG+DN+LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61  GGSGIPGIRWSGIDGDDNILVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD++FDWTILKYQQTQK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGYEFDYIFDWTILKYQQTQK 300

Query: 301 TKSQ-DLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSV 359
           +++Q  L PA+  ++SR M M  D+ +G  +AS SAE  E   S N            S 
Sbjct: 301 SRTQPQLSPAAGGSSSRAMAMDVDRHQGGINASYSAEATERIRSSNAAASSGIRMQFKST 360

Query: 360 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIG-RGHGNKTGASS 418
            + +SS+    K+ + +A +PS SF L     RN  KP  P E  N    GH NK G SS
Sbjct: 361 GKNLSSESPAEKNIVSDAHMPSTSFSLAGFSKRNAPKPMLPTETTNTAHHGHTNKIGPSS 420

Query: 419 SWM 421
           SW+
Sbjct: 421 SWI 423

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523722|ref|XP_003530484.1| PREDICTED: casein kinase I isoform delta-like [Glycine max]

 Score =  639 bits (1648), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/422 (74%), Positives = 347/422 (82%), Gaps = 3/422 (0%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1   MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVL+LADQMI RIEYVH
Sbjct: 61  GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLLLADQMITRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYDFDYVFDWTILKYQQSQK 300

Query: 301 -TKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSV 359
                 L P    +NSR  P+  D  +G+N  + S  V E   + + T     +Q +  V
Sbjct: 301 NVMLPPLSPVPGASNSRATPIDVDSHQGLN--AYSGHVKERIRAGDATGSGVKIQFKSPV 358

Query: 360 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSS 419
            + +S ++   K+  G A+IPS SF   ST  RN  K     EA+N G   G+K G SSS
Sbjct: 359 GKNLSYENPLDKNIFGEANIPSTSFSPASTSKRNSLKQSLSAEASNPGHAQGSKMGPSSS 418

Query: 420 WM 421
           WM
Sbjct: 419 WM 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388495184|gb|AFK35658.1| unknown [Lotus japonicus]

 Score =  639 bits (1647), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 314/424 (74%), Positives = 348/424 (82%), Gaps = 6/424 (1%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1   MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIP  +W GVDGEDNVLVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEY H
Sbjct: 61  GGSGIPGTRWSGVDGEDNVLVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYAH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYDFDYVFDWTILKYQQSQK 300

Query: 301 TKSQ---DLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRP 357
              Q    L P    +NSRV+PM  D  +G+N  + S  V E   S N       +Q + 
Sbjct: 301 NAVQPSLSLQPVPVASNSRVIPMDADNHQGLN--AYSGHVKERIRSGNAATSGVKIQLKS 358

Query: 358 SVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGAS 417
            V   +SS++   K+  G +++PS S+   ++ NR   KP    EA+N G+G G+K   S
Sbjct: 359 PVGRNLSSENPLDKNIFGESNMPSTSYPAGAS-NRTSLKPAFSAEASNPGQGQGSKIAPS 417

Query: 418 SSWM 421
           SSWM
Sbjct: 418 SSWM 421

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513159|ref|XP_003525281.1| PREDICTED: casein kinase I isoform delta-like [Glycine max]

 Score =  637 bits (1643), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 316/422 (74%), Positives = 346/422 (81%), Gaps = 3/422 (0%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1   MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61  GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+R+GYDFD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFARDGYDFDYVFDWTILKYQQSQK 300

Query: 301 -TKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSV 359
                 L P    +NSR +PM  D  +G+N  S S  V E   + + T     +Q +  V
Sbjct: 301 NVMLPPLSPVPGASNSRAIPMDIDNHQGLN--SYSGHVKERIRAGDATGSGVKIQFKSPV 358

Query: 360 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSS 419
            + +S +    K+  G A+IPS SF   ST  RN  K     EA+N G   G+K G SSS
Sbjct: 359 GKNLSYEKPLDKNIFGEANIPSTSFSPASTSQRNSLKQSLSAEASNPGHAQGSKIGPSSS 418

Query: 420 WM 421
            M
Sbjct: 419 LM 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142173|ref|XP_002324433.1| predicted protein [Populus trichocarpa] gi|222865867|gb|EEF02998.1| predicted protein [Populus trichocarpa]

 Score =  630 bits (1626), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 309/421 (73%), Positives = 344/421 (81%), Gaps = 7/421 (1%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVA+KIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1   MERIIGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAIKIENSKTKHPQLLYEAKLYNILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIP+IKW GVDGEDN LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61  GGSGIPSIKWSGVDGEDNALVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDATTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASY HYC SLTFDQRPDYGFLKRLF DLFS  GY+FD+VFDWTI+KYQQ QK
Sbjct: 241 CKSHPVEFASYMHYCHSLTFDQRPDYGFLKRLFRDLFSHGGYEFDYVFDWTIIKYQQAQK 300

Query: 301 TKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVA 360
            +SQ     +   +S  +    +  +G ++A  S+E++   G      P   MQ +  + 
Sbjct: 301 NRSQPRSSPNPACSSHAVQTDMENHQGSHNACYSSEIMRSTG------PGIRMQSKSGLG 354

Query: 361 EKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSSW 420
           + + SD H  K ++ +  IPS SF +  T  R+  KP  P+E+AN   GH NK G SSSW
Sbjct: 355 KNLISDIHADK-NIVSQHIPSTSFQVGGTSKRHASKPVLPNESANPAHGHNNKIGPSSSW 413

Query: 421 M 421
           +
Sbjct: 414 I 414

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356531301|ref|XP_003534216.1| PREDICTED: casein kinase I isoform delta-like [Glycine max]

 Score =  626 bits (1614), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 312/423 (73%), Positives = 343/423 (81%), Gaps = 9/423 (2%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIEN  TKHPQLLYEAK+Y ILQ
Sbjct: 1   MERIIGAKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIP+IKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61  GGSGIPSIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD+VFDWTILKY+Q QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREGYEFDYVFDWTILKYKQAQK 300

Query: 301 TKSQDLLPASRVTNSR-VMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSV 359
            + Q  +     T+S   MPM  D  +G      SAE ++   S N T     +Q +  V
Sbjct: 301 NRVQPHISTVPGTSSSPAMPMDVDNHRG----DVSAERIK---SGNVTGSGVKIQFKSPV 353

Query: 360 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHG-NKTGASS 418
            + + S+    K+  G ++IPS S+ +  T  RN  KP    EA   G G G NK G SS
Sbjct: 354 GKILGSEKPLDKNIFGESNIPSTSYSIAGTSRRNTMKPALSTEAPKPGHGQGSNKIGPSS 413

Query: 419 SWM 421
           SW+
Sbjct: 414 SWI 416

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357500563|ref|XP_003620570.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|357500745|ref|XP_003620661.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495585|gb|AES76788.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495676|gb|AES76879.1| Casein kinase I isoform delta-like protein [Medicago truncatula]

 Score =  620 bits (1600), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 308/423 (72%), Positives = 346/423 (81%), Gaps = 10/423 (2%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           M+RIIG K+KLGRKIGSGSFGEI+LA+H+DT EIVAVKIE   TKHPQLLYEAK+Y ILQ
Sbjct: 1   MDRIIGDKFKLGRKIGSGSFGEIYLATHIDTFEIVAVKIETGKTKHPQLLYEAKLYNILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIP+I+W GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQM+ RIEYVH
Sbjct: 61  GGSGIPSIRWSGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKTVLMLADQMMTRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKAN VY+IDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANLVYVIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFL+RLF +LF+REGY FD+VFDWTILKYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLRRLFRELFAREGYKFDYVFDWTILKYQQSQK 300

Query: 301 TKSQ-DLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSV 359
           +++Q  + P    +N+R MPM  D  +G    + SAE +    S N T      Q + S 
Sbjct: 301 SRAQPHISPVPVASNNRAMPMDIDNQQG----NVSAEQIR---SDNATSSGVKFQFKSSG 353

Query: 360 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHG-NKTGASS 418
            + ++S++  GK+  G A+IPS S    ++  RN  KP    EAAN   G G +K G SS
Sbjct: 354 GKNLASENPLGKNIFGEATIPSTSHSFEAS-RRNSLKPSASTEAANHRHGQGSSKIGPSS 412

Query: 419 SWM 421
           S M
Sbjct: 413 SRM 415

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356495220|ref|XP_003516477.1| PREDICTED: casein kinase I isoform delta-like [Glycine max]

 Score =  619 bits (1597), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 306/412 (74%), Positives = 337/412 (81%), Gaps = 6/412 (1%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MERII  KYKLGRKIGSGSFGEI+LA+++DT EIVAVKIEN  TKHPQLLYEAK+Y ILQ
Sbjct: 1   MERIICAKYKLGRKIGSGSFGEIYLATNIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIPNIKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61  GGSGIPNIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REGY+FD+VFDWTILKYQQ QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGYEFDYVFDWTILKYQQAQK 300

Query: 301 TKSQDLLPASRVTNSR-VMPMRTDKLKGVNDAS--CSAEVLECRGSYNRTRPDADMQHRP 357
            + Q  +     T+S   MPM  D  +G+N  S   +AE ++   S N T     +Q + 
Sbjct: 301 NRVQSRISTVPGTSSSPAMPMDVDNHRGINAYSGDVTAERIK---SGNVTGSGVKIQFKS 357

Query: 358 SVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRG 409
            V + + S+    K+  G A+IPS S+ +  T  RN  KP    EA N G G
Sbjct: 358 PVGKNLGSEKPLDKNIFGEANIPSTSYSVAGTSRRNTLKPALSTEAPNPGHG 409

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449530861|ref|XP_004172410.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 298/423 (70%), Positives = 342/423 (80%), Gaps = 2/423 (0%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           MER+IG KYKLGRKIGSGSFGEI+LA+H++T EIVAVKIEN+ TKHPQLLYEAK+Y ILQ
Sbjct: 1   MERVIGGKYKLGRKIGSGSFGEIYLATHIETFEIVAVKIENNKTKHPQLLYEAKLYSILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GGSGIP  KW G+DGE+NVLVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61  GGSGIPATKWSGIDGEENVLVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDATTNRHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+RE Y+FD+VFDWTI+KYQQ+QK
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREEYEFDYVFDWTIIKYQQSQK 300

Query: 301 TKSQDLLP--ASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPS 358
            ++Q  +        N    PM  +  +G  +   SAEV +   S N + P   +  +  
Sbjct: 301 NRTQPRVSPVVGGTHNHHATPMEGESRQGGFNTYSSAEVTDRVRSDNVSSPAVRLHFKQP 360

Query: 359 VAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASS 418
             + +SSD+    +++ +  + ++SF    +   N  KP    E+ N  +G+G++ G SS
Sbjct: 361 TPKNLSSDNALDMNALNDPRMATSSFTPAGSSRGNSSKPLQSTESPNRVQGNGHRIGPSS 420

Query: 419 SWM 421
           SW+
Sbjct: 421 SWI 423

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	423
TAIR|locus:2117778	415	ckl3 "casein kinase I-like 3"	0.969	0.987	0.713	2.9e-158
TAIR|locus:2117843	414	ckl4 "casein kinase I-like 4"	0.957	0.978	0.705	4.4e-155
TAIR|locus:504954933	435	ckl12 "casein kinase I-like 12	0.754	0.733	0.735	1.9e-131
TAIR|locus:2120765	450	CK1 "casein kinase 1" [Arabido	0.749	0.704	0.732	1.7e-130
TAIR|locus:2024147	471	ADK1 "dual specificity kinase	0.945	0.849	0.612	3.5e-130
TAIR|locus:2167634	476	ckl7 "casein kinase I-like 7"	0.900	0.800	0.625	1.2e-129
TAIR|locus:2030170	465	CKL2 "casein kinase 1-like pro	0.704	0.640	0.765	8.4e-129
TAIR|locus:2050409	433	ckl5 "casein kinase I-like 5"	0.718	0.702	0.740	5.9e-128
TAIR|locus:2090875	442	ckl10 "casein kinase I-like 10	0.704	0.674	0.761	1.2e-127
TAIR|locus:2121338	479	CKL6 "casein kinase I-like 6"	0.704	0.622	0.765	2e-127

TAIR|locus:2117778 ckl3 "casein kinase I-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1542 (547.9 bits), Expect = 2.9e-158, P = 2.9e-158
 Identities = 301/422 (71%), Positives = 338/422 (80%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             MERIIG KYKLGRKIG GSFGEIFLA+HVDT EIVAVKIENS TKHPQLLYEAK+Y+IL+
Sbjct:     1 MERIIGGKYKLGRKIGGGSFGEIFLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYRILE 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GGSGIP IKW+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIE+VH
Sbjct:    61 GGSGIPRIKWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEFVH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD  TNRHIPYRENKNLTGTARYA
Sbjct:   121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA  KKQKYDKICEKK+STPIEVL
Sbjct:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
             CK+HP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD++FDWTI+KYQQ QK
Sbjct:   241 CKNHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIFDWTIIKYQQAQK 300

Query:   301 TKSQD-LLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSV 359
             +++Q   +P S  +N R MP+ T   +G  + S  AE  E   S N   P   + +  + 
Sbjct:   301 SRNQSQAVPGS--SNPRAMPVDTSNHRGGPNISYEAEASERVRSANAIGPSPQINNNTAA 358

Query:   360 AEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSS 419
                   DH   K    N ++PS S     T  RN     GP E +N G G GN+TG +SS
Sbjct:   359 GRTPGFDHPVHK----NMNMPSTSLSPAGTSKRNV----GP-ETSNSGYGSGNRTGWTSS 409

Query:   420 WM 421
             +M
Sbjct:   410 FM 411

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2117843 ckl4 "casein kinase I-like 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1512 (537.3 bits), Expect = 4.4e-155, P = 4.4e-155
 Identities = 297/421 (70%), Positives = 339/421 (80%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             MERIIG KYKLGRKIG GSFGEIFLA+H+DT EIVAVKIENS TKHPQLLYEAK+Y+ L+
Sbjct:     1 MERIIGGKYKLGRKIGGGSFGEIFLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYRTLE 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GGSGIP I+W+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIEYVH
Sbjct:    61 GGSGIPRIRWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEYVH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD  TNRHIPYRENKNLTGTARYA
Sbjct:   121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             SCNTHLGIEQ RRDDLESLGYVLLYFLRGSLPWQGLKA  KKQKYDKICEKK+STPIEVL
Sbjct:   181 SCNTHLGIEQGRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
             CKSHP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREGY+FD+++DWTI+KYQQ+QK
Sbjct:   241 CKSHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREGYEFDYIYDWTIIKYQQSQK 300

Query:   301 TKSQD-LLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSV 359
             T+SQ   +P S  +N+R +PM T   +G    S  A+V +     N + P    Q   +V
Sbjct:   301 TRSQSQAVPGS--SNARAIPMDTSNHRGGTKISHEAQVSDRVRPANASGPSP--QINTAV 356

Query:   360 AEKMSSDHHFGKHSMGNASIPSASFVLPS-TFNRNFQKPEGPDEAANIGRGHGNKTGASS 418
                +  D     H   N ++PS++ + P+ T  RN  +PE     +N G G GNKTG  +
Sbjct:   357 GRSLGFDQ---VHK--NMNMPSSTSLSPAGTSKRNV-RPE----TSNSGFGSGNKTGGWT 406

Query:   419 S 419
             S
Sbjct:   407 S 407

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1289 (458.8 bits), Expect = 1.9e-131, P = 1.9e-131
 Identities = 236/321 (73%), Positives = 282/321 (87%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             ME  +G KY+LGRKIGSGSFGEI+L +H+ TNE VA+K+EN  TKHPQLLYE+K+Y+ILQ
Sbjct:     1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GG+G+PNIKW+GV+G+ N LV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+EY H
Sbjct:    61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             S+ FLHRD+KPDNFLMGLGR+ANQV+IIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct:   121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct:   181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
             C+ +P+EFASYFHYC+SL FD +PDYG+LKR+F DLF REG+ FD+VFDWTILKYQQ+Q 
Sbjct:   241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query:   301 TK--SQDLLPASRVTNSRVMP 319
             T   S+ L+  +  T++ + P
Sbjct:   301 TAPPSRGLVSPAVGTSAGLPP 321

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1280 (455.6 bits), Expect = 1.7e-130, P = 1.7e-130
 Identities = 235/321 (73%), Positives = 281/321 (87%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             ME  +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN  TKHPQLLYE+K+Y+ILQ
Sbjct:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct:    61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct:   121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct:   181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
             C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG+ FD+VFDWTILKYQQ+Q 
Sbjct:   241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300

Query:   301 TK--SQDLLPASRVTNSRVMP 319
             T   S+ L PA  V  S  +P
Sbjct:   301 TAPPSRALNPA--VGTSAALP 319

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1277 (454.6 bits), Expect = 3.5e-130, P = 3.5e-130
 Identities = 250/408 (61%), Positives = 299/408 (73%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             M+ +IG K+KLGRKIGSGSFGE++L  +V T E VAVK+E+  TKHPQL YE+K+Y +LQ
Sbjct:     1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GG+G+PN+KWYGV+G+ NV+V+DLLGPSLEDLF YC RK SLKTVLMLADQ+I R+E++H
Sbjct:    61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             +RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD  T+RHIPYRENKNLTGTARYA
Sbjct:   121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLG+EQSRRDDLE+LGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKV+TPIEVL
Sbjct:   181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
             CK+ P+EF SYF YC+SL FD +PDY +LKRLF DLF REGY FD+VFDWT+LKY Q   
Sbjct:   241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300

Query:   301 TKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGS-----YNRTRPDADMQH 355
             +        +  T +  +       K   +     E  E R S     ++R  P A    
Sbjct:   301 SSGSSSRTRNHTTANPGLTAGASLEK--QERIAGKETRENRFSGAVEAFSRRHP-ATSTT 357

Query:   356 RPSVAEKMSSDHHFGKHSMGNASIPSASFVLPSTFNRNFQKPEGPDEA 403
             R   A + S D    KH  G++  P +S    S+  R       P  A
Sbjct:   358 RDRSASRNSVDGPLSKHPPGDSERPRSSSRYGSSSRRAIPSSSRPSSA 405

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IDA

GO:0007165 "signal transduction" evidence=TAS

TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
 Identities = 242/387 (62%), Positives = 296/387 (76%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             M+ +IG K+KLG+KIGSGSFGE++L  +V T E VAVK+EN  TKHPQL YE+K+Y +LQ
Sbjct:     1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GGSGIPNIKW+GV+G+ +V+V+DLLGPSLEDLF YC RK +LKTVLMLADQ++ R+E++H
Sbjct:    61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             +RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD  T++HIPYRENKNLTGTARYA
Sbjct:   121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLG+EQSRRDDLESLGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct:   181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
             CK+ P+EF SYFHYC+SL FD +PDY +LKRLF DLF REGY FD+VFDWT+LKY Q   
Sbjct:   241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300

Query:   301 TKSQDLLPASRVTNS---RVMPM-RTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHR 356
             +           T        P+ R +++ G    +   ++     +++R  P      R
Sbjct:   301 SSGSSSRTRHHTTAKPGFNADPIERQERILGKE--TTRYKIPGAVEAFSRRHPTTTSSPR 358

Query:   357 PSVAEKMSSDHHFGKHSMGNASIPSAS 383
                  + S D  F K + G++   ++S
Sbjct:   359 DRSRSRNSDDGPFSKQTHGDSERANSS 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1264 (450.0 bits), Expect = 8.4e-129, P = 8.4e-129
 Identities = 229/299 (76%), Positives = 268/299 (89%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             ME  +G K++LGRKIG GSFGEI+L +++ TNE VA+K+EN  TKHPQLLYE+K+YK+LQ
Sbjct:     1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GG+G+PN+KWYGV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI RIE+VH
Sbjct:    61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
              + FLHRDIKPDNFLMGLGR+ANQVY+IDFGLAKKYRD + ++HIPYRENKNLTGTARYA
Sbjct:   121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD-SNHQHIPYRENKNLTGTARYA 179

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLGIEQSRRDDLESLG+VL+YFL+GSLPWQGLKA  KKQKY+KI EKKVST IE L
Sbjct:   180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
             C+ +P+EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q
Sbjct:   240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1256 (447.2 bits), Expect = 5.9e-128, P = 5.9e-128
 Identities = 225/304 (74%), Positives = 267/304 (87%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             ME  +G K++LGRKIGSGSFGEI+L + V TNE VA+K+E+  T HPQL YE+++Y++LQ
Sbjct:     1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GG+GIPN+KWYGV+G+ NVLV+DLLGPSLEDLF YC+R+FSLKTVLMLADQMI R+E++H
Sbjct:    61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             S+ +LHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD +T+RHIPYRENK+L GT RYA
Sbjct:   121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLGIEQSRRDD+ESLGY+L+YFL+GSLPWQGLKA  KKQKYDKI EKKVST IE L
Sbjct:   181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
             C+ HP EFASYFHYC+SL FD +PDY +LKRLF +LF REG+ FDFVFDWT+ KYQQ+Q 
Sbjct:   241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQS 300

Query:   301 TKSQ 304
                Q
Sbjct:   301 GNPQ 304

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
 Identities = 227/298 (76%), Positives = 264/298 (88%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             M+ +IG K+KLGRKIGSGSFGE+++  +V T E VA+K+E   TKHPQL YE+KVY +LQ
Sbjct:     1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GG+G+P+IKW+GV+G  N + +DLLGPSLEDLF YC R FSLKTVLMLADQ+I R+EY+H
Sbjct:    61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             SRGFLHRDIKPDNFLMGLGRKANQVYIID+GLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLGIEQSRRDDLESLGYVL+YF+RGSLPWQGLKA TKKQKY+KI EKK+ TP+EVL
Sbjct:   181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT 298
             CKS+P+EF SYFHYC+SL F+ +PDY +LKRLF DLF REGY FD+VFDWTILKY Q+
Sbjct:   241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
 Identities = 228/298 (76%), Positives = 262/298 (87%)

Query:     1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
             M+ +IG K+KLGRKIG GSFGE+FLA  + T E  AVK+E + TKHPQL YE+K+Y +LQ
Sbjct:     5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64

Query:    61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             GGSGIP++KW+GV G+ N +V+DLLGPSLEDLF YC R+ +LK VLMLADQ+I+R+EY+H
Sbjct:    65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124

Query:   121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
             SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  T+RHIPYRENKNLTGTARYA
Sbjct:   125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184

Query:   181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             S NTHLG+EQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct:   185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244

Query:   241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQT 298
             CKS+P EF SYF YC+SL F+ +PDY +LKRLF DLF REGY FD+VFDWT LK+ Q+
Sbjct:   245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=TAS

GO:0005856 "cytoskeleton" evidence=IDA

GO:0055028 "cortical microtubule" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009744 "response to sucrose stimulus" evidence=RCA

GO:0009749 "response to glucose stimulus" evidence=RCA

GO:0009750 "response to fructose stimulus" evidence=RCA

GO:0042732 "D-xylose metabolic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q556Y4	KC1_DICDI	2, ., 7, ., 1, 1, ., 1	0.6428	0.6950	0.6901	yes	no
P49674	KC1E_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6786	0.7210	0.7331	yes	no
P35508	KC1D_BOVIN	2, ., 7, ., 1, 1, ., 2, 6	0.6949	0.6973	0.7108	yes	no
Q6P647	KC1D_XENTR	2, ., 7, ., 1, 1, ., 1	0.5590	0.9267	0.9445	yes	no
P42168	KC1A_CAEEL	2, ., 7, ., 1, 1, ., 1	0.6360	0.7446	0.9237	yes	no
Q5RC72	KC1D_PONAB	2, ., 7, ., 1, 1, ., 2, 6	0.6881	0.6973	0.7108	yes	no
P29295	HRR25_YEAST	2, ., 7, ., 1, 1, ., 1	0.6254	0.7257	0.6214	yes	no
P40235	HHP1_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6979	0.6808	0.7890	yes	no
O76324	DCO_DROME	2, ., 7, ., 1, 1, ., 1	0.6779	0.6973	0.6704	yes	no
Q8IHZ9	KC1_PLAF7	2, ., 7, ., 1, 1, ., 1	0.6523	0.7139	0.9349	yes	no
Q5BP74	KC1D_XENLA	2, ., 7, ., 1, 1, ., 1	0.5590	0.9267	0.9445	N/A	no
Q9JMK2	KC1E_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6786	0.7210	0.7331	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_LG_VI1653 hypothetical protein (431 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	423
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-36
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-22
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-22
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-18
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-13
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-12
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-12
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	8e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-10
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-08
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-07
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-06
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-06
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
COG2112	201	COG2112, COG2112, Predicted Ser/Thr protein kinase	1e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-05
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-05
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-04
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	3e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	3e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-04
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	8e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	0.001
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	0.001
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	0.001
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	0.001
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.001
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.002
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.002
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.002
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.002
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.002
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.003
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.003
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	0.003
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	0.003
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (418), Expect = 4e-48
 Identities = 79/268 (29%), Positives = 111/268 (41%), Gaps = 31/268 (11%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L RK+GSGSFG ++ A H  T +IVAVKI         K      E ++ + L     
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH--- 57

Query: 65  IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            PNI +      + +   LV++       DLF Y  R    S      +A Q++  +EY+
Sbjct: 58  -PNIVRLIDAFEDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS G +HRD+KP+N L+    +   V I DFGLAKK                   GT  Y
Sbjct: 115 HSNGIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWY 164

Query: 180 ASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
            +    L G     + D+ SLG +L   L G  P+ G     + Q   +I    +     
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP 224

Query: 239 VLCKSHPAEFASYFHYCQSLTFD--QRP 264
               S   E       C  L  D  +RP
Sbjct: 225 KWS-SGSEEAKDLIKKC--LNKDPSKRP 249

Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  136 bits (342), Expect = 4e-36
 Identities = 90/315 (28%), Positives = 138/315 (43%), Gaps = 23/315 (7%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
            Y++ RK+G GSFGE++LA      ++VA+K+     E+   +  + L E ++   L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 63  SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
             I  +  +  D     LV++ + G SLEDL     R    S    L +  Q+++ +EY+
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+G +HRDIKP+N L  L R    V +IDFGLAK   DP +   IP   + ++ GT  Y
Sbjct: 118 HSKGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174

Query: 180 ASCNTHLGIEQ---SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVST 235
            +    LG+     S   D+ SLG  L   L G  P++G K ++   +    I E    +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234

Query: 236 PIEVLCKSHPAEFASYFH--YCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
               L  S+P   +        + L  D +        L HDL +          D + L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL---KLKESDLSDL 291

Query: 294 KYQQTQKTKSQDLLP 308
                       L P
Sbjct: 292 LKPDDSAPLRLSLPP 306

Length = 384

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  128 bits (324), Expect = 5e-35
 Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 21/200 (10%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
           +G G FG ++LA    T + VA+KI   E+S +   +LL E ++ K L      PNI K 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH----PNIVKL 56

Query: 71  YGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
           YGV  D     LV++   G SL+DL      K S   +L +  Q++  +EY+HS G +HR
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N L  L     +V + DFGL+K                K + GT  Y +    LG
Sbjct: 117 DLKPENIL--LDSDNGKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAPEVLLG 167

Query: 188 I-EQSRRDDLESLGYVLLYF 206
               S + D+ SLG +L   
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  119 bits (302), Expect = 2e-31
 Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 27/246 (10%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y++  K+G GSFG+++LA    T ++VA+K+   +       ++L E K+ K L+     
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56

Query: 66  PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           PNI + Y V  D +   LV++   G  L DL    R + S         Q+++ +EY+HS
Sbjct: 57  PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHS 115

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +G +HRD+KP+N L+    +   V + DFGLA++                   GT  Y +
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEK--------LTTFVGTPEYMA 164

Query: 182 CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
               LG    +  D+ SLG V+LY  L G  P+ G       + + KI + K   P    
Sbjct: 165 PEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPPFPPPEW 221

Query: 241 CKSHPA 246
             S  A
Sbjct: 222 DISPEA 227

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (250), Expect = 5e-24
 Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 24/221 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGS 63
           +++ G KIG G+FG+++ A ++DT E++AVK   I+++  K   ++  E KV ++L+   
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58

Query: 64  GIPNI-KWYGVDGEDN-VLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             PN+ K+YGV+     V +      G +LE+L  +  R      + +   Q++  + Y+
Sbjct: 59  --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN-KNLTGTAR 178
           HS G +HRDIKP N  +        + + DFG A K ++ TT       E  ++L GT  
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168

Query: 179 YASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGL 216
           Y +     G +     R  D+ SLG V+L    G  PW  L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.0 bits (242), Expect = 9e-23
 Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 31/216 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
           +YK+  +IG G+ G +F A   +T E VA+K             Q L E K  +  Q   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-- 58

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             P + K   V   G   VLV++ +   L ++     R      V      ++  + Y+H
Sbjct: 59  --PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP------YRENKNLT 174
           + G +HRD+KP N L+        + I DFGLA+ + +     +        YR  + L 
Sbjct: 117 ANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210
           G  +Y       G+      DL ++G +    L GS
Sbjct: 174 GARKYDP-----GV------DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 67/233 (28%), Positives = 101/233 (43%), Gaps = 37/233 (15%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           +K G+ IG GSF  + LA   +TN+  A+KI        E    K   +  E +V   L 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLN 59

Query: 61  GGSGIPNIKWYGV--DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
           G  GI  IK Y    D E+N+  VL+    G  L+  ++        K     A +++  
Sbjct: 60  GHPGI--IKLYYTFQD-EENLYFVLEYAPNGELLQ--YIRKYGSLDEKCTRFYAAEILLA 114

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------------TN 162
           +EY+HS+G +HRD+KP+N L+    K   + I DFG AK     +             + 
Sbjct: 115 LEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                R   +  GTA Y S          +  DL +LG ++   L G  P++G
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 96.9 bits (241), Expect = 1e-22
 Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 53/304 (17%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
           I G ++K+ + IG G FG ++       H   N+ VA KIEN   ++  ++ E  VY  +
Sbjct: 9   ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVA-KIEN--LENETIVMETLVYNNI 65

Query: 60  QGGSGIPNIKWYGVDGEDNV--------------------LVLDLLGPSLEDLF--VYCR 97
                I    W  +   D++                    ++L+ L  + +++F  + C+
Sbjct: 66  YDIDKIAL--WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCK 123

Query: 98  RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
            K  +K ++     M+  +EY+H  G  H DIKP+N +M  G   N+ YIID+G+A  + 
Sbjct: 124 NKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPEN-IMVDGN--NRGYIIDYGIASHF- 176

Query: 158 DPTTNRHIPY-RENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                +HI Y +E K+L  GT  YA  + H G   +RR DLESLGY +L +    LPW+G
Sbjct: 177 -IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235

Query: 216 LKA------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269
                    A K     ++ E K+        K+       +      L+++++PDY  L
Sbjct: 236 FGHNGNLIHAAKCDFIKRLHEGKIKI------KNANKFIYDFIECVTKLSYEEKPDYDAL 289

Query: 270 KRLF 273
            ++F
Sbjct: 290 IKIF 293

Length = 294

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
           ++  G  +G GSFG ++LA   DT E++AVK   +     +    L  E ++   LQ   
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58

Query: 64  GIPNI-KWYGVDGEDNVLVLDLL-----GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
             PNI ++YG + ++    L++      G SL  L +    K     +     Q++  + 
Sbjct: 59  --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSL-LKKFGKLPEPVIRKYTRQILEGLA 115

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           Y+HS G +HRDIK  N L+        V + DFG AK+  D  T          ++ GT 
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETG-----EGTGSVRGTP 167

Query: 178 RYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            + +        G E  R  D+ SLG  ++    G  PW
Sbjct: 168 YWMAPEVIR---GEEYGRAADIWSLGCTVIEMATGKPPW 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 33/173 (19%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTK---HPQLLYEAKVYKILQ 60
           +Y+ G+K+G G++  ++ A   +T  IVA+K     E    K   +   L E K+ + L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 61  GGSGIPNI----KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD----- 110
                PNI      +G     N+ LV + +   LE +    + K     VL  AD     
Sbjct: 61  H----PNIIGLLDVFGHK--SNINLVFEFMETDLEKVI---KDK---SIVLTPADIKSYM 108

Query: 111 QMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
            M  R +EY+HS   LHRD+KP+N L+        + + DFGLA+ +  P   
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPNRK 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
            +++  KIG G FGE++ A H  T + VA+K+    S  K  +++ E ++ K  +     
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56

Query: 66  PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           PNI K+YG  +  ++  +V++   G SL+DL     +  +   +  +  +++  +EY+HS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            G +HRDIK  N L+       +V +IDFGL+ +  D         +    + GT  + +
Sbjct: 117 NGIIHRDIKAANILL--TSDG-EVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
                G     + D+ SLG   +    G  P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 2e-18
 Identities = 69/254 (27%), Positives = 111/254 (43%), Gaps = 41/254 (16%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G GSFG++ L    DT ++ A+K+       K  ++ +      IL   +   I  + +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 71  YGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
                E   LVL+    G    +LF +  +  +FS +     A +++  +EY+HS G ++
Sbjct: 61  AFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116

Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCNT 184
           RD+KP+N L  L    + + + DFGLAK+       TN            GT  Y +   
Sbjct: 117 RDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSRTN---------TFCGTPEYLAPEV 164

Query: 185 HLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP------- 236
            LG    +  D  SLG VLLY  L G  P+    A  +K+ Y+KI +  +  P       
Sbjct: 165 LLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---AEDRKEIYEKILKDPLRFPEFLSPEA 220

Query: 237 ---IEVLCKSHPAE 247
              I  L +  P +
Sbjct: 221 RDLISGLLQKDPTK 234

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 78.7 bits (195), Expect = 1e-16
 Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
            LG+K+G G+FGE++              VAVK   E++  +  +    EA++ + L   
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
              PN+ K  GV  + E   +V++ + G  L       R K SL  +L  A Q IAR +E
Sbjct: 61  ---PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ-IARGME 116

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
           Y+ S+ F+HRD+   N L+G   +   V I DFGL++   D          +P R
Sbjct: 117 YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 61/271 (22%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAK------- 54
           +Y + R IG G  GE++LA     +  VA+K       EN      + L EAK       
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRFLREAKIAADLIH 61

Query: 55  -----VYKILQGGSGI----PNIKWYGVDG-EDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
                VY I   G  +    P I+ Y +     +V   + L   L +       K S+  
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE-------KTSVGA 114

Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK---------- 154
            L +  ++ A IEYVHS+G LHRD+KPDN L+GL     +V I+D+G A           
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLL 171

Query: 155 --KYRDPTTNRH---IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209
                +         IP +    + GT  Y +    LG+  S   D+ +LG +L   L  
Sbjct: 172 DIDVDERNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227

Query: 210 SLPWQGLKAATKKQKYDKICEK-KVSTPIEV 239
           S P+       +++K  KI  +  + +PIEV
Sbjct: 228 SFPY-------RRKKGRKISYRDVILSPIEV 251

Length = 932

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 8e-16
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 15/157 (9%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGI 65
           YK+ +++G G+FG ++LA + +T E+VA+K         +    L E K  + L      
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEH--- 57

Query: 66  PNI-KWYGVDGEDNVL--VLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHS 121
           PNI K   V  E++ L  V + +  +L  L      + FS   +  +  Q++  + ++H 
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 122 RGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYR 157
            GF HRD+KP+N L  G       V I DFGLA++ R
Sbjct: 118 HGFFHRDLKPENLLVSGPEV----VKIADFGLAREIR 150

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 20/161 (12%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
           Y+   K+G G++G ++ A    T EIVA+K   ++N     P   L E  + K L+    
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH--- 57

Query: 65  IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEY 118
            PNI K   V   +    LV +       DL  Y        S   +  +  Q++  + Y
Sbjct: 58  -PNIVKLLDVIHTERKLYLVFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
            HS   LHRD+KP N L+    +   + + DFGLA+ +  P
Sbjct: 114 CHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIP 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 75.2 bits (186), Expect = 2e-15
 Identities = 53/157 (33%), Positives = 77/157 (49%), Gaps = 20/157 (12%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
           +LG+K+G G+FGE++          T   VAVK    G    +    L EA + K L   
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH- 60

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
              PNI +  GV   GE   +V + + G  L D       K +LK +L +A Q IA+ +E
Sbjct: 61  ---PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ-IAKGME 116

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           Y+ S+ F+HRD+   N L  +      V I DFGL++
Sbjct: 117 YLESKNFVHRDLAARNCL--VTEN-LVVKISDFGLSR 150

Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 20/161 (12%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
           KY++ ++IG GSFG+++L       ++  +K   + N   K     L E K+ K L    
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58

Query: 64  GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLF---VYCRRKFSLKTVLMLADQMIARI 116
             PNI K+Y    E   L  V++   G  L           + F  + +L    Q+   +
Sbjct: 59  --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKY 156
           +Y+HSR  LHRDIKP N FL         V + DFG++K  
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVL 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 25/216 (11%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---ILQGGSG- 64
           ++L R IG G+FG++ +    DT ++ A+K  N   K  +      V     ILQ  +  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60

Query: 65  -IPNIKWYGV-DGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVH 120
            + N+ WY   D E+  LV+DLL     DL  +   + KFS + V     +++  +EY+H
Sbjct: 61  FLVNL-WYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-GTARY 179
           S+G +HRDIKPDN L+    +   V+I DF +A           +        T GT  Y
Sbjct: 118 SKGIIHRDIKPDNILLD---EQGHVHITDFNIA---------TKVTPDTLTTSTSGTPGY 165

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            +         S   D  SLG      LRG  P++G
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 25/176 (14%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
            LG+K+G G+FGE++              VAVK   E++  +  +    EA++ + L   
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIAR-I 116
              PNI K  GV  + E  ++V++ + G  L D     R K  SL  +L  A Q IAR +
Sbjct: 61  ---PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ-IARGM 116

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
           EY+ S+ F+HRD+   N L+G       V I DFGL++   D          +P R
Sbjct: 117 EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 14/158 (8%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+   KIG G++G ++ A    T EIVA+K       S       L E K+ K L     
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH--- 57

Query: 65  IPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            PNI K   V     D  LV + +   L  L    +R      +     Q++  + + HS
Sbjct: 58  -PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
            G LHRD+KP+N L+        + + DFGLA+ +  P
Sbjct: 117 HGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 30/246 (12%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYK-ILQGGSGIPNIK-WY 71
           I  G++G +FLA    T +I A+K+   +       + +    + IL        +K +Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 72  GVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----IARI----EYVHS 121
              G+ N+ LV++ L G  L  L         L+ V  L + +    IA I    EY+HS
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASL---------LENVGSLDEDVARIYIAEIVLALEYLHS 111

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYA 180
            G +HRD+KPDN L+        + + DFGL+K        N +   +E+K + GT  Y 
Sbjct: 112 NGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           +    LG   S+  D  SLG +L  FL G  P+ G    T ++ +  I   K+    E +
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGKIE-WPEDV 224

Query: 241 CKSHPA 246
             S  A
Sbjct: 225 EVSDEA 230

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 36/237 (15%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSG 64
           Y+   +IG G++G+++ A +  T E+VA+K   +EN     P   + E K+ + L+    
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56

Query: 65  IPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
            PNI +   +    G+ ++ +V + +   L  L      KF+   +     Q++  ++Y+
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--YRENKNL 173
           HS G LHRDIK  N L  +      + + DFGLA+ Y        TNR I   YR  + L
Sbjct: 117 HSNGILHRDIKGSNIL--INNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
            G  RY        +      D+ S+G +L     G   +QG   +T+ ++ +KI E
Sbjct: 174 LGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKIFE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 30/206 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
           K+ +  +IG G++G+++ A   DT E+VA   V+++N     P   + E K+ + L   +
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67

Query: 64  GIPNIKWYGVDGEDNV----------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
            I N+K    D +D +          LV + +   L  L       FS   +     Q++
Sbjct: 68  -IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--Y 167
             + Y H + FLHRDIK  N L+       Q+ + DFGLA+ Y      P TN+ I   Y
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183

Query: 168 RENKNLTGTARYA------SCNTHLG 187
           R  + L G  RY       SC   LG
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILG 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 71.0 bits (175), Expect = 9e-14
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 40/242 (16%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP--------QLLYEAKVYKILQ 60
           ++  + +G+GSFG + L  H  + +  A+KI +   K           +L E ++ + ++
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS---KAKIVKLKQVEHVLNEKRILQSIR 59

Query: 61  GGSGIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIAR 115
                P +   YG   +D+ L  V++ +     +LF + R+  +F        A Q++  
Sbjct: 60  H----PFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQVVLA 113

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           +EY+HS   ++RD+KP+N L+        + I DFG AK+ +  T            L G
Sbjct: 114 LEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT----------YTLCG 160

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
           T  Y +    L     +  D  +LG +L+Y  L G  P+         Q Y+KI E KV 
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEGKVR 216

Query: 235 TP 236
            P
Sbjct: 217 FP 218

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 52/247 (21%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL--------QGGSG 64
           + I  G+FG ++LA    T +  A+K+     K   ++ + +V  +         QG S 
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKV----LKKSDMIAKNQVTNVKAERAIMMIQGES- 56

Query: 65  IPNIK--WYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR----- 115
            P +   +Y    +D + LV++ L G     L         +KT+  L +    +     
Sbjct: 57  -PYVAKLYYSFQSKDYLYLVMEYLNGGDCASL---------IKTLGGLPEDWAKQYIAEV 106

Query: 116 ---IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
              +E +H RG +HRDIKP+N L+    +   + + DFGL++              ENK 
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKK 152

Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
             GT  Y +  T LG+   +  D  SLG V+  FL G  P+    A T    +D I  ++
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRR 209

Query: 233 VSTPIEV 239
           ++ P EV
Sbjct: 210 INWPEEV 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 44/226 (19%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP----QLLYEAKVYKILQ 60
           +++ G  +GSGSFG ++   ++D  +  AVK   + + G        QL  E  +   LQ
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 61  GGSGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKF-SLKTVL--MLADQMI 113
                PNI ++ G + E++ L   L+L+ G SL  L     +K+ S    +  +   Q++
Sbjct: 61  H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL 112

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             +EY+H R  +HRDIK  N L+        V + DFG+AK+         + +   K+ 
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV--------VEFSFAKSF 161

Query: 174 TGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            G+  +      A    +         D+ SLG  +L    G  PW
Sbjct: 162 KGSPYWMAPEVIAQQGGY-----GLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 68.4 bits (168), Expect = 7e-13
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 30/160 (18%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
            YK   KIG G+ GE++ A+   T + VA+K      ++ +L+  E  + K  +     P
Sbjct: 20  LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----P 75

Query: 67  NI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI------ 116
           NI  +Y   + G++  +V++ + G SL D+      +        + +  IA +      
Sbjct: 76  NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEPQIAYVCREVLQ 127

Query: 117 --EYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153
             EY+HS+  +HRDIK DN L+   G     V + DFG A
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 23/224 (10%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNI-K 69
            +G GS G ++   H  T +I A+K  +         QLL E K   +    S  P + K
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKT--LRSCES--PYVVK 63

Query: 70  WYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFL 125
            YG      +  +VL+ + G SL DL      K     +  +A Q++  ++Y+H+ R  +
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHII 122

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           HRDIKP N L+       +V I DFG++K   +     +          GT  Y S    
Sbjct: 123 HRDIKPSNLLIN---SKGEVKIADFGISKVLENTLDQCN-------TFVGTVTYMSPERI 172

Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
            G   S   D+ SLG  LL    G  P+      +  +    IC
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 45/282 (15%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IE---NSGTKHPQLLY--------EAK 54
            K+  G  IG G++G ++LA +V T E++AVK +E       +H             E +
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 55  VYKILQGGSGIPNIKWY-GVDGEDNVLVLDL---LGPSLEDLFVYCRR--KFSLKTVLML 108
             K L       NI  Y G +  +  L + L    G S+       R   +F  + V   
Sbjct: 61  TLKDLDH----LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFF 113

Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
            +Q++  + Y+HS+G LHRD+K DN L+          I DFG++KK  D   N      
Sbjct: 114 TEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK---ISDFGISKKSDDIYDN-----D 165

Query: 169 ENKNLTGT----ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224
           +N ++ G+    A     +   G   S + D+ SLG V+L    G  PW   +A      
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AA 220

Query: 225 YDKICEKKVSTPI--EVLCKSHPAEFASYFHYCQSLTFDQRP 264
             K+  K+ + PI  +V     P     + + C ++  D RP
Sbjct: 221 MFKLGNKRSAPPIPPDVSMNLSPVA-LDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 26/170 (15%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGS 63
            Y+LG  IG G+FG ++   +++T + VA+K I     K      ++ E  + K L+   
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58

Query: 64  GIPNI-KWYGVDGEDNVL--VLDL-LGPSLEDLFVYCRRKF-----SLKTVLMLADQMIA 114
             PNI K+ G     + L  +L+     SL  +     +KF     SL  V +   Q++ 
Sbjct: 59  --PNIVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVY--QVLQ 110

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
            + Y+H +G +HRDIK  N L     K   V + DFG+A K  D + +  
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDA 157

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 25/180 (13%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y+L   IG G+   ++ A  +  NE VA+K    E   T   +L  E +           
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH---- 58

Query: 66  PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK-----FSLKTVLMLADQMIARI 116
           PN+ K+Y      + L  V+  L G SL D+      +       + TVL    +++  +
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLKGL 115

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           EY+HS G +HRDIK  N L+G   +   V I DFG++    D         +  K   GT
Sbjct: 116 EYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 64.5 bits (158), Expect = 9e-12
 Identities = 71/245 (28%), Positives = 103/245 (42%), Gaps = 53/245 (21%)

Query: 13  RKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIP 66
           +K+G G+FGE++             VAVK         +    L EA+V K L    G P
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL----GHP 56

Query: 67  NI-KWYGV--DGEDNVLVL------DLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIA 114
           N+ +  GV  + E   LVL      DLL     S        +   SLK +L  A Q IA
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ-IA 115

Query: 115 R-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-----TTNRHIPYR 168
           + +EY+ S+ F+HRD+   N L+G   +   V I DFGL++   D       T   +P R
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 169 ----ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKK 222
               E      + +     +     +S   D+ S G VLL+  F  G+ P+ GL      
Sbjct: 173 WMAPE------SLKDGIFTS-----KS---DVWSFG-VLLWEIFTLGATPYPGLSNEEVL 217

Query: 223 QKYDK 227
           +   K
Sbjct: 218 EYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 19/185 (10%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGSG 64
           Y++  K+G G+FGE++ A  + T  +VA+K I     K       L E K+ K L+  + 
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 65  IPNIKWYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
           +P I       + +        +V   +   L  L      K +   +     Q++  I 
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           Y+H    LHRDIK  N L+        + I DFGLA+ Y  P      P  +     GT 
Sbjct: 130 YLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNPKGGGGGGTR 181

Query: 178 RYASC 182
           +Y + 
Sbjct: 182 KYTNL 186

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 30/175 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGS 63
           KY++   +G G++G +    +  T EIVA+K     E+        L E KV + L+   
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-- 59

Query: 64  GIPNI-----------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
              NI           + Y        LV + +  +L +L            V     Q+
Sbjct: 60  --ENIVNLKEAFRRKGRLY--------LVFEYVERTLLELLEASPGGLPPDAVRSYIWQL 109

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           +  I Y HS   +HRDIKP+N L+    ++  + + DFG A+  R    +    Y
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDY 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 10/155 (6%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGIPNIK 69
           +I  G++G ++ A    T EIVA   +K+E      P   L E  +   LQ  + I  +K
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-IVTVK 70

Query: 70  WYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
              V    D + +V++ +   L+ L    ++ F    V  L  Q+++ + ++H    LHR
Sbjct: 71  EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
           D+K  N L+        + I DFGLA++Y  P   
Sbjct: 131 DLKTSNLLL---NNRGILKICDFGLAREYGSPLKP 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 38/278 (13%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
           KL RK+G+G FGE+++ +   T + VAVK    GT  P+  L EA++ K L+        
Sbjct: 9   KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH----DKL 63

Query: 68  IKWYGV--DGEDNVLVLDLLGP-SLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
           ++ Y V  + E   +V + +   SL D   + +    +K  L  ++ +A Q+   + Y+ 
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLD---FLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARY 179
           SR ++HRD+   N L+G         I DFGLA+   D   + +      K  +  TA  
Sbjct: 121 SRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPE 174

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
           A+      I    + D+ S G +LL      G +P+ G+   T ++  +++ E+    P 
Sbjct: 175 AANYGRFTI----KSDVWSFG-ILLTEIVTYGRVPYPGM---TNREVLEQV-ERGYRMPR 225

Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
              C   P E       C     ++RP + +L+    D
Sbjct: 226 PPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 28/275 (10%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
           +++ +KIG G F E++ A+ +   + VA+K     E    K  Q  + E  + K L   +
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSL---KTVLMLADQMIARIEYV 119
            I  +  +  D E N+ VL+L     L  +  Y +++  L   +TV     Q+ + +E++
Sbjct: 64  VIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 120 HSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           HSR  +HRDIKP N F+   G     V + D GL + +   TT  H       +L GT  
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
           Y S         + + D+ SLG +L        P+ G      K     +C+K       
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLFSLCQKIEQCDYP 226

Query: 239 VLCKSHPAE-FASYFHYCQSLTFDQRPDYGFLKRL 272
            L   H +E        C     DQRPD G++ ++
Sbjct: 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 30/167 (17%)

Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-GTKHPQLLYEAKVYKILQGGSG 64
              ++L   IG G++G+++ A H  T ++VA+KI +    +  ++  E   Y IL+  S 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILRKYSN 61

Query: 65  IPNI-KWYGV-------DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
            PNI  +YG          +D + LV++L  G S+ DL      K   K    L ++ IA
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116

Query: 115 RI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
            I         Y+H    +HRDIK  N L+    K  +V ++DFG++
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 21/174 (12%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
           KY+   KIG G+FGE+F A H  T +IVA+K   +EN     P   L E K+ ++L+  +
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72

Query: 64  GIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
            +  I         Y        LV +     L  L      KF+L  +  +   ++  +
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------TNR 163
            Y+H    LHRD+K  N L+    K   + + DFGLA+ +           TNR
Sbjct: 133 YYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.9 bits (154), Expect = 6e-11
 Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 56/177 (31%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL----LYEAKVYKILQGG 62
           +Y+L + IGSG++G +  A    T   VA+K I N            L E K+ + L+  
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLR-- 57

Query: 63  SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
                         +N++ +LD+L P   + F  VY      + T LM  D         
Sbjct: 58  -------------HENIIGLLDILRPPSPEDFNDVY------IVTELMETDLHKVIKSPQ 98

Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
                       Q++  ++Y+HS   +HRD+KP N L+     +N  + I DFGLA+
Sbjct: 99  PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 14/151 (9%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
           +L RK+G+G FGE++     +T   VAVK    GT  P+  L EA++ K L+     P  
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRH----PKL 63

Query: 68  IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           I+ Y V    E   +V +L+  G  LE L     R   L  ++ +A Q+ + + Y+ ++ 
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++HRD+   N L+G   + N   + DFGLA+
Sbjct: 124 YIHRDLAARNVLVG---ENNICKVADFGLAR 151

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 30/231 (12%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIEN-------SGTKHPQLLYEAKVYKILQGGSGIPN 67
           +G+G+FG + L     +    A+K+            +H     E +V K +     I  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH--NEKRVLKEVSH-PFIIR 65

Query: 68  IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + W   D     ++++ + P  E LF Y R   +FS  T L  A +++  +EY+HS+  +
Sbjct: 66  LFWTEHDQRFLYMLMEYV-PGGE-LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           +RD+KP+N L+    K   + + DFG AKK RD T            L GT  Y +    
Sbjct: 124 YRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTW----------TLCGTPEYLAPEVI 170

Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                ++  D  +LG ++   L G  P+           Y+KI   K+  P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKLEFP 218

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
           KY+  R +G G+FG + L       ++V +K   +E            E +V K+L    
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-- 58

Query: 64  GIPN-IKWYGVDGEDNVLVLDLL---GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEY 118
             PN I++Y    ED  L++ +    G +L +     C       T+L    Q++  + +
Sbjct: 59  --PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GT 176
           VH++  LHRD+K  N L+   +    V I DFG++K          I   ++K  T  GT
Sbjct: 117 VHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVGT 164

Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVL 203
             Y S     G   +++ D+ +LG VL
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 23/200 (11%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSGIPNI 68
           R +G G+FGE  L    + + +V  K  N    S  +    L E  +  +LQ     PNI
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61

Query: 69  -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRG 123
             +Y    +DN L++++    G +L D  V  + + F  + VL    Q+++ + Y+H  G
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
            LHRDIK  N  +    KA  + + DFG++K            Y   + + GT  Y S  
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGS-------EYSMAETVVGTPYYMSPE 171

Query: 184 THLGIEQSRRDDLESLGYVL 203
              G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 37/230 (16%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-------QLLYEAKVYKIL 59
             ++ G+ +G G+FG ++L   VDT   +AVK        P        L  E ++ K L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 60  QGGSGIPNI-KWYGVDGEDNVLVL---DLLGPSLED-LFVY------CRRKFSLKTVLML 108
           Q       I ++YG   +D  L +    + G S++D L  Y        RK++       
Sbjct: 62  QH----ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------ 111

Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
             Q++  +EY+HS   +HRDIK  N L      A  V + DFG +K  R  T        
Sbjct: 112 --QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASK--RLQTICSSGTGM 164

Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
             K++TGT  + S     G    R+ D+ S+G  ++  L    PW   +A
Sbjct: 165 --KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 37/164 (22%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
            Y+L ++IGSG++G+++ A  + T E+VA+K+          L     ++I+Q    +  
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--------LEPGDDFEIIQQEISMLK 55

Query: 66  ----PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
               PNI  ++G     + L  V++   G SL+D++   R          L++  IA + 
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--------LSELQIAYVC 107

Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
                   Y+H  G +HRDIK  N L+    +   V + DFG++
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 24/164 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYK 57
           KY+   KIG G++G +F A + +T+EIVA+K          + +S  +   LL E K   
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 58  ILQGGSGIPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
           I         ++ Y V   D    LV +     L+  F  C      + V     Q++  
Sbjct: 61  I---------VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           + + HS   LHRD+KP N L+    K  ++ + DFGLA+ +  P
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIP 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 62/260 (23%), Positives = 97/260 (37%), Gaps = 50/260 (19%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +G G FG + L      N   A+K       +E    +H     E ++ +        P 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS--EKEILEECNH----PF 54

Query: 68  I-KWYG--VDGEDNVLVLDL-LGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS 121
           I K Y    D +   ++++  LG    +L+   R    F   T       ++   EY+H+
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLG---GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARY 179
           RG ++RD+KP+N L+        V ++DFG AKK               K  T  GT  Y
Sbjct: 112 RGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKL----------KSGQKTWTFCGTPEY 158

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA-----------ATKKQKYDK 227
            +    L        D  SLG +LLY  L G  P+                   K ++  
Sbjct: 159 VAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217

Query: 228 ICEKKVSTPIEVLCKSHPAE 247
             +K     I+ L + +P E
Sbjct: 218 YIDKAAKDLIKQLLRRNPEE 237

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 33/116 (28%), Positives = 47/116 (40%), Gaps = 26/116 (22%)

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD------------- 158
           ++  ++ VH  GF+HRDIKPDN L  +    + + + DFGL KK                
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNIL--IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 159 --PTTNRHIPYRENKNLT-------GTARYASCNTHLGIEQSRRDDLESLGYVLLY 205
                N  +  R++K          GT  Y +     G       D  SLG V+LY
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILY 221

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 40/242 (16%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +++G  +G+GSFG + +A H  T E  A+K      K  ++L   +V  + Q  S +  +
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKC----LKKREILKMKQVQHVAQEKSILMEL 75

Query: 69  K-------WYGVDGEDNVLVLDLLGPSLE-----DLFVYCRR--KFSLKTVLMLADQMIA 114
                         E+ V  L      LE     +LF + R+  +F          +++ 
Sbjct: 76  SHPFIVNMMCSFQDENRVYFL------LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
             EY+HS+  ++RD+KP+N L  L  K + V + DFG AKK  D T            L 
Sbjct: 130 AFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTF----------TLC 176

Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
           GT  Y +          +  D  ++G +L  F+ G  P+      T  + Y+KI   ++ 
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLK 233

Query: 235 TP 236
            P
Sbjct: 234 FP 235

Length = 329

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 24/209 (11%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
            ++G+G+ G +    H  T +I+AVK   +E +     Q+L E  +          P I 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----KCNSPYIV 62

Query: 69  KWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGF 124
            +YG    +G+ ++ +  + G SL+ +    + +   + +  +A  ++  + Y+H     
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP N L+       Q+ + DFG++ +  +            K   GT+ Y +   
Sbjct: 123 IHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPER 170

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
             G + S + D+ SLG  L+    G  P+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 25/190 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGS 63
           +Y+   KIG G++G ++ A    TNE +A+K   +E      P   + E  + K +Q G 
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61

Query: 64  GIPNI-KWYGVDGEDNVL-----VLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
              NI +   V   +  L      LDL L   ++    + +    +KT L    Q++  I
Sbjct: 62  ---NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY---QILRGI 115

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENK 171
            Y HS   LHRD+KP N L  + R+ N + + DFGLA+ +  P  T  H    + YR  +
Sbjct: 116 AYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173

Query: 172 NLTGTARYAS 181
            L G+  Y++
Sbjct: 174 ILLGSRHYST 183

Length = 294

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 25/165 (15%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP---QLLYEAKVYKIL 59
            +G +YK    IGSG++G +  A    + + VA+K I ++        + L E K+ +  
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61

Query: 60  QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
           +      NI       +  G D +D  +V+DL+   L  + ++  +  + + +     Q+
Sbjct: 62  KH----DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHI-IHSDQPLTEEHIRYFLYQL 116

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ---VYIIDFGLAK 154
           +  ++Y+HS   +HRD+KP N L+      N+   + I DFG+A+
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 39/144 (27%), Positives = 73/144 (50%), Gaps = 11/144 (7%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYG 72
           K+G GS+G ++ A H +T ++VA+K+        +++ E  + K        P I K+YG
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS----PYIVKYYG 65

Query: 73  VDGEDNVL--VLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
              ++  L  V++  G  S+ D+     +  + + +  +  Q +  +EY+HS   +HRDI
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125

Query: 130 KPDNFLMGLGRKANQVYIIDFGLA 153
           K  N L+    +  Q  + DFG++
Sbjct: 126 KAGNILLN---EEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 34/226 (15%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLL----YEAKVY 56
           K+  G  IGSGSFG ++L  +  + E++AVK         +S  +   +L     E  + 
Sbjct: 1   KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 57  KILQGGSGIPNIKWY---GVDGEDNVLVLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQ 111
           K LQ      NI  Y    +D +   + L+ + G S+  L   Y    F    V     Q
Sbjct: 61  KELQH----ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQ 114

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----DPTTNRHIPY 167
           ++  + Y+H+RG +HRDIK  N L+        + I DFG++KK         TN   P 
Sbjct: 115 ILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP- 170

Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
               +L G+  + +         +R+ D+ SLG +++  L G  P+
Sbjct: 171 ----SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
            + L   IG GSFGE++ A    TN++VA+K+   E +  +   +  E +     +    
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR---- 57

Query: 65  IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
            P I K+YG  + G    ++++   G S  DL      K     +  +  +++  +EY+H
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH 115

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
             G +HRDIK  N L+    +   V + DFG++ +     + R+
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRN 156

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 9   RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 64

Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 65  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124

Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
           HRD++  N L+G     N V  + DFGLA+   D   N +   +  K  +  TA  A+  
Sbjct: 125 HRDLRAANILVG----ENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177

Query: 184 THLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C 
Sbjct: 178 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC- 228

Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
             P         C     ++RP + +L+    D F+
Sbjct: 229 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 42/276 (15%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           + L RK+GSG FGE++     +    VA+KI   +   K      E +  K L+      
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKH--- 63

Query: 67  NIKWYGV--DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
            I  + V   GE   ++ +L+      L  + R    +   + +++ +A Q+   + Y+ 
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKG--SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP---TTNRHIPYRENKNLTGTA 177
            +  +HRD+   N L+G         + DFGLA+  ++    ++++ IPY+       TA
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTA 172

Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK-KVS 234
             A+ +       S + D+ S G +LLY  F  G +P+ G       + YD+I    ++ 
Sbjct: 173 PEAASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPG---MNNHEVYDQITAGYRMP 224

Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270
            P +  C   P E       C +   + RP +  L+
Sbjct: 225 CPAK--C---PQEIYKIMLECWAAEPEDRPSFKALR 255

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 53/265 (20%)

Query: 12  GRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
             +IGSG+ G ++   H  T  + A+K+    +  T   Q+  E +   IL+  +  PN+
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE---ILRDVNH-PNV 134

Query: 69  ----KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
                 +  +GE  VL+  + G SLE   +   +  +      +A Q+++ I Y+H R  
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHRRHI 189

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK---KYRDPTTNRHIPYRENKNLTGTARYAS 181
           +HRDIKP N L+   +    V I DFG+++   +  DP  +            GT  Y S
Sbjct: 190 VHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDPCNSS----------VGTIAYMS 236

Query: 182 ---CNTHLGIEQSRRD----DLESLGYVLLYFLRGSLPW----QGLKAATKKQKYDKICE 230
               NT L       D    D+ SLG  +L F  G  P+    QG  A+        +C 
Sbjct: 237 PERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL-------MCA 287

Query: 231 KKVSTPIEVLCKSHPAEFASYFHYC 255
             +S P E    +   EF  +   C
Sbjct: 288 ICMSQPPEAPATASR-EFRHFISCC 311

Length = 353

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 29/210 (13%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
           +K+ +KIG G F  ++ A  +    +VA+K     E    K  Q  L E  + K L    
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-- 61

Query: 64  GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
             PN IK+     E+N L + L      DL      F   +R    +T+     Q+ + +
Sbjct: 62  --PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           E++HS+  +HRDIKP N  +     A   V + D GL + +   TT  H       +L G
Sbjct: 120 EHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------SLVG 168

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY 205
           T  Y S         + + D+ SLG  LLY
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLG-CLLY 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 37/171 (21%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
           Y+   +IG G++G ++ A  ++T   VA+K   +  S    P   L E  + K L+    
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES-FE 59

Query: 65  IPNIKWYGVDGEDNVLVLD-LLGPSLE--------------DLFVYCRR----KFSLKTV 105
            PNI          V +LD   GP  +              DL  Y  +        +T+
Sbjct: 60  HPNI----------VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI 109

Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
             L  Q++  ++++HS   +HRD+KP N L+       QV I DFGLA+ Y
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLARIY 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 37/165 (22%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
           +++  ++G G +G++FLA   DT EIVA+K          LL++  +V  +L     +  
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK-----SLLFKLNEVRHVLTERDILTT 57

Query: 68  IK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVL----MLAD------- 110
            K  W          ++ LL    +D ++Y   ++      +T+L    +L++       
Sbjct: 58  TKSEW----------LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM 107

Query: 111 -QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            +M   ++ +H  G++HRD+KP+NFL+     +  + + DFGL+K
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 28/173 (16%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL--LYEAKVYKILQGGSGI 65
           YK+  KIG G+F E+  A    T +  A+K ++       Q+  L E +  + L   S  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPH 57

Query: 66  PNIKWYGVDGEDNV---------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           PNI    +   + +         LV +L+  +L +L    +R    K V     Q++  +
Sbjct: 58  PNI----LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
           +++H  G  HRDIKP+N L+    K + + + DFG  +           PY E
Sbjct: 114 DHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYTE 157

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 33/162 (20%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQ----LLYEA------KV 55
           + IG G+FGE+ L   VDTN + A+K       +  +   H +    +L EA      K+
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 56  YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
           Y   Q    +  +  Y + G D + +L  LG   EDL      +F +   L  A      
Sbjct: 67  YYSFQDKDNLYFVMDY-IPGGDMMSLLIRLGIFEEDL-----ARFYIAE-LTCA------ 113

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
           IE VH  GF+HRDIKPDN L+    +   + + DFGL   +R
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 73/275 (26%), Positives = 111/275 (40%), Gaps = 34/275 (12%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGGS 63
           +++ +KIG G F E++ A+ +     VA+K                + E  + K L    
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-- 61

Query: 64  GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
             PN IK+Y    EDN L + L      DL      F   +R    KTV     Q+ + +
Sbjct: 62  --PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           E++HSR  +HRDIKP N F+   G     V + D GL + +   TT  H       +L G
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVG 168

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
           T  Y S         + + D+ SLG +L        P+ G      K     +C+K    
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEQC 223

Query: 236 PIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFL 269
               L   H   E     + C +   ++RPD  ++
Sbjct: 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 29/273 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T + VA+K    GT  P+  L EA++ K L+    +P  
Sbjct: 9   RLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-- 65

Query: 69  KWYGVDGEDNV-LVLDLLGP-SLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGFL 125
             Y V  E+ + +V + +G  SL D       K+  L  ++ +A Q+   + Y+    ++
Sbjct: 66  -LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124

Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
           HRD++  N L+G     N V  I DFGLA+   D   N +   +  K  +  TA  A+  
Sbjct: 125 HRDLRAANILVG----DNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177

Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   + +G +P+ G+     ++  +++ E+    P    C 
Sbjct: 178 GRFTI----KSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQV-ERGYRMPCPQGC- 228

Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
             P         C     D+RP + +++    D
Sbjct: 229 --PESLHELMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 37/169 (21%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGI 65
           KL R IG G++G ++ A    + EIVA   V+++N     P   L E  +   L+     
Sbjct: 11  KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH---- 65

Query: 66  PNIKWYGVDGEDNVLVLDLL-GPSLEDLFV---YCR-----------RKFSLKTVLMLAD 110
           PNI          V + +++ G  L+ +F+   YC              FS   V  L  
Sbjct: 66  PNI----------VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           Q++  ++Y+H    +HRD+K  N L+        + I DFGLA+ Y  P
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAV-KIENSGT----KHPQLLYEAKVYKILQGGSGIPN- 67
           +IG GSFG ++ A++  TNE+VAV K+  SG     K   ++ E K  + L+     PN 
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH----PNT 83

Query: 68  IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           I++ G   +++   LV++    S  DL    ++      +  +    +  + Y+HS   +
Sbjct: 84  IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           HRDIK  N L+    +  QV + DFG A K     +    PY
Sbjct: 144 HRDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 12/168 (7%)

Query: 10  KLGRKIGSGSFGEIFL----ASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  R +G G FG++ L     ++  T E+VAVK               K   IL+     
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 66  PNIKWYGV--DGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSR 122
             +K+ G   +     L L +    L  L  Y  + K +L  +L+ A Q+   + Y+HS+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
            ++HRD+   N L+        V I DFGLAK    P  + +   RE+
Sbjct: 127 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV--PEGHEYYRVRED 169

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
           KY    KIG G+ G +F A  V T + VA+K  N   K P+   ++ E  V K L+  + 
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELIINEILVMKELKNPNI 78

Query: 65  IPNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           +  +  + V  E  V++  L G SL D+    C  +  +  V     + +  +E++H+  
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
            +HRDIK DN L+G+      V + DFG   +     + R         + GT  + +  
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPE 185

Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                    + D+ SLG + +  + G  P+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 7/147 (4%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA+K  N     K   ++ E  V +  +  + +
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
             +  Y V  E  V++  L G SL D+            +  +  + +  +E++HS   +
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVI 137

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGL 152
           HRDIK DN L+G+      V + DFG 
Sbjct: 138 HRDIKSDNILLGMD---GSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 37/246 (15%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGS 63
            Y++   IG GSFG +         +I+  K  + G     +  QL+ E  + + L+   
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH-- 58

Query: 64  GIPNI-KWYG--VDGEDNVLVLDL---LGPSLEDLFVYCRRKFSL---KTVLMLADQMIA 114
             PNI ++Y   +D  +  L + +    G  L  L   C+++      + +  +  Q++ 
Sbjct: 59  --PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 115 RIEYVHSRG-----FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
            +   H+R       LHRD+KP N FL       N V + DFGLAK     ++       
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSS------- 165

Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228
             K   GT  Y S      +    + D+ SLG ++      S P+    A  + Q   KI
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI 222

Query: 229 CEKKVS 234
            E K  
Sbjct: 223 KEGKFR 228

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 27/272 (9%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L +K+G+G FGE+++ +  + N  VAVK    GT  P+  L EA++ K L+       +
Sbjct: 9   QLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDK---LV 64

Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     R   L  ++ +A Q+ A + Y+    ++
Sbjct: 65  QLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G G       I DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 125 HRDLRSANILVGDGLVCK---IADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 178

Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   + +G +P+ G+     ++  +++ E+    P    C  
Sbjct: 179 RFTI----KSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQV-ERGYRMPCPQDC-- 228

Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
            P         C     ++RP + +L+    D
Sbjct: 229 -PISLHELMLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 15/149 (10%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           R+IG GSFG ++ A  V TNE+VA+K      + S  K   ++ E K  + ++     PN
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH----PN 86

Query: 68  -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            I++ G    ++   LV++    S  DL    ++      +  +    +  + Y+HS   
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           +HRDIK  N L+    +  QV + DFG A
Sbjct: 147 IHRDIKAGNILL---TEPGQVKLADFGSA 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 49/227 (21%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGI 65
           IG G++G ++   HV T  +VA+KI N  T         +   LL + +        S  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ-------SQP 61

Query: 66  PNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM---LADQMIARI----- 116
           PNI K+YG           L GP L  +  Y     S++T++    +A++ I+ I     
Sbjct: 62  PNITKYYGS---------YLKGPRLWIIMEYAEGG-SVRTLMKAGPIAEKYISVIIREVL 111

Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
              +Y+H  G +HRDIK  N L+        V + DFG+A      ++ R          
Sbjct: 112 VALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKR-------STF 161

Query: 174 TGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
            GT  + +      G     + D+ SLG  +     G+ P+  + A 
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 25/167 (14%)

Query: 9   YKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTKHPQLLYEAK-----VYKILQGG 62
           Y +   +GSG+FG ++ +    +   ++A+K  N    +P    + +     +  I+   
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEIN--VHNPAFGKDKRERDKSIGDIVSEV 59

Query: 63  SGI------PNIKWYG---VDGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLA 109
           + I      PNI  Y    ++ +   +V+DL+ G  L + F   + K   F+ + +  + 
Sbjct: 60  TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 110 DQMIARIEYVHSRGFL-HRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            QM+  + Y+H    + HRD+ P+N ++G   + ++V I DFGLAK+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 43/135 (31%), Positives = 62/135 (45%), Gaps = 39/135 (28%)

Query: 77  DNVL-VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD---------------------QMIA 114
           DNVL  LD+L P   D F     +  + T LM +D                     Q++ 
Sbjct: 59  DNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP------- 166
            ++Y+HS G LHRDIKP N L+     +N  + I DFGLA+   +P  ++H+        
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDESKHMTQEVVTQY 169

Query: 167 YRENKNLTGTARYAS 181
           YR  + L G+  Y S
Sbjct: 170 YRAPEILMGSRHYTS 184

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-------- 59
           +Y+    +GSG++G +  A      + VAVK          L++  + Y+ L        
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73

Query: 60  QGGSGIPNIKWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +   G+ ++       E+     LV +L+G  L ++ V C+ K S + V  L  Q++  +
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNI-VKCQ-KLSDEHVQFLIYQLLRGL 131

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
           +Y+HS G +HRD+KP N  +    +  ++ I+DFGLA++  D  T
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG- 72
           +IG GSFGE+F      T ++VA+KI +      ++    +   +L         K+YG 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 73  -VDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
            + G    ++++ L  G +L+ L      +F + T+L    +++  ++Y+HS   +HRDI
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127

Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
           K  N L+    +   V + DFG+A +  D    R           GT  + +      I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKR-------NTFVGTPFWMAPEV---IQ 174

Query: 190 QSRRD---DLESLGYVLLYFLRGSLP 212
           QS  D   D+ SLG   +   +G  P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV 73
           KIG GSFGE+F      T ++VA+KI +      ++    +   +L         K+YG 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 74  DGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
             +D  L            LDLL P   D       +  + T+L    +++  ++Y+HS 
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             +HRDIK  N L+    +  +V + DFG+A +  D    R+          GT  + + 
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170

Query: 183 NTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
                I+QS  D   D+ SLG   +   +G  P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 25/152 (16%)

Query: 73  VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132
           V+G D   +L  +G     L V   R +  +TVL L        EY+H+ G +HRD+KPD
Sbjct: 83  VEGGDCATLLKNIGA----LPVDMARMYFAETVLAL--------EYLHNYGIVHRDLKPD 130

Query: 133 NFLM-GLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRE-------NKNLTGTARYASCN 183
           N L+  +G     + + DFGL+K      TTN +  + E       +K + GT  Y +  
Sbjct: 131 NLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186

Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
             L     +  D  ++G +L  FL G +P+ G
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.3 bits (123), Expect = 7e-08
 Identities = 24/146 (16%), Positives = 57/146 (39%), Gaps = 12/146 (8%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY 71
           + +  G    ++L      +E   +KI  S  K      E  + ++L      +P +   
Sbjct: 4   KLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 72  GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
           G     + L+++ + G +L+++      +   + +     +++A++  +      H D+ 
Sbjct: 62  GESDGWSYLLMEWIEGETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116

Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKY 156
           P N L+        + IID+  A   
Sbjct: 117 PGNILV---DDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 33/191 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQ--LLYEAKVYKILQGGS 63
           KY+    +G GS+G +    H +T +IVA+K  +E+   K  +   + E ++ K L+  +
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 64  GIPNI-------KWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIAR 115
            +  I       + Y        LV + +  + L+DL  Y         V     Q++  
Sbjct: 62  LVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRG 112

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-------YRDPTTNRHIPYR 168
           IE+ HS   +HRDIKP+N L+    ++  V + DFG A+        Y D    R   YR
Sbjct: 113 IEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRW--YR 167

Query: 169 ENKNLTGTARY 179
             + L G  +Y
Sbjct: 168 APELLVGDTKY 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A    +   VAVK+ +    +  +LL+ E  + +  Q  + +   K Y
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  VL+  L G +L D+    R   + + +  + + ++  + Y+HS+G +HRDIK 
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145

Query: 132 DNFLMGL-GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
           D+ L+ L GR    V + DFG   +      ++ +P R  K+L GT  + +         
Sbjct: 146 DSILLTLDGR----VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPY 194

Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
               D+ SLG +++  + G  P+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 56/277 (20%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-----PN 67
            KIG G+FG+++    +  N  VAVK     T    L  + K  K LQ    +     PN
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVK-----TCRSTLPPDLKR-KFLQEAEILKQYDHPN 53

Query: 68  I-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHS 121
           I K  GV    +   +V++L+      L  + R+K    ++K +L ++    A +EY+ S
Sbjct: 54  IVKLIGVCVQKQPIYIVMELV--PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIPYR----ENKN 172
           +  +HRD+   N L+G     N + I DFG++++     Y      + IP +    E  N
Sbjct: 112 KNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICE 230
                RY S             D+ S G +LL+  F  G  P+ G+   + +Q  ++I E
Sbjct: 169 ---YGRYTS-----------ESDVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI-E 209

Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
                P   LC   P E       C +   + RP + 
Sbjct: 210 SGYRMPAPQLC---PEEIYRLMLQCWAYDPENRPSFS 243

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK- 69
           + +G G+FGE+ LA  VDT+ + A+K   +       Q+ +      IL        +K 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 70  WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
           +Y    +DN+  V+D + P  + + +  R + F          ++   IE VH  GF+HR
Sbjct: 67  YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
           DIKPDN L+ L      + + DFGL   +R
Sbjct: 126 DIKPDNILIDLD---GHIKLTDFGLCTGFR 152

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 69/272 (25%), Positives = 112/272 (41%), Gaps = 47/272 (17%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGSGIPNI- 68
           +IG G+FGE+F       N  VAVK     T  P L    L EA++ K        PNI 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILKQYSH----PNIV 56

Query: 69  KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSRG 123
           +  GV  +     +V++L+     D   + R    +  +K ++ + +   A +EY+ S+ 
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN-----RHIPYR-ENKNLTGTA 177
            +HRD+   N L+    + N + I DFG++++  D         + IP +          
Sbjct: 115 CIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
           RY+S             D+ S G +LL+  F  G++P+    A    Q+  +  E+ V  
Sbjct: 172 RYSS-----------ESDVWSFG-ILLWEAFSLGAVPY----ANLSNQQTREAIEQGVRL 215

Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
           P   LC   P         C      QRP + 
Sbjct: 216 PCPELC---PDAVYRLMERCWEYDPGQRPSFS 244

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 29/238 (12%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSG-----IPN 67
           IG G+FG+++     DT  I A+K+ +        ++ +      IL          I  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 68  IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
           +K+      D  LV D +  S  +LF + ++  +FS         +++  +E++H    +
Sbjct: 61  LKFSFQTDSDLYLVTDYM--SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
           +RD+KP+N L+        + + DFGL+K     + TTN            GT  Y +  
Sbjct: 119 YRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTTN---------TFCGTTEYLAPE 166

Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             L  +  ++  D  SLG ++     G   W    A   +Q Y  I   KV  P  VL
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVL 221

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)

Query: 9   YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
           ++L R +G+G++G++FL   V   D  ++ A+K+    T        +H +   E +V +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT--ERQVLE 59

Query: 58  ILQGGSGIPNIKW-YGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
            ++    +  + + +  D + + L+LD +     +LF  +Y R  F+   V +   +++ 
Sbjct: 60  AVRRCPFLVTLHYAFQTDTKLH-LILDYVNGG--ELFTHLYQREHFTESEVRVYIAEIVL 116

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            ++++H  G ++RDIK +N L+        V + DFGL+K++      R   +       
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFLAEEEERAYSF------C 167

Query: 175 GTARYASCNTHLGIEQSRRD--DLESLGYVLLYFLRGSLPW 213
           GT  Y +     G         D  SLG +    L G+ P+
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 48/164 (29%), Positives = 68/164 (41%), Gaps = 45/164 (27%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNI- 68
           KIG G++G ++ A    T EIVA+K   +E      P   + E  + K L      PNI 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61

Query: 69  KWYGVDGEDNVLVL-------DL-----------LGPSLEDLFVYCRRKFSLKTVLMLAD 110
           +   V   +N L L       DL           L P L   ++Y               
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY--------------- 106

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           Q++  I Y HS   LHRD+KP N L+    +   + + DFGLA+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 70/237 (29%), Positives = 101/237 (42%), Gaps = 22/237 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIP 66
           +Y++ +KIG GSFG+I+LA     +E   +K E   TK P    EA K   IL      P
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIK-EIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 67  NI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHS 121
           NI  ++    E+  L + +      DL     R+    FS   +L    Q+   ++++H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 122 RGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           R  LHRDIK  N FL   G  A    + DFG+A++  D                GT  Y 
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSM-------ELAYTCVGTPYYL 169

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
           S         + + D+ SLG VL        P++G       Q   KIC+   + PI
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG---NNLHQLVLKICQGYFA-PI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++  N     K   ++ E  V +  +  + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             +  Y V  E  V++  L G SL D+    C  +  +  V     + +  +E++HS   
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRDIK DN L+G+      V + DFG   +     + R         + GT  + +   
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 187

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                   + D+ SLG + +  + G  P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 15/149 (10%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           R+IG GSFG ++ A  V  +E+VA+K      + S  K   ++ E +  + L+     PN
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH----PN 76

Query: 68  -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            I++ G    ++   LV++    S  DL    ++      +  +    +  + Y+HS   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           +HRD+K  N L+    +   V + DFG A
Sbjct: 137 IHRDVKAGNILL---SEPGLVKLGDFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK-WY 71
           IG G+FGE+ L    DT  I A+KI  +    +  Q+ +      IL    G   +K +Y
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 72  GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
               + N+ L+++ L     D+     +K +L    T   +A+ ++A I+ +H  GF+HR
Sbjct: 69  SFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETVLA-IDAIHQLGFIHR 125

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
           DIKPDN L+        V + DFGL
Sbjct: 126 DIKPDNLLLD---AKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 20/159 (12%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           YKLG  IG+GSFG ++ A  +DT+E VA+K      + PQ  Y+ +   I++  + I  I
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQ--YKNRELLIMKNLNHINII 122

Query: 69  ---KWYGVD----GEDNV---LVLDLLGPSLEDLF-VYCRRKFSLKTVL--MLADQMIAR 115
               +Y  +     E N+   +V++ +  ++      Y R   +L   L  + + Q+   
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + Y+HS+   HRD+KP N L  +    + + + DFG AK
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219

Length = 440

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)

Query: 13  RKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           R +G G FG++ L  +     +T E VAVK     +    +    K  +IL+       +
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 69  KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           K+ G+  ED      L+++ L   SL++     + K +LK  L  A Q+   ++Y+ SR 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           ++HRD+   N L+      +QV I DFGL K    
Sbjct: 130 YVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 48/176 (27%), Positives = 71/176 (40%), Gaps = 58/176 (32%)

Query: 8   KY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGG 62
           KY KL  KIG GS+G +F   + +T +IVA+K        P +    L E ++ K L+  
Sbjct: 2   KYEKLS-KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH- 59

Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD------------ 110
              PN            LV      +L ++F   RRK  L  V    D            
Sbjct: 60  ---PN------------LV------NLIEVF---RRKRKLHLVFEYCDHTVLNELEKNPR 95

Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
                       Q +  + + H    +HRD+KP+N L+    K  Q+ + DFG A+
Sbjct: 96  GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 20/158 (12%)

Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
           K  +++G G FG++ L  +     +T E VAVK  N   +         E ++ + L   
Sbjct: 7   KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH- 65

Query: 63  SGIPNI-KWYGV---DGEDNV-LVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               NI K+ GV    G  ++ L+++ L   SL D     R + +LK +L+ + Q+   +
Sbjct: 66  ---ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +Y+ S+ ++HRD+   N L+      + V I DFGLAK
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK- 69
           + +G G+FGE+ LA  VDT  + A+K   +       Q+ +      IL        ++ 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 70  WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
           +Y    +DN+  V+D + P  + + +  R   F          ++   +E VH  GF+HR
Sbjct: 67  YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
           DIKPDN L+    +   + + DFGL   +R
Sbjct: 126 DIKPDNILID---RDGHIKLTDFGLCTGFR 152

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 21/153 (13%)

Query: 15  IGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +G G+FG + L  +     +T E+VAVK +++S  +H +    E ++ K LQ      NI
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH----DNI 67

Query: 69  -KWYGV---DGEDNV-LVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            K+ GV    G  N+ LV++ L P  SL D     R +   + +L+ A Q+   +EY+ S
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++HRD+   N L+      N+V I DFGL K
Sbjct: 127 KRYVHRDLATRNILV---ESENRVKIGDFGLTK 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 39/149 (26%), Positives = 77/149 (51%), Gaps = 11/149 (7%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +K+G+G FGE+++  + + +  VA+K    G+  P+  L EA + K LQ       +
Sbjct: 9   KLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPR---LV 64

Query: 69  KWYGVDGEDNVLVLD--LLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D L      K ++  ++ +A Q+   + ++  + ++
Sbjct: 65  RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           HRD++  N L+    +     I DFGLA+
Sbjct: 125 HRDLRAANILVS---ETLCCKIADFGLAR 150

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 64/287 (22%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
           IG G+FG +    H  +  I+AVK         +  +LL +  V       S  P I K+
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM---RSSDCPYIVKF 68

Query: 71  YGV---DGEDNVLVLDLLGPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYVHSRGF- 124
           YG    +G D  + ++L+  SL+    +VY   K       ++ ++++ +I     +   
Sbjct: 69  YGALFREG-DCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALN 121

Query: 125 --------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
                   +HRD+KP N L  L R  N + + DFG++ +  D                  
Sbjct: 122 YLKEELKIIHRDVKPSNIL--LDRNGN-IKLCDFGISGQLVDSIAK-------------- 164

Query: 177 ARYASCNTHLG---IEQSRRD------DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
            R A C  ++    I+ S RD      D+ SLG  L     G  P+    +      +D+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQ 219

Query: 228 ICEKKVSTPIEVLCKSHPAEFA----SYFHYCQSLTFDQRPDYGFLK 270
           + +  V     +L  S   EF+    ++ + C      +RP Y  L 
Sbjct: 220 LTQ-VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
           + +G GSFG++FLA    TN+  A+K                + E +V  +      + +
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 68  IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
           +       E+   V++ L     DL  + +   KF L      A ++I  ++++HS+G +
Sbjct: 61  LYCTFQTKENLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
           +RD+K DN L+        + I DFG+ K+    D  T             GT  Y +  
Sbjct: 119 YRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKTC---------TFCGTPDYIAPE 166

Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
             LG + +   D  S G +L   L G  P+ G
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 15/152 (9%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
           KLG  IG G FG++ L  +    + VAVK +++  T     L EA V   L+     PN 
Sbjct: 9   KLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNL 62

Query: 68  IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRG 123
           ++  GV  + N L +     +   L  Y R +     +L   L  A  +   +EY+  + 
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           F+HRD+   N L+    +     + DFGLAK+
Sbjct: 123 FVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 27/232 (11%)

Query: 15  IGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK-- 69
           +G GSFG++FL   +   D  ++ A+K+    T   +     K+ + +      P I   
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 70  WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLH 126
            Y    E  + L+LD L     DLF    ++  F+ + V     ++   ++++HS G ++
Sbjct: 64  HYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121

Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK--NLTGTARYASCNT 184
           RD+KP+N L+    +   + + DFGL+K+  D          E K  +  GT  Y +   
Sbjct: 122 RDLKPENILLD---EEGHIKLTDFGLSKESID---------HEKKAYSFCGTVEYMAPEV 169

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                 ++  D  S G ++   L GSLP+QG     +K+    I + K+  P
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQG---KDRKETMTMILKAKLGMP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 35/157 (22%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           IG G+FGE+ L    DT +I A+K  +++   K  QL +  K  + +   S  P   W  
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESDSP---W-- 62

Query: 73  VDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------QMIARI 116
                   V+ L     +  ++Y   +F     L T+L+  D            + +  I
Sbjct: 63  --------VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           E VH  GF+HRDIKPDN L+    +   + + DFGL+
Sbjct: 115 EAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 50.7 bits (122), Expect = 7e-07
 Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 39/167 (23%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---------- 57
           KY++ +K+G G++G ++ A    T E+VA+K               K++           
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALK---------------KIFDAFRNATDAQR 52

Query: 58  ------ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRKFSLKTVLM-- 107
                  LQ     PNI K   V   +N   + L+   +E DL    R    L+ V    
Sbjct: 53  TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRY 111

Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +  Q++  ++Y+HS   +HRD+KP N L  L      V + DFGLA+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNIL--LNSDCR-VKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDP 159
           Q++  + Y+HS   LHRD+KP N  +MG G +   V I D GLA+ +  P
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 28/159 (17%)

Query: 11  LGRKIGSGSFGEIFLASHVD-TNEIVAV-----KIENSGTKHPQLLYEAKVYKILQGGSG 64
           LGR IG G FG+++   ++   NE +AV     K   S +   + L EA + +       
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--- 66

Query: 65  IPNI-KWYGVDGEDNV-LVLDL-----LGPSLEDLFVYCRRKFSLK--TVLMLADQMIAR 115
            P+I K  GV  E+ V +V++L     L   L+        K+SL   ++++ + Q+   
Sbjct: 67  -PHIVKLIGVITENPVWIVMELAPLGELRSYLQ------VNKYSLDLASLILYSYQLSTA 119

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + Y+ S+ F+HRDI   N L+      + V + DFGL++
Sbjct: 120 LAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  + T + VA+K  N     K   ++ E  V +  +  + +
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             +  Y V  E  V++  L G SL D+    C  +  +  V     + +  ++++HS   
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQV 136

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRDIK DN L+G+      V + DFG   +     + R         + GT  + +   
Sbjct: 137 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 186

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                   + D+ SLG + +  + G  P+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)

Query: 13  RKIGSGSFGEIFLASHVDTN-EIVAVK-IENSGT-KHPQLLYEAKVYKILQGGSGIPNIK 69
           R +G+GSFG + LA++ + +   VA+K  E S   K  Q+ +     KIL   +    + 
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 70  WYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            YG   +++ L L L      + F + RR  +F        A Q++   EY+ S   ++R
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N L+    K   + + DFG AK          +       L GT  Y +    L 
Sbjct: 156 DLKPENLLLD---KDGFIKMTDFGFAK----------VVDTRTYTLCGTPEYIAPEILLN 202

Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPW 213
           +   +  D  +LG  +   L G  P+
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 22/169 (13%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNI--- 68
           KIG GS G + +A+   T   VAVK  +    +  +LL+ E  + +  Q     PNI   
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81

Query: 69  -KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
              Y V  E  V++  L G +L D+  + R   + + +  +   ++  + ++H++G +HR
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHR 139

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           DIK D+ L+       +V + DFG   +      ++ +P R  K+L GT
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 15/149 (10%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
           R+IG GSFG ++ A  V TNE+VA+K  +   K        ++ E +  + L+     PN
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH----PN 76

Query: 68  -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            I++ G    ++   LV++    S  D+    ++      +  +    +  + Y+HS   
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           +HRDIK  N L+    +   V + DFG A
Sbjct: 137 IHRDIKAGNILL---TEPGTVKLADFGSA 162

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 55/235 (23%), Positives = 88/235 (37%), Gaps = 73/235 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-----------------IENS----GTKHPQLL--- 50
           +G GSFG++ LA    TNE  A+K                 +E        +HP L    
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 51  --YEAK-----VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
             ++ K     V + L GG  + +I+  G                          +F   
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSG--------------------------RFDEA 96

Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTT 161
                A ++I  ++++H +G ++RD+K DN L+    K   + I DFG+ K+    +   
Sbjct: 97  RARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKA 153

Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
           +            GT  Y +     G + +   D  S G VLLY  L G  P+ G
Sbjct: 154 S---------TFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 23/154 (14%)

Query: 11  LGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIP 66
             +++GSG FG + L      +D    VA+K+   G       + EAKV   L      P
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKID----VAIKMIREGAMSEDDFIEEAKVMMKLSH----P 59

Query: 67  N-IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
           N ++ YGV  +     +V + +  +   L  Y R    K   + +L +   +   +EY+ 
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYM--ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           S GF+HRD+   N L+G   + N V + DFGLA+
Sbjct: 118 SNGFIHRDLAARNCLVG---EDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 24/217 (11%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
           IG G FGE++     DT ++ A+K ++    K  Q   L    ++   L      P I  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 69  KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
             Y     D +  +LDL+     DL  +  +   FS   +   A ++I  +E++H+R  +
Sbjct: 62  MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
           +RD+KP N L+    +   V I D GLA  +     ++  P+       GT  Y +    
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDF-----SKKKPHAS----VGTHGYMAPEVL 167

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
             G+      D  SLG +L   LRG  P++  K   K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 48/288 (16%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           +  +Y+    +GSG++G +   +  DT   + V ++        +++  + Y+ L+    
Sbjct: 15  VPERYQNLSPVGSGAYGSV--CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL--- 69

Query: 65  IPNIKWYGVDG--------------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
           + ++K   V G               D  LV  L+G  L ++ V C+ K +   V  L  
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIY 127

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           Q++  ++Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T         
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT--------- 175

Query: 171 KNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
                T  Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+ 
Sbjct: 176 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLI 230

Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
            + V TP   L K   +E A   +Y QSLT  Q P     K  F ++F
Sbjct: 231 LRLVGTPGAELLKKISSESAR--NYIQSLT--QMP-----KMNFANVF 269

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 45/163 (27%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74
           IG G+FGE+ L    DT  I A+K      +  ++L + +V                 V 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKK----LRKSEMLEKEQVAH---------------VR 49

Query: 75  GEDNVL-------VLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------Q 111
            E ++L       V+ L     ++ ++Y   ++     + T+LM  D            +
Sbjct: 50  AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            I  I+ +H  G++HRDIKPDN L+        + + DFGL  
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKV-------YKILQGGS 63
           +IG GSFGE++      T E+VA+KI   E +  +   +  E  V       Y     GS
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 64  GIPNIK-WYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            +   K W  ++       LDLL P  LE+ ++         T+L    +++  ++Y+HS
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI--------ATILR---EILKGLDYLHS 119

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+    +   V + DFG+A +  D    R+          GT  + +
Sbjct: 120 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169

Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGL 216
                 I+QS  D   D+ SLG   +   +G  P   L
Sbjct: 170 PEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 29/185 (15%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNIK 69
           KIG G++G ++   +  T +IVA+K   +E+     P   + E  + K LQ     PNI 
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH----PNI- 61

Query: 70  WYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEYVH 120
              V  +D +       L+ + L   L+       +   +   L+ +   Q++  I + H
Sbjct: 62  ---VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTG 175
           SR  LHRD+KP N L+        + + DFGLA+ +  P    T+  +   YR  + L G
Sbjct: 119 SRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175

Query: 176 TARYA 180
           + RY+
Sbjct: 176 SPRYS 180

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   T + VAVK ++    +  +LL+ E  + +     + +     Y
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
            V  E  V++  L G +L D+  + R  +  + TV +    ++  + Y+H++G +HRDIK
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL---SVLRALSYLHNQGVIHRDIK 145

Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
            D+ L+       ++ + DFG   +      ++ +P R  K+L GT  + +      +  
Sbjct: 146 SDSILL---TSDGRIKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPY 195

Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
               D+ SLG +++  + G  P+
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 25/225 (11%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKIL 59
           V ++LG+ +G G+FGE++L    DT   +AVK        + +  +   L  E ++ K L
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 60  QGGSGIPNIKWYGV--DGED---NVLVLDLLGPSLED-LFVYCRRKFSLKTVLMLADQMI 113
           +       +++YG   D E+   ++ V  + G S++D L  Y     +         Q++
Sbjct: 62  RHDR---IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQIL 116

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             + Y+HS   +HRDIK  N L      A  V + DFG +K+ +       +     K++
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQ----TICMSGTGIKSV 169

Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
           TGT  + S     G    R+ D+ S+   ++  L    PW   +A
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 16/214 (7%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
           +  G+++G+G+F   + A  V T  ++AVK    + N+ ++  +++   +    L     
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 65  IPNI-KWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
            P+I +  G   ED   N+ V  + G S+  L +     F    ++   +Q++  + Y+H
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
               +HRD+K  N L+   G++   + I DFG A +     T           L GT  +
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAF 174

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            +     G +  R  D+ S+G V++       PW
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 38/274 (13%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGG 62
           + ++ G+ +G G+FG ++L   VDT   +A K      + P+   E        ++L+  
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 63  SGIPNIKWYGV---DGEDNVLVLD--LLGPSLED-------LFVYCRRKFSLKTVLMLAD 110
                +++YG      E  + +    + G S++D       L     RK++         
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--------R 113

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           Q++  + Y+HS   +HRDIK  N L      A  V + DFG +K+ +    +        
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTICMSG----TGI 166

Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
           +++TGT  + S     G    R+ D+ SLG  ++  L    PW   +A        KI  
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFKIAT 223

Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
           +  +  +     SH +E A  F  C  +    RP
Sbjct: 224 QPTNPQL----PSHISEHARDFLGCIFVEARHRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 22/229 (9%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIK 69
           IG GSFG++ LA         AVK+    T     +   ++ E  V         +  + 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 70  WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHR 127
           +     E    VLD +     +LF + +R+  F        A ++ + I Y+HS   ++R
Sbjct: 63  YSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N L+        V + DFGL K+  +P               GT  Y +      
Sbjct: 121 DLKPENILLD---SQGHVVLTDFGLCKEGVEPEET-------TSTFCGTPEYLAPEVLRK 170

Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               R  D   LG VL   L G  P+     +   Q YD I  K +  P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 18/171 (10%)

Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK ++    +  + L EA V K 
Sbjct: 3   MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 58

Query: 59  LQGGSGIPN-IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLML--ADQMI 113
           ++     PN ++  GV   +    +     +  +L  Y R   +  +  V++L  A Q+ 
Sbjct: 59  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 14/202 (6%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   + ++VAVK ++    +  +LL+ E  + +  Q  + +     Y
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R        + LA  ++  +  +H++G +HRDIK 
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLKALSVLHAQGVIHRDIKS 144

Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       +V + DFG   +      ++ +P R  K+L GT  + +      +   
Sbjct: 145 DSILL---THDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPELISRLPYG 194

Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 13/106 (12%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-PYRE 169
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA   R   TN  + PY  
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA---RTACTNFMMTPY-- 182

Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                 T  Y +    LG+      D+ S+G ++   ++GS+ +QG
Sbjct: 183 ----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 11/153 (7%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +K+G+G FGE+++A++ + +  VAVK    G+   +  L EA V K LQ       +
Sbjct: 9   KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK---LV 64

Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K + V  ++ + ++      G  L+ L      K  L  ++  + Q+   + ++  R ++
Sbjct: 65  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           HRD++  N L+     +    I DFGLA+   D
Sbjct: 125 HRDLRAANILVS---ASLVCKIADFGLARVIED 154

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 13/145 (8%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIK-WY 71
           IG G+FGE+ L    DT  + A+KI       +  Q+ +      IL     +  +K +Y
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 72  GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
               + N+ L+++ L     D+     +K +L   +T   +A+ ++A I+ +H  GF+HR
Sbjct: 69  SFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVLA-IDSIHQLGFIHR 125

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
           DIKPDN L+        V + DFGL
Sbjct: 126 DIKPDNLLLD---SKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
           +G G FGE+ +     T +I A+K+     K   LL +  V        IL   +   IP
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKV----MKKSVLLAQETVSFFEEERDILSISNSPWIP 64

Query: 67  NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
            +++   D ++  LV++   G  L  L      +F          +++  I  VH  G++
Sbjct: 65  QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIP 166
           HRDIKP+N L+    +   + + DFG A +   +   N  +P
Sbjct: 125 HRDIKPENVLID---RTGHIKLADFGSAARLTANKMVNSKLP 163

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 17/151 (11%)

Query: 14  KIGSGSFGEIFLA-SHVDTNEI--VAVKIENSG--TKHPQ-LLYEAKVYKILQGGSGIPN 67
           K+G GSFG +          ++  VAVK   S   +      L EA +   L       N
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH----EN 57

Query: 68  -IKWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
            I+ YGV     + +V +L  LG  L+ L       F + T+   A Q+   + Y+ S+ 
Sbjct: 58  LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           F+HRD+   N L+    K   V I DFGL +
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 8/107 (7%)

Query: 80  LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
           LV + L   L+     C    S+  V +   Q++  + Y H R  LHRD+KP N L+   
Sbjct: 80  LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137

Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
            +  ++ + DFGLA+    PT   +N  +   YR    L G+  Y++
Sbjct: 138 -EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 12/176 (6%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           K+G G++  +F      T  +VA+K   +E+        + E  + K L+  + +     
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
              D +   LV + L   L+     C    S+  V +   Q++  + Y H R  LHRD+K
Sbjct: 73  VHTD-KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131

Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
           P N L+    +  ++ + DFGLA+    PT   +N  +   YR    L G++ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 28/212 (13%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNI- 68
            ++G G+ G +      +T  I A+K   +        Q+L E ++ K  +     P I 
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS----PYIV 62

Query: 69  KWYGV-----DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVH 120
           K+YG           + +    G SL+ ++   +++      K +  +A+ ++  + Y+H
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           SR  +HRDIKP N L+    +  QV + DFG++ +  +               TGT+ Y 
Sbjct: 123 SRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA---------GTFTGTSFYM 170

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
           +     G   S   D+ SLG  LL   +   P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 34/273 (12%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +++   IG G++G++F   +       AVKI +      + + EA+ Y IL+  S  PN+
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI-EAE-YNILKALSDHPNV 77

Query: 69  -KWYG-------VDGEDNVLVLDLL-GPSLEDL---FVYCRRKFSLKTVLMLADQMIARI 116
            K+YG        +G+   LVL+L  G S+ DL   F+    +     +  +  + +  +
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +++H    +HRD+K +N L+        V ++DFG++ +    T+ R    R N ++ GT
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQL---TSTRL---RRNTSV-GT 187

Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
             +      +C   L      R D+ SLG   +    G  P   L       K  +    
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247

Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
            +  P     +    EF  +   C +  +++RP
Sbjct: 248 TLHQP-----ELWSNEFNDFIRKCLTKDYEKRP 275

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 19/220 (8%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGGSG 64
           ++LG+ +G G+FG ++L    DT   +AVK      + P+   E        ++L+    
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 65  IPNIKWYGV--DGEDNVLVL---DLLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEY 118
              +++YG   D  +  L +    + G S++D L  Y     +         Q++  + Y
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSY 121

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +HS   +HRDIK  N L         V + DFG +K+ +       +     K++TGT  
Sbjct: 122 LHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGTPY 174

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
           + S     G    R+ D+ S+G  ++  L    PW   +A
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 52/178 (29%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKH---PQLLYEAKVYKILQ 60
           +  KY   + IG G++G +  A + +TNE VA+K I N+        + L E K+ + L 
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL- 61

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
                        D E+ + + D++ P   + F  VY      +   LM  D        
Sbjct: 62  -------------DHENVIAIKDIMPPPHREAFNDVY------IVYELMDTDLHQIIRSS 102

Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
                        Q++  ++Y+HS   LHRD+KP N L+     AN  + I DFGLA+
Sbjct: 103 QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 21/168 (12%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
            Y+   KIG G++G+++ A   +T ++VA+K     ++  G   P  L E  + ++L   
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-PTALREISLLQMLSES 60

Query: 63  SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCRRKFS----LKTVLMLADQ 111
             I  ++   V+  +         LV + L   L+       R        KT+     Q
Sbjct: 61  IYI--VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           ++  + + H  G +HRD+KP N L  + ++   + I D GL + +  P
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIP 164

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 58/252 (23%), Positives = 91/252 (36%), Gaps = 64/252 (25%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           + +G GSFG++ LA    T+E+ AVK+                  ILQ      +++   
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-------------ILQDD----DVECTM 43

Query: 73  VDGEDNVLVLDLLGPSLEDLFV-------------YCR-----------RKFSLKTVLML 108
              E  VL L    P L  L               Y              +F        
Sbjct: 44  T--EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY 101

Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHI 165
           A +++  ++++H RG ++RD+K DN L+        + I DFG+ K+       T     
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTT----- 153

Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK 224
                    GT  Y +             D  +LG VLLY  L G  P++G     + + 
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSPFEG---DDEDEL 204

Query: 225 YDKICEKKVSTP 236
           +  I E +V  P
Sbjct: 205 FQSILEDEVRYP 216

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 24/198 (12%)

Query: 1   MERIIGVKYK-LGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQL---- 49
           M   I  +Y   G  +G G++G++  A    T +IVA+K      I N  TK  QL    
Sbjct: 2   MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61

Query: 50  ------LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
                 L E K+   ++  + +  +  Y V+G+   LV+D++   L+ +    + + +  
Sbjct: 62  GIHFTTLRELKIMNEIKHENIMGLVDVY-VEGDFINLVMDIMASDLKKVV-DRKIRLTES 119

Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
            V  +  Q++  +  +H   F+HRD+ P N  +          I DFGLA++Y  P  + 
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRYGYPPYSD 176

Query: 164 HIPYRENKNLTGTARYAS 181
                +++ +       S
Sbjct: 177 --TLSKDETMQRREEMTS 192

Length = 335

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 40/171 (23%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
           +G +Y+    IG G++G +  A+H  T   VA+K + S  +H       L E K+ +  +
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-KISPFEHQTFCQRTLREIKILRRFK 61

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDL----FVYCRRKFSLKTVL---MLAD-- 110
                          E+ + +LD++ P S E       V    +  L  ++    L++  
Sbjct: 62  H--------------ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH 107

Query: 111 ------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
                 Q++  ++Y+HS   LHRD+KP N L+      N  + I DFGLA+
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLAR 154

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 49/221 (22%), Positives = 106/221 (47%), Gaps = 30/221 (13%)

Query: 9   YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
           ++L + +G+G++G++FL   V   D+ ++ A+K+    T        +H +   E +V +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT--ERQVLE 59

Query: 58  ILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIA 114
            ++    +  +  Y    +  + L+LD +     +LF +   R +F  + V + + +++ 
Sbjct: 60  HIRQSPFLVTLH-YAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            +E++H  G ++RDIK +N L+        V + DFGL+K++ +    R        +  
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFHEDEVERAY------SFC 167

Query: 175 GTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPW 213
           GT  Y + +   G +    +  D  S+G ++   L G+ P+
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 30/238 (12%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIP 66
           +++ + IG G+FGE+ +    + +++ A+KI N     K  +     +   +L  G    
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-- 60

Query: 67  NIKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             +W     Y    E+N+ LV+D  +G  L  L      +           +M+  I+ V
Sbjct: 61  --QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H   ++HRDIKPDN LM +      + + DFG   K  +  T       ++    GT  Y
Sbjct: 119 HQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT------VQSSVAVGTPDY 169

Query: 180 ASCNTHLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
            S      +E  +       D  SLG  +   L G  P+    A +  + Y KI   K
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 40/151 (26%), Positives = 79/151 (52%), Gaps = 10/151 (6%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L +++GSG++G+++ A ++ T E+ AVKI          L + +++ + +      NI
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC--NI 68

Query: 69  -KWYG--VDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             ++G  +  E   + ++  G  SL+D++ +     S   +  +  + +  + Y+HS+G 
Sbjct: 69  VAYFGSYLSREKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLAYLHSKGK 127

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +HRDIK  N L+        V + DFG+A K
Sbjct: 128 MHRDIKGANILL---TDNGDVKLADFGVAAK 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 51/274 (18%)

Query: 14  KIGSGSFGEIF--LASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPN 67
           ++GSG+FG +   +     + + VAVKI  +    P    +LL EA V + L      P 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN----PY 57

Query: 68  I-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           I +  G+ + E  +LV++L  LGP   + F+   +  + K +  L  Q+   ++Y+    
Sbjct: 58  IVRMIGICEAESWMLVMELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 124 FLHRDIKPDNFLMGLGRKANQVY--IIDFGLAK------KYRDPTTNRHIPYRENKNLTG 175
           F+HRD+   N L+       Q Y  I DFGL+K       Y    T+   P +       
Sbjct: 116 FVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK------- 163

Query: 176 TARYA-SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKK 232
              YA  C  +     S + D+ S G VL++  F  G  P++G+K     Q  +    ++
Sbjct: 164 --WYAPECMNYYKF--SSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GER 216

Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           +  P     +  P E       C +   D+RP +
Sbjct: 217 MECP-----QRCPPEMYDLMKLCWTYGVDERPGF 245

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 57/262 (21%), Positives = 108/262 (41%), Gaps = 27/262 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y + R +G GSFG   L  HV++++  A+K E    K    + +++   +L      PN
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK-EIRLPKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 68  IKWY--GVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           I  +    + + ++ +V++    G  ++ + +   + F   T+L    QM   ++++H +
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             LHRDIK  N  +    +  +V + DFG A+    P               GT  Y   
Sbjct: 120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYAC-------TYVGTPYYVPP 169

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
                +  + + D+ SLG +L        P+Q   A + K    K+C+     P+     
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQ---ANSWKNLILKVCQGSYK-PL----- 220

Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
             P+ ++          F + P
Sbjct: 221 --PSHYSYELRSLIKQMFKRNP 240

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 19/152 (12%)

Query: 13  RKIGSGSFGEIFLASHVDTN--EI-VAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +++G G+FG +    ++  +  E+ VAVK    E+      + L EA V   L      P
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56

Query: 67  NI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
            I +  GV  GE  +LV++L  LGP L+  ++  RR+  +  +  LA Q+   + Y+ S+
Sbjct: 57  CIVRLIGVCKGEPLMLVMELAPLGPLLK--YLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            F+HRD+   N L+      +Q  I DFG+++
Sbjct: 115 HFVHRDLAARNVLL---VNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 16/154 (10%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           + G+ + + R +  GS G +F +SH D  + V VK       +   ++EA++ + L   +
Sbjct: 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVK----AGWYASSVHEARLLRRLSHPA 221

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRK---FSLKTVLMLADQMIARIEYV 119
            +  +    V G     +  L+ P    DL+ Y   +     L  V  +A Q+++ I+Y+
Sbjct: 222 VLALLDVRVVGG-----LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI 276

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           H  G +HRDIK +N L+        + + DFG A
Sbjct: 277 HGEGIIHRDIKTENVLVN---GPEDICLGDFGAA 307

Length = 461

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 9/151 (5%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
           +Y   + +G G+FG +  A    T + VA+K        P    +   E K+ K L+  +
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHEN 70

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
            I     +    ED   V +LLG  L  L     R    + +     Q++  ++YVHS G
Sbjct: 71  IISLSDIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG 128

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            +HRD+KP N L+    +   + I DFGLA+
Sbjct: 129 VVHRDLKPSNILIN---ENCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.0 bits (111), Expect = 7e-06
 Identities = 37/151 (24%), Positives = 79/151 (52%), Gaps = 10/151 (6%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           ++L ++IGSG++G+++ A +V+T E+ A+K+          + + ++  I+       NI
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68

Query: 69  -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             ++G     + L + +    G SL+D++ +     S   +  ++ + +  + Y+HS+G 
Sbjct: 69  VAYFGSYLRRDKLWICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +HRDIK  N L+        V + DFG++ +
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQ 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 8/157 (5%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
           R+    Y++ + IG G+FGE+ L  H  T ++ A+K+    E          +E +    
Sbjct: 39  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 59  LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
                 +  + +   D     +V++ + P  + + +        K       +++  ++ 
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYM-PGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 157

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +HS GF+HRD+KPDN L+    K+  + + DFG   K
Sbjct: 158 IHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 45/233 (19%)

Query: 11  LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLL------YEAKVYKIL 59
           L R++G G+FG++FLA     S      +VAVK      K P L        EA++   L
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 64

Query: 60  QGGSGIPNIKWYGV--DGEDNVLVLDLL------------GPSLEDLF----VYCRRKFS 101
           Q       +K+YGV  DG+  ++V + +            GP    L        + +  
Sbjct: 65  QHEH---IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
           L  +L +A Q+ + + Y+ S+ F+HRD+   N L+G       V I DFG++   RD  +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYS 175

Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPW 213
             +  YR   +     R+    + +  + +   D+ S G +L   F  G  PW
Sbjct: 176 TDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 28/227 (12%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
           IG GSFG++ LA H    +  AVK+     K   L  + + + + +    + N+K     
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 71  ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
              +     D +  VLD +     +LF + +R+  F        A ++ + + Y+HS   
Sbjct: 60  GLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           ++RD+KP+N L+        + + DFGL K+  +                GT  Y +   
Sbjct: 118 VYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT-------TSTFCGTPEYLAPEV 167

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
                  R  D   LG VL   L G  P+     A   + YD I  K
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNK 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 24/219 (10%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
           IG G FGE++     DT ++ A+K ++    K  Q   L    ++   L      P I  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 69  KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
             Y     D +  +LDL+     DL  +  +   FS K +   A ++I  +E++H+R  +
Sbjct: 62  MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
           +RD+KP N L+    +   V I D GLA  +     +  +         GT  Y +    
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
             G       D  SLG +L   LRG  P++  K   K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 14/155 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           KY   +KIG GSFG+  L    +  +   +K  N     P+   E++    +      PN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 68  IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVH 120
           I  Y    E+N    +V+D       DL+     +    F    +L    Q+   +++VH
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118

Query: 121 SRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAK 154
            R  LHRDIK  N FL     K   + + DFG+A+
Sbjct: 119 DRKILHRDIKSQNIFLT----KDGTIKLGDFGIAR 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
           K+++   +G G++G +    H +T EIVA+K      EN   K   L  E K+ + L+  
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL-RELKMLRTLKQE 60

Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           + +   + +   G+   LV + +  ++ +L          + V     Q+I  I + H  
Sbjct: 61  NIVELKEAFRRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 123 GFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
             +HRDIKP+N L+      N V  + DFG A+   + +   +  Y        T  Y S
Sbjct: 120 DIVHRDIKPENLLI----SHNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYRS 169

Query: 182 CNTHLGIEQSRRDDLESLGYVL 203
               LG    +  D+ S+G +L
Sbjct: 170 PELLLGAPYGKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 19/112 (16%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP- 166
           Q++  + Y+H R  LHRD+KP N L+       ++ + DFGLA+    P+   +N  +  
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTL 167

Query: 167 -YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
            YR    L G+  Y++C            D+  +G + +  ++G   + G+K
Sbjct: 168 WYRPPDVLLGSTEYSTCL-----------DMWGVGCIFVEMIQGVAAFPGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 42/192 (21%), Positives = 72/192 (37%), Gaps = 38/192 (19%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           +++  G+   ++L         VA+K+    +    L  EAK+ +IL G    P + +Y 
Sbjct: 28  KELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY- 84

Query: 73  VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV--LMLADQMIARIEYVHSRGFLHRDI- 129
             GED + +  + G  L  L +   RK  L+ +      D++          G  H ++ 
Sbjct: 85  --GEDFIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRL----------GIEHGELS 132

Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
           +P   ++        VYIIDF  A   + P           +N+T           L  E
Sbjct: 133 RPWKNVLV---NDRDVYIIDFDSATFKKKP-----------RNVTQALSL------LFRE 172

Query: 190 QSRRDDLESLGY 201
             R +     GY
Sbjct: 173 GLRIEKTILRGY 184

Length = 201

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 29/169 (17%)

Query: 11  LGRKIGSGSFGEIF--LASHVDTNEI---VAVKI---ENSGTKHPQLLYEAKVYKILQGG 62
           L R +G G+FGE++  L    D + +   VAVK      S       L EA    ++   
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMSK 65

Query: 63  SGIPNI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSL--KTVLMLADQM 112
               NI +  GV  E     ++L+L+ G  L+      R    R  SL  K +L  A  +
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 113 IARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKK-YR 157
               +Y+    F+HRDI   N L+   G GR A    I DFG+A+  YR
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 32/229 (13%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
           IG GSFG++ LA H    +  AVK+     K      E K + + +    + N+K     
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQK-HIMAERNVLLKNVKHPFLV 59

Query: 71  ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
              Y     D +  VLD +     +LF + +R+  F        A ++ + + Y+HS   
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP--TTNRHIPYRENKNLTGTARYASC 182
           ++RD+KP+N L+        V + DFGL K+  +   TT+            GT  Y + 
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKTTS---------TFCGTPEYLAP 165

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
                    R  D   LG VL   L G  P+     A   + YD I  K
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNK 211

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 81/278 (29%)

Query: 13  RKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT---------------------KHP- 47
           + +G G +G++F    V   DT +I A+K+    T                     KHP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 48  --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-- 99
              L+Y      K+Y IL+  SG          GE               LF++  R+  
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSG----------GE---------------LFMHLEREGI 96

Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           F   T      ++   +E++H +G ++RD+KP+N L+        V + DFGL K+    
Sbjct: 97  FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHE 153

Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
            T  H          GT  Y +    +     +  D  SLG ++   L G+ P+    A 
Sbjct: 154 GTVTH-------TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT---AE 203

Query: 220 TKKQKYDKICEKKVSTP----------IEVLCKSHPAE 247
            +K+  DKI + K++ P          ++ L K +P+ 
Sbjct: 204 NRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS 241

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 36/238 (15%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
           +K+ +K+G GS+G ++    +  N+  A+K  + G+   +   +A    +IL   +  PN
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PN 60

Query: 68  IKWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI-------- 116
           I  Y    +DG  N L + +      DL     ++   +   ++ +Q I RI        
Sbjct: 61  IISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRK--LIPEQEIWRIFIQLLRGL 116

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYII-DFGLAKKYRDPTTNRHIPYRENKNLTG 175
           + +H +  LHRD+K  N L      AN +  I D G++K  +       I         G
Sbjct: 117 QALHEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMAKTQI---------G 163

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG-----LKAATKKQKYDKI 228
           T  Y +     G   S + D+ SLG +L      + P++      L+   ++ KY  I
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 23/165 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
           +Y+   +IG G++G ++ A    +   VA   V+++ +    P   + E  + K L+   
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 64  GIPNI-KWYGV------DGEDNV-LVLDLLGPSLEDLFVYCRR----KFSLKTVLMLADQ 111
             PNI +   V      D E  V LV + +    +DL  Y  +        +T+  L  Q
Sbjct: 61  H-PNIVRLMDVCATSRTDRETKVTLVFEHVD---QDLRTYLDKVPPPGLPAETIKDLMRQ 116

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            +  ++++H+   +HRD+KP+N L+  G    QV + DFGLA+ Y
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 28/165 (16%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTN--EIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y+L +++G G++G +  A + +T+  E VA+K I N  +K        +  K+L+   G 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 66  PNIKWYGVDGEDNVLVLDLLGPS-LEDLFVY-----CRRKFSLKTVLMLAD--------Q 111
            NI     D       +D++ P    +L++Y           +++   L D        Q
Sbjct: 62  KNITCL-YD-------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ 113

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           ++  ++Y+HS   LHRD+KP N L+       ++ I DFGLA+ +
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 56/179 (31%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLY-EAKVYKILQ 60
            +Y+    +GSG++G++  A    T   VA+K      ++    H +  Y E ++ K + 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72

Query: 61  GGSGIPNIKWYGVDGEDNVL-VLDLLGP--SLEDLFVYCRRKFSLKTVLMLAD------- 110
                           +NV+ +LD+  P  SLED      +   L T LM AD       
Sbjct: 73  ---------------HENVIGLLDVFTPASSLEDF-----QDVYLVTHLMGADLNNIVKC 112

Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155
                        Q++  ++Y+HS G +HRD+KP N    +    + ++ I+DFGLA+ 
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN----IAVNEDCELKILDFGLARH 167

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+  +++GSG++G +   S +D      V I+         L+  + Y+ L+    + +
Sbjct: 16  RYRDLKQVGSGAYGTV--CSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKH 73

Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+              D  LV+  +G  L  L  +   K S   +  L  QM+  +
Sbjct: 74  ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGL 131

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +Y+H+ G +HRD+KP N  +    +  ++ I+DFGLA++
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 35/169 (20%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           +K   K+G G++  ++   +  T EIVA+K  +     GT    +  E  + K L+    
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKH--- 57

Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYC-------------RRKFSLKTVLMLAD 110
             NI + + V   +N L+L         +F Y              R      TV     
Sbjct: 58  -ENIVRLHDVIHTENKLML---------VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           Q++  I + H    LHRD+KP N L+    K  ++ + DFGLA+ +  P
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIP 153

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 44/171 (25%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
           +YK+   IG GS+G +  A    T E VA+K  N   +H     ++L E K+ ++L+   
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRH-- 58

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPS----LEDLFVYCRRKFS-LKTVLMLAD-------- 110
             P+I          V +  ++ P      +D++V      S L  V+   D        
Sbjct: 59  --PDI----------VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ 106

Query: 111 ----QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN---QVYIIDFGLAK 154
               Q++  ++Y+H+    HRD+KP N L      AN   ++ I DFGLA+
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 45.5 bits (107), Expect = 2e-05
 Identities = 50/221 (22%), Positives = 101/221 (45%), Gaps = 30/221 (13%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYKILQGGSGIPN 67
           ++L   +G+G++G+++   HV T ++ A+K+ + +G +  ++  E  + K       I  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 68  IKWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCRRKFSLKT--VLMLADQMIARI 116
             +YG        G D+   LV++  G  S+ DL +   +  +LK   +  +  +++  +
Sbjct: 68  --YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAYICREILRGL 124

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
            ++H    +HRDIK  N L+    +  +V ++DFG++ +  D T  R           GT
Sbjct: 125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGT 174

Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             +      +C+ +       + DL SLG   +    G+ P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 34/188 (18%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYKILQGGS 63
           KIG G++G ++ A +  T E+VA+K          + ++  +   LL E           
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-------- 58

Query: 64  GIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
             PNI K   V   +N   LV + L   L+  F+       +   L+ +   Q++  + +
Sbjct: 59  --PNIVKLLDVIHTENKLYLVFEFLHQDLKK-FMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNL 173
            HS   LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L
Sbjct: 116 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 174 TGTARYAS 181
            G   Y++
Sbjct: 173 LGCKYYST 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 21/56 (37%), Positives = 33/56 (58%), Gaps = 3/56 (5%)

Query: 99  KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             S   V  L  QM+  ++Y+HS G +HRD+KP N  +    +  ++ I+DFGLA+
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 8/107 (7%)

Query: 80  LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
           LV + L   L+     C    ++  V +   Q++  + Y H R  LHRD+KP N L+   
Sbjct: 81  LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138

Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
            +  ++ + DFGLA+    PT   +N  +   YR    L G+  Y++
Sbjct: 139 -ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 31/214 (14%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL---------YEAKVYKILQGGSGI 65
           +G GSFG++ LA      E  AVK      K   +L          E +V  +      +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58

Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRG 123
            ++       E    V++ L     DL  + + K  F L      A +++  ++++HS+G
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYAS 181
            ++RD+K DN ++    +   + I DFG+ K+           + +N+  T  GT  Y +
Sbjct: 117 IIYRDLKLDNVMLD---RDGHIKIADFGMCKEN---------VFGDNRASTFCGTPDYIA 164

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                G++ +   D  S G +L   L G  P+ G
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 18/75 (24%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+                
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182

Query: 156 YRDPTTNRHIPYREN 170
           YR P     + Y+EN
Sbjct: 183 YRAPEVILGMGYKEN 197

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 53/182 (29%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGG 62
           +G +Y   R +G GS G +F A   D ++ VAVK  +          L E K+ + L   
Sbjct: 3   LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-- 60

Query: 63  SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------ 110
                         DN++ V ++LGPS  DL         L +V      M  D      
Sbjct: 61  -------------HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE 107

Query: 111 --------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ----VYIIDFGL 152
                         Q++  ++Y+HS   LHRD+KP N  +      N     + I DFGL
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGL 161

Query: 153 AK 154
           A+
Sbjct: 162 AR 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +K+G+G FGE+++  + ++ + VAVK    GT   Q  L EA + K LQ       +
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 64

Query: 69  KWYGV-DGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           + Y V   E+ + ++      G  L+ L      K  L  ++  + Q+   + Y+  + +
Sbjct: 65  RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           +HRD++  N L+    ++    I DFGLA+   D
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED 155

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           IG GSFG++      DT  I A+K       +  S   H   L E  V   +     +P 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT--LAERTVLAQVNCPFIVP- 57

Query: 68  IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
           +K+     E   LVL  +     +LF + +R  +F L        +++  +E +H    +
Sbjct: 58  LKFSFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK--KYRDPTTNRHIPYRENKNLTGTARYASCN 183
           +RD+KP+N L+        + + DFGL K     D  TN            GT  Y +  
Sbjct: 116 YRDLKPENILLDY---QGHIALCDFGLCKLNMKDDDKTN---------TFCGTPEYLAPE 163

Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             LG   ++  D  +LG VLLY +   LP
Sbjct: 164 LLLGHGYTKAVDWWTLG-VLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 32/227 (14%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGSG 64
           +++  KIG GSFG +F         + A+K   +     +   + + EA+V   L     
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 65  IPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           I   + +   G+ N+++       L  L  +   R      V     Q++  + ++HS+ 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----------------YRDPTTNRHIPY 167
            LHRDIK  N  +      + V I D G+AK                 Y  P      PY
Sbjct: 122 ILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 168 RENKNL--TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
            E  ++   G   Y  C            D  + G ++L  +RG  P
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRGVFP 219

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 17/219 (7%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI--KWY 71
           +G G FGE+       T ++ A K ++    K  +    A   K +        I    Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 72  GVDGEDNV-LVLDLL-GPSLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
             + +D++ LV+ L+ G  L+  ++      F     +  A Q+I  +E++H R  ++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           +KP+N L+        V I D GLA + +             K   GT  Y +     G 
Sbjct: 121 LKPENVLLD---DHGNVRISDLGLAVELKGGKK--------IKGRAGTPGYMAPEVLQGE 169

Query: 189 EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
                 D  +LG  L   + G  P++  K   +K++  +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 32/154 (20%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV------YKILQGGSGIPNI 68
           IG G+FGE+ +    +T ++ A+KI N      ++L  A+         +L  G    + 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREERDVLVNG----DR 60

Query: 69  KW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLAD----QMIARIE 117
           +W     Y    E+N+ LV+D  +G  L  L      KF  +    +A     +M+  I+
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL----SKFEDRLPEDMARFYLAEMVLAID 116

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
            VH  G++HRDIKPDN L+    K   + + DFG
Sbjct: 117 SVHQLGYVHRDIKPDNVLLD---KNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)

Query: 11  LGRKIGSGSFGEIFLASHVD-----TNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
           L R++G G+FG++FLA   +        +VAVK   + S         EA++   LQ   
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR---------------RKFSLKTVLML 108
               +K+YGV  E + L++        DL  + R                + +   +L +
Sbjct: 69  ---IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
           A Q+ A + Y+ S+ F+HRD+   N L+G   +   V I DFG++   RD  +  +  YR
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY--YR 177

Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
              +     R+    + +  + +   D+ SLG VL   F  G  PW  L
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 51/220 (23%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  I+A K         I N   +  Q+L+E     I      
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65

Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 66  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 113

Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161

Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 11/149 (7%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK 69
            L ++IGSG FG ++L   ++  ++    I          + EA+V   L   S    ++
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL---SHPKLVQ 63

Query: 70  WYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            YGV  E +   LV + +    L D     R KFS +T+L +   +   + Y+ S   +H
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123

Query: 127 RDIKPDNFLMGLGRKANQVY-IIDFGLAK 154
           RD+   N L+G     NQV  + DFG+ +
Sbjct: 124 RDLAARNCLVG----ENQVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 36/146 (24%), Positives = 75/146 (51%), Gaps = 9/146 (6%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV-YKILQGGSGIPNIKWYG 72
           ++G G+FG+++ A + +T  + A K+    TK  + L +  V  +IL   +    +K  G
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 73  V---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
               DG+  +++    G +++ + +   R  +   + ++  QM+  ++Y+HS   +HRD+
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK 155
           K  N L+ L      + + DFG++ K
Sbjct: 137 KAGNVLLTLD---GDIKLADFGVSAK 159

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 41/170 (24%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----EN------------SGTKHPQL--LYEAKV 55
           +G G+FG+++ A H +T    A KI     E             S  KHP +  LYEA  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 56  YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
           Y+         N  W         ++++   G +L+ + +   R  +   +  +  QM+ 
Sbjct: 73  YE---------NKLW---------ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
            + ++HS   +HRD+K  N L+ L      V + DFG++ K +     R 
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRD 161

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 20/67 (29%), Positives = 34/67 (50%), Gaps = 5/67 (7%)

Query: 91  DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
           DLF Y  R     L+  + +  +++  + Y+H RG +HRD+K +N  +    +     + 
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLG 227

Query: 149 DFGLAKK 155
           DFG A K
Sbjct: 228 DFGAACK 234

Length = 392

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 52/221 (23%), Positives = 105/221 (47%), Gaps = 30/221 (13%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           ++L   +G+G++G+++   HV T ++ A+K+ +  T+  +   + ++  +L+  S   NI
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEI-NMLKKYSHHRNI 75

Query: 69  -KWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCRRKFSLKT--VLMLADQMIARI 116
             +YG        G D+   LV++  G  S+ DL V   +  +LK   +  +  +++  +
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL-VKNTKGNALKEDWIAYICREILRGL 134

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
            ++H+   +HRDIK  N L+    +  +V ++DFG++ +  D T  R           GT
Sbjct: 135 AHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGT 184

Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             +      +C+ +       R D+ SLG   +    G+ P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 31/221 (14%)

Query: 9   YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYK-------I 58
           ++L + +G+G++G++FL   V   DT ++ A+K+     +   L+ +AK  +       +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKV----LQKAALVQKAKTVEHTRTERNV 57

Query: 59  LQGGSGIPNIK--WYGVDGEDNV-LVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
           L+     P +    Y    E  + L+LD +  S  ++F  +Y R  FS   V   + ++I
Sbjct: 58  LEHVRQSPFLVTLHYAFQTEAKLHLILDYV--SGGEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             +E++H  G ++RDIK +N L+        V + DFGL+K++      R   +      
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFLSEEKERTYSF------ 166

Query: 174 TGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPW 213
            GT  Y +     G     +  D  SLG ++   L G+ P+
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 37/189 (19%)

Query: 8   KYKLGRKIGSGSFGEIF--LASHVDTNEI---VAVKIEN---SGTKHPQLLYEAKVYKIL 59
           K  L R++G GSFG ++  LA  V   E    VA+K  N   S  +  + L EA V K  
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCR------RKFSLKTVLMLAD 110
                  ++ +  GV   G+  ++V++L+     DL  Y R                L  
Sbjct: 67  N----CHHVVRLLGVVSTGQPTLVVMELMA--KGDLKSYLRSRRPEAENNPGLGPPTLQK 120

Query: 111 --QMIARI----EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYRDP 159
             QM A I     Y+ ++ F+HRD+   N ++    +   V I DFG+ +      Y   
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177

Query: 160 TTNRHIPYR 168
                +P R
Sbjct: 178 GGKGLLPVR 186

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)

Query: 14  KIGSGSFGEIFLA--SHVDTNE---IVAVKIENSGTKHPQLLY--EAKVYKILQGGSGIP 66
           ++G G+FG++FLA   ++   +   +VAVK     ++  +  +  EA++  +LQ      
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH--- 68

Query: 67  NIKWYGV--DGEDNVLVLDLL------------GPS---LEDLFVYCRRKFSLKTVLMLA 109
            +++YGV  +G   ++V + +            GP    L         + +L  +L +A
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
            Q+ + + Y+ S  F+HRD+   N L+G G     V I DFG++   RD  +  +  YR 
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180

Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
                   R+    + L  + +   D+ S G VL   F  G  PW  L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 51/241 (21%)

Query: 11  LGRKIGSGSFGEIFLASHV-----DTNEI--VAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G FG++ +A  +       N +  VAVK+  S         L+ E ++ K++ 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
               I N+   G   +D  L + +   S  +L  Y R +                   S 
Sbjct: 82  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 196

Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 197 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 245

Query: 216 L 216
           +
Sbjct: 246 V 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 31/211 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGGSG 64
           +Y L +++G GSFG ++L           +K+      G  +P    +A     L     
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 65  IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIE 117
            P I K++   ++ +   ++ +   G  L+      +   +  S   V     Q++  + 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR---DPTTNRHIPYRENKNLT 174
           Y+H R  LHRD+K  N  +    K N + I DFG+++      D  T            T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166

Query: 175 GTARYASCN--THLGIEQSRRDDLESLGYVL 203
           GT  Y S     H G +   + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 47/225 (20%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+     T+    PY   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART--AGTSFMMTPY--- 185

Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
                T  Y +    LG+      D+ S+G ++   ++G + + G        +++K+ E
Sbjct: 186 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIE 239

Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
            ++ TP     K       +Y         + RP Y              GY F+ +F  
Sbjct: 240 -QLGTPCPEFMKKLQPTVRTY--------VENRPKYA-------------GYSFEKLFPD 277

Query: 291 TIL----KYQQTQKTKSQDLLPASRVTNSRVMPMRTDKLKGVNDA 331
            +     ++ + + ++++DLL       S+++ +   K   V++A
Sbjct: 278 VLFPADSEHNKLKASQARDLL-------SKMLVIDASKRISVDEA 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)

Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 95  QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151

Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 152 V---KSDCTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVD 200

Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 252

Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 253 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 299

Query: 309 ASRVT 313
           A R++
Sbjct: 300 AKRIS 304

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 16/162 (9%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
           +++ + IG G+FGE+ +     T  I A+KI N      ++L  A+     +  + + N 
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW----EMLKRAETACFREERNVLVNG 58

Query: 68  -IKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             +W     Y    E+ + LV+D  +G  L  L      +           +M+  I  +
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
           H   ++HRDIKPDN L+ +      + + DFG   K     T
Sbjct: 119 HQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGT 157

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 47/242 (19%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           +  LG+ +G G FG++ +A  +  ++        VAVK +++  T      L+ E ++ K
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72

Query: 58  ILQGGSGIPNIKW-------------YGVDGEDNVLVLDLLGPSLEDLFVYCR---RKFS 101
           ++     I N+               Y   G     +     P ++  F  C+    + +
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
            K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDY 189

Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
              TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ 
Sbjct: 190 YKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLLWEIFTLGGSPYP 238

Query: 215 GL 216
           G+
Sbjct: 239 GI 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 27/154 (17%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK----- 69
           I  G+FG+++L    + +++ AVK+     K   ++ +  V+++      +   K     
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKV----VKKADMINKNMVHQVQAERDALALSKSPFIV 67

Query: 70  --WYGVDGEDNV-LVLD-LLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
             +Y +   +NV LV++ L+G    SL  ++ Y   + ++K +     ++   ++Y+H  
Sbjct: 68  HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYI----SEVALALDYLHRH 123

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYI--IDFGLAK 154
           G +HRD+KPDN L+     +N+ +I   DFGL+K
Sbjct: 124 GIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 40/174 (22%)

Query: 12  GRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGT--------------KHPQLLYEAK 54
           G K+G G++G ++ A   D     E    +IE +G               KHP ++   K
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65

Query: 55  VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
           V+      S      W         L+ D     L  +  + R   + K  + L   M+ 
Sbjct: 66  VFL-----SHSDRKVW---------LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 115 R--------IEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
                    I Y+H+   LHRD+KP N L MG G +  +V I D G A+ +  P
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 64/203 (31%)

Query: 11  LGRKIGSGSFGEIFLASHVDTNE-----IVAVKI--ENSGTKH-PQLLYEAKVYKILQGG 62
           LG+ +G G+FG++  A  V  +       VAVK+  +++  K    L+ E ++ K++   
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI--- 72

Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLED--LFV---YCR----RKF------------- 100
                       G+ +  +++LLG   ++  L+V   Y      R F             
Sbjct: 73  ------------GK-HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119

Query: 101 ----------SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150
                     + K ++  A Q+   +E++ S+  +HRD+   N L+      + + I DF
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADF 176

Query: 151 GLAK-----KYRDPTTNRHIPYR 168
           GLA+      Y   TTN  +P +
Sbjct: 177 GLARDIHHIDYYRKTTNGRLPVK 199

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 29/204 (14%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK---- 69
           ++G G+FG+++ A + +T  + A K+ +  TK  + L +  V   +      PNI     
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLD 69

Query: 70  --WYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
             +Y    E+N+ +L     G +++ + +   R  +   + ++  Q +  + Y+H    +
Sbjct: 70  AFYY----ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---- 181
           HRD+K  N L  L      + + DFG++ K       R I  R+  +  GT  + +    
Sbjct: 126 HRDLKAGNILFTLD---GDIKLADFGVSAK-----NTRTIQRRD--SFIGTPYWMAPEVV 175

Query: 182 -CNTHLGIEQSRRDDLESLGYVLL 204
            C T        + D+ SLG  L+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLI 199

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 10/110 (9%)

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
           +L  Q++  ++ VHSR  +HRD+K  N FLM  G     + + DFG +K+Y D      +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223

Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                 +  GT  Y +         S++ D+ SLG +L   L    P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 31/178 (17%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEA-KVYKILQGGSGIPNI-KWY 71
           +G G++G ++ A  + T   +A+K I    +++ Q L+E   ++  L+      NI ++ 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR----NIVQYL 71

Query: 72  GVDGEDN---VLVLDLLGPSLEDLFVYCRRKFS-LK----TVLMLADQMIARIEYVHSRG 123
           G D E+    + +  + G SL  L    R K+  LK    T++    Q++  ++Y+H   
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARY 179
            +HRDIK DN L  +   +  V I DFG +K+    +P T         +  TGT +Y
Sbjct: 129 IVHRDIKGDNVL--VNTYSGVVKISDFGTSKRLAGINPCT---------ETFTGTLQY 175

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 40/223 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
           KY + R +GSG+ G +  A  V   E  AVK+          +N        L     + 
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92

Query: 58  ILQGGSGIPNIKWYGVDGEDNV----LVLDLLGPSLEDLFVYCR------RKFSLKTVLM 107
           I++      +         +NV    LVLD       DL    +      R F      +
Sbjct: 93  IVKCHE---DFAKKDPRNPENVLMIALVLDYANAG--DLRQEIKSRAKTNRTFREHEAGL 147

Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           L  Q++  + +VHS+  +HRDIK  N L+   GL      V + DFG +K Y    ++  
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSD-- 199

Query: 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
                 +   GT  Y +         S++ D+ SLG VLLY L
Sbjct: 200 ---DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238

Length = 496

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY 71
           +G G+ G ++ A H+ T  I+AVK+   + +     Q++ E    +IL        I +Y
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE---LEILYKCDSPYIIGFY 65

Query: 72  G---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
           G   V+   ++    + G SL+   VY  RK     +  +A  ++  + Y+ S   LHRD
Sbjct: 66  GAFFVENRISICTEFMDGGSLD---VY--RKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120

Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           +KP N L+       QV + DFG++ +  +            K   GT  Y +     G 
Sbjct: 121 VKPSNMLVN---TRGQVKLCDFGVSTQLVNSIA---------KTYVGTNAYMAPERISGE 168

Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +     D+ SLG   +    G  P+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
           Q++  I Y+H+   LHRD+KP N L MG G +  +V I D G A+ +  P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 43.0 bits (102), Expect = 3e-04
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 21/107 (19%)

Query: 49  LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM 107
           LL EA+        +G+P    Y VD E+  +V++ + G  L+D+            ++ 
Sbjct: 389 LLSEAR-------RAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG------NPELVR 435

Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
              +++A++   H  G +H D+   NF++    + +++Y+IDFGL K
Sbjct: 436 KVGEIVAKL---HKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGK 475

Length = 535

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 27/110 (24%), Positives = 55/110 (50%), Gaps = 13/110 (11%)

Query: 52  EAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
           EA++  +  + G  +P +  Y VD E+ ++V++ + G  L+DL            +    
Sbjct: 49  EARIMSRARKAGVNVPAV--YFVDPENFIIVMEYIEGEPLKDLIN--SNGMEELELSREI 104

Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
            +++ ++   HS G +H D+   N ++       ++Y+IDFGLA+  +D 
Sbjct: 105 GRLVGKL---HSAGIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDL 147

Length = 211

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 16/150 (10%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y + + +  GS G +F+A+     + V +KI   GT     L EA + + +   S I  +
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT----LIEAMLLQNVNHPSVI-RM 122

Query: 69  KWYGVDGEDNVLVLDLLGPSLE-DLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGF 124
           K   V G    +VL    P    DL+ Y     R   +   L++  Q++  + Y+H++  
Sbjct: 123 KDTLVSGAITCMVL----PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +HRD+K +N  +      +QV I D G A+
Sbjct: 179 IHRDVKTENIFI---NDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 41/285 (14%)

Query: 11  LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGG 62
            G+ +G+G+FG++  A     S  D    VAVK+       ++   L+ E K+   L   
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEY 118
             I N+      G   +++ +       DL  + RRK     +L+ +L  + Q+   + +
Sbjct: 99  ENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           + S+  +HRD+   N L+  G+      I DFGLA         R I    N  + G AR
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVK---ICDFGLA---------RDIMNDSNYVVKGNAR 204

Query: 179 ----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK- 231
               + +  +      +   D+ S G +LL+  F  GS P+ G+   +K   Y  I E  
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYG-ILLWEIFSLGSNPYPGMPVDSK--FYKLIKEGY 261

Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
           +++ P        PAE       C      +RP +  + +L    
Sbjct: 262 RMAQPEHA-----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 21/152 (13%)

Query: 14  KIGSGSFGEI------FLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           ++GSG+FG +           +D   I  +K EN  +   +++ EA++   L      P 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDN----PY 56

Query: 68  I-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           I +  GV + E  +LV+++  G  L       + + ++  V+ L  Q+   ++Y+  + F
Sbjct: 57  IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 125 LHRDIKPDNFLMGLGRKANQVY--IIDFGLAK 154
           +HRD+   N L+      NQ Y  I DFGL+K
Sbjct: 117 VHRDLAARNVLL-----VNQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.4 bits (98), Expect = 5e-04
 Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 17/147 (11%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN-IKWYG 72
           K+  G FG++ +  H  T ++   KI  +  K+   + E  V+++++     PN IK Y 
Sbjct: 23  KLIDGKFGKVSVLKHKPTQKLFVQKIIKA--KNFNAI-EPMVHQLMKDN---PNFIKLYY 76

Query: 73  VDG--EDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
                + +VL++D +      DLF   +   K S   V  +  Q++  +  +H    +H 
Sbjct: 77  SVTTLKGHVLIMDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN 133

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAK 154
           DIK +N L    R  +++Y+ D+GL K
Sbjct: 134 DIKLENVL--YDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 10/83 (12%)

Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNR 163
           V +   Q++  + Y+H +  LHRD+KP N L+  LG    ++ + DFGLA+    P+   
Sbjct: 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG----ELKLADFGLARAKSIPSQTY 160

Query: 164 H-----IPYRENKNLTGTARYAS 181
                 + YR    L G   Y+S
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSS 183

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 46/163 (28%), Positives = 68/163 (41%), Gaps = 29/163 (17%)

Query: 15  IGSGSFGEIFLASHVD-----TNEI-VAVKIENSGT---KHPQLLYEAKVYKILQGGSGI 65
           +GSG+FGE++  +  D     +  I VAVK    G    +  + L EA     L      
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH----LMSNFNH 58

Query: 66  PNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---------FSLKTVLMLADQMI 113
           PNI K  GV    E   ++++L+     DL  Y R            +LK +L +   + 
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAK 154
               Y+    F+HRD+   N L+          V I DFGLA+
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 14/126 (11%)

Query: 91  DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
           +LF +  R+  F+ +       ++++ +EY+HSR  ++RDIK +N ++    K   + I 
Sbjct: 81  ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKIT 137

Query: 149 DFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
           DFGL K+   D  T +           GT  Y +       +  R  D   LG V+   +
Sbjct: 138 DFGLCKEGISDGATMK--------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Query: 208 RGSLPW 213
            G LP+
Sbjct: 190 CGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 13/129 (10%)

Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           F  +  L  A +++  +E +H    ++RD+KP+N L+        + I D GLA K    
Sbjct: 99  FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVK---- 151

Query: 160 TTNRHIPYREN-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
                IP  E+ +   GT  Y +         +   D   LG ++   + G  P++G K 
Sbjct: 152 -----IPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206

Query: 219 ATKKQKYDK 227
             K+++ D+
Sbjct: 207 KVKREEVDR 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 53/242 (21%)

Query: 11  LGRKIGSGSFGEIFLA-------SHVDTNEIVAVKI--ENSGTKH-PQLLYEAKVYKILQ 60
           LG+ +G G FG++  A       S  D    VAVK+  +N+  K    L+ E ++ K++ 
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 61  GGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRR----------------KFS 101
               I N+   GV   +G   V+V      +L + F+  RR                + S
Sbjct: 76  KHKNIINL--LGVCTQEGPLYVIVEYAAKGNLRE-FLRARRPPGPDYTFDITKVPEEQLS 132

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
            K ++  A Q+   +EY+ SR  +HRD+   N L+    + N + I DFGLA+      Y
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDY 189

Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
              T+N  +P    K +   A +    TH       + D+ S G +L++  F  G  P+ 
Sbjct: 190 YKKTSNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-ILMWEIFTLGGSPYP 238

Query: 215 GL 216
           G+
Sbjct: 239 GI 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI--ENSGTKH-PQLLYEAKVYK 57
           K  LG+ +G G FG++ +A  +  ++        VAVK+  +++  K    L+ E ++ K
Sbjct: 16  KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75

Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------ 99
           ++     I N+   G   +D  L + +   S  +L  Y R +                  
Sbjct: 76  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNI 190

Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 191 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 239

Query: 213 WQGL 216
           + G+
Sbjct: 240 YPGI 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 27/158 (17%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYGV 73
           IG G++G+++  ++     + AVKI +  +   + + EA+ Y ILQ     PN+ K+YG+
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI-EAE-YNILQSLPNHPNVVKFYGM 87

Query: 74  -------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY------- 118
                   G    LVL+L  G S+ +L      K  L     L + MI+ I Y       
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 119 -VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            +H+   +HRD+K +N L+        V ++DFG++ +
Sbjct: 143 HLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 40.9 bits (96), Expect = 8e-04
 Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 21/157 (13%)

Query: 10  KLGRKIGSGSFGEIFLASHV---DTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
           +  + +GSG+FG ++    +   +  +I VA+K+  E +  K  + +L EA V       
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV----MAS 65

Query: 63  SGIPNI-KWYGVD-GEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIE 117
              P++ +  G+       L+  L+   L  L  Y R        + +L    Q+   + 
Sbjct: 66  VDHPHVVRLLGICLSSQVQLITQLM--PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           Y+  +  +HRD+   N L+   +    V I DFGLAK
Sbjct: 124 YLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 44/225 (19%)

Query: 12  GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI------ 65
           G  +G G++G ++     +  +++AVK     T +  L  E K Y+ LQ    +      
Sbjct: 5   GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSN-VLAAE-KEYEKLQEEVDLLKSLKH 61

Query: 66  PNIKWY-GVDGEDNVL--------------VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
            NI  Y G   +DN +              +L+  GP  E   V+C+             
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE--PVFCK----------YTK 109

Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
           Q++  + Y+H+   +HRDIK +N  LM  G     + +IDFG A++        H  +  
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRL--AWVGLHGTHSN 163

Query: 170 N-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
             K++ GT  + +          R+ D+ S+G  +     G  P 
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 12/48 (25%), Positives = 25/48 (52%), Gaps = 7/48 (14%)

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           ++ ++   H  G +H D+   N ++      +++Y+IDFGL K   + 
Sbjct: 102 LVGKL---HKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEI 142

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 40.8 bits (95), Expect = 9e-04
 Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 34/232 (14%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
           IG GSFG++ LA      +  AVK+     K   L  + + + + +    + N+K     
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQ---KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 71  ---YGVDGEDNV-LVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGF 124
              Y     + +  VLD +     +LF + +  R F        A ++ + + Y+HS   
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKNLTGTARYAS 181
           ++RD+KP+N L+        V + DFGL K+     D TT             GT  Y +
Sbjct: 118 VYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDTTT----------TFCGTPEYLA 164

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
                        D   LG VL   L G  P+     A   + YD I  K +
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPL 213

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 45/273 (16%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPNI- 68
           +G G+FGE+F  +  D    VAVK        PQ      L EA++ K        PNI 
Sbjct: 3   LGKGNFGEVFKGTLKDKTP-VAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55

Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFL 125
           K  GV  +   + + +      D   + R+K      K ++  A    A + Y+ S+  +
Sbjct: 56  KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN----RHIPYR-ENKNLTGTARYA 180
           HRD+   N L+G   + N + I DFG++++  D   +    + IP +          RY+
Sbjct: 116 HRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
           S             D+ S G +LL+  F  G  P+ G+     +++ +K    ++S P  
Sbjct: 173 S-----------ESDVWSYG-ILLWETFSLGVCPYPGMTNQQAREQVEK--GYRMSCP-- 216

Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271
              +  P +       C     + RP +  L++
Sbjct: 217 ---QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 35/177 (19%)

Query: 11  LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGG 62
           L R++G G+FG++FL         +  E+VAVK                EA++    Q  
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH- 67

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL------------GPSLEDLFVYCRRKFSLKTVLM 107
               NI K+YGV  +G+  ++V + +            GP    L         L    +
Sbjct: 68  ---ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 108 L--ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
           L  A Q+ + + Y+ S+ F+HRD+   N L+G       V I DFG++   RD  T 
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---RDVYTT 175

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 36/128 (28%), Positives = 58/128 (45%), Gaps = 13/128 (10%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           Q+I+ +E++H R  ++RD+KP+N L+        V I D GLA + +D  +       + 
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154

Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKI 228
           K   GT  + +     G E     D  +LG  L   +  RG    +G K   K+ K  +I
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRI 213

Query: 229 CEKKVSTP 236
               V+ P
Sbjct: 214 LNDSVTYP 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           Q++  ++++HS   +HRD+KP N L+       Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 11/164 (6%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           K  LG  IG G FG +    +  T + VAVK           L E  V   L   + +  
Sbjct: 7   KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64

Query: 68  IKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGF 124
           +   GV   + + +V++L+       F+  R +   S+  +L  +  +   +EY+ S+  
Sbjct: 65  L---GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
           +HRD+   N L+    +     + DFGLA+       N  +P +
Sbjct: 122 VHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK 162

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           Q++  +  +H  G +HRDIKP+N L+ +     QV IIDFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAA 356

Length = 507

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 24/71 (33%), Positives = 41/71 (57%), Gaps = 7/71 (9%)

Query: 90  EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
           EDL    ++  +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I D
Sbjct: 169 EDL---YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICD 222

Query: 150 FGLAKK-YRDP 159
           FGLA+  Y+DP
Sbjct: 223 FGLARDIYKDP 233

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 60/180 (33%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-------IEN----------------SGTKHPQLL- 50
           +G G FG++ LA +  T E+ A+K       I                  +  +HP L+ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 51  ------YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
                  E  V  +++  +G          G       DL+     D+F   R  F    
Sbjct: 67  LFACFQTEDHVCFVMEYAAG----------G-------DLMMHIHTDVFSEPRAVFYAAC 109

Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
           V++        ++Y+H    ++RD+K DN L+        V I DFGL K+   + D T+
Sbjct: 110 VVL-------GLQYLHENKIVYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTS 159

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 51/220 (23%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +    H  +  I+A K         I N   +  Q+L+E     I      
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65

Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +    +R         + ++++ ++     
Sbjct: 66  ---VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVL 113

Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           RG          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161

Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 8/77 (10%)

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----I 165
           Q++  + Y H R  LHRD+KP N L+    +  ++ + DFGLA+    P+ T  +    +
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 166 PYRENKNLTGTARYASC 182
            YR    L G+  Y++ 
Sbjct: 168 WYRPPDVLLGSTEYSTS 184

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 29/169 (17%)

Query: 9   YKLGRKIGSGSFG---EIFLASHVDTNEIVAVKIE----NSGTKHPQLLYEAKVYKILQG 61
           + LGR +G G FG   E  L S   + + VAVK+      S +   + L EA   K    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 62  GSGIPNI-KWYGVD----GEDNVLVLDLLGPSLE--DL--FVYCRR------KFSLKTVL 106
               PN+ K  GV      +  + +  ++ P ++  DL  F+   R         L+T++
Sbjct: 61  ----PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
                + + +EY+ S+ F+HRD+   N ++    +   V + DFGL+KK
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKK 162

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 33/151 (21%), Positives = 65/151 (43%), Gaps = 8/151 (5%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y + + IG G+FGE+ L  H  + ++ A+K+    E          +E +          
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 65  IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           +  +     D +   +V++ + P  + + +        K       +++  ++ +HS G 
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYM-PGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +HRD+KPDN L+    K   + + DFG   K
Sbjct: 164 IHRDVKPDNMLLD---KHGHLKLADFGTCMK 191

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 45/152 (29%), Positives = 60/152 (39%), Gaps = 33/152 (21%)

Query: 11  LGRKIGSGSFGE--IFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           L   IG        + LA H  TN +VAVK  N    S      L  E    + LQ    
Sbjct: 2   LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH--- 58

Query: 65  IPNIKWYG---VDGEDNVLVLDLLG-PSLEDLFVYCRRKFSLKTVLM--LADQMIARI-- 116
            PNI  Y    +   +  +V  L+   S EDL         LKT     L +  IA I  
Sbjct: 59  -PNILPYVTSFIVDSELYVVSPLMAYGSCEDL---------LKTHFPEGLPELAIAFILK 108

Query: 117 ------EYVHSRGFLHRDIKPDNFLMGLGRKA 142
                 +Y+HS+GF+HR +K  + L+    K 
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 28/210 (13%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
           +G G+FG++ L     + +  A+KI     K   ++ + +V   L     + N +     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 71  ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
              Y    +D +  V++ +     +LF +  R+  FS         ++++ ++Y+HS   
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCN 183
           ++RD+K +N ++    K   + I DFGL K+   D  T         K   GT  Y +  
Sbjct: 117 VYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAAT--------MKTFCGTPEYLAPE 165

Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                +  R  D   LG V+   + G LP+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 3/36 (8%)

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
           ++ +HS GF+HRD+KPDN L+    K+  + + DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 19/75 (25%), Positives = 39/75 (52%), Gaps = 7/75 (9%)

Query: 91  DLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
           +LF   +R+     S +     A +++  +EY+H  G ++RD+KP+N L+    ++  + 
Sbjct: 87  ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIM 143

Query: 147 IIDFGLAKKYRDPTT 161
           + DF L+K+      
Sbjct: 144 LSDFDLSKQSDVEPP 158

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 23/159 (14%)

Query: 9   YKLGRKIGSGSFGEIFLASH-VDTNEIVAVKI--ENSGTKHPQLL-YEAKVYKILQGGSG 64
           Y   R +G GS+GE+ L  H  D  + V  K+   N+  +  +    EA++   L+    
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH--- 58

Query: 65  IPNIKWY--GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI-------AR 115
            PNI  Y    +GED +L + +      DL+    +    K  L+  +Q++         
Sbjct: 59  -PNIVAYRESWEGEDGLLYIVMGFCEGGDLY---HKLKEQKGKLLPENQVVEWFVQIAMA 114

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++Y+H +  LHRD+K  N  +    + N + + D G+A+
Sbjct: 115 LQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIAR 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 39/150 (26%), Positives = 79/150 (52%), Gaps = 14/150 (9%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVK-IENS--GTKHPQLLYEAKVYKILQGGSGIPNIK 69
            ++G G++G +    HV T  I+AVK I  +    +  +LL +  +   ++       + 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS--MRSVDCPYTVT 64

Query: 70  WYG-VDGEDNVLV-LDLLGPSLEDLF--VYCRRKFSLKTVL-MLADQMIARIEYVHSR-G 123
           +YG +  E +V + ++++  SL+  +  VY +     + +L  +A  ++  +EY+HS+  
Sbjct: 65  FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
            +HRD+KP N L+    +  QV + DFG++
Sbjct: 125 VIHRDVKPSNVLIN---RNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.0 bits (89), Expect = 0.004
 Identities = 34/153 (22%), Positives = 66/153 (43%), Gaps = 24/153 (15%)

Query: 12  GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL---------LYEAKVYKILQGG 62
              I  G+   I+L   +    +V  +I     +HP+L           EA++    +  
Sbjct: 1   MDLIKQGAEAIIYLTDFLGLPAVVKERIPK-RYRHPELDEKLRRERTRREARILAKARE- 58

Query: 63  SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           +G+P    Y VD ++ ++V++ + G  L+D     R     +       +++ ++   H 
Sbjct: 59  AGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEARPDLLRE-----VGRLVGKL---HK 110

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            G +H D+   N ++  GR    +Y IDFGL +
Sbjct: 111 AGIVHGDLTTSNIILSGGR----IYFIDFGLGE 139

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	423
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	100.0
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG3087	229	consensus Serine/threonine protein kinase [General	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
COG4248	637	Uncharacterized protein with protein kinase and he	99.23
KOG1243	690	consensus Protein kinase [General function predict	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.85
PRK09902	216	hypothetical protein; Provisional	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.76
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.53
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.47
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.26
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.14
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.09
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.07
PLN02876	822	acyl-CoA dehydrogenase	98.03
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.98
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.8
KOG2270	520	consensus Serine/threonine protein kinase involved	97.77
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.77
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.77
PRK05231	319	homoserine kinase; Provisional	97.68
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.65
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.62
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.56
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.51
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.48
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.36
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.36
PLN02236	344	choline kinase	97.2
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.13
PRK10593	297	hypothetical protein; Provisional	97.11
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.1
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.08
PRK12396	409	5-methylribose kinase; Reviewed	96.93
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.84
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.51
PLN02756	418	S-methyl-5-thioribose kinase	96.45
PRK11768	325	serine/threonine protein kinase; Provisional	96.45
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.35
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.2
PTZ00384	383	choline kinase; Provisional	96.04
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.01
COG2334	331	Putative homoserine kinase type II (protein kinase	95.94
PRK06148	1013	hypothetical protein; Provisional	95.45
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.36
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.2
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.89
PRK06149	972	hypothetical protein; Provisional	93.81

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-55  Score=387.40  Aligned_cols=293  Identities=69%  Similarity=1.195  Sum_probs=286.8

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|++++|+++++||+|+||.+|+|.....|+.||||+......++++..|.+++..|++...+|.+..|+.+..+..+||
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            47899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      +++|.+|++++..|.+.++.++++.++.||+.-++|+|.+++|||||||+|+|++.+....++.|+|||+|+.+.+..+.
T Consensus        91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            99999999999999999999999999999999999999999999999999999998888999999999999999999999


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                      .|+||++.....||.+|++-..+.+.+.+++.|+-|+|++|.++..|.+||++..+.+..+++++|.+.+...+++.+|+
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceeccc
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY  295 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~  295 (423)
                      ++|.+|.-++..|-..-.++-|++..|.++|+-++...++..|+.|||..++.
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkq  303 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQ  303 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHH
Confidence            99999999999999999999999999999999999999999999999998863

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-53  Score=386.98  Aligned_cols=291  Identities=58%  Similarity=1.011  Sum_probs=282.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      |+|-.|+++++||+|+||+++.|+..-++++||||........+++..|.+.++.|.+.++||.+++|+.++.+..||||
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            78899999999999999999999999999999999999888999999999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec--CCCCcEEEeeccceeeecCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~--~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ++|.+|+|++..|+++|+.++++.++.||+.-++|+|++.+|.|||||+|+||+..  .+...|.|+|||+|+.+.++.+
T Consensus       105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            99999999999999999999999999999999999999999999999999999753  2456899999999999999999


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                      ..|+||++.+.+.||.+||+...+.|.+.+++.|+-|||-++++++.|.+||+++++.+..++|++|.+.+...+++.+|
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc  264 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC  264 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                      .++|.+|...+...-.++..+-|+++.+..+|.+++.+.|..+|..|||..+.
T Consensus       265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence            99999999999999999999999999999999999999999999999998765

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-50  Score=386.56  Aligned_cols=266  Identities=25%  Similarity=0.362  Sum_probs=228.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      -.+|.+++.||+|+|++|++|+.+.+++.|||||+.+.     ...+-+.+|-.+|..|.+++.|..++.-+.|...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            36899999999999999999999999999999987643     3444578899999999999999999999999999999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |+||+ +|+|.+++.+. +.|++..+..++.||+.||+|||++|||||||||+|||+   |.++++||+|||.|+.+...
T Consensus       152 vLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChh
Confidence            99999 99999999874 679999999999999999999999999999999999999   69999999999999988754


Q ss_pred             CCCCcc----cccCC--CcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          160 TTNRHI----PYREN--KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       160 ~~~~~~----~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .....-    .+...  ..++||..|.+||++.+...+..+|||+||||||.|+.|.+||.+.+.   ...+++|+.-.+
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~l~y  304 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQALDY  304 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHHhcc
Confidence            433111    11112  569999999999999999999999999999999999999999987554   355666666666


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      .+|     ..+|+.+.+||.++|..||.+|++.++|.+          +.|....||+-+
T Consensus       305 ~fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  305 EFP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGVDWENL  349 (604)
T ss_pred             cCC-----CCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccCChhhh
Confidence            665     566999999999999999999999988855          345556677654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-50  Score=379.87  Aligned_cols=256  Identities=26%  Similarity=0.340  Sum_probs=217.1

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---------CchhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      ..+...|.+.+.||+|+||.|-+|..+.+++.||||+++...         ....+.+|+++|++|+| |+|..+..++.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFE  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeee
Confidence            346788999999999999999999999999999999987532         12236799999999998 66778888888


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      ..+..||||||+ ||.|.+.+.. ++.+.+.....++.||+.||.|||++||+||||||+|||++.++++..+||+|||+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            888999999999 9999999875 56789999999999999999999999999999999999998666678999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      |+......        ...+++||+.|.|||++.+..   +..++|||||||+||-+++|.+||.+....  ....+.|.
T Consensus       326 AK~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQI~  395 (475)
T KOG0615|consen  326 AKVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQIL  395 (475)
T ss_pred             hhccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHHHh
Confidence            99876433        235889999999999998765   345889999999999999999999874432  22455566


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+++..- +..+..++++..+||.+||..||++||++++.++
T Consensus       396 ~G~y~f~-p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGRYAFG-PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCccccc-ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            6666554 3455778999999999999999999999998866

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-49  Score=388.24  Aligned_cols=251  Identities=28%  Similarity=0.407  Sum_probs=224.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+|+.++.||+|||+.||.+++..+|+.||+|++..     ....+.+.+|+++.+.|+| ++|+.++.|+++.++.|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecCCceEEE
Confidence            579999999999999999999999999999998765     3445668999999999998 6677888889999999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      +|+| .++|..+++ .++.+++.+++.++.||+.||.|||+++|||||||..|+|+   +++..|||+|||+|..+..+.
T Consensus        97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence            9999 889988887 57889999999999999999999999999999999999999   588899999999999987654


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .       ...+.+|||.|.|||++....++..+||||+|||||-|+.|++||...   +..+.|.+|....+..|.   
T Consensus       173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk---~vkety~~Ik~~~Y~~P~---  239 (592)
T KOG0575|consen  173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK---TVKETYNKIKLNEYSMPS---  239 (592)
T ss_pred             c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc---hHHHHHHHHHhcCccccc---
Confidence            3       234889999999999999999999999999999999999999999863   455778888888887775   


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                        .++.+.++||.++|+.||.+||++++|+.  +++|++
T Consensus       240 --~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff~~  274 (592)
T KOG0575|consen  240 --HLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFFKS  274 (592)
T ss_pred             --ccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhhhC
Confidence              45889999999999999999999999965  677743

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-50  Score=372.53  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=214.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC-eeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~-~~~lv   81 (423)
                      ..+.+.++.||+|..|+||+|+++.+++.+|+|++...   ....++.+|+++++..++ ++|..++..+.... ...|+
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~s-pyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQS-PYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeEeEEEEeCCceEEee
Confidence            34677889999999999999999999999999988433   345578999999999955 66767766666666 59999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||| +|+|.+++... +++++...-.|+.+|++||.|||. ++||||||||+|||+   +..|.|||||||.++.+.+.
T Consensus       157 mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence            9999 99999998864 679999999999999999999995 999999999999999   58999999999999887665


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCc--hhhhhHHHHHHHHhhhcCCcH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--KAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ..         .+++||..|||||.+.+..|+.++||||||++++||++|++||...  ......+.+..|+....    
T Consensus       233 ~a---------~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp----  299 (364)
T KOG0581|consen  233 IA---------NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP----  299 (364)
T ss_pred             hc---------ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC----
Confidence            22         3789999999999999999999999999999999999999999863  22344566666655332    


Q ss_pred             HHhhc-cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          238 EVLCK-SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       238 ~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +.++. .++++|++||..||++||.+||++.+|++  +.++.+
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~  340 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKK  340 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhh
Confidence            23333 37999999999999999999999999977  555543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=368.97  Aligned_cols=260  Identities=25%  Similarity=0.345  Sum_probs=219.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      -...|++++.||+|+||+||.++.+++++.+|+|++++..     .......|..+|..++| +.++.+.+-+++.+..|
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccCCeEE
Confidence            3578999999999999999999999999999999887643     34458899999999776 66667777778999999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +|+||+ ||.|...+.. .+.|++..+..++..|+.||.|||++|||||||||+|||+   |.+|.++|+|||+|+....
T Consensus       102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhccc
Confidence            999999 8899988875 6779999999999999999999999999999999999999   6999999999999986554


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ...       ...+++||+.|||||++.+..|+..+|+||||+++|||++|..||.+.+.   .+.+++|...+...+. 
T Consensus       178 ~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~~I~~~k~~~~p-  246 (357)
T KOG0598|consen  178 DGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYDKILKGKLPLPP-  246 (357)
T ss_pred             CCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHHHHhcCcCCCCC-
Confidence            433       23468999999999999999999999999999999999999999987543   4666677766643332 


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCC----hHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPD----YGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt----~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                         ..++.+.++++..+|..||++|..    +.+|          ..+.|....||+.+
T Consensus       247 ---~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i----------k~HpfF~~inW~~l  292 (357)
T KOG0598|consen  247 ---GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI----------KRHPFFKGINWEKL  292 (357)
T ss_pred             ---ccCCHHHHHHHHHHhccCHHHhcCCCCChHHh----------hcCcccccCCHHHH
Confidence               235789999999999999999963    3333          44566677788754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7e-49  Score=368.34  Aligned_cols=249  Identities=23%  Similarity=0.317  Sum_probs=207.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -++|.+.+.||.|+||+||+|++++++..||||.+....    ..+.+..|+.+|+.++| ++|..+..+....+..|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecCCeEEEE
Confidence            378999999999999999999999999999999877664    23347899999999996 6677788888889999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC---CcEEEeeccceeeec
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA---NQVYIIDFGLAKKYR  157 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~---~~vkL~DFGla~~~~  157 (423)
                      |||| ||+|.+++.. .+.+++.++..++.||+.||++||+++||||||||+|||++.....   ..+||+|||+|+.+.
T Consensus        88 MEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9999 8999999986 5579999999999999999999999999999999999999754222   679999999999887


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ...        ...+.+|++.|||||++....|+.|+|+||+|+|+|+|++|+.||...+..   +.+..+.......+ 
T Consensus       167 ~~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~---eL~~~~~k~~~~~~-  234 (429)
T KOG0595|consen  167 PGS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK---ELLLYIKKGNEIVP-  234 (429)
T ss_pred             chh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhccccccC-
Confidence            543        234889999999999999999999999999999999999999999865443   33333333322222 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL  269 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  269 (423)
                       .+....+....+++...+..+|.+|-++.+-
T Consensus       235 -~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  235 -VLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             -chhhhccCchhhhhhHHHhcCccccCchHHh
Confidence             1222335667799999999999999887654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-49  Score=352.05  Aligned_cols=249  Identities=24%  Similarity=0.297  Sum_probs=206.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEE-EeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIK-WYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~-~~~~~~~~~~lv   81 (423)
                      ..|+|+++||.|+||+||+|.+..+|..||.|-+.-+.    ..+....|+.+|++|+|++++..+. .+..+.+-.+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45999999999999999999999999999999766443    3345889999999999976665554 344455558999


Q ss_pred             Eecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh--cC--cccccccCCceEEeecCCCCcEEEeeccce
Q 014527           82 LDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHS--RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~--~g--iiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ||+| .|+|..+++.   .++.+++.++|.++.|++.||.++|+  ..  |+||||||.||++   +.+|.|||+|||++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLG  175 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhH
Confidence            9999 8999998864   34569999999999999999999999  45  9999999999999   58999999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      +.+....+.       ...++|||.||+||.+.+..|+.+|||||+||++|||+.-..||.+.   .-.+.-.+|....+
T Consensus       176 r~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~  245 (375)
T KOG0591|consen  176 RFLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY  245 (375)
T ss_pred             hHhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence            998776653       34789999999999999999999999999999999999999999985   33344555655544


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +.-..   ..++.++..||..|+..||+.||+.-.++.
T Consensus       246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             CCCcH---HHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence            32211   345889999999999999999998543333

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.2e-48  Score=349.72  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=211.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~----~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|+.+.++|+|+||+||+|++++||+.||||.+....+.+    -.++|+++|++|.|++.+ .+...+......++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLV-nLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLV-NLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHH-HHHHHHHhcceeEEEe
Confidence            57999999999999999999999999999999877655533    368999999999986554 4444445677899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |||..++.+.+......++...+..++.|++.|+.|+|++++|||||||+|||++   .++.+||||||+|+.+..+...
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcch
Confidence            9999999999988788899999999999999999999999999999999999996   8999999999999998765432


Q ss_pred             CcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------  235 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------  235 (423)
                             ....+.|..|.|||.+.| ..|+..+||||+||++.||++|.+.|.+.++.+....+.+.++.-.+.      
T Consensus       158 -------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  158 -------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             -------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence                   236789999999999998 569999999999999999999999999987766555554443322111      


Q ss_pred             -----------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 -----------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 -----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                       |.+.-...++.-+.+|+..||..||++|++.++++.
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                             122223344567899999999999999999999865

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-47  Score=366.50  Aligned_cols=257  Identities=25%  Similarity=0.358  Sum_probs=210.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcE-EEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC-eeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI-VAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~-vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~-~~~   79 (423)
                      .....+.+.||.|+||+||+|.+.  |.. ||||++.....    ...|.+|+.+|.+|+|++++. +........ ..+
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~-f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQ-FYGACTSPPGSLC  116 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeee-EEEEEcCCCCceE
Confidence            345567788999999999999994  455 99998876432    346999999999999865544 444443443 689


Q ss_pred             EEEecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcC-cccccccCCceEEeecCCCC-cEEEeeccceee
Q 014527           80 LVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK  155 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~g-iiHrDIKp~NILl~~~~~~~-~vkL~DFGla~~  155 (423)
                      |||||+ +|+|.+++.. ..+.+++..++.|+.||+.||.|||+++ ||||||||+|||+   +... .+||+|||+++.
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence            999999 9999999987 3778999999999999999999999999 9999999999999   4665 999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      ......       ......||+.|||||++.  ...|+.|+||||||++||||+||+.||.+....   +....+.....
T Consensus       194 ~~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~~  263 (362)
T KOG0192|consen  194 KVISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGGL  263 (362)
T ss_pred             eccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCC
Confidence            654321       122468999999999999  558999999999999999999999999987653   33334444444


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      ..+++.   .+|+.+..||..||..||+.||++.+|+..|+.+.....
T Consensus       264 Rp~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  264 RPPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            444333   259999999999999999999999999999999887544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-46  Score=356.55  Aligned_cols=266  Identities=25%  Similarity=0.323  Sum_probs=221.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchh----HHHHHHHHHHHcCCCCCCeEEEeeee-CCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSGIPNIKWYGVD-GEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~----~~~E~~~l~~l~~~~~i~~i~~~~~~-~~~~~lv   81 (423)
                      ..|+.+++||+|.||.||+|++..+|+.||+|.+..+...+.    ..+|+.||++|.|++++......... ...+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            568899999999999999999999999999998877664443    68999999999996655554444433 5789999


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      +|||..+|.-++....-+|++.++..++.||+.||+|+|++||+|||||.+||||   |..|.+||+|||+|+.+.....
T Consensus       197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeeccCCCC
Confidence            9999999999998766689999999999999999999999999999999999999   6999999999999998876553


Q ss_pred             CCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc----
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP----  236 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~----  236 (423)
                      ..      ....+-|..|.|||++.|.. |+.+.|+||.||||.||++|++.|++.+..+..+++.++|.......    
T Consensus       274 ~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  274 AP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            22      23667899999999999876 99999999999999999999999999887777777766664321111    


Q ss_pred             -----------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCC
Q 014527          237 -----------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD  283 (423)
Q Consensus       237 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  283 (423)
                                       +.+....+|....+|+..+|..||++|.|+.+.+.  .++|...-+.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF~t~p~~  409 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYFTTEPLP  409 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--CcccccCCCC
Confidence                             12234567889999999999999999999998765  5666444433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-47  Score=367.23  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=214.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      .+++++.||+|.||+||.|.+.. ...||+|.++..... +.+.+|+++|++|+| +++..++..+..++..+|||||+ 
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcc-cCeEEEEEEEecCCceEEEEEecc
Confidence            45678899999999999999954 336999988875544 679999999999998 45556666666666899999999 


Q ss_pred             CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 ~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      .|+|.+++.. .+..+...+.+.++.|||+|++||+++++|||||.++||||   +++..+||+|||+|+...+...   
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y---  358 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEY---  358 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCce---
Confidence            9999999986 45679999999999999999999999999999999999999   5888999999999995444332   


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                         .......-...|.|||.+....++.+||||||||+||||+| |+.||.+++..+..+.+    +...+.|.+..|  
T Consensus       359 ---~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l----e~GyRlp~P~~C--  429 (468)
T KOG0197|consen  359 ---TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL----ERGYRLPRPEGC--  429 (468)
T ss_pred             ---eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH----hccCcCCCCCCC--
Confidence               22334455788999999999999999999999999999999 99999998776544443    445555655555  


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       |+++.++|..||..+|++||||+.+...|++++..
T Consensus       430 -P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  430 -PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             -CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence             99999999999999999999999999999988764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-46  Score=362.67  Aligned_cols=254  Identities=28%  Similarity=0.366  Sum_probs=218.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      ...++|.+.+.||+|+||.|++|.+..+++.||+|++...       ...+.+.+|+.+++.+.+|++|..+..+.....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4568999999999999999999999999999999987664       234457789999999997778888887777788


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC-CcEEEeecccee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLAK  154 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~-~~vkL~DFGla~  154 (423)
                      ..|+||||| ||+|.+++.. .+++.+.++..++.||+.|++|||++||+||||||+|||++   .+ +.+||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccccc
Confidence            899999999 7899999998 78899999999999999999999999999999999999994   66 999999999998


Q ss_pred             eec-CCCCCCcccccCCCcccccccccCcccccCCC-CC-ccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          155 KYR-DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       155 ~~~-~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      ... ...        .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+   ....+.+|...
T Consensus       170 ~~~~~~~--------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~ki~~~  238 (370)
T KOG0583|consen  170 ISPGEDG--------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYRKIRKG  238 (370)
T ss_pred             ccCCCCC--------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHHHHhcC
Confidence            773 222        234789999999999999987 75 89999999999999999999998743   33555556666


Q ss_pred             hcCCcHHHhhccC-hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          232 KVSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       232 ~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .+..|     ..+ +++++.|+.+||..||.+|+++.+|+  .+.+|+.
T Consensus       239 ~~~~p-----~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~  280 (370)
T KOG0583|consen  239 EFKIP-----SYLLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK  280 (370)
T ss_pred             CccCC-----CCcCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence            66655     333 88999999999999999999999997  4666655

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=363.27  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=213.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-Cchh--HHHHHHHHHHHcCCCCCCeEEEeeeeCC-eeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQ--LLYEAKVYKILQGGSGIPNIKWYGVDGE-DNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~--~~~E~~~l~~l~~~~~i~~i~~~~~~~~-~~~   79 (423)
                      ++-.+|.++++||.|+||.||+|+.+.++..||||.++..- ..++  -++|++.|++|..|++|..+.....+.+ ..+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            46689999999999999999999999999999999776542 2222  4799999999996677777765555555 899


Q ss_pred             EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +|||||..+|.++++..++.|++..+..|+.||++||+|+|.+|+.||||||+|||++   ....|||+|||+||.....
T Consensus        87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence            9999999999999998888899999999999999999999999999999999999994   5889999999999987654


Q ss_pred             CCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc-----
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-----  233 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-----  233 (423)
                      .     ||   ...+.|..|.|||++.. ..|+.+.||||+|||++|+.+-++.|.|.+..+...++-.+++...     
T Consensus       164 p-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  164 P-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             C-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            3     22   36788999999999875 4589999999999999999999999999766544444333332211     


Q ss_pred             -----------------CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 -----------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 -----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                       ..++..+....+.++.++|.+|+.+||++|||+.+.++
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                             11233445567899999999999999999999999876

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=337.52  Aligned_cols=259  Identities=23%  Similarity=0.336  Sum_probs=222.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+|++++.||.|+||.|.+++.+.++..+|+|+++....     .+....|..+|+.+.| +.+..+.+-+.+....|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccCCeEEEE
Confidence            579999999999999999999999999999999886642     2346789999999985 5566666677789999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||. ||.|..++.. .++|++..++.++.||+.||+|||+++|++|||||+|||+   |..|.+||+|||+|+.....+
T Consensus       123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~rT  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGRT  198 (355)
T ss_pred             EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCcE
Confidence            9999 8999999886 4579999999999999999999999999999999999999   699999999999999876543


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                                .+.+|||.|+|||++....|+.++|.|||||++|||+.|..||...+.   .+.+++|+..++..|.   
T Consensus       199 ----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP~---  262 (355)
T KOG0616|consen  199 ----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFPS---  262 (355)
T ss_pred             ----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCCc---
Confidence                      278999999999999999999999999999999999999999987554   5889999999998884   


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                        .++.++++|+..+|+.|-.+|-  ..+..--++   -.++.|....||+.+
T Consensus       263 --~fs~~~kdLl~~LL~vD~t~R~--gnlknG~~d---Ik~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  263 --YFSSDAKDLLKKLLQVDLTKRF--GNLKNGVED---IKNHPWFKGVDWEAI  308 (355)
T ss_pred             --ccCHHHHHHHHHHHhhhhHhhh--cCcCCCccc---cccCcccccccHHHH
Confidence              4488999999999999999992  112211122   245667777889765

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=355.57  Aligned_cols=269  Identities=25%  Similarity=0.342  Sum_probs=218.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +--++|++++.||+|+||+||+|+-+.||..+|+|++++...     ...++.|-.+|.. ...+.++.+++-+.+.+++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCee
Confidence            345789999999999999999999999999999999887643     2347788888888 4558888888889999999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ||||||+ ||++..+|.. .+.|++..+..++.+++.||+.||+.|+|||||||+|+||   |..|++||+|||||..+.
T Consensus       217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhh
Confidence            9999999 9999999986 5679999999999999999999999999999999999999   699999999999996443


Q ss_pred             CCCC------------------CCcccc----c------------------CCCcccccccccCcccccCCCCCccchHH
Q 014527          158 DPTT------------------NRHIPY----R------------------ENKNLTGTARYASCNTHLGIEQSRRDDLE  197 (423)
Q Consensus       158 ~~~~------------------~~~~~~----~------------------~~~~~~gt~~Y~aPE~~~~~~~s~~sDIw  197 (423)
                      ....                  ....+.    +                  .....+|||.|+|||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            2100                  000000    0                  01246899999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh--cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC---hHHHHHH
Q 014527          198 SLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKRL  272 (423)
Q Consensus       198 SlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~l~~~  272 (423)
                      ||||||||||.|-+||.+.++.   +.+.+|..-+  +..|.+..+   +++.++||.+||. ||++|..   ++||.  
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~---~T~rkI~nwr~~l~fP~~~~~---s~eA~DLI~rll~-d~~~RLG~~G~~EIK--  443 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQ---ETYRKIVNWRETLKFPEEVDL---SDEAKDLITRLLC-DPENRLGSKGAEEIK--  443 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhhhccCCCcCcc---cHHHHHHHHHHhc-CHHHhcCcccHHHHh--
Confidence            9999999999999999986655   4555555444  555544433   6899999999999 9999975   45553  


Q ss_pred             HHHHHHhcCCCCCcceeceecc
Q 014527          273 FHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       273 L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                              .+.|....||+.+.
T Consensus       444 --------~HPfF~~v~W~~l~  457 (550)
T KOG0605|consen  444 --------KHPFFKGVDWDHLR  457 (550)
T ss_pred             --------cCCccccCCcchhh
Confidence                    45666677887664

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=351.10  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC--eeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE--DNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~--~~~lv~   82 (423)
                      .+|..++.||+|+||.||++.+.++|+..|||......  ..+.+.+|+.+|..|+| ++|+.........+  .++|+|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~-p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNH-PNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCC-CCEEeeCCccccccCeeeEeee
Confidence            45888999999999999999999999999999765541  13458999999999994 44444433323333  689999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC-CCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +|+|.+++...+.++++..+..++.||++||+|||++|||||||||+|||+.   . ++.+||+|||+++......
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCcccccccccc
Confidence            999 9999999997666899999999999999999999999999999999999994   5 6899999999998766411


Q ss_pred             CCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..    ........||+.|||||++.+. ...+++|||||||++.||+||+.||...  ......+..+.....   .+.
T Consensus       173 ~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~---~P~  243 (313)
T KOG0198|consen  173 TK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDS---LPE  243 (313)
T ss_pred             cc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCC---CCC
Confidence            11    1223467899999999999953 3456999999999999999999999874  122233333333331   224


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ++..++++.++|+.+|+..+|++|||+++|++
T Consensus       244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             CCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            45667999999999999999999999999866

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=341.19  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=216.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ....|++.+.||.|..++||+|++..+++.||||+++.+..   .+.+.+|+..|..+.| ++|..++..+..+...|+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEecceeEEe
Confidence            46789999999999999999999999999999999876543   3568999999998877 5666777778888999999


Q ss_pred             Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |.|+ +|++.+++... ...+++..+..|+++++.||.|||.+|.||||||+.||||   +.+|.|||+|||.+..+...
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeeccc
Confidence            9999 99999999743 4569999999999999999999999999999999999999   59999999999999877765


Q ss_pred             CCCCcccccCCCcccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc-
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-  236 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  236 (423)
                      ...  ..++. ..+.||+.|||||++...  .|+.|+||||||++..||.+|..||..+.+.   +.+...+....+.+ 
T Consensus       180 G~R--~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  180 GDR--QVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLTLQNDPPTLL  253 (516)
T ss_pred             Cce--eeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHhcCCCCCcc
Confidence            422  22333 688999999999996533  4999999999999999999999999987654   33333333333211 


Q ss_pred             ----HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          237 ----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       237 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                          .....+.++..|+++|..||.+||.+||++++|++  ..+|+..
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk--h~FFk~~  299 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK--HAFFKKA  299 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc--cHHHhhc
Confidence                22233556789999999999999999999999977  4555543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-44  Score=349.75  Aligned_cols=263  Identities=19%  Similarity=0.321  Sum_probs=204.0

Q ss_pred             cccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeee-
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV-   73 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~-   73 (423)
                      ++-.++|++.+.||+|+||.||+|.+.     .+++.||||++.....   ...+.+|+.++..+.+|+++..+..++. 
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            345689999999999999999999853     3456799998875432   2358899999999955566666654433 


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhc-------------------------------------------------------
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCR-------------------------------------------------------   97 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~-------------------------------------------------------   97 (423)
                      .....+++|||+ +|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            445689999999 899999886421                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCC
Q 014527           98 ------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK  171 (423)
Q Consensus        98 ------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~  171 (423)
                            ..+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++........     ....
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~  234 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKG  234 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcch-----hccc
Confidence                  237788999999999999999999999999999999999   47889999999999865432211     1122


Q ss_pred             cccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHH
Q 014527          172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS  250 (423)
Q Consensus       172 ~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~  250 (423)
                      ...++..|+|||++.+..++.++|||||||++|||++ |..||.+.....  .....+.... ...   .....++.+.+
T Consensus       235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~-~~~---~~~~~~~~l~~  308 (338)
T cd05102         235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGT-RMR---APENATPEIYR  308 (338)
T ss_pred             CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCC-CCC---CCCCCCHHHHH
Confidence            3456788999999999999999999999999999997 999998744321  1111121111 111   12355889999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          251 YFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       251 li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ++.+||+.||++||++.+|++.|++++.+
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-44  Score=350.27  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=211.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+....    ..+.+|+++++.|+|++++..+.+| ....+.|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-Et~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-ETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-cccceEEEEe
Confidence            5799999999999999999999999999999987654332    2488999999999996655555554 4667899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |||-|+|..++.. .++++++.+..++.|++.||.|||+.+|+|||+||.|||+   +..+.+||||||+|+.....+. 
T Consensus        81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~-  155 (808)
T KOG0597|consen   81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS-  155 (808)
T ss_pred             hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence            9997799999886 6789999999999999999999999999999999999999   5899999999999998765433 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                            ......|||.|||||+..+.+|+..+|+||||||+||+++|++||..   ....+.+..|.......|.     
T Consensus       156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p~-----  221 (808)
T KOG0597|consen  156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPPS-----  221 (808)
T ss_pred             ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCcc-----
Confidence                  22467899999999999999999999999999999999999999975   3455667777776666664     


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+..|..|++.+|.+||.+|.+-.+|+.
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            44889999999999999999999888754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=355.27  Aligned_cols=244  Identities=23%  Similarity=0.332  Sum_probs=213.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +-|++++.||.|+.|.|-+|++..||+.+|||++....     ....+.+|+-+|+.+.|++ +..++....+..++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~Hpn-Vl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPN-VLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCC-eeeeeeeeccCceEEEE
Confidence            67999999999999999999999999999999987652     2345899999999999855 44455555577899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      +||+ +|.|.+++.. ++++++.++.+++.||+.|+.|+|..+|+||||||+|+|+   |..+.+||+|||+|..-....
T Consensus        91 lEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCc
Confidence            9999 9999999986 6779999999999999999999999999999999999999   577779999999997654333


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                              .-++.||++.|+|||++.|.+| +.++||||+|||||.|++|++||.+   .+....+.++..+.+..|   
T Consensus       167 --------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~MP---  232 (786)
T KOG0588|consen  167 --------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFEMP---  232 (786)
T ss_pred             --------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcccCC---
Confidence                    2347799999999999999998 6899999999999999999999985   345577888888888877   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                        ..+|.+.++||.+||..||+.|.+.++|++
T Consensus       233 --s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  233 --SNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             --CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence              566999999999999999999999999976

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=330.51  Aligned_cols=260  Identities=22%  Similarity=0.277  Sum_probs=214.2

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchh----HHHHHHHHHHHcCCCCCCeE--EEeeeeCCeeEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSGIPNI--KWYGVDGEDNVL   80 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~----~~~E~~~l~~l~~~~~i~~i--~~~~~~~~~~~l   80 (423)
                      ..|+.+.+|++|+||.||+|+++.+++.||+|.++.+.....    .++|+.+|..++| ++|..+  ...|..-+..||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceeee
Confidence            468899999999999999999999999999998887664443    5899999999996 556666  445667788999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||||..+|..++.....+|...++..++.|++.||+|||...|+||||||+|+|++   ..|.+||+|||+|+.+..+.
T Consensus       155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhcCCc
Confidence            999999999999998888999999999999999999999999999999999999995   89999999999999987764


Q ss_pred             CCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC----
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST----  235 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----  235 (423)
                      .       .....+-|..|.|||++.|.. |+...|+||+|||+.||+++++.|.|....+...++.+.+...-..    
T Consensus       232 k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  232 K-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             c-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            3       223678899999999999876 9999999999999999999999999976665555544433221100    


Q ss_pred             ---------------cHHHh-----hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          236 ---------------PIEVL-----CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       236 ---------------~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                     |...+     +..+++.-.+|+..+|.+||.+|.|+++-++  +.+|.+
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e  366 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRE  366 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--cccccc
Confidence                           00001     1113467789999999999999999998765  555554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5e-44  Score=318.23  Aligned_cols=260  Identities=20%  Similarity=0.255  Sum_probs=213.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .+|...++||+|.||.||+|++..+|+.||||.++....    .-...+|++.|+.++|. +|..+...+...+..-||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~-nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHP-NIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCc-chhhhhhhccCCCceEEEE
Confidence            578999999999999999999999999999998776543    33579999999999974 4555555556778899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+..+|+..++.....++...+..|+.+++.||+|||++.|+||||||.|+|++   .++.+||+|||+|+.+..+...
T Consensus        81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCcc
Confidence            9999999999998788899999999999999999999999999999999999995   8999999999999998766543


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc-----
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-----  236 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-----  236 (423)
                      .       ...+-|..|.|||.+.|.. |+...|+||.|||+.||+.|.+-|.|.++.+....+.++.+......     
T Consensus       158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            2       1337799999999998765 99999999999999999999999999776655554444332221111     


Q ss_pred             ---------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          237 ---------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       237 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                     ...+....+.+..+|+..||..||.+|+++.+.++  ...|+.
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~  286 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKS  286 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhc
Confidence                           11122334667899999999999999999998865  455543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=351.68  Aligned_cols=253  Identities=22%  Similarity=0.366  Sum_probs=210.2

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|...++||+|+.|.||.|+...+++.||||.+...  ...+-+..|+.+|+.++|.+.+..+..|-.. +..|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence            5688899999999999999999999999999976544  4455589999999999987766666555444 889999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + ||+|.|++..  ..+++.++..|+++++.||+|||.+||+|||||.+|||++   .++.+||+|||+|..+...... 
T Consensus       352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~K-  425 (550)
T KOG0578|consen  352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQSK-  425 (550)
T ss_pred             cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccCc-
Confidence            9 8999998874  4499999999999999999999999999999999999995   7888999999999988766553 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            ..+.+||+.|||||+.....|+++.||||||++++||+.|++||-..+..   +.+..|.....  |.-.....
T Consensus       426 ------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---rAlyLIa~ng~--P~lk~~~k  494 (550)
T KOG0578|consen  426 ------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGT--PKLKNPEK  494 (550)
T ss_pred             ------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---HHHHHHhhcCC--CCcCCccc
Confidence                  34889999999999999999999999999999999999999999864433   22222222111  11122345


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +++.|++|+.+||..|+++|+++.+|++  +.+++.
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl~~  528 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLE--HPFLKM  528 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhc--Chhhhh
Confidence            6899999999999999999999999977  455543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=348.14  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=211.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~---~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ...|+..+.||+|+||.||+|.+..+++.||||++..+....   .+++|+.++..+++ +++-.++.....+...+++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHHH
Confidence            457888999999999999999999999999999988665443   57889999999887 55555556666888999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||| ||++.+++.. ...+.+..+..++++++.||.|||.++.+|||||+.|||++   ..+.|||+|||.+..+.....
T Consensus        91 ey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence            999 8999999874 34458899999999999999999999999999999999996   569999999999988776553


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                      .       ..+++||+.|||||++.+..|+.++||||||++++||++|.+||....+......+    .+.   +.+.+.
T Consensus       167 r-------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----pk~---~PP~L~  232 (467)
T KOG0201|consen  167 R-------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----PKS---APPRLD  232 (467)
T ss_pred             c-------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----cCC---CCCccc
Confidence            2       25889999999999999989999999999999999999999999987764322211    111   122333


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..+++.|++||..||.+||+.||++.+|++  +++++.
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK--h~FIk~  268 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK--HKFIKR  268 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhh--hHHHHh
Confidence            467889999999999999999999999976  455544

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-44  Score=340.62  Aligned_cols=241  Identities=24%  Similarity=0.340  Sum_probs=200.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....     ....+.+|+.+++.+.| +++..+..+..+....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccCCeEEEE
Confidence            47999999999999999999999999999999876432     23457889999999987 5555566666677889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence            9999 8899998875 4579999999999999999999999999999999999999   478899999999997654321


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                                ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   +.+..+.......+    
T Consensus       156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~----  218 (291)
T cd05612         156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILAGKLEFP----  218 (291)
T ss_pred             ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCcCCC----
Confidence                      1457899999999999999999999999999999999999999875433   34444444443333    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCC-----hHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLK  270 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~~l~  270 (423)
                       ..++..+.+||.+||..||.+||+     +++++
T Consensus       219 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l  252 (291)
T cd05612         219 -RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK  252 (291)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence             344789999999999999999995     66554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.1e-43  Score=334.09  Aligned_cols=254  Identities=21%  Similarity=0.266  Sum_probs=202.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||.|+||.||+|++..+++.||+|++....   ....+.+|+.+++.++| +++..+..+.......++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH-ANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEEe
Confidence            57999999999999999999999999999999876432   23457899999999987 556666666677788999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc--
Confidence            99889999887766678999999999999999999999999999999999999   4788999999999976543221  


Q ss_pred             cccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc---------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV---------  233 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---------  233 (423)
                           ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+........         
T Consensus       159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence                 1124568999999999876 4589999999999999999999999987554333222222111000         


Q ss_pred             -------------CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 -------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   ..+.......++.++.+||.+||..||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                         00011112345778999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6e-43  Score=339.82  Aligned_cols=240  Identities=22%  Similarity=0.303  Sum_probs=201.3

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +|++.+.||+|+||.||+|++..+++.||||++...     .....+..|.+++..+.|+++++.+..++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999987643     223457789999999998888888888888888999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence            999 8899888765 4568999999999999999999999999999999999999   4788999999999875322211


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   +.+..+.......+     
T Consensus       157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~~-----  221 (324)
T cd05587         157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSYP-----  221 (324)
T ss_pred             -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-----
Confidence                   122457899999999999999999999999999999999999999875433   34444444333322     


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCCh
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~  266 (423)
                      ..++.++.+++.+||..||.+|++.
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            3468899999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=352.19  Aligned_cols=243  Identities=23%  Similarity=0.340  Sum_probs=211.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +--.+|.+++.||+|+||.|++|..+.+++.+|||+++++.     ..+....|.+|+.....|+.+..+..++...++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            44578999999999999999999999999999999988764     3445889999999999888888899999999999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ ||++...  ...+.|++..+..++..|+.||.|||++||||||||.+|||+   |..|.+||+|||+++...
T Consensus       445 ~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence            9999999 6663222  224679999999999999999999999999999999999999   699999999999998654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....       ...+++|||.|||||++.+..|+.++|.|||||+||||+.|..||.+.+.   .+.++.|.......|.
T Consensus       520 ~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~FdsI~~d~~~yP~  589 (694)
T KOG0694|consen  520 GQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFDSIVNDEVRYPR  589 (694)
T ss_pred             CCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCCCCCC
Confidence            2221       34589999999999999999999999999999999999999999998544   4667777777777664


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCCh
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~  266 (423)
                           .++.+..+||+++|.++|++|..+
T Consensus       590 -----~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  590 -----FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----cccHHHHHHHHHHhccCcccccCC
Confidence                 448999999999999999999865

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-43  Score=341.82  Aligned_cols=237  Identities=23%  Similarity=0.347  Sum_probs=199.5

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      -++|++.+.||+|+||.||+|++..+++.||||++....     ....+.+|+.++..+.| +++..+..+..+.+..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEcCCEEEE
Confidence            478999999999999999999999999999999876432     23457899999999987 556566666677889999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC
Confidence            99999 8899988875 4578999999999999999999999999999999999999   57889999999999876432


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      .          ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......+   
T Consensus       172 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~p---  235 (329)
T PTZ00263        172 T----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEKILAGRLKFP---  235 (329)
T ss_pred             c----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHHHhcCCcCCC---
Confidence            2          1457899999999999999999999999999999999999999865432   34444544443333   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCC
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPD  265 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt  265 (423)
                        ..++..+.+||.+||+.||.+||+
T Consensus       236 --~~~~~~~~~li~~~L~~dP~~R~~  259 (329)
T PTZ00263        236 --NWFDGRARDLVKGLLQTDHTKRLG  259 (329)
T ss_pred             --CCCCHHHHHHHHHHhhcCHHHcCC
Confidence              335789999999999999999997

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-43  Score=332.34  Aligned_cols=255  Identities=20%  Similarity=0.253  Sum_probs=200.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||++....    ....+.+|+.+++.++|++ +..+..+....+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN-IVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCcc-ccchhhhEecCCEEEEEE
Confidence            47999999999999999999999999999999876542    2345788999999998754 555555566778899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+.+++.+.+......+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence            999777777766556679999999999999999999999999999999999999   47889999999999876432211


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh----------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------  232 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------  232 (423)
                            ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+....          
T Consensus       157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence                  1124578999999999999899999999999999999999999998754433222222111000          


Q ss_pred             ------cCCc--------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 ------VSTP--------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ------~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                            ...+        .......++..+.+||.+||..||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  0000        00111235788999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.5e-42  Score=332.22  Aligned_cols=253  Identities=20%  Similarity=0.244  Sum_probs=199.9

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+.+++.+.| +++..+..+..+....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC-CCcCeEEEEEecCCeEEEEE
Confidence            4689999999999999999999999999999998764432   2357789999999987 55666767777788999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++....... 
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-  158 (303)
T cd07869          83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH-  158 (303)
T ss_pred             ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence            999999999888766779999999999999999999999999999999999999   4788999999999875433221 


Q ss_pred             CcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------  235 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------  235 (423)
                            ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+....  ...+..+.......      
T Consensus       159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhcc
Confidence                  11245689999999998764 5889999999999999999999999875432  11222111100000      


Q ss_pred             -------------------cHHHh--hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 -------------------PIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 -------------------~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                         .....  ...++..+.+|+.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                               00000  0123567899999999999999999998865

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=8.7e-43  Score=332.50  Aligned_cols=248  Identities=19%  Similarity=0.267  Sum_probs=197.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+|+.++..+.|+ ++..+..++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCC-cEEEEEEEEccCCeEEEEE
Confidence            3889999999999999999999999999999876432     223467899999999874 4555555566778899999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+   ++++.++|+|||++.......
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence            999 78898777543 3468999999999999999999999999999999999999   578899999999998754322


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .        .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+....    .......
T Consensus       157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~  224 (285)
T cd05631         157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV----KEDQEEY  224 (285)
T ss_pred             e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh----hcccccC
Confidence            1        124578999999999999999999999999999999999999998754332222222211    1111223


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCC-----hHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~~l~~  271 (423)
                      ...++.++.+|+.+||+.||.+||+     ++++++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            3456889999999999999999997     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=341.10  Aligned_cols=249  Identities=21%  Similarity=0.307  Sum_probs=202.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||++....     ....+..|+.++..+.| +++..+..++......|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence            47999999999999999999999999999999876432     23457889999999985 6666676777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~-  154 (333)
T cd05600          80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY-  154 (333)
T ss_pred             EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc-
Confidence            9999 8899998865 4568999999999999999999999999999999999999   57889999999999765431 


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH-
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV-  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-  239 (423)
                               .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.... .....+... 
T Consensus       155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  224 (333)
T cd05600         155 ---------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETLQRPVYDD  224 (333)
T ss_pred             ---------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCCc
Confidence                     125579999999999999999999999999999999999999998754432222221111 111111110 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....+++++.++|.+||..+|.+||++++|++
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            01245889999999999999999999888865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-42  Score=333.36  Aligned_cols=262  Identities=19%  Similarity=0.277  Sum_probs=201.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC----------------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSG   64 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~----------------~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~   64 (423)
                      +..++|++.+.||+|+||.||+|.+..                ++..||+|++.....   ...+.+|++++..++| ++
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CC
Confidence            456899999999999999999998642                344799998876432   2358899999999987 55


Q ss_pred             CCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q 014527           65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------RKFSLKTVLMLADQMIARIEYVHSRGFL  125 (423)
Q Consensus        65 i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~------------------~~l~~~~~~~i~~qi~~aL~yLH~~gii  125 (423)
                      +..+..++.+.+..++||||+ +++|.+++....                  ..+++..++.++.||+.||.|||++||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            666666667778899999999 889999886421                  2367888999999999999999999999


Q ss_pred             cccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHH
Q 014527          126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY  205 (423)
Q Consensus       126 HrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~e  205 (423)
                      ||||||+|||+   +.++.+||+|||+++........     .......++..|+|||++.+..++.++|||||||++||
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  232 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYY-----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE  232 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCcee-----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence            99999999999   47889999999999865433211     11223456789999999998889999999999999999


Q ss_pred             HHh--CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          206 FLR--GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       206 llt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      |++  +..||.+............................+|..+.+||.+||+.+|++||++++|.+.|+
T Consensus       233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            986  678888765433222222211111111001112345889999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-42  Score=337.49  Aligned_cols=261  Identities=20%  Similarity=0.267  Sum_probs=199.4

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeee----eCCeeE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNV   79 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~----~~~~~~   79 (423)
                      +|++.+.||+|+||.||+|++..+++.||||++...    .....+.+|+++++.++|++.+..+..+..    .....|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            699999999999999999999999999999987642    223357899999999987554443333321    123579


Q ss_pred             EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence            9999999999998875 4569999999999999999999999999999999999999   57889999999999865332


Q ss_pred             CCCCcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH---------
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI---------  228 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i---------  228 (423)
                      ....    .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.........+...         
T Consensus       157 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         157 TPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            2111    01124578999999999876  56899999999999999999999999875432211111110         


Q ss_pred             --------------HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          229 --------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       229 --------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                    .......+........++.+.++|.+||..||++||+++++++  +.+|+
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~--hp~f~  294 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA--DPYFK  294 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc--Cchhh
Confidence                          1111122222333456788999999999999999999999876  44443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-43  Score=330.52  Aligned_cols=270  Identities=20%  Similarity=0.317  Sum_probs=223.5

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      -+.|++++.||.|.-|+||+|+.+.++..+|+|++.+..     ...+.+.|.+||..+.| +.+|.++..+...+..|+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEE
Confidence            357889999999999999999999999999999987653     23457789999999987 778899888889999999


Q ss_pred             EEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           81 VLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +|||| ||+|..+++.+. +.|++..+..++..++.||+|||-.|||+|||||+||||   .++|.|.|+||.++.....
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCC
Confidence            99999 999999988654 569999999999999999999999999999999999999   5899999999999864321


Q ss_pred             CCC--------------------------------CC-----------------cccccCCCcccccccccCcccccCCC
Q 014527          159 PTT--------------------------------NR-----------------HIPYRENKNLTGTARYASCNTHLGIE  189 (423)
Q Consensus       159 ~~~--------------------------------~~-----------------~~~~~~~~~~~gt~~Y~aPE~~~~~~  189 (423)
                      ..+                                ..                 ...-.....++||-.|.|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            000                                00                 00001234678999999999999999


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC----
Q 014527          190 QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD----  265 (423)
Q Consensus       190 ~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----  265 (423)
                      .+.++|+|+|||++|||+.|..||.|....   +.+..|+......|...   ..+..+++||+++|.+||.+|..    
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~---~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~~rG  385 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---ETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGSKRG  385 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCch---hhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhccccc
Confidence            999999999999999999999999986544   66677777777666443   44688999999999999999987    


Q ss_pred             hHHHHHHHHHHHHhcCCCCCcceeceeccc
Q 014527          266 YGFLKRLFHDLFSREGYDFDFVFDWTILKY  295 (423)
Q Consensus       266 ~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~  295 (423)
                      +.+|          ..+.|....+|..++.
T Consensus       386 A~eI----------K~HpFF~gVnWaLir~  405 (459)
T KOG0610|consen  386 AAEI----------KRHPFFEGVNWALIRC  405 (459)
T ss_pred             hHHh----------hcCccccCCChhheec
Confidence            5665          3466777788987653

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.5e-43  Score=348.21  Aligned_cols=259  Identities=24%  Similarity=0.327  Sum_probs=209.3

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcC-----CCCCCeEEEeeeeC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG-----GSGIPNIKWYGVDG   75 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~-----~~~i~~i~~~~~~~   75 (423)
                      ...+..+|+|.+.||+|+||.|-+|.+..|++.||||+++.... ..+...|+.+|..|+.     ..++..+..|+...
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            34567799999999999999999999999999999999987653 4567889999999982     24566678888899


Q ss_pred             CeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ++.|||+|++..+|.++++..+ ..++...+..++.||+.||.+||+.||||+||||+|||+... ....|||+|||+|.
T Consensus       261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSC  339 (586)
T ss_pred             cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEeccccc
Confidence            9999999999999999998643 459999999999999999999999999999999999999532 34589999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc-
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-  233 (423)
                      .......          ..+.+..|.|||++.|.+|+.+.|+||||||++||++|.+.|.|.+..+....+.++.+... 
T Consensus       340 ~~~q~vy----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  340 FESQRVY----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             ccCCcce----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            7554332          55788999999999999999999999999999999999999998665544443333221100 


Q ss_pred             ------------------------------------------------CCc-----HHH-hhccChHHHHHHHHHHhcCC
Q 014527          234 ------------------------------------------------STP-----IEV-LCKSHPAEFASYFHYCQSLT  259 (423)
Q Consensus       234 ------------------------------------------------~~~-----~~~-~~~~~~~~l~~li~~cl~~d  259 (423)
                                                                      ..|     ... +....-..|.++|.+||.+|
T Consensus       410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d  489 (586)
T KOG0667|consen  410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD  489 (586)
T ss_pred             HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence                                                            000     000 00011246899999999999


Q ss_pred             CCCCCChHHHHH
Q 014527          260 FDQRPDYGFLKR  271 (423)
Q Consensus       260 P~~RPt~~~l~~  271 (423)
                      |.+|++..+.++
T Consensus       490 P~~R~tp~qal~  501 (586)
T KOG0667|consen  490 PAERITPAQALN  501 (586)
T ss_pred             chhcCCHHHHhc
Confidence            999999988755

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.5e-42  Score=327.89  Aligned_cols=254  Identities=20%  Similarity=0.261  Sum_probs=196.9

Q ss_pred             CceEEeceeeecCceeEEEEEECC-CCcEEEEEEecCCCC----chhHHHHHHHHHHHc--CCCCCCeEEEeee-----e
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYGV-----D   74 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~-~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~i~~~~~-----~   74 (423)
                      ++|++.+.||+|+||.||+|++.. +++.||||++.....    ...+.+|+.+++.+.  .|+++..+..++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999864 468899998764332    234678888888775  2455555544332     3


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ....++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence            45689999999999999987543 458999999999999999999999999999999999999   47889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh---
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---  230 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---  230 (423)
                      +......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.....   
T Consensus       158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~  229 (290)
T cd07862         158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  229 (290)
T ss_pred             EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            8654321        12255789999999999998999999999999999999999999987654432222211110   


Q ss_pred             ----------------hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 ----------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                      .....+.+.....++..+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                            00111122333456788999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-42  Score=336.15  Aligned_cols=240  Identities=21%  Similarity=0.308  Sum_probs=201.0

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +|++.+.||+|+||.||+|++..+++.||||++....     .......|..++..+.+++++..+..++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999877532     12235678888888888888888888888888999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence            999 8899888765 4569999999999999999999999999999999999999   5788999999999975432211


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....   ..+..+.......|     
T Consensus       157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~~~~p-----  221 (323)
T cd05616         157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHNVAYP-----  221 (323)
T ss_pred             -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence                   122557999999999999999999999999999999999999999875443   34444554444333     


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCCh
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~  266 (423)
                      ..++.++.+++.+||+.+|++|++.
T Consensus       222 ~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            3468899999999999999999986

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.9e-43  Score=338.21  Aligned_cols=239  Identities=22%  Similarity=0.306  Sum_probs=194.9

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||||++....     ....+.+|+.+++.+.| +++..+..++...+..++||||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999886432     22346789999999987 55666666677888999999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~-----  150 (323)
T cd05571          80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA-----  150 (323)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence            889888765 5679999999999999999999999999999999999999   5788999999999875332211     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..   ..+..+.......+     ..+++
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~~~~~~~p-----~~~~~  220 (323)
T cd05571         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP-----RTLSP  220 (323)
T ss_pred             --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence              123567999999999999999999999999999999999999999764332   33333333333322     45688


Q ss_pred             HHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      ++.++|.+||..||++||     ++.+|++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            999999999999999999     6776643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=346.34  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=205.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      |..+...+++.||+|.||+||+|+|-  | .||||+++.+..    .+.|..|+.++++-+|.+ |..+..|...... .
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N-IlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN-ILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh-heeeehhhcCCce-e
Confidence            45567789999999999999999983  3 499999886543    334899999999999854 4444445544444 8


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||+.+| |.+|..++...+.+|...+.+.|+.||++|+.|||.++|||||||..|||+   .++++|||+|||++..-..
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeee
Confidence            999999 778999998777889999999999999999999999999999999999999   4679999999999975432


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      -....     ......|...|||||+++.+   +|++.+|||||||++|||++|.+||....   ..+.+..+..+-...
T Consensus       541 w~g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---~dqIifmVGrG~l~p  612 (678)
T KOG0193|consen  541 WSGEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---RDQIIFMVGRGYLMP  612 (678)
T ss_pred             ecccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC---hhheEEEecccccCc
Confidence            21111     22355788999999999744   58999999999999999999999998422   223333333332233


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      .........|.++++|+..||..++++||.|.+|+..|+.++.
T Consensus       613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            3334445668999999999999999999999999998887765

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-43  Score=327.03  Aligned_cols=259  Identities=23%  Similarity=0.303  Sum_probs=208.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC----eeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE----DNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~----~~~lv~   82 (423)
                      -.|+-.+.+|.|+||.||.|....+++.||||..-.+...  -.+|+.+|+.+.|++.+..+++|....+    +..+||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            3688899999999999999999999999999965554433  3489999999998666665555544322    346999


Q ss_pred             eccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           83 DLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        83 e~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||+..+|.+.++..   +.+++...+..+..||++||.|||+.||+||||||.|+|++  .+.+.+||||||.|+.+...
T Consensus       102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccC
Confidence            99999999998853   57799999999999999999999999999999999999995  45699999999999988765


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH-
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI-  237 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-  237 (423)
                      +.+        .....|..|.|||.+.|.. |+.+.||||.|||+.||+.|++.|.|.+..+....+.++.+..-...+ 
T Consensus       180 epn--------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  180 EPN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             CCc--------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            533        3667899999999999875 999999999999999999999999997766555544444322111111 


Q ss_pred             --------------------HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          238 --------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       238 --------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                          .......+++..+|+.++|.++|.+|.++.+++.  +.+|.+
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFde  311 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFDE  311 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhHH
Confidence                                1133456899999999999999999999988855  444443

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3e-42  Score=341.43  Aligned_cols=258  Identities=20%  Similarity=0.326  Sum_probs=204.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .++|++.+.||+|+||.||+|++...     +..||||++.....   ...+.+|+.+++.+..|++++.+..++.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            45799999999999999999986543     35799999875432   23478899999999656777777777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR-----------------------------------------------------------   97 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------------------------------------------   97 (423)
                      .++||||+ +|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999 899999885421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccc
Q 014527           98 ----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY  167 (423)
Q Consensus        98 ----------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~  167 (423)
                                ..+++..++.++.||+.||.|||++||+||||||+|||++   +++.+||+|||+++........     
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~-----  268 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNY-----  268 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcce-----
Confidence                      2378889999999999999999999999999999999994   7889999999999865433211     


Q ss_pred             cCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.......   .+...........   .....|+
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~---~~~~~~~  342 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMS---RPDFAPP  342 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCcc---CCCCCCH
Confidence            11123345678999999998899999999999999999997 999998654321   2222222222221   1133588


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ++.+++.+||+.||++||++.+|++.|++++
T Consensus       343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.4e-42  Score=346.26  Aligned_cols=261  Identities=22%  Similarity=0.263  Sum_probs=198.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee-------eCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-------DGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-------~~~   76 (423)
                      ...++|++++.||+|+||.||+|.+..+++.||||.+....  ....+|+.+++.++|++.+.....+..       ...
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            34578999999999999999999999999999999875433  335679999999988665554433322       112


Q ss_pred             eeEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           77 DNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ..++||||++++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++  ...+.+||+|||+|
T Consensus       141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla  218 (440)
T PTZ00036        141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccc
Confidence            4679999999999887753   245699999999999999999999999999999999999994  23457999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +.+.....        .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+.......
T Consensus       219 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        219 KNLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             hhccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            86643221        1245789999999998764 58999999999999999999999998765443222222211100


Q ss_pred             --------------cCCc-------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          233 --------------VSTP-------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       233 --------------~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                    ...+       ...+....|+++.+||.+||..||.+||++.+++.  +.+|.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~--hp~f~  355 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA--DPFFD  355 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC--ChhHH
Confidence                          0000       01122346789999999999999999999999865  44443

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.6e-42  Score=350.69  Aligned_cols=256  Identities=19%  Similarity=0.254  Sum_probs=193.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCC-----CCCeEEE-eeeeCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGS-----GIPNIKW-YGVDGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~-----~i~~i~~-~~~~~~~   77 (423)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++... .......|+.+++.+.+..     ++..+.. +......
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            3578999999999999999999999999999999986532 2334677888888887643     2333433 3334567


Q ss_pred             eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecC-------------CCC
Q 014527           78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR-------------KAN  143 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~-------------~~~  143 (423)
                      .|+||++++++|.+++.. .+.+++..+..|+.||+.||+|||+ .|||||||||+|||++..+             +..
T Consensus       207 ~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        207 MCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            899999999999998875 4579999999999999999999998 5999999999999995321             112


Q ss_pred             cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHH
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ  223 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~  223 (423)
                      .+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+........
T Consensus       286 ~vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        286 RVRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             eEEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            5999999987543211          225689999999999999999999999999999999999999998755433332


Q ss_pred             HHHHHHhhhc-------------------------CCcHH--Hh-------hccChHHHHHHHHHHhcCCCCCCCChHHH
Q 014527          224 KYDKICEKKV-------------------------STPIE--VL-------CKSHPAEFASYFHYCQSLTFDQRPDYGFL  269 (423)
Q Consensus       224 ~~~~i~~~~~-------------------------~~~~~--~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~~l  269 (423)
                      .+.++.....                         ..+..  ..       .....+.+.+||.+||.+||++||+++++
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~  435 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM  435 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence            2222211000                         00000  00       00013567899999999999999999999


Q ss_pred             HH
Q 014527          270 KR  271 (423)
Q Consensus       270 ~~  271 (423)
                      ++
T Consensus       436 L~  437 (467)
T PTZ00284        436 TT  437 (467)
T ss_pred             hc
Confidence            76

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.5e-42  Score=326.91  Aligned_cols=262  Identities=26%  Similarity=0.453  Sum_probs=192.0

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCC---CcEEEEEEecCCCCchhH----------HHHHHH---HHHHcCCCC
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKHPQL----------LYEAKV---YKILQGGSG   64 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~~~~~----------~~E~~~---l~~l~~~~~   64 (423)
                      +..+.+++|++.+.||+|+||.||+|.+..+   +..+|+|+..........          ..++..   +..+.| .+
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h-~~   84 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH-LG   84 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC-CC
Confidence            3568889999999999999999999998877   667888875433221100          111222   222333 44


Q ss_pred             CCeEEEeeeeCC----eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC
Q 014527           65 IPNIKWYGVDGE----DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR  140 (423)
Q Consensus        65 i~~i~~~~~~~~----~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~  140 (423)
                      ++.+..++....    ..+++|+++..++.+++.. ....++..+..++.||+.||+|||+++|+||||||+|||+   +
T Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~  160 (294)
T PHA02882         85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---D  160 (294)
T ss_pred             CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---c
Confidence            555554444332    4578899988888887765 3346888899999999999999999999999999999999   4


Q ss_pred             CCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh
Q 014527          141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT  220 (423)
Q Consensus       141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~  220 (423)
                      ..+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            77899999999998775432211111111224579999999999999999999999999999999999999998763221


Q ss_pred             hHH------HHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          221 KKQ------KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       221 ~~~------~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ...      .+..+....      ......|..+.+++..||..+|++||++++|++.|
T Consensus       241 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            111      111111111      12245588999999999999999999999998876

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-42  Score=340.84  Aligned_cols=257  Identities=18%  Similarity=0.185  Sum_probs=200.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..++|++.+.||+|+||.||+|.+..+++.||||...    ...+.+|+++++.|+| ++|..+..++......++|||+
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINH-PSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCC-CCCCCEeEEEEECCeeEEEEec
Confidence            4578999999999999999999999999999999753    2357899999999987 5566666666778889999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      ++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+|+........  
T Consensus       165 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~--  238 (391)
T PHA03212        165 YKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINAN--  238 (391)
T ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccccc--
Confidence            99999888865 4568999999999999999999999999999999999999   47889999999999754322211  


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh----hHHHHHHHHhhhc-------
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----KKQKYDKICEKKV-------  233 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~i~~~~~-------  233 (423)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||.......    ....+..+.....       
T Consensus       239 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        239 ----KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ----ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence                1224679999999999999999999999999999999999998875422100    0011111111000       


Q ss_pred             -------------------C----CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          234 -------------------S----TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       234 -------------------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                         .    .+.......+|.++.+||.+||+.||.+||+++++++  +.+|.
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~  380 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQ  380 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--Chhhc
Confidence                               0    0000111235778999999999999999999999976  45543

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.7e-42  Score=332.91  Aligned_cols=241  Identities=22%  Similarity=0.318  Sum_probs=201.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +|++.+.||+|+||.||+|++..+++.||||++...     .....+..|..++..+.|++++..+..++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            478999999999999999999999999999987643     222346788899988888888888888888888999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence            999 8899888764 4569999999999999999999999999999999999999   5788999999999875432221


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   ..+..+.......+     
T Consensus       157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~p-----  221 (323)
T cd05615         157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSYP-----  221 (323)
T ss_pred             -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence                   123457899999999999999999999999999999999999999875432   34444544444333     


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYG  267 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~  267 (423)
                      ..++.++.+++.+||..+|.+|++..
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         222 KSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            34588999999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=322.68  Aligned_cols=263  Identities=21%  Similarity=0.253  Sum_probs=209.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEec----CCCCchhHHHHHHHHHHHcCCCCCCeEEEeee----eCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~----~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~----~~~   76 (423)
                      +..+|..++.||.|+||.|..|.++.+|+.||||.+.    .....++..+|+++++.++|.+.+.....+..    .-.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4567777899999999999999999999999999654    33445568999999999998666655555544    345


Q ss_pred             eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ..|+|+|+++.+|..+++. +..++...+..++.||+.||.|+|+.+|+||||||.|+|+   +.+..+||||||+|+..
T Consensus       100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL  175 (359)
T ss_pred             eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence            7899999999999998875 4459999999999999999999999999999999999999   58889999999999987


Q ss_pred             cCCCCCCcccccCCCcccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH-------
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI-------  228 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i-------  228 (423)
                      .......     .....+.|..|.|||++. ...|+.+.||||+||||.||++|+..|.|.+.....+.+..+       
T Consensus       176 ~~~~~~~-----~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  176 DKFFEDG-----FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             cccCccc-----chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            5431111     123668899999999876 456999999999999999999999999985544333222221       


Q ss_pred             ----------------HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          229 ----------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       229 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                      .......+...+.++.++...+|+.+||..||.+|+|+++.++  +..+.
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~--hPYl~  314 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA--HPYLA  314 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc--Chhhh
Confidence                            1122233344555677889999999999999999999998865  44443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.1e-42  Score=323.25  Aligned_cols=256  Identities=14%  Similarity=0.237  Sum_probs=204.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      |-..+|++.+.||+|+||.||+|.+.   ..+..||+|+++.....   ..+.+|+.++..++| +++..+..+......
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecCCC
Confidence            45678999999999999999999875   34668999988765332   347889999999876 566677777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+   +.++.++|+|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence            99999999 778888887655679999999999999999999999999999999999999   47889999999987653


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......      ......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.....   .+..+.. ....
T Consensus       158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~-~~~~  227 (266)
T cd05064         158 KSEAIY------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVED-GFRL  227 (266)
T ss_pred             cccchh------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHC-CCCC
Confidence            221110      1113345678999999999999999999999999999775 999998765432   2222222 2222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +.   ...+|..+.+++.+||+.+|++||++++|.+.|+.+
T Consensus       228 ~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 PA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            22   245689999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-42  Score=335.44  Aligned_cols=244  Identities=24%  Similarity=0.320  Sum_probs=200.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCC-cEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~-~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +.-++|++.+.||+|+||.||+|.+..++ ..||+|++...     .....+.+|+.++..+.| +++..+..++.+...
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~  105 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDESY  105 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEEeCCE
Confidence            44568999999999999999999876554 68999987532     233457889999999987 556667667778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence            99999999 8899998875 4579999999999999999999999999999999999999   57889999999999865


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ....          ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..   ..+..+.......|
T Consensus       182 ~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p  248 (340)
T PTZ00426        182 DTRT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKILEGIIYFP  248 (340)
T ss_pred             CCCc----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHhcCCCCCC
Confidence            4321          2457999999999999988999999999999999999999999875432   33444544443333


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCC-----ChHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLK  270 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~  270 (423)
                           ..+++.+.++|.+||+.+|.+|+     ++++|+
T Consensus       249 -----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~  282 (340)
T PTZ00426        249 -----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK  282 (340)
T ss_pred             -----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence                 34588999999999999999996     666654

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.7e-42  Score=339.55  Aligned_cols=257  Identities=21%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             CCceEEeceeeecCceeEEEEEE-----CCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~-----~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .++|++.+.||+|+||.||+|++     ..++..||||+++...   ....+.+|+.++..+.+|+++..+..++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35799999999999999999975     2456789999986543   233578899999999666788888778888889


Q ss_pred             eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR-----------------------------------------------------------   97 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------------------------------------------   97 (423)
                      .++||||+ +|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            99999999 899998886422                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           98 ---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        98 ---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                                     ..+++..++.++.||+.||.|||++||+||||||+|||++   ..+.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcccc
Confidence                           1367888999999999999999999999999999999994   6788999999999866433211


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                           .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .+.+..........   .
T Consensus       271 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~  339 (375)
T cd05104         271 -----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKMIKEGYRMLS---P  339 (375)
T ss_pred             -----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHHHHhCccCCC---C
Confidence                 11123345678999999999999999999999999999998 899998654321   11222222222111   1


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ...|.++.+||..||+.||++||++.+|++.|++.
T Consensus       340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            23478999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.5e-42  Score=334.72  Aligned_cols=244  Identities=22%  Similarity=0.325  Sum_probs=195.8

Q ss_pred             ceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++...      .....+..|+.++..+.+++++..+..++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999874   47889999987642      12234778999999998888888888888888899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence            9999999 8899888865 5569999999999999999999999999999999999999   478899999999997654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHH-HHHHHHhhhcCC
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ-KYDKICEKKVST  235 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~  235 (423)
                      ......      .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... ....+...... 
T Consensus       157 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  229 (332)
T cd05614         157 SEEKER------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-  229 (332)
T ss_pred             ccCCCc------cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC-
Confidence            332211      12457999999999998754 7899999999999999999999997543222222 22222222221 


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCCh
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  266 (423)
                          ....++..+.++|.+||..||++||++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             ----CCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence                223468899999999999999999944

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=333.05  Aligned_cols=239  Identities=23%  Similarity=0.327  Sum_probs=193.9

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ||+|+||.||+|++..+++.||+|++...     .....+.+|+.++..++|+ ++..+..++...+..++||||+ +++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCP-FIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-cEeceeeEEecCCeEEEEEcCCCCCc
Confidence            79999999999999999999999987642     2233467899999999774 4555655666778999999999 889


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                      |.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......       
T Consensus        80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-------  148 (312)
T cd05585          80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD-------  148 (312)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence            9988875 5579999999999999999999999999999999999999   5788999999999875432221       


Q ss_pred             CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHH
Q 014527          169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF  248 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  248 (423)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......+     ..+++++
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~  220 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRKILQEPLRFP-----DGFDRDA  220 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCCCCC-----CcCCHHH
Confidence            122457999999999999999999999999999999999999999864432   33444444333332     4568899


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          249 ASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       249 ~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      .++|.+||..||.+||++..+.++|
T Consensus       221 ~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         221 KDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            9999999999999998765444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-41  Score=331.39  Aligned_cols=272  Identities=21%  Similarity=0.300  Sum_probs=212.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +..++|++.++||+|+||.||+|.+..++..+|+|++.....   ...+.+|+++++.++| +++..+..++.+.+..++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEECCEEEE
Confidence            567899999999999999999999999999999998765432   2458899999999986 556666667778889999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||||+ +++|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||+   +.++.+||+|||++..+..
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence            99999 8899998875 45689999999999999999999985 79999999999999   4778899999999876533


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH------------
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD------------  226 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~------------  226 (423)
                      ..         .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.            
T Consensus       157 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (333)
T cd06650         157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET  227 (333)
T ss_pred             hc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence            21         124578999999999999889999999999999999999999997543321111100            


Q ss_pred             -------------------------HHHhhhcCCcHHHh-hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          227 -------------------------KICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       227 -------------------------~i~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                                               .+............ ...++.++.+||.+||+.||++||++++|+.  +.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~~  305 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKRS  305 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhcC
Confidence                                     00000000000000 0134678999999999999999999999965  7777766


Q ss_pred             CCCCCcceece
Q 014527          281 GYDFDFVFDWT  291 (423)
Q Consensus       281 ~~~~~~~~dw~  291 (423)
                      .....+.+.|.
T Consensus       306 ~~~~~~~~~~~  316 (333)
T cd06650         306 EAEEVDFAGWL  316 (333)
T ss_pred             ccccccHHHHH
Confidence            55555666774

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.2e-42  Score=332.81  Aligned_cols=235  Identities=20%  Similarity=0.291  Sum_probs=194.7

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||||++....     ....+..|.+++..+.+++++..+..++......|+||||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999876432     22346778888888877788888888888888999999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|...+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~-----  151 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV-----  151 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence            889887765 4579999999999999999999999999999999999999   5788999999999876433221     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   ..+..+.......+     ..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~  221 (321)
T cd05591         152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESILHDDVLYP-----VWLSK  221 (321)
T ss_pred             --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence              122457899999999999999999999999999999999999999875433   34444444433332     23578


Q ss_pred             HHHHHHHHHhcCCCCCCCCh
Q 014527          247 EFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~  266 (423)
                      ++.++|..||..||++||+.
T Consensus       222 ~~~~ll~~~L~~dp~~R~~~  241 (321)
T cd05591         222 EAVSILKAFMTKNPNKRLGC  241 (321)
T ss_pred             HHHHHHHHHhccCHHHcCCC
Confidence            99999999999999999943

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.6e-42  Score=331.57  Aligned_cols=237  Identities=18%  Similarity=0.278  Sum_probs=195.8

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||||++...     .....+..|..++..+.+++++..+..++...+..|+||||+ +
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999987643     223346788888888877788888888888889999999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~-----  151 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK-----  151 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence            899887765 4679999999999999999999999999999999999999   5788999999999875432211     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   +.+..+.......+     ..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~  221 (320)
T cd05590         152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDEVVYP-----TWLSQ  221 (320)
T ss_pred             --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCCH
Confidence              122457999999999999999999999999999999999999999875433   33444444333322     34588


Q ss_pred             HHHHHHHHHhcCCCCCCCChHH
Q 014527          247 EFASYFHYCQSLTFDQRPDYGF  268 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~~  268 (423)
                      ++.++|..||+.||.+||++.+
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCCCC
Confidence            9999999999999999999844

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-41  Score=329.90  Aligned_cols=236  Identities=22%  Similarity=0.309  Sum_probs=193.2

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||||+++...     ....+..|..++..+.+|+++..+..++......++||||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999886432     23345667777777666788888877777888999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~-----  151 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG-----  151 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence            899888765 4579999999999999999999999999999999999999   4788999999999976433221     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   +.+..+.......     ...++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~-----~~~~~~  221 (316)
T cd05592         152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSILNDRPHF-----PRWISK  221 (316)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCC-----CCCCCH
Confidence              123557999999999999999999999999999999999999999875432   3333333322222     234588


Q ss_pred             HHHHHHHHHhcCCCCCCCChH
Q 014527          247 EFASYFHYCQSLTFDQRPDYG  267 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~  267 (423)
                      ++.++|.+||..||.+||++.
T Consensus       222 ~~~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         222 EAKDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCCh
Confidence            999999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=314.25  Aligned_cols=254  Identities=24%  Similarity=0.302  Sum_probs=217.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .+...|++.+.||+|.|+.||++.+..+|+.+|+|+++..    ...+.+.+|++|.+.|+| ++|..+..-.......|
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY   86 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhcccceeE
Confidence            5678899999999999999999999999999999987643    356679999999999998 55666665556778899


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||+|++ |++|..-+.. +--+++..+-.+++||++||.|+|.+||||||+||+|+|+...+...-+||+|||+|..+.+
T Consensus        87 lvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999 8888766654 34588999999999999999999999999999999999998766777899999999998873


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ..        ....+.|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+.   ...++.|....+..+.+
T Consensus       166 g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~~g~yd~~~~  234 (355)
T KOG0033|consen  166 GE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIKAGAYDYPSP  234 (355)
T ss_pred             cc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhccccCCCCc
Confidence            22        23477999999999999999999999999999999999999999998543   36677788877777654


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      . +..++++.++|+++||..||.+|.|+.|.++
T Consensus       235 ~-w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  235 E-WDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             c-cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            3 4677899999999999999999999987654

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-41  Score=330.50  Aligned_cols=239  Identities=22%  Similarity=0.321  Sum_probs=193.8

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeEEE
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      |++.+.||+|+||.||+|.+..+++.||||+++..     .....+.+|++++..+.  .|+++..+..+.......|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999988643     22344677777765543  246677777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|...+.  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence            9999 788877764  4579999999999999999999999999999999999999   578899999999987533221


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .       ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+....   +.+..+.......+    
T Consensus       156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~~~~p----  221 (324)
T cd05589         156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIVNDEVRYP----  221 (324)
T ss_pred             C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC----
Confidence            1       123567999999999999999999999999999999999999999875433   33334444333322    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYG  267 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~  267 (423)
                       ..++..+.++|.+||..||.+||+..
T Consensus       222 -~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         222 -RFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             -CCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence             34588999999999999999999543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.1e-41  Score=329.96  Aligned_cols=260  Identities=19%  Similarity=0.309  Sum_probs=204.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +..++|++.+.||+|+||.||+|++..++..||+|++.....   ...+.+|+++++.++| +++..+..+....+..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEE
Confidence            457899999999999999999999999999999998875432   3458899999999987 556666666677888999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+   +.++.+||+|||++.....
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCcccccccc
Confidence            99999 7899998875 45689999999999999999999986 69999999999999   4788999999999876543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH-----------
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK-----------  227 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----------  227 (423)
                      ..         .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..           
T Consensus       157 ~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             cc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence            22         1245789999999999999999999999999999999999999975433211111000           


Q ss_pred             ----------------------------HHhhhcCCc-HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          228 ----------------------------ICEKKVSTP-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       228 ----------------------------i~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                                  ......... .......+++++.+||.+||..||++||++++|++  +.++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~--h~~~~  305 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN--HTFIK  305 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc--ChHHh
Confidence                                        000000000 00001235789999999999999999999999976  45554


Q ss_pred             h
Q 014527          279 R  279 (423)
Q Consensus       279 ~  279 (423)
                      .
T Consensus       306 ~  306 (331)
T cd06649         306 R  306 (331)
T ss_pred             h
Confidence            3

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.7e-42  Score=331.98  Aligned_cols=239  Identities=22%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||+|++....     ....+.+|+++++.+.| +++..+..++...+..|+||||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999876432     22346789999999987 55666666667788999999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~-----  150 (323)
T cd05595          80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA-----  150 (323)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence            888877764 4579999999999999999999999999999999999999   4788999999999875432221     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..   ..+..+.......+     ..+++
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~~~~~~~p-----~~~~~  220 (323)
T cd05595         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP-----RTLSP  220 (323)
T ss_pred             --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCCH
Confidence              112457999999999999999999999999999999999999999764432   33333333333322     45688


Q ss_pred             HHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      ++.++|.+||..||.+||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            999999999999999998     5665543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-41  Score=321.35  Aligned_cols=253  Identities=19%  Similarity=0.241  Sum_probs=196.7

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHc--CCCCCCeEEEeeee-----CC
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVD-----GE   76 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~-----~~   76 (423)
                      +|++.+.||+|+||+||+|++..+++.||+|++....    ....+.+|+.+++.+.  .|+++..+..++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5999999999999999999999999999999876432    2234678888888775  23555555443322     34


Q ss_pred             eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..+++||++.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence            579999999889999887543 358999999999999999999999999999999999999   4788999999999986


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh----
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK----  231 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----  231 (423)
                      ......        .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......    
T Consensus       158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  229 (288)
T ss_pred             ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence            543221        12456899999999999989999999999999999999999999875443322222221110    


Q ss_pred             ---------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 ---------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                     ....+.......++..+.++|.+||+.||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                           0011122333456888999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.6e-42  Score=332.33  Aligned_cols=239  Identities=21%  Similarity=0.312  Sum_probs=194.4

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||||++....     ....+.+|+.+++.+.| +++..+..++...+..++||||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999886432     23357789999999887 56666767777888999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~-----  150 (328)
T cd05593          80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA-----  150 (328)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence            888877764 4579999999999999999999999999999999999999   5788999999999875432211     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..   +....+.......     ...++.
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~~-----p~~~~~  220 (328)
T cd05593         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEDIKF-----PRTLSA  220 (328)
T ss_pred             --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhccCCccC-----CCCCCH
Confidence              112457999999999999989999999999999999999999999864432   2233333222222     245688


Q ss_pred             HHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      ++.++|.+||..||.+||     ++.+|++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            999999999999999997     6777654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-41  Score=326.13  Aligned_cols=259  Identities=21%  Similarity=0.283  Sum_probs=204.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .+|++.+.||+|+||.||+|++..+++.||+|.++...   ....+.+|+.+++.++| +++..+..+....+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC-CCcceEEEEEeeCCeEEEEEe
Confidence            67999999999999999999999999999999876432   23357789999999987 556666666777888999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |+.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.......  
T Consensus        85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc--
Confidence            99889999887766678999999999999999999999999999999999999   4788999999999976543221  


Q ss_pred             cccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC--------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS--------  234 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--------  234 (423)
                           ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+.......        
T Consensus       160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         160 -----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             -----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence                 1123467899999999875 45899999999999999999999999876544333333222111000        


Q ss_pred             --------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          235 --------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       235 --------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                    .+.......++.++.++|.+||..||.+||++.++++  +.++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~  290 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK--HAYFR  290 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--Chhhh
Confidence                          0001122346788999999999999999999999866  44443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-43  Score=326.90  Aligned_cols=247  Identities=22%  Similarity=0.357  Sum_probs=213.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCch-----hHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~-----~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      +..+|++.+.||+|.||.|-+|.....|+.||||.++++....     .+.+|++||..|+| ++|..|+..+...+..+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH-PhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH-PHIIQIYEVFENKDKIV  129 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC-CceeehhhhhcCCceEE
Confidence            3468999999999999999999998999999999877654322     37899999999998 55556666777888999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |||||. +|.|.|++.. .+.+++.++..+++||++|+.|+|.++++|||||.+|||+   |.++.+||+|||++..+.+
T Consensus       130 ivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence            999999 9999999987 4579999999999999999999999999999999999999   6899999999999988765


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ...        -.+++|++-|++||++.|.+| ++.+|-|||||+||.|+.|..||.+.+.   ...+.+|..+.+..|.
T Consensus       206 ~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs~GaYrEP~  274 (668)
T KOG0611|consen  206 KKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQISRGAYREPE  274 (668)
T ss_pred             ccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhhcccccCCC
Confidence            542        248899999999999999998 6899999999999999999999998543   3555666666665543


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                            -|....-||+.||..||++|.|+++|...+
T Consensus       275 ------~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  275 ------TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                  267888999999999999999999987754

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=330.47  Aligned_cols=262  Identities=22%  Similarity=0.284  Sum_probs=206.9

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----------------chhHHHHHHHHHHHcCCCCCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HPQLLYEAKVYKILQGGSGIP   66 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------------~~~~~~E~~~l~~l~~~~~i~   66 (423)
                      +..-++|++++.||+|.||.|-+|++..+++.||||++.+...                .+...+|+.+|++|.| ++++
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H-~nVV  171 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH-PNVV  171 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC-cCee
Confidence            4556899999999999999999999999999999999764321                2357899999999998 4454


Q ss_pred             eEEEeee--eCCeeEEEEecc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           67 NIKWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        67 ~i~~~~~--~~~~~~lv~e~~-~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      .+..+-.  ..+..|||+||| .|.+...-  .... +++.+++.|+++++.||+|||.+|||||||||+|+|++   ++
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~  246 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SD  246 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CC
Confidence            5433322  456789999999 55443221  1233 89999999999999999999999999999999999995   78


Q ss_pred             CcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCC----CCccchHHHHHHHHHHHHhCCCCCCCchh
Q 014527          143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKA  218 (423)
Q Consensus       143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDIwSlGvil~elltG~~Pf~~~~~  218 (423)
                      ++|||+|||.+..+.........  .......|||.|+|||...++.    .+.+.||||+||+||.|+.|++||-+.  
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--  322 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--  322 (576)
T ss_pred             CcEEeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--
Confidence            99999999999876433211110  0112468999999999988733    367899999999999999999999864  


Q ss_pred             hhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                       ...+.+.+|....+..|...   .+.+.+++||.+||.+||++|.+..+|+.  +.+....
T Consensus       323 -~~~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~--Hpwvt~~  378 (576)
T KOG0585|consen  323 -FELELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKL--HPWVTRD  378 (576)
T ss_pred             -hHHHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhhee--cceeccC
Confidence             44577888888877777543   34688999999999999999999999854  5555444

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-41  Score=335.54  Aligned_cols=265  Identities=22%  Similarity=0.337  Sum_probs=203.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||+||+|++..+++.||||++....     ....+..|+.++..+.| +++..+.....+....|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCeEEEE
Confidence            47999999999999999999999999999999986432     22357789999999876 5566666667788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence            9999 8899998875 5679999999999999999999999999999999999999   578899999999997653211


Q ss_pred             CCC-------ccc---------------------ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 014527          161 TNR-------HIP---------------------YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP  212 (423)
Q Consensus       161 ~~~-------~~~---------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~P  212 (423)
                      ...       ..+                     .......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            100       000                     0001245799999999999999999999999999999999999999


Q ss_pred             CCCchhhhhHHHHHHHHhhh--cCCcHHHhhccChHHHHHHHHHHhcCCCC---CCCChHHHHHHHHHHHHhcCCCCCcc
Q 014527          213 WQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFD---QRPDYGFLKRLFHDLFSREGYDFDFV  287 (423)
Q Consensus       213 f~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~---~RPt~~~l~~~L~~~~~~~~~~~~~~  287 (423)
                      |.+....   +.+.++....  ...|..   ..+++++.++|.+++. +|.   .||++++|++          +.|...
T Consensus       236 f~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~----------hp~f~~  298 (363)
T cd05628         236 FCSETPQ---ETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT----------NPFFEG  298 (363)
T ss_pred             CCCCCHH---HHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC----------CCCCCC
Confidence            9875433   3344443322  112211   1347889999998765 455   4578887743          455556


Q ss_pred             eeceec
Q 014527          288 FDWTIL  293 (423)
Q Consensus       288 ~dw~~~  293 (423)
                      .||+.+
T Consensus       299 ~~~~~~  304 (363)
T cd05628         299 VDWEHI  304 (363)
T ss_pred             CCHHHH
Confidence            677654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-41  Score=328.75  Aligned_cols=238  Identities=21%  Similarity=0.291  Sum_probs=193.5

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||+|+++..     .....+..|..++..+.+++++..+..++.+.+..|+||||+ +
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999988643     233446778888877766678888877778888999999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN-----  151 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence            899888765 4579999999999999999999999999999999999999   4788999999999875322111     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....   +.+..+.......     ...++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~~~~~-----~~~~~~  221 (316)
T cd05620         152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVDTPHY-----PRWITK  221 (316)
T ss_pred             --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCC-----CCCCCH
Confidence              123567999999999999999999999999999999999999999875433   2333332222221     234578


Q ss_pred             HHHHHHHHHhcCCCCCCCChH-HH
Q 014527          247 EFASYFHYCQSLTFDQRPDYG-FL  269 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~-~l  269 (423)
                      ++.++|.+||..||++||++. +|
T Consensus       222 ~~~~li~~~l~~dP~~R~~~~~~~  245 (316)
T cd05620         222 ESKDILEKLFERDPTRRLGVVGNI  245 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHH
Confidence            999999999999999999974 44

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=332.71  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=219.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      +...|++.+.||.|.||.||+|+.+.+|+.+|+|++.....     ...+.+|+.+|+.+.+|+++..+...+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45689999999999999999999999999999998776543     2468999999999997788888888888889999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC-CCcEEEeeccceeeec
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYR  157 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~~~  157 (423)
                      +|||+| ||.|.+.+...  .+++..+..++.|++.|+.|||+.||+||||||+|||+...+. .+.+|++|||+|....
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            999999 89999999875  3999999999999999999999999999999999999975433 3589999999999877


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ...        .....+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+....   ....++....+....
T Consensus       191 ~~~--------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~~~i~~~~~~f~~  259 (382)
T KOG0032|consen  191 PGE--------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIFLAILRGDFDFTS  259 (382)
T ss_pred             CCc--------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHHHHHHcCCCCCCC
Confidence            622        223779999999999999999999999999999999999999999986543   444466666665443


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ..+..++..++++|..|+..||..|+++.++++
T Consensus       260 -~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  260 -EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence             344677899999999999999999999999877

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=336.09  Aligned_cols=250  Identities=23%  Similarity=0.282  Sum_probs=213.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ..+|.+++.+|+|+||.+++++++..+..||+|.+....    .......|+.++.++.|++++.....+..++...+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            468999999999999999999999999999999876543    2334789999999998866665556666566669999


Q ss_pred             Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |+|| ||++.+.+...+ ..|+++.++.|+.||+.|+.|||+++|+|||||+.|||++   .++.|+|+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence            9999 999999998766 5699999999999999999999999999999999999996   7888899999999988766


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..       ......||+.||+||++.+.+|+.|+|||||||++|||++-+.+|.+.+.   ...+.+|+...+. |   
T Consensus       160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~~~~-P---  225 (426)
T KOG0589|consen  160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRGLYS-P---  225 (426)
T ss_pred             hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhccCC-C---
Confidence            42       23478999999999999999999999999999999999999999987443   3555666665522 2   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      +...++.+++.+|..||..+|..||++.+|+..
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            234558999999999999999999999999875

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-42  Score=337.79  Aligned_cols=253  Identities=24%  Similarity=0.361  Sum_probs=203.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+..|++++..+.| ++++.+..+..+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecCCeEEEE
Confidence            4799999999999999999999999999999987643     223457889999999886 5566666666788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence            9999 88999998764 679999999999999999999999999999999999999   578899999999998765433


Q ss_pred             CCCc----------------------ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchh
Q 014527          161 TNRH----------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA  218 (423)
Q Consensus       161 ~~~~----------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~  218 (423)
                      ....                      ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            0000                      000112345799999999999999999999999999999999999999987553


Q ss_pred             hhhHHHHHHHHh--hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC-hHHHHH
Q 014527          219 ATKKQKYDKICE--KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKR  271 (423)
Q Consensus       219 ~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~~l~~  271 (423)
                      .   ..+.++..  .....+..   ..+++++.++|..||. +|.+||+ ++++++
T Consensus       236 ~---~~~~~i~~~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         236 Q---ETYNKIINWKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             H---HHHHHHhccCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            3   33333333  22222211   2258999999999997 9999999 988865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=346.92  Aligned_cols=266  Identities=18%  Similarity=0.224  Sum_probs=211.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEE-eee-----e-CC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKW-YGV-----D-GE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~-~~~-----~-~~   76 (423)
                      ..+++|.+.|.+|||+.||+|++...+..||+|.+-...  ....+.+|+.+|+.|.+|++|+.+.. ...     . .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            567899999999999999999999887899999654432  23347899999999998888766644 211     1 24


Q ss_pred             eeEEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEeeccc
Q 014527           77 DNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      .++|.|||| ||+|.|++... ...|++.+++.|+.|+++|+.+||...  |||||||-+||||+   .++..||||||.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGS  192 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGS  192 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcccc
Confidence            568999999 68999999743 456999999999999999999999987  99999999999994   888999999999


Q ss_pred             eeeecCCC-CCCcccc-cCCCcccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          153 AKKYRDPT-TNRHIPY-RENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       153 a~~~~~~~-~~~~~~~-~~~~~~~gt~~Y~aPE~~---~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      |....... ......+ ...-....|+.|+|||++   .+.+.+.|+|||||||+||.|+....||.+...       ..
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------la  265 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LA  265 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------ee
Confidence            86432221 1111100 011133569999999987   477899999999999999999999999986421       23


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCC
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF  284 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~  284 (423)
                      |+..++..|..   ..++..|++||..||+.||++||++-+++..+-.+........
T Consensus       266 Ilng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~  319 (738)
T KOG1989|consen  266 ILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP  319 (738)
T ss_pred             EEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence            67777777754   4568999999999999999999999999998888877665443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-42  Score=351.90  Aligned_cols=260  Identities=23%  Similarity=0.331  Sum_probs=219.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ..+.++.+.||+|.||+||+|+...     ....||||.++.....   .+|++|++++..|+| ++|+.+...+..++.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREGDP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccCCe
Confidence            3456788999999999999998653     3457999998877654   469999999999998 567677777778999


Q ss_pred             eEEEEecc-CCCHHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRR-------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN  143 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~-------------~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~  143 (423)
                      .++|+||+ .|+|.++|.....             .++..+.+.|+.|||.|++||-++.+|||||..+|+||+   +..
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cce
Confidence            99999999 9999999985421             278899999999999999999999999999999999995   889


Q ss_pred             cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhH
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK  222 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~  222 (423)
                      .|||+|||+++.....+..     +......-..+|||||.+....++.+||||||||+|||+++ |+.||.+....   
T Consensus       641 ~VKIsDfGLsRdiYssDYY-----k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---  712 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYY-----KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---  712 (774)
T ss_pred             EEEecccccchhhhhhhhh-----cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence            9999999999987665543     33334556789999999999999999999999999999998 99999998776   


Q ss_pred             HHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      +.++.+..+++ .+.+   ..+|.++.+||..||+.+|.+||+|.+|...|+.+.....
T Consensus       713 EVIe~i~~g~l-L~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  713 EVIECIRAGQL-LSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             HHHHHHHcCCc-ccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            44444545544 3333   4559999999999999999999999999999998876543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=316.53  Aligned_cols=254  Identities=19%  Similarity=0.257  Sum_probs=206.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC------e
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE------D   77 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~------~   77 (423)
                      .|+.+++||+|+||+||+|+.+.+|+.||+|.++....    .....+|+.+++.|+|.+++..+..+....+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            47778899999999999999999999999998776544    2346999999999999887767766665555      7


Q ss_pred             eEEEEeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           78 NVLVLDLLGPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      .++|+||+..+|..++....   ..++...+..++.||+.||+|||+++|+||||||.||||+   +.+.+||+|||+|+
T Consensus        92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKLADFGLAR  168 (323)
T ss_pred             EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEeeeccchHH
Confidence            89999999999999999776   4688899999999999999999999999999999999994   79999999999999


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .+.-+.       +.....++|..|.|||++.|. .|+...||||+|||++||++++..|.+....+....+.++....-
T Consensus       169 a~~ip~-------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  169 AFSIPM-------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             HhcCCc-------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence            655333       223467889999999999988 599999999999999999999999999776544444433332210


Q ss_pred             CC--c--------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 ST--P--------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ~~--~--------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..  |                    .....+...+...+++.+||+.+|.+|.+++..+.
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~  301 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT  301 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence            00  0                    00111122347899999999999999999988765

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-42  Score=336.66  Aligned_cols=255  Identities=22%  Similarity=0.323  Sum_probs=199.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||+||+|++..+++.||||++....     ....+.+|+.++..+.| ++++.+..++.+....++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence            47999999999999999999999999999999886432     22346789999999985 6666777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....
T Consensus        80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence            9999 8899998875 4569999999999999999999999999999999999999   578999999999997653321


Q ss_pred             CCCcc-----------------c---------cc-----CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhC
Q 014527          161 TNRHI-----------------P---------YR-----ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG  209 (423)
Q Consensus       161 ~~~~~-----------------~---------~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG  209 (423)
                      .....                 +         +.     .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            10000                 0         00     01134699999999999999999999999999999999999


Q ss_pred             CCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC---hHHHHH
Q 014527          210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKR  271 (423)
Q Consensus       210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~l~~  271 (423)
                      ..||.+....   +.+..+.........+. ...+++++.++|.+|+. +|.+|++   +++++.
T Consensus       236 ~~Pf~~~~~~---~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQ---ETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHH---HHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999875443   33333333221111111 12457899999999996 9999998   666533

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4e-42  Score=334.80  Aligned_cols=250  Identities=21%  Similarity=0.307  Sum_probs=200.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...     ....+..|+.++..+.| ++++.+..+..+....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCeEEEE
Confidence            47999999999999999999999999999999887532     22346778888887765 6666776677778889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||++..+....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence            9999 899999998766789999999999999999999999999999999999999   578999999999998765432


Q ss_pred             CCCcccccCCCcccccccccCccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ..      ......||+.|+|||++.      +..++.++|||||||++|+|++|+.||......   ..+..+......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~~~  227 (330)
T cd05601         157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTYNNIMNFQRF  227 (330)
T ss_pred             ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---HHHHHHHcCCCc
Confidence            21      112347899999999987      456789999999999999999999999875443   233333332211


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...+ ....++..+.+||..||. +|.+||++++++.
T Consensus       228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1100 112458899999999998 9999999988743

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-41  Score=321.82  Aligned_cols=242  Identities=21%  Similarity=0.205  Sum_probs=195.9

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeee----CCeeEEEEe
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLVLD   83 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~~~~lv~e   83 (423)
                      ..|++|++|.||+|.+  +++.||||+++....     .+.+.+|+.++..++|+ ++..+..++.+    ....++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCC-CEEEEeeeEEecccCCCceEEEEE
Confidence            5789999999999998  788999998875432     23467999999999986 55555544444    356799999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +|+|.+++.. .+.+++...+.++.|++.||.|||+. +++||||||+|||+   ++++.+||+|||+++.......
T Consensus       103 y~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~~  178 (283)
T PHA02988        103 YCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPPF  178 (283)
T ss_pred             eCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhccccc
Confidence            99 8899999875 45789999999999999999999984 99999999999999   4788999999999976543221


Q ss_pred             CCcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                                ...|+..|+|||++.+  ..++.++|||||||++|||++|+.||.+....   +.+..+.......+.+ 
T Consensus       179 ----------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~-  244 (283)
T PHA02988        179 ----------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLIINKNNSLKLP-  244 (283)
T ss_pred             ----------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCCCCCCC-
Confidence                      3468899999999976  67899999999999999999999999875433   3333443333332222 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                        ...|+.+.+|+.+||+.||++||++++|++.|+.+.
T Consensus       245 --~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        245 --LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              245889999999999999999999999999998763

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-41  Score=333.02  Aligned_cols=254  Identities=22%  Similarity=0.262  Sum_probs=194.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC----
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG----   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~----   75 (423)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++|++.+..+..+....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35689999999999999999999999999999999886432    2345778999999998755554444333221    


Q ss_pred             -CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 -~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                       ...|+||||++++|...+.   ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~  171 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  171 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence             3579999999888877764   358899999999999999999999999999999999999   478899999999997


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH-----
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-----  229 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~-----  229 (423)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.+..     
T Consensus       172 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  243 (359)
T cd07876         172 TACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA  243 (359)
T ss_pred             ccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence            5432211        124578999999999999999999999999999999999999998754322111111100     


Q ss_pred             --------------hhhcCCc---HHH------------hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 --------------EKKVSTP---IEV------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 --------------~~~~~~~---~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                    ......+   ...            .....++.+.+||.+||..||++||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                          0000000   000            01123567899999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=334.72  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=206.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      |-+..|+++++||+||.+.||+|...+ .+.||+|......    ....+..|+.+|.+|+++..|..++.|...++..|
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            558899999999999999999998654 4556666433222    23348999999999999988888999999999999


Q ss_pred             EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||||-..+|..++......++...+..+..||+.|+.++|.+||||.||||.|||+    -.|.+||+|||.|..+...
T Consensus       437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcc
Confidence            999999999999999766666666899999999999999999999999999999999    5899999999999988877


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCC-----------CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-----------QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----------~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (423)
                      ++..     ....-+||+.|||||.+....           .++++||||||||||+|+.|+.||....  ....++..|
T Consensus       513 TTsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI  585 (677)
T KOG0596|consen  513 TTSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI  585 (677)
T ss_pred             ccce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh
Confidence            6543     234668999999999996443           4679999999999999999999998643  223444455


Q ss_pred             HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .......+.+....  +.++.++++.||..||.+||+..+|++
T Consensus       586 ~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             cCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            44433222222222  234999999999999999999998865

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-42  Score=303.56  Aligned_cols=245  Identities=24%  Similarity=0.331  Sum_probs=215.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      -++|++++.||+|.||.||+|+.++++-.||+|++-+.     ....++.+|+++...|+| ++|..++.|+.+....|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheeccceeEE
Confidence            36799999999999999999999999999999986543     345578999999999998 556677888889999999


Q ss_pred             EEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           81 VLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++||. .|.+...+... ..++++.....++.|+|.||.|+|.++||||||||+|+|++   ..+.+||+|||.+.....
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecCC
Confidence            99999 88888877743 45699999999999999999999999999999999999995   889999999999876442


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                               ....+++||..|.+||+..+..++..+|+|++|++.||++.|..||....   ..+.|.+|....+..|  
T Consensus       177 ---------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p--  242 (281)
T KOG0580|consen  177 ---------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFP--  242 (281)
T ss_pred             ---------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCC--
Confidence                     13358899999999999999999999999999999999999999998654   5577888877777777  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                         ..++.+.+++|.+|+.++|.+|....+++.
T Consensus       243 ---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  243 ---STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ---cccChhHHHHHHHHhccCccccccHHHHhh
Confidence               456899999999999999999999988876

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-41  Score=330.13  Aligned_cols=261  Identities=20%  Similarity=0.311  Sum_probs=203.9

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||+|++....     ....+..|+.++..+.+++++..+..++.+....|+||||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999987532     22347789999999987888888888888889999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD-----  151 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence            899887764 4579999999999999999999999999999999999999   4788999999999875332211     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh----hhHHHHHHHHhhhcCCcHHHhhc
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||......    ........+.......|     .
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p-----~  224 (327)
T cd05617         152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP-----R  224 (327)
T ss_pred             --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC-----C
Confidence              112467999999999999999999999999999999999999999643211    11122233333322222     3


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      .++..+.+++.+||..||.+|+++... ..++++   ..+.|....+|...
T Consensus       225 ~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i---~~h~~f~~~~~~~~  271 (327)
T cd05617         225 FLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSDI---KSHTFFRSIDWDLL  271 (327)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHH---HcCCCCCCCCHHHH
Confidence            458899999999999999999986422 112222   23455555677643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-43  Score=338.16  Aligned_cols=238  Identities=22%  Similarity=0.331  Sum_probs=199.6

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCH
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL   89 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL   89 (423)
                      -++.||+|+.|.||+|+.  .++.||||.++.     .-..+++-|++|+|++ |..+...+.....+||||||| .|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e-----lkETdIKHLRkLkH~N-II~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE-----LKETDIKHLRKLKHPN-IITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhh-----hhhhhHHHHHhccCcc-eeeEeeeecCCceeEEeeeccccccH
Confidence            356799999999999987  578899995432     2346788899999854 445566666777899999999 8999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccC
Q 014527           90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE  169 (423)
Q Consensus        90 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  169 (423)
                      ..+++. ++.++......|..+||.|+.|||.+.|||||||.-||||+   .+..|||+|||.++...+..+.       
T Consensus       200 ~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STk-------  268 (904)
T KOG4721|consen  200 YEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTK-------  268 (904)
T ss_pred             HHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhh-------
Confidence            999885 67799999999999999999999999999999999999996   6779999999999987766443       


Q ss_pred             CCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHH
Q 014527          170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFA  249 (423)
Q Consensus       170 ~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~  249 (423)
                       -.++||..|||||++.+.+.+.|+||||||||||||+||..||.+.+..   ..+.-+....+..|.+..|   |+.|+
T Consensus       269 -MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~LpvPstc---P~Gfk  341 (904)
T KOG4721|consen  269 -MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLPVPSTC---PDGFK  341 (904)
T ss_pred             -hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccccCcccC---chHHH
Confidence             2789999999999999999999999999999999999999999875433   2333333444455555444   99999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          250 SYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       250 ~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      -||++||+..|..||+|.+|+..|+
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHh
Confidence            9999999999999999999987765

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3e-41  Score=327.11  Aligned_cols=235  Identities=22%  Similarity=0.311  Sum_probs=194.7

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||||++...     .....+..|.+++..+.+|+++..+..+....+..++||||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999988643     223446788888888877788888888888888999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV-----  151 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence            899887765 4579999999999999999999999999999999999999   4788999999999875322211     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   ..+..+.......+     ..++.
T Consensus       152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~  221 (318)
T cd05570         152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSILEDEVRYP-----RWLSK  221 (318)
T ss_pred             --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC-----CcCCH
Confidence              112457899999999999999999999999999999999999999865432   33333433333322     34688


Q ss_pred             HHHHHHHHHhcCCCCCCCCh
Q 014527          247 EFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~  266 (423)
                      ++.+||.+||..||.+||++
T Consensus       222 ~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         222 EAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             HHHHHHHHHccCCHHHcCCC
Confidence            99999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-41  Score=345.74  Aligned_cols=254  Identities=24%  Similarity=0.249  Sum_probs=199.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC---
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG---   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~---   75 (423)
                      +..+++|++.+.||+|+||+||+|++..+++.||||++.....    ...+.+|+.++..+.|++.+.....+....   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3457899999999999999999999999999999998865432    234667888887776644333222222111   


Q ss_pred             ----CeeEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEE
Q 014527           76 ----EDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI  147 (423)
Q Consensus        76 ----~~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL  147 (423)
                          ...++||||+ +|+|.+++...   ...+++..+..++.|++.||.|||++||+||||||+|||++   .++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCCEEE
Confidence                1367999999 89999988643   34689999999999999999999999999999999999994   7889999


Q ss_pred             eeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      +|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....   +.+..
T Consensus       185 ~DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~  256 (496)
T PTZ00283        185 GDFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHK  256 (496)
T ss_pred             EecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH
Confidence            9999998764332111     123567999999999999999999999999999999999999999875432   33333


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +......    .+...+++++.+++..||+.||.+||++.++++
T Consensus       257 ~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        257 TLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HhcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            3332221    233456899999999999999999999999876

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-41  Score=328.69  Aligned_cols=239  Identities=20%  Similarity=0.303  Sum_probs=194.0

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||||+++...     ....+..|..++..+.+++++..+..++.+....|+||||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999999999999999887532     22347789999999977788888888888889999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.......     
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~-----  151 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD-----  151 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence            899887764 5679999999999999999999999999999999999999   4788999999999875322211     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh------hhHHHHHHHHhhhcCCcHHHh
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~  240 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ........+.......|    
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----  225 (329)
T cd05588         152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----  225 (329)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----
Confidence              122567999999999999999999999999999999999999999642211      11122233333333322    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYG  267 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~  267 (423)
                       ..++.++.++|.+||+.||.+|+++.
T Consensus       226 -~~~~~~~~~li~~~L~~dP~~R~~~~  251 (329)
T cd05588         226 -RSLSVKASSVLKGFLNKDPKERLGCH  251 (329)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence             44588999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.8e-41  Score=326.13  Aligned_cols=238  Identities=23%  Similarity=0.324  Sum_probs=193.6

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||+||+|++..+++.||||+++..     ........|..++..+.+++++..+..++.+.+..++||||+ +
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999987653     223446678888877656677888877778888999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-----  151 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA-----  151 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence            899988875 4568999999999999999999999999999999999999   4788999999999875322211     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......+     ..++.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~  221 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRMDNPCYP-----RWLTR  221 (316)
T ss_pred             --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----ccCCH
Confidence              122457899999999999999999999999999999999999999875433   23333322222211     34578


Q ss_pred             HHHHHHHHHhcCCCCCCCChH-HH
Q 014527          247 EFASYFHYCQSLTFDQRPDYG-FL  269 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~-~l  269 (423)
                      ++.++|.+||..||++||++. +|
T Consensus       222 ~~~~li~~~l~~~P~~R~~~~~~l  245 (316)
T cd05619         222 EAKDILVKLFVREPERRLGVKGDI  245 (316)
T ss_pred             HHHHHHHHHhccCHhhcCCChHHH
Confidence            899999999999999999986 44

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-41  Score=329.28  Aligned_cols=261  Identities=21%  Similarity=0.322  Sum_probs=202.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEE-eeeeC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKW-YGVDG   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~-~~~~~   75 (423)
                      -+++|++.+.||+|+||.||+|.+..     +++.||+|++.....   .+.+..|+.++..+.+++++..+.. +...+
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            35789999999999999999997543     457899998875433   2347789999999955556655544 44456


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc---------------------------------------------------------
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR---------------------------------------------------------   97 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------------------------------------------------------   97 (423)
                      ...+++|||+ +++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            6788999999 889998885421                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCccc
Q 014527           98 ---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT  174 (423)
Q Consensus        98 ---~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~  174 (423)
                         ..+++..+..++.||+.||+|||++||+||||||+|||++   .++.++|+|||+++.+......     .......
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~  236 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY-----VRKGDAR  236 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcch-----hhccCCC
Confidence               2578999999999999999999999999999999999994   6789999999999876432211     1122345


Q ss_pred             ccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHH
Q 014527          175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH  253 (423)
Q Consensus       175 gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~  253 (423)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||.+....   +.+...........   .....++++.+++.
T Consensus       237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~l~~  310 (337)
T cd05054         237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCRRLKEGTRMR---APEYATPEIYSIML  310 (337)
T ss_pred             CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHHHHhccCCCC---CCccCCHHHHHHHH
Confidence            6778999999999999999999999999999998 99999764322   11222222211111   12345789999999


Q ss_pred             HHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          254 YCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       254 ~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +||+.+|++||++++|++.|++++..
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-41  Score=335.06  Aligned_cols=262  Identities=18%  Similarity=0.229  Sum_probs=204.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++..+|++.+.||+|+||.||+|...  .+++.||+|.+...   ....+|+++++.++|++ +..+..++......+++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~-iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRA-IINLIHAYRWKSTVCMV  164 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCC-ccceeeeEeeCCEEEEE
Confidence            55678999999999999999999764  35678999987643   34578999999998754 55555555677889999


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+   +..+.++|+|||+++.......
T Consensus       165 ~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        165 MPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             ehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCcccc
Confidence            9999999999884 35679999999999999999999999999999999999999   5788999999999976654322


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------  235 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------  235 (423)
                      ..     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+.......      
T Consensus       241 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        241 TP-----QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             cc-----cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            11     1225679999999999999999999999999999999999999998754433223333322211100      


Q ss_pred             -----------------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          236 -----------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       236 -----------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                                             +.......++.++.++|.+||..||++||++.+++.  +.+|.+.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~--~p~f~~~  381 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS--LPLFTKE  381 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh--Cchhhcc
Confidence                                   000011234678899999999999999999999966  4555443

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-40  Score=350.10  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=199.0

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEee-eeCC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGE   76 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~-~~~~   76 (423)
                      +.+.-++|++++.||.|+||+||+|++..++..||+|++....    ....+..|+.++..|.|++.+..+..+. ....
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            3455689999999999999999999999999999999876432    2345889999999999866555554433 3446


Q ss_pred             eeEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhc-------CcccccccCCceEEeec------
Q 014527           77 DNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-------GFLHRDIKPDNFLMGLG------  139 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-------giiHrDIKp~NILl~~~------  139 (423)
                      .+||||||+ +++|.+++...   ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            789999999 78999988753   24699999999999999999999984       59999999999999531      


Q ss_pred             --------CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHhC
Q 014527          140 --------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRG  209 (423)
Q Consensus       140 --------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~elltG  209 (423)
                              +....+||+|||++..+.....        .....||+.|+|||++.+  ..++.++||||||||||+|++|
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                    1234599999999976543221        124579999999999865  3488999999999999999999


Q ss_pred             CCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..||......  .+.+.. .......+    ....+.++.+||..||..+|.+||++.+++.
T Consensus       240 k~PF~~~~~~--~qli~~-lk~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        240 KTPFHKANNF--SQLISE-LKRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCcCCcH--HHHHHH-HhcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9999764332  122222 22222211    1345789999999999999999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=338.29  Aligned_cols=258  Identities=27%  Similarity=0.372  Sum_probs=212.8

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCc---E-EEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNE---I-VAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~---~-vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      ..+-.+.++||+|+||+||+|+.+..+.   . ||||..+...     ...++.+|+++|+.++| ++|..++++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAVLEE  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCC
Confidence            4455677999999999999999875322   3 8999877422     23458999999999987 66767777778999


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      .++||||+| ||+|.+++......++..+.+.++.+.|.||+|||++++|||||..+|+|++   ..+.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccC
Confidence            999999999 9999999998776799999999999999999999999999999999999995   667789999999876


Q ss_pred             ecCCCCCCcccccCCC-cccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          156 YRDPTTNRHIPYRENK-NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .....        ... ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+......   ..++....+
T Consensus       312 ~~~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI~~~~~  380 (474)
T KOG0194|consen  312 GSQYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKIVKNGY  380 (474)
T ss_pred             Cccee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHHHhcCc
Confidence            43111        111 2245689999999999999999999999999999999 8999999877643   334434444


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      +.+.+.   ..|..+..++.+||..+|++||++.++.+.|+.+.....
T Consensus       381 r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  381 RMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             cCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            444433   448999999999999999999999999999999887654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-41  Score=329.79  Aligned_cols=239  Identities=22%  Similarity=0.317  Sum_probs=193.2

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||+|++....     ....+..|++++..+.| +++..+..++......|+||||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999876432     22346778888888876 56666767777888999999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      ++|..++.. .+.+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----  151 (325)
T cd05594          80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA----  151 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence            888877764 4579999999999999999999997 799999999999999   5788999999999875432221    


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   .....+.......+     ..++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~  220 (325)
T cd05594         152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP-----RTLS  220 (325)
T ss_pred             ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCC
Confidence               112457999999999999999999999999999999999999999864432   22333333333222     4568


Q ss_pred             HHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          246 AEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      +++.++|.+||+.||++|+     ++.++++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            8999999999999999997     7777654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.7e-41  Score=323.82  Aligned_cols=261  Identities=21%  Similarity=0.289  Sum_probs=205.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcE----EEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~----vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .+-..+|++.+.||+|+||.||+|.+..+++.    ||||++.....   ...+..|+.+++.+.|++ +..+..++.. 
T Consensus         3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~g~~~~-   80 (316)
T cd05108           3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH-VCRLLGICLT-   80 (316)
T ss_pred             ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC-CCeEEEEEcC-
Confidence            34567899999999999999999998765553    89998764332   345788999999998755 4445444443 


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...+++++|+ +|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~  157 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAK  157 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccc
Confidence            3567888888 899999998766678999999999999999999999999999999999999   477899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .........     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....    +..+.....
T Consensus       158 ~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~  228 (316)
T cd05108         158 LLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGE  228 (316)
T ss_pred             cccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhCCC
Confidence            765432211     1112334678999999999999999999999999999998 999998754332    223333333


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..+..   ..++..+.+++.+||..+|++||++.+|+..|..+....
T Consensus       229 ~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         229 RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            33322   234788999999999999999999999999988876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=320.15  Aligned_cols=248  Identities=19%  Similarity=0.255  Sum_probs=196.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|++.+.||+|+||+||+|.+..+++.||||++....     ....+.+|+.+++.++| +++..+..++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC-CCEeeeeeeecCCCeEEEEE
Confidence            4899999999999999999999899999999876432     12346789999999987 44555655666778899999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++   ++.+.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence            999 78998877643 3469999999999999999999999999999999999999   477899999999997654322


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .        .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+.......    ....
T Consensus       157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~  224 (285)
T cd05605         157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----QEEY  224 (285)
T ss_pred             c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----cccc
Confidence            1        123478999999999999899999999999999999999999998754432222222211111    1112


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      ...++..+.+||.+||..||++||     ++++|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            244688999999999999999999     6666533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.5e-41  Score=327.45  Aligned_cols=261  Identities=21%  Similarity=0.325  Sum_probs=201.4

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..+++.||+|++....     ....+..|+.++..+.+++++..+..++......++||||+ +
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999877532     22346788888888876788888888888889999999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~-----  151 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD-----  151 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence            888877764 5679999999999999999999999999999999999999   5788999999999875432221     


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh------hhHHHHHHHHhhhcCCcHHHh
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~  240 (423)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ........+.......|    
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----  225 (329)
T cd05618         152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----  225 (329)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----
Confidence              122467999999999999999999999999999999999999999632111      11122233333333322    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                       ..++..+.++|.+||..||++||++.... .+.++   ..+.|...++|...
T Consensus       226 -~~~~~~~~~ll~~~L~~dP~~R~~~~~~~-~~~~i---~~hp~f~~~~~~~~  273 (329)
T cd05618         226 -RSLSVKAASVLKSFLNKDPKERLGCHPQT-GFADI---QGHPFFRNVDWDLM  273 (329)
T ss_pred             -CCCCHHHHHHHHHHhcCCHHHcCCCCCCC-CHHHH---hcCCCCCCCCHHHH
Confidence             45588999999999999999999853211 01222   23455555677543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.6e-41  Score=327.52  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=197.6

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.||+|+||+||+|++..+++.||+|++....     ....+..|... ++.+.| +++..+..++...+..++||||+ 
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcCCeEEEEEeCCC
Confidence            47999999999999999999999999876432     12234445444 455555 66767777777888999999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~----  151 (325)
T cd05602          80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG----  151 (325)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence            7889888765 5668899999999999999999999999999999999999   4788999999999975432221    


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......     ...++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~-----~~~~~  220 (325)
T cd05602         152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPLQL-----KPNIT  220 (325)
T ss_pred             ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCcCC-----CCCCC
Confidence               123567999999999999999999999999999999999999999865433   3334443333222     23568


Q ss_pred             HHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          246 AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      ..+.++|.+||+.+|.+||++.+...   ++.   +..|...++|..+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~---~i~---~~~~~~~~~~~~~  262 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDFM---EIK---NHIFFSPINWDDL  262 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCHH---HHh---cCcccCCCCHHHH
Confidence            89999999999999999999865322   222   2334456777543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.1e-41  Score=333.63  Aligned_cols=259  Identities=20%  Similarity=0.278  Sum_probs=205.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .++|++++.||+|+||.||+|++...     +..||||++.....   .+.+.+|++++..+..|++++.+..++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            46788999999999999999987532     34699998865432   34588999999999856778888777788889


Q ss_pred             eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR-----------------------------------------------------------   97 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------------------------------------------   97 (423)
                      .||||||| +|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            99999999 899998876421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           98 ------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        98 ------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                                                          ..+++..++.++.||+.||.|||+++|+||||||+|||++   .
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---Q  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---C
Confidence                                                2377888999999999999999999999999999999994   6


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhh
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT  220 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~  220 (423)
                      ++.+||+|||+++........     .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            788999999999876433211     11223456788999999999899999999999999999997 999998643321


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                        ..+..+ ......+   ....+|..+.+++.+||+.+|++||++.+|.+.|+.++.
T Consensus       348 --~~~~~~-~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 --TFYNKI-KSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --HHHHHH-hcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence              111222 2222222   123558899999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=326.57  Aligned_cols=252  Identities=23%  Similarity=0.287  Sum_probs=198.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+..|..++..+.| ++++.+..++.+....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCceEEEEecCCeEEEE
Confidence            4799999999999999999999999999999987632     223347788888888765 6677777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            9999 899999997666779999999999999999999999999999999999999   478899999999997654432


Q ss_pred             CCCcccccCCCcccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ..      ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+....   +.+..+.......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~  227 (331)
T cd05597         157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKEHF  227 (331)
T ss_pred             Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCcc
Confidence            21      1123468999999999873     34788999999999999999999999864432   3333443332222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCC--CCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~l~~  271 (423)
                      ........++..++++|.+||..++++  |++++++++
T Consensus       228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            222223446889999999998754433  677776644

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-41  Score=319.17  Aligned_cols=256  Identities=21%  Similarity=0.317  Sum_probs=204.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCC-----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~-----~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +.-++|++.+.||+|+||.||+|.+...+     ..||+|.+.....   ...+.+|+.++..+.| +++..+..+....
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH-PNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC-cccceEEEEEcCC
Confidence            34468999999999999999999976544     6799998765432   2347889999999987 4555666666677


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG  139 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~  139 (423)
                      ...+++|||+ +++|.+++....               ..+++..++.++.||+.||.|||++|++||||||+||+++  
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~--  158 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG--  158 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc--
Confidence            7899999999 789999887532               4578899999999999999999999999999999999994  


Q ss_pred             CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchh
Q 014527          140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA  218 (423)
Q Consensus       140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~  218 (423)
                       +++.++|+|||+++........     .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus       159 -~~~~~~L~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         159 -EGLTVKISDFGLSRDIYSADYY-----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             -CCCcEEECCCcceeeccccccc-----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence             7789999999999865432211     11224456889999999998889999999999999999998 9999987554


Q ss_pred             hhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      .+   ....+..... .+   ....+|.++.+|+.+||+.||++||++.+|++.|+.
T Consensus       233 ~~---~~~~i~~~~~-~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 QE---VIEMIRSRQL-LP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH---HHHHHHcCCc-CC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            32   2222322221 11   234568999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.6e-41  Score=315.01  Aligned_cols=257  Identities=20%  Similarity=0.333  Sum_probs=206.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +....|.+.+.||+|+||.||+|.+.++++.||+|+...... ...+.+|+++++.+.|+ ++..+..+.......+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP-NLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCC-ChhheEEEEcCCCCcEEEE
Confidence            345679999999999999999999999999999998765432 34588999999999874 4555555666777889999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||+   ++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccce
Confidence            999 889999886543 458999999999999999999999999999999999999   478899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   ....+ ......   .
T Consensus       159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~-~~~~~~---~  225 (263)
T cd05052         159 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL-EKGYRM---E  225 (263)
T ss_pred             ee------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-HCCCCC---C
Confidence            11      1112334678999999999999999999999999999998 999998754332   22222 222211   2


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ....+|.++.+++.+||..+|++||++.+|.+.|+.++
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            23456899999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-40  Score=315.71  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=205.7

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~----~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      |+.+...+|++.+.||+|+||+||+|++..++.    .||+|++.....   ...+.+|+.++..+.| +++..+..++.
T Consensus         1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~   79 (279)
T cd05109           1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVCRLLGICL   79 (279)
T ss_pred             CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCC-CCCceEEEEEc
Confidence            567788999999999999999999999876665    489998765433   3357788888888876 45555555544


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      . ...+++|+|+ +|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++   +++.+||+|||+
T Consensus        80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~  155 (279)
T cd05109          80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGL  155 (279)
T ss_pred             C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCc
Confidence            3 4567899998 8899999876566799999999999999999999999999999999999994   678899999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      ++..........     .....++..|+|||.+.+..++.++|||||||++|||++ |..||.........    .....
T Consensus       156 ~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~~~~  226 (279)
T cd05109         156 ARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP----DLLEK  226 (279)
T ss_pred             eeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHC
Confidence            987654322110     112244678999999999889999999999999999998 99999765433222    22222


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ....+.   ...++..+.+++.+||..||++||++.+|++.|+++...
T Consensus       227 ~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         227 GERLPQ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CCcCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            222221   134588999999999999999999999999988877544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-41  Score=335.96  Aligned_cols=255  Identities=23%  Similarity=0.303  Sum_probs=197.5

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++++.||+|+||.||+|++..+++.||||++...     .....+.+|+.++..+.| +++..+...+.+.+..|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999987642     233457889999999987 5565666666778899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|..+....
T Consensus        80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence            9999 8899998875 4568999999999999999999999999999999999999   578899999999985432110


Q ss_pred             CCCc------------------------------------ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHH
Q 014527          161 TNRH------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL  204 (423)
Q Consensus       161 ~~~~------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~  204 (423)
                      ....                                    ..........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0000                                    0000112457999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCC---ChHHHHH
Q 014527          205 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFLKR  271 (423)
Q Consensus       205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~  271 (423)
                      ||++|+.||.+......   ...+.........+ ....+++++.++|.+|+ .+|.+|+   ++.+++.
T Consensus       236 ell~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         236 EMLVGQPPFLADTPAET---QLKVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             ehhhCCCCCCCCCHHHH---HHHHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999987554322   22222211111111 11346789999999977 5999999   7777743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.8e-41  Score=331.77  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=201.0

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      -.++|++.+.||+|+||.||+|++..+++.||+|++...     .....+..|+.+++.++| +++..+..+..+....+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCEEE
Confidence            346899999999999999999999999999999987642     122346789999998876 55666666777888999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccC
Confidence            999999 8899998864  468999999999999999999999999999999999999   5789999999999987543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCC----CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ....      ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+....   ..+.++......
T Consensus       195 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~  265 (370)
T cd05596         195 NGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMDHKNS  265 (370)
T ss_pred             CCcc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCCc
Confidence            2211      11245799999999998754    3789999999999999999999999875432   334444433221


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCC--CCChHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR  271 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~l~~  271 (423)
                      ...+. ...++.++.++|..||..+|.+  |+++++|++
T Consensus       266 ~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            11111 1245889999999999999987  999998855

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.9e-41  Score=334.41  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=196.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ..|++++.||+|+||+||+|++..+++.||||++....     ....+..|+.+++.++| ++++.+..++.+.+..++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv   79 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV   79 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecCCEEEEE
Confidence            36899999999999999999999999999999886432     22347889999999976 5666777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+++.+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          80 MDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccc
Confidence            9999 8899998875 4568999999999999999999999999999999999999   478899999999986442111


Q ss_pred             CCCcc----------------------------------------cccCCCcccccccccCcccccCCCCCccchHHHHH
Q 014527          161 TNRHI----------------------------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG  200 (423)
Q Consensus       161 ~~~~~----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlG  200 (423)
                      .....                                        .........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00000                                        00001245799999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCCchhhhhHHHHHHHHhh--hcCCcHHHhhccChHHHHHHHHHHh--cCCCCCCCChHHHHH
Q 014527          201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYFHYCQ--SLTFDQRPDYGFLKR  271 (423)
Q Consensus       201 vil~elltG~~Pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~RPt~~~l~~  271 (423)
                      |++|||++|..||.......   ....+...  ....+.   ...+++++.+||.+|+  ..++..||++++|+.
T Consensus       236 ~il~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTE---TQLKVINWENTLHIPP---QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHH---HHHHHHccccccCCCC---CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            99999999999998754322   22222221  111111   1245789999999855  445556999998865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=304.57  Aligned_cols=268  Identities=19%  Similarity=0.217  Sum_probs=207.3

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEE----eeeeCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKW----YGVDGE   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~----~~~~~~   76 (423)
                      .|.+++|+|.+.||+|||+-||+++...+++.||+|.+....  ..+..++|++..+++++++.++.+..    -.....
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            366899999999999999999999999999999999665443  44568999999999999655544421    112345


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEeec
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDF  150 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~DF  150 (423)
                      ..||+++|+ .|+|.+.+....   ..+++.+++.|+.+|++||++||+..  ++||||||.|||++   +.+.++|.||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~  173 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDL  173 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEec
Confidence            689999999 899999987553   35899999999999999999999998  99999999999996   6899999999


Q ss_pred             cceeeecCCCCC--CcccccCCCcccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHH
Q 014527          151 GLAKKYRDPTTN--RHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY  225 (423)
Q Consensus       151 Gla~~~~~~~~~--~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~  225 (423)
                      |.+....-.-..  .....+.......|..|.|||.+.-   ...+.++|||||||+||.|+.|.-||...-.. -....
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSla  252 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSLA  252 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeEE
Confidence            998764322111  1112223334567999999999974   44689999999999999999999999642110 00011


Q ss_pred             HHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ..+....+..|...   .+++.+.++|+.||+.||.+||++.+|+..++++.
T Consensus       253 LAv~n~q~s~P~~~---~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 LAVQNAQISIPNSS---RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EeeeccccccCCCC---CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            12333344444332   36899999999999999999999999999888763

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.8e-41  Score=325.28  Aligned_cols=235  Identities=24%  Similarity=0.330  Sum_probs=189.2

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.||+|+||+||+|++..+++.||||++....     ....+..|... ++.+.| +++..+..++...+..++||||+ 
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCC-CCCCCeeEEEEeCCEEEEEEcCCC
Confidence            47999999999999999999999999876432     22334555554 455655 66666767777888999999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~----  151 (323)
T cd05575          80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK----  151 (323)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence            8899888765 5679999999999999999999999999999999999999   5788999999999875432211    


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   +.+..+.......     ...++
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~-----~~~~~  220 (323)
T cd05575         152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNKPLRL-----KPNIS  220 (323)
T ss_pred             ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCC-----CCCCC
Confidence               123457999999999999999999999999999999999999999875432   3444444433322     23458


Q ss_pred             HHHHHHHHHHhcCCCCCCCChH
Q 014527          246 AEFASYFHYCQSLTFDQRPDYG  267 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RPt~~  267 (423)
                      ..+.++|.+||+.||.+||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            8999999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8e-41  Score=324.82  Aligned_cols=240  Identities=23%  Similarity=0.323  Sum_probs=192.6

Q ss_pred             eceeeecCceeEEEEEEC---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527           12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++.||+|+||.||+|++.   .+++.||||++...      .....+..|+.+++.++|+ ++..+..++...+..|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP-FIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCC-chhceeeEEecCCeEEEEE
Confidence            368999999999999874   46889999987642      1223467899999999874 5555555666778899999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence            999 7899888765 5568899999999999999999999999999999999999   5788999999999875432221


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....   ..+..+.......+     
T Consensus       156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~~~~~~~~-----  220 (323)
T cd05584         156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGKLNLP-----  220 (323)
T ss_pred             -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----
Confidence                   112457999999999999988999999999999999999999999875432   33444444433322     


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      ..+++.+.++|.+||..+|++||     +++++++
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            34588999999999999999999     6666644

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.9e-41  Score=330.29  Aligned_cols=246  Identities=22%  Similarity=0.291  Sum_probs=192.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ..+|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+++++.++| +++..+..+.......++||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC-CCcceeeeEeccCCeEEEEE
Confidence            3578899999999999999999999999999998865432   2457899999999987 55666666667788899999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+.     ....+..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+.....
T Consensus       152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence            999 6777542     335678889999999999999999999999999999999   4788999999999987643321


Q ss_pred             CCcccccCCCcccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                             ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+.......+....    
T Consensus       224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  292 (353)
T PLN00034        224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----  292 (353)
T ss_pred             -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence                   1124578999999998743     234578999999999999999999997433222222222221111    


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .......++.++.+||.+||..||++||++.+|++
T Consensus       293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11122455889999999999999999999999866

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.8e-41  Score=315.35  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=201.9

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .+...++|++.+.||+|+||.||+|++..+++.||+|+.....  ....+.+|+.++..+.|++ +..+..++...+..+
T Consensus         4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~-ii~~~~~~~~~~~~~   82 (267)
T cd06646           4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN-IVAYFGSYLSREKLW   82 (267)
T ss_pred             ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCCEEE
Confidence            4556788999999999999999999999999999999886543  2335778999999998854 555555666778899


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||++   +..+.++|+|||++.....
T Consensus        83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence            999999 6789888764 4578999999999999999999999999999999999999   4788899999999987643


Q ss_pred             CCCCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ...       ......|+..|+|||.+.   ...++.++|||||||++|||++|..||.......   ....+.......
T Consensus       159 ~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~  228 (267)
T cd06646         159 TIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMSKSNFQP  228 (267)
T ss_pred             ccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh---hheeeecCCCCC
Confidence            221       112456889999999885   3447889999999999999999999997543221   111111222222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      +.......++..+.++|.+||..+|++||++++|++.
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            2222223567899999999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-40  Score=312.38  Aligned_cols=248  Identities=21%  Similarity=0.280  Sum_probs=200.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      ..+|++.+.||+|+||.||+|..  .+..||+|..........+.+|+.+++.++|.+.++.+..+.......+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46899999999999999999976  4778999998877666678999999999988655554444445566789999999


Q ss_pred             -CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           86 -GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        86 -~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                       +++|.+++..... .+++..++.++.||+.||+|||++|++||||||+||++   ++++.+||+|||+++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~--  157 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccCC--
Confidence             7899998875433 48899999999999999999999999999999999999   4788999999999876543221  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                              ...++..|+|||.+.+..++.++|||||||++|+|++ |+.||.......   ....+. .....   ....
T Consensus       158 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~-~~~~~---~~~~  222 (256)
T cd05082         158 --------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE-KGYKM---DAPD  222 (256)
T ss_pred             --------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh-cCCCC---CCCC
Confidence                    2344668999999998889999999999999999997 999997643322   222221 11111   1224


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      .+|+.+.+++.+||..+|++||++.++++.|++
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            568999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-40  Score=327.37  Aligned_cols=253  Identities=20%  Similarity=0.234  Sum_probs=194.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-----eC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~   75 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++|++.+..+..+..     ..
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4589999999999999999999999899999999886532    22357789999999988655554444332     22


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++||||+.++|.+.+.   ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        95 ~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART  168 (355)
T ss_pred             ceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCccccc
Confidence            3579999999888887764   358999999999999999999999999999999999999   4788999999999976


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH------
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC------  229 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~------  229 (423)
                      ......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..............      
T Consensus       169 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             CCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            543221        124578999999999999999999999999999999999999998754322211111100      


Q ss_pred             -------------hhhcC-----Cc----------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 -------------EKKVS-----TP----------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 -------------~~~~~-----~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   .....     .+          ........+.++.+||.+||..||++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                         00000     00          00001123567899999999999999999999876

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-40  Score=329.20  Aligned_cols=250  Identities=20%  Similarity=0.253  Sum_probs=195.0

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-----eC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~   75 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.+.|++.+..+..+..     ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4579999999999999999999999999999999886532    23457789999999988655554443322     22


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...|+||||++++|.+.+.   ..++...+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~  175 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART  175 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence            4579999999989888774   358899999999999999999999999999999999999   4788999999999976


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......        .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....   .++.......
T Consensus       176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~  244 (364)
T cd07875         176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTP  244 (364)
T ss_pred             cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCC
Confidence            543221        12457899999999999999999999999999999999999999875543222   2221110000


Q ss_pred             c-------------------------HHH------------hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 P-------------------------IEV------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~-------------------------~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .                         ...            .....+..+.+||.+||..||.+||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0                         000            00112457899999999999999999998865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-41  Score=333.76  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=196.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++++.||+|+||.||+|.+..+++.||||++....     ....+.+|++++..+.| ++++.+..++.+....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCeeEEE
Confidence            47999999999999999999999999999999875422     22347789999999876 5666777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence            9999 8899998875 4679999999999999999999999999999999999999   478899999999997432211


Q ss_pred             CCCc-------ccc---------------------------------cCCCcccccccccCcccccCCCCCccchHHHHH
Q 014527          161 TNRH-------IPY---------------------------------RENKNLTGTARYASCNTHLGIEQSRRDDLESLG  200 (423)
Q Consensus       161 ~~~~-------~~~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlG  200 (423)
                      ....       ...                                 .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0000       000                                 000135799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCchhhhhHHHHHHHHhh--hcCCcHHHhhccChHHHHHHHHHHhcCCCCCC---CChHHHHH
Q 014527          201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR---PDYGFLKR  271 (423)
Q Consensus       201 vil~elltG~~Pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~~l~~  271 (423)
                      |++|||++|..||.+....   +.+..+...  ....+.   ...++.++.+||.+||. +|.+|   +++.+++.
T Consensus       236 vil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         236 AIMFECLIGWPPFCSENSH---ETYRKIINWRETLYFPD---DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHH---HHHHHHHccCCccCCCC---CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            9999999999999875433   233333321  111111   12357899999999997 77766   47777654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-40  Score=317.80  Aligned_cols=258  Identities=18%  Similarity=0.235  Sum_probs=205.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCc--EEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~--~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++...   ....+.+|+.++.++.+|+++..+..+.......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999999877664  47888776422   2245788999999997667787887777788889999


Q ss_pred             Eecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcE
Q 014527           82 LDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV  145 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~v  145 (423)
                      |||+ +++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence            9999 789999986432               248899999999999999999999999999999999999   478899


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK  224 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~  224 (423)
                      ||+|||++........        ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   .
T Consensus       159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~  227 (297)
T cd05089         159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L  227 (297)
T ss_pred             EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence            9999999864321110        112233567999999998889999999999999999997 999998754432   2


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                      +..+... ...+   ....++..+.+|+.+||..+|.+||++++|++.|+.++.....
T Consensus       228 ~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         228 YEKLPQG-YRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HHHHhcC-CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            2222221 1111   1234588999999999999999999999999999999876654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.2e-41  Score=333.09  Aligned_cols=254  Identities=22%  Similarity=0.298  Sum_probs=196.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+|++++.||+|+||+||+|++..+++.||||++....     ....+.+|+++++.+.| +++..+...+.+....|+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeCCEEEEE
Confidence            36999999999999999999999999999999876432     23357889999999987 5566676677788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..+....
T Consensus        80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence            9999 8899998865 4568999999999999999999999999999999999999   578899999999986432110


Q ss_pred             CCCc----------------------------------------ccccCCCcccccccccCcccccCCCCCccchHHHHH
Q 014527          161 TNRH----------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG  200 (423)
Q Consensus       161 ~~~~----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlG  200 (423)
                      ....                                        ..-.......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0000                                        000001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC---hHHHH
Q 014527          201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLK  270 (423)
Q Consensus       201 vil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~l~  270 (423)
                      |++|||++|+.||.+....   +....+.........+ ....+++++.++|.+|+ .+|.+|++   +++++
T Consensus       236 vil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPL---ETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHH---HHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            9999999999999875433   2222333211111111 11345788999999876 59999997   66554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.5e-41  Score=326.59  Aligned_cols=250  Identities=22%  Similarity=0.251  Sum_probs=197.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....     ....+..|..++..+.| +++..+..++.+.+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC-QWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence            47999999999999999999999999999999876421     22236677788777765 6677777777888999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            9999 899999998766789999999999999999999999999999999999999   478899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ..      ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......   +.+..+.......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~  227 (331)
T cd05624         157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHEERF  227 (331)
T ss_pred             ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---HHHHHHHcCCCcc
Confidence            21      1123579999999999876     45788999999999999999999999865433   3344443332222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCC--CCChHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFL  269 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~l  269 (423)
                      +.+.....++.++.++|.+||...+.+  |++++++
T Consensus       228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~  263 (331)
T cd05624         228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDF  263 (331)
T ss_pred             cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHH
Confidence            222223456889999999999865543  3455544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=323.44  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=217.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      |.+=|.+.+.||+|.|..|-+|++.-+|+.||||++.+...    ...+.+|++.|+.++| ++|+.++.........||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhcccceEEE
Confidence            45779999999999999999999999999999999876543    3358999999999988 556566666667788999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |+|+- +|+|.+++.+....+.+..+..++.||+.|+.|+|+..+|||||||+|+++-  ..-|.|||.|||++..+...
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCCCc
Confidence            99999 8899999998888999999999999999999999999999999999999885  57899999999999776544


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      .        .-.+.+|+..|-|||++.|..|+ +++||||||||||-|++|++||+..++.   +.+-.|++-++..|..
T Consensus       173 ~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---ETLTmImDCKYtvPsh  241 (864)
T KOG4717|consen  173 K--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---ETLTMIMDCKYTVPSH  241 (864)
T ss_pred             c--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---hhhhhhhcccccCchh
Confidence            3        33478999999999999999986 6889999999999999999999976554   5566678888887755


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .     +.+.++||..||..||.+|.+.++|..
T Consensus       242 v-----S~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  242 V-----SKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             h-----hHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            4     889999999999999999999999865

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.7e-40  Score=316.71  Aligned_cols=254  Identities=20%  Similarity=0.265  Sum_probs=201.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||.|+||.||+|++..+++.||+|.+....   ....+.+|+.+++.++| +++..+..++......++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC-CCcceEEEEEecCCeEEEEEe
Confidence            57999999999999999999999999999999876432   23357789999999987 556666666777888999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |+.++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.++|+|||++........  
T Consensus        85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC--
Confidence            99989999888766779999999999999999999999999999999999999   4788999999999976433221  


Q ss_pred             cccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc---------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV---------  233 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---------  233 (423)
                           ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..+.....         
T Consensus       160 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 -----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             -----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence                 11234678999999998764 478899999999999999999999987554322222222111000         


Q ss_pred             -------CCc------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 -------STP------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 -------~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                             ..+      .......+++.+++||.+||..||.+||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                   000      11122356888999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-40  Score=316.19  Aligned_cols=241  Identities=21%  Similarity=0.279  Sum_probs=189.9

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ||+|+||+||+|.+..+++.||+|++....     ....+..|+++++.+.| +++..+..++......++||||+ +++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            699999999999999999999999876432     12346789999999966 55666666666778899999999 889


Q ss_pred             HHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           89 LEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        89 L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      |.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..+.....    
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~----  152 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS----  152 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence            9877643   23468999999999999999999999999999999999999   4788999999999976644322    


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhH-HHHHHHHhhhcCCcHHHhhccC
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                         ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......... .....+.....     .....+
T Consensus       153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  224 (280)
T cd05608         153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-----TYPDKF  224 (280)
T ss_pred             ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC-----CCcccC
Confidence               122457899999999999999999999999999999999999999764322111 11222211111     122456


Q ss_pred             hHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      +..+.+++.+||+.||++||     +++++++
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            88999999999999999999     4455544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-40  Score=337.89  Aligned_cols=250  Identities=20%  Similarity=0.214  Sum_probs=202.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC-CcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~-~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ...|.+.+.||+|+||.||+|....+ ++.||+|.+.....  ...+..|+.++..++| ++++.+..++...+..||||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEECCEEEEEE
Confidence            34599999999999999999998877 78899997654332  2346789999999987 55666777777888999999


Q ss_pred             ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        83 e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||+ +++|.+++...   ...+++..+..++.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.+..
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCC
Confidence            999 89999887532   3458999999999999999999999999999999999999   4788999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ....     ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   +.+..+.......   
T Consensus       222 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~---  290 (478)
T PTZ00267        222 SVSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVLYGKYDP---  290 (478)
T ss_pred             cccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCC---
Confidence            3211     1223567999999999999999999999999999999999999999864432   3333333332221   


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ....++.++.++|..||..+|++||++++++.
T Consensus       291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             12345789999999999999999999998864

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-40  Score=325.20  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=199.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||++++..+++.||+|++...     .....+..|..++..+.| +++..+..+..+....++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCEEEEE
Confidence            4799999999999999999999999999999987532     122236778888877765 5666777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence            9999 899999998766779999999999999999999999999999999999999   578899999999997654322


Q ss_pred             CCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ..      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||......   +.+.++.......
T Consensus       157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~  227 (332)
T cd05623         157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKERF  227 (332)
T ss_pred             cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCccc
Confidence            11      112357999999999986     345789999999999999999999999875433   3444444433322


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCC--CCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~l~~  271 (423)
                      +.+.....++.++.+||.+|+..++++  |++++++++
T Consensus       228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            223333456899999999999765544  567776643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5e-41  Score=331.11  Aligned_cols=268  Identities=22%  Similarity=0.324  Sum_probs=204.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.|++.+.||+|+||.||+|++..+++.||||++...     .....+..|+.++..+.| ++++.+...+.+....++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence            4799999999999999999999999999999988642     223457789999999876 5555666666788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence            9999 8899998875 4569999999999999999999999999999999999999   578999999999987553221


Q ss_pred             CCCcc----------------------------cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 014527          161 TNRHI----------------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP  212 (423)
Q Consensus       161 ~~~~~----------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~P  212 (423)
                      .....                            ........+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            10000                            00001235799999999999999999999999999999999999999


Q ss_pred             CCCchhhhhHHHHHHHHhhh--cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceec
Q 014527          213 WQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW  290 (423)
Q Consensus       213 f~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw  290 (423)
                      |.+....   ..+..+....  ...+..   ..+++++.++|.+|+ .||.+|++...+.+.       ..+.|....+|
T Consensus       236 f~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei-------~~hp~f~~~~~  301 (360)
T cd05627         236 FCSETPQ---ETYRKVMNWKETLVFPPE---VPISEKAKDLILRFC-TDSENRIGSNGVEEI-------KSHPFFEGVDW  301 (360)
T ss_pred             CCCCCHH---HHHHHHHcCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcCCCCCHHHH-------hcCCCCCCCCH
Confidence            9875443   3333333221  111111   125788999999977 499999975333222       23455566788


Q ss_pred             eec
Q 014527          291 TIL  293 (423)
Q Consensus       291 ~~~  293 (423)
                      ..+
T Consensus       302 ~~~  304 (360)
T cd05627         302 GHI  304 (360)
T ss_pred             HHH
Confidence            654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-40  Score=310.23  Aligned_cols=255  Identities=24%  Similarity=0.341  Sum_probs=202.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||.+....     ....+.+|+++++.++| +++..+..++.+.+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-cceeeeeeeEEECCeEEEE
Confidence            68999999999999999999999999999999765322     12347889999999987 4555566666677889999


Q ss_pred             Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |||+ +++|.+++...   ...+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccceecc
Confidence            9999 67998887642   34489999999999999999999999999999999999994   67889999999988764


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....       .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ........+.... ..+.
T Consensus       158 ~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~  228 (267)
T cd08228         158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCD-YPPL  228 (267)
T ss_pred             chhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCC-CCCC
Confidence            33211       1234688999999999988899999999999999999999999975332 1122222222211 1111


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                        .....+..+.++|.+||..+|++||++.++++.|+.+
T Consensus       229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              1123578899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.7e-40  Score=315.05  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=203.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      -.++|.+.+.||+|+||.||+|.+..     +++.||||++......   ..+.+|+++++.+.|+ ++..+..++....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~   81 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE-NIVKFYGVCTEGD   81 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCC-CchheeeEEecCC
Confidence            35679999999999999999998753     3578999998765433   4688999999999874 5666666677778


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR-------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      ..+++|||+ +++|.+++....             ..+++..+..++.||+.||.|||++|++||||||+||++   +.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence            899999999 899999986532             347889999999999999999999999999999999999   478


Q ss_pred             CcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhh
Q 014527          143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK  221 (423)
Q Consensus       143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~  221 (423)
                      +.++|+|||+++........     .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..... 
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-  232 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-  232 (280)
T ss_pred             CeEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence            99999999999765332211     11223456788999999999999999999999999999998 999997654432 


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                        ....+.......+    ...+|..+.+++.+||..||++||++.+|++.|+
T Consensus       233 --~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 --VIECITQGRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --HHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              2333332222221    2346889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-40  Score=326.00  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=195.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-----e
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~   74 (423)
                      .+.++|++.+.||.|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++|++.+..+..+..     .
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            35679999999999999999999999999999999876532    22346789999999988555444333221     2


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....|++|++++++|.+++.  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~  166 (343)
T cd07878          92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR  166 (343)
T ss_pred             cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccce
Confidence            24579999999999988775  4569999999999999999999999999999999999999   478899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh-
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-  232 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-  232 (423)
                      ......          ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....... 
T Consensus       167 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         167 QADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             ecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            654322          24578999999999987 468999999999999999999999998654332222211111000 


Q ss_pred             ----------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 ----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ----------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                            ............++.+.+||.+||..||.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                  000011112344667899999999999999999999875

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-40  Score=328.98  Aligned_cols=259  Identities=20%  Similarity=0.250  Sum_probs=198.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC-----ee
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-----DN   78 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~-----~~   78 (423)
                      +|++.+.||+|+||.||+|.+..+++.||||.+....    ....+.+|+++++.++|++.+. +..+.....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS-ALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCC-HhheecCCCccccceE
Confidence            4789999999999999999999999999999875432    2345788999999998755444 433333333     68


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |+||||++++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        80 ~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          80 YVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence            99999999899887754 4579999999999999999999999999999999999999   4788999999999986543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh-------
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE-------  230 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-------  230 (423)
                      ....      ......+|+.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+.......+.....       
T Consensus       156 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         156 DESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             Cccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            3211      112346789999999998754 78999999999999999999999987654433222221111       


Q ss_pred             -------------hhcCCc-HH---HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          231 -------------KKVSTP-IE---VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       231 -------------~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                   .....+ ..   ......++++.+||.+||+.||.+||++.+++.  +.++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~  293 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA--HPYLDE  293 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc--CHhhCC
Confidence                         001111 00   112345788999999999999999999999865  455543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-40  Score=310.64  Aligned_cols=255  Identities=23%  Similarity=0.372  Sum_probs=202.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.++||+|+||.||+|++..+ ..||+|++..... ...+.+|+.+++.+.|+ ++..+..+. .....++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~~~-~~~~~~lv~   79 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE-KLVQLYAVV-SEEPIYIVT   79 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCC-CcceEEEEE-CCCCcEEEE
Confidence            4568899999999999999999998665 4599998875433 45688999999999874 455554443 345679999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.++.|++.||+|||+.+|+||||||+||+++   +++.++|+|||.++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeeccccc
Confidence            999 78999998753 34589999999999999999999999999999999999994   78899999999998664332


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......++..|+|||...+..++.++|||||||++|+|++ |..||.+....   +.+..+.. ....+.  
T Consensus       157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~~-~~~~~~--  224 (262)
T cd05071         157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVER-GYRMPC--  224 (262)
T ss_pred             cc------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHhc-CCCCCC--
Confidence            11      1123356778999999998889999999999999999999 89999765433   22222222 111111  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                       ...+|..+.+++.+||+.+|++||+++++.+.|+++|
T Consensus       225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence             2345889999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.5e-40  Score=314.09  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=208.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      |-..+|.+.+.||+|+||.||+|.+.     .++..||+|.+.....  ...+.+|+.++..++| +++..+..++....
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~   80 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGD   80 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCC
Confidence            44678999999999999999999863     3456699998765432  3458899999999987 56777777777888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN  143 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~  143 (423)
                      ..+++|||+ +++|.+++....            ..+++..++.++.||+.||+|||++|++||||||+|||+   ++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence            999999999 889999887432            248999999999999999999999999999999999999   4788


Q ss_pred             cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhH
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK  222 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~  222 (423)
                      .++|+|||+++........     .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......   
T Consensus       158 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---  229 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---  229 (288)
T ss_pred             cEEeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            9999999999765432211     11223445788999999999889999999999999999998 99999875433   


Q ss_pred             HHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..+..+.......    .....+.++.+|+.+||+.||.+||++.++...|+++.+..
T Consensus       230 ~~~~~i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         230 EVIECITQGRVLQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHHHHHHcCCcCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            2333333322211    12345889999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.4e-40  Score=313.90  Aligned_cols=244  Identities=22%  Similarity=0.307  Sum_probs=194.3

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|+..+.||+|+||+||+|.+..+++.||+|++....     ....+.+|+++++.++|+ ++..+..++...+..+++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCc-CceeEEEEEecCCEEEEEE
Confidence            4788999999999999999999999999999876432     123467899999999874 4555666666778899999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++   ++.+.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence            999 78888877643 3469999999999999999999999999999999999999   477899999999987653322


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .        .....|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.......+.+..    .........
T Consensus       157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~----~~~~~~~~~  224 (285)
T cd05632         157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----RVLETEEVY  224 (285)
T ss_pred             c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----hhhcccccc
Confidence            1        1245789999999999998999999999999999999999999987543322222211    111111122


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYG  267 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~  267 (423)
                      ...++.++.+|+..||+.||++||++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            345688999999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-41  Score=326.74  Aligned_cols=237  Identities=24%  Similarity=0.358  Sum_probs=193.4

Q ss_pred             eceeeecCceeEEEEEEC---CCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527           12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++.||+|+||.||++++.   .+++.||+|++....    ....+..|++++..++| +++..+..++.+....|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCEEEEEEcC
Confidence            367999999999999864   578899999886432    23346789999999987 5566666667778899999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC--
Confidence            9 7899888864 4569999999999999999999999999999999999999   4788999999999876543321  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                           ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......   +.+..+.......+     ..
T Consensus       154 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i~~~~~~~p-----~~  220 (318)
T cd05582         154 -----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMILKAKLGMP-----QF  220 (318)
T ss_pred             -----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHHHcCCCCCC-----CC
Confidence                 112457899999999999988999999999999999999999999865432   33344444333322     34


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGF  268 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~  268 (423)
                      +++.+.++|.+||+.||++||++.+
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            5889999999999999999999776

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.1e-40  Score=316.69  Aligned_cols=262  Identities=20%  Similarity=0.312  Sum_probs=206.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC-------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-------~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      +..++|.+.+.||+|+||.||+|++..       +...||+|++.....   ...+..|+.++..+..++++..+..++.
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            345789999999999999999998743       234699998875432   2347789999999965677877877777


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEe
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG  137 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~  137 (423)
                      .....++||||+ +++|.+++....               ..+++.+++.++.||+.||+|||++|++||||||+|||+ 
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-  173 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-  173 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence            888999999999 789999987532               248899999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCc
Q 014527          138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL  216 (423)
Q Consensus       138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~  216 (423)
                        +.++.+||+|||+++.........     ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.
T Consensus       174 --~~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~  246 (307)
T cd05098         174 --TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  246 (307)
T ss_pred             --cCCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence              477899999999987654322111     1112234578999999999889999999999999999998 89999764


Q ss_pred             hhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ...   +....+ .......   .....+.++.+|+.+||..+|++||++.+|++.|++++...
T Consensus       247 ~~~---~~~~~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         247 PVE---ELFKLL-KEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             CHH---HHHHHH-HcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            332   222222 2222111   22345889999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-40  Score=328.69  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=198.3

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...     .....+.+|+.+++.+.| +++..+..+..+....|
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~~  119 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEE
Confidence            457899999999999999999999999999999987532     122346788888888876 55666666677888999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+|.....
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence            999999 8899998864  458999999999999999999999999999999999999   5789999999999987643


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCC----CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ....      ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+....   ..+.++......
T Consensus       195 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~~i~~~~~~  265 (370)
T cd05621         195 TGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYSKIMDHKNS  265 (370)
T ss_pred             CCce------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCcc
Confidence            2211      123557999999999997643    788999999999999999999999875433   334444433221


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCC--CCChHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR  271 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~l~~  271 (423)
                      ...+. ...++..+++++..||..++.+  |++++++++
T Consensus       266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            11111 1235788999999999855543  889888766

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4e-40  Score=316.98  Aligned_cols=260  Identities=19%  Similarity=0.229  Sum_probs=205.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcE--EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~--vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +--++|++.+.||+|+||.||+|.+..++..  +++|.+....   ....+.+|++++..+.+|++++.+..++......
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            3346899999999999999999998877754  5777655322   2235778999999996668888888888888899


Q ss_pred             EEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           79 VLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      ++||||+ +++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||+   +.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCC
Confidence            9999999 889999986532               247899999999999999999999999999999999999   478


Q ss_pred             CcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhh
Q 014527          143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK  221 (423)
Q Consensus       143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~  221 (423)
                      +.+||+|||++.......        ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..... 
T Consensus       161 ~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-  231 (303)
T ss_pred             CcEEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-
Confidence            899999999986322111        1112234678999999988889999999999999999998 999998654432 


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                        ....+. ......   .....++.+.+|+.+||+.+|++||++++++..|..++....
T Consensus       232 --~~~~~~-~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         232 --LYEKLP-QGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             --HHHHHh-cCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence              222221 111111   113457899999999999999999999999999998876554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.8e-40  Score=311.51  Aligned_cols=259  Identities=17%  Similarity=0.210  Sum_probs=201.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCc----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~----~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      -.++|++.+.||+|+||+||+|.+..+++    .|++|........   ..+..|+.++..+.|+ ++..+..++. ...
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~-~iv~~~~~~~-~~~   82 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA-YIVRLLGICP-GAS   82 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCC-CcceEEEEEC-CCc
Confidence            35789999999999999999999987766    4777776543322   3456666677777774 4545544443 445


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++++||+ +++|.+++......+++..++.|+.||+.||.|||++|++||||||+|||+   +.++.+||+|||+++..
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            67889988 899999998766779999999999999999999999999999999999999   57889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .......     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....    +..+.......
T Consensus       160 ~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~~~~~  230 (279)
T cd05111         160 YPDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLEKGERL  230 (279)
T ss_pred             cCCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHCCCcC
Confidence            4332111     1123456788999999998899999999999999999998 999998754332    22223322222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      +..   ...+..+.+++..||..+|++||++.++.+.|..+....
T Consensus       231 ~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         231 AQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             CCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            222   224778999999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-42  Score=331.61  Aligned_cols=243  Identities=22%  Similarity=0.312  Sum_probs=206.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|.-++.||.|+||.||-|++..+.+.||||.+....     ....+++|++.|+.|.|+ +...+..|+......|+||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HP-ntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHP-NTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCC-CcccccceeeccchHHHHH
Confidence            3666788999999999999999999999999876543     345689999999999984 4556677777788899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |||-|+-.|++.-.++++.+.++..|+.+.+.||.|||+.+.||||||..|||++   +.+.|||+|||.|.....    
T Consensus       106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P----  178 (948)
T KOG0577|consen  106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP----  178 (948)
T ss_pred             HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc----
Confidence            9999999999998888999999999999999999999999999999999999995   899999999999976543    


Q ss_pred             CcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          163 RHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                             ...++|||.|||||++.   .+.|+-++|||||||++.||...++|+..+++.....-   |....-+..   
T Consensus       179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH---IAQNesPtL---  245 (948)
T KOG0577|consen  179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNESPTL---  245 (948)
T ss_pred             -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH---HHhcCCCCC---
Confidence                   23789999999999987   34589999999999999999999999998877643332   322221111   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      -...++..|+.|+..||++-|.+||+.+++++
T Consensus       246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            12456899999999999999999999998865

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.4e-40  Score=308.27  Aligned_cols=250  Identities=27%  Similarity=0.438  Sum_probs=201.5

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchh----HHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~----~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      |++++.||+|+||+||+|.+..+++.||+|++........    ..+|+.+++.+.| +++..+..+.......+++||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRH-PNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTB-TTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccc-cccccccccccccccccccccc
Confidence            8999999999999999999999999999999887654333    3458999999965 6677777777788999999999


Q ss_pred             cCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 LGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      +.+ +|.+++. ....+++..++.++.||+.||.+||++||+|+||||+||++   +.++.++|+|||.+........  
T Consensus        80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~--  153 (260)
T PF00069_consen   80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE--  153 (260)
T ss_dssp             ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred             ccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence            955 9999888 35679999999999999999999999999999999999999   5889999999999986521111  


Q ss_pred             cccccCCCcccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          164 HIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                           ......++..|+|||++. +..++.++||||||+++|+|++|..||...........+.+........... ...
T Consensus       154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  227 (260)
T PF00069_consen  154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-QSR  227 (260)
T ss_dssp             -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-SHT
T ss_pred             -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-ccc
Confidence                 223567899999999998 8889999999999999999999999999763333333333332222111110 001


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+.++.++|..||+.||++||++.++++
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12479999999999999999999998865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-40  Score=322.77  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=201.9

Q ss_pred             CCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEE-eeeeCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKW-YGVDGE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~-~~~~~~   76 (423)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||+++....   ...+.+|+.++..+.+++++..+.. +...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            468999999999999999999853     4578899999875433   2347789999999977666666544 444556


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc----------------------------------------------------------
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------   97 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~----------------------------------------------------------   97 (423)
                      ..+++|||+ +++|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            789999999 889999886421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccC
Q 014527           98 --------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE  169 (423)
Q Consensus        98 --------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  169 (423)
                              ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.........     ..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~~  237 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VR  237 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcch-----hh
Confidence                    236788889999999999999999999999999999999   47889999999999765332211     11


Q ss_pred             CCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHH
Q 014527          170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF  248 (423)
Q Consensus       170 ~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  248 (423)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  . ...........+.+   ...++++
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~-~~~~~~~~~~~~~~---~~~~~~~  311 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E-FCRRLKEGTRMRAP---DYTTPEM  311 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H-HHHHHhccCCCCCC---CCCCHHH
Confidence            123345678999999999899999999999999999997 999997643321  1 11111111111111   2347789


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          249 ASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       249 ~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .+++..||+.+|++||++.+|++.|+.++..
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-40  Score=323.85  Aligned_cols=236  Identities=24%  Similarity=0.292  Sum_probs=188.3

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~-l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.||+|+||+||+|++..+++.||||++....     ....+..|..+ ++.+.| +++..+..++...+..++||||+ 
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-p~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCC-CCCccEEEEEecCCEEEEEEcCCC
Confidence            46999999999999999999999999876431     22335556554 444555 66667777777888999999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~----  151 (325)
T cd05604          80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD----  151 (325)
T ss_pred             CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence            7888877764 5679999999999999999999999999999999999999   5788999999999875322211    


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..   +.+..+.......     ....+
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~~~~~~~~-----~~~~~  220 (325)
T cd05604         152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPLVL-----RPGAS  220 (325)
T ss_pred             ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHHHcCCccC-----CCCCC
Confidence               122557999999999999999999999999999999999999999865432   3334443333222     23457


Q ss_pred             HHHHHHHHHHhcCCCCCCCChHH
Q 014527          246 AEFASYFHYCQSLTFDQRPDYGF  268 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RPt~~~  268 (423)
                      ..+.++|.+||..+|.+||++.+
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCC
Confidence            88999999999999999998853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.9e-40  Score=315.92  Aligned_cols=256  Identities=18%  Similarity=0.215  Sum_probs=190.2

Q ss_pred             eceeeecCceeEEEEEEC--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEee-eeCCeeEEEEeccCCC
Q 014527           12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS   88 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~-~~~~~~~lv~e~~~~s   88 (423)
                      +++||+|+||+||+|++.  .+++.||+|.+........+.+|+.+++.++|++.+..+..+. ......+++|||++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD   85 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence            568999999999999976  4678899999877666667889999999999866555544443 2345689999999999


Q ss_pred             HHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec-CCCCcEEEeeccceeeecCC
Q 014527           89 LEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        89 L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~-~~~~~vkL~DFGla~~~~~~  159 (423)
                      |.+++....        ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+|+.....
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~  165 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP  165 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence            998876421        248899999999999999999999999999999999999532 34578999999999876433


Q ss_pred             CCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhh------hHHHHHHHHhhh
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------KKQKYDKICEKK  232 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~------~~~~~~~i~~~~  232 (423)
                      ...    ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......      ....+..+....
T Consensus       166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             Ccc----ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            211    1122356789999999999874 58999999999999999999999997532110      011111111100


Q ss_pred             cCCc---------------------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTP---------------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~---------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....                                 .+......+.++.+||.+||+.||.+|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000                                 00000112456889999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-40  Score=313.22  Aligned_cols=240  Identities=20%  Similarity=0.263  Sum_probs=190.2

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ||+|+||.||+|++..+++.||+|.+....     ....+..|+++++.+.| +++..+..++......++||||+ +++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999999999999999875422     22345679999999976 55656666666778899999999 889


Q ss_pred             HHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccc
Q 014527           89 LEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY  167 (423)
Q Consensus        89 L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~  167 (423)
                      |.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.++|+|||++........      
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------  150 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------  150 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence            98877543 3358999999999999999999999999999999999999   4788999999999987643221      


Q ss_pred             cCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                        .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ...+...........    .....++.
T Consensus       151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  224 (277)
T cd05607         151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK----FEHQNFTE  224 (277)
T ss_pred             --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc----cccccCCH
Confidence              11346899999999999988999999999999999999999999764322 111222222221111    11235688


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHH
Q 014527          247 EFASYFHYCQSLTFDQRPDYGFLK  270 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~~l~  270 (423)
                      ++.++|.+||+.||++||++.++.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccch
Confidence            999999999999999999997764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.9e-40  Score=326.87  Aligned_cols=251  Identities=23%  Similarity=0.310  Sum_probs=197.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++....     ....+.+|+.+++.+.| +++..+.....+....
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~  118 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYL  118 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence            44589999999999999999999999999999999875321     22336678888888776 5666666667788899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcC
Confidence            9999999 8899998864  458999999999999999999999999999999999999   478899999999998764


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCC----CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .....      ......||+.|+|||++.+..    ++.++|||||||++|||++|..||.+....   ..+.++.....
T Consensus       194 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~  264 (371)
T cd05622         194 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN  264 (371)
T ss_pred             cCCcc------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCC
Confidence            33211      122557999999999997643    789999999999999999999999874432   34444443322


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCC---CCChHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQ---RPDYGFLKR  271 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~---RPt~~~l~~  271 (423)
                      ....+. ...++..++++|..||. +|..   |+++++|++
T Consensus       265 ~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~  303 (371)
T cd05622         265 SLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR  303 (371)
T ss_pred             cccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhc
Confidence            111111 13568899999999998 4544   667777754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.5e-40  Score=312.21  Aligned_cols=258  Identities=20%  Similarity=0.292  Sum_probs=202.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +-.++|++.+.||+|+||.||+|.+..     ++..||+|.......   ...+.+|+.+++.++| +++..+..++.+.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH-QNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccC
Confidence            456789999999999999999999976     678899998764432   2347889999999987 4566666666677


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEe
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      ...++||||+ +++|.+++....      ..+++..++.++.||+.||+|||+++++||||||+|||++.......+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            7889999999 889999987543      248999999999999999999999999999999999999633334579999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~  227 (423)
                      |||+++........     ........+..|+|||++.+..++.++|||||||++|+|++ |..||.+.....   ....
T Consensus       162 dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~  233 (277)
T cd05036         162 DFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEF  233 (277)
T ss_pred             cCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            99999876322211     11112234568999999999899999999999999999997 999998754332   2222


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      +... ...   .....+|..+.+++.+||+.+|++||++.+|++.|.
T Consensus       234 ~~~~-~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGG-GRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcC-CcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            2211 111   122456889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-40  Score=308.24  Aligned_cols=255  Identities=16%  Similarity=0.280  Sum_probs=204.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .++|++.+.||+|+||.||+|.+...   ...||||++.....   ...+.+|+.++..++| +++..+..+.......+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH-PNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCcceEeEEEecCCceE
Confidence            46899999999999999999998643   45799998765433   2357889999999987 45666666667778899


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++|||+ +++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+   +.++.++|+|||+++....
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence            999999 789999987766679999999999999999999999999999999999999   4788999999999987752


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....     ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   +....+.. ....+.
T Consensus       159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~  229 (266)
T cd05033         159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVED-GYRLPP  229 (266)
T ss_pred             cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHc-CCCCCC
Confidence            22111     1112345678999999999899999999999999999998 99999765433   22222222 112221


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      .   ..+|..+.+++.+||+.+|++||++++|++.|+++
T Consensus       230 ~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         230 P---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1   34588999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.5e-40  Score=307.29  Aligned_cols=249  Identities=19%  Similarity=0.263  Sum_probs=199.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .+|++.+.||+|+||.||+|.+.. +..+|+|.+.... ....+.+|+.+++.++| +++..+..++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCC-CCceeEEEEEccCCCEEEEEEcC
Confidence            579999999999999999998754 5579999876543 34568899999999987 55656666667778899999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       +++|.+++......+++..++.++.|++.||.|||++||+||||||+||++   ++++.+||+|||+++........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT--  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCcee--
Confidence             789999887655578999999999999999999999999999999999999   47889999999998765432211  


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                          ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   +.+..+..... ...   ...
T Consensus       157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~~~-~~~---~~~  225 (256)
T cd05114         157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRGFR-LYR---PKL  225 (256)
T ss_pred             ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCCC-CCC---CCC
Confidence                1123345678999999998889999999999999999999 99999865433   22333322211 111   123


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      .+..+.+++.+||..+|++||++++|++.|
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            478899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-40  Score=321.93  Aligned_cols=235  Identities=26%  Similarity=0.342  Sum_probs=188.2

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~-~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.||+|+||.||+|++..+++.||+|++....     ....+..|.. +++.+.| +++..+..++.+.+..++||||+ 
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCEEEEEEcCCC
Confidence            47999999999999999999999999876432     2233555554 4555665 56666767777888999999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......    
T Consensus        80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~----  151 (321)
T cd05603          80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE----  151 (321)
T ss_pred             CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence            7888877764 5678999999999999999999999999999999999999   5788999999999875332221    


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                         ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.   .+.+..+.......+     ...+
T Consensus       152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~-----~~~~  220 (321)
T cd05603         152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNILHKPLQLP-----GGKT  220 (321)
T ss_pred             ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCC
Confidence               12345789999999999998999999999999999999999999987543   234444444433332     3457


Q ss_pred             HHHHHHHHHHhcCCCCCCCChH
Q 014527          246 AEFASYFHYCQSLTFDQRPDYG  267 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RPt~~  267 (423)
                      ..+.++|.+||+.+|.+||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            8899999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=306.47  Aligned_cols=254  Identities=24%  Similarity=0.352  Sum_probs=204.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+.. ++.||||.+.... ....+.+|+.+++.++| +++..+..++......+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH-PKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCC-CCccceeEEEecCCCeeeee
Confidence            456789999999999999999998754 5679999886543 34568899999999987 55666666777788899999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++   ++++.++|+|||+++......
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCc
Confidence            999 899999987543 468999999999999999999999999999999999999   478899999999998775332


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....   ..+..+. .....+.  
T Consensus       158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~-~~~~~~~--  225 (261)
T cd05068         158 YE------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQVD-QGYRMPC--  225 (261)
T ss_pred             cc------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH-cCCCCCC--
Confidence            11      1112233468999999999889999999999999999999 99999875433   2222222 2222221  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                       ....+..+.+++.+||+.+|++||++++|...|++
T Consensus       226 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 -PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             13458899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.3e-40  Score=312.22  Aligned_cols=255  Identities=20%  Similarity=0.295  Sum_probs=200.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +..++|++.+.||+|+||.||+|.+..     ++..||||++.....   ...+.+|+.+++.++| +++..+..+....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence            567899999999999999999998642     356799998764332   2347889999999876 4565666666777


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcE
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV  145 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~v  145 (423)
                      ...++||||+ +++|.+++....         ..+++..++.++.|++.||.|||+.|++||||||+|||++   +++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCCE
Confidence            8899999999 889999886532         2357788999999999999999999999999999999994   78899


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK  224 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~  224 (423)
                      +|+|||+++........     .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....   +.
T Consensus       159 ~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~  230 (277)
T cd05062         159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QV  230 (277)
T ss_pred             EECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            99999998765432221     11123355788999999999889999999999999999999 79999875433   22


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      +..+......    ......+..+.+++.+||+.+|++||++.++++.|+
T Consensus       231 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         231 LRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            2222222221    122455889999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.5e-40  Score=305.63  Aligned_cols=246  Identities=21%  Similarity=0.331  Sum_probs=195.0

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      +.||+|+||.||+|++..+++.||+|.......   ...+.+|+++++.+.| +++..+..++......++||||+ +++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            479999999999999998999999998764332   3458899999999986 55666666677778899999999 889


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                      |.+++......+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++..........     
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~-----  151 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS-----  151 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc-----
Confidence            999887655568999999999999999999999999999999999999   477889999999987643221100     


Q ss_pred             CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                      .......+..|+|||.+.+..++.++|||||||++|+|++ |..||..........    ........+   ....+|..
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~----~~~~~~~~~---~~~~~~~~  224 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE----AIEQGVRLP---CPELCPDA  224 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH----HHHcCCCCC---CcccCCHH
Confidence            0111123467999999998889999999999999999998 999997654432211    112222222   12345889


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          248 FASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      +.+++.+||..+|++||++.+|.+.|.
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.7e-40  Score=308.97  Aligned_cols=254  Identities=22%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      |-..+|++.++||+|+||.||+|.+. ++..||+|.+.... ..+.+.+|+.+++.++|. ++..+..+..+....+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD-KLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCC-CeeeEEEEEcCCCCcEEEE
Confidence            34578999999999999999999865 45679999876533 345688999999999874 4555555666778899999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.++.|++.||+|||+.+++||||||+||++   +..+.++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCc
Confidence            999 88999988653 3568999999999999999999999999999999999999   478899999999998764432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........   ...+.. ....+.  
T Consensus       158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~-~~~~~~--  225 (261)
T cd05072         158 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQR-GYRMPR--  225 (261)
T ss_pred             ee------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHHc-CCCCCC--
Confidence            11      1113345678999999998889999999999999999998 9999987543322   222221 222221  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                       ...+|.++.+++.+||..+|++||++++|.+.|++
T Consensus       226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 -MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             13468899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-41  Score=300.50  Aligned_cols=265  Identities=21%  Similarity=0.228  Sum_probs=222.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC------C----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------K----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~------~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      -.+|.-.+.||.|..+.|-++.++.+++.+|+|++....      .    .+.-.+|+.+|+++.+|++|..+..+....
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            457888899999999999999999999999999765321      1    123567999999999999999998888888


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...++|+|+| .|.|.|++.. .-.++++....|++|+.+|++|||.++||||||||+|||+   |++.++||+|||+|+
T Consensus        96 sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence            9999999999 8999999975 4469999999999999999999999999999999999999   689999999999999


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCC------CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (423)
                      .+.....        -...+|||.|+|||.+...      .|+...|+||+|||||-|+.|.+||..-+   ..-.+..|
T Consensus       172 ~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~I  240 (411)
T KOG0599|consen  172 QLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRMI  240 (411)
T ss_pred             ccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHHH
Confidence            8766543        2378999999999998632      47889999999999999999999998633   23455667


Q ss_pred             HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH--HHHHHHHhcCCCCCc
Q 014527          229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR--LFHDLFSREGYDFDF  286 (423)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~--~L~~~~~~~~~~~~~  286 (423)
                      +++++.+..+. +..++...++||.+||+.||.+|.++++.+.  .|.++.......+..
T Consensus       241 meGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  241 MEGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             HhcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence            78888776544 4677889999999999999999999999876  455555554444433

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-40  Score=332.18  Aligned_cols=255  Identities=22%  Similarity=0.244  Sum_probs=198.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +.+..|.+.+.||+|+||.||+|.+..+++.||||...    ...+.+|+++++.|+| ++|..+..++......++|||
T Consensus       166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~H-pnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSH-PAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEEE
Confidence            34678999999999999999999999999999999632    2346789999999987 556666666777888999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      ++.++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.........
T Consensus       241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccccccc
Confidence            99999999887656679999999999999999999999999999999999999   477899999999998764322111


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh----hhHHHHHHHHhh-hcC---C
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEK-KVS---T  235 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~-~~~---~  235 (423)
                           ......||..|+|||++.+..++.++|||||||+||||++|..|+......    .....+.+++.. ...   .
T Consensus       318 -----~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        318 -----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             -----cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence                 112457999999999999999999999999999999999987665332110    001111111111 100   0


Q ss_pred             c--------------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 P--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~--------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +                          .-.....++..+.+||.+||+.||.+||++.+|++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            0                          00000123567899999999999999999999976

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-40  Score=323.15  Aligned_cols=250  Identities=21%  Similarity=0.258  Sum_probs=193.9

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      ...|++.+.||+|+||.||+|++..+++.||+|+....    ....|+.+++.++| +++..+..++......++|||++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNH-PSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCC-CCCcChhheEEeCCeeEEEEEcc
Confidence            45799999999999999999999999999999985432    34679999999987 45666666667788899999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      .++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+   +..+.+||+|||+++.......    
T Consensus       140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~----  212 (357)
T PHA03209        140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA----  212 (357)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc----
Confidence            999999988767789999999999999999999999999999999999999   5788999999999875332211    


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh-------hHHHHHHHHhhhcCCcHH
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-------KKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~-------~~~~~~~i~~~~~~~~~~  238 (423)
                          .....||..|+|||++.+..++.++|||||||++|||+++..|+.......       ....+..+.......+..
T Consensus       213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        213 ----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             ----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence                124578999999999999999999999999999999998655542211111       001111111110000000


Q ss_pred             -----------------------------HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 -----------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 -----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                                   .....++..+.+||.+||+.||.+||++.++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                                         001234667888999999999999999999876

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=348.10  Aligned_cols=259  Identities=20%  Similarity=0.298  Sum_probs=212.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCc-----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~-----~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ....++.+.||+|.||+||.|.......     .||||.++.....   .+|.+|+.+|..++|++. ..+.....+...
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNi-v~liGv~l~~~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNI-VSLIGVCLDSGP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcce-eeEEEeecCCCC
Confidence            4567889999999999999999874322     3999987766543   458999999999998554 445445556888


Q ss_pred             eEEEEecc-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeec
Q 014527           78 NVLVLDLL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF  150 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DF  150 (423)
                      .+|++||| +|+|..++...      ...++..+.+.++.|||.|++||+++++|||||..+|+|++   ....|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEccc
Confidence            99999999 99999999987      56799999999999999999999999999999999999994   7799999999


Q ss_pred             cceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHH
Q 014527          151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      |+|+.+.....     |+......-..+|||||.+....++.|+|||||||+|||+++ |..||.+.+..+....+  ..
T Consensus       847 GlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~--~~  919 (1025)
T KOG1095|consen  847 GLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV--LE  919 (1025)
T ss_pred             chhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH--Hh
Confidence            99995544433     233333344679999999999999999999999999999999 99999987765433322  22


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      +.++..|     ..+|+.+.++|.+||+.+|++||+|..|++.+..++...
T Consensus       920 ggRL~~P-----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  920 GGRLDPP-----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             CCccCCC-----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            3344444     345999999999999999999999999999888877643

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1e-39  Score=314.01  Aligned_cols=259  Identities=21%  Similarity=0.308  Sum_probs=204.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +..++|.+.+.||+|+||.||+|.+.     .++..||||+++....   .+.+.+|+.+++.+.+++++..+..++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34568999999999999999999863     3456799998765432   235788999999996557777777777788


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      +..+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||+++|+|+||||+|||+   +..+.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence            8899999999 789999887533 238999999999999999999999999999999999999   47789999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +........     .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .+.+.....
T Consensus       189 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~~~~  260 (302)
T cd05055         189 RDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLIKEG  260 (302)
T ss_pred             ccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHHHcC
Confidence            765433211     01123456788999999999899999999999999999998 999998654322   122222222


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ....   .....++++.+++.+||..+|++||++.+|++.|.++
T Consensus       261 ~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 YRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            2111   1234578999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-39  Score=309.35  Aligned_cols=253  Identities=21%  Similarity=0.230  Sum_probs=197.7

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||+|+||.||+|++..+++.||||++....    ....+.+|+.+++.+.| +++..+..+..++...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeCCeEEEEEe
Confidence            5899999999999999999999899999999876432    23457889999999986 556667667778889999999


Q ss_pred             ccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+.++|.+++....  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence            99889988886533  568999999999999999999999999999999999999   4788999999999976543221


Q ss_pred             CCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh----------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE----------  230 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----------  230 (423)
                             ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+...............          
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence                   11234678899999998764 478999999999999999999999986443221111111000          


Q ss_pred             -----------hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 -----------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 -----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                 .............+++++.++|.+||..||++||++.+|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                       00000111122346889999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-40  Score=314.45  Aligned_cols=260  Identities=19%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCC--------------cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTN--------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNI   68 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~--------------~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i   68 (423)
                      .++|++.+.||+|+||.||+|++..++              ..||+|.+.....   ...+.+|++++..++| +++..+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN-PNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCcCeE
Confidence            468999999999999999999875432              3589998875432   2357889999999987 556666


Q ss_pred             EEeeeeCCeeEEEEecc-CCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEE
Q 014527           69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM  136 (423)
Q Consensus        69 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl  136 (423)
                      ..++......++||||+ +++|.+++....           ..+++..++.++.|++.||.|||++|++||||||+|||+
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            66667788899999999 889999886421           136888999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCCC
Q 014527          137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPWQ  214 (423)
Q Consensus       137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt--G~~Pf~  214 (423)
                      +   +++.+||+|||++.........     .......++..|+|||.+.+..++.++|||||||++|+|++  |..||.
T Consensus       163 ~---~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         163 G---NHYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             c---CCCcEEecccccccccccCcce-----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            4   6788999999999765432211     11223345778999999998889999999999999999988  778887


Q ss_pred             CchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      .............................+|+.+.+|+.+||+.+|++||++++|++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            654433222222111111110001112345889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.2e-40  Score=312.16  Aligned_cols=253  Identities=19%  Similarity=0.279  Sum_probs=199.8

Q ss_pred             CceEEeceeeecCceeEEEEEEC----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~----~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ..|++.+.||+|+||.||+|.+.    .++..|++|.+......   ..+.+|+.+++.+.| +++..+..+.......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCceE
Confidence            57899999999999999999863    35578999987653322   347889999999986 55656666667778899


Q ss_pred             EEEecc-CCCHHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           80 LVLDLL-GPSLEDLFVYCR----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      ++|||+ +++|.+++....                ..+++..++.++.||+.||.|||++||+||||||+|||+   +.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence            999999 789999885321                247889999999999999999999999999999999999   477


Q ss_pred             CcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhh
Q 014527          143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK  221 (423)
Q Consensus       143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~  221 (423)
                      +.+||+|||+++.........     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+......
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYR-----VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV  235 (283)
T ss_pred             CcEEeccccccccccCCccee-----cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            889999999998764332111     1223456778999999998889999999999999999998 9999987543222


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                         ...+.. ....+   ....+++.+.+++.+||+.||++||++.+|.+.|..
T Consensus       236 ---~~~~~~-~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 ---IEMVRK-RQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHc-CCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               222222 21111   234568999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-41  Score=325.28  Aligned_cols=234  Identities=22%  Similarity=0.296  Sum_probs=187.2

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      ||+|+||+||+|++..+++.||||++....     .......|..++..+.  +++++..+...+......|+||||+ +
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999875421     1123455666666654  6677888877778888999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.......     
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~-----  151 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK-----  151 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence            899888765 5679999999999999999999999999999999999999   4788999999999875432211     


Q ss_pred             ccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          167 YRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....   +.+..+.......+.    ..++
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~----~~~~  222 (330)
T cd05586         152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYRNIAFGKVRFPK----NVLS  222 (330)
T ss_pred             --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHHHHHcCCCCCCC----ccCC
Confidence              12256799999999999765 4899999999999999999999999864332   334444443333332    2357


Q ss_pred             HHHHHHHHHHhcCCCCCCCCh
Q 014527          246 AEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RPt~  266 (423)
                      +++.++|.+||..||.+||++
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCC
Confidence            899999999999999999954

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.8e-40  Score=311.84  Aligned_cols=248  Identities=20%  Similarity=0.270  Sum_probs=195.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|++.+.||+|+||.||+|.+..+++.||||.+.....     ...+..|+.+++.++|++ +..+...+.+.+..++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~-i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCC-eeeeeEEEecCCEEEEEE
Confidence            47889999999999999999999999999998754321     234678999999998754 444555556678899999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++   +..+.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence            999 889988875433 358999999999999999999999999999999999999   478899999999987653322


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .        .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..............+....    ....
T Consensus       157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~  224 (285)
T cd05630         157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----QEEY  224 (285)
T ss_pred             c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----hhhc
Confidence            1        113478999999999999899999999999999999999999998643321112222211111    1122


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCC-----hHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~~l~~  271 (423)
                      ...+++++.+|+.+||+.||++||+     ++++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            3456889999999999999999999     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.5e-40  Score=313.75  Aligned_cols=260  Identities=19%  Similarity=0.298  Sum_probs=200.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCC----------------cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTN----------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIP   66 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~----------------~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~   66 (423)
                      .++|++.+.||+|+||.||+|.+...+                ..||+|++.....   ...+.+|++++..+.| +++.
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-PNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-CCEe
Confidence            468999999999999999999876533                4689998876542   3457889999999987 4555


Q ss_pred             eEEEeeeeCCeeEEEEecc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceE
Q 014527           67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL  135 (423)
Q Consensus        67 ~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NIL  135 (423)
                      .+..++......+++||++ +++|.+++....          ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            5666666778899999999 789999887543          26899999999999999999999999999999999999


Q ss_pred             EeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCC
Q 014527          136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPW  213 (423)
Q Consensus       136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt--G~~Pf  213 (423)
                      ++   ..+.++|+|||+++........     .......++..|+|||.+.+..++.++|||||||++|+|++  |..||
T Consensus       163 i~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         163 VG---KNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             ec---CCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            94   6789999999999765433211     11224456788999999998889999999999999999998  78898


Q ss_pred             CCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      ...............................|.++.+++.+||+.||++||++.+|++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            7654332222221111100011111112345789999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-39  Score=311.51  Aligned_cols=256  Identities=18%  Similarity=0.295  Sum_probs=202.0

Q ss_pred             ceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+.....   ...+.+|+.+++.+.|+ ++..+..++...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP-HVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCC-CEeeEEEEEecCCCcE
Confidence            58899999999999999998753     235699998765443   23578899999999874 5555655666778899


Q ss_pred             EEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceE
Q 014527           80 LVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL  135 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NIL  135 (423)
                      ++|||+ +++|.+++....                       ..+++..++.++.|++.||.|||++|++||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            999999 789999876421                       24788999999999999999999999999999999999


Q ss_pred             EeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 014527          136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ  214 (423)
Q Consensus       136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~  214 (423)
                      +   ++++.+||+|||+++........     .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus       160 l---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         160 V---AEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             E---cCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            9   47889999999999765432211     11123345678999999998889999999999999999998 999998


Q ss_pred             CchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +.....    +..........+.   ...++.++.+++..||+.+|++||++.+|++.|++++.+
T Consensus       232 ~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         232 GIAPER----LFNLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             CCCHHH----HHHHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            754332    2222222222221   245588999999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.6e-40  Score=314.27  Aligned_cols=261  Identities=19%  Similarity=0.304  Sum_probs=206.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-------CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-------~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      +...+|++.+.||+|+||.||+|++.       ..+..||+|+.....   ....+.+|+.++..+.+++++..+..+..
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            45678999999999999999999853       234579999876532   23458899999999965577777777777


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEe
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG  137 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~  137 (423)
                      .....+++|||+ +++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            788899999999 789999987532               2478889999999999999999999999999999999994


Q ss_pred             ecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCc
Q 014527          138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL  216 (423)
Q Consensus       138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~  216 (423)
                         .++.+||+|||+++.........     ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       172 ---~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         172 ---ENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ---CCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence               78899999999998764432211     1123345678999999999889999999999999999998 88999765


Q ss_pred             hhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...   +....+... ....   ....++..+.+|+.+||..+|++||++.+|++.|++++.-
T Consensus       244 ~~~---~~~~~~~~~-~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         244 PVE---ELFKLLKEG-HRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CHH---HHHHHHHcC-CcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            433   222222221 1111   1234588999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-39  Score=311.31  Aligned_cols=259  Identities=23%  Similarity=0.306  Sum_probs=207.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~~--~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      -.++|.+.+.||+|+||.||+|.+..     ++..+++|.+......  ..+.+|+.++..+.| +++..+..++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~   81 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDGDP   81 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCc
Confidence            35679999999999999999998642     4556999987655432  458899999999987 566677777778888


Q ss_pred             eEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      .++||||+ +++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||+   +.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence            99999999 899999986432               348899999999999999999999999999999999999   47


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhh
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT  220 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~  220 (423)
                      ++.++|+|||++.........     .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  233 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE  233 (291)
T ss_pred             CCcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            889999999999765433211     11224456889999999999899999999999999999999 999997654432


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                         .+..+......    ......|..+.+++.+||+.+|++||++.+|++.|+++.+.
T Consensus       234 ---~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         234 ---VIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---HHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence               22222222221    11234588999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=315.39  Aligned_cols=248  Identities=19%  Similarity=0.288  Sum_probs=209.7

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      -|.++++||+|+||.||+|.++.+|+.||||....+...+++.+|+.++++... ++++.++.-......+||||||| .
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S-~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKS-KYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCC-chhhhhhhhhccCCceEeehhhcCC
Confidence            467889999999999999999999999999999888888999999999999887 44545544444667899999999 7


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      |+..+++...++.+++.++..++...+.||+|||...-||||||..|||+   +.+|..||+|||.|..+.+....    
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAK----  185 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAK----  185 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHh----
Confidence            89999999888999999999999999999999999999999999999999   58899999999999887665433    


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                         ..++.||+.|||||++....|+.++||||||++..||..|++||.+..+......   |  ..-++|.-..+..++.
T Consensus       186 ---RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---I--PT~PPPTF~KPE~WS~  257 (502)
T KOG0574|consen  186 ---RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---I--PTKPPPTFKKPEEWSS  257 (502)
T ss_pred             ---hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---c--cCCCCCCCCChHhhhh
Confidence               3478999999999999999999999999999999999999999988665421111   1  1111222222334589


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +|.++++.||.++|++|-++-+|.+
T Consensus       258 ~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  258 EFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            9999999999999999999887755

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=305.55  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=203.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++|++.+.||.|+||.||+|.+..+++.+++|++....  ....+.+|+.+++.++| +++..+..+..+....+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH-PNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC-CChhceEEEEEeCCEEEEEEeC
Confidence            68999999999999999999999889999999877543  34568899999999987 4555566667788899999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||++   ++++.++|+|||++........  
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~--  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA--  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh--
Confidence            9 678888887655789999999999999999999999999999999999999   4788999999999876543221  


Q ss_pred             cccccCCCcccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                           ......++..|+|||.+.+.   .++.++|||||||++|+|++|+.||........   ...+....+..+....
T Consensus       157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  228 (262)
T cd06613         157 -----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LFLISKSNFPPPKLKD  228 (262)
T ss_pred             -----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCCCccccc
Confidence                 11245788899999999877   789999999999999999999999987543322   2222222222222122


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...++.++.+++.+||..+|.+||++++|+.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2345788999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.8e-40  Score=311.75  Aligned_cols=251  Identities=22%  Similarity=0.263  Sum_probs=196.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+.....    ...+.+|+.+++.++|+ ++..+..+..+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCC-CeeeHHHHhccCCceEEEEe
Confidence            58999999999999999999999999999998764322    23577899999999874 55555555667788999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |++++|.+++......+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++.......  
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC--
Confidence            99989999887666779999999999999999999999999999999999999   4788999999999976543221  


Q ss_pred             cccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC-------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST-------  235 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-------  235 (423)
                           ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||......  .+.+..+.......       
T Consensus       155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07839         155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPG  227 (284)
T ss_pred             -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHH
Confidence                 112346788999999987754 789999999999999999999886432221  12222221110000       


Q ss_pred             -----------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 -----------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 -----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                       ........+++++.++|.+||..||.+||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                             001122346789999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=329.07  Aligned_cols=249  Identities=17%  Similarity=0.308  Sum_probs=203.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|.|+..||.|+||.||+|..+.++-..|-|++....  ....++-|++||..+.| +++..+...+...+.++|.+||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdH-P~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDH-PVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCC-hHHHHHHHHHhccCceEEEEee
Confidence            35788999999999999999999888888889876543  34458899999999986 4444444333456789999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      | ||....++....+.+++.++..+++|++.||.|||+++|||||||..|||++   -+|.|+|+|||.+........  
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~q--  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQ--  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHHh--
Confidence            9 7778888888899999999999999999999999999999999999999996   789999999999876543332  


Q ss_pred             cccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          164 HIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                           ....++|||+|||||+..     ..+|+.++||||||++|.||..+.+|....++....   .+|..  -.+|.-
T Consensus       186 -----kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl---lKiaK--SePPTL  255 (1187)
T KOG0579|consen  186 -----KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAK--SEPPTL  255 (1187)
T ss_pred             -----hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH---HHHhh--cCCCcc
Confidence                 234789999999999875     567999999999999999999999999887665333   23322  222322


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .-+..++..|.+|+..||.+||..||++.+|++
T Consensus       256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            333567889999999999999999999999864

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-39  Score=308.89  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=205.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~----~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +-.++|++.+.||+|+||.||+|.+..    ++..|++|++.....   ...+.+|+.+++.+.|++.++.+..+.....
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            457899999999999999999999875    357899998765433   2347789999999977655554444444567


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEe
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      ..+++++|+ +++|.+++....       ..+++..++.++.||+.||+|||+++++||||||+||+++   +++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEEC
Confidence            789999999 789999887532       3589999999999999999999999999999999999994   77899999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~  227 (423)
                      |||+++.+.......     ......++..|+|||.+.+..++.++|||||||++|++++ |+.||.......   .. .
T Consensus       160 d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~-~  230 (280)
T cd05043         160 DNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MA-A  230 (280)
T ss_pred             CCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HH-H
Confidence            999998654332110     1113345778999999999889999999999999999999 999998754432   22 2


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ........+.   ...+|+++.+++.+||..+|++||++.++++.|+++.++
T Consensus       231 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         231 YLKDGYRLAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHcCCCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            2222222221   123588999999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-39  Score=304.95  Aligned_cols=246  Identities=23%  Similarity=0.279  Sum_probs=201.0

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +|++.+.||.|+||.||++.+..+++.||+|.++...   ..+.+..|+.+++.++| +++..+..++......+++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEee
Confidence            5899999999999999999999999999999875432   33457889999999987 5566666677788899999999


Q ss_pred             c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        85 ~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      + +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++   ++++.++|+|||++........ 
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence            9 78998888643 3458999999999999999999999999999999999999   4788999999999976644322 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                            ......|++.|+|||++.+..++.++|+||||+++|+|++|..||......   ..+..+...... +   ...
T Consensus       156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~---~~~  222 (255)
T cd08219         156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLILKVCQGSYK-P---LPS  222 (255)
T ss_pred             ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHHHHHhcCCCC-C---CCc
Confidence                  112456889999999999988999999999999999999999999864332   222233222221 1   123


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++..+.++|.+||+.||++||++.+|+.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence            45788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=307.71  Aligned_cols=262  Identities=19%  Similarity=0.271  Sum_probs=207.2

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~----~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ..+...+|++.+.||+|+||.||+|.+..++.    .||+|.......   ...+.+|+.++..+.|++ +..+..++..
T Consensus         2 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~   80 (279)
T cd05057           2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPH-VVRLLGICLS   80 (279)
T ss_pred             cccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEec
Confidence            45667899999999999999999999876654    589998765543   235788999999998754 4444444444


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                       ...++||||+ +++|.+++......+++..++.++.||+.||+|||+.||+||||||+|||+   ++++.+||+|||++
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~  156 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLA  156 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccc
Confidence             7889999999 889999988766679999999999999999999999999999999999999   47889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +.........     ......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.......+   .+. ..
T Consensus       157 ~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~-~~  227 (279)
T cd05057         157 KLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---LLE-KG  227 (279)
T ss_pred             ccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHh-CC
Confidence            8765332211     0112234678999999988889999999999999999998 999998765433222   222 22


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ...+.+   ...+..+.+++.+||..+|++||++.+|++.|.++++..
T Consensus       228 ~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         228 ERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            222221   234778999999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9e-40  Score=312.47  Aligned_cols=259  Identities=20%  Similarity=0.311  Sum_probs=204.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +-.++|++.+.||+|+||.||+|.+...     ...||+|+.......   ..+.+|+.+++.+..++++..+..++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3457899999999999999999998643     367999987754332   34778999999995556777776677777


Q ss_pred             CeeEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG  139 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~  139 (423)
                      ...+++|||+ +++|.+++...               ...+++..++.++.||+.||.|||++||+||||||+|||++  
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~--  166 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--  166 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc--
Confidence            8899999999 88999998642               24588999999999999999999999999999999999994  


Q ss_pred             CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchh
Q 014527          140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA  218 (423)
Q Consensus       140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~  218 (423)
                       +++.+||+|||+++.........     ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus       167 -~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         167 -EDHVMKIADFGLARDIHHIDYYR-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             -CCCeEEeCcccccccccccccee-----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence             78899999999998765432111     1112345678999999998889999999999999999997 9999986543


Q ss_pred             hhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ..   .+..+.. .....   .....+..+.+|+.+||..||++||++.+|++.|++++
T Consensus       241 ~~---~~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 EE---LFKLLKE-GYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HH---HHHHHHc-CCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            22   2222211 11111   12345789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=307.55  Aligned_cols=252  Identities=21%  Similarity=0.368  Sum_probs=196.7

Q ss_pred             eEEeceeeecCceeEEEEEECCC---CcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC-----
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-----   76 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~-----   76 (423)
                      |++.+.||+|+||.||+|.+..+   +..||||++.....    ...+.+|+..++.+.|++ +..+..+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN-VMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCC-eeeEEeeeccCCccccC
Confidence            67899999999999999987653   47899998875432    235788999999998754 444443333322     


Q ss_pred             -eeEEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEee
Q 014527           77 -DNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        77 -~~~lv~e~~-~~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                       ..+++|||+ +++|..++....     ..+++..++.++.|++.||.|||++|++||||||+||++   ++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECC
Confidence             378999999 889998885432     358999999999999999999999999999999999999   4788999999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i  228 (423)
                      ||+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   +.+..+
T Consensus       157 fg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05035         157 FGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL  228 (273)
T ss_pred             ccceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            9999876543321     11122345678999999998889999999999999999999 99999875443   223333


Q ss_pred             HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      .... ...   ....++..+.+++.+||+.||++||++.+|++.|+++
T Consensus       229 ~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGN-RLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCC-CCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2221 111   2245688999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-39  Score=306.28  Aligned_cols=250  Identities=17%  Similarity=0.266  Sum_probs=200.8

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      .++|++.+.||+|+||.||+|.+.. +..||||.+.... ....+.+|+.++..+.| +++..+..++......+++|||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCC-CCeeeEEEEEccCCCcEEEEEc
Confidence            4679999999999999999998754 4469999776543 34568899999999986 5666777777777888999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|.+++......+++..++.++.||+.||.|||++|++|+||||+|||+   +.++.+||+|||+++........ 
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCcee-
Confidence            9 789999887655579999999999999999999999999999999999999   47889999999998765433211 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                           ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+...... +.   ..
T Consensus       157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~-~~---~~  224 (256)
T cd05113         157 -----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGLRL-YR---PH  224 (256)
T ss_pred             -----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCCCC-CC---CC
Confidence                 1113345678999999998889999999999999999998 999998654332   22233322211 11   12


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ..+..+.+++.+||+.+|++||++.+|+..|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            3478999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-39  Score=324.89  Aligned_cols=258  Identities=22%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             CCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||||+++.....   ..+.+|++++..+..|+++..+..++.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            456888999999999999999864     34568999998754332   3578899999999855777777777777788


Q ss_pred             eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR-----------------------------------------------------------   97 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------------------------------------------   97 (423)
                      .++||||+ +|+|.+++....                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            99999999 899999886432                                                           


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec
Q 014527           98 --------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG  139 (423)
Q Consensus        98 --------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~  139 (423)
                                                            ..+++..++.++.||+.||.|||+++|+||||||+|||++  
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~--  273 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC--  273 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe--
Confidence                                                  1367778899999999999999999999999999999994  


Q ss_pred             CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchh
Q 014527          140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA  218 (423)
Q Consensus       140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~  218 (423)
                       +.+.+||+|||+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       274 -~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         274 -EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             -CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence             6789999999999865432211     11123457889999999998889999999999999999998 8999976443


Q ss_pred             hhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ..   ............+.   ...++.++.+|+.+||..+|.+||++++|++.|+.++
T Consensus       348 ~~---~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NE---QFYNAIKRGYRMAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hH---HHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            22   22222222222211   2345789999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.3e-39  Score=303.73  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=203.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..     .....+.+|+++++.+.| +++..+..++...+..+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~-~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCeeeeeeeeecCCeEEEE
Confidence            6899999999999999999999989999999977532     124468899999999987 4555555556677889999


Q ss_pred             Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |||+ +++|.+++...   ...+++..++.++.||+.||.|||+.||+||||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            9999 78999988643   3458999999999999999999999999999999999999   478899999999987654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....       .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ........+..... .+.
T Consensus       158 ~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~  228 (267)
T cd08224         158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDY-PPL  228 (267)
T ss_pred             CCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCC-CCC
Confidence            33221       1234688899999999988899999999999999999999999965331 11122222222111 111


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +  ...++..+.++|.+||..+|++||++.+|++.|+++
T Consensus       229 ~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         229 P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            1  124578999999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-39  Score=305.90  Aligned_cols=248  Identities=19%  Similarity=0.300  Sum_probs=193.3

Q ss_pred             eeeecCceeEEEEEEC--CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CC
Q 014527           14 KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP   87 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~   87 (423)
                      .||+|+||.||+|.+.  ..+..||+|++.....   .+.+.+|+.+++.++|++.+..+. +. .....++||||+ ++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~-~~-~~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG-VC-EAEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEE-EE-cCCCeEEEEEeCCCC
Confidence            4899999999999875  4456799998875533   245789999999998755444433 33 345789999999 88


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccc
Q 014527           88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY  167 (423)
Q Consensus        88 sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~  167 (423)
                      +|.+++......+++..++.++.||+.||.|||++|++||||||+|||+   +.++.+||+|||++..........    
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----  152 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYY----  152 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccce----
Confidence            9999887656679999999999999999999999999999999999999   478899999999997654332111    


Q ss_pred             cCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                      .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..   ..+.. ....+   .....++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~-~~~~~---~~~~~~~  225 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---SFIEQ-GKRLD---CPAECPP  225 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHHHC-CCCCC---CCCCCCH
Confidence            11112234678999999998889999999999999999996 99999876544322   22222 11111   1234588


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ++.++|.+||..+|++||++.+|.+.|+.++
T Consensus       226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.6e-40  Score=309.03  Aligned_cols=252  Identities=19%  Similarity=0.273  Sum_probs=199.3

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++....  ...+.+|+.+++.++| +++..+..+....+..+++|
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h-~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEE
Confidence            34689999999999999999999999999999998765432  2346789999999976 55556666667788999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++.. .+.+++.+++.++.|++.||.|||+.|++|+||||+||++   +..+.++|+|||++........
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc
Confidence            999 7799998765 4579999999999999999999999999999999999999   4788999999999876643221


Q ss_pred             CCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                             ......|+..|+|||.+.   +..++.++|||||||++|+|++|..||.......   ............+..
T Consensus       162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~  231 (267)
T cd06645         162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKL  231 (267)
T ss_pred             -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCcc
Confidence                   123457899999999975   4458899999999999999999999997543321   111121222222211


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....++..+.++|.+||..+|++||++++|++
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            111245788999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-39  Score=307.60  Aligned_cols=251  Identities=19%  Similarity=0.314  Sum_probs=198.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeee------CCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVD------GED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~------~~~   77 (423)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|+..... ....+..|+.++..+.+++++..+..++..      ...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            4678999999999999999999999999999999876543 334588999999999666667666555443      245


Q ss_pred             eEEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           78 NVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      .+++|||+ +++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||++   ++++.++|+|||++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence            79999999 77999988753 3468999999999999999999999999999999999999   4788999999999976


Q ss_pred             ecCCCCCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      ......       ......|+..|+|||++.     +..++.++|||||||++|||++|..||..........   .+..
T Consensus       161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~---~~~~  230 (272)
T cd06637         161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---LIPR  230 (272)
T ss_pred             cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH---HHhc
Confidence            543221       123567899999999986     3357889999999999999999999997644322111   1111


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....   ......++..+.+||.+||..+|.+||++.++++
T Consensus       231 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1111   1112345789999999999999999999998865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.2e-40  Score=313.96  Aligned_cols=254  Identities=18%  Similarity=0.216  Sum_probs=200.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ..+|++.+.||+|+||.||+|.+..+     ++.||||+++.....   ..+..|+.++..++| +++..+..+......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~   82 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH-PNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcCCCc
Confidence            35688999999999999999987543     578999998755432   347789999998887 455566666667778


Q ss_pred             eEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           78 NVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      .++++||+ +++|.+++...               ...+++..++.++.|++.||.|||++||+||||||+|||+.   +
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---D  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---C
Confidence            99999999 78888887532               13478889999999999999999999999999999999994   7


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhh
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT  220 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~  220 (423)
                      ++.+||+|||+++........     .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.... 
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-  233 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-  233 (283)
T ss_pred             CCceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            788999999998865432211     11223456789999999998889999999999999999998 88999875443 


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                        +.+..+......    .....+|..+.+++..||+.+|++||++.+|+..|+.
T Consensus       234 --~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 --DVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              333333332221    1234568999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2e-39  Score=342.42  Aligned_cols=263  Identities=27%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....     ...+.+|++++..++| +++..+..++.+.+..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeCCEEEEE
Confidence            689999999999999999999999999999998865322     2357889999999987 5555666666778899999


Q ss_pred             Eecc-CCCHHHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeec
Q 014527           82 LDLL-GPSLEDLFVYC----------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF  150 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DF  150 (423)
                      |||+ |++|.+++...          ...++...++.++.||+.||+|||++||+||||||+|||+   +.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999 88999988642          1235677889999999999999999999999999999999   47889999999


Q ss_pred             cceeeecCCCCCC-----------cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh
Q 014527          151 GLAKKYRDPTTNR-----------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA  219 (423)
Q Consensus       151 Gla~~~~~~~~~~-----------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~  219 (423)
                      |+++.........           ...........||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9998763211100           00111223457999999999999999999999999999999999999999864322


Q ss_pred             hhHHHHHHHHhhhcCCcHHH-hhccChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHHHh
Q 014527          220 TKKQKYDKICEKKVSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSR  279 (423)
Q Consensus       220 ~~~~~~~~i~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RP-t~~~l~~~L~~~~~~  279 (423)
                      ...  .    ......+... ....+|+.+.+++.+||..||++|| +++++.+.|+.++..
T Consensus       238 ki~--~----~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        238 KIS--Y----RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh--h----hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            111  1    1111111111 1235688999999999999999996 668888888887754

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.4e-39  Score=311.99  Aligned_cols=260  Identities=19%  Similarity=0.290  Sum_probs=198.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECC----------------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIP   66 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~----------------~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~   66 (423)
                      .++|++.+.||+|+||.||+|.+..                +...||+|++.....   ...+.+|+.+++.++| +++.
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcc
Confidence            4689999999999999999986532                344699998875432   2458899999999976 5566


Q ss_pred             eEEEeeeeCCeeEEEEecc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceE
Q 014527           67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL  135 (423)
Q Consensus        67 ~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NIL  135 (423)
                      .+..++......+++|||+ +++|.+++....          ..+++..++.++.||+.||+|||++|++||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            6777777788899999999 789999887532          23678899999999999999999999999999999999


Q ss_pred             EeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCC
Q 014527          136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPW  213 (423)
Q Consensus       136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt--G~~Pf  213 (423)
                      ++   .++.++|+|||+++.+......     .......++..|+|||...+..++.++|||||||++|||++  |..||
T Consensus       163 i~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         163 VG---KNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             Ec---CCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            94   6889999999999865432211     11122345678999999988889999999999999999998  78999


Q ss_pred             CCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      ..............................+|+.+.+|+..||+.||.+||++.+|.+.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            7654432222211111111000000111345789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-39  Score=305.63  Aligned_cols=254  Identities=21%  Similarity=0.365  Sum_probs=202.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +|..+.|+++++||+|+||.||+|... +++.||+|.+.... ....+.+|+.+++.++|+ ++..+..+. .....+++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~-~~~~~~~v   78 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP-RLVRLYAVV-TQEPIYII   78 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCc-CeeeEEEEE-ccCCcEEE
Confidence            467889999999999999999999865 46789999877544 345688999999999875 444444443 44568999


Q ss_pred             Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||+ +++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||++   ++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCC
Confidence            9999 88999988643 3468999999999999999999999999999999999999   47889999999999776532


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ...      ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+........   .+ ......+  
T Consensus       156 ~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~-~~~~~~~--  223 (260)
T cd05067         156 EYT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---NL-ERGYRMP--  223 (260)
T ss_pred             Ccc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH-HcCCCCC--
Confidence            211      1123345778999999998889999999999999999999 999998755432222   22 2222222  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                       .....|.++.+++.+||..+|++||++++|...|++
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 -RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             123458899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-39  Score=302.63  Aligned_cols=246  Identities=25%  Similarity=0.304  Sum_probs=201.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .|++.+.||+|+||.||+|.+..+++.|++|.+...    .....+.+|+++++.++| +++..+..++......++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC-CCeehheeeeccCCEEEEEEE
Confidence            488999999999999999999999999999987643    233457889999999987 445555556667788999999


Q ss_pred             cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++   .++.++|+|||+++.......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCccc
Confidence            99 88999998764 45789999999999999999999999999999999999994   778999999999987654322


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .....+.......    ..
T Consensus       157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~----~~  222 (256)
T cd08529         157 -------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIRGVFPP----VS  222 (256)
T ss_pred             -------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCC----Cc
Confidence                   112456889999999999988999999999999999999999999865432   2333333322221    11


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..++..+.+++.+||+.+|++||++.+|++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            245889999999999999999999998865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-39  Score=309.02  Aligned_cols=256  Identities=20%  Similarity=0.247  Sum_probs=198.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe-----
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED-----   77 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~-----   77 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||+.....    ....+.+|+.+++.+.+++++..+..++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999999999999999876443    234578899999999887778777666655444     


Q ss_pred             eEEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           78 NVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      .|++|||+.++|.+++....    ..+++..++.++.||+.||.|||++||+||||||+||+++  ...+.+||+|||++
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence            79999999889999886532    3489999999999999999999999999999999999995  23789999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +.+.....       ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus       159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  231 (295)
T cd07837         159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP  231 (295)
T ss_pred             eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            86543221       1123356889999998875 457899999999999999999999998754432222211110000


Q ss_pred             --------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 --------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 --------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          ...........++.++.++|.+||..||.+||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                                000111122456889999999999999999999998864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-39  Score=310.15  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=200.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||.++....   ...+..|+.++.+..+++++..+..+.......+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            479999999999999999999999999999998775432   23466677766666666777777777777888999999


Q ss_pred             ccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           84 LLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        84 ~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |+.++|.+++...   ...+++..++.++.||+.||.|||++ +++||||||+|||+   +.++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence            9999998888643   34589999999999999999999997 99999999999999   57889999999999765432


Q ss_pred             CCCCcccccCCCcccccccccCcccccC----CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLG----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ..        .....++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.....  ..+.+..+..... .
T Consensus       158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~-~  226 (283)
T cd06617         158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPS-P  226 (283)
T ss_pred             cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCC-C
Confidence            21        113467889999999865    4468899999999999999999999975322  1122222222111 1


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      .  .....+|.++.++|.+||..+|++||++++|+.  ..++....
T Consensus       227 ~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~  268 (283)
T cd06617         227 Q--LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFELHL  268 (283)
T ss_pred             C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhhcc
Confidence            1  111245889999999999999999999999966  45554443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.6e-40  Score=307.59  Aligned_cols=248  Identities=25%  Similarity=0.436  Sum_probs=194.2

Q ss_pred             EEeceeeecCceeEEEEEEC----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527           10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~----~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++.+.||.|.||.||+|.+.    ..+..|+||+++....   ...+.+|++.+..++| +++..+..+....+..++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH-PNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB-TTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc-cccccccccccccccccccc
Confidence            57889999999999999997    3467799999966443   3568999999999965 66767777777777899999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.|+.||+.||.|||+++++|+||+++|||++   .++.+||+|||++.......
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence            999 68999999876 56799999999999999999999999999999999999994   78899999999998763221


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..     ...........|+|||.+.+..++.++||||||+++|||++ |+.||......   +....+..... .+   
T Consensus       158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~~~~~~~~~-~~---  225 (259)
T PF07714_consen  158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EIIEKLKQGQR-LP---  225 (259)
T ss_dssp             SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHHHHHHTTEE-TT---
T ss_pred             cc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccc-ce---
Confidence            11     12224457789999999999889999999999999999999 78999876443   23333322222 11   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ....+|..+.++|..||..+|++||++.+|++.|
T Consensus       226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1234589999999999999999999999998865

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=305.42  Aligned_cols=250  Identities=20%  Similarity=0.297  Sum_probs=199.8

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|++.... ....+.+|+++++.++| +++..+..++......++||||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH-PNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCceEEEEec
Confidence            357899999999999999999876 46679999876543 34468889999999987 4566666667777889999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|.+++......+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++...+.... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc-
Confidence            9 889999987655678999999999999999999999999999999999999   47889999999999765432211 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                           ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.......   ....+.. ....+.   ..
T Consensus       157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~-~~~~~~---~~  224 (256)
T cd05059         157 -----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVSA-GYRLYR---PK  224 (256)
T ss_pred             -----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHHc-CCcCCC---CC
Confidence                 1112234568999999999899999999999999999999 899998654432   2222221 111111   13


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ..|.++.+++.+||..+|++||++.+|++.|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            4588999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-39  Score=304.81  Aligned_cols=253  Identities=22%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+..+ ..||+|++.... ....+.+|+.+++.+.|++.++.+..+  .....+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v~   79 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV--SEEPIYIVT   79 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCcEEEE
Confidence            4567899999999999999999987654 459999876543 334688999999999986655544333  345678999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++   ++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence            999 679999887533 348999999999999999999999999999999999999   478899999999997664332


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....   ....+.. ....+   
T Consensus       157 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~-~~~~~---  223 (260)
T cd05069         157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER-GYRMP---  223 (260)
T ss_pred             cc------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCCCC---
Confidence            11      1123346778999999998889999999999999999999 999998754432   2222222 22221   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      .....|..+.+++.+||..+|++||++++|.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            123568899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6e-40  Score=308.13  Aligned_cols=251  Identities=21%  Similarity=0.330  Sum_probs=204.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ..+|++.+.||.|+||.||+|.+.. +..|++|++.....  ...+..|+.+++.++| +++..+..++......++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecCCCeEEEEe
Confidence            3579999999999999999999887 88899998876543  4568899999999986 556666666778888999999


Q ss_pred             cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++   ++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCccc
Confidence            99 78999998753 3458999999999999999999999999999999999999   4788999999999976643221


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....   +.+..+.. ....+.   
T Consensus       160 ~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~-~~~~~~---  225 (261)
T cd05148         160 L-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITA-GYRMPC---  225 (261)
T ss_pred             c-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHh-CCcCCC---
Confidence            1       113345778999999998889999999999999999998 89999875433   23333322 222222   


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      ...+|+.+.++|.+||..+|.+||++.+|.+.|+.
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            23558899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-39  Score=306.43  Aligned_cols=257  Identities=18%  Similarity=0.282  Sum_probs=204.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~---~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      -.++|++.+.||+|+||.||+|.+..++   ..||+|.+.....   ...+.+|+.++..++| +++..+..++...+..
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcc
Confidence            3578999999999999999999986444   3699998765432   2357889999999976 5666677777778889


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++......+++.+++.++.|++.||.|||++|++||||||+|||+   +.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence            9999999 789999988666678999999999999999999999999999999999999   478899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ......    .......++..|+|||.+.+..++.++|||||||++|++++ |..||.+.....   .+..+.. ....+
T Consensus       158 ~~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~-~~~~~  229 (267)
T cd05066         158 DDPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE-GYRLP  229 (267)
T ss_pred             ccccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC-CCcCC
Confidence            432111    01112234568999999998889999999999999999886 999998754432   2222222 22222


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      .   ...+|+.+.+++.+||+.+|.+||++.++++.|.++
T Consensus       230 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         230 A---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            1   134588999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-39  Score=306.77  Aligned_cols=255  Identities=24%  Similarity=0.316  Sum_probs=203.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+....     ....+.+|+.+++.+.| +++..+..++...+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC-CchhhhhheeEeCCeEEEE
Confidence            57899999999999999999998899999999765422     22357789999999976 5555566666677889999


Q ss_pred             Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |||+ +++|.+++...   ...+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence            9999 78999988642   3458999999999999999999999999999999999999   478899999999987654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....       .....++..|+|||.+.+..++.++||||||+++|+|++|..||.+... ........+...... + 
T Consensus       158 ~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~-  227 (267)
T cd08229         158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP-P-  227 (267)
T ss_pred             cCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCC-C-
Confidence            33221       1245688999999999988899999999999999999999999976432 112222222211111 1 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                       ......+..+.+++.+||..+|++||++.+|++.+.++
T Consensus       228 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 -LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             -CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence             11134578999999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-39  Score=305.25  Aligned_cols=258  Identities=18%  Similarity=0.268  Sum_probs=204.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCc---EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~---~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      |..++|+..+.||+|+||.||+|.+..++.   .+|+|.+.....   ...+..|++++..+.|+ ++..+..++...+.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEccCCC
Confidence            456789999999999999999999876554   699998765432   34578899999999874 56666677777788


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..+..++.|++.||+|||+.|++||||||+||++   +.++.+||+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence            99999999 789999887656679999999999999999999999999999999999999   47889999999999766


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ........    .......+..|+|||.+.+..++.++|||||||++|||++ |..||......   .....+.. ....
T Consensus       158 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i~~-~~~~  229 (268)
T cd05063         158 EDDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAIND-GFRL  229 (268)
T ss_pred             ccccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhc-CCCC
Confidence            43322110    0112223567999999998889999999999999999997 99999765432   22222222 2222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +.   ...+|..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       230 ~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 PA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            21   124588999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.4e-39  Score=305.80  Aligned_cols=253  Identities=23%  Similarity=0.386  Sum_probs=199.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ....+.+|+.+++.++|++.+. +..+. .....+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~-~~~~~-~~~~~~lv~   79 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ-LYAVV-SEEPIYIVT   79 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEE-EEeEE-CCCCcEEEE
Confidence            56778999999999999999999875 45669999877543 3456889999999998755444 43333 345678999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+||+++   +++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCcc
Confidence            999 78999988653 34589999999999999999999999999999999999994   67899999999998764332


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....   ....+. .....+.  
T Consensus       157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~-~~~~~~~--  224 (260)
T cd05070         157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVE-RGYRMPC--  224 (260)
T ss_pred             cc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH-cCCCCCC--
Confidence            11      1112345678999999998889999999999999999999 999998754432   222222 1222221  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                       ....|..+.+++.+||..+|++||++++|.+.|++
T Consensus       225 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 -PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             23458899999999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-39  Score=306.82  Aligned_cols=253  Identities=19%  Similarity=0.322  Sum_probs=194.8

Q ss_pred             eEEeceeeecCceeEEEEEECCCCc--EEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-----eCCe
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGED   77 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~--~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~~~   77 (423)
                      |.+.+.||+|+||.||+|.+..++.  .||+|.++...    ....+..|+.+++.++|++.+..+..+..     ....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999877665  59999876542    23357889999999987554444433321     1234


Q ss_pred             eEEEEecc-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           78 NVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                      .+++|||+ +++|.+++...     ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence            68999999 78998887532     2348899999999999999999999999999999999999   478899999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      +++........     .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+....   +.+..+..
T Consensus       158 ~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~  229 (272)
T cd05075         158 LSKKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLRQ  229 (272)
T ss_pred             cccccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc
Confidence            99876433211     11223356778999999999999999999999999999999 89999875433   22232322


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ... .+   ....++..+.++|.+||+.+|++||++++|++.|+++
T Consensus       230 ~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNR-LK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC-CC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            211 11   1234588999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-39  Score=310.76  Aligned_cols=252  Identities=17%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ..++.|++.+.||.|+||.||+|++..+++.|++|++.....  ...+.+|+.+++.+.| +++..+..++......++|
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH-PYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CcEeeeEEEEEeCCeEEEE
Confidence            346789999999999999999999999999999999865432  3457789999999987 4566666666677889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|..++......+++..++.++.||+.||.|||++|++||||||+||++   +.++.++|+|||++.......
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccc
Confidence            9999 778877776656679999999999999999999999999999999999999   478899999999987543321


Q ss_pred             CCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .       ......++..|+|||.+.     ...++.++|||||||++|+|++|..||......   ..+.++....  .
T Consensus       165 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~--~  232 (292)
T cd06644         165 Q-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--P  232 (292)
T ss_pred             c-------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHHhcCC--C
Confidence            1       122456889999999985     344688999999999999999999999764432   2222222211  1


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +.......++.++.++|.+||..+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111122345788999999999999999999998855

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-39  Score=315.32  Aligned_cols=263  Identities=19%  Similarity=0.307  Sum_probs=207.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCC-------CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-------~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      +...+|++++.||+|+||.||+|++...       ...||+|++.....   ...+.+|+.+++.+..++++..+..++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            4456899999999999999999986432       23699998775432   2457889999999965577777777777


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEe
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG  137 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~  137 (423)
                      .....+++|||+ +++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence            778899999999 789999987532               2478889999999999999999999999999999999994


Q ss_pred             ecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCc
Q 014527          138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL  216 (423)
Q Consensus       138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~  216 (423)
                         .++.+||+|||+++........     .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       169 ---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         169 ---EDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ---CCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence               7789999999999866432211     11122344578999999999999999999999999999998 89999875


Q ss_pred             hhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      ....   .+..+.. ....+   .....+.++.+++.+||+.+|++||++.+|++.|+.++....
T Consensus       241 ~~~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         241 PVEE---LFKLLKE-GHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             CHHH---HHHHHHc-CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            4332   2222222 11111   123457899999999999999999999999999999986554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-39  Score=309.37  Aligned_cols=258  Identities=24%  Similarity=0.317  Sum_probs=196.1

Q ss_pred             Cce-EEeceeeecCceeEEEEEE----CCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeee--CC
Q 014527            7 VKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GE   76 (423)
Q Consensus         7 ~~y-~i~~~Lg~G~fg~Vy~a~~----~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~   76 (423)
                      ++| ++.+.||+|+||+||++..    ..++..||+|++.....   ...+.+|+++++.++|+ ++..+..++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE-NIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCCc
Confidence            455 9999999999999988753    34678899998875432   34578899999999874 44455444332  34


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..+++|||+ +++|.+++..  ..+++..++.++.|++.||.|||++||+||||||+|||+   +.++.++|+|||+++.
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~  156 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKA  156 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccccc
Confidence            678999999 8899988864  459999999999999999999999999999999999999   4778999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-----------HHH
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-----------KQK  224 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-----------~~~  224 (423)
                      .......    +.......++..|+|||.+.+..++.++|||||||++|+|++|..||........           ...
T Consensus       157 ~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05080         157 VPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR  232 (283)
T ss_pred             cCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence            6543211    1111233456779999999988899999999999999999999999865321100           000


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      +..........+   ....+|.++.+++.+||+.+|++||++++|++.|+++.
T Consensus       233 ~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111111111   12345889999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=308.04  Aligned_cols=256  Identities=20%  Similarity=0.309  Sum_probs=202.9

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ++..++|++.+.||+|+||.||+|.+...     +..||+|.......   ...+.+|+.++..+.| +++..+..+...
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~   80 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC-HHVVRLLGVVST   80 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEcC
Confidence            35568999999999999999999998643     37899998765432   2347789999999876 556667777777


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ  144 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~  144 (423)
                      ....++||||+ +++|.+++....         ..+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCC
Confidence            78899999999 789999986432         236788999999999999999999999999999999999   47889


Q ss_pred             EEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 014527          145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ  223 (423)
Q Consensus       145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~  223 (423)
                      +||+|||+++.......     +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   
T Consensus       158 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---  229 (277)
T cd05032         158 VKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---  229 (277)
T ss_pred             EEECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---
Confidence            99999999976543321     112224456789999999998889999999999999999998 999998654332   


Q ss_pred             HHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      ....+.... ..+   ....+|.++.+++.+||+.+|++||++.+|++.|+
T Consensus       230 ~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         230 VLKFVIDGG-HLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHHhcCC-CCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            222222211 111   12345889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-39  Score=305.82  Aligned_cols=258  Identities=18%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCc---EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~---~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .+.|++.+.||+|+||.||+|.+..+++   .||||++.....   ...+..|+.+++.+.| +++..+..+.......+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-cCcceEEEEECCCCceE
Confidence            4679999999999999999999876654   599998875432   3358889999999986 55666766677788899


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++....+.+++..++.++.|++.||.|||++|++||||||+||++   +.++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence            999999 779999887666679999999999999999999999999999999999999   4788999999999876543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ......  +........+..|+|||.+.+..++.++|||||||++||+++ |..||........   ...+. .....+.
T Consensus       159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~-~~~~~~~  232 (269)
T cd05065         159 DTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIE-QDYRLPP  232 (269)
T ss_pred             Cccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHH-cCCcCCC
Confidence            322110  111111122457999999999899999999999999999886 9999987544322   22221 2222222


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      .   ..+|..+.+++.+||..+|++||++++|+..|+.+
T Consensus       233 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         233 P---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             c---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1   34588999999999999999999999999988865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.2e-39  Score=308.24  Aligned_cols=258  Identities=21%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +..++|++.+.||+|+||.||+|.++.     .+..||+|.+......   ..+.+|+.+++.+.| +++..+..+..+.
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence            456899999999999999999997652     3457999987654322   246788899999976 5666676666777


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcE
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV  145 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~v  145 (423)
                      ...++||||+ +++|.+++....         ..++...+..++.||+.||.|||++||+||||||+|||++   .++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcE
Confidence            8899999999 899999987532         2356778999999999999999999999999999999994   78899


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK  224 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~  224 (423)
                      +|+|||+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   +.
T Consensus       159 ~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~  230 (288)
T cd05061         159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QV  230 (288)
T ss_pred             EECcCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence            99999998765432211     11223345778999999998889999999999999999998 89999875433   22


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ...+......    ......++.+.+++.+||+.+|++||++.++++.|++.+
T Consensus       231 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 LKFVMDGGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            2222222111    112345789999999999999999999999998888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.3e-39  Score=305.58  Aligned_cols=251  Identities=22%  Similarity=0.248  Sum_probs=197.0

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC--CeeEEEEe
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVLD   83 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~~~lv~e   83 (423)
                      |++.+.||+|+||.||+|.+..+++.||+|++....   ......+|+.++..+.+++++..+..++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            788999999999999999999999999999876532   2223457888899887667777777666666  78999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |+.++|.+.+......+++..++.++.||+.||+|||++|++||||+|+||+++   . +.+||+|||+++........ 
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~-  155 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPPY-  155 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCCc-
Confidence            998899998876556799999999999999999999999999999999999994   5 99999999999866433211 


Q ss_pred             cccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh----------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------  232 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------  232 (423)
                             ....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+..+............          
T Consensus       156 -------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         156 -------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             -------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence                   13457889999997654 457889999999999999999999998754432222221111000          


Q ss_pred             -----cC------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 -----VS------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 -----~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                           ..      .....+...++.++.++|.+||..+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                 00      0011223456889999999999999999999998865

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.4e-39  Score=303.71  Aligned_cols=246  Identities=22%  Similarity=0.343  Sum_probs=192.5

Q ss_pred             eeeecCceeEEEEEE--CCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           14 KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~--~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      .||+|+||.||+|.+  ..++..||+|+++....    .+.+..|+.+++.+.|+ ++..+..+. ..+..++||||+ +
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~-~~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNP-YIVRMIGIC-EAESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCC-CcceEEEEE-cCCCcEEEEecCCC
Confidence            689999999999965  35678899999875443    23578899999999875 454554444 345678999999 6


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||.|||+   +.++.+||+|||+++........    
T Consensus        80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~----  151 (257)
T cd05116          80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENY----  151 (257)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCe----
Confidence            789888864 4579999999999999999999999999999999999999   47789999999999876443221    


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                      +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....+.... ..+   ....+|
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~~~~-~~~---~~~~~~  224 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIESGE-RME---CPQRCP  224 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHCCC-CCC---CCCCCC
Confidence            011112344678999999988889999999999999999998 999998754432   222222221 111   224568


Q ss_pred             HHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          246 AEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +++.++|.+||+.||++||++++|...|+++
T Consensus       225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            9999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.7e-39  Score=304.89  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=198.5

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|+.+++.++| +++..+..+.......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC-CCEeeeeeEEeeCCEEEEEE
Confidence            47999999999999999999999899999999875432    22447789999999987 45555666666788899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+.+++.+.+......+++..++.++.||+.||.|||+.|++||||||+||++   +.++.++|+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCccc
Confidence            999666555555445679999999999999999999999999999999999999   47789999999999876543211


Q ss_pred             CcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh---------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------  232 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------  232 (423)
                             .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+....+.......         
T Consensus       157 -------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         157 -------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             -------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence                   123467889999999876 457899999999999999999999998765433222222111100         


Q ss_pred             --------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 --------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 --------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                    ...+.......++..+.+||.+||..+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                          001112233456889999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=302.55  Aligned_cols=250  Identities=25%  Similarity=0.333  Sum_probs=200.2

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      +.|++.+.||+|++|.||+|.+..+++.||+|.+....       ....+.+|+++++.+.| +++..+..+..+.+..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEccCCeEE
Confidence            57999999999999999999999999999999875432       12347789999999976 55666666667778999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +++||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||++   ++++.++|+|||+++....
T Consensus        81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence            999999 7899888875 4568999999999999999999999999999999999999   4778999999999976543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      .....    .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......   ..+..+......   .
T Consensus       157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~---~  226 (263)
T cd06625         157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTN---P  226 (263)
T ss_pred             ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHhccCCC---C
Confidence            22110    0012456788999999999999999999999999999999999999764332   222222222111   1


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....++..+.++|.+||..+|.+||++.+|++
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            223456889999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.4e-39  Score=302.11  Aligned_cols=247  Identities=19%  Similarity=0.245  Sum_probs=197.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .|++.+.||.|++|.||+|.+..+++.||+|.+....    ....+..|+++++.++|++.+..+..+.......+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4899999999999999999999889999999876433    233578899999999875544433333334456799999


Q ss_pred             cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+.+... ...+++.+++.++.|++.||.|||++||+||||||+||++   +..+.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence            99 78998888753 3458999999999999999999999999999999999999   4788999999999987644322


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..   .....+......    ...
T Consensus       158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~----~~~  223 (257)
T cd08223         158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVYRIIEGKLP----PMP  223 (257)
T ss_pred             -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCC----CCc
Confidence                   123456899999999999999999999999999999999999999764332   222223232221    122


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+++.+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            456889999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.8e-39  Score=307.16  Aligned_cols=244  Identities=22%  Similarity=0.312  Sum_probs=192.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+|++++..+.| +++..+..++...+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEECCEEEEEEe
Confidence            368899999999999999999999999999998765422   2357889999999987 555566666667788999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|..+     ..+++..+..++.|++.||.|||+.||+|+||||+|||+   +.++.++|+|||++........ 
T Consensus        80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~~-  150 (279)
T cd06619          80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSIA-  150 (279)
T ss_pred             cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccccc-
Confidence            99 6666433     347889999999999999999999999999999999999   4788999999999976543221 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh----HHHHHHHHhhhcCCcHH
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK----KQKYDKICEKKVSTPIE  238 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~i~~~~~~~~~~  238 (423)
                              ....||..|+|||.+.+..++.++|||||||++|+|++|+.||........    ......+....   +..
T Consensus       151 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~  219 (279)
T cd06619         151 --------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---PPV  219 (279)
T ss_pred             --------cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---CCC
Confidence                    245789999999999998999999999999999999999999975332111    11111111111   111


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......++++.++|.+||+.+|++||+++++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            112345788999999999999999999999866

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-39  Score=303.63  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=204.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .++|++.+.||+|+||.||+|.+..+++.|++|.+........+.+|+++++.++| +++..+..+..+....++++||+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS-PYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCC-CcEeeeeeeeecCCcEEEEEecC
Confidence            36899999999999999999999988999999998766556779999999999966 55666666666778999999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       +++|.+++......+++..++.++.|++.||.|||+.|++||||+|+||++   +.++.++|+|||++........   
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~---  154 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA---  154 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc---
Confidence             789999987667789999999999999999999999999999999999999   4788999999999987654321   


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                          ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..........   .+..  ...+.......+
T Consensus       155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---~~~~--~~~~~~~~~~~~  225 (256)
T cd06612         155 ----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---MIPN--KPPPTLSDPEKW  225 (256)
T ss_pred             ----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---hhcc--CCCCCCCchhhc
Confidence                1124457889999999999899999999999999999999999998654332111   1111  111111112345


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +..+.++|.+||+.+|++||++.+|+.
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            788999999999999999999998865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=320.83  Aligned_cols=259  Identities=21%  Similarity=0.339  Sum_probs=219.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.....+||-|.||+||.|.|++..-.||||.++.+.. ..+|+.|+.+|+.+.|++ ++.+...+.....+|||+||| 
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpN-LVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN-LVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCcc-HHHHhhhhccCCCeEEEEeccc
Confidence            34567789999999999999999999999999987764 456999999999999854 555555666777899999999 


Q ss_pred             CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 ~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      .|+|.+++..+++. ++.-..+.++.||..|++||..+++|||||..+|+|++   ++..||++|||+++.+..++...|
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTAH  423 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTAH  423 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceecc
Confidence            99999999988754 67777888999999999999999999999999999995   888999999999999887765433


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            ....-.+.|.|||.+.-..++.|+|||+|||+|||+.| |.-||.+.+-.....    ++++.+....+   .+
T Consensus       424 ------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~----LLEkgyRM~~P---eG  490 (1157)
T KOG4278|consen  424 ------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYG----LLEKGYRMDGP---EG  490 (1157)
T ss_pred             ------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHH----HHhccccccCC---CC
Confidence                  23445778999999999999999999999999999998 999999976553333    34445544433   44


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCC
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD  283 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  283 (423)
                      +|+.+.+||..||+++|.+||+|.+|.+.|+.+|....++
T Consensus       491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis  530 (1157)
T KOG4278|consen  491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS  530 (1157)
T ss_pred             CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence            5999999999999999999999999999999999766544

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.6e-39  Score=310.50  Aligned_cols=261  Identities=20%  Similarity=0.311  Sum_probs=205.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECC-------CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~-------~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      -..+|.+.+.||+|+||.||+|++..       ....||+|++......   ..+..|+.+++.+.+++++..+..++.+
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            35689999999999999999998642       3456999987754332   3477899999999766777777777777


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL  138 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~  138 (423)
                      ....+++|||+ +++|.+++....               ..+++.++..++.||+.||.|||++||+||||||+|||++ 
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-  168 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-  168 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc-
Confidence            78899999999 889999987532               3488999999999999999999999999999999999994 


Q ss_pred             cCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                        .++.+||+|||+++.........     ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus       169 --~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         169 --EDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             --CCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence              77899999999998654322111     1112234568999999999889999999999999999999 899998754


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ...   .+..+... ....   ....++.++.+++.+||..+|++||++.+|++.|..+....
T Consensus       242 ~~~---~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         242 VEE---LFKLLREG-HRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHH---HHHHHHcC-CCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            332   22222221 1111   12345789999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.4e-39  Score=308.71  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=199.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ..+|++.+.||+|+||.||+|.+..+++.|++|.+....  ....+.+|+.+++.+.|+ ++..+..++......++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~-~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP-NIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCC-CEeeEEEEEEeCCEEEEeec
Confidence            468999999999999999999999899999999876543  234578899999998774 55556556667889999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++.  ...+++.++..++.|++.||.|||++||+||||||+|||+   +.++.++|+|||++.........
T Consensus        98 ~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          98 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             ccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhccccccc
Confidence            99 889999875  3468999999999999999999999999999999999999   47789999999998765432211


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......  ..+. +....  .+......
T Consensus       173 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~-~~~~~--~~~~~~~~  240 (296)
T cd06654         173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL-IATNG--TPELQNPE  240 (296)
T ss_pred             -------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH-HhcCC--CCCCCCcc
Confidence                   124468899999999998889999999999999999999999997654321  1111 11111  11111123


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++..+.++|.+||..+|++||++.+|++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            46788999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.4e-39  Score=307.89  Aligned_cols=248  Identities=17%  Similarity=0.298  Sum_probs=196.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .|++.+.||+|+||.||+|.+..++..+++|.+.....  ...+.+|+++++.+.| +++..+..++......++||||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC-CCeeeEEEEEeeCCEEEEEEEec
Confidence            47899999999999999999999999999998765432  3357789999999987 45556666666788899999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       +++|..++......+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++........   
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~---  158 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ---  158 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc---
Confidence             778877776555679999999999999999999999999999999999999   4788999999999876543221   


Q ss_pred             ccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          165 IPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                          ......++..|+|||++.     +..++.++|||||||++|+|++|..||......   +.+..+......  ...
T Consensus       159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~--~~~  229 (282)
T cd06643         159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEPP--TLA  229 (282)
T ss_pred             ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHhhcCCC--CCC
Confidence                122456899999999984     445788999999999999999999999865432   222222221111  111


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....++.++.++|.+||+.+|++||+++++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12346889999999999999999999988754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.1e-39  Score=308.17  Aligned_cols=265  Identities=18%  Similarity=0.197  Sum_probs=202.9

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeee-eCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~-~~~~~~l   80 (423)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+.+++.++|.+.+..+..+.. ..+..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4689999999999999999999999999999998764332    2246689999999998654444433322 2356899


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||+.++|.+++......+++..++.++.||+.||.|||+.|++||||||+||++   +..+.+||+|||++.......
T Consensus        86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCcc
Confidence            99999889999988766779999999999999999999999999999999999999   478899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh-------
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------  232 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------  232 (423)
                      ..       .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.......       
T Consensus       163 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         163 KP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             CC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence            11       113345788999999876 457899999999999999999999998765443332222211100       


Q ss_pred             ---------cCC------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          233 ---------VST------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       233 ---------~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                               ...      .........++.+.++|.+||..||++||++++++.  +.+|.+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~~~  298 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEKPL  298 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccCCC
Confidence                     000      001111234788999999999999999999999965  566654443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.6e-39  Score=308.42  Aligned_cols=257  Identities=20%  Similarity=0.311  Sum_probs=200.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+.....   ..++.+|++++..++| +++..+..++.+.+..++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCEEEEEee
Confidence            479999999999999999999999999999998765432   2347889999999976 556666666778889999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++.. .+.+++..+..++.||+.||.|||+ .+++||||||+|||++   .++.++|+|||++....... 
T Consensus        80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCcccccccc-
Confidence            99 7899998875 4678999999999999999999997 5999999999999994   67889999999987553321 


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH--------------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK--------------  227 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------------  227 (423)
                              .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..              
T Consensus       155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence                    1245789999999999988899999999999999999999999975432211111100              


Q ss_pred             ---------------HHhhhcCCcHHHh-hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          228 ---------------ICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       228 ---------------i~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                     +............ ...++.++++|+.+||..+|++||++.+|++  +.++..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~  292 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK--HPFIKR  292 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhh
Confidence                           0000000000000 1125778999999999999999999999866  455543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-39  Score=307.26  Aligned_cols=251  Identities=18%  Similarity=0.323  Sum_probs=198.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeee------eCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~------~~~~   77 (423)
                      -.+.|++.+.||.|+||.||+|.+..+++.||+|+..... ....+..|+.++..+.+++++..+..++.      ....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            3578999999999999999999999999999999876543 33467889999999976677777655543      2457


Q ss_pred             eEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      .+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||++   ++++.++|+|||++..
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~  170 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhh
Confidence            89999999 679999887533 458889999999999999999999999999999999999   4788899999999876


Q ss_pred             ecCCCCCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      ......       ......|+..|+|||.+.     +..++.++|||||||++|+|++|..||.......   .+..+..
T Consensus       171 ~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~  240 (282)
T cd06636         171 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPR  240 (282)
T ss_pred             hhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---hhhhHhh
Confidence            543221       123457899999999986     3457889999999999999999999997654322   1111111


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                         ..+.......++.++.++|.+||+.||.+||++.+|++
T Consensus       241 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 ---NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence               11112223456889999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.4e-39  Score=306.03  Aligned_cols=255  Identities=23%  Similarity=0.328  Sum_probs=201.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +...+|.+.++||+|+||.||+|...     .++..+++|.+.....  ...+.+|++++..++| +++..+..++....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~   80 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH-QHIVRFYGVCTEGR   80 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC-CCCceEEEEEecCC
Confidence            45678999999999999999999753     3466799998764332  3458899999999977 55666666777788


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      ..+++|||+ +++|.+++....              ..+++..++.++.||+.||+|||++|++||||||+|||++   +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence            899999999 889999887532              2478999999999999999999999999999999999994   7


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhh
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT  220 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~  220 (423)
                      ++.+||+|||+++.......     +.......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  232 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE  232 (280)
T ss_pred             CCCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence            88999999999976543221     111223445788999999999899999999999999999998 999997654332


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                         .+..+..... .   .....+|+.+.+++.+||+.||++||++++|.+.|+
T Consensus       233 ---~~~~~~~~~~-~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 ---AIECITQGRE-L---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ---HHHHHHcCcc-C---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence               2222222111 1   112356889999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=300.50  Aligned_cols=245  Identities=26%  Similarity=0.370  Sum_probs=200.7

Q ss_pred             ceeeecCceeEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.||+|+||.||+|.+...   +..|++|++.....   ...+.+|++.+..+.| +++..+..+.......+++|||+ 
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC-CChheeeeeecCCCceEEEEEecc
Confidence            4789999999999999865   88899999876554   3568899999999985 66666666666788899999999 


Q ss_pred             CCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           86 GPSLEDLFVYC--------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        86 ~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      +++|.+++...        ...+++..++.++.||+.||+|||++|++||||||+||++   +.++.++|+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence            99999998875        4679999999999999999999999999999999999999   477999999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ....     +.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+.. .... 
T Consensus       157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~-~~~~-  226 (262)
T cd00192         157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK-GYRL-  226 (262)
T ss_pred             cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc-CCCC-
Confidence            4332     112235567889999999998889999999999999999999 699998764432   2222222 1111 


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                        .....+|.++.+++.+||..+|.+||++.+|++.|
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         227 --PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             --CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              12234588999999999999999999999998876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.5e-39  Score=301.69  Aligned_cols=251  Identities=25%  Similarity=0.369  Sum_probs=200.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+......           ..+.+|+.+++.+.| +++..+..++....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Confidence            588999999999999999999888999999977643221           347789999999987 55666777777888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..+++|||+ +++|.+++.. ...+++..+..++.|++.||+|||+.|++||||+|+||++   ++++.++|+|||+++.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~  155 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK  155 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence            999999999 7799988875 4568999999999999999999999999999999999999   4788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......... .........|+..|+|||.+.+..++.++|||||||++|+|++|+.||......   ..+..+....   
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~---  228 (267)
T cd06628         156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIGENA---  228 (267)
T ss_pred             cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHhccC---
Confidence            653221110 011122456889999999999888999999999999999999999999875432   2222222211   


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       .......++..+.++|.+||+.+|.+||++.+|++
T Consensus       229 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         229 -SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             11222456889999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=301.62  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+. .++.||||.+.... ....+.+|+.+++.++| +++..+..++......+++|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH-DKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC-CCEeeeeeeeecCCceEEEE
Confidence            56789999999999999999999975 45779999887543 34568999999999987 55666666666778899999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||++   ++++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccchh
Confidence            999 789999887533 468999999999999999999999999999999999999   478999999999998764321


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      .      .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+....   ..+..+.. ....+.. 
T Consensus       158 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~-~~~~~~~-  226 (261)
T cd05034         158 Y------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVER-GYRMPRP-  226 (261)
T ss_pred             h------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-CCCCCCC-
Confidence            1      11113334678999999999889999999999999999998 99999875433   22333322 2222211 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                        ...|.++.+++.+||..+|++||++++|.+.|+.
T Consensus       227 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 --PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              3348899999999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.7e-39  Score=305.20  Aligned_cols=252  Identities=20%  Similarity=0.294  Sum_probs=196.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeee-----eCCee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDN   78 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~~~~   78 (423)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+..... ....+..|+.++..+..|+++..+..++.     .+...
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            3578999999999999999999999999999999876533 23457889999999965566666654432     34568


Q ss_pred             EEEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           79 VLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ++||||+ +++|.+++..   ....+++..+..++.|++.||.|||+++|+||||||+||+++   ..+.++|+|||+++
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~  172 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSA  172 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEccCCcee
Confidence            9999999 8899887753   234688999999999999999999999999999999999994   67889999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      .......       ......|++.|+|||.+..     ..++.++|||||||++|+|++|+.||.......   .+..+.
T Consensus       173 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~~~~  242 (286)
T cd06638         173 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALFKIP  242 (286)
T ss_pred             ecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHhhcc
Confidence            7643221       1124468999999999853     447889999999999999999999998654321   111111


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..  ..+.......++..+.++|.+||+.+|++||++.+|++
T Consensus       243 ~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~  282 (286)
T cd06638         243 RN--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ  282 (286)
T ss_pred             cc--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11  11111112335778999999999999999999999876

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-38  Score=308.67  Aligned_cols=256  Identities=19%  Similarity=0.237  Sum_probs=188.3

Q ss_pred             eceeeecCceeEEEEEECC--CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEee-eeCCeeEEEEeccCCC
Q 014527           12 GRKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS   88 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~--~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~-~~~~~~~lv~e~~~~s   88 (423)
                      +.+||+|+||.||+|++..  ++..||+|.+........+.+|+.+++.++|++.+..+..+. ......+++|||++++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD   85 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence            4689999999999999764  567899998877666667889999999999865554444333 3456789999999999


Q ss_pred             HHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec-CCCCcEEEeeccceeeecCC
Q 014527           89 LEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        89 L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~-~~~~~vkL~DFGla~~~~~~  159 (423)
                      |.+++....        ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.....
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~  165 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP  165 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence            988875321        248899999999999999999999999999999999999432 35678999999999876543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhh------HHHHHHHHhhh
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------KQKYDKICEKK  232 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~------~~~~~~i~~~~  232 (423)
                      ...    ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........      ...+..+....
T Consensus       166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            221    1122355789999999999874 579999999999999999999999975321100      00011110000


Q ss_pred             c----------------------------CCc-----HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 V----------------------------STP-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~----------------------------~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .                            ...     .+......+..+.+||.+||..||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            0                            000     00001122456889999999999999999998864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-39  Score=300.69  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +-.+.|++.+.||.|+||.||+|..  .++.||||.+..... ..++..|+.++..++|. ++..+..+..+....++||
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHP-NLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCc-ceeeeEEEEcCCCCeEEEE
Confidence            3467899999999999999999987  478899999876654 55688999999999875 4555555555678899999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||++   +.++.++|+|||.++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccccc
Confidence            999 689999887543 268999999999999999999999999999999999999   478899999999998763222


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      .          ....+..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ....+ ......   .
T Consensus       157 ~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~-~~~~~~---~  219 (256)
T cd05039         157 D----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV-EKGYRM---E  219 (256)
T ss_pred             c----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH-hcCCCC---C
Confidence            1          2234567999999998889999999999999999997 999997654322   22222 212111   1


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      ....+|+.+.++|.+||..+|++||++++|++.|+.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            123458999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=304.03  Aligned_cols=254  Identities=21%  Similarity=0.266  Sum_probs=197.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+.....   ...+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecCCeEEEEEe
Confidence            689999999999999999999998899999998764322   2346789999999987 556667777778889999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCc--
Confidence            99889999887766678999999999999999999999999999999999999   4788999999999875432211  


Q ss_pred             cccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHHhhh---------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKK---------  232 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~---------  232 (423)
                           ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... +....+.+.....         
T Consensus       159 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         159 -----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             -----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence                 1113356889999999876 45889999999999999999999999764421 1111111110000         


Q ss_pred             -------------cCCcHHHhhccCh--HHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 -------------VSTPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 -------------~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   ...+.......+.  .++.+++.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                         0001111112233  78899999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.2e-39  Score=307.79  Aligned_cols=261  Identities=20%  Similarity=0.278  Sum_probs=203.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCc----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~----~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .+-.++|++.+.||+|+||.||+|.+..++.    .||+|++......   ..+.+|+.++..+.|++ +..+..++.. 
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~n-iv~~~~~~~~-   80 (303)
T cd05110           3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH-LVRLLGVCLS-   80 (303)
T ss_pred             ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC-cccEEEEEcC-
Confidence            4557889999999999999999999887775    4788987654332   25778999999997754 4444444333 


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...++++||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~  157 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLAR  157 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccc
Confidence            3467899999 789999987656678999999999999999999999999999999999999   467889999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .........     ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....    +..+.....
T Consensus       158 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~  228 (303)
T cd05110         158 LLEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGE  228 (303)
T ss_pred             cccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCC
Confidence            764322110     1113345778999999999899999999999999999997 999998754322    222222222


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..+..   ...+..+.+++..||..+|++||++++|++.|+.+....
T Consensus       229 ~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         229 RLPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            22221   234788999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9e-39  Score=300.30  Aligned_cols=253  Identities=19%  Similarity=0.266  Sum_probs=193.2

Q ss_pred             ceeeecCceeEEEEEECC---CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~---~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.||+|+||.||+|.+..   ....||||.+.....   ...+.+|+.+++.++|++.+..+..+.......+++|||+ 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   345799998754332   2357789999999987655554444444556689999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|.+++......+++..++.++.||+.||.|||+.+++||||||+|||+   ++.+.+||+|||+++.........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~--  155 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYS--  155 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCccee--
Confidence            889999987655667888899999999999999999999999999999999   478899999999997654322111  


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                       ........++..|+|||.+.+..++.++|||||||++|||++ |..||......   .....+... ...+.   ....
T Consensus       156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~---~~~~  227 (262)
T cd05058         156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQG-RRLLQ---PEYC  227 (262)
T ss_pred             -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhcC-CCCCC---CCcC
Confidence             111123456778999999998889999999999999999999 56677654332   222222221 11111   1335


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      |..+.+++..||..+|++||++.+|+..|++++.
T Consensus       228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            7899999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-39  Score=305.27  Aligned_cols=260  Identities=24%  Similarity=0.269  Sum_probs=197.7

Q ss_pred             CCceEEeceeeecCceeEEEEEE----CCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEee--eeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG--VDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~----~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~--~~~~~   77 (423)
                      ...|++.+.||+|+||.||+|..    ..+++.||||.+.....  ...+.+|++++..++|++ +..+..+.  .+...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN-IVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCC-eeEEEEEEccCCCCc
Confidence            46899999999999999999984    35688999998765443  235789999999998754 44444332  33456


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||+++..
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccccc
Confidence            89999999 899999987655679999999999999999999999999999999999999   47889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh------------HHH
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------------KQK  224 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~------------~~~  224 (423)
                      .......    .......++..|+|||.+.+..++.++|||||||++|||++|..|+........            ...
T Consensus       159 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         159 PQDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cCCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            4432210    011122345569999999988899999999999999999998877653221100            000


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +..+.......+   ....++.++.+|+.+||..+|++||++.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111111111111   1234578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-39  Score=304.25  Aligned_cols=247  Identities=19%  Similarity=0.242  Sum_probs=195.3

Q ss_pred             ceeeecCceeEEEEEECCCCc--EEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~--~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|++..++.  .+++|......   ....+.+|++++..+.+++++..+..++......+++|||+ +
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999987775  46888776432   23457889999999976778878877777788899999999 8


Q ss_pred             CCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           87 PSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        87 ~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                      ++|.+++....               ..+++..++.++.|++.||+|||++|++||||||+|||+   ++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence            89999987532               247899999999999999999999999999999999999   478899999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      ++.......        .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+.....   .+..+..
T Consensus       158 l~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~~  226 (270)
T cd05047         158 LSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQ  226 (270)
T ss_pred             Cccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHHhC
Confidence            986322111        1112234567999999988889999999999999999997 999997654332   2222211


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                       .....   .....+.++.+++.+||..+|.+||++.+++..|++++
T Consensus       227 -~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 -GYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -CCCCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             11111   11345788999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.3e-39  Score=301.36  Aligned_cols=245  Identities=21%  Similarity=0.277  Sum_probs=197.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .++|++.+.||+|+||.||++..  +++.||+|+.........+.+|+.++..++|++.++ +..+... +..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~-~~~~~~~-~~~~~v~e~~   80 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVR-LLGVILH-NGLYIVMELM   80 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCe-EEEEEcC-CCcEEEEECC
Confidence            46899999999999999999864  678899999877666667899999999998755554 4444433 4579999999


Q ss_pred             -CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           86 -GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        86 -~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                       +++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++........  
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~~--  155 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVD--  155 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccCC--
Confidence             789999987543 358999999999999999999999999999999999999   4788999999999876433211  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                              ....+..|+|||.+.+..++.++|||||||++|+|++ |+.||........   ...+ .......   ...
T Consensus       156 --------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~-~~~~~~~---~~~  220 (254)
T cd05083         156 --------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KECV-EKGYRME---PPE  220 (254)
T ss_pred             --------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH-hCCCCCC---CCC
Confidence                    2234568999999998889999999999999999997 9999987544322   2222 2222211   124


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      .+|..+.+++.+||+.+|++||++++|+..|+
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            56889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=306.98  Aligned_cols=249  Identities=19%  Similarity=0.318  Sum_probs=200.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++|++.+.||.|+||.||+|.+..++..||+|+.....  ....+..|+++++.++| +++..+..++......++||||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEeec
Confidence            57999999999999999999998889999999876543  23357889999999985 6677777677788899999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++   +.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc--
Confidence            9 779988887766779999999999999999999999999999999999999   4788999999999876533221  


Q ss_pred             cccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          164 HIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                           ......+++.|+|||.+.     +..++.++|||||||++|+|++|+.||......   +.+..+.....  +..
T Consensus       159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~  228 (280)
T cd06611         159 -----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKILKSEP--PTL  228 (280)
T ss_pred             -----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHHhcCCC--CCc
Confidence                 122456899999999975     344678999999999999999999999875433   22222222111  111


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....++.++.++|..||..+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            112345789999999999999999999998865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.2e-39  Score=307.85  Aligned_cols=252  Identities=20%  Similarity=0.293  Sum_probs=198.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .+|+..+.||+|+||.||++.+..+++.||||.+....   ....+.+|+.++.++..++++..+..+.......+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            46778899999999999999999999999999876433   233578899999999755777777777777888999999


Q ss_pred             ccCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           84 LLGPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        84 ~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |++.++.++...    ....+++..+..++.|++.||+|||+. +|+||||||+|||+   +..+.++|+|||+++....
T Consensus        84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhcc
Confidence            998888776542    235699999999999999999999975 99999999999999   4778999999999976543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ....        ....|+..|+|||.+.+.   .++.++|||||||++|+|++|+.||....  ...+.+.++.......
T Consensus       161 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~  230 (288)
T cd06616         161 SIAK--------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI  230 (288)
T ss_pred             CCcc--------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence            3211        234678899999999876   68999999999999999999999997643  1122222222211111


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ........++.++.+||.+||+.+|++||++++|+.
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111346889999999999999999999999866

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-39  Score=301.75  Aligned_cols=251  Identities=21%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeee------CCee
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD------GEDN   78 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~------~~~~   78 (423)
                      .++|++.+.||+|+||.||+|.+..+++.|++|++..... ...+.+|+.+++.+..++++..+..++..      ....
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            4789999999999999999999998899999998775543 35688999999999656777777666544      3458


Q ss_pred             EEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           79 VLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ++||||+ +++|.+++...   ...+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccce
Confidence            9999999 77998888653   3579999999999999999999999999999999999999   478899999999987


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      .......       ......|+..|+|||.+...     .++.++|||||||+||+|++|..||......   ..+..+.
T Consensus       162 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~  231 (275)
T cd06608         162 QLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFKIP  231 (275)
T ss_pred             ecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHHhh
Confidence            6543322       12245689999999988642     3678999999999999999999999764332   2222222


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......  -.....++..+.++|.+||..||++||++++|++
T Consensus       232 ~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RNPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            211111  0111235789999999999999999999999865

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-38  Score=305.44  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=201.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      .+|++.+.||.|+||.||+|.+..+++.|+||.+....  ....+.+|+.+++.++|+ ++..+..+....+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP-NIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCC-ceeeeeeeEecCceEEEEEEe
Confidence            57999999999999999999999999999999876433  334578899999999875 455566566678889999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|..++..  ..+++.++..++.|++.||.|||++|++||||||+||++   +.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655          98 LAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             cCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccccc-
Confidence            9 8888887763  468999999999999999999999999999999999999   47889999999998765433211 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.+.......   ..+....  .+.......
T Consensus       172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---~~~~~~~--~~~~~~~~~  240 (296)
T cd06655         172 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNG--TPELQNPEK  240 (296)
T ss_pred             ------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcC--CcccCCccc
Confidence                  12446889999999999888999999999999999999999999875433221   1121111  111112245


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      +++.+.++|.+||..+|.+||++.+|+.  .+++.
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~  273 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLK  273 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhh
Confidence            6889999999999999999999999865  45543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2e-38  Score=302.98  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   ..+.+|+.+++.+.| +++..+..++......++|||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC-CCEeEEEEEEecCCeEEEEEe
Confidence            6899999999999999999999989999999987654322   256789999999987 556677777778888999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |++++|.+.+......+++..+..++.||+.||.|||+.||+|+||||+|||+   +.++.+||+|||+++.......  
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~--  158 (291)
T cd07870          84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ--  158 (291)
T ss_pred             cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC--
Confidence            99989988876555668899999999999999999999999999999999999   4788999999999876433221  


Q ss_pred             cccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc---------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV---------  233 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---------  233 (423)
                           ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+....  .+.+.++.....         
T Consensus       159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         159 -----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             -----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhh
Confidence                 11234578999999998764 4788999999999999999999999865432  122222111000         


Q ss_pred             ----------------CCcHHHhhc--cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 ----------------STPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ----------------~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                      .........  ..+..+.+++.+||..||.+||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                            000011111  12568999999999999999999988753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-39  Score=311.91  Aligned_cols=258  Identities=21%  Similarity=0.232  Sum_probs=196.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeee----eCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~----~~~~   77 (423)
                      ++++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+|+.+++.++|++.+..+..+..    ....
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            5689999999999999999999999999999999876422   23347789999999997554443333221    2235


Q ss_pred             eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      .+++|||++++|.+++.  ...+++..++.++.||+.||.|||+.||+||||||+|||+   +..+.+||+|||++....
T Consensus        83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeecc
Confidence            79999999989988775  4569999999999999999999999999999999999999   478899999999998764


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh------
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------  230 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~------  230 (423)
                      .......    ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..+..      
T Consensus       158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         158 PEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             ccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            4322111    1234578999999998765 4689999999999999999999999976433221111111100      


Q ss_pred             -----------------hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 -----------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 -----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                       .....+........+.++.++|.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~  291 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA  291 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                             00011112233455788999999999999999999999877

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-38  Score=301.86  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=201.9

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|+.+++.+.| +++..+..+.......++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecCCeeEEEec
Confidence            5899999999999999999999899999999876543    23468899999999986 556666666677889999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |++++|.+++......+++..++.++.||+.||.|||++|++|+||||+||++   +..+.++|+|||++........  
T Consensus        80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~--  154 (286)
T cd07832          80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP--  154 (286)
T ss_pred             ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC--
Confidence            99999999988766779999999999999999999999999999999999999   4688999999999987654321  


Q ss_pred             cccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh----------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------  232 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------  232 (423)
                          +......++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.................          
T Consensus       155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence                1122456899999999987644 6899999999999999999988887654332221111111000          


Q ss_pred             ------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                  ...+........+..+.++|.+||..+|++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                        000112223456789999999999999999999998865

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-38  Score=304.01  Aligned_cols=235  Identities=25%  Similarity=0.379  Sum_probs=196.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+|+++++.+.| +++..+..+..+....++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH-PFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCeEEEE
Confidence            47999999999999999999999999999999876432     23457889999999985 5666677777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~  155 (290)
T cd05580          80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT  155 (290)
T ss_pred             EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCCC
Confidence            9999 8999998876 4679999999999999999999999999999999999999   478899999999998764331


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                                ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.....   ......+.......+    
T Consensus       156 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~----  218 (290)
T cd05580         156 ----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKILEGKVRFP----  218 (290)
T ss_pred             ----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCccCC----
Confidence                      245689999999999988899999999999999999999999976542   233333333333222    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCC
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRP  264 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RP  264 (423)
                       ..++..++++|.+||..||.+|+
T Consensus       219 -~~~~~~l~~li~~~l~~~p~~R~  241 (290)
T cd05580         219 -SFFSPDAKDLIRNLLQVDLTKRL  241 (290)
T ss_pred             -ccCCHHHHHHHHHHccCCHHHcc
Confidence             34588999999999999999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.2e-39  Score=306.72  Aligned_cols=259  Identities=23%  Similarity=0.286  Sum_probs=197.1

Q ss_pred             CceEEeceeeecCceeEEEEEE----CCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeee--CCe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED   77 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~----~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~~   77 (423)
                      .-|++.+.||+|+||.||+|++    ..++..||+|.+....   ....+.+|+.+++.+.|++ +..+..++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN-IVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCC-eeeeeeEEecCCCCc
Confidence            4579999999999999999985    3567889999876443   2235788999999998754 4444444333  356


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+||+++   .++.++|+|||+++.+
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCcccccc
Confidence            89999999 8999998876555689999999999999999999999999999999999994   6789999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchh-----------hhhHHHH
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-----------ATKKQKY  225 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~-----------~~~~~~~  225 (423)
                      ......    +.......++..|+|||.+.+..++.++|||||||++|+|+++..|+.....           .......
T Consensus       160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            543221    1112245677889999999988899999999999999999998776532110           0000111


Q ss_pred             HHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ..........+   ....++..+.+|+.+||+.+|++||++++|++.|+++
T Consensus       236 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111111111   1234688999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-38  Score=299.15  Aligned_cols=254  Identities=22%  Similarity=0.362  Sum_probs=200.6

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+..++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ...+.+|+.+++.+.|.+. ..+..+... ...+++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~-~~~~~v   78 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-VKLHAVVTK-EPIYII   78 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCc-ceEEEEEcC-CCeEEE
Confidence            3678899999999999999999998654 55699998765432 3468899999999987554 444444444 678999


Q ss_pred             Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||++   +..+.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCC
Confidence            9999 78999998753 3457889999999999999999999999999999999999   47889999999999766432


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ...      ......++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+......   .+. .....+  
T Consensus       156 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~-~~~~~~--  223 (260)
T cd05073         156 EYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---ALE-RGYRMP--  223 (260)
T ss_pred             Ccc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHh-CCCCCC--
Confidence            211      1122345678999999998889999999999999999998 999998754432222   221 222211  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                       .....|.++.+++.+||..+|++||++.+|.+.|+.
T Consensus       224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             124568899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-39  Score=305.40  Aligned_cols=256  Identities=17%  Similarity=0.251  Sum_probs=200.5

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+|+.+++.+.| +++..+..++......++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC-CcHHhhhhheecCCeEEEEEe
Confidence            478999999999999999999998999999998765322   3457889999999977 455555556667788999999


Q ss_pred             cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           84 LL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        84 ~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |+ +++|..++...  ...+++..+..++.||+.||.|||+ .||+||||||+||+++   .++.++|+|||++..+...
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCC
Confidence            99 77888877643  2368999999999999999999997 5999999999999994   6889999999998765432


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCC------CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      ..         ....++..|+|||.+.+..      ++.++|||||||++|+|++|+.||...........+..+.....
T Consensus       157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd06622         157 LA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP  227 (286)
T ss_pred             cc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence            21         2346788999999986543      58899999999999999999999976443322222222222211


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                          ......++.++.++|.+||..+|++||++++|+.  ..++....
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~  269 (286)
T cd06622         228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYK  269 (286)
T ss_pred             ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--Chhhhhcc
Confidence                1122346889999999999999999999999976  45555443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.8e-39  Score=301.21  Aligned_cols=254  Identities=21%  Similarity=0.302  Sum_probs=199.3

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....        ....+.+|+++++.++|. ++..+..+..+.+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP-HIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCC-ceehhhceeccCCeEE
Confidence            5889999999999999999999999999999876433        134578899999999874 4555555666778899


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++|++|+||+|+||+++  .....++|+|||++.....
T Consensus        80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence            999999 7899998875 45789999999999999999999999999999999999994  2234699999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      .......   ......++..|+|||.+.+..++.++|||||||++|+|++|..||..............+......   .
T Consensus       157 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~  230 (268)
T cd06630         157 KGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---P  230 (268)
T ss_pred             ccccCCc---cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---C
Confidence            3221110   122456889999999999888999999999999999999999999754332222222222111111   1


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....+++++.+++.+||..+|++||++.+|+.
T Consensus       231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            222345789999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=294.95  Aligned_cols=266  Identities=21%  Similarity=0.344  Sum_probs=213.4

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~---~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +.+++..||.|+.|+||+++.+.+|...|||.+......+   +++..+.++..-..++.|+....|+......+|.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            4456788999999999999999999999999887655433   4667777777766678888888889999999999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      +..-+..++....+.+++..+-.+..-++.||.||-. +||||||+||+|||+   |+.|.+||||||++-.+.+.... 
T Consensus       173 Ms~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh-  248 (391)
T KOG0983|consen  173 MSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH-  248 (391)
T ss_pred             HHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccccc-
Confidence            9888888888888889999999999999999999975 589999999999999   69999999999999887765432 


Q ss_pred             cccccCCCcccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                             ....|.+.|||||.+.-.   .|+.++||||||++++||.||..||.+.+  ...+.+.++.+...  |.-..
T Consensus       249 -------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~eP--P~L~~  317 (391)
T KOG0983|consen  249 -------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNEEP--PLLPG  317 (391)
T ss_pred             -------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhcCC--CCCCc
Confidence                   355799999999998743   58999999999999999999999999854  23345555555222  21111


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceec
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW  290 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw  290 (423)
                      -..+++.|.+|+..||.+|+.+||.+.+|++  +.++........++-+|
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~a~~dVa~W  365 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYETAEVDVASW  365 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchHHHhc--CcceeecchhhccHHHH
Confidence            2347999999999999999999999999876  34433332222334455

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=297.93  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=194.0

Q ss_pred             ceeeecCceeEEEEEECCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~---~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      ++||+|+||.||+|.+...+   ..||+|.+.....   ...+..|+.+++.+.|+ ++..+..+. .....++||||+ 
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~-~~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP-CIVRLIGVC-KGEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCC-CeeeEEEEE-cCCceEEEEEeCC
Confidence            47999999999999876554   7899998875543   34578899999999874 444444443 345689999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+|||+   +.++.+||+|||+++........   
T Consensus        79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~---  151 (257)
T cd05060          79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY---  151 (257)
T ss_pred             CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence            7899998875 3479999999999999999999999999999999999999   47889999999999876443221   


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                       +.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+... ...+   ....+
T Consensus       152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~-~~~~---~~~~~  223 (257)
T cd05060         152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESG-ERLP---RPEEC  223 (257)
T ss_pred             -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcC-CcCC---CCCCC
Confidence             111122234568999999998889999999999999999998 999998754432   22222221 1111   22345


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +..+.++|.+||..+|++||++.+|.+.|+.+
T Consensus       224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            88999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=343.70  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=215.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----Cc-hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~-~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +-..+|+|++.||+|+||+|.+++++.+++.||+|++++..    .. .-|..|-.+|..- ...-|..+++.+.+..+.
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccce
Confidence            44578999999999999999999999999999999987632    22 2255555665543 346677778888899999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ ||+|..++.... ++++..+..++..|+.||.-||+.|+|||||||+|||+   |..|.+||+|||.+..+.
T Consensus       151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcC
Confidence            9999999 999999998766 89999999999999999999999999999999999999   699999999999998887


Q ss_pred             CCCCCCcccccCCCcccccccccCccccc----C-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh-
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHL----G-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-  231 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-  231 (423)
                      ......      ....+|||.|.|||++.    + +.|++.+|+||+||++|||+.|..||...   ...+.|.+|+.. 
T Consensus       227 ~dG~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad---slveTY~KIm~hk  297 (1317)
T KOG0612|consen  227 ADGTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD---SLVETYGKIMNHK  297 (1317)
T ss_pred             CCCcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH---HHHHHHHHHhchh
Confidence            665443      23678999999999996    3 46899999999999999999999999864   445667777766 


Q ss_pred             -hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC---hHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          232 -KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       232 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                       .+.+|...   .++++.++||...+. +|+.|..   ++++.          .+.|....||..++
T Consensus       298 ~~l~FP~~~---~VSeeakdLI~~ll~-~~e~RLgrngiedik----------~HpFF~g~~W~~iR  350 (1317)
T KOG0612|consen  298 ESLSFPDET---DVSEEAKDLIEALLC-DREVRLGRNGIEDIK----------NHPFFEGIDWDNIR  350 (1317)
T ss_pred             hhcCCCccc---ccCHHHHHHHHHHhc-ChhhhcccccHHHHH----------hCccccCCChhhhh
Confidence             45555222   369999999999885 7888887   66663          35667777896554

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.8e-39  Score=311.30  Aligned_cols=254  Identities=18%  Similarity=0.217  Sum_probs=191.6

Q ss_pred             Eeceeeec--CceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527           11 LGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus        11 i~~~Lg~G--~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +++.||+|  +|++||++.+..+++.||||.+.....    ...+.+|+.+++.++| +++..+..++...+..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCEEEEEEec
Confidence            57889999  789999999999999999998875432    2346779999999977 5566666677788899999999


Q ss_pred             c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        85 ~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      + +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.++|+||+.+.........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcccccccc
Confidence            9 78999988653 34589999999999999999999999999999999999994   7789999999876544322111


Q ss_pred             CcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC-----
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST-----  235 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-----  235 (423)
                      ............++..|+|||++.+  ..++.++|||||||++|||++|+.||........   ...........     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~  234 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTT  234 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCcccccccc
Confidence            1000011123456788999999976  4589999999999999999999999986443211   11111110000     


Q ss_pred             --c----------------------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 --P----------------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 --~----------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                        +                                  .......+++.+.+||.+||+.||++||++++|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence              0                                  00011234678999999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=302.54  Aligned_cols=262  Identities=21%  Similarity=0.311  Sum_probs=212.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +.-++|.+++.||+|.||.|.+++.+.+++.||||+++++..     ...-+.|-++|+..+| +.+..+.+-+...+..
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhccCceE
Confidence            445789999999999999999999999999999999876532     2235678888888876 4444556667788999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||. ||.|.-.+.. .+.+++.....+...|+.||.|||+++||+||||.+|.|+   |.+|.+||+|||+++.-.
T Consensus       244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcc
Confidence            9999999 8888777765 5679999999999999999999999999999999999999   799999999999998643


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....       ..++++|||.|+|||++....|++++|.|.+||+||||++|++||...+.   ...+..|....+..| 
T Consensus       320 ~~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~kFP-  388 (516)
T KOG0690|consen  320 KYGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLKFP-  388 (516)
T ss_pred             cccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhccCC-
Confidence            3322       34589999999999999999999999999999999999999999986443   344555655566655 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCC--hHHHHHHHHHHHHhcCCCCCcceecee
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPD--YGFLKRLFHDLFSREGYDFDFVFDWTI  292 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt--~~~l~~~L~~~~~~~~~~~~~~~dw~~  292 (423)
                          ..++++.+.|+..+|.+||.+|..  .++..+..+       ..|....||+.
T Consensus       389 ----r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~-------h~FF~~v~W~~  434 (516)
T KOG0690|consen  389 ----RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR-------HRFFASVDWEA  434 (516)
T ss_pred             ----ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh-------hhhhccCCHHH
Confidence                455899999999999999999962  233333322       33444567754

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-38  Score=304.20  Aligned_cols=253  Identities=21%  Similarity=0.265  Sum_probs=197.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-------hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-------~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +|++.+.||+|+||.||+|.+..+++.||||.+......       ..+..|+++++.++| +++..+..+..+....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH-PNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC-CCChhhhheeecCCEEEE
Confidence            589999999999999999999988999999987654322       346789999999986 455556556666888999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+   +.++.++|+|||++.......
T Consensus        80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence            99999999999987544469999999999999999999999999999999999999   478899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh--------
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--------  231 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--------  231 (423)
                      ..       .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+................        
T Consensus       157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         157 RK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             cc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence            11       123356788999999865 45789999999999999999998888765433222221111000        


Q ss_pred             ------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 ------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                  ....+........+..+.++|..||..+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                        0011112223445788999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=315.12  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=199.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC-eeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~-~~~lv~e   83 (423)
                      +.|.-...||+|+||.||+|...+ +..||||.+.....  ..+|..|+.++.+++| +++..+..|+.+.+ ..+||+|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H-~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH-PNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC-cCcccEEEEEecCCceEEEEEE
Confidence            466677899999999999999754 48899998776654  4679999999999995 66777777777777 5999999


Q ss_pred             cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---cccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |+ .|+|.+.+..... .++|..++.|+.++|.||+|||...   ||||||||+|||+   |.+..+||+|||+|+....
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE  229 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence            99 8899999986555 8999999999999999999999854   9999999999999   6899999999999965543


Q ss_pred             -CCCCCcccccCCCcc-cccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh---hHH---------H
Q 014527          159 -PTTNRHIPYRENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT---KKQ---------K  224 (423)
Q Consensus       159 -~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~---~~~---------~  224 (423)
                       ....        ... .||..|+|||.+..+..+.|+|||||||+|.||++|+.|........   ..+         .
T Consensus       230 ~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~  301 (361)
T KOG1187|consen  230 GDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK  301 (361)
T ss_pred             cccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence             2211        112 79999999999998889999999999999999999998887432111   111         1


Q ss_pred             HHHHHhhhcCCcHHHhhccCh-----HHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHP-----AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      +..+++..+..      ..++     ..+..+...|++.+|.+||++.++++.|+.+.
T Consensus       302 ~~eiiD~~l~~------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  302 LREIVDPRLKE------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             hhheeCCCccC------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            11222222110      1112     24778888999999999999999988886544

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-38  Score=298.39  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=203.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +-..+|++.+.||+|+||.||+|.+...   ...|+||.......   .+.+.+|+.+++.+.|++ +..+..+.. ...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~-~~~   80 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH-IVKLIGVIT-ENP   80 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCc-hhceeEEEc-CCC
Confidence            4467899999999999999999987643   34699998765442   335888999999998755 444444443 355


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||+|||+.|++||||||+|||++   ..+.++|+|||+++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence            78999999 8899999976556789999999999999999999999999999999999994   6789999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....   ....+.... ..
T Consensus       158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~-~~  227 (270)
T cd05056         158 EDESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRIENGE-RL  227 (270)
T ss_pred             ccccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcCC-cC
Confidence            543211      1112234568999999988889999999999999999986 999998755432   222222211 11


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +   ....+|..+.++|.+||..+|++||++.++++.|+++..+
T Consensus       228 ~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 P---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1   1245688999999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.3e-39  Score=303.78  Aligned_cols=260  Identities=23%  Similarity=0.305  Sum_probs=203.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECC----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeee--CC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~----~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~   76 (423)
                      ...|++.+.||+|+||.||+|.+..    ++..||||++.....   ...+.+|+++++.+.| +++..+..++..  ..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~-~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-ENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC-CChheEEeeeecCCCC
Confidence            4578899999999999999998653    478899999876554   4568899999999977 455555555544  55


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..+++|||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence            789999999 889999998655579999999999999999999999999999999999999   4779999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh-----------hHHH
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-----------KKQK  224 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~-----------~~~~  224 (423)
                      .......    +.......++..|+|||.+.+..++.++|||||||++|||++|..||.......           ....
T Consensus       159 ~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05038         159 LPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR  234 (284)
T ss_pred             cccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence            6533211    111122345667999999998889999999999999999999999987532211           0111


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +..........+.   ...+|.++.+++.+||..+|++||++.+|++.|+.+
T Consensus       235 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 LLELLKEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            2222222222221   134578999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-39  Score=304.46  Aligned_cols=254  Identities=19%  Similarity=0.305  Sum_probs=199.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -.++|++.+.||+|+||+||+|.+..+++.||+|+......   ...+.+|+++++.++| +++..+..+.......++|
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecCCEEEEE
Confidence            35789999999999999999999999999999998764432   3468899999999976 5666666667777899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ .+++||||||+||++   ++++.++|+|||++......
T Consensus        82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence            9999 7788887765 4568999999999999999999997 699999999999999   47889999999998654322


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh----hHHHHHHHHhhhcCC
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----KKQKYDKICEKKVST  235 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~i~~~~~~~  235 (423)
                      ..         ....|+..|+|||++.+..++.++|||||||++|+|++|..||.......    ....+..........
T Consensus       158 ~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd06620         158 IA---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE  228 (284)
T ss_pred             cc---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence            21         24578999999999988889999999999999999999999998644310    001111111111111


Q ss_pred             cHHHhh-ccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          236 PIEVLC-KSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       236 ~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      ....+. ..+|.++.+|+.+||..||++||+++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111111 1257889999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-38  Score=297.00  Aligned_cols=246  Identities=21%  Similarity=0.274  Sum_probs=199.7

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||+|+||.||+|.+..+++.+|||.+....    ....+..|+++++.++|+ ++..+..........++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP-NIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCC-chhheeeeEecCCEEEEEEe
Confidence            6999999999999999999999999999999876532    234578899999999874 55555555667788999999


Q ss_pred             cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++  ++.+.++|+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence            99 789999987643 4589999999999999999999999999999999999995  3455789999999987654321


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                              .....++..|+|||.+.+..++.++||||||+++|+|++|..||......   .....+......    ...
T Consensus       158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~  222 (256)
T cd08220         158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKIMSGTFA----PIS  222 (256)
T ss_pred             --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHHHhcCCC----CCC
Confidence                    12456889999999999888999999999999999999999999765432   222223222211    122


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..++.++.+++.+||..+|++||++.+|+.
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            346889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-38  Score=313.05  Aligned_cols=254  Identities=21%  Similarity=0.262  Sum_probs=195.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-----e
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~   74 (423)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++|++.+..+..+..     +
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            45789999999999999999999999999999999876432    22357789999999988655544443332     2


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....|+||||+.++|.+.+..   .++...+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  166 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  166 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence            235799999999899888753   28999999999999999999999999999999999999   578899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh---
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---  231 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---  231 (423)
                      .......        .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+......   
T Consensus       167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  238 (353)
T cd07850         167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD  238 (353)
T ss_pred             eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            7543221        12346789999999999999999999999999999999999999865432211111110000   


Q ss_pred             ----------------hcC---CcHHHh-------------hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 ----------------KVS---TPIEVL-------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ----------------~~~---~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                      ...   .+....             ....+..+.++|.+||..||++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                            000   000000             1134667899999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.4e-38  Score=294.57  Aligned_cols=247  Identities=24%  Similarity=0.301  Sum_probs=203.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||.|+||.||.+++..+++.|++|.+....    ....+.+|+.+++.++| +++..+..++.+....+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecCCeEEEEEE
Confidence            6999999999999999999999999999999765432    23457899999999976 566667666777889999999


Q ss_pred             cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++   .++.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEcccccc
Confidence            99 78999988754 34689999999999999999999999999999999999994   778899999999987644332


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......+++.|+|||.+.+..++.++|||||||++|+|++|..||......   +....+........    .
T Consensus       157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~----~  222 (256)
T cd08221         157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQGNYTPV----V  222 (256)
T ss_pred             -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC----c
Confidence                   112456899999999999888999999999999999999999999764332   33333333332221    1


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      ..++.++.++|.+||..+|++||+++++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            4568899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.9e-38  Score=301.90  Aligned_cols=251  Identities=19%  Similarity=0.288  Sum_probs=196.5

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----CeeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----EDNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----~~~~   79 (423)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.... ....+..|+.+++.+.+++++..+..++...     ...+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            478999999999999999999999999999999886543 3355788999999996556776665554432     4689


Q ss_pred             EEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           80 LVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      +||||+ +++|.+++..   ....+++..++.++.|++.||+|||+.|++||||||+||++   +.++.+||+|||++..
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~  177 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchh
Confidence            999999 7899988753   24568999999999999999999999999999999999999   4788899999999876


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      .......       .....|+..|+|||.+...     .++.++|||||||++|+|++|+.||......   ..+..+..
T Consensus       178 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~~~  247 (291)
T cd06639         178 LTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKIPR  247 (291)
T ss_pred             ccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHHhc
Confidence            5432211       1234688999999998643     3688999999999999999999999865432   22222222


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....  ......++..+.++|.+||+.+|++||++.+|++
T Consensus       248 ~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         248 NPPPT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11110  0111234678999999999999999999999865

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.9e-38  Score=301.99  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=195.5

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+++++.+.| +++..+..++......++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH-ENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC-cchhhHHHhcccCCeEEEEE
Confidence            479999999999999999999998899999998654322    3357789999999987 55556666667788899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+.+.+.+.+......+++..++.++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccc
Confidence            999554444444335569999999999999999999999999999999999999   47889999999999876443221


Q ss_pred             CcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh----------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK----------  231 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----------  231 (423)
                             .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+....+......          
T Consensus       157 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         157 -------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             -------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence                   1234678999999998764 4788999999999999999999999764432221111111000          


Q ss_pred             -------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 -------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   ....+.......++..+.+++.+||..+|++||++.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                         0001111223466889999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.9e-38  Score=302.63  Aligned_cols=254  Identities=21%  Similarity=0.313  Sum_probs=201.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      -.++|++.+.||+|+||.||+|.+..     ++..||+|++.....   ...+.+|+.++..+.| +++..+..++....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~~   81 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVGK   81 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCC
Confidence            35789999999999999999998743     577899998875433   3457889999999987 56666666667778


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCce
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR---------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF  134 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NI  134 (423)
                      ..+++|||+ +++|.+++....                     ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            899999999 789999986421                     2478889999999999999999999999999999999


Q ss_pred             EEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 014527          135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW  213 (423)
Q Consensus       135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf  213 (423)
                      |+   +.++.++|+|||++.........     ........+..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       162 l~---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         162 LV---GENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             Ee---cCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            99   47889999999998765432211     11123345678999999998899999999999999999997 88999


Q ss_pred             CCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      .+....   +....+...... +   .....|.++.+|+.+||+.+|++||++.+|++.|+
T Consensus       234 ~~~~~~---~~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         234 YGMAHE---EVIYYVRDGNVL-S---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCCHH---HHHHHHhcCCCC-C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            765443   223333222221 1   12345889999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=305.63  Aligned_cols=255  Identities=21%  Similarity=0.307  Sum_probs=201.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+.....     ...+..|++++..+.| ++++.+..++......+++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecCCEEEEE
Confidence            479999999999999999999999999999998775432     2347889999999986 5666666667778889999


Q ss_pred             Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||++   +.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence            9999 88999988753 3568999999999999999999999999999999999999   47889999999998765332


Q ss_pred             CCCCcc----------------------cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCch
Q 014527          160 TTNRHI----------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK  217 (423)
Q Consensus       160 ~~~~~~----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~  217 (423)
                      ......                      .-.......||..|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            111000                      0001124578999999999999889999999999999999999999998654


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC----hHHHHH
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD----YGFLKR  271 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~~l~~  271 (423)
                      ..   ..+..+.......+..   ..++..+.++|.+||..+|++||+    +++|+.
T Consensus       237 ~~---~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RD---ETFSNILKKEVTFPGS---PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hH---HHHHHHhcCCccCCCc---cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            33   3333333333332221   125889999999999999999999    666544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3e-38  Score=304.05  Aligned_cols=258  Identities=20%  Similarity=0.294  Sum_probs=201.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.|++|.+....     ....+.+|+++++.++| ++++.+...+......++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecCCEEEEE
Confidence            47999999999999999999999999999999876543     22346789999998876 5566666666777889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||||+||++   +..+.++|+|||+++......
T Consensus        80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence            9999 7899998865 4568999999999999999999999999999999999999   478899999999987422111


Q ss_pred             CCCc--------ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          161 TNRH--------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       161 ~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      ....        ..........++..|+|||.+.+..++.++|||||||++|+|++|..||.+....   +.+..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~~~  232 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDD  232 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc
Confidence            1000        0000112346788999999999888999999999999999999999999865432   3333333332


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      ...+...  ..+|.++.++|.+||+.+|++||+...+.++++
T Consensus       233 ~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         233 IEWPEGD--EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             cCCCCcc--ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            2222211  246889999999999999999999876666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-38  Score=305.67  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=199.0

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+....  ....+.+|+.+++.+.| +++..+..++......++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCEEEEeec
Confidence            478999999999999999999999899999999876433  23457789999998876 455566666667888999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++..  ..+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.++|+|||++.........
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCccC
Confidence            99 8899998753  468999999999999999999999999999999999999   47889999999999765433221


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....+++.|+|||.+.+..++.++|||||||++|+|++|..||.+......   ...+...  ..+......
T Consensus       172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~~~~--~~~~~~~~~  239 (297)
T cd06656         172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATN--GTPELQNPE  239 (297)
T ss_pred             -------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeeeccC--CCCCCCCcc
Confidence                   1244688999999999998899999999999999999999999976433211   1111111  111111223


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++..+.+++.+||..+|++||++++|++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            45788999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=316.63  Aligned_cols=256  Identities=22%  Similarity=0.328  Sum_probs=210.2

Q ss_pred             eEEeceeeecCceeEEEEEECCC--C--cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDT--N--EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~--~--~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .++.++||.|-||.||.|.+...  |  --||||..+.+.   ..+.|+.|+.+|+.++|+++|..|..+  .....|||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~--~e~P~Wiv  468 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC--VEQPMWIV  468 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee--eccceeEE
Confidence            34567899999999999988643  2  349999887654   345699999999999985555444333  34578999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||++ -|.|..++......++......++.||+.||.|||++++|||||..+|||++   ....|||+|||+++.+.+..
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccc
Confidence            9999 8999999998788899999999999999999999999999999999999995   77899999999999887665


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ...      .....-...|||||.+.-..++.++|||-|||++||++. |..||++..+.+..-.+    +..-+.|.+ 
T Consensus       546 yYk------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----EnGeRlP~P-  614 (974)
T KOG4257|consen  546 YYK------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----ENGERLPCP-  614 (974)
T ss_pred             hhh------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----cCCCCCCCC-
Confidence            422      223345678999999999999999999999999999887 99999998776544332    223333333 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                        +.+|+.+..|+.+||+++|.+||.+.+|+..|.+++..+..
T Consensus       615 --~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~  655 (974)
T KOG4257|consen  615 --PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI  655 (974)
T ss_pred             --CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence              45599999999999999999999999999999999986544

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.6e-38  Score=307.83  Aligned_cols=272  Identities=22%  Similarity=0.270  Sum_probs=206.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +.++|++.+.||.|+||.||+|.+..+++.||||.+...    .....+..|+.++..+.|++.+.....+.......++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            578899999999999999999999999999999976532    2334578899999999885554444444444667899


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      +|||++++|..++.  ...++...+..++.||+.||.|||++||+||||+|+|||+   +..+.++|+|||++.......
T Consensus        88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~~  162 (328)
T cd07856          88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQM  162 (328)
T ss_pred             EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCCc
Confidence            99999999988776  3468889999999999999999999999999999999999   478899999999987543211


Q ss_pred             CCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH----------
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC----------  229 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~----------  229 (423)
                                ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.+..          
T Consensus       163 ----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         163 ----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence                      13467889999998876 568999999999999999999999997654322211111110          


Q ss_pred             -------------hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh-----cCCCCCcceece
Q 014527          230 -------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR-----EGYDFDFVFDWT  291 (423)
Q Consensus       230 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~-----~~~~~~~~~dw~  291 (423)
                                   ......+.......++..+.++|.+||+.+|++||++++++.  ..++..     ..+.+...|||.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~--~~~~~~~~~~~~~~~~~~~~~~~  310 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA--HPYLAPYHDPTDEPVAEEKFDWS  310 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CCccccccCCccccCchhhcCCc
Confidence                         011122333344567889999999999999999999999866  333321     122233467775


Q ss_pred             ec
Q 014527          292 IL  293 (423)
Q Consensus       292 ~~  293 (423)
                      ..
T Consensus       311 ~~  312 (328)
T cd07856         311 FN  312 (328)
T ss_pred             hh
Confidence            43

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=300.14  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++.....   ...+.+|+.+++.+.|+ ++..+..+..+....++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSP-YITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCC-CeeeeeEEEEECCeEEEEEE
Confidence            479999999999999999999999999999998765432   23578899999999864 55556666667789999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++..  ..+++..++.++.|++.||.|||+++++||||+|+||++   ++++.++|+|||+++........
T Consensus        80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeecccccc
Confidence            99 7899988874  378999999999999999999999999999999999999   47889999999999877644221


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....+++.|+|||.+.+..++.++|||||||++|+|++|..||......   .....+..... ....  ..
T Consensus       155 -------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~-~~~~--~~  221 (274)
T cd06609         155 -------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLFLIPKNNP-PSLE--GN  221 (274)
T ss_pred             -------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHHHhhhcCC-CCCc--cc
Confidence                   22456888999999999988999999999999999999999999765432   22222222211 1111  11


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .++..+.+++.+||..+|++||+++++++  +.++.+
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~~  256 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIKK  256 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhh--ChhhcC
Confidence            26889999999999999999999999966  455543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-38  Score=304.83  Aligned_cols=270  Identities=21%  Similarity=0.327  Sum_probs=210.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +..+.|++.+.||+|+||.||+|.+..+++.||||++.....   ...+..|+.++..+..+++++.+..++.+....++
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            345789999999999999999999998899999998865432   23466777777777766778888888888889999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +|||+++++.+++......+++..+..++.||+.||.|||+ .||+||||+|+||++   +.++.+||+|||++..+...
T Consensus        92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCC
Confidence            99999989999887766789999999999999999999997 599999999999999   47889999999998765432


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCC----CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ...        ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......  .+.+..+.......
T Consensus       169 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~  238 (296)
T cd06618         169 KAK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPS  238 (296)
T ss_pred             Ccc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCC
Confidence            211        1335788999999997654    788999999999999999999999753221  22233333222111


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceec
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW  290 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw  290 (423)
                      . + ....++.++.+|+.+||..||++||+++++++  ..++.......+...+|
T Consensus       239 ~-~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~~~~~~~~~~  289 (296)
T cd06618         239 L-P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIRRYETAEVDVAGW  289 (296)
T ss_pred             C-C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--ChhhhccchhHHHHHHH
Confidence            1 0 11235789999999999999999999999976  45555544444444444

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.5e-38  Score=294.19  Aligned_cols=244  Identities=20%  Similarity=0.304  Sum_probs=193.0

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      +.||+|+||.||+|... ++..||+|++.....   ...+.+|+.+++.+.| +++..+..++......++||||+ +++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH-PNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CCcCeEEEEEecCCccEEEEECCCCCc
Confidence            46899999999999864 578899998765433   2347889999999976 55666666667778899999999 899


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                      |.+++......+++..++.++.|++.||.|||++|++||||||+||++   +.++.+||+|||++.........      
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------  149 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS------  149 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc------
Confidence            999887655678999999999999999999999999999999999999   47889999999998754332211      


Q ss_pred             CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                      ......++..|+|||.+.+..++.++||||||+++|++++ |..||.+........   .+. .....   .....+|..
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~---~~~-~~~~~---~~~~~~~~~  222 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---QVE-KGYRM---SCPQKCPDD  222 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHH-cCCCC---CCCCCCCHH
Confidence            1112344678999999998889999999999999999998 999998754432222   221 11111   112345889


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          248 FASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      +.+++.+||+.+|++||++.+|.+.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=300.06  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...    ....+.+|+++++.+.| +++..+..++...+..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-ENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC-CCeeehhheEEECCEEEEEE
Confidence            47999999999999999999999999999999876432    33568899999999996 45656666666788899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+++++.+.+......+++..++.++.||+.||.|||+.|++||||+|+||++   ++++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence            999777777666556679999999999999999999999999999999999999   47899999999999876544321


Q ss_pred             CcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh----------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK----------  231 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----------  231 (423)
                            ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+....+...........          
T Consensus       157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence                  11245678899999999888 7899999999999999999999999865433221111111100          


Q ss_pred             --------hcCC---c--HH-HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 --------KVST---P--IE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 --------~~~~---~--~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                              ....   +  .. .....++.++.++|.+||..+|++||++++|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                    0000   0  00 111234888999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.6e-38  Score=304.50  Aligned_cols=263  Identities=24%  Similarity=0.265  Sum_probs=198.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeee-------e
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-------D   74 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~-------~   74 (423)
                      -++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+++++.++|++.+..+..+..       .
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4799999999999999999999999999999998754322    2357889999999988555444433322       2


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....++||||+++++...+......+++..+..++.||+.||.|||++||+||||||+|||+   ++++.++|+|||+++
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccch
Confidence            33579999999889988887656679999999999999999999999999999999999999   578899999999998


Q ss_pred             eecCCCCCCcc----cccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          155 KYRDPTTNRHI----PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       155 ~~~~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      ...........    .........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.......+.+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            65443221110    01112345678899999988754 47899999999999999999999998765543333322221


Q ss_pred             hhh----------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKK----------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~----------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...                      ...........+++.+.++|.+||..||.+||++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            110                      000111112334578899999999999999999988764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.5e-38  Score=296.45  Aligned_cols=247  Identities=23%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             ceeeecCceeEEEEEECC-CCc--EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHVD-TNE--IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~-~~~--~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.||+|++|.||+|.+.. .++  .||||.+.....   ...+.+|+.++..++|++ +..+..+... ...+++|||+ 
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN-LIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCC-ccceeEEEcC-CeEEEEEEecC
Confidence            468999999999999865 333  699998876544   345788999999998755 4455444444 7889999999 


Q ss_pred             CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 ~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      +++|.+.+.... ..+++..++.++.|++.||+|||++|++||||||+||+++   .++.+||+|||+++.+......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~--  153 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH--  153 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc--
Confidence            899999987644 5689999999999999999999999999999999999994   7789999999999876543221  


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                        +.......++..|+|||.+.+..++.++|||||||++|+|++ |..||........   ...+.......+   ....
T Consensus       154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~---~~~~  225 (257)
T cd05040         154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDKEGERLE---RPEA  225 (257)
T ss_pred             --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHhcCCcCC---CCcc
Confidence              112224457788999999999899999999999999999998 9999976544432   222222111111   1234


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      .|..+.+++..||+.+|++||++.+|++.|.
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            5889999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.8e-38  Score=299.70  Aligned_cols=253  Identities=19%  Similarity=0.234  Sum_probs=196.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .|++.+.||.|+||.||+|++..+++.||||.+....    ....+..|+++++.++| +++..+..+..+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC-CCCcchhhhcccCCcEEEEee
Confidence            4899999999999999999999999999999876443    22458899999999987 455556556667888999999


Q ss_pred             ccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+.++|.+++... ...+++..++.++.||+.||+|||+.|++||||+|+||++   +.++.+||+|||++........ 
T Consensus        80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence            9988898888653 3568999999999999999999999999999999999999   5788999999999876543221 


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh---------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------  232 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------  232 (423)
                            ......++..|+|||.+.+.. ++.++|||||||++|+|+||+.||.+.........+.......         
T Consensus       156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence                  112335688999999987654 6889999999999999999999997654332211111110000         


Q ss_pred             ------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                  ...........++.++.++|.+||+.||++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                        000111223346788999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-38  Score=298.75  Aligned_cols=253  Identities=21%  Similarity=0.276  Sum_probs=199.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +|++.+.||.|++|.||+|++..+++.||||++....   ....+.+|+.+++.++| +++..+..++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence            5899999999999999999999999999999876543   23457789999999976 6677777777788899999999


Q ss_pred             cCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           85 LGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        85 ~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      +.++|.+++....  ..+++..+..++.||+.||.|||++|++||||||+||++   ++++.++|+|||++........ 
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-
Confidence            9889999887543  458999999999999999999999999999999999999   4788999999999975543211 


Q ss_pred             CcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC-------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-------  234 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------  234 (423)
                            ......++..|++||.+.+. .++.++|||||||++|+|++|+.||.+.........+.........       
T Consensus       156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence                  11234578899999998764 4789999999999999999999999875443222221111100000       


Q ss_pred             --------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 --------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 --------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                    ..........+..+.++|.+||+.||.+||++.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                          0011122345788999999999999999999998864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.6e-38  Score=299.83  Aligned_cols=260  Identities=22%  Similarity=0.258  Sum_probs=199.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+....    ....+.+|+++++.+.| +++..+..++.+....++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecCCeEEEEE
Confidence            57999999999999999999999899999999875432    22457889999999987 56667777777888999999


Q ss_pred             eccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||++++|.+.+..... .+++..+..++.||+.||+|||++|++||||+|+||+++  ..++.+||+|||++........
T Consensus        81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence            9998899888764332 368889999999999999999999999999999999995  3456799999999976533211


Q ss_pred             CCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh--------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------  232 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------  232 (423)
                             ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...................        
T Consensus       159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence                   11234678899999998764 57899999999999999999999998654332211111110000        


Q ss_pred             -------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          233 -------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       233 -------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                   ...........+++++.+++.+||+.+|++||++.++++  ..+|.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--~~~~~  288 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--HEYFK  288 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--CchHh
Confidence                         001111122456788999999999999999999999876  44443

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.4e-38  Score=302.70  Aligned_cols=254  Identities=22%  Similarity=0.257  Sum_probs=198.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeC--CeeEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVL   80 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~~~l   80 (423)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.++.....    ..+.+|+.++..+.| +++..+..+....  ...|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcEEE
Confidence            5799999999999999999999989999999987644322    245789999999986 5555565555545  88999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||+.++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||+   +..+.++|+|||++.......
T Consensus        84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccCCc
Confidence            99999889999987656679999999999999999999999999999999999999   478899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC-----
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-----  234 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-----  234 (423)
                      .       ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.........     
T Consensus       161 ~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         161 K-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             c-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence            1       112345788999999987654 689999999999999999999999875544332222211110000     


Q ss_pred             --------------C---cH-HHhhcc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 --------------T---PI-EVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 --------------~---~~-~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                    .   .. ..+... +++.+.++|.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                          0   00 001111 4778999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.3e-38  Score=303.25  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=198.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+.+|+++++.++| +++..+..++.+.+..
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~   90 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLREHTA   90 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeCCeE
Confidence            345679999999999999999999988899999998754321     2347789999999986 5566666667788889


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++||||+.+++.+++......+++..+..++.||+.||.|||+.||+||||+|+||++   ++++.++|+|||++.....
T Consensus        91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence            9999999999999887666779999999999999999999999999999999999999   4788999999999875432


Q ss_pred             CCCCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .           ....++..|+|||++.   ...++.++||||||+++|+|++|..||........   ...+...... 
T Consensus       168 ~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~-  232 (307)
T cd06607         168 A-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNDSP-  232 (307)
T ss_pred             C-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HHHHhcCCCC-
Confidence            2           1346788999999885   34578899999999999999999999986543321   1112111111 


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                        ......++..+.++|.+||..+|++||++.+|+.
T Consensus       233 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         233 --TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             --CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              1111235788999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3e-38  Score=298.31  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=188.8

Q ss_pred             ceeeecCceeEEEEEEC--CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|.+.  .++..+|+|.++.....   ..+.+|+.+++.++|++ +..+..++.+....++||||+ +
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSN-LLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCC-EeeEEEEEcCCCCcEEEEECCCC
Confidence            46899999999999865  34567999987654322   35788999999998754 555555666777889999999 7


Q ss_pred             CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           87 PSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        87 ~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ++|.+++....    ..+++..++.++.|++.||+|||++|++||||||+||+++   ..+.+||+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~-  155 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDY-  155 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCcce-
Confidence            89999886432    2356778889999999999999999999999999999994   778999999999865432211 


Q ss_pred             CcccccCCCcccccccccCcccccCC-------CCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGI-------EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                          +.......++..|+|||++.+.       .++.++|||||||++|||++ |..||..........  ..+......
T Consensus       156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~--~~~~~~~~~  229 (269)
T cd05087         156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT--YTVREQQLK  229 (269)
T ss_pred             ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH--HHhhcccCC
Confidence                1112245678899999998643       35789999999999999996 999998654432211  122222333


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      .+.+......++.+.+++..|| .+|++||++++|+..|.
T Consensus       230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            3333333456788999999999 68999999999987763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=302.31  Aligned_cols=259  Identities=20%  Similarity=0.253  Sum_probs=196.0

Q ss_pred             ceEEeceeeecCceeEEEEEECC--CCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC--Cee
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVD--TNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDN   78 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~--~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~~   78 (423)
                      +|++.+.||+|+||.||+|.+..  +++.||||++..     ......+.+|+.++..++|+ ++..+..++.+.  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE-NVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCC-CccceEEEEeCCCCceE
Confidence            58999999999999999999988  889999998876     23345678899999999874 455555555555  789


Q ss_pred             EEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee-cCCCCcEEEeeccce
Q 014527           79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA  153 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~-~~~~~~vkL~DFGla  153 (423)
                      ++||||++++|.+++....    ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||++
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999999889988876432    25899999999999999999999999999999999999952 112789999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhh------hHHHHH
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------KKQKYD  226 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~------~~~~~~  226 (423)
                      .........    ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.....      ....+.
T Consensus       160 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             cccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            876443221    1122345788999999988764 57899999999999999999999998644321      001111


Q ss_pred             HHHhhh--------------------------cCCc---H-HHhh--ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          227 KICEKK--------------------------VSTP---I-EVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       227 ~i~~~~--------------------------~~~~---~-~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++...                          ...+   . ....  ...+..+.+++.+||+.||++||++.+++.
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111100                          0000   0 0000  145678999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=293.22  Aligned_cols=245  Identities=22%  Similarity=0.341  Sum_probs=195.8

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ++||.|+||.||+|.+.. ++.||+|+......   ...+..|+++++.+.| +++..+..++......++||||+ +++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            478999999999999877 89999998765443   3458889999999986 55666767777888899999999 889


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                      |.+++......+++..++.++.|++.||.|||+++++||||||+|||+   +.++.++|+|||++..........     
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~-----  150 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV-----  150 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence            999887655678999999999999999999999999999999999999   478899999999997654221110     


Q ss_pred             CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........   + ......+.   ....|.+
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~-~~~~~~~~---~~~~~~~  223 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---I-ESGYRMPA---PQLCPEE  223 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---H-hcCCCCCC---CccCCHH
Confidence            0112234567999999998889999999999999999999 8999987554322222   1 11111111   2345889


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          248 FASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      +.+++.+||..+|++||++++|++.|+
T Consensus       224 ~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         224 IYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-38  Score=296.40  Aligned_cols=255  Identities=21%  Similarity=0.275  Sum_probs=202.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||.|+||+||+|.+..++..|++|++....   ....+.+|+++++.+.| +++..+.......+..+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-PNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC-CCEEEEEEEEeeCCEEEEEEe
Confidence            47999999999999999999998889999999886543   23458899999999987 455556666677889999999


Q ss_pred             cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ++ +++|.+++....  ..+++..+..++.||+.||.|||+.||+||||+|+||++   ++++.++|+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence            99 889999987542  468999999999999999999999999999999999999   467899999999998766543


Q ss_pred             CCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC-CcHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS-TPIE  238 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~  238 (423)
                      ....   .......|+..|+|||.+... .++.++|+|||||++|+|++|+.||......   +.+.+....... .+..
T Consensus       157 ~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~  230 (267)
T cd06610         157 DRTR---KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG  230 (267)
T ss_pred             cccc---cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence            2210   112345789999999998877 6899999999999999999999999865433   222222222111 1111


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....++..+.+++..||..||++||++++|++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111356789999999999999999999998865

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.4e-39  Score=301.13  Aligned_cols=240  Identities=18%  Similarity=0.243  Sum_probs=184.4

Q ss_pred             ceeeecCceeEEEEEECCCCc-------EEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527           13 RKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~-------~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +.||.|+||.||+|.+...+.       .|++|+......  .+.+..|+.+++.+.| +++..+..++......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH-KHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC-CChhheeeEEEeCCCcEEEEe
Confidence            469999999999999865443       388887654332  2457788899998876 556666666667788999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC-----CCcEEEeeccceeeec
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-----ANQVYIIDFGLAKKYR  157 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~-----~~~vkL~DFGla~~~~  157 (423)
                      |+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.     ...++|+|||++....
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            99 78999988765667899999999999999999999999999999999999962211     1247999999986543


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhC-CCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ..           ....++..|+|||.+.+. .++.++|||||||++|+|++| ..||.........    .+.......
T Consensus       160 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~----~~~~~~~~~  224 (258)
T cd05078         160 PK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL----QFYEDRHQL  224 (258)
T ss_pred             Cc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH----HHHHccccC
Confidence            21           235678899999999874 579999999999999999998 4666554332211    122222222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      +     ...+.++.++|.+||+.+|++||++++|++.|
T Consensus       225 ~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         225 P-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             C-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            2     23357899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.2e-38  Score=299.32  Aligned_cols=240  Identities=25%  Similarity=0.338  Sum_probs=183.8

Q ss_pred             eeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      .||+|+||.||+|.+..+++.||+|++.....     .....+|..++..+.  +++++..+..+....+..++||||+ 
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999998764321     122345555455443  3455666666666778899999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++........    
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~----  152 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP----  152 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc----
Confidence            7888887764 4569999999999999999999999999999999999999   5788999999999875543221    


Q ss_pred             cccCCCcccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          166 PYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                           ....|+..|+|||.+. +..++.++|||||||++|+|++|..||.......... ....   ....+ ..+...+
T Consensus       153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~---~~~~~-~~~~~~~  222 (279)
T cd05633         153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM---TLTVN-VELPDSF  222 (279)
T ss_pred             -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHH---hhcCC-cCCcccc
Confidence                 2346899999999987 4568999999999999999999999997644322221 1111   11111 1223456


Q ss_pred             hHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      +.++.++|.+||..||++||     +++++++
T Consensus       223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            88999999999999999999     4766644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=326.83  Aligned_cols=264  Identities=20%  Similarity=0.235  Sum_probs=190.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCC-cEEEEE------------------Eec-CCCCchhHHHHHHHHHHHcCCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVK------------------IEN-SGTKHPQLLYEAKVYKILQGGS   63 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~-~~vaiK------------------i~~-~~~~~~~~~~E~~~l~~l~~~~   63 (423)
                      .+.++|++++.||+|+||+||+|..+... ..+++|                  ... .......+.+|+.++..++| +
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H-p  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH-E  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC-C
Confidence            34578999999999999999998765322 112222                  111 11123347899999999987 5


Q ss_pred             CCCeEEEeeeeCCeeEEEEeccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec
Q 014527           64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG  139 (423)
Q Consensus        64 ~i~~i~~~~~~~~~~~lv~e~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~  139 (423)
                      ++..+..++...+..|++|++++++|.+++...    ........+..|+.||+.||.|||++|||||||||+|||+   
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---  300 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---  300 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence            566677777788889999999998888877532    1224467788999999999999999999999999999999   


Q ss_pred             CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh
Q 014527          140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA  219 (423)
Q Consensus       140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~  219 (423)
                      +.++.+||+|||+++.+......      ......||..|+|||++.+..++.++|||||||+||||++|..++......
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             CCCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            47889999999999876543221      112467999999999999999999999999999999999987654322211


Q ss_pred             hhHHHHHHHHhh------hcCC-------------------cHHH--hhccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          220 TKKQKYDKICEK------KVST-------------------PIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       220 ~~~~~~~~i~~~------~~~~-------------------~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      .....+.++...      .+..                   ....  ....++..+.++|.+||+.||.+||++.+++. 
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~-  453 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA-  453 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh-
Confidence            111222221110      0000                   0001  11235678889999999999999999999966 


Q ss_pred             HHHHHHh
Q 014527          273 FHDLFSR  279 (423)
Q Consensus       273 L~~~~~~  279 (423)
                       +.+|..
T Consensus       454 -hp~f~~  459 (501)
T PHA03210        454 -LPLFSA  459 (501)
T ss_pred             -Chhhhc
Confidence             455443

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-38  Score=295.30  Aligned_cols=252  Identities=19%  Similarity=0.281  Sum_probs=197.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      +|++.+.||.|+||.||+|.. .+++.+|+|.+.....        ...+.+|+.+++.++| +++..+..++.+....+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC-CCEeeEeeEeecCCeEE
Confidence            588999999999999999986 4688899998764321        1347889999999987 45666666667778999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++|||+ +++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||++   ++.+.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence            999999 8899988865 4568999999999999999999999999999999999999   5788999999999876532


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ...... .........|+..|+|||.+.+..++.++|||||||++|+|++|..||........   ...+...  ....+
T Consensus       155 ~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~--~~~~~  228 (265)
T cd06631         155 VGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYIGAH--RGLMP  228 (265)
T ss_pred             cccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HHHhhhc--cCCCC
Confidence            211100 00112245689999999999998899999999999999999999999976443221   1111111  11112


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....++.++.++|.+||..+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            233557889999999999999999999998864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-38  Score=297.00  Aligned_cols=249  Identities=18%  Similarity=0.249  Sum_probs=187.0

Q ss_pred             ceeeecCceeEEEEEECC--CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~--~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|....  ....+++|.+.....   ...+.+|+.+++.+.| +++..+...+......++||||+ +
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC-CCcceEEEEECCCCceEEEEEeCCC
Confidence            468999999999997543  345788997654332   2347789999998876 55556656666778899999999 7


Q ss_pred             CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           87 PSLEDLFVYCRR----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        87 ~sL~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ++|.+++.....    .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence            899999875432    24678889999999999999999999999999999999   57889999999998654322110


Q ss_pred             CcccccCCCcccccccccCcccccC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                           .......++..|+|||++..       ..++.++|||||||++|||++ |..||..........  ..+......
T Consensus       157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--~~~~~~~~~  229 (269)
T cd05042         157 -----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK--QVVREQDIK  229 (269)
T ss_pred             -----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH--HHhhccCcc
Confidence                 01123345778999998753       356889999999999999999 889998654332111  112222333


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      .+.+.....++..+.+++..|| .||++||++++|.+.|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            3334445567899999999999 5999999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.2e-38  Score=299.48  Aligned_cols=254  Identities=21%  Similarity=0.320  Sum_probs=203.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ...|+..+.||.|+||.||+|.+..++..||||++.....   ...+.+|+.+++.+.| ++++.+..++.+....++||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence            3568899999999999999999998899999998765432   3357889999999976 56666766777888999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++.  ...+++..+..++.|++.||+|||+.+++|+||+|+||++   +.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence            999 889998876  3568999999999999999999999999999999999999   4788999999999977643321


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......++..|+|||.+.+..++.++|+|||||++|||++|..||..........   .+.. ...   +...
T Consensus       157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~-~~~---~~~~  222 (277)
T cd06640         157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---LIPK-NNP---PTLT  222 (277)
T ss_pred             -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---hhhc-CCC---CCCc
Confidence                   1123467889999999998889999999999999999999999998754332111   1111 111   1222


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      ..+|..+.+++.+||..+|++||++++++.  ..++...+
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~  260 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK--HKFIVKNA  260 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHh--ChHhhhcc
Confidence            345789999999999999999999999966  34444433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.7e-38  Score=293.34  Aligned_cols=250  Identities=20%  Similarity=0.298  Sum_probs=198.9

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..+|++.+.||.|+||.||+|.+.. +..+|+|++.... ....+..|+++++.+.|+ ++..+..++......+++|||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHP-KLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCC-CeeeEEEEEccCCceEEEEEc
Confidence            3579999999999999999998854 6789999876543 345688999999999874 455566666677788999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|.+++......+++..++.++.|++.||+|||+.|++||||||+||++   +.++.++|+|||+++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCccc-
Confidence            9 789998887656678999999999999999999999999999999999999   47789999999999865432211 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                           ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   .....+... .....   ..
T Consensus       157 -----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-~~~~~---~~  224 (256)
T cd05112         157 -----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETINAG-FRLYK---PR  224 (256)
T ss_pred             -----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHhCC-CCCCC---CC
Confidence                 1123345678999999998889999999999999999998 99999764332   222222211 11111   12


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ..+..+.+|+.+||+.+|++||+++++++.|
T Consensus       225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            3478999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6e-38  Score=301.80  Aligned_cols=259  Identities=24%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeee-------C
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------G   75 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~-------~   75 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+.....    ...+.+|+.+++.+.|++.++.+..+...       .
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            579999999999999999999999999999998754322    22456899999999886555544433221       2


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++||||++++|.+++......+++.+++.++.||+.||+|||++|++|+||||+||++   +..+.+||+|||++..
T Consensus        92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~  168 (310)
T cd07865          92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARA  168 (310)
T ss_pred             ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCccc
Confidence            3469999999999999887655579999999999999999999999999999999999999   4788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc-
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-  233 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-  233 (423)
                      +........   .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.........+..+..... 
T Consensus       169 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         169 FSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             ccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            654332110   1112346788999999887654 78899999999999999999999987554333333333221100 


Q ss_pred             ---------------CCcH-------HHh-hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 ---------------STPI-------EVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ---------------~~~~-------~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                     ..+.       ..+ ....+..+.++|.+||..||++||+++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                           0000       000 0012456789999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-38  Score=298.28  Aligned_cols=240  Identities=15%  Similarity=0.184  Sum_probs=182.6

Q ss_pred             ceeeecCceeEEEEEECC------------CCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527           13 RKIGSGSFGEIFLASHVD------------TNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~------------~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +.||+|+||.||+|+...            ....|++|++.....  ...+..|+.++..+.| +++..+..++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence            468999999999998532            123589998765432  2346778888888887 5666677777777888


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC----CCCcEEEeeccce
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR----KANQVYIIDFGLA  153 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~----~~~~vkL~DFGla  153 (423)
                      +++|||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++...    ....++|+|||++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            9999999 6777777665556799999999999999999999999999999999999995211    1123899999998


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCccccc-CCCCCccchHHHHHHHHHHHH-hCCCCCCCchhhhhHHHHHHHHhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDIwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      ......           ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.........    .....
T Consensus       160 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~  224 (262)
T cd05077         160 ITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFYEG  224 (262)
T ss_pred             ccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHHhc
Confidence            654321           1346788999999887 466899999999999999998 589998764332211    11121


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ....     ....+.++.+||.+||+.||.+||++.+|++.|
T Consensus       225 ~~~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 QCML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CccC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1111     122367899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=301.00  Aligned_cols=287  Identities=43%  Similarity=0.682  Sum_probs=237.5

Q ss_pred             cCC-ceEEeceeeecCceeEEEEEECCCC-cEEEEEEecCCCCc--hhHHHHHHHHHHHc---CCCCCCeEEEee-eeCC
Q 014527            5 IGV-KYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTKH--PQLLYEAKVYKILQ---GGSGIPNIKWYG-VDGE   76 (423)
Q Consensus         5 ~~~-~y~i~~~Lg~G~fg~Vy~a~~~~~~-~~vaiKi~~~~~~~--~~~~~E~~~l~~l~---~~~~i~~i~~~~-~~~~   76 (423)
                      ... +|++.+.||+|+||.||.|.+..++ ..+|+|+.......  ..+..|..++..+.   +..+++.+...+ ....
T Consensus        15 ~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   15 KVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            344 8999999999999999999987764 67999987764332  26899999999998   457899999999 5788


Q ss_pred             eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC--CCCcEEEeeccce
Q 014527           77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLA  153 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~--~~~~vkL~DFGla  153 (423)
                      ..||||+++|.+|.++..... +.++..+++.|+.|++.+|++||+.|++||||||+|++++...  ....++|.|||+|
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            899999999999999987655 7899999999999999999999999999999999999997543  1257999999999


Q ss_pred             e--eecCCCCCCcccccC-CCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          154 K--KYRDPTTNRHIPYRE-NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       154 ~--~~~~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      +  .+.........+.+. ...+.||.+|++++++.+.+.+++.|+||+++++.+|+.|.+||.+.........+.+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            9  433332221233333 3456799999999999999999999999999999999999999988776555555554444


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                      ......   .+...|.++.+++..+-..++.++|++..+...|.+.+...+..++.+|||+...
T Consensus       255 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~  315 (322)
T KOG1164|consen  255 KLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKL  315 (322)
T ss_pred             hhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccc
Confidence            333322   3344578999999999999999999999999999999999999999999998654

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9e-39  Score=300.62  Aligned_cols=248  Identities=21%  Similarity=0.327  Sum_probs=199.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+.....   ...+.+|+++++.+.| +++..+..++......++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCC-CchhhhheeeecCCEEEEEEE
Confidence            468899999999999999999999999999998765432   3457889999999985 556666656667789999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++   ..+.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHHh
Confidence            99 589999988655789999999999999999999999 9999999999999994   688999999999876543221


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchh--hhhHHHHHHHHhhhcCCcHHH
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~  239 (423)
                               ....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  .........+.....    ..
T Consensus       157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~  223 (265)
T cd06605         157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----PR  223 (265)
T ss_pred             ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----CC
Confidence                     125688899999999998999999999999999999999999976421  111122222222111    11


Q ss_pred             hhcc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +... ++.++.++|.+||..+|++||++.+|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1111 5889999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.4e-38  Score=295.35  Aligned_cols=246  Identities=21%  Similarity=0.230  Sum_probs=201.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||+|+||.||++++..+++.||+|.+...    .....+.+|+.+++.++| +++..+..+....+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC-CCeeeeEeeecCCCeEEEEEe
Confidence            699999999999999999999999999999987643    223468889999999987 556667667777889999999


Q ss_pred             cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+|||+   +.++.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence            99 889999887533 358999999999999999999999999999999999999   4778999999999986644321


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                      .       .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||......   ..+..+.......    ..
T Consensus       157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~----~~  222 (256)
T cd08218         157 L-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVLKIIRGSYPP----VS  222 (256)
T ss_pred             h-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHHHHhcCCCCC----Cc
Confidence            1       12346788999999999988999999999999999999999999754332   3333333322211    22


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..++.++.++|.+||+.+|++||++.+|++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            455889999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.7e-38  Score=298.37  Aligned_cols=253  Identities=19%  Similarity=0.306  Sum_probs=201.5

Q ss_pred             CCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ..+|++.+.||.|+||.||+|+.+.     +.+.|++|........   ..+.+|+++++.++| +++..+..++.+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~   82 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREAEP   82 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCCCc
Confidence            3689999999999999999999754     3467999987654433   458899999999976 556667667777788


Q ss_pred             eEEEEecc-CCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEe
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      .++||||+ +++|.+++....        ..+++..++.++.||+.||+|||+.||+||||||+|||++   ..+.++|+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEEc
Confidence            99999999 789999987533        1589999999999999999999999999999999999994   78899999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~  227 (423)
                      |||++........      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ..+..
T Consensus       160 ~~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~  230 (275)
T cd05046         160 LLSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNR  230 (275)
T ss_pred             ccccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHH
Confidence            9999875432211      12224466788999999998889999999999999999998 88999764432   22333


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      +.......+.   ...+|..+.+++.+||+.+|++||++.+++..|.
T Consensus       231 ~~~~~~~~~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGKLELPV---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCcCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            3222222221   2345889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.8e-38  Score=293.36  Aligned_cols=248  Identities=25%  Similarity=0.388  Sum_probs=199.4

Q ss_pred             eEEeceeeecCceeEEEEEECCCC----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~----~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +++.+.||.|+||.||+|.+...+    ..||+|++.....   ...+..|+.++..+.| +++..+..++.+....+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH-PNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCeeEEE
Confidence            467899999999999999998766    8899999876553   4468899999999955 6666676666677889999


Q ss_pred             Eecc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||++ +++|.+++...... +++..+..++.||+.||+|||+.|++||||||+||++   +.++.++|+|||++......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence            9999 88999998764444 9999999999999999999999999999999999999   47789999999999876544


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ....     . ....++..|+|||.+.+..++.++|||||||++|+|++ |..||......   ..+..+..... .+  
T Consensus       157 ~~~~-----~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~~~~-~~--  224 (258)
T smart00219      157 DYYK-----K-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLKKGYR-LP--  224 (258)
T ss_pred             cccc-----c-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCC-CC--
Confidence            2211     1 12236789999999988889999999999999999998 88999764433   22222222221 11  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                       .....|.++.+++.+||..+|++||++.++++.|
T Consensus       225 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 -KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             1233688999999999999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.5e-38  Score=306.82  Aligned_cols=259  Identities=20%  Similarity=0.225  Sum_probs=196.0

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeee--------
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVD--------   74 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--------   74 (423)
                      ++++|++.+.||.|+||.||+|.+..+++.||+|.+....  ....+.+|+++++.++|++.+..+..+...        
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            4789999999999999999999999999999999875543  234578899999999876544443333221        


Q ss_pred             -----CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEee
Q 014527           75 -----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        75 -----~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                           ....++||||++++|.+++.  ...+++..++.++.||+.||.|||+.||+||||||+||+++  ..++.++|+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d  158 (342)
T cd07854          83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD  158 (342)
T ss_pred             ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence                 23578999999888888775  34699999999999999999999999999999999999995  3456899999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (423)
                      ||++...........    ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.............
T Consensus       159 fg~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         159 FGLARIVDPHYSHKG----YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             cccceecCCcccccc----ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999976543221110    1123357889999998764 45889999999999999999999999765433221111100


Q ss_pred             -------------------H---hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          229 -------------------C---EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       229 -------------------~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                         .   ......+.......++.++.+||.+||..||.+||++++|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                               0   011112222333456788999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.3e-38  Score=306.98  Aligned_cols=265  Identities=20%  Similarity=0.291  Sum_probs=202.4

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEE-ee---eeCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKW-YG---VDGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~-~~---~~~~   76 (423)
                      ++.+|++.+.||.|+||.||+|.+..+++.||+|++....    ....+.+|+.+++.+.|+ +++.+.. +.   ....
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD-NIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCC-CccCHHHhccccCCCCc
Confidence            4689999999999999999999999999999999876532    234577899999999864 4544432 22   2345


Q ss_pred             eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ..++||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        82 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          82 DVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL  157 (334)
T ss_pred             eEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence            6899999998888888764 4569999999999999999999999999999999999999   47899999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH-------
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI-------  228 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i-------  228 (423)
                      ........   .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...       
T Consensus       158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         158 SSSPTEHK---YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             cccCcCCC---cccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            44322110   11124578899999999876 45889999999999999999999999765432211111110       


Q ss_pred             ----------------HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          229 ----------------CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       229 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                      .......+...+....+.++.++|.+||+.+|++||++++++.  ..++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~--~~~~~~  299 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ--HPFLAQ  299 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh--Chhhhh
Confidence                            0111112223344567899999999999999999999998866  455543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=7e-38  Score=293.80  Aligned_cols=247  Identities=23%  Similarity=0.308  Sum_probs=198.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEee-eeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~-~~~~~~~lv~   82 (423)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.....    ...+..|+.+++.++|++.+..+..+. ......+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58999999999999999999999999999998764332    334778999999998855444333332 2445679999


Q ss_pred             ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH-----hcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVH-----SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        83 e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH-----~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ||+ +++|.+++...   ...+++..++.++.||+.||.|||     +.+++|+||||+||+++   ..+.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccccc
Confidence            999 78999998754   456899999999999999999999     89999999999999994   7899999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .........       .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......   .....+.....
T Consensus       158 ~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~  227 (265)
T cd08217         158 KILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIKEGKF  227 (265)
T ss_pred             ccccCCccc-------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHhcCCC
Confidence            876543321       12446899999999999988999999999999999999999999875422   22222222221


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                          ......++..+.+++.+||..+|++||++++|++
T Consensus       228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                1223456889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-38  Score=295.52  Aligned_cols=236  Identities=18%  Similarity=0.256  Sum_probs=185.3

Q ss_pred             ceeeecCceeEEEEEECCCC----------cEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527           13 RKIGSGSFGEIFLASHVDTN----------EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~----------~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.||+|+||.||+|.+..++          ..|++|+...... ...+.+|+.+++.+.|+ ++..+..++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHK-HLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCc-chhheeeEEec-CCcEEE
Confidence            47899999999999998766          3588887665443 56688999999999874 45555444444 678999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC-------cEEEeeccce
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-------QVYIIDFGLA  153 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~-------~vkL~DFGla  153 (423)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   ..+       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence            9999 8899998876555799999999999999999999999999999999999995   333       7999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCC--CCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      ......           ....++..|+|||.+.+.  .++.++|||||||++|+|++ |..||...........+    .
T Consensus       156 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~----~  220 (259)
T cd05037         156 ITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY----Q  220 (259)
T ss_pred             cccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH----h
Confidence            765431           133567789999999877  78999999999999999999 68888765432222211    1


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      .....+.     .....+.++|.+||..+|.+||++.+|++.|
T Consensus       221 ~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 DQHRLPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             cCCCCCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1111111     1136899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=293.63  Aligned_cols=255  Identities=19%  Similarity=0.209  Sum_probs=211.5

Q ss_pred             cCCceEEe-ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee----eCCeeE
Q 014527            5 IGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~-~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~----~~~~~~   79 (423)
                      +-.+|.+. ++||-|-.|.|-.+.++.+++.+|+|++...   +...+|+++.-....|++|+.|...+.    ....+.
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds---~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS---PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC---HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            34667766 5789999999999999999999999988643   456789998888888888877744432    345678


Q ss_pred             EEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           80 LVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      +|||++ ||.|...+...+ ..|++.++..|+.||..|+.|||+.+|.||||||+|+|++....+..+||+|||+|+...
T Consensus       136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            999999 999999988654 359999999999999999999999999999999999999877778899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHHhhhcCCc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTP  236 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~  236 (423)
                      ....        -.+.+-|+.|.|||++....|+...|+||+||++|-|++|.+||........ ...-.+|..+.+.+|
T Consensus       216 ~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  216 EPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             CCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            4332        2356789999999999999999999999999999999999999986544322 233345666777777


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++ +..+++..+++|+.+|..+|.+|.+++++.+
T Consensus       288 ~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  288 EPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             Chh-HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            554 4677899999999999999999999988865

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.9e-38  Score=295.35  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeEEEeeee--CCe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED   77 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~~   77 (423)
                      ..|++.+.||+|+||.||+|.+..++..|++|.+.....       ...+.+|+.+++.++|++ +..+..+...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER-IVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCC-eeeEEEEEEcCCCCE
Confidence            479999999999999999999999999999998754321       124778999999998754 4444443332  466


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .+++|||+ +++|.+++.. ...+++..++.++.||+.||+|||+.+|+||||||+||++   +.++.++|+|||+++..
T Consensus        81 ~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccc
Confidence            78999999 7899988875 4468999999999999999999999999999999999999   57889999999999765


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .......    .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......   +.+........   
T Consensus       157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~~~~---  226 (266)
T cd06651         157 QTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIATQPT---  226 (266)
T ss_pred             ccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhcCCC---
Confidence            4321110    0112346889999999999988999999999999999999999999865332   22222211111   


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .......+++.+.+++ .||..+|++||++++|++
T Consensus       227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1122234577889998 688899999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=295.17  Aligned_cols=252  Identities=21%  Similarity=0.258  Sum_probs=195.9

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCe-----
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGED-----   77 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~-----   77 (423)
                      |++.+.||+|+||.||+|++..+++.||+|++.....    ...+.+|+.+++.+.  .++++..+..++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7899999999999999999988899999998864332    224667888888775  24566666666655555     


Q ss_pred             eEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .+++||++.++|.+++.... ..+++..++.++.||+.||.|||+.+++|+||+|+||++   +.++.+||+|||++..+
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence            89999999889999887543 358999999999999999999999999999999999999   46799999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh------
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------  230 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~------  230 (423)
                      ......        ....++..|+|||.+.+..++.++|||||||++|+|++|..||.+....+....+.....      
T Consensus       158 ~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         158 SFEMAL--------TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             cCCccc--------ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence            433211        133578899999999998999999999999999999999999987554322222211100      


Q ss_pred             -------------hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 -------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 -------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   .............++..+.++|.+||+.||++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                         00011112222345678899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.5e-38  Score=306.65  Aligned_cols=255  Identities=21%  Similarity=0.245  Sum_probs=196.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----   75 (423)
                      +.++|++.+.||+|+||.||+|++..+++.||||.+...    .....+.+|+.+++.++|++ +..+..+....     
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~~~~~~~~~~~~~~   81 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN-VIAIKDIMPPPHREAF   81 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCC-ccchHHheeccccccc
Confidence            568999999999999999999999999999999987542    12335778999999998754 44443332221     


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...+++|||++++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+||++   +.++.+||+|||+++.
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          82 NDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLART  157 (337)
T ss_pred             CcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCccccc
Confidence            35799999999999888764 4579999999999999999999999999999999999999   4788999999999986


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh---
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---  231 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---  231 (423)
                      ......       ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+......   
T Consensus       158 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         158 TSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             cCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            643321       1124467889999998875 45889999999999999999999999764332211111111100   


Q ss_pred             --------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 --------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          ....+.......+++++.++|.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~  290 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA  290 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence                                0011112233467889999999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=292.56  Aligned_cols=261  Identities=23%  Similarity=0.301  Sum_probs=216.9

Q ss_pred             eEEe-ceeeecCceeEEEEEECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            9 YKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         9 y~i~-~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~--~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      |++. +.||+|+|+.|--+....++..||||++.+...+  .++.+|++++...++|.+|..+..|+.++..+|||||-+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence            4443 5789999999999999999999999998876543  458999999999999999999988899999999999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       ||+|...+.+ ++.|++.++..+..+|+.||.|||.+||.||||||+|||....+.-.-||||||.++...........
T Consensus       159 ~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  159 RGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             cCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence             9999998876 56799999999999999999999999999999999999997555556799999998865443322221


Q ss_pred             ccccCCCcccccccccCccccc---CC--CCCccchHHHHHHHHHHHHhCCCCCCCchhh------------hhHHHHHH
Q 014527          165 IPYRENKNLTGTARYASCNTHL---GI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------------TKKQKYDK  227 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~---~~--~~s~~sDIwSlGvil~elltG~~Pf~~~~~~------------~~~~~~~~  227 (423)
                      .....-.+.+|+..|||||+..   +.  .|+.+.|+||||||||.|+.|.+||.+.-..            -....+..
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence            1111234668999999999764   32  3899999999999999999999999874322            24566778


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      |.++++.+|... +..++.+.++++..+|..++.+|.++.+++.
T Consensus       318 IQEGkYeFPdkd-WahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  318 IQEGKYEFPDKD-WAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HhccCCcCChhh-hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            888888888554 5678999999999999999999998887755

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-37  Score=291.88  Aligned_cols=249  Identities=26%  Similarity=0.359  Sum_probs=205.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||.|++|.||+|.+..+++.|+||++.....   ...+..|+..+..++| +++..+..+.......+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccCCeEEEEEE
Confidence            468999999999999999999999999999998876543   4568899999999985 566667666777789999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||+ .|++||||+|+||++   +.++.++|+|||++........
T Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence            99 6999999875 3679999999999999999999999 999999999999999   4789999999999987654332


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                      .       .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........+....+.....    ....
T Consensus       156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~  224 (264)
T cd06623         156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP  224 (264)
T ss_pred             c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence            1       1244678999999999998899999999999999999999999987542222333333332211    1222


Q ss_pred             cc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KS-HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~-~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .. ++..+.++|..||..+|++||++.+|++
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            33 6889999999999999999999999977

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=297.39  Aligned_cols=252  Identities=20%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|++.+.||.|+||.||+|.+..+++.||+|++....   ....+.+|+.+++.+.  .++++..+..++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5889999999999999999999999999999876532   2345788999999997  2455555666667788899999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++..  ..+++..++.++.|++.||.|||+.||+|+||+|+||+++   ..+.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCcc
Confidence            999 8899888753  4789999999999999999999999999999999999994   688999999999987654432


Q ss_pred             CCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .       .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.....   ....+.. .  .+....
T Consensus       157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~-~--~~~~~~  223 (277)
T cd06917         157 K-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMMLIPK-S--KPPRLE  223 (277)
T ss_pred             c-------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhcccc-C--CCCCCC
Confidence            1       124468899999999875 447899999999999999999999998644321   1111111 1  111111


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...++.++.+++..||..||++||++.+++.  ..++.+
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~  260 (277)
T cd06917         224 DNGYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKA  260 (277)
T ss_pred             cccCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhc
Confidence            1236889999999999999999999999966  455543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.3e-38  Score=292.20  Aligned_cols=245  Identities=25%  Similarity=0.356  Sum_probs=198.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +|+..+.||+|+||.||+|.+..+++.|++|.+....       ....+.+|+.+++.++| +++..+..+.......++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecCCeEEE
Confidence            5888999999999999999998889999999875433       23457889999999976 556666667777788999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||++   +.++.+||+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence            99999 7899988865 3468999999999999999999999999999999999999   47889999999998775433


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ..        .....++..|+|||.+.... ++.++|+|||||++|+|++|..||......   .....+....   ...
T Consensus       156 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~---~~~  221 (258)
T cd06632         156 SF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFKIGRSK---ELP  221 (258)
T ss_pred             cc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHHHHhcc---cCC
Confidence            21        12456889999999998776 899999999999999999999999765422   2222221111   111


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....+++.+.+++.+||+.+|++||++++++.
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            223456789999999999999999999998864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-37  Score=292.23  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=192.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeEEEeeee--CCe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED   77 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~~   77 (423)
                      .+|++.+.||+|+||.||+|.+..+++.||||.+.....       ...+.+|+.+++.+.|++ +..+..+..+  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER-IVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCC-eeeEEeEeccCCCce
Confidence            579999999999999999999999999999998753221       124678999999998744 4445444433  356


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .+++|||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+|+||||+|||+   +.++.++|+|||+++..
T Consensus        81 ~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccc
Confidence            78999999 7899988765 3568999999999999999999999999999999999999   47889999999999865


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .......    .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......   ..+.++......  
T Consensus       157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~--  227 (265)
T cd06652         157 QTICLSG----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTN--  227 (265)
T ss_pred             ccccccc----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHHHHhcCCCC--
Confidence            4321110    1122456889999999999888999999999999999999999999865322   222222211111  


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       .......+..+.++|.+||. +|++||++++|++
T Consensus       228 -~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         228 -PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             11223446789999999994 9999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-38  Score=304.01  Aligned_cols=247  Identities=19%  Similarity=0.304  Sum_probs=194.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|.....||+|+||.||++.+..++..||||.+....  ....+.+|+.+++.++|+ ++..+..++...+..++||||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~-~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE-NVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCC-cHHHHHHheecCCeEEEEEeC
Confidence            44566778999999999999998889999999875432  234578899999999874 454555555677889999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++........  
T Consensus       101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~--  173 (292)
T cd06658         101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP--  173 (292)
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence            9 778888764  3468999999999999999999999999999999999999   4778999999999875533221  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                           ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........   +..+.. ...... .....
T Consensus       174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~-~~~~~~-~~~~~  243 (292)
T cd06658         174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIRD-NLPPRV-KDSHK  243 (292)
T ss_pred             -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-cCCCcc-ccccc
Confidence                 11245689999999999988899999999999999999999999986543322   222211 111111 11124


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+..+.+++..||..||.+||+++++++
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            5788999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.4e-37  Score=301.22  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ....|+..+.||+|+||.||+|++..++..||+|++.....     ...+..|+++++.++| +++..+..++.+....+
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~  101 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLREHTAW  101 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCeEE
Confidence            34568899999999999999999998999999998764321     2357789999999986 45556666667788899


Q ss_pred             EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +||||+.++|.+++......+++..+..++.||+.||.|||++||+||||+|+||++   +.++.++|+|||++......
T Consensus       102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc
Confidence            999999889998887667779999999999999999999999999999999999999   47889999999998654321


Q ss_pred             CCCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                                 ....|+..|+|||.+.   +..++.++|||||||++|+|++|..||......   ..+..+........
T Consensus       179 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~  244 (317)
T cd06635         179 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPTL  244 (317)
T ss_pred             -----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhccCCCC
Confidence                       2446888999999974   445889999999999999999999999765332   22222222221111


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                         ....++..+.+++.+||+.+|.+||++.+|++...
T Consensus       245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             ---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence               11345788999999999999999999999977443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=296.33  Aligned_cols=252  Identities=21%  Similarity=0.236  Sum_probs=196.1

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      |++.+.||.|++|.||+|.+..++..||+|++....    ....+.+|+++++.++| ++++.+..++.+....+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC-CCccCHhheeccCCeEEEEEec
Confidence            678999999999999999999899999999876543    22457889999999987 4555565566677899999999


Q ss_pred             cCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 LGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      ++++|.+++.... ..+++..++.++.|++.||+|||+++++||||+|+||+++   .++.++|+|||++........  
T Consensus        80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc--
Confidence            9889999887533 3689999999999999999999999999999999999994   688999999999975533211  


Q ss_pred             cccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH-------------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-------------  229 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~-------------  229 (423)
                           ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.+..             
T Consensus       155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence                 11233568899999988764 47899999999999999999999998654322111111100             


Q ss_pred             --------hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 --------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 --------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                              ..............++..+.++|.+||+.+|++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    000011112233556789999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.4e-38  Score=305.66  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeee--eC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DG   75 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~--~~   75 (423)
                      +..+.++|++.+.||+|+||.||+|.+..+++.||||.+...    .....+.+|+.++..+.+++++..+..++.  +.
T Consensus         2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            556789999999999999999999999888999999976432    233457789999999933455555544433  34


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++||||+.++|..++..  ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++..
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~  156 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARS  156 (337)
T ss_pred             ceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence            46899999998899888764  378899999999999999999999999999999999999   5789999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH-----
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-----  229 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~-----  229 (423)
                      .........  ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+....     
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         157 LSELEENPE--NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             ccccccccc--CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            654332110  011224568999999998865 457899999999999999999999997654332222211110     


Q ss_pred             ------------------hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 ------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                        ......+.....+.++.++.++|.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                              001111222333456889999999999999999999999876

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=318.47  Aligned_cols=243  Identities=22%  Similarity=0.285  Sum_probs=198.8

Q ss_pred             eeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCHH
Q 014527           14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE   90 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~   90 (423)
                      .||+|.||+||-|++..+...+|||-+...  ...+-+..|+.+.+.|+|.+++..+.. ...++.+-|.||-+ ||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs-~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGS-VSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhc-cCCCCeEEEEeecCCCCcHH
Confidence            589999999999999999999999965433  233448899999999998665544444 44556778999999 99999


Q ss_pred             HHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           91 DLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        91 ~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                      +++...-+++  .+.++-.+..||++||.|||...|||||||-+|+|+.  .-.|.+||+|||.++.+..-..       
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP-------  731 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP-------  731 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-------
Confidence            9998766677  8899999999999999999999999999999999996  4578999999999988754432       


Q ss_pred             CCCcccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          169 ENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                      ...++.||..|||||++..++  |+.++|||||||++.||.||++||..+...  ...+.++...+..++++.   .++.
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmyKvHP~iPe---elsa  806 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMYKVHPPIPE---ELSA  806 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcceecCCCCcH---HHHH
Confidence            235889999999999998654  899999999999999999999999876433  223334433444444433   4488


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +.+.||.+|+..+|.+||++.+|+.
T Consensus       807 eak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  807 EAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHcCCCcccCccHHHhcc
Confidence            9999999999999999999998854

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.5e-38  Score=296.69  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=191.7

Q ss_pred             ceeeecCceeEEEEEECCCC------cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527           13 RKIGSGSFGEIFLASHVDTN------EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~------~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +.||+|+||.||+|++....      +.||||.+....   ....+.+|+.+++.+.|+ ++..+..++......+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHP-NIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCC-CeeeEeeeecCCCCeEEEEe
Confidence            46899999999999986543      679999765443   344688999999999874 45556556667778999999


Q ss_pred             cc-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC--CCCcEEEeecccee
Q 014527           84 LL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAK  154 (423)
Q Consensus        84 ~~-~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~--~~~~vkL~DFGla~  154 (423)
                      |+ +++|.+++...      ...+++..++.++.||+.||.|||+++++|+||||+||+++..+  ....++|+|||+++
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99 88999988642      13478899999999999999999999999999999999995211  12289999999997


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      ........     .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ....+.... 
T Consensus       160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~-  230 (269)
T cd05044         160 DIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVTAGG-  230 (269)
T ss_pred             cccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHhcCC-
Confidence            65433211     11223356788999999999999999999999999999998 999997654332   222221111 


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      ..   .....+|..+.++|.+||..+|.+||++++|.+.|+
T Consensus       231 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11   112345889999999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-37  Score=294.41  Aligned_cols=251  Identities=27%  Similarity=0.401  Sum_probs=198.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +|.+.+.||.|+||.||+|.+..+++.||||.++....            .+.+..|+.++..++| ++++.+..++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence            68999999999999999999988899999997653211            1246789999999987 5566666677788


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      +..++||||+ +++|.+++... ..++...+..++.||+.||.|||++|++||||+|+||++   +.++.++|+|||+++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~  156 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK  156 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence            8999999999 88999988764 578999999999999999999999999999999999999   478899999999997


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      .........     ......|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||......   +.+..+....
T Consensus       157 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~  228 (272)
T cd06629         157 KSDDIYDND-----QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKR  228 (272)
T ss_pred             ccccccccc-----ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhccc
Confidence            654321111     112456889999999988655  789999999999999999999999754332   2222222221


Q ss_pred             cCCc-HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTP-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .... .......++..+.++|.+||..+|++||++++|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111 12233456889999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-37  Score=299.13  Aligned_cols=259  Identities=22%  Similarity=0.285  Sum_probs=200.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC---
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG---   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~---   75 (423)
                      .+..++|++.+.||+|+||.||+|.+..+++.||||+++....    ...+.+|+.+++.++|++ +..+..++.+.   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~-i~~~~~~~~~~~~~   81 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN-IVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCC-eeeeeheecCcchh
Confidence            4556889999999999999999999999999999998865432    234678999999998754 44444433332   


Q ss_pred             -------CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEe
Q 014527           76 -------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        76 -------~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                             ...++++||+++++..++......+++..++.++.||+.||.|||+.||+||||||+||++   ++.+.+||+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~  158 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA  158 (302)
T ss_pred             hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence                   3789999999888888887655579999999999999999999999999999999999999   478899999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      |||++.........      ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+..
T Consensus       159 dfg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~  232 (302)
T cd07864         159 DFGLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR  232 (302)
T ss_pred             cccccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            99999876543211      11133567889999988754 478899999999999999999999986554433333333


Q ss_pred             HHhhhcC----------------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          228 ICEKKVS----------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       228 i~~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+.....                      ......+..+|..+.+++..||..+|++||++++|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2221110                      0111223356899999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-37  Score=301.88  Aligned_cols=257  Identities=19%  Similarity=0.271  Sum_probs=196.3

Q ss_pred             ceEEeceeeecCceeEEEEEECCC--CcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee----eCCe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGED   77 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~--~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~----~~~~   77 (423)
                      +|++.+.||+|+||.||+|++..+  +..||||.+....    ....+.+|+.+++.+.++++++.+..+..    ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999877  8899999876432    23457889999999976667766654432    2345


Q ss_pred             eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      .+++|++++++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence            789999999999988864 5579999999999999999999999999999999999999   478899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH-------
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-------  229 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~-------  229 (423)
                      .......   .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||................       
T Consensus       157 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         157 ENPGENA---GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ccccccc---ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            4322110   11224578999999998776 468999999999999999999999997644322111111100       


Q ss_pred             -----h-----------hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 -----E-----------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 -----~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                           .           .....+........+..+.+++.+||+.||.+||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 0           00111122233445788999999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.4e-38  Score=297.81  Aligned_cols=239  Identities=17%  Similarity=0.238  Sum_probs=183.8

Q ss_pred             eeeecCceeEEEEEECCC------------------------CcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCe
Q 014527           14 KIGSGSFGEIFLASHVDT------------------------NEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPN   67 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~------------------------~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~   67 (423)
                      .||+|+||.||+|....+                        ...|++|++.....  ...+..|+.+++.+.| ++++.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence            699999999999975321                        23588898764332  2346778888888876 66777


Q ss_pred             EEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec----CCC
Q 014527           68 IKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----RKA  142 (423)
Q Consensus        68 i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~----~~~  142 (423)
                      +..++......++||||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++..    ...
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            777788888999999999 788888876656679999999999999999999999999999999999999521    112


Q ss_pred             CcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHH-hCCCCCCCchhhh
Q 014527          143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT  220 (423)
Q Consensus       143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~ell-tG~~Pf~~~~~~~  220 (423)
                      ..+||+|||++.......           ...++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus       161 ~~~kl~d~g~~~~~~~~~-----------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         161 PFIKLSDPGVSFTALSRE-----------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ceeeecCCcccccccccc-----------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            358999999986432211           2356788999998875 55899999999999999985 6999998754332


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ...    ........+     ...++.+.++|.+||+.+|++||++.+|++.|
T Consensus       230 ~~~----~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KER----FYEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHH----HHHhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            221    222222222     12356899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-37  Score=295.70  Aligned_cols=253  Identities=21%  Similarity=0.270  Sum_probs=194.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEee-eeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~-~~~~~~~lv~   82 (423)
                      ++|+..+.||.|++|.||+|.+..+++.||+|++.....   ...+.+|+++++.+.|++.+..+..+. ......++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            479999999999999999999999999999998775432   345889999999998755444333332 2345689999


Q ss_pred             ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           83 DLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        83 e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||+ +++|.+++..   ....+++..+..++.||+.||.|||+.|++|+||+|+||++   +..+.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccccc
Confidence            999 8899888653   23458999999999999999999999999999999999999   4778899999999875533


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchh--hhhHHHHHHHHhhhcCCc
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~  236 (423)
                      ...         ....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ....+....+........
T Consensus       158 ~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd06621         158 SLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL  228 (287)
T ss_pred             ccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence            221         134578899999999998999999999999999999999999986522  111222222221111100


Q ss_pred             HHHh--hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....  ...+++.+.++|.+||..+|++||++.+|++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0000  0124678999999999999999999998876

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.4e-38  Score=295.85  Aligned_cols=244  Identities=28%  Similarity=0.346  Sum_probs=198.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....     ....+.+|+++++.++| +++..+..+.......++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCCCeEEEEE
Confidence            5899999999999999999999899999999876432     23468889999999987 45555555566778899999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++   ++++.++|+|||++........
T Consensus        80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc
Confidence            999 88999888753 579999999999999999999999999999999999999   5788999999999877644321


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                              .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.................     ......
T Consensus       156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~  222 (258)
T cd05578         156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLYP  222 (258)
T ss_pred             --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccCc
Confidence                    1245688899999999988899999999999999999999999987554222222222111     112223


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCCh--HHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDY--GFL  269 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~--~~l  269 (423)
                      ..+|..+.++|.+||..||.+||++  +++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l  252 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDL  252 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHH
Confidence            4568999999999999999999999  544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2e-37  Score=292.47  Aligned_cols=247  Identities=21%  Similarity=0.260  Sum_probs=192.0

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      .....||+|+||.||+|.+..++..|++|.......  ...+.+|+.+++.++| +++..+..++...+..++++||+ +
T Consensus        11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH-RNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeccCCEEEEEEecCCC
Confidence            344689999999999999998999999998765432  3458899999999987 45556666677788999999999 7


Q ss_pred             CCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           87 PSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        87 ~sL~~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      ++|.+++......+  +...+..++.||+.||.|||++||+||||||+||+++  ...+.++|+|||++........   
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~---  164 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP---  164 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC---
Confidence            89999887644455  8889999999999999999999999999999999994  2367899999999876543221   


Q ss_pred             ccccCCCcccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                          ......++..|+|||.+.+..  ++.++||||||+++|+|++|..||........  ...........   .....
T Consensus       165 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~---~~~~~  235 (268)
T cd06624         165 ----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKIH---PEIPE  235 (268)
T ss_pred             ----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhccC---CCCCc
Confidence                112346789999999987644  78899999999999999999999976432211  11111100111   11224


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+++++.+++.+||+.+|++||++.+|+.
T Consensus       236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            45789999999999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=292.99  Aligned_cols=242  Identities=22%  Similarity=0.356  Sum_probs=191.5

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||.|+||.||+|.+..+++.||||++.....     ...+..|..++.....++++..+..++...+..+++|||+ +
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            579999999999999998999999998764321     1224455555555545577777777777888999999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+||++   +..+.++|+|||++.....        
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~--------  149 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE--------  149 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc--------
Confidence            899998875 4568999999999999999999999999999999999999   4788999999999875432        


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChH
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA  246 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (423)
                         .....++..|+|||.+.+..++.++||||||+++|+|++|..||......   +.+..+.......+. .....++.
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~  222 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNILSRRINWPE-EVKEFCSP  222 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcccCCCC-cccccCCH
Confidence               12446788999999999888999999999999999999999999765433   333333333322221 12235689


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          247 EFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       247 ~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      ++.++|.+||+.+|++||++..+.+++
T Consensus       223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         223 EAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            999999999999999999876665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-37  Score=294.00  Aligned_cols=243  Identities=19%  Similarity=0.307  Sum_probs=190.8

Q ss_pred             CceEEecee--eecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKI--GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~L--g~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++|++.+.+  |+|+||.||++....+++.+|+|+.......   ..|+.....+.+++++..+..++...+..++||||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~   90 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY   90 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence            567777776  9999999999999999999999987653221   12344444455567787787777788899999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC-cEEEeeccceeeecCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~  162 (423)
                      + +++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||++.   ..+ .++|+|||++.......  
T Consensus        91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~~--  164 (267)
T PHA03390         91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTPS--  164 (267)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCCc--
Confidence            9 88999998753 4799999999999999999999999999999999999995   555 89999999987654321  


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                               ...++..|+|||++.+..++.++|||||||++|+|++|..||.........  ........ ..+ ....+
T Consensus       165 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~-~~~-~~~~~  231 (267)
T PHA03390        165 ---------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ-QKK-LPFIK  231 (267)
T ss_pred             ---------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh-ccc-CCccc
Confidence                     346889999999999989999999999999999999999999854322110  11111111 111 12223


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCC-hHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPD-YGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt-~~~l~~  271 (423)
                      .+++.+.++|.+||+.+|.+||+ ++++++
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            56899999999999999999995 587764

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=295.76  Aligned_cols=252  Identities=23%  Similarity=0.276  Sum_probs=200.9

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      |++.+.||.|++|.||+|.+..+++.+++|.+.....    ...+..|+.+++.++| +++..+..+..+....+++|||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccCCCEEEEEec
Confidence            6788999999999999999988999999998765432    3457889999999985 5666666666677899999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      +.++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++   +.++.++|+|||.+........   
T Consensus        80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~---  153 (283)
T cd05118          80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR---  153 (283)
T ss_pred             cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc---
Confidence            9889999888766789999999999999999999999999999999999999   4778999999999987654431   


Q ss_pred             ccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh------------
Q 014527          165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------------  231 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------------  231 (423)
                          ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+...........            
T Consensus       154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence                11234678899999999877 6899999999999999999999999765443222221111000            


Q ss_pred             ----------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 ----------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                ............++.++.++|..||..||.+||++.+|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      0011112233456889999999999999999999998865

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=322.57  Aligned_cols=261  Identities=18%  Similarity=0.290  Sum_probs=219.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~---~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      |-....+|.+.||.|.||+|++|+.+..+   ..||||.++....   ...|+.|+.||-++.| ++|..+.........
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSKP  704 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCce
Confidence            33455689999999999999999988655   4599999987643   3359999999999998 556667777778888


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ..||+||| .|+|..+|....+.|+..+..-+++.|+.|++||-+.|+|||||..+|||+   +.+-.+|++|||+++.+
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeec
Confidence            99999999 999999999888899999999999999999999999999999999999999   58889999999999988


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .+.....   | ......-..+|.|||.+.-..++.++|||||||+|||.++ |..||.++++.+...    -++..+..
T Consensus       782 edd~~~~---y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk----aIe~gyRL  853 (996)
T KOG0196|consen  782 EDDPEAA---Y-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK----AIEQGYRL  853 (996)
T ss_pred             ccCCCcc---c-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH----HHHhccCC
Confidence            6654211   1 1112233579999999999999999999999999999876 999999987754333    33455556


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      |.+.-|   |..+.+||..||++|-.+||.|.+|+..|++++..
T Consensus       854 PpPmDC---P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  854 PPPMDC---PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             CCCCCC---cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            655545   99999999999999999999999999999998854

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-38  Score=300.10  Aligned_cols=245  Identities=22%  Similarity=0.299  Sum_probs=197.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++.....   ...+.+|+.+++.+.| ++++.+..++......++|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccCCceEEEEE
Confidence            467888999999999999999988899999998764432   2357889999999986 556666666667788999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++.  ...+++..+..++.||+.||.|||++|++|+||+|+||+++   .++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcch-
Confidence            99 778888775  45689999999999999999999999999999999999994   778999999999976543221 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                            ......++..|+|||.+.+..++.++|||||||++|||++|..||.........   ..+.... .   ..+..
T Consensus       157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~-~---~~~~~  223 (277)
T cd06642         157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPKNS-P---PTLEG  223 (277)
T ss_pred             ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhhcCC-C---CCCCc
Confidence                  112346788999999999988999999999999999999999999764432211   1111111 1   11223


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+..+.+++.+||..+|++||++.+|+.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            45788999999999999999999999977

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.9e-38  Score=292.02  Aligned_cols=247  Identities=23%  Similarity=0.291  Sum_probs=198.3

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||.|+||.||+|.+..++..||+|.+...    .....+.+|+.+++.++|+ ++..+..+.......++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~-~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP-NIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCC-ChhhhhheeccCCeEEEEEe
Confidence            589999999999999999999999999999987643    2344678999999999874 55555556667788999999


Q ss_pred             cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++.... ..+++..+..++.||+.||.|||+.+++|+||||+||+++  ++...++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence            99 889999886533 3589999999999999999999999999999999999995  2334679999999977644321


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                      .       .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||......   +.+..+......    ...
T Consensus       158 ~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~----~~~  223 (257)
T cd08225         158 L-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QLVLKICQGYFA----PIS  223 (257)
T ss_pred             c-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhcccCC----CCC
Confidence            1       12346889999999999888999999999999999999999999764332   222223222211    122


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..++.++.++|.+||..+|++||++.+|++
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            456789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-37  Score=301.77  Aligned_cols=266  Identities=20%  Similarity=0.257  Sum_probs=200.8

Q ss_pred             CCcccCCceEE-eceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----------------hhHHHHHHHHHHHcCCC
Q 014527            1 MERIIGVKYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------PQLLYEAKVYKILQGGS   63 (423)
Q Consensus         1 ~~~i~~~~y~i-~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----------------~~~~~E~~~l~~l~~~~   63 (423)
                      |..-+.++|.. .+.||.|+||+||+|.+..+++.||||++......                ..+.+|++++..+.| +
T Consensus         2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~   80 (335)
T PTZ00024          2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-E   80 (335)
T ss_pred             CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-c
Confidence            34456778864 57799999999999999989999999987643322                146789999999987 4


Q ss_pred             CCCeEEEeeeeCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC
Q 014527           64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN  143 (423)
Q Consensus        64 ~i~~i~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~  143 (423)
                      ++..+..++...+..+++|||+.++|.+++.. ...+++..+..++.||+.||+|||++||+||||+|+||++   +..+
T Consensus        81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~  156 (335)
T PTZ00024         81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG  156 (335)
T ss_pred             ceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence            55566666677889999999998899998864 4569999999999999999999999999999999999999   4788


Q ss_pred             cEEEeeccceeeecCCCCCCccc-------ccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIP-------YRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG  215 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~  215 (423)
                      .++|+|||++.............       ........++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999998765221110000       00111335688999999987654 68999999999999999999999987


Q ss_pred             chhhhhHHHHHHHHhhhc--------------------CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          216 LKAATKKQKYDKICEKKV--------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       216 ~~~~~~~~~~~~i~~~~~--------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .........+........                    ...........+..+.++|.+||+.+|++||++++++.
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            554322222211111000                    00011122345788999999999999999999999865

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=301.24  Aligned_cols=266  Identities=21%  Similarity=0.306  Sum_probs=211.4

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCC-----CCCeEEEeeeeC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWYGVDG   75 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~-----~i~~i~~~~~~~   75 (423)
                      ++++.++|++.+.+|+|.||.|-.+.+..++..|||||++.-.. .+..+-|+++++++.+..     -+..+..++...
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            56788999999999999999999999999999999999876543 344678999999995432     223335556678


Q ss_pred             CeeEEEEeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC--------------
Q 014527           76 EDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--------------  140 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~--------------  140 (423)
                      +..|||+|.+|.++.+++... -..++...+..++.|++.+++|||+.+++|-||||+|||+..++              
T Consensus       164 ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  164 GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            899999999999999999753 34699999999999999999999999999999999999995221              


Q ss_pred             ---CCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCch
Q 014527          141 ---KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK  217 (423)
Q Consensus       141 ---~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~  217 (423)
                         ....|+|+|||.|..-.+..          ...+.|..|.|||++.|-.++..+||||+||||+||++|...|+...
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             ccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence               14468999999998755443          26788999999999999999999999999999999999999999877


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHh----------------------------hc----------cChHHHHHHHHHHhcCC
Q 014527          218 AATKKQKYDKICEKKVSTPIEVL----------------------------CK----------SHPAEFASYFHYCQSLT  259 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~----------~~~~~l~~li~~cl~~d  259 (423)
                      +.+....+++|++.....-+...                            |+          .--.++.+||+.||..|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            66655566655442111000000                            00          00235899999999999


Q ss_pred             CCCCCChHHHHHHHHHHHHh
Q 014527          260 FDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       260 P~~RPt~~~l~~~L~~~~~~  279 (423)
                      |.+|+|+.|.+.  +.+|..
T Consensus       394 P~~RiTl~EAL~--HpFF~~  411 (415)
T KOG0671|consen  394 PARRITLREALS--HPFFAR  411 (415)
T ss_pred             ccccccHHHHhc--CHHhhc
Confidence            999999998854  565543

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-37  Score=292.98  Aligned_cols=250  Identities=20%  Similarity=0.340  Sum_probs=197.8

Q ss_pred             ceEEeceeeecCceeEEEEEECC-CCcEEEEEEecCCC------------CchhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT------------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~-~~~~vaiKi~~~~~------------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....            ....+..|+.++.....++++..+..++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 67889999765321            112356777777764445667777777778


Q ss_pred             CCeeEEEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                      ....+++|||+ +++|.+++..   ....+++..++.++.|++.||.|||+ .|++|+||+|+|||+   +..+.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence            88999999999 7899888753   24468999999999999999999996 789999999999999   4788999999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      ||++........        .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......   .....+.
T Consensus       158 fg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~  226 (269)
T cd08528         158 FGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKIV  226 (269)
T ss_pred             ccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHHh
Confidence            999987544321        12456889999999999988999999999999999999999999764332   2222232


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      ..... +..  ...+++.+.++|.+||+.||++||++.++...+.
T Consensus       227 ~~~~~-~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EAVYE-PLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hccCC-cCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            32222 111  1245789999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=315.22  Aligned_cols=250  Identities=20%  Similarity=0.260  Sum_probs=203.9

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC-C--cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT-N--EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~-~--~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .++.++.++||+|.||.|++|.|... |  ..||||+++.+..   ...|++|+.+|.+|+| +++..++....+ ....
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H-~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH-PHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC-cceeEEeeeecc-chhh
Confidence            45567889999999999999999743 2  3599999887654   3569999999999998 444444433333 6788


Q ss_pred             EEEecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           80 LVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ||||++ .|+|.+.+.. .+..|-......++.|||.||.||.++++|||||..+|+|+.   ....|||+|||+.+.+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccC
Confidence            999999 9999999987 445688899999999999999999999999999999999994   67899999999999887


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .....    |.......-...|+|||.+.-..++.++|||+|||++|||++ |+.||.+.......+.++    .+...+
T Consensus       264 ~ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----~~erLp  335 (1039)
T KOG0199|consen  264 ENEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----AGERLP  335 (1039)
T ss_pred             CCCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----ccccCC
Confidence            65442    222334445678999999999999999999999999999999 999999987765444443    333333


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+.   .+|+.+.+++..||..+|++||+|..|++
T Consensus       336 RPk---~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  336 RPK---YCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CCC---CChHHHHHHHHHhccCCccccccHHHHHH
Confidence            333   34999999999999999999999999974

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.5e-38  Score=300.79  Aligned_cols=247  Identities=20%  Similarity=0.306  Sum_probs=197.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|.....||+|+||.||+|.+..+++.||||++....  ....+.+|+.++..+.| +++..+..++...+..+++|||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeCCeEEEEEec
Confidence            34556678999999999999998889999999875432  34457889999999986 5565666666678899999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +++|..++.  ...+++..++.++.||+.||.|||++|++||||||+||++   +.++.++|+|||++........  
T Consensus       100 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         100 LQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc--
Confidence            9 778888765  3568999999999999999999999999999999999999   5788999999999875543221  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                           ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......   +.+..+....  .+.......
T Consensus       173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~--~~~~~~~~~  242 (297)
T cd06659         173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSP--PPKLKNAHK  242 (297)
T ss_pred             -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhccC--CCCccccCC
Confidence                 112457899999999999888999999999999999999999999764432   2222222111  111112245


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ++..+.++|.+||..+|++||++++|++
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            6789999999999999999999999877

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3e-37  Score=286.75  Aligned_cols=247  Identities=25%  Similarity=0.413  Sum_probs=201.7

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .|++.+.||+|++|.||+|.+..+++.|++|++....  ....+.+|+++++.+.| +++..+..++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEEEecC
Confidence            4889999999999999999998889999999987665  45668999999999985 56666766677778899999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       +++|.+++......+++..+..++.|++.||.|||++|++||||+|+||+++   +++.++|+|||.+........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc---
Confidence             6899998876546799999999999999999999999999999999999994   688999999999877654321   


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                           .....++..|+|||.+.+..++.++||||||+++|+|++|..||...........   .....  .+.......+
T Consensus       154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~--~~~~~~~~~~  223 (253)
T cd05122         154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IATNG--PPGLRNPEKW  223 (253)
T ss_pred             -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcC--CCCcCccccc
Confidence                 1245788999999999988899999999999999999999999986533222211   11111  1111111223


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +..+.++|.+||..||++||++.++++
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            788999999999999999999998864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-37  Score=293.53  Aligned_cols=240  Identities=24%  Similarity=0.292  Sum_probs=184.9

Q ss_pred             eeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      .||+|+||.||+|.+..+++.||+|++.....     ......|..+++.+.  +++++..+..++...+..++||||+ 
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999998999999998764321     112344555544443  3455666666667788899999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.++|+|||++..+....     
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-----  151 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-----  151 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-----
Confidence            8888887764 5579999999999999999999999999999999999999   477899999999987553321     


Q ss_pred             cccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          166 PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                          .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.||..............+.....     .+...+
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  222 (278)
T cd05606         152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----ELPDSF  222 (278)
T ss_pred             ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC-----CCCCcC
Confidence                1244789999999999754 589999999999999999999999987533222222211111111     122345


Q ss_pred             hHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      +.++.+++.+||..+|.+||     ++.++++
T Consensus       223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            88999999999999999999     8877754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.3e-37  Score=288.22  Aligned_cols=252  Identities=27%  Similarity=0.418  Sum_probs=199.0

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||+|+||.||+|.+..+++.|++|++.....    ...+..|+.+++.++| +++..+..+....+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC-CChhheeeeEecCCEEEEEEe
Confidence            69999999999999999999988899999998776543    3457889999999987 556666666677888999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++   +.+.+||+|||++.........
T Consensus        80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCCCc
Confidence            99 7899998875 44589999999999999999999999999999999999994   6889999999999876543321


Q ss_pred             CcccccCCCcccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ...   ......++..|+|||.+.+..   ++.++||||||+++|++++|..||......  ......+.. ......+ 
T Consensus       156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~~-~~~~~~~-  228 (264)
T cd06626         156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVGA-GHKPPIP-  228 (264)
T ss_pred             ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHhc-CCCCCCC-
Confidence            110   012356789999999998776   889999999999999999999999764322  111111211 1111111 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....++..+.++|.+||+.+|.+||++.+|+.
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11234788999999999999999999998854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-37  Score=290.75  Aligned_cols=240  Identities=21%  Similarity=0.280  Sum_probs=192.1

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ||.|+||.||+|++..+++.||+|++....     ....+.+|+++++.+.| +++..+..+..++...+++|||+ +++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            689999999999999889999999876432     23458889999999976 55555655667788899999998 889


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                      |.+++.. ...++...+..++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++........       
T Consensus        80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~-------  148 (262)
T cd05572          80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK-------  148 (262)
T ss_pred             HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc-------
Confidence            9998875 3468999999999999999999999999999999999999   4788999999999987654321       


Q ss_pred             CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHH
Q 014527          169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF  248 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  248 (423)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... +....+..+.........+   ...++++
T Consensus       149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~  223 (262)
T cd05572         149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFP---NYIDKAA  223 (262)
T ss_pred             -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCC---cccCHHH
Confidence             1234678999999999888899999999999999999999999987542 1223333333211111111   2337899


Q ss_pred             HHHHHHHhcCCCCCCCC-----hHHHHH
Q 014527          249 ASYFHYCQSLTFDQRPD-----YGFLKR  271 (423)
Q Consensus       249 ~~li~~cl~~dP~~RPt-----~~~l~~  271 (423)
                      .++|.+||..+|++||+     ++++++
T Consensus       224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         224 KDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            99999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-37  Score=300.90  Aligned_cols=251  Identities=22%  Similarity=0.294  Sum_probs=191.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeee-----C
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD-----G   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~-----~   75 (423)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.+.|++.+..+..+...     .
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            4679999999999999999999999899999999876432    223578899999999875544433333221     2


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++||||+..+|..+.   ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        93 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~  166 (342)
T cd07879          93 QDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARH  166 (342)
T ss_pred             ceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcC
Confidence            356999999987777654   3468999999999999999999999999999999999999   4788999999999875


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh----
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE----  230 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----  230 (423)
                      .....          ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+.....    
T Consensus       167 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         167 ADAEM----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP  236 (342)
T ss_pred             CCCCC----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            43211          23467889999999876 4588999999999999999999999987543221111111000    


Q ss_pred             ----------------h---hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 ----------------K---KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ----------------~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                      .   .............+..+.++|.+||+.||++||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                            0   0001111122345778999999999999999999999965

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-37  Score=297.53  Aligned_cols=254  Identities=23%  Similarity=0.318  Sum_probs=201.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....  ....+.+|+.+++.+.| +++..+..++...+..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeCCcEEEEEe
Confidence            478999999999999999999998889999999875432  33457889999999986 556666666677888999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++..  ..+++..+..++.|++.||.|||++|++||||||+||++   +.++.++|+|||++.........
T Consensus        97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccccc
Confidence            99 8899988763  458899999999999999999999999999999999999   47789999999998765433221


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....+++.|+|||.+.+..++.++|||||||++|++++|+.||...+....   +..+...  ..+......
T Consensus       172 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~~~--~~~~~~~~~  239 (293)
T cd06647         172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATN--GTPELQNPE  239 (293)
T ss_pred             -------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehhcC--CCCCCCCcc
Confidence                   1244688999999999988899999999999999999999999976443211   1111111  111111123


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .++..+.++|.+||..+|++||++.+|+.  +.++..
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~  274 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKI  274 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence            45788999999999999999999999865  455543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-37  Score=300.56  Aligned_cols=249  Identities=21%  Similarity=0.305  Sum_probs=194.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----   75 (423)
                      +.++|++.+.||+|+||.||+|.+..++..||||++.....    ...+.+|+.+++.+.|++.+..+..+..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            57889999999999999999999999999999998754322    234778999999998755544444333222     


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++||||++++|.+++.  ...+++..++.++.||+.||.|||+.||+||||||+||+++   ..+.++|+|||++..
T Consensus        93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg~~~~  167 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ  167 (343)
T ss_pred             ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccccc
Confidence            2468999999999988876  45699999999999999999999999999999999999994   788999999999876


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .....          ....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+......   +.++......
T Consensus       168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~~~~~~~~  234 (343)
T cd07880         168 TDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ---LMEIMKVTGT  234 (343)
T ss_pred             cccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCC
Confidence            53321          13467889999999876 3588999999999999999999999986543222   1111111110


Q ss_pred             --------------------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 --------------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 --------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                                .........+++.+.++|.+||..||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                      0111223456788999999999999999999999875

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.9e-37  Score=296.36  Aligned_cols=245  Identities=24%  Similarity=0.340  Sum_probs=197.0

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ...|...+.||+|+||.||+|++..+++.|++|++.....     ...+..|+++++.++| +++..+..++.+....++
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEE
Confidence            3457778889999999999999999999999998764322     2347789999999986 566667777778889999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||+.+++.+++......+++.+++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++.....  
T Consensus        99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633          99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC--
Confidence            99999889999887666779999999999999999999999999999999999999   4778999999999854321  


Q ss_pred             CCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                               .....|+..|+|||.+.   +..++.++|||||||++|+|++|..||.........   ..+......   
T Consensus       174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~~~---  238 (313)
T cd06633         174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNDSP---  238 (313)
T ss_pred             ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhcCCC---
Confidence                     12456889999999985   355888999999999999999999999875433222   222211111   


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......++..+.+++.+||+.+|.+||++.+++.
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112345778999999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-37  Score=301.37  Aligned_cols=255  Identities=20%  Similarity=0.248  Sum_probs=198.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----Cee
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----EDN   78 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----~~~   78 (423)
                      +|++.+.||.|+||.||+|++..+++.||||.+....    ..+.+.+|+.+++.++| +++..+..+....     ...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-ENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC-cchhhhhhhhcccCcccccce
Confidence            6999999999999999999998889999999876532    34568899999999986 4454454444333     378


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |++|||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.....
T Consensus        80 ~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          80 YIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecc
Confidence            99999998888888764 4479999999999999999999999999999999999999   4779999999999987655


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh------
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------  231 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------  231 (423)
                      .....    .......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.........+......      
T Consensus       156 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         156 DEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             ccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            43110    012244678999999999988 7899999999999999999999999876543222221111100      


Q ss_pred             -----------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 -----------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 -----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                       ....+.......++..+.++|.+||+.+|++||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                             0001111223446889999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-38  Score=313.95  Aligned_cols=253  Identities=21%  Similarity=0.329  Sum_probs=207.1

Q ss_pred             Cce-EEeceeeecCceeEEEEEECCCCcEEEE---E---EecCCCCchhHHHHHHHHHHHcCCCCCCeEEEe-eeeCCee
Q 014527            7 VKY-KLGRKIGSGSFGEIFLASHVDTNEIVAV---K---IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY-GVDGEDN   78 (423)
Q Consensus         7 ~~y-~i~~~Lg~G~fg~Vy~a~~~~~~~~vai---K---i~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~-~~~~~~~   78 (423)
                      ++| ++...||+|+|-+||+|.+..+|..||-   |   +.+.....++|..|+++|+.|+|++++..+..+ .......
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            444 6778999999999999999988887773   3   233444456799999999999996665555333 3344557


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      .+|+|++ .|+|..++++ .++++.+.+..|++||+.||.|||++.  |||||||.+||||+  ...|.|||+|+|+|..
T Consensus       119 n~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence            8999999 9999999886 557999999999999999999999985  99999999999997  6789999999999998


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .+....         ..++|||.|||||++. ..|+..+||||||++|+||+|+.+||....  ...+.|.++..+..+.
T Consensus       196 ~r~s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  196 LRKSHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPA  263 (632)
T ss_pred             hhcccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHH
Confidence            776543         2579999999999998 679999999999999999999999998754  3457788877766544


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ....   --.+++++||.+||.. ..+||++.+|+.  +.+|...
T Consensus       264 sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~d  302 (632)
T KOG0584|consen  264 ALSK---VKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDED  302 (632)
T ss_pred             Hhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhccc
Confidence            3333   3378999999999999 999999999865  5555543

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=292.41  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC--CeeEEEE
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVL   82 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~~~lv~   82 (423)
                      |++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|+.+++.+.|.+ +..+..+..+.  ...++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPN-IVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCC-eeeheeeEecCCCCcEEEEe
Confidence            789999999999999999999889999999887543    2335788999999998744 44454444444  7899999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||++++|.+++......+++..++.++.||+.||+|||++|++|+||+|+||++   ++++.++|+|||++.........
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc
Confidence            999889999887654679999999999999999999999999999999999999   47889999999999876554321


Q ss_pred             CcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc--------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--------  233 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------  233 (423)
                            ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+........        
T Consensus       157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         157 ------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             ------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence                  11133567889999987754 578999999999999999999999987554322222211110000        


Q ss_pred             --------------CCcHHHhhcc-ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 --------------STPIEVLCKS-HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 --------------~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                    .......... ++..+.+++.+||..+|.+||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                          0000111122 3788999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.4e-37  Score=293.77  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=206.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ....|++.+.||+|+||.||+|.+..++..|++|++..... ...+..|+++++.++| +++..+..++......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC-CCeeEEEEEEEECCEEEEEEe
Confidence            34678999999999999999999988899999998876543 5568899999999987 566667777777889999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++......+++..++.++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh-
Confidence            99 699999998654479999999999999999999999999999999999999   4788999999999865543221 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                            ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......   ....+...... +.. ...
T Consensus       172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-~~~-~~~  240 (286)
T cd06614         172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALFLITTKGIP-PLK-NPE  240 (286)
T ss_pred             ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCC-CCc-chh
Confidence                  1123457889999999998889999999999999999999999998654332   22222221111 111 113


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .++..+.++|.+||+.+|.+||++.+|++  ..++.+
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~  275 (286)
T cd06614         241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLKK  275 (286)
T ss_pred             hCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhhc
Confidence            36889999999999999999999999965  444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=292.54  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=196.2

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      |++.+.||+|+||.||+|....+++.|+||.+.....   .....+|+..+..+.+++++..+..++.+....++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7899999999999999999988899999998765422   2235678899999984466666665666788999999999


Q ss_pred             CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 ~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||++   ++.+.++|+|||++........   
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~---  154 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP---  154 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC---
Confidence            999999887643 468999999999999999999999999999999999999   4789999999999986543221   


Q ss_pred             ccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh-----------
Q 014527          165 IPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-----------  232 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-----------  232 (423)
                           .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+............           
T Consensus       155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence                 123467889999998854 457899999999999999999999997654433222211111100           


Q ss_pred             -----------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 -----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 -----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                 ............+..+.++|.+||+.+|++||++++|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                       001111222233678999999999999999999998864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.8e-37  Score=296.93  Aligned_cols=247  Identities=20%  Similarity=0.295  Sum_probs=196.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ....|+..+.||+|+||.||+|++..+++.||+|.+....     ....+.+|+++++.++|+ ++..+..+.......+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP-NTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCC-CcccEEEEEEcCCeeE
Confidence            3456888999999999999999999899999999875321     123467899999999874 4555556666778899


Q ss_pred             EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +||||+.+++.+++......+++..+..++.|++.||.|||+++++||||+|+|||+   +.++.++|+|||++......
T Consensus        92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc
Confidence            999999889988887666679999999999999999999999999999999999999   46789999999998765422


Q ss_pred             CCCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                                 ....++..|+|||.+.   ...++.++|||||||++|+|++|..||..........   .+....... 
T Consensus       169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~-  233 (308)
T cd06634         169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESPA-  233 (308)
T ss_pred             -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---HHhhcCCCC-
Confidence                       1346788999999985   3457889999999999999999999997654332211   222211111 


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                        .....++..+.++|.+||..+|++||++++++..
T Consensus       234 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         234 --LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             --cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence              1123457889999999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=298.85  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=212.0

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +|-..+|.++..||+|+||.|.+|..+.+.+.+|||+++++...     +--+.|-++|.....++.+..++.++..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            45567899999999999999999999999999999998876422     2246677888877788888888889999999


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      +|+||||+ ||+|--.+++ -+++.+..+..++..|+-||-+||++|||+||||.+|||+   |..+.|||+|||+++.-
T Consensus       425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence            99999999 8888777765 5679999999999999999999999999999999999999   69999999999999754


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .-..       ....+++|||.|+|||++...+|+..+|.|||||+||||+.|+.||.+.+   ..+.+..|.+.....|
T Consensus       501 i~~~-------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~ehnvsyP  570 (683)
T KOG0696|consen  501 IFDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIMEHNVSYP  570 (683)
T ss_pred             ccCC-------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHccCcCc
Confidence            3222       13458999999999999999999999999999999999999999999854   4477778888888777


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCCh
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  266 (423)
                           +.++.+..+++...|.+.|.+|...
T Consensus       571 -----KslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  571 -----KSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             -----ccccHHHHHHHHHHhhcCCccccCC
Confidence                 5568999999999999999999643

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-37  Score=299.56  Aligned_cols=259  Identities=21%  Similarity=0.294  Sum_probs=196.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-----e
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~   74 (423)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+.+|+.++..++|++.+..+..+..     .
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            35689999999999999999999999899999999876532    12457789999999988555444443322     1


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....++++++++++|.+++.  ...+++..++.++.||+.||+|||++||+||||||+||++   ++++.+||+|||+++
T Consensus        94 ~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~  168 (345)
T cd07877          94 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR  168 (345)
T ss_pred             cccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccccc
Confidence            23478999999999988775  3469999999999999999999999999999999999999   478899999999987


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh---
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---  230 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---  230 (423)
                      ......          ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....   
T Consensus       169 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         169 HTDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             cccccc----------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            643221          24467889999999876 4688999999999999999999999976443222111111000   


Q ss_pred             --------------------hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          231 --------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       231 --------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                          ..............++++.++|..||..||.+||++.+++.  +.+|.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~f~~  305 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQ  305 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc--Chhhhh
Confidence                                00000111112235778999999999999999999998865  455543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.4e-37  Score=286.97  Aligned_cols=246  Identities=23%  Similarity=0.313  Sum_probs=201.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||.|+||.||+|.+..++..|++|++....    ....+..|+++++.++| +++..+..........++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-PNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC-CChhheEEEEecCCEEEEEEE
Confidence            5899999999999999999999889999999877543    33458889999999986 455555555566789999999


Q ss_pred             cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           84 LL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        84 ~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ++ +++|.+++...   ...+++..++.++.|++.||.|||++|++|+||+|+||+++   ..+.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceeecccC
Confidence            99 67999988765   36799999999999999999999999999999999999994   6789999999999876543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..       ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......   +..........    ..
T Consensus       157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~----~~  222 (258)
T cd08215         157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKILKGQY----PP  222 (258)
T ss_pred             cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHHhcCCC----CC
Confidence            31       112457889999999999888999999999999999999999999765422   22222222221    12


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +...++..+.+++.+||..+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            23356889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.6e-37  Score=291.55  Aligned_cols=245  Identities=21%  Similarity=0.295  Sum_probs=198.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .-|++.+.||.|+||.||+|.+..+++.||||+......   ...+.+|+.++..+.| +++..+..++......++|||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeCCeEEEEEE
Confidence            357889999999999999999988899999998764332   2357789999999987 456666666677888999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++.  ...+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.........
T Consensus        83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchhh
Confidence            99 778888775  4568999999999999999999999999999999999999   47789999999998765432211


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....++..|+|||.+.+..++.++|||||||++|+|++|..||......   .....+....    ...+..
T Consensus       158 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~----~~~~~~  223 (277)
T cd06641         158 -------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLFLIPKNN----PPTLEG  223 (277)
T ss_pred             -------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHHHHhcCC----CCCCCc
Confidence                   12346788999999999888899999999999999999999999765432   2222221111    112234


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++.++.+++.+||..+|.+||++.+++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            56889999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=301.55  Aligned_cols=247  Identities=21%  Similarity=0.277  Sum_probs=204.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +-.+.|..-+.||+|+||+||-++.+.||+.||+|.+.+..     ...-.+.|-.+|.++... .|+.+.+.+...+..
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~-FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP-FIVSLAYAFETKDAL  260 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC-cEEEEeeeecCCCce
Confidence            44577899999999999999999999999999999655432     333467899999998874 566666667788899


Q ss_pred             EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      |+||..| ||+|.-.+-..+ ..|++..++.++.+|+.||++||..+||+|||||+|||+   |+.|.|.|+|+|+|..+
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEec
Confidence            9999999 888877665443 469999999999999999999999999999999999999   79999999999999988


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ......        ...+||..|||||++.+..|+...|.|||||++|||+.|+-||.........+.++    .+....
T Consensus       338 ~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd----rr~~~~  405 (591)
T KOG0986|consen  338 PEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD----RRTLED  405 (591)
T ss_pred             CCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH----HHHhcc
Confidence            765432        24589999999999999999999999999999999999999998755443333322    222223


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCCh
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  266 (423)
                      .......++++.++|.+.+|.+||.+|...
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            344457779999999999999999999754

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.1e-37  Score=293.27  Aligned_cols=253  Identities=28%  Similarity=0.398  Sum_probs=204.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+.....     ....+..|+.++..+..+++++.+..++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999876532     2345788999999998456777776666778889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||++ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcc
Confidence            9999 9999998876 4479999999999999999999999999999999999999   478899999999998765433


Q ss_pred             CCCc-------------ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          161 TNRH-------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       161 ~~~~-------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      ....             ..........++..|+|||.+.+..++.++||||||+++|++++|..||......   ..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~  233 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTFQK  233 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH
Confidence            2110             0112334567889999999999888999999999999999999999999865422   33333


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCCh----HHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY----GFLKR  271 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~~l~~  271 (423)
                      +.......+     ..+++.+.++|..||+.+|++||++    ++|++
T Consensus       234 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 ILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            333232222     3458899999999999999999999    66643

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-38  Score=308.98  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=208.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -+.|.+.+.||+|.|+.|.+|++..++..||||++.+....    ..+.+|+++|+.|.| ++|..+..+-......|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeecceeEEE
Confidence            36799999999999999999999999999999988765432    337899999999998 5566666666678899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +|.+.+++.. .+.+.+.++..++.|+++|++|||+++|+|||||++|||+   +.+..+||+|||++..+....
T Consensus       134 ~eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecccc
Confidence            9999 9999999987 4456679999999999999999999999999999999999   577789999999999887443


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      .        ..+++|++.|+|||++.|..| ++.+|+||+|++||-|+.|.+||.+..-.   +.-.+.+..++..|...
T Consensus       210 ~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---~Lr~rvl~gk~rIp~~m  278 (596)
T KOG0586|consen  210 M--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---ELRPRVLRGKYRIPFYM  278 (596)
T ss_pred             c--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---cccchheeeeeccccee
Confidence            2        347899999999999999987 68999999999999999999999874432   33344555666665433


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                           +.+..++|.++|.++|.+|++.++|..
T Consensus       279 -----s~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  279 -----SCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -----echhHHHHHHhhccCccccCCHHHhhh
Confidence                 678999999999999999999999866

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-37  Score=288.14  Aligned_cols=249  Identities=24%  Similarity=0.335  Sum_probs=194.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeEEEeeee--CCe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED   77 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~~   77 (423)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....       ....+.+|+++++.++|.+ +..+..+..+  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~-i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR-IVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCC-cceEEEEEEcCCCCE
Confidence            57999999999999999999999999999999864321       1235778999999998755 4444444433  356


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||+++..
T Consensus        81 ~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccc
Confidence            78999999 7899988865 3458999999999999999999999999999999999999   47889999999999865


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .......    .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......   ..+.++..   ...
T Consensus       157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~---~~~  226 (264)
T cd06653         157 QTICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKIAT---QPT  226 (264)
T ss_pred             ccccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHHHc---CCC
Confidence            4321110    0112456889999999999988999999999999999999999999864332   22222221   112


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+..+..+++.+.++|.+||. +|..||++.+++.
T Consensus       227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            223345668899999999999 5799999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.1e-37  Score=292.71  Aligned_cols=246  Identities=21%  Similarity=0.297  Sum_probs=197.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .|...+.||+|++|.||+|.+..+++.|++|.+....  ....+.+|+.+++.+.| +++..+..+....+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h-~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH-PNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC-CChheEEEEEEcCCeEEEEEecc
Confidence            5666789999999999999998889999999875432  23457889999999876 55666666667788899999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       +++|.+++..  ..+++..+..++.||+.||+|||++||+||||+|+||++   +.++.++|+|||++........   
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~---  170 (285)
T cd06648          99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP---  170 (285)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc---
Confidence             8899998875  568999999999999999999999999999999999999   4788999999998875433221   


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                          ......|+..|+|||.+.+..++.++|||||||++|+|++|..||......   ..+..+.....  +.......+
T Consensus       171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~~~~~  241 (285)
T cd06648         171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIRDNLP--PKLKNLHKV  241 (285)
T ss_pred             ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHhcCC--CCCcccccC
Confidence                112456889999999999888999999999999999999999999764332   22222222211  111111235


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +..+.++|.+||..+|++||++.+|++
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            789999999999999999999998865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-37  Score=302.70  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=194.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----   75 (423)
                      +.++|++.+.||+|+||.||+|++..+++.||||++....    ....+.+|+.+++.+.|++.+.....+....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            5789999999999999999999999999999999876432    2244678999999998755444333332221     


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++|+||++++|.+++..  ..+++..++.++.||+.||.|||+.||+||||||+||+++   .++.++|+|||++..
T Consensus        93 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~dfg~~~~  167 (343)
T cd07851          93 QDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLARH  167 (343)
T ss_pred             ccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEcccccccc
Confidence            24899999999999998863  5699999999999999999999999999999999999994   788999999999976


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh---
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---  231 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---  231 (423)
                      .....          ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.........+......   
T Consensus       168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         168 TDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             ccccc----------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            54321          244678899999998753 5789999999999999999999999865443222221111100   


Q ss_pred             --------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 --------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          .............++.+.++|.+||+.+|++||++.+|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                                0000111222345789999999999999999999999865

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.5e-37  Score=288.46  Aligned_cols=248  Identities=19%  Similarity=0.270  Sum_probs=183.9

Q ss_pred             ceeeecCceeEEEEEECCC--CcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527           13 RKIGSGSFGEIFLASHVDT--NEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~--~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      +.||+|+||.||+|.....  ...+++|.+....   ....+.+|+.+++.++| +++..+..++.+....++||||+ +
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC-cchhheEEEecCCCccEEEEecCCC
Confidence            3699999999999975433  3356777665433   23468889999999987 45555555566778899999999 7


Q ss_pred             CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           87 PSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        87 ~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      ++|.+++....   ..++...++.++.||+.||+|||+++++||||||+|||+   +.++.++|+|||++........  
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~--  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY--  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence            89999887532   346777889999999999999999999999999999999   4788999999999864321110  


Q ss_pred             cccccCCCcccccccccCcccccC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhh-hcC
Q 014527          164 HIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK-KVS  234 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~-~~~  234 (423)
                         ........++..|+|||++..       ..++.++|||||||++|||++ |..||......   +.+..+... ...
T Consensus       155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~~  228 (268)
T cd05086         155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHVIKDQQVK  228 (268)
T ss_pred             ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhhcccc
Confidence               011224567899999998753       235789999999999999997 67888765443   222222222 222


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF  273 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L  273 (423)
                      .+.+.....+++.+.+++..|| .+|++||++++|++.|
T Consensus       229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            2223333456888999999999 6799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.5e-37  Score=290.49  Aligned_cols=251  Identities=19%  Similarity=0.333  Sum_probs=192.6

Q ss_pred             eEEeceeeecCceeEEEEEECC---CCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC------
Q 014527            9 YKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG------   75 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~---~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~------   75 (423)
                      |++.+.||+|+||.||+|.+..   +++.||||++.....    .+++.+|+++++.+.| +++..+..++...      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH-PNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCCCCcc
Confidence            6788999999999999998653   568899998865432    2347889999999987 4555555444322      


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                      ...+++++|+ +++|.+++....     ..+++..++.++.||+.||+|||++||+||||||+||++   +.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECc
Confidence            1247888988 788888765321     247899999999999999999999999999999999999   4788999999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i  228 (423)
                      ||+++........     .......+++.|++||.+.+..++.++|||||||++|+|++ |..||.+....   ..+..+
T Consensus       157 fg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05074         157 FGLSKKIYSGDYY-----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL  228 (273)
T ss_pred             ccccccccCCcce-----ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence            9999865432211     11123345678999999998889999999999999999999 89999865432   222222


Q ss_pred             Hhhh-cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          229 CEKK-VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       229 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      .... ...     ....+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       229 ~~~~~~~~-----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKGNRLKQ-----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcCCcCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2211 111     134578999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.3e-37  Score=290.63  Aligned_cols=238  Identities=22%  Similarity=0.278  Sum_probs=186.8

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ||+|+||+||+|.+..+++.||+|++....     ....+..|+++++.++| +++..+..+....+..|+||||+ +++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            689999999999999999999999875422     23346789999999985 55666666666778899999999 789


Q ss_pred             HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccc
Q 014527           89 LEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY  167 (423)
Q Consensus        89 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~  167 (423)
                      |.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||++   +.++.++|+|||++........      
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~------  150 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKK------  150 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCc------
Confidence            998887543 369999999999999999999999999999999999999   4788999999999876543211      


Q ss_pred             cCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                        .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.   ......+ ......+++.
T Consensus       151 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~  224 (277)
T cd05577         151 --IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLEMA-VEYPDKFSPE  224 (277)
T ss_pred             --cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hcccccc-ccCCccCCHH
Confidence              124467889999999998889999999999999999999999997654321112111   1111111 1122445889


Q ss_pred             HHHHHHHHhcCCCCCCCChHH
Q 014527          248 FASYFHYCQSLTFDQRPDYGF  268 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~  268 (423)
                      +.++|.+||+.+|++||++.+
T Consensus       225 ~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         225 AKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             HHHHHHHHccCChhHccCCCc
Confidence            999999999999999994433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.5e-36  Score=283.22  Aligned_cols=249  Identities=27%  Similarity=0.368  Sum_probs=201.7

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC--CeeEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLV   81 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~~~lv   81 (423)
                      +|++.+.||+|++|.||+|.+..+++.|++|+......    ...+.+|+.+++.+.| +++..+.......  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-PNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC-CCEeeEEEEEecCCCCeEEEE
Confidence            58899999999999999999998899999998876543    4568899999999996 4455555555555  788999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      +|++ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++   ..+.++|+|||.+.......
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence            9999 899999887643 899999999999999999999999999999999999994   68899999999998776543


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      ..     .......++..|+|||.+.+...+.++||||||+++|+|++|..||.....  .......+....   .....
T Consensus       156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~---~~~~~  225 (260)
T cd06606         156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSG---EPPEI  225 (260)
T ss_pred             cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccC---CCcCC
Confidence            21     011245788999999999988899999999999999999999999987541  122222222111   11122


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...++..+.++|.+||..+|++||++.+++.
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            3445889999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.6e-37  Score=292.52  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=199.1

Q ss_pred             ceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +|++.+.||+|+||.||+|++.   .+++.||||++....      ....+..|+.++..+.++++++.+..........
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   467889999876432      2234778999999998778888887777778889


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence            9999999 7799888764 4568999999999999999999999999999999999999   477899999999987654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHHhhhcC
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVS  234 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~  234 (423)
                      .....      ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||........ .+....+......
T Consensus       157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd05583         157 AEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP  230 (288)
T ss_pred             ccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence            33221      112356889999999988765  78899999999999999999999964322111 1212222222211


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                           ....++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       231 -----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         231 -----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                 123457899999999999999999999888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=306.10  Aligned_cols=242  Identities=21%  Similarity=0.322  Sum_probs=206.2

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccCCC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPS   88 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~~s   88 (423)
                      +.||+|.||+||-|.++++|+.||||++.+-    ....++..|+.||+.+.| ++|..+...+...+..++|||-+.|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcch
Confidence            6899999999999999999999999987643    234568999999999986 78888988899999999999999888


Q ss_pred             HHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccc
Q 014527           89 LEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY  167 (423)
Q Consensus        89 L~~~l~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~  167 (423)
                      ..+.+. ...+++++.....++.||+.||.|||-++|+|+||||+|||+...+...++||||||+|+.+.+..-      
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF------  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF------  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh------
Confidence            777765 4467899999999999999999999999999999999999998777778999999999999876543      


Q ss_pred             cCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                        ....+||+.|+|||++++..|++.-|+||.|||+|--+.|..||....+  .   -++|....+-.|. .-++.++++
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--I---ndQIQNAaFMyPp-~PW~eis~~  794 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--I---NDQIQNAAFMYPP-NPWSEISPE  794 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--h---hHHhhccccccCC-CchhhcCHH
Confidence              3478999999999999999999999999999999999999999985332  2   2233344443332 334677899


Q ss_pred             HHHHHHHHhcCCCCCCCChHHH
Q 014527          248 FASYFHYCQSLTFDQRPDYGFL  269 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l  269 (423)
                      ..+||..+|+..-.+|.+.+.-
T Consensus       795 AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  795 AIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             HHHHHHHHHHHHHHHhcchHhh
Confidence            9999999999999999887654

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-36  Score=289.64  Aligned_cols=243  Identities=20%  Similarity=0.337  Sum_probs=192.5

Q ss_pred             ceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      .|++.+.||.|+||.||+|++.   .+++.||+|++....      ....+..|+.++..+.+++++..+..++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   478899999876432      2245778999999998788888888777778889


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+|||+   +.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence            9999999 7899998875 4568999999999999999999999999999999999999   478899999999998654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHH-HHHHHhhhcC
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVS  234 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~  234 (423)
                      .....      ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||........... ...+......
T Consensus       157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (290)
T cd05613         157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  230 (290)
T ss_pred             ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence            32211      11245688999999998753  367899999999999999999999974322211112 2222221111


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCC
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPD  265 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  265 (423)
                           ....+++.+.+++.+||..+|++||+
T Consensus       231 -----~~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         231 -----YPQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             -----CCccCCHHHHHHHHHHhcCCHHHhcC
Confidence                 12345789999999999999999983

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=281.21  Aligned_cols=245  Identities=24%  Similarity=0.358  Sum_probs=200.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||+|++|.||+|.+..+++.|++|.+.....    ...+.+|++++..+.|+ ++..+..+..+....+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP-NIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCC-CccEEEEEEEeCCEEEEEEe
Confidence            58999999999999999999998899999998776542    34578999999999874 56666666677789999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ++ +++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++   .++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence            99 77998888753 6799999999999999999999999999999999999994   6789999999999876543321


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....++..|+|||...+..++.++||||||+++|+|++|..||......   ...........    .....
T Consensus       156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~  221 (254)
T cd06627         156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AALFRIVQDDH----PPLPE  221 (254)
T ss_pred             -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhccCC----CCCCC
Confidence                   12456889999999998888899999999999999999999999865432   22222221111    11234


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++..+.+++.+||..+|++||++.+++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            56889999999999999999999998864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-36  Score=296.22  Aligned_cols=253  Identities=17%  Similarity=0.193  Sum_probs=188.3

Q ss_pred             eceeeec--CceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527           12 GRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus        12 ~~~Lg~G--~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      ...||.|  +||+||+|++..+++.||+|+......    .+.+.+|+.+++.++| +++..+..++..+...++||||+
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecCCceEEEEecc
Confidence            3456666  999999999999999999999775432    2347788888888876 56767777777888899999999


Q ss_pred             -CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           86 -GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        86 -~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                       +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+.   .++.++++||+.+..........
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccc
Confidence             78999988753 24589999999999999999999999999999999999994   77899999998764433222111


Q ss_pred             cccccCCCcccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc-----
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-----  236 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-----  236 (423)
                      ...+.......++..|+|||++.+.  .++.++|||||||++|+|++|+.||.......   .+..........+     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHHhcCCCCCCccccc
Confidence            1111122233456789999999764  47899999999999999999999998654321   1111111000000     


Q ss_pred             -------------------------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 -------------------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 -------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                                           .......+++.+.+||.+||..||++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                                 00011234678999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=289.15  Aligned_cols=252  Identities=21%  Similarity=0.238  Sum_probs=198.6

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      |++.+.||+|+||.||+|+...+++.||+|++....    ....+..|+.+++.+.| +++..+..+..+....++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999877542    23457789999999986 5565666666677899999999


Q ss_pred             cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        85 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      ++++|.+++......+++..++.++.|++.||.|||++||+||||+|+||++   ++++.++|+|||++........   
T Consensus        80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~---  153 (282)
T cd07829          80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR---  153 (282)
T ss_pred             cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence            9889999998755679999999999999999999999999999999999999   4789999999999976643321   


Q ss_pred             ccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh------------
Q 014527          165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------------  231 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------------  231 (423)
                          ......++..|+|||.+.+. .++.++|||||||++|||++|..||...........+......            
T Consensus       154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence                11234567889999998876 7899999999999999999999999875433222221111100            


Q ss_pred             ---------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 ---------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                               .............+..+.++|..||..+|++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                     0000111222345788999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=302.25  Aligned_cols=262  Identities=18%  Similarity=0.268  Sum_probs=211.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -.....+.++||+|-||+|.+|.- ..+..||+|+++.+..   ...|.+|+++|.+|+| ++|..+...+..++.++++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-PNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-PNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCC-CCeeEEEeeeecCCchHHH
Confidence            345678899999999999999985 3368899999886643   3469999999999976 5566666667778899999


Q ss_pred             Eecc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +||+ .|+|.+++.....+ +..+....|+.||+.||+||.+.++|||||.+.|+|+   +.+.++||+|||+++.+...
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccC
Confidence            9999 99999999865433 3556677899999999999999999999999999999   58999999999999976655


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ..     |+.....+-..+|||+|.+.-++++.++|||+||+++||+++  ...||..+++....+.........-....
T Consensus       691 ~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  691 DY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             Cc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            43     334445667899999999999999999999999999999875  88999887765444443333333222222


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ...+.-+|.++.++|..||..+-.+||+|++|...|.+.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            223345599999999999999999999999998877653

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-36  Score=290.26  Aligned_cols=251  Identities=20%  Similarity=0.316  Sum_probs=198.0

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CC
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP   87 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~   87 (423)
                      ....||+|+||.||++....+++.||||.+....  ....+.+|+.+++.+.| ++++.+..++...+..+++|||+ ++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeCCEEEEEEecCCCC
Confidence            3467999999999999999999999999875432  23457889999999987 56666666677888999999999 77


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccc
Q 014527           88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY  167 (423)
Q Consensus        88 sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~  167 (423)
                      +|.+++.  ...+++..+..++.|++.||+|||+.|++||||+|+||++   +.++.++|+|||++........      
T Consensus       103 ~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~------  171 (292)
T cd06657         103 ALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP------  171 (292)
T ss_pred             cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc------
Confidence            8887664  4568999999999999999999999999999999999999   4778999999999876543221      


Q ss_pred             cCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                       ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.........   + ......... ....++..
T Consensus       172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~-~~~~~~~~~-~~~~~~~~  245 (292)
T cd06657         172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---I-RDNLPPKLK-NLHKVSPS  245 (292)
T ss_pred             -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H-HhhCCcccC-CcccCCHH
Confidence             11245688999999999888899999999999999999999999986443322221   1 111111111 11345788


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      +.+++.+||..+|.+||++.+|+.  ++++.+.+
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~  277 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLK--HPFLAKAG  277 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhc--ChHHhccC
Confidence            999999999999999999999866  56655544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-36  Score=284.76  Aligned_cols=244  Identities=20%  Similarity=0.307  Sum_probs=199.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+....    ....+.+|+++++.++| ++++.+..++.+....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999876432    23357789999999986 566667666667789999999


Q ss_pred             cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           84 LL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        84 ~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |+ +++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++   ..+.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence            99 88999887642   35689999999999999999999999999999999999995   6788999999999776543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..         ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..   .....+...... +   
T Consensus       157 ~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~---  220 (256)
T cd08530         157 MA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKVQRGKYP-P---  220 (256)
T ss_pred             Cc---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCCC-C---
Confidence            11         1345788999999999988999999999999999999999999875432   222222222222 1   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....++.++.+++.+||..+|++||++.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            12345889999999999999999999998865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=310.13  Aligned_cols=269  Identities=21%  Similarity=0.296  Sum_probs=204.8

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC---CCCchhHHHHHHHHHHHcCCCCCCeEEEeeee------CC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD------GE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~---~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~------~~   76 (423)
                      +.-|...+.||+|+||.||+++++.+|+.||||.++.   ....+..-+|++++++|+| ++|+.+.....+      ..
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh-~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNH-PNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCc-hhhhhhcccCCccccCcccc
Confidence            3567788999999999999999999999999998876   3455567899999999995 445444333222      34


Q ss_pred             eeEEEEecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC-CCCcEEEeeccc
Q 014527           77 DNVLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGL  152 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~-~~~~vkL~DFGl  152 (423)
                      ..++||||| +|+|...+...  ...+++.+++.++.+++.||.|||++||+||||||.||++-.+. .....||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            568999999 99999999743  24599999999999999999999999999999999999995443 334579999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHHh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICE  230 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~  230 (423)
                      |+.+.+...        ...+.||..|.+||++.. ..|+..+|.|||||++|+++||.+||-..... ...+....+..
T Consensus       171 Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  171 ARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             cccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            998877653        237899999999999994 78999999999999999999999999643222 11122222221


Q ss_pred             hhcCC-----------c---------HHHhhccChHHHHHHHHHHhcCCCCCCC--ChHHHHHHHHHHHHhcCCC
Q 014527          231 KKVST-----------P---------IEVLCKSHPAEFASYFHYCQSLTFDQRP--DYGFLKRLFHDLFSREGYD  283 (423)
Q Consensus       231 ~~~~~-----------~---------~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~~l~~~L~~~~~~~~~~  283 (423)
                      ++...           |         ...++..+-..+...+..+|..+|.+|.  .+.+....+.+++...-..
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvh  317 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVH  317 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeE
Confidence            11110           1         0112222234566778888999999999  8888888888888765543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=335.35  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=202.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +.-+|+-...||.|.||.||.|...++|+..|+|-++...    ..+.+.+|..++..|.| ++++.++....+.+..+|
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecHHHHHH
Confidence            3457788889999999999999999999999999655332    33457889999999988 455566666778888999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      .|||| +|+|.+++.. ++..++.....+..|++.||.|||++|||||||||+||++   +.++.+|++|||.|..+...
T Consensus      1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence            99999 9999998874 5567777788899999999999999999999999999999   57889999999999988765


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh-hhcCC
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE-KKVST  235 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~-~~~~~  235 (423)
                      ...  .+ ..-....||+.|||||++.+..   ...++||||||||..||+||+.||..++..  .+.+.++.. .+...
T Consensus      1388 ~~~--~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1388 AQT--MP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKPQI 1462 (1509)
T ss_pred             hhc--CC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCCCC
Confidence            321  11 2334678999999999998654   578999999999999999999999876543  233333322 22222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      |     .+++.+-++||.+||..||..|.++.+|++
T Consensus      1463 P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 P-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             c-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            3     336889999999999999999988876654

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-36  Score=285.71  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=194.4

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ||.|+||.||+|++..+++.|++|++....     ....+.+|+++++.+.| +++..+..........|++|||+ +++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999999889999999876543     23457889999999986 55555555566778899999999 789


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC-cccc
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR-HIPY  167 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~-~~~~  167 (423)
                      |.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||++   +.++.++|+|||++.......... ....
T Consensus        80 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          80 LASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence            99988763 479999999999999999999999999999999999999   478899999999987654321100 0000


Q ss_pred             cCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       168 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|..||......   +.+..+.......+..   ..++..
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~  229 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILNGKIEWPED---VEVSDE  229 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCcCCCcc---ccCCHH
Confidence            1122456788999999999888999999999999999999999999765432   3333333323332211   124889


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          248 FASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      +.+++.+||+.+|++||++..+.+.|+
T Consensus       230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         230 AIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            999999999999999999966655544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.8e-37  Score=286.95  Aligned_cols=245  Identities=21%  Similarity=0.266  Sum_probs=192.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +|.+.+.||+|+||.||+|.+...+..+++|+.+..       .....+..|+.+++.++| +++..+..+..+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC-CcHHHHHHHHhcCCceEE
Confidence            699999999999999999999877777777765431       122246678889999877 445555555566778999


Q ss_pred             EEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           81 VLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ||||+ +++|.+++..   ....+++..++.++.|++.||.|||++|++|+||||+||+++    .+.++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence            99999 7899888764   235689999999999999999999999999999999999994    467999999999776


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .....       ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ......+.....   
T Consensus       156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~~---  222 (260)
T cd08222         156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT---  222 (260)
T ss_pred             CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHcCCC---
Confidence            44322       12245678899999999888899999999999999999999999975332   222222222211   


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ......++.++.++|.+||..+|++||++.++++
T Consensus       223 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 -PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             1122455889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=300.12  Aligned_cols=264  Identities=22%  Similarity=0.293  Sum_probs=212.0

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---------CchhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      ..+..+|-++..||+|||++||+|.+...++.||||+-....         ..+...+|.+|.+.|.|+.++..+.++..
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            457789999999999999999999999999999999844322         22346789999999999877777777888


Q ss_pred             eCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CcccccccCCceEEeecCCCCcEEEeecc
Q 014527           74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        74 ~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                      +.+.+|-|+|||.|+-.|++....+.++++++..|+.||+.||.||...  .|||-||||.|||+-.+...|.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            9999999999996665566665678899999999999999999999976  59999999999999877788999999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCC----CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      +++.+.+................||..|++||.+.-.    ..+.++||||+|||+|.++.|+.||...........+..
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9999988776655545556678899999999998633    268899999999999999999999986433222222222


Q ss_pred             HHhh-hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHH
Q 014527          228 ICEK-KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL  269 (423)
Q Consensus       228 i~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  269 (423)
                      |+.. .+.+|..   +.++.+.++||++||++.-++|.+..+|
T Consensus       699 IlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  699 ILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             hhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence            2221 2222222   2347899999999999999999887666

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-37  Score=282.28  Aligned_cols=260  Identities=21%  Similarity=0.278  Sum_probs=200.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCc----EEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~----~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ..|++.+.||+|.||.||+|...+++.    .+|||.++..    .......+|+.+++.|+|++.+..+..+-......
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468999999999999999997665432    6899987765    33445789999999999977776665555557889


Q ss_pred             EEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec-CCCCcEEEeeccce
Q 014527           79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLA  153 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~-~~~~~vkL~DFGla  153 (423)
                      ++++||...+|..++...+    +.++...+..|+.||+.|+.|||+.-|+||||||.|||+..+ ...|+|||+|||+|
T Consensus       104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla  183 (438)
T KOG0666|consen  104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA  183 (438)
T ss_pred             EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence            9999999999999997543    458999999999999999999999999999999999999621 23589999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhh------hHHHHH
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------KKQKYD  226 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~------~~~~~~  226 (423)
                      +.+.++-.    |+.....++-|..|.|||.+.|.. |+.+.||||.|||+.||+|-++.|.+.....      ....+.
T Consensus       184 R~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  184 RLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             HHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99877643    222344678899999999999876 8999999999999999999988887633211      111222


Q ss_pred             HHHhhhcCCcHHH---------------------------------hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          227 KICEKKVSTPIEV---------------------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       227 ~i~~~~~~~~~~~---------------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +|.+- +..|...                                 ..+.-++...+|+.++|..||-+|.|+++.++
T Consensus       260 rIf~v-LG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEV-LGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHH-cCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            22221 1111000                                 01112455789999999999999999987655

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.2e-36  Score=314.70  Aligned_cols=143  Identities=23%  Similarity=0.465  Sum_probs=125.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....     ...+..|+.++..++| +++..+..++......|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEECCEEEEE
Confidence            689999999999999999999998999999999875432     2457888999988877 5566666667788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      |||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||+   +.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            9999 8899998865 4568999999999999999999999999999999999999   477899999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=306.24  Aligned_cols=250  Identities=20%  Similarity=0.342  Sum_probs=210.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeee-----eCCeeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~~~~~   79 (423)
                      ...|+|.+.||.|.+|.||+++.+++++.+|+||...+.. .+++..|.++++.+.+|++++.+++++.     .++.+|
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            4679999999999999999999999999999999886654 4568889999999999999999877765     357889


Q ss_pred             EEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           80 LVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |||||| +|+.-|+.+.. +.++.+..+..|++.++.||.+||...+||||||-.|||++   ..+.|||+|||.+..+.
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeeeee
Confidence            999999 89999998744 56799999999999999999999999999999999999996   89999999999998876


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      .....       ..+++||+.|||||++...     .|+.++|+||||++..||.-|.+|+.++.+...   +..|   .
T Consensus       175 sT~gr-------RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~I---p  241 (953)
T KOG0587|consen  175 STVGR-------RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLI---P  241 (953)
T ss_pred             ccccc-------ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hccC---C
Confidence            55432       3477999999999999754     367899999999999999999999998766521   1111   2


Q ss_pred             cCCcHH-HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTPIE-VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+|.. .-+..++.+|.++|..||.+|.++||+..++++
T Consensus       242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            222222 224567899999999999999999999988754

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=303.23  Aligned_cols=265  Identities=21%  Similarity=0.299  Sum_probs=213.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+++++..||-|+||.|-++........+|+|++++..     ..+.+..|-++|...+. +.|+.++-.+.+..+.|+.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s-~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRS-DFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc-hHHHHHHHHhccchhhhhh
Confidence            45677889999999999999886655568999877542     23347788899988874 6666666566688899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||-| ||.|...+.. ++.|+..++..++..+++|++|||++|||+|||||+|+|+   +..|-+||.|||+|+.+....
T Consensus       499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence            9999 9999999986 6679999999999999999999999999999999999999   689999999999999887654


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .        ..+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.+..   ..|..|+.+.-..   .+
T Consensus       575 K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---ktYn~ILkGid~i---~~  640 (732)
T KOG0614|consen  575 K--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---KTYNLILKGIDKI---EF  640 (732)
T ss_pred             c--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHhhhhhh---hc
Confidence            2        34889999999999999999999999999999999999999999987665   4444444432211   12


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceeccc
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY  295 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~  295 (423)
                      ++.++....+||.++...+|.+|..+.  ..-+.++   ..+.|...|||+.++.
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~--~~gI~DI---kkH~Wf~gfdweglr~  690 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLGYQ--KGGINDI---KKHRWFEGFDWEGLRS  690 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhccc--cCChHHH---HhhhhhhcCChhhhhh
Confidence            255688899999999999999997631  1112222   3356777899988753

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=285.83  Aligned_cols=267  Identities=25%  Similarity=0.313  Sum_probs=211.8

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeEEEeee---eC
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWYGV---DG   75 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~--l~~~~~i~~i~~~~~---~~   75 (423)
                      ++|.++++.++.+.||+|.||+||+|+|  .|+.||||++... ++....+|.++++.  |+|.+++-.|..-..   .-
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            4678899999999999999999999999  5788999999764 45668888888875  566544433321111   12


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcccccccCCceEEeecCCCCcEE
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVY  146 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------giiHrDIKp~NILl~~~~~~~~vk  146 (423)
                      ...+||++|. .|+|.|++..  ..++.+..++++..+|.||+|||-.        .|.|||||..|||+   ..++.+.
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~  356 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC  356 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEE
Confidence            4579999999 9999999984  6799999999999999999999953        49999999999999   5899999


Q ss_pred             EeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCC------CCccchHHHHHHHHHHHHhC----------C
Q 014527          147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRG----------S  210 (423)
Q Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~~sDIwSlGvil~elltG----------~  210 (423)
                      |+|+|+|...........++   +...+||.+|||||++...-      .-..+||||||.|+||++..          +
T Consensus       357 IADLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  357 IADLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             EeeceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            99999999887765444443   33668999999999986432      12478999999999999863          6


Q ss_pred             CCCCCchhh--hhHHHHHHHHhhhcCCcHHHhhccCh--HHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          211 LPWQGLKAA--TKKQKYDKICEKKVSTPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       211 ~Pf~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      +||.+.-+.  ...+...-++.+++.+.++..+...|  ..+.++|+.||..||.-|-++--|.+.|.++.+
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            888875433  23444445667777777776666555  468899999999999999999999999988763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=302.16  Aligned_cols=242  Identities=21%  Similarity=0.263  Sum_probs=201.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +...|++...+|.|+|+.|-.+.+..+++..++|++...  ..+..+|+.++....+++++..+.....+..+.|+|||+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            456799999999999999999999999999999998776  334567888888888889998888888899999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + |+-+.+.+.. .+.+. .++..|+.+|+.|+.|||++|||||||||+|||+.  ++.+.++|+|||.++.......  
T Consensus       398 l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~~--  471 (612)
T KOG0603|consen  398 LDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSCD--  471 (612)
T ss_pred             ccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhhc--
Confidence            9 6666666553 22233 78888999999999999999999999999999994  3788999999999987665411  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                              ..+-|..|.|||++...+|+.++||||||++||+|++|+.||......  .+.+.++....+.       ..
T Consensus       472 --------tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~  534 (612)
T KOG0603|consen  472 --------TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------EC  534 (612)
T ss_pred             --------ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------cc
Confidence                    335689999999999999999999999999999999999999864433  2333333322222       45


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +++..++||.+||+.||.+||+++++..
T Consensus       535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  535 VSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            6899999999999999999999999855

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.3e-36  Score=287.99  Aligned_cols=259  Identities=19%  Similarity=0.242  Sum_probs=187.7

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .+++.+|.|  |.||.++...+++.||||++....    ....+..|+.+++.++|+ ++..+..+....+..+++|||+
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~-~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP-NILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCc-chhhhhheeecCCeEEEEEecc
Confidence            344444444  556666666689999999876542    234588999999999875 4555555666778899999999


Q ss_pred             -CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           86 -GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        86 -~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                       +++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++   .++.+||+|||.+..........
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeeccccccc
Confidence             78899888753 34689999999999999999999999999999999999994   67899999999987664432211


Q ss_pred             cccccCCCcccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh---------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------  232 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------  232 (423)
                      ...........++..|+|||.+.+.  .++.++|||||||++|+|++|+.||.......  ....++....         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence            1111122345678899999998763  48899999999999999999999998643321  1111111000         


Q ss_pred             ------cC-------C------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          233 ------VS-------T------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       233 ------~~-------~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                            ..       .      ........++.++.+++..||..||++||+++++++  ..++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~p~~~  299 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN--HSFFK  299 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc--CchHh
Confidence                  00       0      000111223568899999999999999999999977  44443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=280.59  Aligned_cols=251  Identities=20%  Similarity=0.291  Sum_probs=200.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..+-+..||.|+||+|++..++.+|+..|||.++....   ..+++.|.+...+-..+++|+.++.....+...||.||+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            34456789999999999999999999999998776543   445888888877777777776666555677889999999


Q ss_pred             cCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           85 LGPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        85 ~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      +..+|..++..    ....+++..+-.|..-.+.||.||-. ..||||||||+|||+   +..|.|||||||.+-.+.+.
T Consensus       145 Md~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             HhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHH
Confidence            99999888763    24568999999999999999999975 589999999999999   68999999999999766544


Q ss_pred             CCCCcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc-
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-  236 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  236 (423)
                      -..        ..-.|...|||||.+..  ..|+.+|||||||++|||+.||+.||.+.+.  ..+.+..+..+..+.. 
T Consensus       222 iAk--------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  222 IAK--------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILL  291 (361)
T ss_pred             HHh--------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeec
Confidence            321        24478899999999973  3489999999999999999999999998654  3344444433332221 


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...-+-.++..+..+|..||.+|-.+||.+.+|++
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            12223457889999999999999999999999876

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=255.07  Aligned_cols=254  Identities=21%  Similarity=0.271  Sum_probs=204.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .+|.-.++||+|.||+||+|+...+++.||+|..+.+...    ...++|+-+++.|.|.+ |..++..-......-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhkn-ivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN-IVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcc-eeehhhhhccCceeEEeH
Confidence            3577889999999999999999999999999987765433    35899999999999854 555555555677889999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |||..+|..++...++.++.+.+..++.|++.||.|+|+++++||||||.|.|+   +.++.+||+|||+|+.+.-+.  
T Consensus        81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce--
Confidence            999999999999999999999999999999999999999999999999999999   589999999999998765432  


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcH---
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI---  237 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~---  237 (423)
                           +.....+-|..|.+|.++.|.. |+...|+||.|||+.|+.. |.+.|.+.+..+....+.+..........   
T Consensus       156 -----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             -----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence                 3334567799999999999877 8999999999999999997 88889886655444444443322111100   


Q ss_pred             ------------------HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          238 ------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       238 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                        ..+.+.+...=+++++++|.-+|.+|.++++.++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                              0111222344589999999999999999987654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=273.86  Aligned_cols=234  Identities=25%  Similarity=0.361  Sum_probs=190.7

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ||.|+||.||+|.+..+++.||+|++.....     ...+..|+.+++.+.| +++..+...+......+++||++ +++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-PFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC-CcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            6899999999999988899999998765432     2357889999999986 45555555566788899999999 999


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                      |.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||+++   ..+.++|+|||++........       
T Consensus        80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~-------  148 (250)
T cd05123          80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGS-------  148 (250)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCC-------
Confidence            9998875 34689999999999999999999999999999999999994   778999999999987654321       


Q ss_pred             CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHH
Q 014527          169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF  248 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  248 (423)
                      ......++..|+|||.+.+...+.++|+||||+++|+|++|..||.....   .+.+..+.......     ....+..+
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-----~~~~~~~l  220 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLRF-----PEFLSPEA  220 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCCC-----CCCCCHHH
Confidence            11245688899999999988889999999999999999999999976433   23333333322222     23448899


Q ss_pred             HHHHHHHhcCCCCCCCChHH
Q 014527          249 ASYFHYCQSLTFDQRPDYGF  268 (423)
Q Consensus       249 ~~li~~cl~~dP~~RPt~~~  268 (423)
                      .+++.+||..||++||++.+
T Consensus       221 ~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         221 RDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHhcCCHhhCCCccc
Confidence            99999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=276.07  Aligned_cols=269  Identities=20%  Similarity=0.310  Sum_probs=219.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      -+.|.+++.||+|+|..|.+++.+++.+.||+|++++.     ...+-.+.|-.++..-..++.+.-++.++......++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46899999999999999999999999999999986643     3344478888888888877777777888999999999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |.||. ||+|--.+.. .++++++.+..+...|+.||.|||++|||+||||.+|+|+   |..+.+||+|+|+++.-..+
T Consensus       329 vieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence            99999 7777665554 6789999999999999999999999999999999999999   69999999999999865444


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCc-----hhhhhHHHHHHHHhhhcC
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL-----KAATKKQKYDKICEKKVS  234 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~-----~~~~~~~~~~~i~~~~~~  234 (423)
                      ..       ...+++|||.|.|||++.|.+|+..+|.|+|||+|+||+.|+-||.-.     ...+....++-|+++.+.
T Consensus       405 gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  405 GD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             Cc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            33       345889999999999999999999999999999999999999999632     122344556667777777


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                      .|     ..++.....+++.-|++||.+|....-- .-|.++   .++.|.-..||+.+.
T Consensus       478 ip-----rslsvkas~vlkgflnkdp~erlgc~~~-~g~~di---k~h~ffr~idwd~le  528 (593)
T KOG0695|consen  478 IP-----RSLSVKASHVLKGFLNKDPKERLGCRPQ-TGFSDI---KSHAFFRSIDWDLLE  528 (593)
T ss_pred             cc-----ceeehhhHHHHHHhhcCCcHHhcCCCcc-cchhhh---hcchhhhhCCHHHHh
Confidence            76     3447778889999999999999643211 022222   345555567898764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.1e-36  Score=313.94  Aligned_cols=257  Identities=21%  Similarity=0.253  Sum_probs=192.0

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeee---------
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGV---------   73 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~---------   73 (423)
                      ..+|+.++.||+||||.||+|+.+-+|+.||||.+....   ....+.+|+.++.+|+|++.+..+..+..         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            357888999999999999999999999999999776543   23348899999999998654421100000         


Q ss_pred             --------------------------------------------------------------------eC----------
Q 014527           74 --------------------------------------------------------------------DG----------   75 (423)
Q Consensus        74 --------------------------------------------------------------------~~----------   75 (423)
                                                                                          ++          
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                00          


Q ss_pred             -------------------------------CeeEEEEeccCCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcC
Q 014527           76 -------------------------------EDNVLVLDLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRG  123 (423)
Q Consensus        76 -------------------------------~~~~lv~e~~~~sL~~~l~~~~~~l-~~~~~~~i~~qi~~aL~yLH~~g  123 (423)
                                                     ...||-||||..++...+...+... .....+++++||+.||.|+|++|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                           1247889999777766666544333 47889999999999999999999


Q ss_pred             cccccccCCceEEeecCCCCcEEEeeccceeeec----C------CCCCCc-ccccCCCcccccccccCcccccCCC---
Q 014527          124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----D------PTTNRH-IPYRENKNLTGTARYASCNTHLGIE---  189 (423)
Q Consensus       124 iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~----~------~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~---  189 (423)
                      ||||||||.||++   ++.+.|||+|||+|....    .      ...... ..-......+||.-|+|||++.+..   
T Consensus       718 iIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             eeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999   589999999999998722    0      000000 1111234678999999999998765   


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHH
Q 014527          190 QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL  269 (423)
Q Consensus       190 ~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  269 (423)
                      |+.|+|+|||||||+||+.   ||.  +..+....+..+....++.+ ..+...--+.-+.+|+.|++.||++|||+.+|
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence            9999999999999999994   676  34555566666555555555 22222223456889999999999999999998


Q ss_pred             HH
Q 014527          270 KR  271 (423)
Q Consensus       270 ~~  271 (423)
                      +.
T Consensus       869 L~  870 (1351)
T KOG1035|consen  869 LN  870 (1351)
T ss_pred             hh
Confidence            65

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-37  Score=275.22  Aligned_cols=261  Identities=23%  Similarity=0.256  Sum_probs=204.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-------
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-------   73 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-------   73 (423)
                      ..+.|+-..+||+|.||+||+|+.+.+++.||+|+.-.+.    -....++|+++|..|.|.+.+..+..+..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            4577888899999999999999999999999998533221    22347899999999999776655533321       


Q ss_pred             eCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        74 ~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      +...+|+|+.+|..+|..++.....+++..++..++.++..||.|+|+..|+|||+||+|+||   +.++.+||+|||++
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGla  171 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLA  171 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccccc
Confidence            334589999999999999998766789999999999999999999999999999999999999   48899999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +.+..........   ....+-|..|.+||.+.|.. |+++.|||..|||+.||+||.+.|++.+.......+..++...
T Consensus       172 r~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  172 RAFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             cceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            8876554333221   23556799999999998764 8999999999999999999999999876655555555444332


Q ss_pred             cCCcHHH--------------hh----c---------cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTPIEV--------------LC----K---------SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~~~~--------------~~----~---------~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....+.              +.    .         .-.++..+|+.++|..||.+|+++++.+.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            1111000              00    0         01346789999999999999999998865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=279.51  Aligned_cols=137  Identities=27%  Similarity=0.521  Sum_probs=116.3

Q ss_pred             CCcccC-CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCC-------CCCeEEEe
Q 014527            1 MERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGS-------GIPNIKWY   71 (423)
Q Consensus         1 ~~~i~~-~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-~~~~~E~~~l~~l~~~~-------~i~~i~~~   71 (423)
                      ++.++. ++|.+.++||.|.|++||+|.+..+.+.||+||.+..... +..+.|+++|+.++...       +|..+..+
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            466776 9999999999999999999999999999999998876543 34789999999997543       33333222


Q ss_pred             ----eeeCCeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEe
Q 014527           72 ----GVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMG  137 (423)
Q Consensus        72 ----~~~~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~  137 (423)
                          |..+.+.|||+|++|.+|+.++.+.. +.++...+..|++||+.||.|||.+ ||||-||||+|||+.
T Consensus       151 FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence                34677899999999999999998664 5699999999999999999999975 999999999999994

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-35  Score=303.25  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=208.2

Q ss_pred             CceEEeceeeecCceeEEEEEECC-------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~-------~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      .+.++.+.||+|.||.|++|....       ....||||.++....   .+.+..|+++|+.+.+|+++..+..++....
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            444677799999999999997541       145699998776544   3568999999999998888888887777788


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR  140 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~  140 (423)
                      ..++|+||+ .|+|.+++...+               ..++..+.+.++.||+.|++||+++.+|||||..+|||++   
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~---  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT---  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---
Confidence            999999999 999999998766               3489999999999999999999999999999999999995   


Q ss_pred             CCCcEEEeeccceeeecCCCCCCcccccCCCccc--ccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                      .+..+||+|||+|+........     .. ....  -...|||||.+....|+.++|||||||+|||+++ |..||.+..
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y-----~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYY-----RT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             CCCEEEEccccceeccCCCCce-----Ee-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            7789999999999865443321     11 1112  2456999999999999999999999999999999 999999854


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...  ..+. ..........+.   .+++++.++|..||+.+|++||+|.++.+.|...+..
T Consensus       527 ~~~--~l~~-~l~~G~r~~~P~---~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  527 PTE--ELLE-FLKEGNRMEQPE---HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             cHH--HHHH-HHhcCCCCCCCC---CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            221  2222 233333333333   3389999999999999999999999999999997654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.6e-35  Score=270.64  Aligned_cols=221  Identities=17%  Similarity=0.170  Sum_probs=174.0

Q ss_pred             cCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHh
Q 014527           18 GSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC   96 (423)
Q Consensus        18 G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~   96 (423)
                      |.||.||+|++..+++.||+|.+....   ....|...+.... +++++.+..++...+..+++|||+ +++|.+++.. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence            899999999999999999999886543   2334444444434 356666767777888999999999 7899998865 


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCccccc
Q 014527           97 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT  176 (423)
Q Consensus        97 ~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt  176 (423)
                      ...+++..+..++.|++.||.|||++||+||||||+||++   +.++.++|+|||.+........          ...++
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~~----------~~~~~  145 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSCD----------GEAVE  145 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccccc----------cCCcC
Confidence            3469999999999999999999999999999999999999   4788899999998865543211          23456


Q ss_pred             ccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHh
Q 014527          177 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQ  256 (423)
Q Consensus       177 ~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl  256 (423)
                      ..|+|||.+.+..++.++|||||||++|||++|..||......        + ......   .+...+++.++++|.+||
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~-~~~~~~---~~~~~~~~~~~~li~~~l  213 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------I-NTHTTL---NIPEWVSEEARSLLQQLL  213 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------c-cccccc---CCcccCCHHHHHHHHHHc
Confidence            7899999998888999999999999999999999887642211        0 000000   112345788999999999


Q ss_pred             cCCCCCCCChHH
Q 014527          257 SLTFDQRPDYGF  268 (423)
Q Consensus       257 ~~dP~~RPt~~~  268 (423)
                      +.||++||++.+
T Consensus       214 ~~dp~~R~~~~~  225 (237)
T cd05576         214 QFNPTERLGAGV  225 (237)
T ss_pred             cCCHHHhcCCCc
Confidence            999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.9e-35  Score=300.86  Aligned_cols=259  Identities=20%  Similarity=0.232  Sum_probs=172.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC----CcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEE----e-eeeCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT----NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW----Y-GVDGE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~----~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~----~-~~~~~   76 (423)
                      .++|++.+.||+|+||.||+|++..+    +..||||.+......+....| . +....+......+..    . .....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~-l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-R-VRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-H-HHhhchhhHHHHHHhhhcccccccCC
Confidence            46899999999999999999999888    899999987643322221111 1 111111111111111    1 23566


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEE
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRK-------------------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM  136 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl  136 (423)
                      ..++||||+ +++|.+++......                   .....+..++.||+.||.|||++||+||||||+|||+
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl  288 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF  288 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence            789999999 78898887643211                   1234466899999999999999999999999999999


Q ss_pred             eecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCC----------------------CCccc
Q 014527          137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----------------------QSRRD  194 (423)
Q Consensus       137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----------------------~s~~s  194 (423)
                      +  ++.+.+||+|||+|+.+......      ......+++.|+|||.+....                      ++.++
T Consensus       289 ~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        289 S--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             e--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            5  34578999999999865433221      123567899999999764322                      34567


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh--------------hcCCcHH---HhhccChHHHHHHHHHHhc
Q 014527          195 DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--------------KVSTPIE---VLCKSHPAEFASYFHYCQS  257 (423)
Q Consensus       195 DIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--------------~~~~~~~---~~~~~~~~~l~~li~~cl~  257 (423)
                      |||||||+||||+++..|+....     ..+.+....              .......   ...........+||.+||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNL-----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHH-----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999999887765311     111111110              0000000   0001112345689999999


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhcC
Q 014527          258 LTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       258 ~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      .||.+||++.++++  +.+|...+
T Consensus       436 ~dP~kR~ta~e~L~--Hpff~~~~  457 (566)
T PLN03225        436 FKGRQRISAKAALA--HPYFDREG  457 (566)
T ss_pred             CCcccCCCHHHHhC--CcCcCCCC
Confidence            99999999999976  56665444

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8.1e-36  Score=286.53  Aligned_cols=209  Identities=22%  Similarity=0.296  Sum_probs=178.5

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCC-----CCCCeEEEeeee
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGG-----SGIPNIKWYGVD   74 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~-----~~i~~i~~~~~~   74 (423)
                      ++.++.++|.+....|+|-|++|-+|.+..-+..|||||+.... .++.-+.|+++|++|+..     .|+..+.-.+..
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            46789999999999999999999999999889999999987654 455678999999999753     223333333456


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~--l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      .+++|||+|.+.-+|.++++..+..  |.+..+..++.||..||..|-..||+|.||||+||||.  .....+||||||.
T Consensus       506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGS  583 (752)
T KOG0670|consen  506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGS  583 (752)
T ss_pred             cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCcc
Confidence            7899999999999999999976654  78899999999999999999999999999999999996  5677899999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT  220 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~  220 (423)
                      |....+...   .      .+.-+..|.|||++.|.+|+...|+||+||+||||.||+..|.|.+...
T Consensus       584 A~~~~enei---t------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~  642 (752)
T KOG0670|consen  584 ASFASENEI---T------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ  642 (752)
T ss_pred             ccccccccc---c------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence            987665432   2      3345778999999999999999999999999999999999999865543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=286.58  Aligned_cols=257  Identities=21%  Similarity=0.256  Sum_probs=209.3

Q ss_pred             ceEEeceeeecCceeEEEEEECCCC----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~----~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ..+..++||+|+||+||+|.|.-.+    .+||||++.....   ..+++.|+-+|..|.|++.+..+.. .... ...|
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgv-c~~s-~~ql  774 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGV-CMLS-TLQL  774 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhh-cccc-hHHH
Confidence            3456788999999999999987444    3699998775543   4569999999999998555444433 3222 2779


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |++|+ .|.|.++++..+..+-....+.|+.||++||.|||.++++||||..+||||   .....+||.|||+|+.+...
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcc
Confidence            99999 999999999988899999999999999999999999999999999999999   47889999999999987665


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ......+     ...-.+.|||-|.+....|+.++|||||||++|||+| |..||.+....+....+++    ..+.+.+
T Consensus       852 ~~ey~~~-----~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----geRLsqP  922 (1177)
T KOG1025|consen  852 EKEYSAP-----GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----GERLSQP  922 (1177)
T ss_pred             ccccccc-----ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----cccCCCC
Confidence            5433221     3344678999999999999999999999999999999 9999999877655554432    2223322


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      .   ..+.++.-+|.+||..|++.||+|+++...|..+.+...
T Consensus       923 p---iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  923 P---ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             C---CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            3   338899999999999999999999999999998876544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.9e-34  Score=314.68  Aligned_cols=248  Identities=13%  Similarity=0.168  Sum_probs=187.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-C
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G   86 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~   86 (423)
                      .|...+.||+|+||.||+|++..++..||||.+.....  ....|++++++++| +++..+..++.+....++||||+ +
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH-PNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC-CCcceEEEEEEcCCCCEEEEeCCCC
Confidence            46667889999999999999988999999998764332  23457888999976 56667777777788899999999 8


Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH---SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      ++|.+++.    .+++..+..|+.||+.||+|||   +.+|+||||||+||++   +.+...++. ||.+......    
T Consensus       768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~~----  835 (968)
T PLN00113        768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCTD----  835 (968)
T ss_pred             CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccccC----
Confidence            99999885    3899999999999999999999   6799999999999999   456666664 6654432211    


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh-hHHHHHHH----------Hhhh
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKI----------CEKK  232 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i----------~~~~  232 (423)
                             ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+.          .+..
T Consensus       836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence                   13367899999999999999999999999999999999999995422110 00001000          0000


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ..... ........++.+++.+||+.+|++||+++++++.|+.+..
T Consensus       909 ~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            00000 0000113467889999999999999999999999998765

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-34  Score=281.90  Aligned_cols=270  Identities=22%  Similarity=0.297  Sum_probs=205.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      -..-|..++.||-|+||+|.+++..+|...||+|.+++...     ...+..|-.||..-.. +-++.+++-+.+.+.+|
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEeccCCceE
Confidence            34568899999999999999999999999999998765432     2235667778777664 66777788888999999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||+|. ||++-.+|.. -+-|.+..+..++..+..|+++.|+.|+|||||||+||||   |.+|.|||+||||+.-++-
T Consensus       706 FVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeecccccccee
Confidence            999999 9999999886 4569999999999999999999999999999999999999   6999999999999975431


Q ss_pred             CCCCC------c---------------------cccc--------CCCcccccccccCcccccCCCCCccchHHHHHHHH
Q 014527          159 PTTNR------H---------------------IPYR--------ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL  203 (423)
Q Consensus       159 ~~~~~------~---------------------~~~~--------~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil  203 (423)
                      .....      |                     +..+        ....++||+.|+|||++....|+..+|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence            10000      0                     0000        12357899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC---hHHHHHHHHHHHHhc
Q 014527          204 LYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKRLFHDLFSRE  280 (423)
Q Consensus       204 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~l~~~L~~~~~~~  280 (423)
                      |||+.|+.||..........++... +.-+..   ..|.+++.+..++|.++. .+++.|..   +++|          .
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv~nw-~~~l~~---~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~v----------K  926 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKVINW-RNFLHI---PYQGNLSKEALDLIQKLC-CSADSRLGKNGADQV----------K  926 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeeeeeh-hhcccc---ccccccCHHHHHHHHHHh-cChhhhhcccchhhh----------h
Confidence            9999999999876554433332211 111111   234566888888888754 46788863   2223          3


Q ss_pred             CCCCCcceeceecc
Q 014527          281 GYDFDFVFDWTILK  294 (423)
Q Consensus       281 ~~~~~~~~dw~~~~  294 (423)
                      .+.|....||..++
T Consensus       927 aHpfFkgIDfsslR  940 (1034)
T KOG0608|consen  927 AHPFFKGIDFSSLR  940 (1034)
T ss_pred             cCccccccchHhhh
Confidence            45666677886544

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=272.01  Aligned_cols=257  Identities=23%  Similarity=0.295  Sum_probs=193.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHc-CCCCCCeEEEeeee----CCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSGIPNIKWYGVD----GEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~-~~~~i~~i~~~~~~----~~~~~lv~   82 (423)
                      ..++.+.||+|.||.||+|..  +++.||||++... ..+.++.|-+|+.... .|++|..+......    ...++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            456788999999999999987  6799999998753 4566888888877642 23444444333332    34789999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      +|. .|+|.+++.  ...+++....+|+..|++||+|||+.         .|+|||||.+||||   ..+.+..|+|||+
T Consensus       288 ~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccce
Confidence            999 999999998  45699999999999999999999963         59999999999999   5899999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCC-CC-----ccchHHHHHHHHHHHHhCC------------CCCC
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QS-----RRDDLESLGYVLLYFLRGS------------LPWQ  214 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~~sDIwSlGvil~elltG~------------~Pf~  214 (423)
                      |..+.......     .....+||.+|||||++.|.- +.     .+.||||+|.|||||++.-            +||.
T Consensus       363 Al~~~p~~~~~-----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  363 ALRLEPGKPQG-----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eEEecCCCCCc-----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            99887433221     223578999999999998754 22     3689999999999999752            3343


Q ss_pred             Cc--hhhhhHHHHHHHHhhhcCCcHHHhh--ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          215 GL--KAATKKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       215 ~~--~~~~~~~~~~~i~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ..  ......+....+..++.++.++..+  .....-+++.+..||..||+.|.|+.-+.+.+.++.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            10  1112223333344444444444333  334567999999999999999999999988887764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.6e-32  Score=251.68  Aligned_cols=236  Identities=26%  Similarity=0.363  Sum_probs=188.4

Q ss_pred             CceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCHHHHHH
Q 014527           19 SFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFV   94 (423)
Q Consensus        19 ~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~   94 (423)
                      +||.||+|.+..+++.||+|++.....   ...+.+|++.++.++| +++..+..+.......++++|++ +++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999988899999999876554   4678999999999965 56666666666778899999999 459999887


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCccc
Q 014527           95 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT  174 (423)
Q Consensus        95 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~  174 (423)
                      ... .++...++.++.+++.+|.|||+.+++|+||+|+||+++   ..+.++|+|||.+........        .....
T Consensus        80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~--------~~~~~  147 (244)
T smart00220       80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGL--------LTTFV  147 (244)
T ss_pred             hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccc--------ccccc
Confidence            533 389999999999999999999999999999999999994   678999999999987655421        12456


Q ss_pred             ccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHH
Q 014527          175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY  254 (423)
Q Consensus       175 gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~  254 (423)
                      ++..|+|||.+.+..++.++||||||+++|+|++|..||......  ......+........  .....++.++.+++.+
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~  223 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPPFP--PPEWKISPEAKDLIRK  223 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCCc--cccccCCHHHHHHHHH
Confidence            788999999999888999999999999999999999999763222  122222222111111  1111158899999999


Q ss_pred             HhcCCCCCCCChHHHHH
Q 014527          255 CQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       255 cl~~dP~~RPt~~~l~~  271 (423)
                      ||..+|++||++.++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      224 LLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HccCCchhccCHHHHhh
Confidence            99999999999999875

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=261.01  Aligned_cols=261  Identities=18%  Similarity=0.263  Sum_probs=206.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~~~---~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      -..++++...+-+|.||.||+|.+++.     .+.|.+|.++.....-   .++.|.-.+..+.|++..+.......+..
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            346788888999999999999988743     2346677666544333   36778777888887666666666666777


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEe
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      ..++++.+. -|+|..++..++       +.++..+...++.|++.|++|||++||||.||..+|++|   |+.-+|||+
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVklt  438 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLT  438 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEec
Confidence            888888888 689999988654       237778889999999999999999999999999999999   688999999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHH
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~  227 (423)
                      |=.+++.+-......     -.........|||||.+....|+.++||||||++||||+| |+.||...++.+....+..
T Consensus       439 DsaLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             cchhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            999998765443321     1223345678999999999999999999999999999999 9999998776544333322


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                        +.++..|     -++|+++..+|..||...|++||++++++..|.++-.+.
T Consensus       514 --GyRlaQP-----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  514 --GYRLAQP-----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             --cceecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence              2333333     344999999999999999999999999999999886554

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=284.04  Aligned_cols=247  Identities=21%  Similarity=0.190  Sum_probs=190.2

Q ss_pred             EeceeeecCce-eEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccCCCH
Q 014527           11 LGRKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSL   89 (423)
Q Consensus        11 i~~~Lg~G~fg-~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~~sL   89 (423)
                      -.+.+|.|+.| .||+|..  .++.||||.+-.. ...-..+|+..|+.-+.|+++..++....+....||..|+|..+|
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL  589 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE-FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSL  589 (903)
T ss_pred             cHHHcccCCCCcEEEEEee--CCceehHHHHhhH-hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhH
Confidence            34678899887 6899988  7889999965432 234568999999999888888666666667888999999999999


Q ss_pred             HHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC--CCCcEEEeeccceeeecCCCCCCc
Q 014527           90 EDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        90 ~~~l~~~~~~---l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                      .+++......   ......+.++.|++.||++||+.+||||||||.||||+..+  ...+++|+|||+++.+......  
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS--  667 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS--  667 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch--
Confidence            9999863111   11245688899999999999999999999999999997543  3358899999999988765432  


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                        ++......||-.|+|||++.....+.++|||||||++|+.++ |.+||......     -..|.........  +...
T Consensus       668 --~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-----~~NIl~~~~~L~~--L~~~  738 (903)
T KOG1027|consen  668 --FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-----QANILTGNYTLVH--LEPL  738 (903)
T ss_pred             --hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-----hhhhhcCccceee--eccC
Confidence              334567889999999999999888899999999999999999 59999863322     1223333222110  0011


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...+..+||.+|++.+|..||++.+|+.
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1127899999999999999999999854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-33  Score=239.26  Aligned_cols=210  Identities=20%  Similarity=0.281  Sum_probs=166.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ...-+..||+|++|.|-+.++..+|...|+|.+...-.   ..++++|+.+......++.+..++.........+|.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            34456789999999999999999999999997765433   334677777766655555544443333467789999999


Q ss_pred             cCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           85 LGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        85 ~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      +..+|..+..+   .+..+++..+-+|+..++.||.|||++ .+||||+||+|||+   +..|+||+||||.+-.+.+.-
T Consensus       127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhh
Confidence            99999888763   356799999999999999999999987 89999999999999   689999999999998876654


Q ss_pred             CCCcccccCCCcccccccccCcccccCC----CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      ..        ..-.|...|||||.+..+    .|+.++||||||+++.||.++++||....  +..+++..+.+
T Consensus       204 Ak--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqvVe  267 (282)
T KOG0984|consen  204 AK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQVVE  267 (282)
T ss_pred             HH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHHhc
Confidence            22        124688899999998633    58999999999999999999999998543  34455555444

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=250.13  Aligned_cols=257  Identities=19%  Similarity=0.298  Sum_probs=194.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCCCCCeE-EEeeeeCCeeEEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSGIPNI-KWYGVDGEDNVLVL   82 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-~~~~~~~~E~~~l~~l~~~~~i~~i-~~~~~~~~~~~lv~   82 (423)
                      +...|.|.+.||+|.||.+-+|+++.++..+|+|.+... ....+|.+|...--.|.+|.+|..- ...+...+.+++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            457899999999999999999999999999999976554 4556789998877777766665433 33455667889999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ .|+|.+-+.  ...+-+.....++.|+++||.|||++++||||||.+||||-.. +..+|||||||+.+.....-.
T Consensus       102 E~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             ccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCceeh
Confidence            999 888887665  3458889999999999999999999999999999999999533 455999999999876433211


Q ss_pred             CCcccccCCCcccccccccCcccccCC---C--CCccchHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHHhhhcCC
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGI---E--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVST  235 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~  235 (423)
                                ...-+..|.+||.....   .  ..+.+|||.||+++|.++||++||+.....+. .-.+.+.. ++...
T Consensus       179 ----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~-~rk~~  247 (378)
T KOG1345|consen  179 ----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL-KRKNP  247 (378)
T ss_pred             ----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh-cccCc
Confidence                      23346678999976532   2  46789999999999999999999984322221 11222222 23333


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      ..+.....+++.+..++++-|..+|++|-..-+..+.-..
T Consensus       248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            4455567778899999999999999999655555444333

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-34  Score=255.63  Aligned_cols=252  Identities=19%  Similarity=0.270  Sum_probs=187.5

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeee----CCeeEEE
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLV   81 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~~~~lv   81 (423)
                      +--+.||.|+||.||.+++.++|+.||+|.+..-    ...+.+.+|++++..++|.+.+..+......    -...|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4457899999999999999999999999965421    2345688999999999886554333222211    1346788


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      +|++..+|..++.. ...++...+.-++.||++||.|||+.||+||||||.|.|+   +.+..+||||||+|+.......
T Consensus       136 TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  136 TELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchhhh
Confidence            99998888887764 5679999999999999999999999999999999999999   5889999999999997655433


Q ss_pred             CCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh--------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------  232 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------  232 (423)
                      ..      ....+-|-.|.|||++.|.. |+.+.||||.|||+.||+..+..|+...+....+.+..+++..        
T Consensus       212 ~h------MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  212 LN------MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             hh------hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            21      12345688999999999876 8999999999999999999999998765554433333222111        


Q ss_pred             ------------cCCcH-HHhhc-----cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 ------------VSTPI-EVLCK-----SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ------------~~~~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                  ...|. ..+..     ....+...++..++..||+.|.+.++.+.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence                        00010 00000     11235677888899999999988766544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=5.2e-31  Score=266.55  Aligned_cols=256  Identities=19%  Similarity=0.171  Sum_probs=176.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC----------------CCCcEEEEEEecCCCC----------------chhHHH
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV----------------DTNEIVAVKIENSGTK----------------HPQLLY   51 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~----------------~~~~~vaiKi~~~~~~----------------~~~~~~   51 (423)
                      +-.++|++.++||+|+||.||+|.+.                ..++.||||.+.....                .+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            44678999999999999999999752                2346799998764321                112344


Q ss_pred             HHHHHHHHcCCCCCC----eEEEeee--------eCCeeEEEEecc-CCCHHHHHHHhc---------------------
Q 014527           52 EAKVYKILQGGSGIP----NIKWYGV--------DGEDNVLVLDLL-GPSLEDLFVYCR---------------------   97 (423)
Q Consensus        52 E~~~l~~l~~~~~i~----~i~~~~~--------~~~~~~lv~e~~-~~sL~~~l~~~~---------------------   97 (423)
                      |+.++.++.+.+...    .+..|+.        .....++||||+ +++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            667777777654321    1112211        235679999999 889988876321                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccc
Q 014527           98 --RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG  175 (423)
Q Consensus        98 --~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~g  175 (423)
                        ..+++..++.++.|++.||.|||+++|+||||||+|||+   +.++.+||+|||+++........      ......+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~g~~  372 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLYGML  372 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------CccccCC
Confidence              124567889999999999999999999999999999999   46789999999999754332111      1112345


Q ss_pred             cccccCcccccCCCC----------------------CccchHHHHHHHHHHHHhCCC-CCCCchhhhhH--------HH
Q 014527          176 TARYASCNTHLGIEQ----------------------SRRDDLESLGYVLLYFLRGSL-PWQGLKAATKK--------QK  224 (423)
Q Consensus       176 t~~Y~aPE~~~~~~~----------------------s~~sDIwSlGvil~elltG~~-Pf~~~~~~~~~--------~~  224 (423)
                      |+.|+|||.+.....                      ..+.||||+||++|+|++|.+ ||.+.......        ..
T Consensus       373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~  452 (507)
T PLN03224        373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR  452 (507)
T ss_pred             CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence            889999999864321                      134799999999999999986 77643221111        11


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCC---CCCCChHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTF---DQRPDYGFLKR  271 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~~l~~  271 (423)
                      +..+.......+   .....++..++|+.+||..+|   .+|++++++++
T Consensus       453 ~r~~~~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        453 WRMYKGQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HHhhcccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            111111122221   234557899999999999876   68999998865

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.1e-32  Score=239.18  Aligned_cols=251  Identities=19%  Similarity=0.309  Sum_probs=192.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeee--CCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~~~~lv~e   83 (423)
                      ..+|++.+++|+|.|++||.|....+++.++||+++. ...+.+.+|+++|+.|.++++|..+.....+  .....+++|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            3679999999999999999999999999999999876 3456799999999999988887776554443  344679999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |. ..+...++.    .++...+..++.+++.||.|+|++||+|||+||.|++++  .....++|+|+|+|..+......
T Consensus       116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eY  189 (338)
T KOG0668|consen  116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEY  189 (338)
T ss_pred             hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCcee
Confidence            99 555555543    488899999999999999999999999999999999995  45678999999999877654321


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCC-chhhhhHHHHHHHHh----------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG-LKAATKKQKYDKICE----------  230 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~-~~~~~~~~~~~~i~~----------  230 (423)
                              ...+.+..|--||.+.... |+..-|+|||||+|..|+..+.||.. .+..+..-++.++++          
T Consensus       190 --------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  190 --------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             --------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence                    2345677888999988655 78899999999999999999999853 333332222222211          


Q ss_pred             hhcC--------------CcHHHhh-----ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 KKVS--------------TPIEVLC-----KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ~~~~--------------~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+.              .+...+.     .-.+++..+|+.++|..|-.+|+|+.|...
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1111              1111110     112578999999999999999999998754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.9e-30  Score=229.54  Aligned_cols=208  Identities=30%  Similarity=0.440  Sum_probs=180.3

Q ss_pred             eeecCceeEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCHH
Q 014527           15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE   90 (423)
Q Consensus        15 Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~   90 (423)
                      ||+|++|.||++....+++.+++|+.......   ..+.+|+..++.+.+ ++++.+..+.......+++||++ +++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            68999999999999888999999998876653   679999999999987 67777777777778999999999 49999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC-CCcEEEeeccceeeecCCCCCCcccccC
Q 014527           91 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPTTNRHIPYRE  169 (423)
Q Consensus        91 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~  169 (423)
                      +++......++...++.++.+++.+|.+||++|++|+||+|.||++.   . .+.++|+|||.+........       .
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~  149 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L  149 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence            99876445689999999999999999999999999999999999994   5 68999999999987654431       1


Q ss_pred             CCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHH
Q 014527          170 NKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF  248 (423)
Q Consensus       170 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l  248 (423)
                      .....+...|++||.+... .++.++|+|+||+++++|                                       ..+
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~  190 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL  190 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence            1245678899999999887 788999999999999999                                       468


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHH
Q 014527          249 ASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       249 ~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      .+++..|+..+|++||++.++++.
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhC
Confidence            899999999999999999988764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=260.13  Aligned_cols=195  Identities=24%  Similarity=0.351  Sum_probs=167.8

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcC--CCCCCeEEEeeeeC
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQG--GSGIPNIKWYGVDG   75 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----------~~~~~~~E~~~l~~l~~--~~~i~~i~~~~~~~   75 (423)
                      .|..++.||+|+||.|++|.++++...|+||.+.+..          .--.+-.|+.||..|+.  |++|.++..++.+.
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            4999999999999999999999999999999766543          11235689999999983  35555667778899


Q ss_pred             CeeEEEEecc--CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           76 EDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        76 ~~~~lv~e~~--~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      +++||+||--  +-+|.+++.. ...+++.++..|+.|++.|+++||++||||||||-+|+.+   +.+|.+||+|||.|
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa  717 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA  717 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence            9999999998  5678887765 6679999999999999999999999999999999999999   68999999999998


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCC
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQG  215 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~  215 (423)
                      .......         ...++||..|+|||++.|..| +..-|||+||++||.++....||..
T Consensus       718 a~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            7654322         237899999999999999987 6788999999999999999999964

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=267.80  Aligned_cols=250  Identities=18%  Similarity=0.274  Sum_probs=203.8

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ..+|+++..+|+|+||.||+|+++.+++..|+|+++...  ...-++.|+-+++..+|+++++.+..| ...+..+|+||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-lr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-LRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-hhhcCcEEEEE
Confidence            467999999999999999999999999999999877543  455678899999988887666555443 35567899999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      || +|+|.+...- .+.+++.++...++..+.||+|||++|-+|||||-.|||++   +.+.+||.|||.+..+...-. 
T Consensus        93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati~-  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATIA-  167 (829)
T ss_pred             ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhhh-
Confidence            99 7888887653 56799999999999999999999999999999999999995   899999999999977665433 


Q ss_pred             CcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          163 RHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                            ..+.+.||+.|||||+..   .+.|...+|||++|++..|+-.-+.|........   .+.-.-...+..|.-.
T Consensus       168 ------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr---~l~LmTkS~~qpp~lk  238 (829)
T KOG0576|consen  168 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR---ALFLMTKSGFQPPTLK  238 (829)
T ss_pred             ------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH---HHHHhhccCCCCCccc
Confidence                  345889999999999864   5568999999999999999999888876654432   2222223344444444


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLK  270 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  270 (423)
                      -...+.+.|.+|++.||.++|.+||+++.++
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            4456788999999999999999999998764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=240.58  Aligned_cols=252  Identities=20%  Similarity=0.234  Sum_probs=193.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeee-----eC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~   75 (423)
                      +..+|.-++.+|.|.- .|-.|.+.-.++.||+|.....    ...++..+|..++..+.|.+.+..+..|..     .-
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            4568888999999988 7888888888999999965433    344567899999999999776665555443     22


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...|+|||++..+|...+.   -.++-+.+..|+.|++.|++|||+.||+||||||+||++   ..++.+||.|||+|+.
T Consensus        94 ~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   94 QEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART  167 (369)
T ss_pred             HhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence            4579999999999999887   247788999999999999999999999999999999999   5889999999999986


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh---
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---  232 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---  232 (423)
                      ....  .      .....+.|..|.|||++.+..+...+||||+||++.||++|+..|.|.+..+...++....+..   
T Consensus       168 e~~~--~------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  168 EDTD--F------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             cCcc--c------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            5433  1      2235688999999999999999999999999999999999999998754332221111110000   


Q ss_pred             -------------------cCCcHHHhh------------ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 -------------------VSTPIEVLC------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 -------------------~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                         .........            +.-....++++.+||..||++|.+++++++
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                               000000000            111345889999999999999999988765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=5.4e-31  Score=248.86  Aligned_cols=261  Identities=24%  Similarity=0.370  Sum_probs=199.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECC---CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~---~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.+.|.++++||+|+|+.||+|.+..   ..+.||+|.+........+..|++.|..+.+..++..+..+....+..++|
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            45779999999999999999999887   788999998887777788999999999999999999998888899999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ .....+++.    .++..++..+++.++.||.++|.+|||||||||.|||++  ...++-.|+|||+|.......
T Consensus       114 lp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             ecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHhhh
Confidence            9999 556666654    478999999999999999999999999999999999996  566788999999998211100


Q ss_pred             ------C----------CC---------------------cccccCCCcccccccccCcccccCCC-CCccchHHHHHHH
Q 014527          161 ------T----------NR---------------------HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYV  202 (423)
Q Consensus       161 ------~----------~~---------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvi  202 (423)
                            .          ..                     ...-.......||+.|.|||++...+ .+.++||||.|||
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence                  0          00                     00011223567999999999988654 7899999999999


Q ss_pred             HHHHHhCCCCCCCchhh-hhH------------HHHHHHHhh-------h----------cC--------------CcHH
Q 014527          203 LLYFLRGSLPWQGLKAA-TKK------------QKYDKICEK-------K----------VS--------------TPIE  238 (423)
Q Consensus       203 l~elltG~~Pf~~~~~~-~~~------------~~~~~i~~~-------~----------~~--------------~~~~  238 (423)
                      +.-++++.+||....+. ...            .+.....+.       .          +.              ....
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            99999999999542211 000            000000000       0          00              0001


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......|..+.+|+.+||..||.+|.++++.+.
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            111234568899999999999999999998754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=4.4e-28  Score=221.38  Aligned_cols=197  Identities=32%  Similarity=0.489  Sum_probs=166.0

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      |.+.+.||.|++|.||+|....+++.+++|......   ....+.+|++.+..+.+ +++..+..+.......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH-PNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CChhhheeeeecCCceEEEEecc
Confidence            678899999999999999998889999999987654   34568889999999976 55656666666778899999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       +++|.+++......+++..+..++.+++.+|.+||+++++|+||+|.||+++   ..+.++|+|||++.........  
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~--  154 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA--  154 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc--
Confidence             5599998876433389999999999999999999999999999999999994   6799999999999887554310  


Q ss_pred             ccccCCCcccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 014527          165 IPYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLRGSLPWQG  215 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDIwSlGvil~elltG~~Pf~~  215 (423)
                          ......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus       155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                11245678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.7e-28  Score=216.75  Aligned_cols=167  Identities=17%  Similarity=0.181  Sum_probs=129.5

Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      |+|.+++...+..+++..++.|+.||+.||.|||+++      ||+|||+   +.++.+|+  ||+++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence            6889999866667999999999999999999999998      9999999   47888998  9999865432       


Q ss_pred             ccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH--HhhccC
Q 014527          167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE--VLCKSH  244 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~  244 (423)
                           ...||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+..+..........  .....+
T Consensus        63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  135 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV  135 (176)
T ss_pred             -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence                 225889999999999999999999999999999999999999764322  12222222221111000  001122


Q ss_pred             hH--HHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          245 PA--EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       245 ~~--~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      +.  ++.++|.+||..+|.+||++.+|++.+..+..
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            33  69999999999999999999999988766544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=5.1e-29  Score=269.20  Aligned_cols=188  Identities=14%  Similarity=0.181  Sum_probs=135.2

Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee----------------
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----------------  138 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~----------------  138 (423)
                      ....+++||+++++|.+++......+++.+++.++.||+.||.|||++||+||||||+||||+.                
T Consensus        52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~  131 (793)
T PLN00181         52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG  131 (793)
T ss_pred             cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence            3457888999999999999765567999999999999999999999999999999999999941                


Q ss_pred             cCCCCcEEEeeccceeeecCCCC--------CCccccc-CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhC
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTT--------NRHIPYR-ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG  209 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~--------~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG  209 (423)
                      .+..+.+||+|||+++.......        ....++. ......||+.|||||++.+..++.++|||||||+||||++|
T Consensus       132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~  211 (793)
T PLN00181        132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP  211 (793)
T ss_pred             ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence            12344567777777654321100        0000000 01124689999999999999999999999999999999999


Q ss_pred             CCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..|+....     ..+..+..... .+. . ... .+....++..||..+|.+||++.+|++
T Consensus       212 ~~~~~~~~-----~~~~~~~~~~~-~~~-~-~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        212 VSSREEKS-----RTMSSLRHRVL-PPQ-I-LLN-WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CCchhhHH-----HHHHHHHHhhc-Chh-h-hhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            88876421     11111211111 111 1 111 345678899999999999999999975

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.4e-26  Score=221.67  Aligned_cols=180  Identities=18%  Similarity=0.192  Sum_probs=136.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECC-CCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-~~~~vaiKi~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      +.+.++|++.+.||+|+||+||+|++.. +++.||||+.....       ....+.+|+++++.|.|++.++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            5678999999999999999999999876 67778999765321       133488999999999998877766543   


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc-cCCceEEeecCCCCcEEEeeccc
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDI-Kp~NILl~~~~~~~~vkL~DFGl  152 (423)
                       ...|+||||+ |++|.. +.    ...   ...++.|++.||.|||++||+|||| ||+|||+   +.++.+||+|||+
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL  158 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence             3579999999 666752 21    111   2467899999999999999999999 9999999   4678899999999


Q ss_pred             eeeecCCCCCCccc-ccCCCcccccccccCcccccCCC------CCccchHH
Q 014527          153 AKKYRDPTTNRHIP-YRENKNLTGTARYASCNTHLGIE------QSRRDDLE  197 (423)
Q Consensus       153 a~~~~~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~------~s~~sDIw  197 (423)
                      |+.+........+. +..-....+++.|+|||.+....      .+..+|-|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99876554332221 11224677889999999987543      23446665

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=5.7e-24  Score=203.16  Aligned_cols=257  Identities=30%  Similarity=0.425  Sum_probs=191.8

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      |++.+.||.|+||.||++.+.   ..+++|.+.....     ...+.+|+.++..+.+++++..+..++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999986   7789998765543     34588999999999987656666555566666899999


Q ss_pred             cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC-cEEEeeccceeeecCC
Q 014527           84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDP  159 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~-~vkL~DFGla~~~~~~  159 (423)
                      ++ ++++.+++....  ..+....+..++.|++.+|.|+|+.+++||||||+||++.   ..+ .++++|||+++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence            99 788886665433  2699999999999999999999999999999999999994   555 7999999999865543


Q ss_pred             CCCCcccccCCCcccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHHhhhcCC
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKVST  235 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~  235 (423)
                      ....... .......||..|+|||.+.+   ..++...|+||+|++++++++|..||...... ........+.......
T Consensus       156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            3211000 12346789999999999998   57889999999999999999999998765431 0112222222211110


Q ss_pred             cHHHhhcc----ChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          236 PIEVLCKS----HPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       236 ~~~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      ........    ....+.+++..|+..+|..|.+.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00011111    12578999999999999999988766543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=3.4e-24  Score=200.25  Aligned_cols=231  Identities=23%  Similarity=0.253  Sum_probs=149.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcC---------C--CCCCe----
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQG---------G--SGIPN----   67 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~---------~--~~i~~----   67 (423)
                      .+...+.||.|+++.||.|++..+++.+|+|+......     .+++.+|.-....+.+         +  -.+|.    
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45678899999999999999999999999998654432     1224444422222111         0  00111    


Q ss_pred             ------EEEeeeeCC-----eeEEEEeccCCCHHHHHHHh---cCC---CCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q 014527           68 ------IKWYGVDGE-----DNVLVLDLLGPSLEDLFVYC---RRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIK  130 (423)
Q Consensus        68 ------i~~~~~~~~-----~~~lv~e~~~~sL~~~l~~~---~~~---l~~~~~~~i~~qi~~aL~yLH~~giiHrDIK  130 (423)
                            ...-..+..     ..+++|+.+.++|.+++...   ...   +.....+.+..|+++.+++||+.|++|+||+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                  111111111     34778888899999887532   111   2334456677999999999999999999999


Q ss_pred             CCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC--------CCCCccchHHHHHHH
Q 014527          131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGYV  202 (423)
Q Consensus       131 p~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDIwSlGvi  202 (423)
                      |+||++   +.+|.++|+||+..........          ....+..|.+||....        ..++.+.|.|+||++
T Consensus       173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             GGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             eeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            999999   5899999999998876443211          1234577999997743        246889999999999


Q ss_pred             HHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCC
Q 014527          203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR  263 (423)
Q Consensus       203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  263 (423)
                      +|.|++|..||...........            .-..|..+|+.++.||..+|+.||.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999999987543321111            222455789999999999999999988

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=4.8e-25  Score=227.76  Aligned_cols=254  Identities=20%  Similarity=0.249  Sum_probs=183.8

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecC----CCCchh----HHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQ----LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~----~~~~~~----~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .....+|.|++|.|+.+........++.|....    ......    +..|.-+-..|.|.+.+..+..+... ....-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-DGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-ccchhh
Confidence            466789999999888888776666666664431    111111    33444445556665544444322222 222223


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||||.++|..++.. ...++..++..++.|++.||+|||+.||.||||||+|++++   ..+.+||+|||.+..+..+..
T Consensus       400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCcc
Confidence            99996588888764 34799999999999999999999999999999999999995   788999999999988765543


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCc-cchHHHHHHHHHHHHhCCCCCCCchhhhhHH-HHHHHHhhhcCCcHHH
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSR-RDDLESLGYVLLYFLRGSLPWQGLKAATKKQ-KYDKICEKKVSTPIEV  239 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~sDIwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~~~  239 (423)
                      ...   .....++|+..|+|||++.+.+|++ ..||||.|++++.|++|+.||......+... ................
T Consensus       476 ~~~---~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~  552 (601)
T KOG0590|consen  476 KNI---HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR  552 (601)
T ss_pred             hhh---hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence            311   1344789999999999999999875 6799999999999999999997644332211 1111112223333444


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +...+|...+.+|.+||+.+|.+|.++++|++
T Consensus       553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            55677999999999999999999999999876

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.5e-23  Score=190.39  Aligned_cols=171  Identities=16%  Similarity=0.230  Sum_probs=128.9

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchh-----------HHHHHHHHHHHcCCCCCCeEEE
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----------LLYEAKVYKILQGGSGIPNIKW   70 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~-----------~~~E~~~l~~l~~~~~i~~i~~   70 (423)
                      +.++.++|++.+.||.|+||.||++..  ++..+|||++.......+           +.+|++.+.++.| ++++.+..
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~~d  102 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASLND  102 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcceE
Confidence            467899999999999999999999765  466799999875432221           4788889999976 56777765


Q ss_pred             eeeeC--------CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           71 YGVDG--------EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        71 ~~~~~--------~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      ++...        ...+|+|||+ |.+|.++..     ++.    ....+++.+|..||+.|++||||||+||+++   +
T Consensus       103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~  170 (232)
T PRK10359        103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K  170 (232)
T ss_pred             eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence            54432        3578999999 567877632     332    3466999999999999999999999999995   5


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHH
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL  207 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ell  207 (423)
                      ++ ++|+|||...........                   ........++.++|+||||+++..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~-------------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK-------------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhH-------------------HHHHHHhHhcccccccceeEeehHHH
Confidence            56 999999988654322110                   11334445678999999999988765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=4.2e-23  Score=184.66  Aligned_cols=136  Identities=21%  Similarity=0.246  Sum_probs=103.4

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----------chh-----------------HHHHHHHHHHHcCCC
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQ-----------------LLYEAKVYKILQGGS   63 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----------~~~-----------------~~~E~~~l~~l~~~~   63 (423)
                      .+.||+|+||.||+|.+. +|+.||||+++....           ...                 ...|++++..+.+. 
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA-   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC-
Confidence            568999999999999986 899999999865421           111                 23499999999763 


Q ss_pred             CCCeEEEeeeeCCeeEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcccccccCCceEEeecCC
Q 014527           64 GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        64 ~i~~i~~~~~~~~~~~lv~e~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~giiHrDIKp~NILl~~~~~  141 (423)
                      +++....+..  ...+|||||+++ ++...... ...++...+..++.||+.+|.|| |+.||+||||||+|||++    
T Consensus        80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----  152 (190)
T cd05147          80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----  152 (190)
T ss_pred             CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence            3222222221  234899999955 44333222 45799999999999999999999 799999999999999994    


Q ss_pred             CCcEEEeeccceeee
Q 014527          142 ANQVYIIDFGLAKKY  156 (423)
Q Consensus       142 ~~~vkL~DFGla~~~  156 (423)
                      .+.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=4.5e-22  Score=210.03  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=185.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +-+..|.|.+.||+|+||.||+|...+ ++.||||+.+.....+- .-=.+++.+|+  -.+.+-.+.......+.-+||
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf-YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF-YICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee-eehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            346789999999999999999999877 99999999887665431 11122333333  112233333334456677999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec----CCCCcEEEeeccceeee
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----RKANQVYIIDFGLAKKY  156 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~----~~~~~vkL~DFGla~~~  156 (423)
                      +||. .|+|.+++. ..+.+++..++.++.||+.-+++||..+|||+||||+|+||...    .+...++|+|||.+-.+
T Consensus       773 ~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999 999999998 46679999999999999999999999999999999999999642    23457999999998655


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .--...     ......++|-.+-.+|+..|.+++..+|.|.|+.+++-||.|++-=              ...+.....
T Consensus       852 ~lfp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~g~~~~~  912 (974)
T KOG1166|consen  852 KLFPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKNGSSWMV  912 (974)
T ss_pred             eEcCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcCCcceec
Confidence            432221     1234678899999999999999999999999999999999985431              101100000


Q ss_pred             HHHhhccC-hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          237 IEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       237 ~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ...+.+.+ -+-+.+|+..+|+.|-..=|...+|...|+.++.+.
T Consensus       913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence            00000000 133678888888866666688899988888887654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=8.1e-22  Score=176.68  Aligned_cols=138  Identities=22%  Similarity=0.251  Sum_probs=105.6

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----------------------------hhHHHHHHHHHHHcCC
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------------------PQLLYEAKVYKILQGG   62 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----------------------------~~~~~E~~~l~~l~~~   62 (423)
                      +.+.||+|+||.||+|.+. +|+.||||+++.....                            ..+.+|...+..+.+.
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999997754210                            1135788889998874


Q ss_pred             CCCCeEEEeeeeCCeeEEEEeccCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecC
Q 014527           63 SGIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR  140 (423)
Q Consensus        63 ~~i~~i~~~~~~~~~~~lv~e~~~~s-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~  140 (423)
                      . ++....+...  ..+|||||++|. +..... ....++...+..++.|++.+|.+||+ +||+||||||+|||++   
T Consensus        80 ~-i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---  152 (190)
T cd05145          80 G-VPVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---  152 (190)
T ss_pred             C-CCCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence            3 3332222222  358999999543 433222 23568889999999999999999999 9999999999999993   


Q ss_pred             CCCcEEEeeccceeeec
Q 014527          141 KANQVYIIDFGLAKKYR  157 (423)
Q Consensus       141 ~~~~vkL~DFGla~~~~  157 (423)
                       ++.++|+|||+|....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             6889999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=5.8e-23  Score=213.26  Aligned_cols=248  Identities=18%  Similarity=0.143  Sum_probs=173.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +|...+.||++.|=.|.+|++.+ |. |+||++-+..      ...+.+.|++ ....++ +++..+...-......|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~-pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKA-PNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcC-CcccchHHHHHhhHHHHHH
Confidence            78899999999999999998754 44 9999876543      1233445555 333444 4443343334455677889


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      -+|...+|.|.+.. +.-+..-+...|+.||+.||..+|..||+|||||.+||||+   ..+=+.|+||..-+...-+.+
T Consensus       100 RqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence            99999999998863 33477888999999999999999999999999999999996   788899999987765433222


Q ss_pred             CCc-ccccCCCcccccccccCcccccCC----------C-CCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHH
Q 014527          162 NRH-IPYRENKNLTGTARYASCNTHLGI----------E-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       162 ~~~-~~~~~~~~~~gt~~Y~aPE~~~~~----------~-~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i  228 (423)
                      +.. ..|. ..+...-..|.|||.+...          . .+++-||||+||++.||++ |++||.-.      +.+ ..
T Consensus       176 NPadf~fF-FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~-aY  247 (1431)
T KOG1240|consen  176 NPADFTFF-FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLL-AY  247 (1431)
T ss_pred             CcccceEE-EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHH-hH
Confidence            211 1110 1122233579999988542          1 4678899999999999998 78888531      111 11


Q ss_pred             HhhhcCCcHHHhhccC-hHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          229 CEKKVSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       229 ~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      .... ....+.....+ ...++.+|..|++.||++|.++++.++.
T Consensus       248 r~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  248 RSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111 11112221111 3479999999999999999999988775

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=6.5e-22  Score=176.12  Aligned_cols=191  Identities=16%  Similarity=0.111  Sum_probs=139.1

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCch------hHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~------~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +.+...|++|+||+||.+..  .+..++.+.+.......      .+.+|+++|+.|.+++++|.+..+    ...+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678899999999998865  67778877665544321      367899999999988889988665    3469999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc-cCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDI-Kp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      +|+ |.+|......        ....++.|++.+|.++|++||+|||| ||+|||++   .++.++|+|||+|.......
T Consensus        78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcc
Confidence            998 6666543211        12457889999999999999999999 79999994   67889999999998544322


Q ss_pred             CC------CcccccCCCcccccccccCcccccCC-CCC-ccchHHHHHHHHHHHHhCCCCCCCc
Q 014527          161 TN------RHIPYRENKNLTGTARYASCNTHLGI-EQS-RRDDLESLGYVLLYFLRGSLPWQGL  216 (423)
Q Consensus       161 ~~------~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s-~~sDIwSlGvil~elltG~~Pf~~~  216 (423)
                      ..      .++..-...-...++.|++|+...-. ..+ .+.+.++.|+.+|.++|+..|+.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            10      00000000012257788888866533 233 5679999999999999999988653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-23  Score=206.51  Aligned_cols=224  Identities=22%  Similarity=0.322  Sum_probs=183.5

Q ss_pred             eeeecCceeEEEEEEC---CCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           14 KIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      .+|+|.||.|++++-.   +.+..+|+|+.+.....    .....|..++...+.++.+..++..+......++++++. 
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            3789999999987643   45677999987654321    235567788888887788888888888888999999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      ++.|...+.. ...+.+..+..+...++-|++++|+.+|+|||+|++||++   +..|.+++.|||+++..-...     
T Consensus        81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhh-----
Confidence            6677766553 4568888899999999999999999999999999999999   689999999999998765443     


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                            ..+||..|||||++.  ....++|.||||++++||++|..||.+       +....|.......|...     .
T Consensus       152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p~~l-----~  211 (612)
T KOG0603|consen  152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMPREL-----S  211 (612)
T ss_pred             ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCchhh-----h
Confidence                  228999999999999  467789999999999999999999987       34445655566665433     6


Q ss_pred             HHHHHHHHHHhcCCCCCCCCh
Q 014527          246 AEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       246 ~~l~~li~~cl~~dP~~RPt~  266 (423)
                      ...++++..++..+|..|-..
T Consensus       212 ~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  212 AEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHHhhCHHHHhcc
Confidence            789999999999999999755

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.87  E-value=2.2e-22  Score=208.77  Aligned_cols=215  Identities=24%  Similarity=0.404  Sum_probs=156.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      ...|..++.|..|+||.||.++++.+.+.+|+|+-+. +   .+.+.  ++..                .+..+.|    
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~---lilRn--ilt~----------------a~npfvv----  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N---LILRN--ILTF----------------AGNPFVV----  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc-c---hhhhc--cccc----------------cCCccee----
Confidence            4679999999999999999999999999999975322 1   11111  1111                1112222    


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC---
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN---  162 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~---  162 (423)
                       |+-..+++. -+.++..        ++.+++|||+.||+|||+||+|.+|+   .-+.+||.|||+++........   
T Consensus       136 -gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 -GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             -chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhh
Confidence             444444442 2234432        38899999999999999999999995   8899999999998764322111   


Q ss_pred             -Ccc----cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          163 -RHI----PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       163 -~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                       .++    .-...+.++||+.|.|||++..+.|+..+|+|++|+|+||++.|..||.+.+..   +.+..++......+.
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---elfg~visd~i~wpE  279 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDIEWPE  279 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---HHHhhhhhhhccccc
Confidence             011    011235679999999999999999999999999999999999999999986554   445555555444443


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCC
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRP  264 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RP  264 (423)
                      .  ...++++.++++.++|..+|..|-
T Consensus       280 ~--dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  280 E--DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             c--CcCCCHHHHHHHHHHHHhChHhhc
Confidence            3  345689999999999999999996

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-21  Score=182.32  Aligned_cols=188  Identities=19%  Similarity=0.274  Sum_probs=139.7

Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC-CCcEEEeecccee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~-~~~vkL~DFGla~  154 (423)
                      ...|+||.-+..+|..++.  .+..+......++.|+++|+.|||.+||.|||+|.+|||+-.+|+ ...++|+|||++-
T Consensus       316 ~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  316 KTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             ceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence            3569999999999999986  445788889999999999999999999999999999999976543 3578899999985


Q ss_pred             eecCCCCCCcccccCC-CcccccccccCcccccCCCC------CccchHHHHHHHHHHHHhCCCCCCCchhhhhH-HHHH
Q 014527          155 KYRDPTTNRHIPYREN-KNLTGTARYASCNTHLGIEQ------SRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYD  226 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~------s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~-~~~~  226 (423)
                      --..  .....||... ....|...-||||+....+=      -.++|.|+.|.+.||+++...||.+....... ..|+
T Consensus       394 Ad~~--hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq  471 (598)
T KOG4158|consen  394 ADDN--HGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ  471 (598)
T ss_pred             eccc--cccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence            3222  1122333222 24567888999999875431      24899999999999999999999862221111 0111


Q ss_pred             HHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                         +    ...+.+...+|+.+++++...|+.||.+|++..-....|+
T Consensus       472 ---e----~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  472 ---E----SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             ---h----hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence               1    1123344567999999999999999999998765555554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5.5e-22  Score=177.99  Aligned_cols=243  Identities=12%  Similarity=0.150  Sum_probs=181.4

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ...+.-+|.+...|+.|+|+|.  |..++.|+++...    ....|..|.-.|+.+.|++..+.+..+. ......++..
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-sppnlv~isq  267 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-SPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-CCCCceEeee
Confidence            3456678899999999999994  4557788776443    2335788888899999877777666554 4467788889


Q ss_pred             cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEE--eeccceeeec
Q 014527           84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYI--IDFGLAKKYR  157 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL--~DFGla~~~~  157 (423)
                      |+ .|+|..++..... .++..++.+++.+|++|++|||+..  |.---|....+++   |++.+.+|  +|--++-.  
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq--  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ--  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee--
Confidence            98 8999999875432 2677899999999999999999975  4445688899999   45655544  44333211  


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCC---ccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s---~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                                  .....-.+.||+||.+...+-+   +++|+|||++++|||.|...||.+..+.+-.-   ++.-..+.
T Consensus       343 ------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---kialeglr  407 (448)
T KOG0195|consen  343 ------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---KIALEGLR  407 (448)
T ss_pred             ------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---hhhhcccc
Confidence                        0122447899999999877643   57899999999999999999999877664332   22222222


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      .   ..+++++..+..||.-|+..||.+||.|+.|+-.|+..
T Consensus       408 v---~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  408 V---HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             c---cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            2   23356688999999999999999999999999988865

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=4.6e-20  Score=170.59  Aligned_cols=140  Identities=21%  Similarity=0.259  Sum_probs=108.0

Q ss_pred             ceEEeceeeecCceeEEEEE-ECCCCcEEEEEEecCCCC--------------------------chhHHHHHHHHHHHc
Q 014527            8 KYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTK--------------------------HPQLLYEAKVYKILQ   60 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~-~~~~~~~vaiKi~~~~~~--------------------------~~~~~~E~~~l~~l~   60 (423)
                      -|.+.+.||+|+||.||+|. +..+|+.||||++.....                          ...+.+|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 667899999998764321                          012468999999998


Q ss_pred             CC-CCCCeEEEeeeeCCeeEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-cccccccCCceEEe
Q 014527           61 GG-SGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMG  137 (423)
Q Consensus        61 ~~-~~i~~i~~~~~~~~~~~lv~e~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-iiHrDIKp~NILl~  137 (423)
                      +. ..+|.+..+    ...++||||+++ +|...... ...+....+..++.||+.+|.+||++| |+||||||+||+++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            52 223333322    235899999955 55544322 344666778899999999999999999 99999999999993


Q ss_pred             ecCCCCcEEEeeccceeee
Q 014527          138 LGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus       138 ~~~~~~~vkL~DFGla~~~  156 (423)
                          .+.++|+|||.|...
T Consensus       184 ----~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 ----DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ----CCCEEEEEChhhhcc
Confidence                678999999998643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.8e-18  Score=155.27  Aligned_cols=131  Identities=25%  Similarity=0.410  Sum_probs=105.0

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +.||+|++|.||+|.+  .+..|++|+......          ...+.+|+.++..+.+. +++....++.+....+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKA-GVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHC-CCCCCeEEEEeCCCCEEEE
Confidence            6789999999999987  677899997654321          12467899999999864 3444444445667789999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ||+ |++|.+++....    . ....++.+++.+|.+||+.|++|||++|.|||++    .+.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence            999 789998876422    2 8889999999999999999999999999999993    67899999998753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.5e-19  Score=176.81  Aligned_cols=213  Identities=16%  Similarity=0.229  Sum_probs=161.7

Q ss_pred             HHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc-ccccccCCceE
Q 014527           58 ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-LHRDIKPDNFL  135 (423)
Q Consensus        58 ~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gi-iHrDIKp~NIL  135 (423)
                      .+.| .++..+.+...++...++|.+|| .|+|.|.+.....++++.-...++++|+.||.|||.-.| .|+.|++.|++
T Consensus         3 ~l~h-~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl   81 (484)
T KOG1023|consen    3 QLDH-DNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL   81 (484)
T ss_pred             ccch-hhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence            3444 55666777777788999999999 999999998767778999999999999999999998765 99999999999


Q ss_pred             EeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCC-------CCccchHHHHHHHHHHHHh
Q 014527          136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-------QSRRDDLESLGYVLLYFLR  208 (423)
Q Consensus       136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-------~s~~sDIwSlGvil~ellt  208 (423)
                      +   |....+||+|||+.........     +.......-..-|.|||.+.+..       .+.+.||||||++++|+++
T Consensus        82 v---d~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   82 V---DSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             e---eeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            9   6899999999999876643110     01111223456799999998752       3667999999999999999


Q ss_pred             CCCCCCCchhhh-hHHHHHHHHhhhc---CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          209 GSLPWQGLKAAT-KKQKYDKICEKKV---STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       209 G~~Pf~~~~~~~-~~~~~~~i~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      .+.||....... ..+.+..+.....   .+.+... ...++++..++..||..+|.+||+++.+...++.+....
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccCccccccccCChHHHHHHHHhcCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            999998633222 1233333333121   1112211 255778999999999999999999999999998887653

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.8e-18  Score=156.44  Aligned_cols=136  Identities=17%  Similarity=0.185  Sum_probs=101.8

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcC----CCCCCeEEEeeeeCC---e-eEE
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQG----GSGIPNIKWYGVDGE---D-NVL   80 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~----~~~i~~i~~~~~~~~---~-~~l   80 (423)
                      -.+.||+|+||.||.  +..++.. +||+....  .....+.+|+.+++.|.|    +++|+.++.+..+..   . +.+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            357899999999995  6666665 69987643  234568999999999953    466766665555442   3 337


Q ss_pred             EEeccC---CCHHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCcccccccCCceEEeecC-CCCcEEEeeccce
Q 014527           81 VLDLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARI-EYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLA  153 (423)
Q Consensus        81 v~e~~~---~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~giiHrDIKp~NILl~~~~-~~~~vkL~DFGla  153 (423)
                      ||||+|   ++|.+++..  ..+++.  ..++.|++.++ +|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus        83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            899964   899999964  346655  46688888888 999999999999999999996432 3458999995544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=3.9e-18  Score=153.73  Aligned_cols=127  Identities=21%  Similarity=0.360  Sum_probs=100.2

Q ss_pred             eeeecCceeEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527           14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .||+|+||.||+|.+  ++..|++|+......          ..++.+|++++..+.+.. ++....+.......+++||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence            489999999999985  577899997543221          134668999999998743 3334444556677899999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      |+ |++|.+++....        ..++.|++.+|.+||+.|++|||++|+||+++    .+.++|+|||++..
T Consensus        78 ~~~g~~l~~~~~~~~--------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN--------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH--------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence            99 888888765311        18899999999999999999999999999993    68899999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=3.2e-19  Score=174.18  Aligned_cols=174  Identities=25%  Similarity=0.326  Sum_probs=130.2

Q ss_pred             CeeEEEEecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      .+.||.|++| ..+|.+++...  ....+....+.++.|++.|++|   +|.+|||+||.||++.   .+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence            3578999999 88999998632  2347788999999999999999   9999999999999995   666899999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      ........+.. -++.......||..||+||.+.+..|+.++||||||++|+||+. -..+|..      ......+...
T Consensus       403 ~ts~~~~~~~~-~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~r~g  475 (516)
T KOG1033|consen  403 VTSQDKDETVA-PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDIRDG  475 (516)
T ss_pred             eeecccCCccc-chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhhhcC
Confidence            87765544111 12233446789999999999999999999999999999999997 3333322      1222222222


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCCh
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY  266 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  266 (423)
                      .++ |  .....+| +-..|+.+++...|.+||++
T Consensus       476 ~ip-~--~~~~d~p-~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  476 IIP-P--EFLQDYP-EEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             CCC-h--HHhhcCc-HHHHHHHHhcCCCcccCchH
Confidence            222 1  1122334 45689999999999999943

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=8.1e-18  Score=151.73  Aligned_cols=136  Identities=23%  Similarity=0.328  Sum_probs=104.0

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC------------------------chhHHHHHHHHHHHcCCC
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------------------HPQLLYEAKVYKILQGGS   63 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~------------------------~~~~~~E~~~l~~l~~~~   63 (423)
                      .|.+.+.||+|+||.||+|... +++.||||++.....                        ......|..++..+.+..
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3889999999999999999874 799999998654320                        112567888888887642


Q ss_pred             -CCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           64 -GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        64 -~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                       .++...  .  ....+++|||+ +++|..+..       ......++.+++.++.++|+.||+||||||+||++   +.
T Consensus        95 i~v~~~~--~--~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~  160 (198)
T cd05144          95 FPVPKPI--D--WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD  160 (198)
T ss_pred             CCCCcee--e--cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence             223222  2  24568999999 666655432       13567889999999999999999999999999999   46


Q ss_pred             CCcEEEeeccceeeecC
Q 014527          142 ANQVYIIDFGLAKKYRD  158 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~  158 (423)
                      ++.++|+|||++.....
T Consensus       161 ~~~~~liDfg~~~~~~~  177 (198)
T cd05144         161 DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcEEEEECCccccCCC
Confidence            88999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=3.2e-17  Score=169.72  Aligned_cols=133  Identities=23%  Similarity=0.394  Sum_probs=103.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--C--------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--T--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~--------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      ..|...+.||+|+||+||+|.+...  .+++|+....  .        ....+.+|++++..++++. ++....+.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVDPE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEeCC
Confidence            3456678999999999999987543  3444432111  1        1134788999999998744 555555666667


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+ +++|.+++.         ....++.|++.+|.+||+.|++||||||+|||+    +++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence            789999999 889988775         356789999999999999999999999999999    367899999999864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.70  E-value=1.5e-16  Score=141.93  Aligned_cols=135  Identities=27%  Similarity=0.377  Sum_probs=95.9

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hh----------------------HHHHHHHHHHHcCCC-C
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQ----------------------LLYEAKVYKILQGGS-G   64 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~----------------------~~~E~~~l~~l~~~~-~   64 (423)
                      .+.||+|+||.||+|.+. +++.||||++......    ..                      ...|...+..+.+.. .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999976 7899999987653211    01                      135666666665432 2


Q ss_pred             CCeEEEeeeeCCeeEEEEeccCC-CHH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCC
Q 014527           65 IPNIKWYGVDGEDNVLVLDLLGP-SLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        65 i~~i~~~~~~~~~~~lv~e~~~~-sL~-~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~  141 (423)
                      ++....+    ...++||||+.+ .+. ..+....  . ...+..++.+++.++.++|. .||+||||||+||+++    
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence            3333322    246899999944 221 1111111  1 16788999999999999999 9999999999999993    


Q ss_pred             CCcEEEeeccceeeecC
Q 014527          142 ANQVYIIDFGLAKKYRD  158 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~  158 (423)
                      ++.++|+|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            78899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=9.2e-16  Score=130.75  Aligned_cols=132  Identities=20%  Similarity=0.270  Sum_probs=107.4

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCCeEEEeeeeCCeeEEEEeccC-CC
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-SGIPNIKWYGVDGEDNVLVLDLLG-PS   88 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~-~~i~~i~~~~~~~~~~~lv~e~~~-~s   88 (423)
                      +.+.||.|.++.||++...  +..+++|+.........+..|+.++..+.+. ..++.+..+....+..+++|||+. ..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4678999999999999974  3679999876654445789999999999876 566777666666678999999994 44


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      +..+        +......++.+++.+|.+||..   +++|+||+|+||+++   ..+.++|+|||.+..
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence            4432        5567778899999999999985   799999999999995   568999999998853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=3.4e-15  Score=138.41  Aligned_cols=132  Identities=16%  Similarity=0.215  Sum_probs=96.3

Q ss_pred             ceee-ecCceeEEEEEECCCCcEEEEEEecCCC---------------CchhHHHHHHHHHHHcCCCC-CCeEEEeee-e
Q 014527           13 RKIG-SGSFGEIFLASHVDTNEIVAVKIENSGT---------------KHPQLLYEAKVYKILQGGSG-IPNIKWYGV-D   74 (423)
Q Consensus        13 ~~Lg-~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---------------~~~~~~~E~~~l~~l~~~~~-i~~i~~~~~-~   74 (423)
                      ..|| .|+.|+||.+..  .+..++||.+....               ....+.+|++++..|.+... +|....+.. .
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 888999999876  46779999764311               12357889999999987432 344433322 2


Q ss_pred             CCe---eEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEee
Q 014527           75 GED---NVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        75 ~~~---~~lv~e~~~--~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                      ...   .++|||++.  .+|.+++..  ..++..    .+.||+.+|.+||++||+||||||+|||++   .++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence            222   259999994  488887753  345544    357899999999999999999999999994   567899999


Q ss_pred             ccceee
Q 014527          150 FGLAKK  155 (423)
Q Consensus       150 FGla~~  155 (423)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.7e-17  Score=171.95  Aligned_cols=255  Identities=26%  Similarity=0.296  Sum_probs=189.0

Q ss_pred             CCceEEeceeeecCceeEEEEEECC-CCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~-~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ...|.+.+.||+|+|+.|-.+.... ....+|.|.+....    .......|..+-..+..|.++..+.......+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3568899999999999999887643 34456777554432    112234477776777655666666666667888999


Q ss_pred             EEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCcccccccCCceEEeecCCCC-cEEEeeccceeee
Q 014527           81 VLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY  156 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDIKp~NILl~~~~~~~-~vkL~DFGla~~~  156 (423)
                      +++|. ++++.+.+..... ..+...+..++.|+..+|.|+| ..++.||||||+|.+++   ..+ .+++.|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhccc
Confidence            99998 8888777732232 5778889999999999999999 99999999999999994   556 8999999999887


Q ss_pred             cC-CCCCCcccccCCCcccc-cccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          157 RD-PTTNRHIPYRENKNLTG-TARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       157 ~~-~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .. .....     .....+| ++.|+|||.+.+.. .....|+||.|+++.-+++|..||.......  ..+......+.
T Consensus       176 ~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~  248 (601)
T KOG0590|consen  176 RNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG  248 (601)
T ss_pred             cccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence            76 32221     2234567 99999999999854 5788999999999999999999997644332  22222222221


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ......+..+.....+++.+++..+|+.|.+.+++..
T Consensus       249 -~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 -RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence             1112334566788999999999999999999888743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=1.6e-15  Score=150.93  Aligned_cols=255  Identities=18%  Similarity=0.151  Sum_probs=189.9

Q ss_pred             ccCCceEEeceeee--cCceeEEEEEE--CCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGS--GSFGEIFLASH--VDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~--G~fg~Vy~a~~--~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+...    ....-.+|+....++..+.+...........
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~  190 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS  190 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence            34566778899999  99999999998  7888999999633221    2223456666666666555554434445577


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHH----HHHHHHhcCcccccccCCceEEeecCCC-CcEEEeec
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA----RIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDF  150 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~giiHrDIKp~NILl~~~~~~-~~vkL~DF  150 (423)
                      +..++-+|+|+.+|..+......-++...++.++.+...    ||.++|+.+++|-|+||+||++.   .+ ...+++||
T Consensus       191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df  267 (524)
T KOG0601|consen  191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDF  267 (524)
T ss_pred             CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCc
Confidence            889999999999999988765566889999999999999    99999999999999999999995   44 78999999


Q ss_pred             cceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      |+...+.+......  +.......|...|++||...+ -++..+|||+||.++.+..++..++....... ...+    .
T Consensus       268 ~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~----r  339 (524)
T KOG0601|consen  268 GLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQL----R  339 (524)
T ss_pred             ceeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccc----c
Confidence            99998876653322  112223467889999999887 47889999999999999999877665421110 0111    1


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ... ...+.|...+..+...+..|++.+|-.|++++.+..
T Consensus       340 -~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 -QGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -ccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             111 224455666777888999999999999998887654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=3.4e-13  Score=135.61  Aligned_cols=138  Identities=23%  Similarity=0.361  Sum_probs=96.2

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCCc------------------------------------------hhHH
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------------------------------------------PQLL   50 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~------------------------------------------~~~~   50 (423)
                      +.||+|++|+||+|+.. +|+.||||+.+.....                                          -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999865 6899999997543100                                          0134


Q ss_pred             HHHHHHHHHc----CCCCCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHHhcCc
Q 014527           51 YEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA-RIEYVHSRGF  124 (423)
Q Consensus        51 ~E~~~l~~l~----~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~-aL~yLH~~gi  124 (423)
                      +|++.+..+.    +.+.+..-..|.......+|||||+ |++|.++.........   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            5555555554    2233322233333345679999999 7788777653222232   3456666666 4788999999


Q ss_pred             ccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527          125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus       125 iHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      +|+|++|.||++   +.++.++|+|||++..+.
T Consensus       279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence            999999999999   477899999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.50  E-value=2.6e-13  Score=120.83  Aligned_cols=136  Identities=16%  Similarity=0.197  Sum_probs=99.5

Q ss_pred             eceeeecCceeEEEEEECC------CCcEEEEEEecCCC--------------C----------chh----HHHHHHHHH
Q 014527           12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGT--------------K----------HPQ----LLYEAKVYK   57 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~------~~~~vaiKi~~~~~--------------~----------~~~----~~~E~~~l~   57 (423)
                      ...||.|--+.||.|....      .+..+|||+.+...              .          ...    ..+|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998643      24789999744211              0          111    238999999


Q ss_pred             HHcCC-CCCCeEEEeeeeCCeeEEEEeccCCC-HHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcccccccCCc
Q 014527           58 ILQGG-SGIPNIKWYGVDGEDNVLVLDLLGPS-LED-LFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDN  133 (423)
Q Consensus        58 ~l~~~-~~i~~i~~~~~~~~~~~lv~e~~~~s-L~~-~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~giiHrDIKp~N  133 (423)
                      ++... -.+|.+..+    ...+|||||++++ +.. .+.  ...++...+..+..|++.+|..| |..||||+||++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            98753 345555543    5689999999653 211 122  22355667788899999999999 89999999999999


Q ss_pred             eEEeecCCCCcEEEeeccceeeec
Q 014527          134 FLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus       134 ILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ||+.    ++.++|+|||.|....
T Consensus       156 IL~~----~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH----DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE----CCcEEEEECCCceeCC
Confidence            9993    5789999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=1.9e-13  Score=119.68  Aligned_cols=126  Identities=21%  Similarity=0.301  Sum_probs=96.5

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCH
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL   89 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL   89 (423)
                      .+.|+.|.++.||+++.  .++.|++|+..... ....+..|+.+++.+.+...+|.+..+.  ....++|||++ |.++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            46788999999999986  47789999876543 2345789999999998766677776553  33468999999 5454


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc-----ccccccCCceEEeecCCCCcEEEeecccee
Q 014527           90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        90 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gi-----iHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...      .   .....++.+++.+|..||+.++     +|+|++|.||+++    .+.++|+|||.+.
T Consensus        79 ~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence            432      0   1123456899999999999985     9999999999994    5679999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=4.9e-12  Score=129.01  Aligned_cols=139  Identities=19%  Similarity=0.312  Sum_probs=93.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----------------------------------------
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------------------------------------   46 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----------------------------------------   46 (423)
                      .|+. +.||+|++|+||+|+.+++|+.||||+.+..-..                                         
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4565 7899999999999999888999999998643100                                         


Q ss_pred             -hhHHHHHHHHHHHc----CCCCCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCC-----CCHHHHHHHHHHHHHH
Q 014527           47 -PQLLYEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRK-----FSLKTVLMLADQMIAR  115 (423)
Q Consensus        47 -~~~~~E~~~l~~l~----~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~-----l~~~~~~~i~~qi~~a  115 (423)
                       -.+.+|+..+.++.    +.+.+..-..|.......+|||||+ |+.+.++-......     +....+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence             01455665555554    2222221133333456789999999 77887643211222     3333344444444   


Q ss_pred             HHHHHhcCcccccccCCceEEeecCCCC----cEEEeeccceeeec
Q 014527          116 IEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIIDFGLAKKYR  157 (423)
Q Consensus       116 L~yLH~~giiHrDIKp~NILl~~~~~~~----~vkL~DFGla~~~~  157 (423)
                          ...|++|+|+||.||+++   .++    +++++|||++..+.
T Consensus       277 ----f~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ----FRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ----HhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECC
Confidence                468999999999999995   444    99999999997654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.44  E-value=1.2e-12  Score=112.43  Aligned_cols=144  Identities=19%  Similarity=0.230  Sum_probs=110.8

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEE-ecCCCC---------chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTK---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi-~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ....|-+|+-+.|+++.+  .|+.++||. +.+.-.         ..+..+|++++.++... +|+.-..++.+.....|
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence            577889999999999987  688888884 222222         22367899999988753 56555667778888899


Q ss_pred             EEeccCC--CHHHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           81 VLDLLGP--SLEDLFVYCRRKFSL-KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        81 v~e~~~~--sL~~~l~~~~~~l~~-~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      +|||..|  ++.+++...-..-.. .....++.+|-+.|.-||..+|||+||..+||++..++....+.|+|||++....
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~  167 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR  167 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence            9999966  888888754333333 3347899999999999999999999999999999755555567999999986543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.40  E-value=1.9e-13  Score=143.08  Aligned_cols=278  Identities=20%  Similarity=0.168  Sum_probs=191.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchh-HHHHHHHHHHHcCCCCCCeEEEe---eeeCCeeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNIKWY---GVDGEDNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~-~~~E~~~l~~l~~~~~i~~i~~~---~~~~~~~~lv   81 (423)
                      -..+.+.+-+-+|.++.++.+.-..++...++|+......... -.+++.--+.+..+++.|.+...   .......+++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            3557788889999999999998777776666665433221100 00111111111122223333322   2356678999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC-
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~-  159 (423)
                      ++|+ +++|...+.. ....+.+-+......+..+++|||+..++|||++|.|+|..   ..+..++.|||........ 
T Consensus       883 ~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCcccccccccccc
Confidence            9999 7788887765 33567777788888999999999999999999999999994   7889999999843321110 


Q ss_pred             -C-------------------CCCcc---cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Q 014527          160 -T-------------------TNRHI---PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL  216 (423)
Q Consensus       160 -~-------------------~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~  216 (423)
                       .                   .....   ..+......||+.|.+||...+......+|+|++|++++|.++|..||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence             0                   00000   112345678999999999999999999999999999999999999999865


Q ss_pred             hhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecccc
Q 014527          217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQ  296 (423)
Q Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~  296 (423)
                      ...   +.++.+.......+..  ....+.+.++++...+..+|.+|-.+.--       -...+..|....||+.+..+
T Consensus      1039 tpq---~~f~ni~~~~~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1039 TPQ---QIFENILNRDIPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred             chh---hhhhccccCCCCCCCC--ccccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCccccccc
Confidence            443   5555565555554432  23457889999999999999999876421       12367788888899887654


Q ss_pred             hhh
Q 014527          297 QTQ  299 (423)
Q Consensus       297 ~~~  299 (423)
                      ...
T Consensus      1107 ~~~ 1109 (1205)
T KOG0606|consen 1107 KAE 1109 (1205)
T ss_pred             cCc
Confidence            433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=5.3e-12  Score=109.00  Aligned_cols=128  Identities=24%  Similarity=0.415  Sum_probs=97.9

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEe-cCCCCch---------hHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIE-NSGTKHP---------QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~-~~~~~~~---------~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ..+++|+-+.||.+.+  -+..+++|.- .+.-..+         +..+|++++..+.. ..++.-..|..+.....|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence            4578999999999977  4555888852 2222222         35789999999886 46777777888889999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ||. |..|.+.+...        ...++..+-.-+.-||..||+|+||.++||+++    .+.+.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence            999 45555566542        255677777778899999999999999999994    55699999999864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=1.6e-12  Score=129.71  Aligned_cols=241  Identities=19%  Similarity=0.138  Sum_probs=165.9

Q ss_pred             CCceEEeceeeecCceeEEEEEEC-CCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~-~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      -.+|.++..||.|.|+.|+.+... .++..|++|-+.....    ...-..|+.+...+..+.+++....-.......|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            467889999999999999998766 6788899995543321    11235677777777655555543222223345568


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      -.||| ++++.... .....+.+...+.+..|++.++.++|++.++|+|+||+||++.  .+.+..++.|||.+..+.-.
T Consensus       344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~--~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS--NDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec--cchhhhhcccccccccccee
Confidence            89999 55554443 3455688899999999999999999999999999999999995  22278899999998653221


Q ss_pred             CCCCcccccCCCccccccccc--CcccccCCCCCccchHHHHHHHHHHHHhCCC-CCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          160 TTNRHIPYRENKNLTGTARYA--SCNTHLGIEQSRRDDLESLGYVLLYFLRGSL-PWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~s~~sDIwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ..          ......+++  +++......+..+.|++|||..+.+.+++.. ++.+..       ...+........
T Consensus       421 ~~----------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~~i~~~~~p~~  483 (524)
T KOG0601|consen  421 SG----------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SLTIRSGDTPNL  483 (524)
T ss_pred             cc----------cccccccccccchhhccccccccccccccccccccccccCcccCccccc-------ceeeecccccCC
Confidence            11          223333444  5666667778899999999999999999753 333211       111222222111


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                           ......+..+...+...++..||.+.++..
T Consensus       484 -----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  484 -----PGLKLQLQVLLKVMINPDRKRRPSAVELSL  513 (524)
T ss_pred             -----CchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence                 222467888888999999999998877644

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.23  E-value=2.3e-10  Score=109.79  Aligned_cols=258  Identities=14%  Similarity=0.210  Sum_probs=164.0

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCe-E-----EEeeeeCCe-e
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN-I-----KWYGVDGED-N   78 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~-i-----~~~~~~~~~-~   78 (423)
                      +.-....+.||+|+-+.+|-.-..   ...+-||........+-.. ...|...-.++.+.. +     ..++-+... .
T Consensus        10 ge~i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk-~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          10 GEPIPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK-VAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CcccCCCccccCCccceeeecchh---hchhheeecCCCchHHHHH-HHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            333456788999999999975432   2245687766543322111 111222211122211 1     223333333 6


Q ss_pred             EEEEeccCC--CHHHHHHHh--c---CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           79 VLVLDLLGP--SLEDLFVYC--R---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        79 ~lv~e~~~~--sL~~~l~~~--~---~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                      -+.|..+.|  ....++.-.  +   ....+...++.++.|+.+.+.||..|.+-+|+.++|||++   +++.|.|.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEccc
Confidence            688888733  344444311  1   1367899999999999999999999999999999999996   78899999855


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhC-CCCCCCchhh----hh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAA----TK  221 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG-~~Pf~~~~~~----~~  221 (423)
                      .-.......        .....+|...|.+||.-.     +..-+...|.|.||+++++|+.| ++||.+....    ..
T Consensus       163 sfqi~~ng~--------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p  234 (637)
T COG4248         163 SFQINANGT--------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP  234 (637)
T ss_pred             ceeeccCCc--------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence            433322211        123568999999999765     44457789999999999999886 9999874321    11


Q ss_pred             HH-H-------HH-HHHhhhcCCcHHHhhccChHHHHHHHHHHhcCC--CCCCCChHHHHHHHHHHHH
Q 014527          222 KQ-K-------YD-KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLT--FDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       222 ~~-~-------~~-~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPt~~~l~~~L~~~~~  278 (423)
                      .+ .       +. +-.......|...-+.-+|+.+..++.+|+...  +.-||+++.-+..|..+-.
T Consensus       235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            11 0       00 001112223333334456899999999999754  5689999887777666543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=8.8e-10  Score=111.51  Aligned_cols=170  Identities=15%  Similarity=0.136  Sum_probs=123.0

Q ss_pred             EE-EEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccCCCHHHHHHHhcCC
Q 014527           23 IF-LASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK   99 (423)
Q Consensus        23 Vy-~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~   99 (423)
                      +| .|..+.++.+|.|.+.+....  .....+-++.|+.|+|+.++..+..+. .....|||+|.+.. |..++..    
T Consensus        27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV~P-l~~~lk~----  100 (690)
T KOG1243|consen   27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERVRP-LETVLKE----  100 (690)
T ss_pred             cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeecccc-HHHHHHH----
Confidence            44 466677888999998776655  444677889999999866555554444 45589999999832 4445544    


Q ss_pred             CCHHHHHHHHHHHHHHHHHHH-hcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCccccccc
Q 014527          100 FSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR  178 (423)
Q Consensus       100 l~~~~~~~i~~qi~~aL~yLH-~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~  178 (423)
                      +....+...+.||+.||.||| +.+++|++|.-+.|+|   +..|..||++|-++..........       ....--..
T Consensus       101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~-------~~~~~~~s  170 (690)
T KOG1243|consen  101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPA-------KSLYLIES  170 (690)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCccc-------ccchhhhc
Confidence            336778889999999999997 6789999999999999   589999999999987654333211       11122234


Q ss_pred             ccCcccccCCCCCccchHHHHHHHHHHHHhCC
Q 014527          179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGS  210 (423)
Q Consensus       179 Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~  210 (423)
                      |..|+.+....  -..|.|-|||++++++.|.
T Consensus       171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            55666544332  3469999999999999993

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=1.7e-10  Score=105.33  Aligned_cols=136  Identities=21%  Similarity=0.325  Sum_probs=99.4

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCC-CCCeEEEeeeeC---CeeEEEEecc
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGS-GIPNIKWYGVDG---EDNVLVLDLL   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~-~i~~i~~~~~~~---~~~~lv~e~~   85 (423)
                      +.|+.|.++.||++...+ |+.+++|+.....   ....+..|++++..+.+.. .+|.+..+....   +..+++||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998743 5789999876544   2456899999999998743 256665555443   2568999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------------------------------  121 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-------------------------------------------  121 (423)
                       |.++.+.+..  ..++......++.+++.+|.+||+                                           
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence             5555553321  346666777777777777777773                                           


Q ss_pred             -------------cCcccccccCCceEEeecCC--CCcEEEeecccee
Q 014527          122 -------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDFGLAK  154 (423)
Q Consensus       122 -------------~giiHrDIKp~NILl~~~~~--~~~vkL~DFGla~  154 (423)
                                   ..++|+|+.|.||+++   .  .+.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCcEEEEEeccccc
Confidence                         2368999999999995   4  4568999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=2.3e-09  Score=100.70  Aligned_cols=132  Identities=17%  Similarity=0.141  Sum_probs=94.4

Q ss_pred             eeEEEEEECCCCcEEEEEEecCCC-------------CchhHHHHHHHHHHHcCC-CCCCeEEEeeee-----CCeeEEE
Q 014527           21 GEIFLASHVDTNEIVAVKIENSGT-------------KHPQLLYEAKVYKILQGG-SGIPNIKWYGVD-----GEDNVLV   81 (423)
Q Consensus        21 g~Vy~a~~~~~~~~vaiKi~~~~~-------------~~~~~~~E~~~l~~l~~~-~~i~~i~~~~~~-----~~~~~lv   81 (423)
                      ..|+++..  .|+.|.||......             ....+.+|...+..|... -..|....|+..     ....+||
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34666654  57789999653322             111377999999888542 122333445543     2357899


Q ss_pred             EeccCC--CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee----cCCCCcEEEeecccee
Q 014527           82 LDLLGP--SLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----GRKANQVYIIDFGLAK  154 (423)
Q Consensus        82 ~e~~~~--sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~----~~~~~~vkL~DFGla~  154 (423)
                      ||++++  +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||+..    .+....+.|+||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999955  688887532 344667788899999999999999999999999999999952    1235789999999875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=1e-10  Score=108.61  Aligned_cols=179  Identities=12%  Similarity=0.150  Sum_probs=119.2

Q ss_pred             CCeeEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEe
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      .....+++||+ .|++..+|+..   ...+......+|+.||+.||.|||+..  |+|+++..+-|++.   .++-+|+.
T Consensus       144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig  220 (458)
T KOG1266|consen  144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIG  220 (458)
T ss_pred             ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEec
Confidence            34568899999 89999998743   455888999999999999999999874  99999999999994   67766664


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC-CchhhhhHHHHHH
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDK  227 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~-~~~~~~~~~~~~~  227 (423)
                      --.-.....  . .....-.......+-+.|.|||.-.....+-++|||+||....+|.-+..--. +.......+.+..
T Consensus       221 ~~ap~s~h~--s-~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~  297 (458)
T KOG1266|consen  221 SVAPDSTHP--S-VNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN  297 (458)
T ss_pred             ccCccccch--h-hhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh
Confidence            211110000  0 00000011223356788999998766667779999999999999988765422 2111111111111


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK  270 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  270 (423)
                      .   .+..  +      ..--+.++..|+.-.|..||++..++
T Consensus       298 ~---i~~l--e------n~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  298 V---IIGL--E------NGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             h---eeec--c------CccccCcCcccccCCCCCCcchhhhh
Confidence            1   1110  0      12235788899999999999998774

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=2.8e-10  Score=101.00  Aligned_cols=125  Identities=27%  Similarity=0.365  Sum_probs=81.9

Q ss_pred             eEEEEEECCCCcEEEEEEecCCC--------------C--------------chhHHHHHHHHHHHcCCC-CCCeEEEee
Q 014527           22 EIFLASHVDTNEIVAVKIENSGT--------------K--------------HPQLLYEAKVYKILQGGS-GIPNIKWYG   72 (423)
Q Consensus        22 ~Vy~a~~~~~~~~vaiKi~~~~~--------------~--------------~~~~~~E~~~l~~l~~~~-~i~~i~~~~   72 (423)
                      .||.|... .+..+|||+.+...              .              .....+|.+.|..+.... .+|.+..+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999864 47789999854221              0              012578999999998753 466665442


Q ss_pred             eeCCeeEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCcccccccCCceEEeecCCCCcEEEee
Q 014527           73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY-VHSRGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        73 ~~~~~~~lv~e~~~--~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                          ..+|||||++  |.....+....  ++......++.+++..+.. +|..||+|+||.+.|||++    .+.++|+|
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID  149 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID  149 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence                5689999997  64444444321  2245667788888886655 5799999999999999994    44999999


Q ss_pred             ccceeeec
Q 014527          150 FGLAKKYR  157 (423)
Q Consensus       150 FGla~~~~  157 (423)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=2.3e-10  Score=116.03  Aligned_cols=155  Identities=14%  Similarity=0.190  Sum_probs=111.2

Q ss_pred             HHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCC--CcccccccccCccccc
Q 014527          110 DQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN--KNLTGTARYASCNTHL  186 (423)
Q Consensus       110 ~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~--~~~~gt~~Y~aPE~~~  186 (423)
                      .+++.||.|+|.. ++||++|.|++|.+   +..+..||+.|+++.....+.......|...  ....-...|.|||.+.
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455999999965 89999999999999   5899999999999877665433222222222  2334567899999999


Q ss_pred             CCCCCccchHHHHHHHHHHHH-hCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC
Q 014527          187 GIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD  265 (423)
Q Consensus       187 ~~~~s~~sDIwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  265 (423)
                      +...+.++|+|||||++|.+. .|+.-+.........    ................++|.++++-+.+++..+..-||+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~  258 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT  258 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchh----hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence            988899999999999999998 566655543222111    111122222222233677999999999999999999998


Q ss_pred             hHHHHH
Q 014527          266 YGFLKR  271 (423)
Q Consensus       266 ~~~l~~  271 (423)
                      +.++..
T Consensus       259 ~~~l~~  264 (700)
T KOG2137|consen  259 LDLLLS  264 (700)
T ss_pred             hhhhhc
Confidence            776644

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=3e-08  Score=85.26  Aligned_cols=128  Identities=25%  Similarity=0.444  Sum_probs=99.3

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ++.+.|++|.+|.||++.+  .+..+|+|+-..+.....+..|++++..+......|.++.|+.+    ++.|||. |..
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            4567899999999999998  56689999999999999999999999999999999999998754    3559999 558


Q ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccC--CceEEeecCCCCcEEEeeccceee
Q 014527           89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP--DNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        89 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp--~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      |.+....    .+...+.    .++++---|-..||-|..|.-  .||++    .++.+.|+||..|..
T Consensus        99 L~~~~~~----~~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIG----GDRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhc----ccHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence            8776542    1223333    344444445667999999864  46666    456999999999863

>PRK09902 hypothetical protein; Provisional

Probab=98.83  E-value=1.6e-07  Score=84.16  Aligned_cols=135  Identities=13%  Similarity=0.131  Sum_probs=99.6

Q ss_pred             eecCceeEEEEEECCCCcEEEEEEec--------CCCCchhHHHHHHHHHHHcCCC-CCCeEEEeeee----CCeeEEEE
Q 014527           16 GSGSFGEIFLASHVDTNEIVAVKIEN--------SGTKHPQLLYEAKVYKILQGGS-GIPNIKWYGVD----GEDNVLVL   82 (423)
Q Consensus        16 g~G~fg~Vy~a~~~~~~~~vaiKi~~--------~~~~~~~~~~E~~~l~~l~~~~-~i~~i~~~~~~----~~~~~lv~   82 (423)
                      |.||.+-|++...  .|+.+-+|...        .....+.+.+|...+..|.... .+|.+.+++..    ....+||+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            5589999999875  34468888533        1234567999999999997532 14444444332    22368999


Q ss_pred             eccC--CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc--EEEeeccceee
Q 014527           83 DLLG--PSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKK  155 (423)
Q Consensus        83 e~~~--~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~--vkL~DFGla~~  155 (423)
                      |-++  .+|.+++.... .+.+......++.+++..|.-||+.|+.|+|+-+.|||+.   ..+.  |+++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~---~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK---TEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec---CCCCeeEEEEEhhccch
Confidence            9886  68888875422 3467788889999999999999999999999999999994   3344  99999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=4.8e-08  Score=88.56  Aligned_cols=109  Identities=20%  Similarity=0.268  Sum_probs=82.2

Q ss_pred             chhHHHHHHHHHHHcCC-CCCCeEEEeeeeC----CeeEEEEeccCC--CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 014527           46 HPQLLYEAKVYKILQGG-SGIPNIKWYGVDG----EDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEY  118 (423)
Q Consensus        46 ~~~~~~E~~~l~~l~~~-~~i~~i~~~~~~~----~~~~lv~e~~~~--sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~y  118 (423)
                      .....+|...+..|... -.+|....++...    ...++|+|++.+  +|.+++..... .+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            44678899888888642 2234445555432    245899999943  68888875333 6777889999999999999


Q ss_pred             HHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527          119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus       119 LH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ||..||+|+|+++.|||+..++....+.|+||+.++.
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999996333344899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=5.3e-08  Score=87.51  Aligned_cols=138  Identities=20%  Similarity=0.275  Sum_probs=92.6

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchh-----------HHHHHHHHHHHcC--CCCCCeE
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----------LLYEAKVYKILQG--GSGIPNI   68 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~-----------~~~E~~~l~~l~~--~~~i~~i   68 (423)
                      +.++.++|.+.+.+-.....-|.+...  +++.+++|..+......+           ..+++..+..+..  ......+
T Consensus        26 ~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   26 EKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             HHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            357789999999999888777777654  678899998765443221           2344444444432  1111111


Q ss_pred             EEeee-----eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           69 KWYGV-----DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        69 ~~~~~-----~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      .....     .....+++|||+ |..|.++..     +++    .++..|.++|.-||+.|+.|+|..|.|++++    +
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~  170 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----N  170 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----C
Confidence            11111     224557999999 656665432     222    3556788889999999999999999999994    5


Q ss_pred             CcEEEeecccee
Q 014527          143 NQVYIIDFGLAK  154 (423)
Q Consensus       143 ~~vkL~DFGla~  154 (423)
                      +.++++||+..+
T Consensus       171 ~~i~iID~~~k~  182 (229)
T PF06176_consen  171 NGIRIIDTQGKR  182 (229)
T ss_pred             CcEEEEECcccc
Confidence            669999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=6.9e-07  Score=88.34  Aligned_cols=210  Identities=17%  Similarity=0.204  Sum_probs=142.5

Q ss_pred             ceeEEEEEECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeEEE---eeeeCCeeEEEEecc--CCCHHHH
Q 014527           20 FGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKW---YGVDGEDNVLVLDLL--GPSLEDL   92 (423)
Q Consensus        20 fg~Vy~a~~~~~~~~vaiKi~~~~~~~--~~~~~E~~~l~~l~~~~~i~~i~~---~~~~~~~~~lv~e~~--~~sL~~~   92 (423)
                      -.+.|+|....+|..|++|.+......  .....-++.++++.|.+.|+.-..   +.......++|++|+  .++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            357899999999999999988433221  123455778899998766654322   223456789999999  6688887


Q ss_pred             HHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           93 FVYC--------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        93 l~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      .-..              +.+.++..+|.++.|+..||.++|+.|+.-+-|.|.+||++   .+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecC
Confidence            6421              23477899999999999999999999999999999999994   555899988887655433


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ...                     |.+.   --.+-|.=.||.+++.|.||..- |......  ...+            
T Consensus       446 d~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~--~s~~------------  487 (655)
T KOG3741|consen  446 DPT---------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQ--SSHL------------  487 (655)
T ss_pred             CCC---------------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchH--HHHH------------
Confidence            221                     1111   12357999999999999998543 2211111  1101            


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+...++.+++++|......++.+ -+..+|+.
T Consensus       488 ~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  488 TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence            1112334667788888888888776 34555443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.76  E-value=6.6e-08  Score=88.74  Aligned_cols=133  Identities=20%  Similarity=0.314  Sum_probs=97.1

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC------------------------CchhHHHHHHHHHHHcCC-C
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------------------KHPQLLYEAKVYKILQGG-S   63 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~------------------------~~~~~~~E~~~l~~l~~~-~   63 (423)
                      +.++.+||.|--+.||.|.+. .|.++|||.-+...                        ......+|.++|..|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            457889999999999999976 48889999632110                        111257899999999754 3


Q ss_pred             CCCeEEEeeeeCCeeEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           64 GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        64 ~i~~i~~~~~~~~~~~lv~e~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      .+|...    +.+...+|||+..| .|...      +++.+..-.++..|+.-+.-+-..||||+|+.+=|||++   ++
T Consensus       172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~d  238 (304)
T COG0478         172 KVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---ED  238 (304)
T ss_pred             CCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cC
Confidence            444433    34678999999955 33221      234556666777777777777789999999999999994   78


Q ss_pred             CcEEEeeccceee
Q 014527          143 NQVYIIDFGLAKK  155 (423)
Q Consensus       143 ~~vkL~DFGla~~  155 (423)
                      +.++++||--+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            8999999976643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.69  E-value=3.4e-07  Score=84.11  Aligned_cols=71  Identities=18%  Similarity=0.141  Sum_probs=57.0

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeEEEeeeeCCeeEEEEeccCC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP   87 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~-i~~i~~~~~~~~~~~lv~e~~~~   87 (423)
                      ..||+|..+.||+.    .+..+++|+.........+.+|.+++..+..... +|.+..++.+.+...++||++.|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            57899999999984    2446889988776666678999999999986544 67888888777788899999955

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=2.1e-06  Score=87.50  Aligned_cols=139  Identities=22%  Similarity=0.328  Sum_probs=91.9

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCCc------------------------------------------hhHH
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------------------------------------------PQLL   50 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~------------------------------------------~~~~   50 (423)
                      ..|+.++-|+||+|+... |+.||||+.+.+-..                                          -.+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568899999999999765 999999985532100                                          0145


Q ss_pred             HHHHHHHHHcCC----CCCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q 014527           51 YEAKVYKILQGG----SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL  125 (423)
Q Consensus        51 ~E~~~l~~l~~~----~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gii  125 (423)
                      +|+..+..+.+.    +.+..-..|.......+|+|||+ |..+.+........++.+.+.....++.  +..+=..|+.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            666666665532    22221133444456779999999 6677776443334566444433332222  3344458999


Q ss_pred             cccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527          126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus       126 HrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |.|..|.||++   +.++++.+.|||+...+.
T Consensus       288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         288 HADPHPGNILV---RSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ccCCCccceEE---ecCCcEEEEcCcceecCC
Confidence            99999999999   478999999999986543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.53  E-value=9.7e-07  Score=80.33  Aligned_cols=135  Identities=22%  Similarity=0.301  Sum_probs=92.2

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCC---------------------chh-----HHHHHHHHHHHcCC-CC
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------------------HPQ-----LLYEAKVYKILQGG-SG   64 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---------------------~~~-----~~~E~~~l~~l~~~-~~   64 (423)
                      ...|..|--+.||+|.. .++..||+|+.+....                     ..+     ..+|...|.++... -.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34566777789999974 4578899998664321                     001     35677777777642 11


Q ss_pred             CCeEEEeeeeCCeeEEEEeccCCCH--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCC
Q 014527           65 IPNIKWYGVDGEDNVLVLDLLGPSL--EDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        65 i~~i~~~~~~~~~~~lv~e~~~~sL--~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~  141 (423)
                      +|.-..+    ...+|||||+|...  .-.|.  .-.+...++..+..++++.+.-|-. .++||+||..=|||+    .
T Consensus       132 vP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~  201 (268)
T COG1718         132 VPEPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----H  201 (268)
T ss_pred             CCCceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----E
Confidence            2222222    35689999996541  11111  1123444788889999999998877 899999999999999    3


Q ss_pred             CCcEEEeeccceeeec
Q 014527          142 ANQVYIIDFGLAKKYR  157 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~  157 (423)
                      ++.++++|||-|....
T Consensus       202 ~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CCeEEEEECccccccC
Confidence            8899999999986544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=1.9e-06  Score=78.91  Aligned_cols=139  Identities=18%  Similarity=0.241  Sum_probs=81.5

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeEEEeee---eCCeeEEEEecc-C
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGV---DGEDNVLVLDLL-G   86 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~-i~~i~~~~~---~~~~~~lv~e~~-~   86 (423)
                      ++.|+.|..+.||++....  ..+++|+.........+..|..+++.|..... +|.+..+..   .....+++|+++ |
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            4678999999999998744  58999987665344568899999999986544 566655432   334568999999 5


Q ss_pred             CCHHH----------------HHHHh---c-C--CCCHHH---------HHHH------------HHHHHH-HHHHHH--
Q 014527           87 PSLED----------------LFVYC---R-R--KFSLKT---------VLML------------ADQMIA-RIEYVH--  120 (423)
Q Consensus        87 ~sL~~----------------~l~~~---~-~--~l~~~~---------~~~i------------~~qi~~-aL~yLH--  120 (423)
                      ..+..                .+...   . .  .+....         ....            ...+.. .+..++  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            55555                11110   0 0  000000         0000            111222 233333  


Q ss_pred             -----hcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          121 -----SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       121 -----~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                           ...++|+|+.|.|||++  +.++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceee--eccceeEEEecccce
Confidence                 24599999999999995  356777899998874

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.47  E-value=2.3e-06  Score=79.56  Aligned_cols=75  Identities=23%  Similarity=0.308  Sum_probs=54.3

Q ss_pred             eeeecCc-eeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCHHH
Q 014527           14 KIGSGSF-GEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLED   91 (423)
Q Consensus        14 ~Lg~G~f-g~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~   91 (423)
                      .|..|.. ..||++..  .+..++||+..... ...+.+|+++++.+...-.+|.+..++...+..++||+++ |.++..
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            3445555 78999965  34678899876543 4568899999999986656777777776666789999999 545543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.26  E-value=7.5e-06  Score=83.29  Aligned_cols=141  Identities=23%  Similarity=0.312  Sum_probs=91.9

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCCc---------------------------------------hhHHHHH
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---------------------------------------PQLLYEA   53 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---------------------------------------~~~~~E~   53 (423)
                      +.||.-+.|+||+|+.+. |+.||||+.+..-..                                       -.|.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            578999999999999766 999999985533110                                       0144555


Q ss_pred             HHHHHHc----CCC-----CCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014527           54 KVYKILQ----GGS-----GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG  123 (423)
Q Consensus        54 ~~l~~l~----~~~-----~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g  123 (423)
                      +-..++.    +-.     .+|.++  .......+|+|||+ |..+.|+-.-....++...+..-+.++..  +-|=..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence            4443332    322     134443  33445679999999 65555554433556777755544444332  2334568


Q ss_pred             cccccccCCceEEeec-CCCCcEEEeeccceeeecC
Q 014527          124 FLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus       124 iiHrDIKp~NILl~~~-~~~~~vkL~DFGla~~~~~  158 (423)
                      ++|+|=.|.||++..+ ..+..+.|.|||+...+..
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            9999999999999632 2467999999999876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.14  E-value=4e-07  Score=92.09  Aligned_cols=183  Identities=10%  Similarity=0.067  Sum_probs=132.2

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee--eCCeeEEEEeccCC
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLDLLGP   87 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~--~~~~~~lv~e~~~~   87 (423)
                      ....-+++|+++.+++.+...+...+ .+++...   ....-++++|.++++++  +.+.+++.  .+...+++|+++++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~--~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPN--PVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCC--CcccccccCCcccccchhhhhhcC
Confidence            34455678999999999876655444 6655443   34566888899999866  33433333  44567899999944


Q ss_pred             C--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           88 S--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        88 s--L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      .  .........-.+...+...+++.-+.+|++||+.-=+|+|    ||+.    ..+..++.||+....+....     
T Consensus       319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~-----  385 (829)
T KOG0576|consen  319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM-----  385 (829)
T ss_pred             CccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc-----
Confidence            3  2222211112244555667778888999999998888999    8887    46889999999987765443     


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ  214 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~  214 (423)
                         ......+|+.++|||+..+..+....|+|++|.-..++.-|.+|-.
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence               2347789999999999999999999999999998888877776653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.09  E-value=2e-05  Score=72.91  Aligned_cols=72  Identities=19%  Similarity=0.165  Sum_probs=47.0

Q ss_pred             ceeeecCce-eEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCeEEEeeeeCC---eeEEEEecc-
Q 014527           13 RKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGE---DNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg-~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~--~~i~~i~~~~~~~~---~~~lv~e~~-   85 (423)
                      +.|+.|+.. .||+..     ..+++|+.........+.+|++++..|...  -.+|.+...+...+   ..+++|+++ 
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            567777766 599762     347889876644555799999999999753  23455544443322   347899998 


Q ss_pred             CCCH
Q 014527           86 GPSL   89 (423)
Q Consensus        86 ~~sL   89 (423)
                      |.++
T Consensus        78 G~~l   81 (235)
T cd05155          78 GETA   81 (235)
T ss_pred             CCCC
Confidence            4343

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.07  E-value=0.00012  Score=65.62  Aligned_cols=129  Identities=20%  Similarity=0.285  Sum_probs=90.6

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCC------------------CchhHHHHHHHHHHHc-C----CCCCCeE
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------------KHPQLLYEAKVYKILQ-G----GSGIPNI   68 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~------------------~~~~~~~E~~~l~~l~-~----~~~i~~i   68 (423)
                      ...||+|+.-.||.-  .. +...+||+.....                  ...+..+|+..+..+. .    ..+++.+
T Consensus         6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            457899999999964  32 3447899877655                  2456788888887777 3    2456666


Q ss_pred             EEeeeeCCeeEEEEecc-------CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           69 KWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        69 ~~~~~~~~~~~lv~e~~-------~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      +.+.....-..+|+|..       ..+|.+++.  ...++. ...   ..+-+-..||-+.+|+.+||+|.||++...++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            66666666778888877       236777774  334555 333   33334456888999999999999999987655


Q ss_pred             CC-cEEEee
Q 014527          142 AN-QVYIID  149 (423)
Q Consensus       142 ~~-~vkL~D  149 (423)
                      .. .++|+|
T Consensus       157 ~~~~lvlID  165 (199)
T PF10707_consen  157 GEFRLVLID  165 (199)
T ss_pred             CceEEEEEe
Confidence            55 788888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.03  E-value=6.2e-05  Score=82.23  Aligned_cols=76  Identities=14%  Similarity=0.231  Sum_probs=52.2

Q ss_pred             eceeeecCceeEEEEEECCCC--cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCC--CeEEEeeeeC---CeeEEE
Q 014527           12 GRKIGSGSFGEIFLASHVDTN--EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGI--PNIKWYGVDG---EDNVLV   81 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~--~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i--~~i~~~~~~~---~~~~lv   81 (423)
                      .+.|+.|.+..+|+......+  ..+++|+.....   ....+.+|+++++.|..+..+  |.+..++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998765432  467788754332   234688999999999743334  5555554443   357899


Q ss_pred             EeccCC
Q 014527           82 LDLLGP   87 (423)
Q Consensus        82 ~e~~~~   87 (423)
                      ||++.|
T Consensus       123 ME~v~G  128 (822)
T PLN02876        123 MEYLEG  128 (822)
T ss_pred             EEecCC
Confidence            999954

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.98  E-value=0.00011  Score=65.55  Aligned_cols=124  Identities=19%  Similarity=0.254  Sum_probs=84.3

Q ss_pred             CceEEeceeeecCc-eeEEEEEECCCCcEEEEEEecCC-----------------------CCchhHHHHHHHHHHHcCC
Q 014527            7 VKYKLGRKIGSGSF-GEIFLASHVDTNEIVAVKIENSG-----------------------TKHPQLLYEAKVYKILQGG   62 (423)
Q Consensus         7 ~~y~i~~~Lg~G~f-g~Vy~a~~~~~~~~vaiKi~~~~-----------------------~~~~~~~~E~~~l~~l~~~   62 (423)
                      ..++.++.||.|.- |.||+++.  .|+.||||++..-                       .....|..|.+.+.+|++.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68899999999999 99999987  6789999983210                       0112377899999988864


Q ss_pred             CC--C--CeEEEeee-e-----------------CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014527           63 SG--I--PNIKWYGV-D-----------------GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH  120 (423)
Q Consensus        63 ~~--i--~~i~~~~~-~-----------------~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH  120 (423)
                      ..  +  ...+.|-. +                 .....||.||....-         .+    ...-+.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence            33  2  22222221 1                 011246777662211         12    2334567888889999


Q ss_pred             hcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527          121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus       121 ~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ..||+-+|+++.|..=        =+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC--------CEEEecccC
Confidence            9999999999999863        279999865

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.84  E-value=0.0019  Score=62.96  Aligned_cols=70  Identities=19%  Similarity=0.171  Sum_probs=47.9

Q ss_pred             eeeecCceeEEEEEECCCCcEEEEEEec----C-----CCCchhHHHHHHHHHHHcCC--CCCCeEEEeeeeCCeeEEEE
Q 014527           14 KIGSGSFGEIFLASHVDTNEIVAVKIEN----S-----GTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~----~-----~~~~~~~~~E~~~l~~l~~~--~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .||.|....||++.....++.|+||.-.    .     .-...+...|.+.|+.....  ..+|.++  ..+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence            5799999999999975444679999421    1     22334567788888776542  2455544  44667778999


Q ss_pred             ecc
Q 014527           83 DLL   85 (423)
Q Consensus        83 e~~   85 (423)
                      |++
T Consensus        80 EdL   82 (370)
T TIGR01767        80 EDL   82 (370)
T ss_pred             hhC
Confidence            998

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.80  E-value=0.00013  Score=68.24  Aligned_cols=131  Identities=16%  Similarity=0.139  Sum_probs=77.5

Q ss_pred             eeeecCceeEEEEEECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccCC-CHH
Q 014527           14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLE   90 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~--~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~~-sL~   90 (423)
                      .+..|-.+.+|+...  +++.+++|+.......  -...+|.++++.+......|.+.....    .++||||+.| .+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            355677889999873  5667899976543322  246889999999987655677655432    3689999943 322


Q ss_pred             H--------------HHHHhc------CCCCHH-HHHHHHHHH---------HHHHHHHHh--------cCcccccccCC
Q 014527           91 D--------------LFVYCR------RKFSLK-TVLMLADQM---------IARIEYVHS--------RGFLHRDIKPD  132 (423)
Q Consensus        91 ~--------------~l~~~~------~~l~~~-~~~~i~~qi---------~~aL~yLH~--------~giiHrDIKp~  132 (423)
                      .              .+....      ..++.. .+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            1              111111      112221 111221111         111222211        25899999999


Q ss_pred             ceEEeecCCCCcEEEeecccee
Q 014527          133 NFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       133 NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ||+++   +++ +.|+||..|.
T Consensus       157 Nil~~---~~~-~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVT---PQG-LKLIDWEYAS  174 (256)
T ss_pred             cEEEe---CCC-CEEEeccccC
Confidence            99995   333 7899998874

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.77  E-value=0.00027  Score=67.94  Aligned_cols=139  Identities=21%  Similarity=0.250  Sum_probs=97.0

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----------------------Cch------hHHHHHHHHHHHcC
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------------------KHP------QLLYEAKVYKILQG   61 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----------------------~~~------~~~~E~~~l~~l~~   61 (423)
                      .|...|..|--+.||.|.. .+|..+||||.+..-                      ..+      -...|++-|.+|..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            4556788899999999985 557789999754210                      000      14678888888875


Q ss_pred             CCCCCeEEEeeeeCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCcccccccCCceEEeecC
Q 014527           62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGR  140 (423)
Q Consensus        62 ~~~i~~i~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDIKp~NILl~~~~  140 (423)
                      . +||.-.-.  .-...+|||+|+|.+-.-.-.-....++...+..+-.|++.-+.-|- ..++||.||.-=|+|+    
T Consensus       226 a-GIP~PePI--lLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----  298 (520)
T KOG2270|consen  226 A-GIPCPEPI--LLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----  298 (520)
T ss_pred             c-CCCCCCce--eeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----
Confidence            3 23322111  11346899999965433221112345778888888899998888874 5689999999999999    


Q ss_pred             CCCcEEEeeccceeee
Q 014527          141 KANQVYIIDFGLAKKY  156 (423)
Q Consensus       141 ~~~~vkL~DFGla~~~  156 (423)
                      .+|.++|+|-+-+...
T Consensus       299 hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             ECCEEEEEEccccccC
Confidence            6899999999877543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.77  E-value=0.00046  Score=63.55  Aligned_cols=71  Identities=15%  Similarity=0.164  Sum_probs=48.5

Q ss_pred             eceeeecCceeEEEEEECC-CCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccC
Q 014527           12 GRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG   86 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~-~~~~vaiKi~~~~~~~-~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~   86 (423)
                      ++.|..|-...+|++.... .++.|++|+....... ....+|+.++..+......|.+.....    ..++|||+.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~   75 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP   75 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence            4567778888999997543 2567999987643221 234689999999976666777754332    248999983

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.77  E-value=0.00057  Score=67.80  Aligned_cols=73  Identities=27%  Similarity=0.326  Sum_probs=52.5

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecC---------CCCchhHHHHHHHHHHHcCC--CCCCeEEEeeeeCCeeEE
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENS---------GTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~---------~~~~~~~~~E~~~l~~l~~~--~~i~~i~~~~~~~~~~~l   80 (423)
                      .+.||.|.+..||++.....++.|+||....         .....+...|.+.|..+...  ..+|.+..+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4678999999999999865445899997431         11334577888888887642  456777666  4466899


Q ss_pred             EEeccC
Q 014527           81 VLDLLG   86 (423)
Q Consensus        81 v~e~~~   86 (423)
                      |||++.
T Consensus       109 VME~L~  114 (401)
T PRK09550        109 VMEDLS  114 (401)
T ss_pred             EEecCC
Confidence            999984

>PRK05231 homoserine kinase; Provisional

Probab=97.68  E-value=0.0012  Score=63.90  Aligned_cols=73  Identities=11%  Similarity=0.086  Sum_probs=46.3

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeEEE------eeeeCCeeEEEEec
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL   84 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~-~i~~i~~------~~~~~~~~~lv~e~   84 (423)
                      .+.|+.|....+|++...  +..+++|+.. ......+..|..++..|.... .+|.+..      +....+..++++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            355667777899998753  3368899876 334456677888888876422 1333321      22335567899999


Q ss_pred             cCC
Q 014527           85 LGP   87 (423)
Q Consensus        85 ~~~   87 (423)
                      +.|
T Consensus       104 l~G  106 (319)
T PRK05231        104 LEG  106 (319)
T ss_pred             cCC
Confidence            844

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.65  E-value=0.00066  Score=65.42  Aligned_cols=138  Identities=18%  Similarity=0.282  Sum_probs=80.0

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeEEE------eeeeCCeeEEEEec
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKW------YGVDGEDNVLVLDL   84 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~-i~~i~~------~~~~~~~~~lv~e~   84 (423)
                      .+.++.|....+|++.. . +..+++|+.........+..|.+++..|..... ++.+..      +....+..++++++
T Consensus        27 i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            55677777789999864 3 335888987664445567788888888864221 333321      11234567899999


Q ss_pred             cCC-CH-----H------HHHHHh---cCCC--------CHHH---HH------------HHHHHHHHHHHHHHh-----
Q 014527           85 LGP-SL-----E------DLFVYC---RRKF--------SLKT---VL------------MLADQMIARIEYVHS-----  121 (423)
Q Consensus        85 ~~~-sL-----~------~~l~~~---~~~l--------~~~~---~~------------~i~~qi~~aL~yLH~-----  121 (423)
                      +.| .+     .      ..+...   ...+        ....   ..            .....+...++++..     
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            843 21     1      111110   0111        0000   00            011123344555542     


Q ss_pred             --cCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          122 --RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       122 --~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                        .+++|+|+.+.||+++   .++.+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence              6899999999999994   45556899999863

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.62  E-value=0.00053  Score=74.48  Aligned_cols=197  Identities=16%  Similarity=0.125  Sum_probs=125.8

Q ss_pred             HHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE----EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014527           49 LLYEAKVYKILQGGSGIPNIKWYGVDGEDNV----LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG  123 (423)
Q Consensus        49 ~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~----lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g  123 (423)
                      ...|...+.++.|. ++..+..|+......-    +..++| ..++...+.. -..++..+++.+..++..||.|+|+..
T Consensus       229 ~E~e~~~l~k~~~~-n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHD-NLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccc-cccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            45566667777764 4444444444332222    334556 5566666654 456889999999999999999999996


Q ss_pred             cccccccCCceEEeecCCCCcEEEe--eccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCC--ccchHHHH
Q 014527          124 FLHRDIKPDNFLMGLGRKANQVYII--DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS--RRDDLESL  199 (423)
Q Consensus       124 iiHrDIKp~NILl~~~~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s--~~sDIwSl  199 (423)
                      ..|.-|...-..-...+..+.+.++  ||+.++.+.......        ....+..|.++|......+.  +..|+|.+
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhhhHHHHH
Confidence            6665554442222222445566666  999888766544321        23345667788887766654  45799999


Q ss_pred             HHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          200 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       200 Gvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      |..+..+..|..+-...                 ..+...++........+....|+..++++|+.+.+++..
T Consensus       379 gll~~~~~~~~~i~~~~-----------------~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKS-----------------AVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHHHhhhhhcCcccccc-----------------cchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            99999999876553210                 011111111122367788889999999999999888663

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.56  E-value=0.00053  Score=65.81  Aligned_cols=69  Identities=16%  Similarity=0.101  Sum_probs=48.2

Q ss_pred             ceeeecCceeEEEEEECC------CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527           13 RKIGSGSFGEIFLASHVD------TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~------~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      +.|..|-...+|++....      .++.|++|+...... .....+|.+++..+......|.+..+..    ..+|++|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence            456667777999987543      257899999765432 2457899999999987666677665553    23578887

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.51  E-value=0.00041  Score=61.78  Aligned_cols=100  Identities=21%  Similarity=0.257  Sum_probs=74.4

Q ss_pred             HHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccC-CCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 014527           50 LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG-PSLEDLFV--YCRRKFSLKTVLMLADQMIARIEYVHS---RG  123 (423)
Q Consensus        50 ~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~-~sL~~~l~--~~~~~l~~~~~~~i~~qi~~aL~yLH~---~g  123 (423)
                      ..|.-+++.|.+..++|.+.+++  +  .+++.||.+ +++.....  ..-...++..+..|+.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C--G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC--G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC--C--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            35888899999877777775543  2  367889885 44432100  001236899999999999999999987   34


Q ss_pred             cccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527          124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus       124 iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      +.-.|++|+||-++   +++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence            77799999999994   7789999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.48  E-value=0.0014  Score=62.67  Aligned_cols=137  Identities=14%  Similarity=0.154  Sum_probs=80.5

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeEEE------eeeeCCeeEEEEec
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL   84 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~-~i~~i~~------~~~~~~~~~lv~e~   84 (423)
                      .+.|..|....+|++..  .+..+++|+... .....+..|++++..|.... .++.+..      +....+..++++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            55677787789999864  344689998765 44556888999999986532 1333321      12234566899999


Q ss_pred             cCC-CHH-----------HHHHHh---cCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------c
Q 014527           85 LGP-SLE-----------DLFVYC---RRKF----------SLKTV----------LMLADQMIARIEYVHS-------R  122 (423)
Q Consensus        85 ~~~-sL~-----------~~l~~~---~~~l----------~~~~~----------~~i~~qi~~aL~yLH~-------~  122 (423)
                      +.| .+.           ..+...   ...+          .+...          ......+..++.++..       .
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            943 321           111100   0001          00000          0011123334445443       4


Q ss_pred             CcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       123 giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      +++|+|+.|.|||++   +++.+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFD---GDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence            799999999999994   45556899998874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.36  E-value=0.0011  Score=62.85  Aligned_cols=45  Identities=13%  Similarity=0.104  Sum_probs=30.5

Q ss_pred             ecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 014527           17 SGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG   62 (423)
Q Consensus        17 ~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~   62 (423)
                      +|-...||.+.. ..|..+++|.-........+.+|++++..|...
T Consensus        21 ~g~~~~v~~i~~-~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~   65 (276)
T cd05152          21 SGLDFQVVFAKD-TDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH   65 (276)
T ss_pred             CcceeEEEEEEc-CCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence            333445555532 347789999876544556789999999999864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.36  E-value=0.00016  Score=68.47  Aligned_cols=132  Identities=20%  Similarity=0.340  Sum_probs=91.3

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----------C--------------CchhHHHHHHHHHHHcCC-C
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----------T--------------KHPQLLYEAKVYKILQGG-S   63 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----------~--------------~~~~~~~E~~~l~~l~~~-~   63 (423)
                      +.++++||-|--+.||.+.+. .|++.++|+-+..          .              ..-...+|...|+.|..+ .
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            568899999999999999875 4778999952211          0              001246788889988752 2


Q ss_pred             CCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        64 ~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      -+|...    +....++|||++ |-.|.....       ...+-.+...+..-+.-|-.+|+||+|..-=||++   +++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd  238 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD  238 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence            233322    446789999999 555544321       12233344455555677888999999999999999   478


Q ss_pred             CcEEEeeccceee
Q 014527          143 NQVYIIDFGLAKK  155 (423)
Q Consensus       143 ~~vkL~DFGla~~  155 (423)
                      +.++++||--...
T Consensus       239 ~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  239 DKIVVIDFPQMVS  251 (465)
T ss_pred             CCEEEeechHhhc
Confidence            8999999976543

>PLN02236 choline kinase

Probab=97.20  E-value=0.0069  Score=59.36  Aligned_cols=137  Identities=15%  Similarity=0.183  Sum_probs=80.4

Q ss_pred             eceeeecCceeEEEEEECC----CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           12 GRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~----~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      ...|..|-...+|++....    .++.|++|+...... .-....|..+++.+.....-|.+..++..+    .|++|+ 
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            3455558888999987532    246799998765432 112477999999998877777776554322    578888 


Q ss_pred             CCCHHHH--------------HHHh-cCC------CC-HHHHHHHHHHH-----------------HHHHHHH----H--
Q 014527           86 GPSLEDL--------------FVYC-RRK------FS-LKTVLMLADQM-----------------IARIEYV----H--  120 (423)
Q Consensus        86 ~~sL~~~--------------l~~~-~~~------l~-~~~~~~i~~qi-----------------~~aL~yL----H--  120 (423)
                      +.++...              +... ...      .. ...+..++.++                 ...+..|    .  
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            3333210              1100 000      11 22232332221                 1111122    1  


Q ss_pred             --hcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          121 --SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       121 --~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                        ...++|+|+++.|||++  +.++.++|+||..|.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence              23589999999999995  334689999998874

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.13  E-value=0.002  Score=64.67  Aligned_cols=166  Identities=20%  Similarity=0.189  Sum_probs=95.2

Q ss_pred             CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014527           44 TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG  123 (423)
Q Consensus        44 ~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g  123 (423)
                      ....+++-....++.+.|.+....+..-.......++|||+++.+|.+++....  +-.....              .+|
T Consensus        24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~   87 (725)
T KOG1093|consen   24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHG   87 (725)
T ss_pred             CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------ccc
Confidence            344456777788888887544433333333455689999999999999987432  2111111              222


Q ss_pred             cccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHH
Q 014527          124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVL  203 (423)
Q Consensus       124 iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil  203 (423)
                      +.|     -|          .++.+| .++...              ....                .+|+||||+|.++
T Consensus        88 ~~~-----~~----------~~~~td-~~~t~~--------------~~~~----------------~pKsdVwsl~~i~  121 (725)
T KOG1093|consen   88 VLH-----LN----------IIYITD-HFLTKY--------------PSPI----------------GPKSDVWSLGFII  121 (725)
T ss_pred             cce-----eh----------hhhccc-cccccC--------------CCCC----------------CcchhhhhHHHHH
Confidence            222     22          233333 111000              0111                1499999999999


Q ss_pred             HHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH----HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          204 LYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI----EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       204 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++.-|...|......+....+.+..........    ......++..+.++...|+-..|..||...++.+
T Consensus       122 ~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  122 LELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            9999998888765444333333222111110000    0112234777889999999999999997776644

>PRK10593 hypothetical protein; Provisional

Probab=97.11  E-value=0.0049  Score=59.08  Aligned_cols=107  Identities=17%  Similarity=0.097  Sum_probs=74.5

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCeEEEeeee---CCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIPNIKWYGVD---GEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~--~i~~i~~~~~~---~~~~~lv~   82 (423)
                      .-.-.+.||.|..+.||+....  +..+++|+.+.......+..|++.++.|....  .+|.+..++.+   .+..+|||
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDS--QGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hhheeeecCCccceeEEEEEcC--CCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            4445678999999999998642  23477888544334457999999999998643  46677655433   36689999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR  122 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~  122 (423)
                      |++ +.++.+.      ..+......+..+++.+|..||+.
T Consensus        93 E~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         93 ERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             eccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            999 5455431      123444566777888888889874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.10  E-value=6.2e-05  Score=83.23  Aligned_cols=131  Identities=11%  Similarity=-0.011  Sum_probs=100.0

Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcC-----cccccccCCceEEeecCCCCc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQ  144 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~---l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDIKp~NILl~~~~~~~~  144 (423)
                      .....+.+++++ +|.+.+.+.+...+   +...-+.....+.+.+..-+|+..     .+|++||+-|.+|   ..+..
T Consensus      1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred             CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence            344568899999 89999888753322   344444455555477888877652     7899999999999   47788


Q ss_pred             EEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 014527          145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ  214 (423)
Q Consensus       145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~  214 (423)
                      +|+.++|+.+.......       ..+...+++.|++|++.....++.++|+|..|+-+|++..|..+|-
T Consensus      1379 v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             ccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            99999999983322221       2235678889999999999899999999999999999999988874

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.08  E-value=0.0069  Score=58.99  Aligned_cols=73  Identities=14%  Similarity=0.122  Sum_probs=46.9

Q ss_pred             ceEEeceeeecCceeEEEEEECCC---CcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~~-~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ..++. .|..|=...+|++.....   +..|++|+....... -...+|..+++.+.....-|.+..+...+    +|.+
T Consensus        16 ~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~   90 (330)
T PLN02421         16 DFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQS   90 (330)
T ss_pred             ceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence            33444 444477778999875432   237999987654321 12468999999998876667776554222    5788


Q ss_pred             cc
Q 014527           84 LL   85 (423)
Q Consensus        84 ~~   85 (423)
                      |+
T Consensus        91 fi   92 (330)
T PLN02421         91 FI   92 (330)
T ss_pred             hh
Confidence            87

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.93  E-value=0.0077  Score=59.45  Aligned_cols=72  Identities=21%  Similarity=0.284  Sum_probs=50.1

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEE----ecC----CCCchhHHHHHHHHHHHcC--CCCCCeEEEeeeeCCeeEEE
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKI----ENS----GTKHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi----~~~----~~~~~~~~~E~~~l~~l~~--~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+.||.|.-..||++.+...++.|+||.    ++.    .-...+...|.+.|+.+..  +..+|.++.|  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5678999999999999844356799994    221    1233456788888887764  2346666554  56677889


Q ss_pred             Eecc
Q 014527           82 LDLL   85 (423)
Q Consensus        82 ~e~~   85 (423)
                      ||++
T Consensus       112 MEdL  115 (409)
T PRK12396        112 MEDL  115 (409)
T ss_pred             HHhC
Confidence            9888

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.84  E-value=0.018  Score=54.89  Aligned_cols=73  Identities=19%  Similarity=0.262  Sum_probs=51.8

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeEEEEecc
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      +-.+.|+.|....+|+..  .+++.+.||+-. ......+..|++-|+.|.  ..-.+|.+..++...+..+|+|||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            445678889999999987  567889999876 344556899999999994  4566888888888888889999998

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.51  E-value=0.067  Score=51.35  Aligned_cols=29  Identities=45%  Similarity=0.832  Sum_probs=24.5

Q ss_pred             cCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       122 ~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      .+++|+|+.+.||+++   . +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            4789999999999994   3 678999998763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.45  E-value=0.063  Score=53.41  Aligned_cols=73  Identities=12%  Similarity=0.281  Sum_probs=49.5

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEec-----CCC----CchhHHHHHHHHHHHcC--CCCCCeEEEeeeeCCeeE
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGT----KHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~-----~~~----~~~~~~~E~~~l~~l~~--~~~i~~i~~~~~~~~~~~   79 (423)
                      -.+.||.|....||++.+  .+..|+||.-.     ...    ...+...|++.|+.+..  +..+|.++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            466789999999999986  34569999643     111    33445667777776653  235676666654  6678


Q ss_pred             EEEeccCC
Q 014527           80 LVLDLLGP   87 (423)
Q Consensus        80 lv~e~~~~   87 (423)
                      ++||++.+
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            89999944

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.45  E-value=0.087  Score=51.19  Aligned_cols=68  Identities=13%  Similarity=0.073  Sum_probs=42.4

Q ss_pred             cCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEE-------EeeeeCCeeEEEEeccCC
Q 014527           18 GSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIK-------WYGVDGEDNVLVLDLLGP   87 (423)
Q Consensus        18 G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~-------~~~~~~~~~~lv~e~~~~   87 (423)
                      +.-..||++.. .++..+++|+.+... ...++..|.+.+..|... .++.+.       .+...++..+.++++++|
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~-gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA-EIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC-CCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            34457898874 346679999876543 455678899998888752 233221       112234566788888843

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.35  E-value=0.034  Score=53.51  Aligned_cols=139  Identities=17%  Similarity=0.295  Sum_probs=75.5

Q ss_pred             EEeceeeecCceeEEEEEECCCCcEEEEEEecC-C---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC----eeEEE
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-G---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE----DNVLV   81 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~----~~~lv   81 (423)
                      .+++.+..|---.+|....  +++.++++ ... .   .......+|.++++.+... .+|.-..++.+.+    ..|.|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~-~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDV-DVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             ceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCC-CCCCcccccccccCCCCCceEE
Confidence            3455554454445565554  37778888 321 1   2233467788888887753 3444333333333    45999


Q ss_pred             EeccCC-------------------CHHHHHHHhcC-------------CCCHHHHHHHHHHH--------------HHH
Q 014527           82 LDLLGP-------------------SLEDLFVYCRR-------------KFSLKTVLMLADQM--------------IAR  115 (423)
Q Consensus        82 ~e~~~~-------------------sL~~~l~~~~~-------------~l~~~~~~~i~~qi--------------~~a  115 (423)
                      |+++.|                   .|.+.+....+             .+...++..+..+.              ..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999954                   12222221110             01111122222222              222


Q ss_pred             HHHHHhc--------CcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527          116 IEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus       116 L~yLH~~--------giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..+|+.+        .++|+|+.+.||++.   +...+=+.||+++..
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l  228 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence            3444432        489999999999995   455588999999864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.20  E-value=0.016  Score=52.51  Aligned_cols=50  Identities=22%  Similarity=0.224  Sum_probs=32.5

Q ss_pred             CcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527           32 NEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus        32 ~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      ++.|+||+..... ..-....|..+++.+.....-|.+..++..    ..|.+|+
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i   52 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFI   52 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEe
Confidence            4578999887663 334567899999999876666777665432    2566777

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=96.04  E-value=0.12  Score=51.44  Aligned_cols=71  Identities=15%  Similarity=0.119  Sum_probs=45.5

Q ss_pred             eceeeecCceeEEEEEECCCC------cEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527           12 GRKIGSGSFGEIFLASHVDTN------EIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~------~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      .+.|..|-...+|++......      +.|++++..... ..-...+|.++++.|.....-|.+...+.    .+++.||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            345555888899999754321      125555432211 11124679999999998888888876653    3688999


Q ss_pred             cC
Q 014527           85 LG   86 (423)
Q Consensus        85 ~~   86 (423)
                      +.
T Consensus       131 Ie  132 (383)
T PTZ00384        131 VE  132 (383)
T ss_pred             ec
Confidence            83

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.01  E-value=0.032  Score=54.03  Aligned_cols=73  Identities=21%  Similarity=0.282  Sum_probs=59.1

Q ss_pred             eCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      +..+.|++|++-|+++.-.     .....+++..++.+.+.-|.-+..+ .+-|||+.-.||||    +.|.|.|+||-+
T Consensus       297 e~~y~yl~~kdhgt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfkl  367 (488)
T COG5072         297 ETLYLYLHFKDHGTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFKL  367 (488)
T ss_pred             CceEEEEEEecCCceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEeee
Confidence            4456788888888877543     2246788899999888888777765 68999999999999    489999999999


Q ss_pred             eee
Q 014527          153 AKK  155 (423)
Q Consensus       153 a~~  155 (423)
                      ++.
T Consensus       368 sRl  370 (488)
T COG5072         368 SRL  370 (488)
T ss_pred             eec
Confidence            984

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.94  E-value=0.051  Score=52.71  Aligned_cols=131  Identities=18%  Similarity=0.206  Sum_probs=77.2

Q ss_pred             CceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeE-------EEeeeeCC--eeEEEEeccCC-C
Q 014527           19 SFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-------KWYGVDGE--DNVLVLDLLGP-S   88 (423)
Q Consensus        19 ~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i-------~~~~~~~~--~~~lv~e~~~~-s   88 (423)
                      .-..||++...+ ++ +++|+........++..|...+..|......+..       .....-..  ..+-+.+|++| .
T Consensus        37 ~eN~~f~~~~~~-g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQTED-GR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEecC-CC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            455789887633 33 4999988876677788999999988754322111       11122233  77788888844 3


Q ss_pred             HHH-----HHHH----------hcCC-----------CCHH----H---------HHHHHHHHHHHHHHHHh--------
Q 014527           89 LED-----LFVY----------CRRK-----------FSLK----T---------VLMLADQMIARIEYVHS--------  121 (423)
Q Consensus        89 L~~-----~l~~----------~~~~-----------l~~~----~---------~~~i~~qi~~aL~yLH~--------  121 (423)
                      +..     .+..          ..+.           ..+.    .         -.....++...+..+.+        
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            331     1100          0011           1111    0         01133444455555553        


Q ss_pred             cC--cccccccCCceEEeecCCCC-cEEEeecccee
Q 014527          122 RG--FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK  154 (423)
Q Consensus       122 ~g--iiHrDIKp~NILl~~~~~~~-~vkL~DFGla~  154 (423)
                      -+  +||+|+.|.||++.   ... .+-++||+-+.
T Consensus       195 ~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence            23  99999999999994   444 48899999874

>PRK06148 hypothetical protein; Provisional

Probab=95.45  E-value=0.25  Score=55.51  Aligned_cols=47  Identities=15%  Similarity=0.140  Sum_probs=33.4

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG   61 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~   61 (423)
                      +.|+ |..-.+|++.. .+++.+++|+.+.......+..|.+++..|..
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~   77 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA   77 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence            4554 45678898874 45667999999876655566777778877764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.36  E-value=0.31  Score=46.92  Aligned_cols=29  Identities=24%  Similarity=0.440  Sum_probs=25.6

Q ss_pred             CcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       123 giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      +++|+|+.+.|||+   +.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence            79999999999999   466789999998874

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.20  E-value=0.062  Score=52.87  Aligned_cols=60  Identities=23%  Similarity=0.280  Sum_probs=43.6

Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCcccccccCCceEEe
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLMG  137 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~giiHrDIKp~NILl~  137 (423)
                      ...+|+.+|. |-++..++..  ...+++.+..++.=.+.||--+ --.+++|.|+.|.||++.
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ccceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            3456777777 7788887764  3355666777777777776444 456899999999999995

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.89  E-value=0.58  Score=44.14  Aligned_cols=46  Identities=22%  Similarity=0.346  Sum_probs=33.9

Q ss_pred             HHHHHHHHHHHHHHHhc--CcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          106 LMLADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       106 ~~i~~qi~~aL~yLH~~--giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...+..+-.++.-++..  -++|+|+.|+|+|.+   +.+.++|+||-.|.
T Consensus       135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg  182 (269)
T COG0510         135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCC
Confidence            33444555555555544  589999999999994   56999999998774

>PRK06149 hypothetical protein; Provisional

Probab=93.81  E-value=0.82  Score=51.24  Aligned_cols=47  Identities=15%  Similarity=0.122  Sum_probs=32.3

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG   62 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~   62 (423)
                      ..|+.+. -.+|++...  +..+++|+.+.......+..|..++..|...
T Consensus        37 ~~L~s~~-d~nf~v~t~--~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~   83 (972)
T PRK06149         37 TELGSQQ-DRNFRVDSD--GGRFVLKICHAAYAAVELEAQHAALRHLAER   83 (972)
T ss_pred             EecCCcC-cceEEEEec--CCcEEEEeCCccCChHHHHHHHHHHHHHHhh
Confidence            4555333 368888753  3468889988665666788888888888653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	423
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-147
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-127
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-127
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-127
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		5e-97
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		5e-97
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-95
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		4e-95
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		5e-95
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		3e-94
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		9e-93
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		1e-26
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		2e-25
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		2e-25
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		1e-24
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-14
2jii_A	352	Structure Of Vaccinia Related Kinase 3 Length = 352		3e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-05
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-05
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-04
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-04
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-04
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-04
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-04
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-04
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-04
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-04
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-04
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-04
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-04
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-04
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-04
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-04
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-04
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-04
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-04

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score =  516 bits (1329), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 239/337 (70%), Positives = 284/337 (84%), Gaps = 2/337 (0%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G K++LGRKIGSGSFGEI+L +++ TNE VA+K+EN  TKHPQLLYE+K+Y+ILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG+GIPN++W+GV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI R+E+VH
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD +T++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKY+KI EKKV+T IE L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           C+ +P EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q 
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 TKSQDLLPASRVTNSRVMP--MRTDKLKGVNDASCSA 335
             +           S + P  ++ D+  GV++   S 
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSG 337

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score =  452 bits (1164), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 206/294 (70%), Positives = 257/294 (87%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E   TKHPQL  E+K YK++Q
Sbjct: 3   MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 62
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294
           CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK
Sbjct: 243 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score =  452 bits (1164), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 205/295 (69%), Positives = 256/295 (86%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKY 295
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score =  451 bits (1161), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 205/294 (69%), Positives = 255/294 (86%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 3   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score =  351 bits (900), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 166/292 (56%), Positives = 212/292 (72%), Gaps = 2/292 (0%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           ++GV YK+GR+IG GSFG IF  +++  N+ VA+K E   +  PQL  E + YK+L G +
Sbjct: 7   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           GIPN+ ++G +G  NVLV+DLLGPSLEDL   C RKFS+KTV M A QM+AR++ +H + 
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 124 FLHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            ++RDIKPDNFL+G    + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTARY S
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
            NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+  LC
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 246
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
              P EF  Y HY ++L FD  PDY +L+ LF  +  R     D  FDW +L
Sbjct: 247 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score =  351 bits (900), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 166/292 (56%), Positives = 212/292 (72%), Gaps = 2/292 (0%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           ++GV YK+GR+IG GSFG IF  +++  N+ VA+K E   +  PQL  E + YK+L G +
Sbjct: 6   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 65
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           GIPN+ ++G +G  NVLV+DLLGPSLEDL   C RKFS+KTV M A QM+AR++ +H + 
Sbjct: 66  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 125
Query: 124 FLHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            ++RDIKPDNFL+G    + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTARY S
Sbjct: 126 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 185
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
            NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+  LC
Sbjct: 186 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 245
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
              P EF  Y HY ++L FD  PDY +L+ LF  +  R     D  FDW +L
Sbjct: 246 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 297

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score =  346 bits (887), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 167/289 (57%), Positives = 223/289 (77%), Gaps = 3/289 (1%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           ++G  +++G+KIG G+FGE+ L  ++ TNE VA+K+E   ++ PQL  E + YK L  G 
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           GIP + ++G  G+ N +VL+LLGPSLEDLF  C R FSLKTVLM+A Q+I+R+EYVHS+ 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 124 FLHRDIKPDNFLMGL-GRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            ++RD+KP+NFL+G  G K  QV +IIDFGLAK+Y DP T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
            NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEVLC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
           ++ P E A+Y  Y + L F ++PDY +L++LF DLF R+GY FD+ +DW
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score =  345 bits (884), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 166/289 (57%), Positives = 222/289 (76%), Gaps = 3/289 (1%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           ++G  +++G+KIG G+FGE+ L  ++ TNE VA+K+E   ++ PQL  E + YK L  G 
Sbjct: 27  MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 86
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           GIP + ++G  G+ N +VL+LLGPSLEDLF  C R FSLKTVLM+A Q+I+R+EYVHS+ 
Sbjct: 87  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 146
Query: 124 FLHRDIKPDNFLMGL-GRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            ++RD+KP+NFL+G  G K  QV +IIDF LAK+Y DP T +HIPYRE+K+LTGTARY S
Sbjct: 147 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 206
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
            NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEVLC
Sbjct: 207 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 266
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
           ++ P E A+Y  Y + L F ++PDY +L++LF DLF R+GY FD+ +DW
Sbjct: 267 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 314

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score =  344 bits (883), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 166/289 (57%), Positives = 222/289 (76%), Gaps = 3/289 (1%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           ++G  +++G+KIG G+FGE+ L  ++ TNE VA+K+E   ++ PQL  E + YK L  G 
Sbjct: 6   MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           GIP + ++G  G+ N +VL+LLGPSLEDLF  C R FSLKTVLM+A Q+I+R+EYVHS+ 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 124 FLHRDIKPDNFLMGL-GRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            ++RD+KP+NFL+G  G K  QV +IIDF LAK+Y DP T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
            NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEVLC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
           ++ P E A+Y  Y + L F ++PDY +L++LF DLF R+GY FD+ +DW
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score =  342 bits (876), Expect = 3e-94,   Method: Compositional matrix adjust.
 Identities = 158/288 (54%), Positives = 219/288 (76%), Gaps = 2/288 (0%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           +G  +++G+KIG G+FGE+ L  ++ TNE VA+K+E   ++ PQL  E + YK L    G
Sbjct: 2   MGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLSATEG 61
Query: 65  IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           +P + ++G  G+ N +VL+LLGPSLEDLF  C R F+LKTVLM+A Q+I R+EYVH++  
Sbjct: 62  VPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHTKSL 121
Query: 125 LHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
           ++RD+KP+NFL+G    ++ + ++IIDFGLAK+Y DP T +HIPYRE+K+LTGTARY S 
Sbjct: 122 IYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSI 181
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
           NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEVLC+
Sbjct: 182 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 241
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
           + P E A+Y  Y + L F ++PDY +L++LF DLF R G+ FD+ +DW
Sbjct: 242 NFPEEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRSGFVFDYEYDW 289

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score =  337 bits (863), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 158/285 (55%), Positives = 217/285 (76%), Gaps = 3/285 (1%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSGIPNI 68
           ++G+KIG G+FGE+ L  ++ TNE VA+K+E   ++ PQL  E + YK L   G G+P +
Sbjct: 3   RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLGSAGEGLPQV 62
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
            ++G  G+ N +VL+LLGPSLEDLF  C R F+LKTVLM+A Q+++R+EYVHS+  ++RD
Sbjct: 63  YYFGPXGKYNAMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSKNLIYRD 122
Query: 129 IKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           +KP+NFL+G    +K + ++IIDFGLAK+Y DP T +HIPYRE+K+LTGTARY S NTHL
Sbjct: 123 VKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL 182
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246
           G EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIE LC++ P 
Sbjct: 183 GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRNTPIEALCENFPE 242
Query: 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT 291
           E A+Y  Y + L F ++PDY +L+ LF DLF ++GY FD+ +DW 
Sbjct: 243 EMATYLRYVRRLDFFEKPDYEYLRTLFTDLFEKKGYTFDYAYDWV 287

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 94/302 (31%), Positives = 144/302 (47%), Gaps = 36/302 (11%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKV 55
           ++ + G ++ LG+KIGSG FG I+LA        D   +V V+ + +G    +L +  +V
Sbjct: 31  LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 56  YK------------------ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR 97
            K                   L  GSG+   K          +V++ LG  L+ +     
Sbjct: 91  AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSY----RFMVMERLGIDLQKISGQ-N 145
Query: 98  RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
             F   TVL L  +M+  +EY+H   ++H DIK  N L+G  +  +QVY+ D+GL+  YR
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY-KNPDQVYLADYGLS--YR 202
Query: 158 DPTTNRHIPYREN--KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-Q 214
                 H  Y+EN  K   GT  + S + H G+  SRR D+E LGY +L +L G LPW Q
Sbjct: 203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262
Query: 215 GLK--AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272
            LK   A +  K + + E   S        S   E A +     SL +D++P+Y  LK++
Sbjct: 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322
Query: 273 FH 274
            +
Sbjct: 323 LN 324

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 89/315 (28%), Positives = 150/315 (47%), Gaps = 33/315 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIE--NSGTKHPQLLYEAKVYKILQ 60
           ++K+G  IG G FG I+LA       V ++    VK+E  ++G    +L +  +  K  Q
Sbjct: 36  EWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 61  GGS----------GIPNIKWYGVDGEDN------VLVLDLLGPSLEDLFVYCRRKFSLKT 104
                        G+P  K++G    D        +++D  G  L+ ++    ++FS KT
Sbjct: 96  IQKWIRTRKLKYLGVP--KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           VL L+ +++  +EY+H   ++H DIK  N L+   +  +QVY++D+GLA  YR      H
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLA--YRYCPEGVH 210
Query: 165 IPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222
             Y+E+      GT  + S + H G+  SRR DLE LGY ++ +L G LPW+      K 
Sbjct: 211 KEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270
Query: 223 QKYDKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
            +  KI  ++    +   C   K+ P E A Y    + L + ++P Y  L+ +       
Sbjct: 271 VRDSKIRYRENIASLMDKCFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330
Query: 280 EGYDFDFVFDWTILK 294
            G   D   D ++++
Sbjct: 331 IGSKDDGKLDLSVVE 345

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 89/315 (28%), Positives = 150/315 (47%), Gaps = 33/315 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIE--NSGTKHPQLLYEAKVYKILQ 60
           ++K+G  IG G FG I+LA       V ++    VK+E  ++G    +L +  +  K  Q
Sbjct: 36  EWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 61  GGS----------GIPNIKWYGVDGEDN------VLVLDLLGPSLEDLFVYCRRKFSLKT 104
                        G+P  K++G    D        +++D  G  L+ ++    ++FS KT
Sbjct: 96  IQKWIRTRKLKYLGVP--KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           VL L+ +++  +EY+H   ++H DIK  N L+   +  +QVY++D+GLA  YR      H
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLA--YRYCPEGVH 210
Query: 165 IPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222
             Y+E+      GT  + S + H G+  SRR DLE LGY ++ +L G LPW+      K 
Sbjct: 211 KEYKEDPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270
Query: 223 QKYDKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
            +  KI  ++    +   C   K+ P E A Y    + L + ++P Y  L+ +       
Sbjct: 271 VRDSKIRYRENIASLMDKCFPEKNKPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330
Query: 280 EGYDFDFVFDWTILK 294
            G   D   D ++++
Sbjct: 331 IGSKDDGKLDLSVVE 345

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 146/312 (46%), Gaps = 29/312 (9%)
Query: 9   YKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIE--NSGTKHPQLLYEAKVYKILQG 61
           +K+G  IG G FG I+LA       V ++    VK+E  ++G    +L +  +  K  Q 
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 62  GS----------GIPNIKWYGVDGEDN------VLVLDLLGPSLEDLFVYCRRKFSLKTV 105
                       G+P  K++G    D        +++D  G  L+ ++    ++FS KTV
Sbjct: 97  QKWIRTRKLKYLGVP--KYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
           L L+ +++  +EY+H   ++H DIK  N L+   +  +QVY++D+GLA +Y     ++  
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225
                +   GT  + S + H G+  SRR DLE LGY ++ +L G LPW+      K  + 
Sbjct: 214 AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD 273
Query: 226 DKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY 282
            KI  ++    +   C    + P E A Y    + L + ++P Y  L+ +        G 
Sbjct: 274 SKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333
Query: 283 DFDFVFDWTILK 294
             D   D ++++
Sbjct: 334 KDDGKLDLSVVE 345

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 93
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 94  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT  Y
Sbjct: 151 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRDDLCGTLDY 198
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 252

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 130 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 177
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 231

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 93
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 94  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 150
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 151 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 198
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 252

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 68
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 69  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L+GT  Y
Sbjct: 126 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSC---------HAPSSRRTTLSGTLDY 173
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 227

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT  Y
Sbjct: 130 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGTLDY 177
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 231

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 68
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 69  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT  Y
Sbjct: 126 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGTLDY 173
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 227

>pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 20/227 (8%)
Query: 64  GIPNIKWYGVDGED-NVLVLDLLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            IP    +GV  +    LVL  LG SL+  L V  +   S ++VL +A +++  +E++H 
Sbjct: 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE 177
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARY 179
             ++H ++  +N  +      +QV +  +G A +Y    + +H+ Y E       G   +
Sbjct: 178 NEYVHGNVTAENIFVD-PEDQSQVTLAGYGFAFRYC--PSGKHVAYVEGSRSPHEGDLEF 234
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK---KQKYDKICEKKVSTP 236
            S + H G   SRR DL+SLGY +L +L G LPW      T+   KQK  K  +K    P
Sbjct: 235 ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK-QKFVDK--PGP 291
Query: 237 IEVLCKS--HPAE-FASYFHYCQSLTFDQRPDYGFLKR----LFHDL 276
               C     P+E    Y     +LT++++P Y  L+     L  DL
Sbjct: 292 FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT  Y
Sbjct: 128 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRDDLCGTLDY 175
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 229

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 226

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 226

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 226

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTELCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 226

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 129
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 130 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 177
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 128 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 175
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 84
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 85  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 141
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 142 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 189
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 243

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 68
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 69  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 125
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 126 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRDTLCGTLDY 173
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 227

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 71
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 72  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 128
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 129 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 176
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 230

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 69
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 70  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 127 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRXXLCGTLDY 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 228

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA   ++  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 125 HSKKVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRAALCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T +  Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQDTYKRISRVEFTFP 226

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 66
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 67  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 123
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 124 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 171
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 225

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 128 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRAALCGTLDY 175
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 229

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 128 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 175
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 229

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRXXLCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 226

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRAALCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 226

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 67
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 68  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 125 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTXLCGTLDY 172
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 226

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 128 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRXXLCGTLDY 175
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 229

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L      +++   ++  KF  +       ++   + Y 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 130 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 177
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 231

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA       I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 64
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 65  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 121
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 122 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDY 169
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 69
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 70  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 126
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I +FG +          H P      L GT  Y
Sbjct: 127 HSKRVIHRDIKPENLLLG---SAGELKIANFGWSV---------HAPSSRRTTLCGTLDY 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 228

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 72
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L      +++   ++  KF  +       ++   + Y 
Sbjct: 73  ---PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC 129
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y
Sbjct: 130 HSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRXXLXGTLDY 177
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 231

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH- 70
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + YG   +   + L L    L  ++   ++  KF  +       ++   + Y 
Sbjct: 71  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS+  +HRDIKP+N L+G    A ++ I +FG +          H P      L GT  Y
Sbjct: 128 HSKRVIHRDIKPENLLLG---SAGELKIANFGWSV---------HAPSSRRTTLCGTLDY 175
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                  G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFP 229

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFL----ASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+  +K+GSG++GE+ L     +HV+    +  K   S + + +LL E  V K+L     
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH--- 95
Query: 65  IPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
            PNI K Y    D  +  LV++   G  L D  ++ R KF+     ++  Q+++ + Y+H
Sbjct: 96  -PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
               +HRD+KP+N L+    K   + I+DFGL+  + +         ++ K   GTA Y 
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--------KKMKERLGTAYYI 205
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           +    L  +   + D+ S+G +L   L G  P+ G
Sbjct: 206 APEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGG 239

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           + +GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH-QLRREVEIQSHLRH- 71
Query: 63  SGIPNI-KWYGV--DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
              PNI + YG   D     L+L+   LG    +L    R  F  +       ++   + 
Sbjct: 72  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALS 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           Y HS+  +HRDIKP+N L+G      ++ I DFG +          H P      L GT 
Sbjct: 127 YCHSKRVIHRDIKPENLLLG---SNGELKIADFGWSV---------HAPSSRRTTLCGTL 174
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            Y       G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE---AHTYQETYRRISRVEFTFP 230

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           + +GR +G G FG ++LA    +  I+A+K+      E +G +H QL  E ++   L+  
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEH-QLRREVEIQSHLRH- 71
Query: 63  SGIPNI-KWYGV--DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
              PNI + YG   D     L+L+   LG    +L    R  F  +       ++   + 
Sbjct: 72  ---PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALS 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           Y HS+  +HRDIKP+N L+G      ++ I DFG +          H P      L GT 
Sbjct: 127 YCHSKRVIHRDIKPENLLLG---SNGELKIADFGWSV---------HAPSSRRDTLCGTL 174
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            Y       G     + DL SLG +   FL G  P++   A T ++ Y +I   + + P
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE---AHTYQETYRRISRVEFTFP 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 17/241 (7%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKIL 59
           +II  +YK+  K+G G    ++LA     N  VA+K   I     +     +E +V+   
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 60  QGGSGIPNIKWYGVDGEDNV--LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           Q  S    +    VD ED+   LV++ + GP+L + ++      S+ T +   +Q++  I
Sbjct: 67  QL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE-YIESHGPLSVDTAINFTNQILDGI 124
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           ++ H    +HRDIKP N L+   +    + I DFG+AK   + +        +  ++ GT
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETS------LTQTNHVLGT 175
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            +Y S     G       D+ S+G VL   L G  P+ G  A +   K+ +     V+T 
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235
Query: 237 I 237
           +
Sbjct: 236 V 236

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKI 58
           I   +YK  R +G GSFGE+ L     T +  AVK+ +       T    LL E ++ K 
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 88
Query: 59  LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
           L   + +   +++   G   ++     G  L D  +  R++FS      +  Q+++ I Y
Sbjct: 89  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITY 147
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H    +HRD+KP+N L+    K   + IIDFGL+  +           ++ K+  GTA 
Sbjct: 148 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--------KKMKDKIGTAY 199
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           Y +     G     + D+ S G +L   L G  P+ G
Sbjct: 200 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 235

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKI 58
           I   +YK  R +G GSFGE+ L     T +  AVK+ +       T    LL E ++ K 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 59  LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
           L   + +   +++   G   ++     G  L D  +  R++FS      +  Q+++ I Y
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITY 141
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H    +HRD+KP+N L+    K   + IIDFGL+  +           ++ K+  GTA 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIGTAY 193
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           Y +     G     + D+ S G +L   L G  P+ G
Sbjct: 194 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKI 58
           I   +YK  R +G GSFGE+ L     T +  AVK+ +       T    LL E ++ K 
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 106
Query: 59  LQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIAR 115
           L      PNI K Y    +     L     +  +LF  +  R++FS      +  Q+++ 
Sbjct: 107 LDH----PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 162
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           I Y+H    +HRD+KP+N L+    K   + IIDFGL+  +           ++ K+  G
Sbjct: 163 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIG 214
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           TA Y +     G     + D+ S G +L   L G  P+ G
Sbjct: 215 TAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 253

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 98/221 (44%), Gaps = 23/221 (10%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKI 58
           I   +YK  R +G GSFGE+ L     T +  AVK+ +       T    LL E ++ K 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 59  LQGGSGIPNIKWYGVDGEDN---VLVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
           L      PNI       ED     LV ++  G  L D  +  R++FS      +  Q+++
Sbjct: 83  LDH----PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLS 137
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            I Y H    +HRD+KP+N L+    K   + IIDFGL+  +           ++ K+  
Sbjct: 138 GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKXKDKI 189
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           GTA Y +     G     + D+ S G +L   L G  P+ G
Sbjct: 190 GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKI 58
           I   +YK  R +G GSFGE+ L     T +  AVK+ +       T    LL E ++ K 
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 105
Query: 59  LQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIAR 115
           L      PNI K Y    +     L     +  +LF  +  R++FS      +  Q+++ 
Sbjct: 106 LDH----PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 161
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           I Y+H    +HRD+KP+N L+    K   + IIDFGL+  +           ++ K+  G
Sbjct: 162 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIG 213
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           TA Y +     G     + D+ S G +L   L G  P+ G
Sbjct: 214 TAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG 252

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 27/224 (12%)
Query: 13  RKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY 71
           RK+GSG+FG++ L     +  E V   I    ++ P    EA++ ++L+       IK +
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEI-EVLKSLDHPNIIKIF 86
Query: 72  GV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRGFL 125
            V  D  +  +V++    G  LE +     R  +L    V  L  QM+  + Y HS+  +
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVV 146
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           H+D+KP+N L       + + IIDFGLA+ ++   ++ H     + N  GTA Y      
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFK---SDEH-----STNAAGTALY------ 192
Query: 186 LGIEQSRRD-----DLESLGYVLLYFLRGSLPWQGLKAATKKQK 224
           +  E  +RD     D+ S G V+ + L G LP+ G      +QK
Sbjct: 193 MAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + IG+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     D+F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + IG+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     D+F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y + + +GSG+ GE+ LA    T + VA+KI         ++    P L  E ++ +IL
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI-EIL 75
Query: 60  Q--GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +      I  IK +  D ED  +VL+L+ G  L D  V  +R     T  +   QM+  +
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 133
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+H  G +HRD+KP+N L+    +   + I DFG +K   + +  R         L GT
Sbjct: 134 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGT 185
Query: 177 ARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQ------GLKAATKKQKYD- 226
             Y +    + +  +   R  D  SLG +L   L G  P+        LK      KY+ 
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 245
Query: 227 ------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                 ++ EK +    ++L     A F +          D+      +KR F DL S E
Sbjct: 246 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED-----MKRKFQDLLSEE 300

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
           +Y +   +G GSFGE+       T +  AVK+ N  +   +    +L E ++ K L    
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-- 80
Query: 64  GIPNI-KWYGV--DGEDNVLVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             PNI K + +  D     +V +L  G  L D  +  R++FS      +  Q+ + I Y+
Sbjct: 81  --PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYM 137
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H    +HRD+KP+N L+    K   + IIDFGL+  ++  T        + K+  GTA Y
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--------KMKDRIGTAYY 189
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
            +     G     + D+ S G +L   L G+ P+ G      K +YD +  K+V T
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG------KNEYDIL--KRVET 236

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
           +Y +   +G GSFGE+       T +  AVK+ N  +   +    +L E ++ K L    
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-- 80
Query: 64  GIPNI-KWYGV--DGEDNVLVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             PNI K + +  D     +V +L  G  L D  +  R++FS      +  Q+ + I Y+
Sbjct: 81  --PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYM 137
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H    +HRD+KP+N L+    K   + IIDFGL+  ++  T        + K+  GTA Y
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--------KMKDRIGTAYY 189
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
            +     G     + D+ S G +L   L G+ P+ G      K +YD +  K+V T
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG------KNEYDIL--KRVET 236

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y + + +GSG+ GE+ LA    T + VA+KI         ++    P L  E ++ +IL
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI-EIL 69
Query: 60  Q--GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +      I  IK +  D ED  +VL+L+ G  L D  V  +R     T  +   QM+  +
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 127
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+H  G +HRD+KP+N L+    +   + I DFG +K   + +  R         L GT
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGT 179
Query: 177 ARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQ------GLKAATKKQKYD- 226
             Y +    + +  +   R  D  SLG +L   L G  P+        LK      KY+ 
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 227 ------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                 ++ EK +    ++L     A F +          D+      +KR F DL S E
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED-----MKRKFQDLLSEE 294

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y + + +GSG+ GE+ LA    T + VA+KI         ++    P L  E ++ +IL
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI-EIL 69
Query: 60  Q--GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +      I  IK +  D ED  +VL+L+ G  L D  V  +R     T  +   QM+  +
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 127
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+H  G +HRD+KP+N L+    +   + I DFG +K   + +  R         L GT
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGT 179
Query: 177 ARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQ------GLKAATKKQKYD- 226
             Y +    + +  +   R  D  SLG +L   L G  P+        LK      KY+ 
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 227 ------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                 ++ EK +    ++L     A F +          D+      +KR F DL S E
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED-----MKRKFQDLLSEE 294

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y + + +GSG+ GE+ LA    T + VA+KI         ++    P L  E ++ +IL
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI-EIL 69
Query: 60  Q--GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +      I  IK +  D ED  +VL+L+ G  L D  V  +R     T  +   QM+  +
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 127
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+H  G +HRD+KP+N L+    +   + I DFG +K   + +  R         L GT
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGT 179
Query: 177 ARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQ------GLKAATKKQKYD- 226
             Y +    + +  +   R  D  SLG +L   L G  P+        LK      KY+ 
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 227 ------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                 ++ EK +    ++L     A F +          D+      +KR F DL S E
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED-----MKRKFQDLLSEE 294

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y + + +GSG+ GE+ LA    T + VA+KI         ++    P L  E ++ +IL
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI-EIL 68
Query: 60  Q--GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +      I  IK +  D ED  +VL+L+ G  L D  V  +R     T  +   QM+  +
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 126
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+H  G +HRD+KP+N L+    +   + I DFG +K   + +  R         L GT
Sbjct: 127 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGT 178
Query: 177 ARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQ------GLKAATKKQKYD- 226
             Y +    + +  +   R  D  SLG +L   L G  P+        LK      KY+ 
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 238
Query: 227 ------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                 ++ EK +    ++L     A F +          D+      +KR F DL S E
Sbjct: 239 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED-----MKRKFQDLLSEE 293

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
           +Y +   +G GSFGE+       T +  AVK+ N  +   +    +L E ++ K L    
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-- 80
Query: 64  GIPNI-KWYGV--DGEDNVLVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             PNI K + +  D     +V +L  G  L D  +  R++FS      +  Q+ + I Y+
Sbjct: 81  --PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYM 137
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H    +HRD+KP+N L+    K   + IIDFGL+  ++  T        + K+  GTA Y
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--------KMKDRIGTAYY 189
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
            +     G     + D+ S G +L   L G+ P+ G      K +YD +  K+V T
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG------KNEYDIL--KRVET 236

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 105/231 (45%), Gaps = 19/231 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKKT 225

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + IG+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------------------ENSGT-KHP 47
           +Y+LG  +G G   E+ LA  +  +  VAVK+                   +N+    HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 48  QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM 107
            ++      +       +P I    VDG            +L D+ V+     + K  + 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGV-----------TLRDI-VHTEGPMTPKRAIE 120
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           +       + + H  G +HRD+KP N L+      N V ++DFG+A+   D   +     
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANILIS---ATNAVKVVDFGIARAIADSGNS----V 173
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 174 XQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA HV T   VAVKI +    +P    +L  E ++ KIL     
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNH--- 73
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--QMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y      +K     A   Q+++ ++Y H 
Sbjct: 74  -PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G+  YA+
Sbjct: 133 KYIVHRDLKAENLLLD---GDMNIKIADFGFSNEF---TVGNKL-----DTFCGSPPYAA 181
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------TLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 93  EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 150
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 151 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------TLCGTPEYLAPEIIL 197
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 198 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 244

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMXGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 129/300 (43%), Gaps = 43/300 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y + + +GSG+ GE+ LA    T + VA++I         ++    P L  E ++ +IL
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI-EIL 194
Query: 60  Q--GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +      I  IK +  D ED  +VL+L+ G  L D  V  +R     T  +   QM+  +
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 252
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+H  G +HRD+KP+N L+    +   + I DFG +K   + +  R         L GT
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGT 304
Query: 177 ARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQ------GLKAATKKQKYD- 226
             Y +    + +  +   R  D  SLG +L   L G  P+        LK      KY+ 
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 227 ------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                 ++ EK +    ++L     A F +          D+      +KR F DL S E
Sbjct: 365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED-----MKRKFQDLLSEE 419

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
           +Y+LG  +G G   E+ LA  +  +  VAVK+  +        Y  +  +  Q  + +  
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY-LRFRREAQNAAALNH 71
Query: 66  PNIKWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
           P I      GE          +V++ + G +L D+ V+     + K  + +       + 
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMTPKRAIEVIADACQALN 130
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           + H  G +HRD+KP N ++      N V ++DFG+A+   D   +      +   + GTA
Sbjct: 131 FSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNS----VTQTAAVIGTA 183
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           +Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSXQEYSDWKEKK 224

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 17/229 (7%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGIP 66
           + L + +G G++GE+ LA +  T E VAVKI +       P+ + +      +     + 
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV- 67
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRGF 124
            +K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G 
Sbjct: 68  -VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
            HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +   
Sbjct: 127 THRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPEL 178
Query: 185 HLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
               E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 43/301 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y + + +GSG+ GE+ LA    T + VA++I         ++    P L  E ++ +IL
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI-EIL 208
Query: 60  Q--GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           +      I  IK +  D ED  +VL+L+ G  L D  V  +R     T  +   QM+  +
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAV 266
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+H  G +HRD+KP+N L+    +   + I DFG +K   + +  R         L GT
Sbjct: 267 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--------TLCGT 318
Query: 177 ARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQ------GLKAATKKQKYD- 226
             Y +    + +  +   R  D  SLG +L   L G  P+        LK      KY+ 
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 378
Query: 227 ------KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                 ++ EK +    ++L     A F +          D+      +KR F DL S E
Sbjct: 379 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED-----MKRKFQDLLSEE 433
Query: 281 G 281
Sbjct: 434 N 434

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 67  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 124 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 175
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 223

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            +      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLMID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 69  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 177
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H++T    A+KI  +    K  ++ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            +      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N ++    +   + + DFGLAK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLMID---QQGYIQVTDFGLAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L       L  Y R+   F          ++++ +EY+H +G 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N +  GTA+Y S   
Sbjct: 154 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-SFVGTAQYVSPEL 205
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                 S+  DL +LG ++   + G  P++ 
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            Y      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N +  GTA+Y S   
Sbjct: 155 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-SFVGTAQYVSPEL 206
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H++T    A+KI  +    K  ++ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            +      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N ++    +   + + DFGLAK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLMID---QQGYIKVTDFGLAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            Y      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            +      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            Y      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G++GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMXGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 132 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 183
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 214

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++   P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEY-APGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 131 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 182
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 183 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 213

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++   P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEY-APGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 128 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 185
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 186 RDLKPENLLID---QQGYIQVTDFGFAKRVKGATW----------TLCGTPEYLAPEIIL 232
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 233 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 279

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 130 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 181
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------------------ENSGT-KHP 47
           +Y+LG  +G G   E+ LA  +  +  VAVK+                   +N+    HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 48  QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM 107
            ++      +       +P I    VDG            +L D+ V+     + K  + 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGV-----------TLRDI-VHTEGPMTPKRAIE 120
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           +       + + H  G +HRD+KP N ++      N V ++DFG+A+   D   +     
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNS----V 173
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N +  GTA+Y S   
Sbjct: 151 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-SFVGTAQYVSPEL 202
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------------------ENSGT-KHP 47
           +Y+LG  +G G   E+ LA  +  +  VAVK+                   +N+    HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 48  QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM 107
            ++      +       +P I    VDG            +L D+ V+     + K  + 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGV-----------TLRDI-VHTEGPMTPKRAIE 120
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           +       + + H  G +HRD+KP N ++      N V ++DFG+A+   D   +     
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNS----V 173
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 155 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 206
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 129 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 180
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 181 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 211

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 152 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 203
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------------------ENSGT-KHP 47
           +Y+LG  +G G   E+ LA  +  +  VAVK+                   +N+    HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 48  QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM 107
            ++      +       +P I    VDG            +L D+ V+     + K  + 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGV-----------TLRDI-VHTEGPMTPKRAIE 120
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           +       + + H  G +HRD+KP N ++      N V ++DFG+A+   D   +     
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNS----V 173
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            +   + GTA+Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 152 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RANA-FVGTAQYVSPEL 203
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 154 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 205
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 159 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 210
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 128 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 185
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 186 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 232
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 233 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 279

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 136 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 152 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 203
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 100 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 157
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 158 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 204
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 205 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 251

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 154 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 205
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 154 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 205
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 154 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 205
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 157 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 208
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 239

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
           +Y+LG  +G G   E+ LA  +  +  VAVK+  +        Y  +  +  Q  + +  
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY-LRFRREAQNAAALNH 88
Query: 66  PNIKWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
           P I      GE          +V++ + G +L D+ V+     + K  + +       + 
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMTPKRAIEVIADACQALN 147
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           + H  G +HRD+KP N ++      N V ++DFG+A+   D   +      +   + GTA
Sbjct: 148 FSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNS----VTQTAAVIGTA 200
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           +Y S     G     R D+ SLG VL   L G  P+ G
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 154 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 205
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +F        A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF  + LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 151 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 202
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +    +K 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            +      N+ ++    P  E +F + RR  +FS       A Q++   EY+HS   ++R
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    L 
Sbjct: 167 DLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIILS 213
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 214 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLAGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +F        A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLXGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +F        A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYQMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 19/230 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQ-LLYEAKVYKILQGGSGI 65
           + L + +G G+ GE+ LA +  T E VAVKI +       P+ +  E  + K+L   + +
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIARIEYVHSRG 123
              K+YG   E N+  L L   S  +LF        +          Q++A + Y+H  G
Sbjct: 68  ---KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRDIKP+N L+    + + + I DFGLA  +R    NR    R    + GT  Y +  
Sbjct: 125 ITHRDIKPENLLLD---ERDNLKISDFGLATVFR--YNNRE---RLLNKMCGTLPYVAPE 176
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                E  +   D+ S G VL   L G LPW   + +   Q+Y    EKK
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKK 224

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 125/275 (45%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L +++G+G FGE+++ +  + N  VA+K    GT  P+  L EA++ K L+       +
Sbjct: 12  QLIKRLGNGQFGEVWMGTW-NGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDK---LV 67
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     R   L  ++ +A Q+ A + Y+    ++
Sbjct: 68  QLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 127
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G G       I DFGLA+   D   N     +  K  +  TA  A+   
Sbjct: 128 HRDLRSANILVGNGLICK---IADFGLARLIED---NEXTARQGAKFPIKWTAPEAALYG 181
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   + +G +P+ G+     ++  +++ E+    P    C  
Sbjct: 182 RFTI----KSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQV-ERGYRMPCPQDC-- 231
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P        +C     ++RP + +L+    D F+
Sbjct: 232 -PISLHELMIHCWKKDPEERPTFEYLQSFLEDYFT 265

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADEPIQIYEKIVSGKVRFP 258

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 22/229 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +    +K 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 71  -YGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
            +      N+ ++    P  E +F + RR  +F        A Q++   EY+HS   ++R
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    L 
Sbjct: 166 DLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIILS 212
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 KGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 94  EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 151
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 152 RDLKPENLLID---EQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 198
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 199 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 245

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           R +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +I Q  +   +  +
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +VL+   P  E +F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVLEY-APGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLLID---QQGYIKVADFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 112/237 (47%), Gaps = 25/237 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSG-- 64
           +++ R IG GSFG++ +    DT ++ A+K  N     +  ++    K  +I+QG     
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 65  IPNIKWYGV-DGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHS 121
           + N+ WY   D ED  +V+DLL     DL  + ++   F  +TV +   +++  ++Y+ +
Sbjct: 77  LVNL-WYSFQDEEDMFMVVDLLLGG--DLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+KPDN L+    +   V+I DF +A      T        +   + GT  Y +
Sbjct: 134 QRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRET--------QITTMAGTKPYMA 182
Query: 182 ---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
               ++  G   S   D  SLG      LRG  P+  ++++T  ++     E  V T
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH-IRSSTSSKEIVHTFETTVVT 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPAIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 12/211 (5%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +K G+ +G GSF    LA  + T+   A+KI  +    K  ++ Y  +   ++       
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGF 124
            +K Y    +D  L   L      +L  Y R+   F          ++++ +EY+H +G 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+KP+N L+    +   + I DFG A K   P + +    R N    GTA+Y S   
Sbjct: 152 IHRDLKPENILLN---EDMHIQITDFGTA-KVLSPESKQA---RAN-XFVGTAQYVSPEL 203
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                  +  DL +LG ++   + G  P++ 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H++T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++   P  E +F + RR  +F        A Q++   EY+HS   ++
Sbjct: 108 EFSFKDNSNLYMVMEY-APGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 165
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 166 RDLKPENLMID---QQGYIKVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 212
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 213 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 259

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T   VA+KI +    +P    +L  E ++ KIL     
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH--- 70
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVY--CRRKFSLKTVLMLADQMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y     +   K       Q+++ ++Y H 
Sbjct: 71  -PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G+  YA+
Sbjct: 130 KRIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TVGGKL-----DTFCGSPPYAA 178
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 213

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H +T    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ + P  E +F + RR  +F        A Q++   EY+HS   ++
Sbjct: 100 EFSFKDNSNLYMVMEYV-PGGE-MFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 157
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 158 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 204
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 205 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 251

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 33/257 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           +++L + +G GSFG++FL   +   D  ++ A+K+    T   +     K+ + +     
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 65  IPNIK--WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            P I    Y    E  + L+LD L     DLF    ++  F+ + V     ++   ++++
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS G ++RD+KP+N L+    +   + + DFGL+K+  D     +       +  GT  Y
Sbjct: 143 HSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAY-------SFCGTVEY 192
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP--- 236
            +         ++  D  S G ++   L G+LP+QG     +K+    I + K+  P   
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMILKAKLGMPQFL 249
Query: 237 -------IEVLCKSHPA 246
                  + +L K +PA
Sbjct: 250 SPEAQSLLRMLFKRNPA 266

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +F+       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 23/236 (9%)
Query: 9   YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           ++L + +G GSFG++FL   V   D+  + A+K+    T   +     K+ + +      
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 66  PNIK--WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVH 120
           P +    Y    E  + L+LD L     DLF    ++  F+ + V     ++   ++++H
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S G ++RD+KP+N L+    +   + + DFGL+K+  D     +       +  GT  Y 
Sbjct: 148 SLGIIYRDLKPENILLD---EEGHIKLTDFGLSKEAIDHEKKAY-------SFCGTVEYM 197
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
           +         S   D  S G ++   L GSLP+QG     +K+    I + K+  P
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQG---KDRKETMTLILKAKLGMP 250

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           + +GR +G G FG ++LA       I+A+K+      E  G +H QL  E ++   L+  
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH- 74
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + Y    +   + L L      +L+   ++  +F  +      +++   + Y 
Sbjct: 75  ---PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H R  +HRDIKP+N LMG      ++ I DFG +          H P    + + GT  Y
Sbjct: 132 HERKVIHRDIKPENLLMGY---KGELKIADFGWSV---------HAPSLRRRXMCGTLDY 179
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                  G     + DL   G +   FL G  P+
Sbjct: 180 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------ENSGTKHPQLLYEAKVYKI 58
           +Y+  +K+GSG++GE+ L     T    A+KI          NSG     LL E  V K 
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA----LLDEVAVLKQ 77
Query: 59  LQGGSGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
           L      PNI K Y    D  +  LV+++  G  L D  +  R+KFS     ++  Q+++
Sbjct: 78  LDH----PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLS 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
              Y+H    +HRD+KP+N L+    +   + I+DFGL+  +            + K   
Sbjct: 133 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--------KMKERL 184
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           GTA Y +    L  +   + D+ S G +L   L G  P+ G
Sbjct: 185 GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGG 224

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGS 63
           ++L + +G GSFG++FLA    TN+  A+K                + E +V  +     
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHS 121
            + ++       E+   V++ L     DL  + +   KF L      A ++I  ++++HS
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARY 179
           +G ++RD+K DN L+    K   + I DFG+ K+    D  TN            GT  Y
Sbjct: 138 KGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNE---------FCGTPDY 185
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            +    LG + +   D  S G +L   L G  P+ G
Sbjct: 186 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 33/257 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           +++L + +G GSFG++FL   +   D  ++ A+K+    T   +     K+ + +     
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 65  IPNIK--WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            P I    Y    E  + L+LD L     DLF    ++  F+ + V     ++   ++++
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS G ++RD+KP+N L+    +   + + DFGL+K+  D     +       +  GT  Y
Sbjct: 144 HSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAY-------SFCGTVEY 193
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP--- 236
            +         ++  D  S G ++   L G+LP+QG     +K+    I + K+  P   
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMILKAKLGMPQFL 250
Query: 237 -------IEVLCKSHPA 246
                  + +L K +PA
Sbjct: 251 SPEAQSLLRMLFKRNPA 267

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 33/257 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           +++L + +G GSFG++FL   +   D  ++ A+K+    T   +     K+ + +     
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 65  IPNIK--WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            P I    Y    E  + L+LD L     DLF    ++  F+ + V     ++   ++++
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS G ++RD+KP+N L+    +   + + DFGL+K+  D     +       +  GT  Y
Sbjct: 143 HSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAY-------SFCGTVEY 192
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP--- 236
            +         ++  D  S G ++   L G+LP+QG     +K+    I + K+  P   
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMILKAKLGMPQFL 249
Query: 237 -------IEVLCKSHPA 246
                  + +L K +PA
Sbjct: 250 SPEAQSLLRMLFKRNPA 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T   VA+KI +    +P    +L  E ++ KIL     
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH--- 73
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVY--CRRKFSLKTVLMLADQMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y     +   K       Q+++ ++Y H 
Sbjct: 74  -PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G   YA+
Sbjct: 133 KRIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TVGGKL-----DAFCGAPPYAA 181
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +F        A Q++   EY+HS   ++
Sbjct: 128 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 185
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 186 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 232
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 233 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 279

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 117/264 (44%), Gaps = 23/264 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +K ++ +A Q    ++Y+H++  +H
Sbjct: 84  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    + N V I DFGLA +      +R     + + L+G+  + +    +
Sbjct: 144 RDLKSNNIFL---HEDNTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEV-I 194
Query: 187 GIEQSR----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
            ++ S     + D+ + G VL   + G LP+  +    + Q  + +    +S  +  +  
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMVGRGSLSPDLSKVRS 252
Query: 243 SHPAEFASYFHYCQSLTFDQRPDY 266
           + P         C     D+RP +
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSF 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T + VAVKI    + + +   +L  E ++ K+L     
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH--- 72
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--QMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y      +K     A   Q+++ ++Y H 
Sbjct: 73  -PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G+  YA+
Sbjct: 132 KFIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TFGNKL-----DTFCGSPPYAA 180
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +F        A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +F        A Q++   EY+HS   ++
Sbjct: 102 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 159
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 160 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 206
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 207 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 253

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +F        A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 325
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 326 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385
Query: 126 HRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
           HRD++  N L+G     N V  + DFGLA+   D   N +   +  K  +  TA  A+  
Sbjct: 386 HRDLRAANILVG----ENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 438
Query: 184 THLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C 
Sbjct: 439 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC- 489
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
             P         C     ++RP + +L+    D F+
Sbjct: 490 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N ++    +   + + DFG AK+ +  T            L GT  Y +    +
Sbjct: 165 RDLKPENLIID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIII 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +F        A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT  Y +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEYLAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T + VAVKI    + + +   +L  E ++ K+L     
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH--- 72
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--QMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y      +K     A   Q+++ ++Y H 
Sbjct: 73  -PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G+  YA+
Sbjct: 132 KFIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TFGNKL-----DTFCGSPPYAA 180
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           + +G GSF       H  +N+  AVKI  S         E    K+ +G   I  +    
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKI-ISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 73  VDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
            D     LV++LL     +LF   ++K  FS      +  ++++ + ++H  G +HRD+K
Sbjct: 76  HDQLHTFLVMELLNGG--ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
           P+N L        ++ IIDFG A+    P  N+ +     K    T  YA+      + Q
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFAR--LKPPDNQPL-----KTPCFTLHYAAPEL---LNQ 183
Query: 191 SRRD---DLESLGYVLLYFLRGSLPWQG 215
           +  D   DL SLG +L   L G +P+Q 
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQS 211

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------ENSGTKHPQLLYEAKVYKI 58
           +Y+  +K+GSG++GE+ L     T    A+KI          NSG     LL E  V K 
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA----LLDEVAVLKQ 60
Query: 59  LQGGSGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
           L      PNI K Y    D  +  LV+++  G  L D  +  R+KFS     ++  Q+++
Sbjct: 61  LDH----PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLS 115
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
              Y+H    +HRD+KP+N L+    +   + I+DFGL+  +            + K   
Sbjct: 116 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--------KMKERL 167
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           GTA Y +    L  +   + D+ S G +L   L G  P+ G
Sbjct: 168 GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPFGG 207

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 116/264 (43%), Gaps = 23/264 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 16  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +K ++ +A Q    ++Y+H++  +H
Sbjct: 72  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 131
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    + N V I DFGLA        +R     + + L+G+  + +    +
Sbjct: 132 RDLKSNNIFL---HEDNTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEV-I 182
Query: 187 GIEQSR----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
            ++ S     + D+ + G VL   + G LP+  +    + Q  + +    +S  +  +  
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMVGRGSLSPDLSKVRS 240
Query: 243 SHPAEFASYFHYCQSLTFDQRPDY 266
           + P         C     D+RP +
Sbjct: 241 NCPKRMKRLMAECLKKKRDERPSF 264

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYK 57
           KY+   KIG G++G +F A + +T+EIVA+K          + +S  +   LL E K   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 58  ILQGGSGIPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
           I         ++ + V   D    LV +     L+  F  C      + V     Q++  
Sbjct: 63  I---------VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           + + HSR  LHRD+KP N L+    +  ++ + DFGLA+ +  P 
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLIN---RNGELKLADFGLARAFGIPV 155

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 116/264 (43%), Gaps = 23/264 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G      + ++     G SL         KF +K ++ +A Q    ++Y+H++  +H
Sbjct: 84  LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    + N V I DFGLA +      +R     + + L+G+  + +    +
Sbjct: 144 RDLKSNNIFL---HEDNTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEV-I 194
Query: 187 GIEQSR----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
            ++ S     + D+ + G VL   + G LP+  +    + Q  + +    +S  +  +  
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMVGRGSLSPDLSKVRS 252
Query: 243 SHPAEFASYFHYCQSLTFDQRPDY 266
           + P         C     D+RP +
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSF 276

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 76
Query: 69  KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + +V++ +  G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 137 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 191 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 76
Query: 69  KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + +V++ +  G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 137 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 191 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T + VAV+I    + + +   +L  E ++ K+L     
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH--- 72
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--QMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y      +K     A   Q+++ ++Y H 
Sbjct: 73  -PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G+  YA+
Sbjct: 132 KFIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TFGNKL-----DTFCGSPPYAA 180
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T + VAVKI    + + +   +L  E ++ K+L     
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH--- 72
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--QMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y      +K     A   Q+++ ++Y H 
Sbjct: 73  -PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G   YA+
Sbjct: 132 KFIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TFGNKL-----DAFCGAPPYAA 180
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGS 63
           + L + +G GSFG++FLA    TN+  A+K                + E +V  +     
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHS 121
            + ++       E+   V++ L     DL  + +   KF L      A ++I  ++++HS
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARY 179
           +G ++RD+K DN L+    K   + I DFG+ K+    D  TN            GT  Y
Sbjct: 137 KGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNX---------FCGTPDY 184
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            +    LG + +   D  S G +L   L G  P+ G
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 14  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 69
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 70  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 129
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 130 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 183
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 184 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 233
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 234 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T + VAV+I    + + +   +L  E ++ K+L     
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH--- 72
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--QMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y      +K     A   Q+++ ++Y H 
Sbjct: 73  -PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G+  YA+
Sbjct: 132 KFIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TFGNKL-----DEFCGSPPYAA 180
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 76
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 137 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 191 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 242
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 243 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 303 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 356
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 357 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 406
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 407 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 76
Query: 69  KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + +V + +  G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 137 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 191 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
           +Y+L  ++G G+F  +     + T +  A KI N    S   H +L  EA++ ++L+   
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH-- 62
Query: 64  GIPNI-KWYGVDGED--NVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
             PNI + +    E+  + LV DL+  G   ED  +  R  +S         Q++  + +
Sbjct: 63  --PNIVRLHDSISEEGFHYLVFDLVTGGELFED--IVAREYYSEADASHCIQQILESVNH 118
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
            H  G +HRD+KP+N L+    K   V + DFGLA
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 242
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 243 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 303 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 356
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 357 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 406
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 407 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T + VAVKI    + + +   +L  E ++ K+L     
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH--- 65
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--QMIARIEYVHS 121
            PNI K + V   +  L L +   S  ++F Y      +K     A   Q+++ ++Y H 
Sbjct: 66  -PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G+  YA+
Sbjct: 125 KFIVHRDLKAENLLLDADM---NIKIADFGFSNEF---TFGNKL-----DTFCGSPPYAA 173
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 208

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 242
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 243 QLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 303 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 356
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 357 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 406
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 407 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNI 68
           + +G+GSFG + L  H ++    A+KI  +    K  Q+ +     +ILQ  +   +  +
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++   D  +  +V++ +     ++F + RR  +FS       A Q++   EY+HS   ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+KP+N L+    +   + + DFG AK+ +  T            L GT    +    L
Sbjct: 165 RDLKPENLLID---QQGYIQVTDFGFAKRVKGRTW----------XLCGTPEALAPEIIL 211
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
               ++  D  +LG VL+Y +    P     A    Q Y+KI   KV  P
Sbjct: 212 SKGYNKAVDWWALG-VLIYEMAAGYP--PFFADQPIQIYEKIVSGKVRFP 258

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 76
Query: 69  KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + +V++ +  G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
           HRD++  N L+G     N V  + DFGLA+   D   N     +  K  +  TA  A+  
Sbjct: 137 HRDLRAANILVG----ENLVCKVADFGLARLIED---NEXTARQGAKFPIKWTAPEAALY 189
Query: 184 THLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C 
Sbjct: 190 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC- 240
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
             P         C     ++RP + +L+    D F+
Sbjct: 241 --PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 12  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 67
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 68  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 127
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 128 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 181
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 182 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 231
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 232 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 265

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------------------KHPQ 48
           Y++ + +G GSFG++ LA H  T + VA+KI N                       +HP 
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 49  LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLML 108
           ++   K+Y +++    I             ++V++  G  L D ++  R K S +     
Sbjct: 76  II---KLYDVIKSKDEI-------------IMVIEYAGNELFD-YIVQRDKMSEQEARRF 118
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
             Q+I+ +EY H    +HRD+KP+N L+    +   V I DFGL+    D          
Sbjct: 119 FQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNF------- 168
Query: 169 ENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 213
             K   G+  YA+     G +      D+ S G +L   L   LP+
Sbjct: 169 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 10  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 65
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 66  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 126 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 179
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 180 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 229
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 230 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 263

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 94/236 (39%), Gaps = 36/236 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           Y +  ++G G+F  +    H  T    A KI N    S     +L  EA++ + LQ    
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--- 64
Query: 65  IPNIKWYGVDGEDNV-------LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
            PNI    V   D++       LV DL+  G   ED+    R  +S         Q++  
Sbjct: 65  -PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILES 117
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           I Y HS G +HR++KP+N L+    K   V + DFGLA +  D                G
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAG 169
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-----QGLKAATKKQKYD 226
           T  Y S         S+  D+ + G +L   L G  P+       L A  K   YD
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 11/241 (4%)
Query: 9   YKLGRKI-GSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
           YKL  ++ G G++ ++  A  +   +  AVKI  + +G    ++  E +     QG   I
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
             +  +  D     LV + L        +  ++ F+ +    +   + A ++++H++G  
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIA 133
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN-- 183
           HRD+KP+N L     K + V I DF L    +   +   I   E     G+A Y +    
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 184 ---THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT---KKQKYDKICEKKVSTPI 237
              T       +R DL SLG VL   L G  P+ G   A     + +  ++C+ K+   I
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 253
Query: 238 E 238
           +
Sbjct: 254 Q 254

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------------------KHPQ 48
           Y++ + +G GSFG++ LA H  T + VA+KI N                       +HP 
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 49  LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLML 108
           ++   K+Y +++    I             ++V++  G  L D ++  R K S +     
Sbjct: 66  II---KLYDVIKSKDEI-------------IMVIEYAGNELFD-YIVQRDKMSEQEARRF 108
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
             Q+I+ +EY H    +HRD+KP+N L+    +   V I DFGL+    D          
Sbjct: 109 FQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNF------- 158
Query: 169 ENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 213
             K   G+  YA+     G +      D+ S G +L   L   LP+
Sbjct: 159 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGS 63
           Y++ + +G GSFG++ LA H  T + VA+KI N           ++  E    ++L+   
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-- 72
Query: 64  GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             P+I K Y V    ++ ++V++  G  L D ++  R K S +       Q+I+ +EY H
Sbjct: 73  --PHIIKLYDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
               +HRD+KP+N L+    +   V I DFGL+    D            K   G+  YA
Sbjct: 130 RHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNF--------LKTSCGSPNYA 178
Query: 181 SCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 213
           +     G +      D+ S G +L   L   LP+
Sbjct: 179 APEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 33/242 (13%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQGG 62
           +++GR +G G FG ++LA    ++ IVA+K      IE  G +H QL  E ++    Q  
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEH-QLRREIEI----QAH 79
Query: 63  SGIPNIKW---YGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
              PNI     Y  D     L+L+    G   ++L   C   F  +    + +++   + 
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEELADALM 137
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           Y H +  +HRDIKP+N L+G      ++ I DFG +          H P    K + GT 
Sbjct: 138 YCHGKKVIHRDIKPENLLLG---LKGELKIADFGWSV---------HAPSLRRKTMCGTL 185
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
            Y       G   + + DL  +G +    L G+ P++   +A+  + Y +I +  +  P 
Sbjct: 186 DYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE---SASHNETYRRIVKVDLKFPA 242
Query: 238 EV 239
            V
Sbjct: 243 SV 244

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 76
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 137 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 191 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 94/236 (39%), Gaps = 36/236 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           Y +  ++G G+F  +    H  T    A KI N    S     +L  EA++ + LQ    
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--- 64
Query: 65  IPNIKWYGVDGEDNV-------LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
            PNI    V   D++       LV DL+  G   ED  +  R  +S         Q++  
Sbjct: 65  -PNI----VRLHDSIQEESFHYLVFDLVTGGELFED--IVAREFYSEADASHCIQQILES 117
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           I Y HS G +HR++KP+N L+    K   V + DFGLA +  D                G
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAG 169
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-----QGLKAATKKQKYD 226
           T  Y S         S+  D+ + G +L   L G  P+       L A  K   YD
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 11  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 66
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 67  QLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 126
Query: 126 HRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
           HRD++  N L+G     N V  + DFGLA+   D   N     +  K  +  TA  A+  
Sbjct: 127 HRDLRAANILVG----ENLVCKVADFGLARLIED---NEXTARQGAKFPIKWTAPEAALY 179
Query: 184 THLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C 
Sbjct: 180 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC- 230
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
             P         C     ++RP + +L+    D F+
Sbjct: 231 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 264

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----QLLYEAKVYKILQGGS 63
           +K+G  +G GSF  ++ A  + T   VA+K+ +    +      ++  E K++  L+  S
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSR 122
            I  +  Y  D     LVL++      + ++  R K FS         Q+I  + Y+HS 
Sbjct: 73  -ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
           G LHRD+   N L  L R  N + I DFGLA + +       +P+ ++  L GT  Y S 
Sbjct: 132 GILHRDLTLSNLL--LTRNMN-IKIADFGLATQLK-------MPHEKHYTLCGTPNYISP 181
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                       D+ SLG +    L G  P+
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------------------KHPQ 48
           Y++ + +G GSFG++ LA H  T + VA+KI N                       +HP 
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 49  LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLML 108
           ++   K+Y +++    I             ++V++  G  L D ++  R K S +     
Sbjct: 70  II---KLYDVIKSKDEI-------------IMVIEYAGNELFD-YIVQRDKMSEQEARRF 112
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
             Q+I+ +EY H    +HRD+KP+N L+    +   V I DFGL+    D          
Sbjct: 113 FQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSNIMTDGNF------- 162
Query: 169 ENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 213
             K   G+  YA+     G +      D+ S G +L   L   LP+
Sbjct: 163 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 94/236 (39%), Gaps = 36/236 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           Y +  ++G G+F  +    H  T    A KI N    S     +L  EA++ + LQ    
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--- 63
Query: 65  IPNIKWYGVDGEDNV-------LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
            PNI    V   D++       LV DL+  G   ED+    R  +S         Q++  
Sbjct: 64  -PNI----VRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILES 116
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           I Y HS G +HR++KP+N L+    K   V + DFGLA +  D                G
Sbjct: 117 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAG 168
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-----QGLKAATKKQKYD 226
           T  Y S         S+  D+ + G +L   L G  P+       L A  K   YD
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 224

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYK 57
           KY+   KIG G++G +F A + +T+EIVA+K          + +S  +   LL E K   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 58  ILQGGSGIPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
           I         ++ + V   D    LV +     L+  F  C      + V     Q++  
Sbjct: 63  I---------VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           + + HSR  LHRD+KP N L+    +  ++ + +FGLA+ +  P 
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPV 155

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
           +Y+L  ++G G+F  +     + T +  A KI N    S   H +L  EA++ ++L+   
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH-- 62
Query: 64  GIPNI-KWYGVDGED--NVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
             PNI + +    E+  + LV DL+  G   ED  +  R  +S         Q++  + +
Sbjct: 63  --PNIVRLHDSISEEGFHYLVFDLVTGGELFED--IVAREYYSEADASHCIQQILESVNH 118
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
            H  G +HRD+KP+N L+    K   V + DFGLA
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 23/214 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           Y +  ++G G+F  +    H  T    A KI N    S     +L  EA++ + LQ    
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--- 87
Query: 65  IPNI-KWYGVDGEDNV--LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
            PNI + +    E++   LV DL+  G   ED  +  R  +S         Q++  I Y 
Sbjct: 88  -PNIVRLHDSIQEESFHYLVFDLVTGGELFED--IVAREFYSEADASHCIQQILESIAYC 144
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS G +HR++KP+N L+    K   V + DFGLA +  D                GT  Y
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--------GFAGTPGY 196
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            S         S+  D+ + G +L   L G  P+
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K ++       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKIRHEK---LV 76
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 137 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 191 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 73
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ ++ Q+ + + YV    ++
Sbjct: 74  QLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 134 HRDLRAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 187
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 188 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 237
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 238 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 271

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGS 63
           Y +   +G GSFG++ LA+H  T + VA+K     +      H ++  E    K+L+   
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-- 68
Query: 64  GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             P+I K Y V     D V+V++  G  L D ++  +++ +         Q+I  IEY H
Sbjct: 69  --PHIIKLYDVITTPTDIVMVIEYAGGELFD-YIVEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
               +HRD+KP+N L+        V I DFGL+    D            K   G+  YA
Sbjct: 126 RHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTDGNF--------LKTSCGSPNYA 174
Query: 181 SCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPW 213
           +     G +      D+ S G VL   L G LP+
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 76
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD+   N L+G         + DFGLA+   D   N +   +  K  +  TA  A+   
Sbjct: 137 HRDLAAANILVGENLVCK---VADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 191 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 241 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 274

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 123/273 (45%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 66
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+ + P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFVLILERMEP-VQDLFDFITERGALQEELARSFFWQVLE 125
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 174
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 231
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 232 SSECQHLIR-----------WCLALRPSDRPTF 253

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQGG 62
           + + R +G G FG ++LA       I+A+K+      E  G +H QL  E ++   L+  
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH- 73
Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
              PNI + Y    +   + L L      +L+   ++  +F  +      +++   + Y 
Sbjct: 74  ---PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H R  +HRDIKP+N LMG      ++ I DFG +          H P    + + GT  Y
Sbjct: 131 HERKVIHRDIKPENLLMGY---KGELKIADFGWSV---------HAPSLRRRXMCGTLDY 178
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                  G     + DL   G +   FL G  P+
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 100/251 (39%), Gaps = 55/251 (21%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------------------KHPQ 48
           Y LG  +G G+FG++ +  H  T   VAVKI N                       +HP 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 49  LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY-CRR-KFSLKTVL 106
           ++   K+Y+++   S I  +  Y   GE               LF Y C+  +   K   
Sbjct: 78  II---KLYQVISTPSDIFMVMEYVSGGE---------------LFDYICKNGRLDEKESR 119
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
            L  Q+++ ++Y H    +HRD+KP+N L+     A    I DFGL+    D    R   
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAK---IADFGLSNMMSDGEFLR--- 173
Query: 167 YRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225
                   G+  YA+     G +      D+ S G +L   L G+LP+      T    +
Sbjct: 174 -----XSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LF 225
Query: 226 DKICEKKVSTP 236
            KIC+    TP
Sbjct: 226 KKICDGIFYTP 236

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y+L + IG G+F ++ LA H+ T + VAVKI    + + +   +L  E ++ K+L     
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNH--- 72
Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVY--CRRKFSLKTVLMLADQMIARIEYVHS 121
            PNI K + V   +  L L     S  ++F Y     +   K       Q+++ ++Y H 
Sbjct: 73  -PNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N L+        + I DFG + ++   T    +         G   YA+
Sbjct: 132 KFIVHRDLKAENLLLD---ADXNIKIADFGFSNEF---TFGNKL-----DAFCGAPPYAA 180
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQG 215
                G +    + D+ SLG +L   + GSLP+ G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKV 55
           ++R +  KY+L +K+G G++G ++ +    T E+VAVK      +NS T   +   E  +
Sbjct: 3   VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMI 61
Query: 56  YKILQGGSGIPNI-KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTV--LMLADQ 111
              L G   I N+      D + +V LV D +   L  +     R   L+ V    +  Q
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI----RANILEPVHKQYVVYQ 117
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY---RDPTTNRHIPYR 168
           +I  I+Y+HS G LHRD+KP N L+        V + DFGL++ +   R  T N  IP  
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLSRSFVNIRRVTNN--IPLS 172
Query: 169 ENKN 172
            N+N
Sbjct: 173 INEN 176

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 73
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ ++ Q+ + + YV    ++
Sbjct: 74  QLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGLA+   D   N     +  K  +  TA  A+   
Sbjct: 134 HRDLRAANILVGENLVCK---VADFGLARLIED---NEWTARQGAKFPIKWTAPEAALYG 187
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 188 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 237
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 238 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 271

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
           KY+   KIG G+FGE+F A H  T + VA+K   +EN     P   L E K+ ++L+  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 64  GIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
            +  I+        Y        LV D     L  L      KF+L  +  +   ++  +
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            Y+H    LHRD+K  N L+    +   + + DFGLA+ +
Sbjct: 139 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 175

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 82
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 141
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 190
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 247
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 248 SSECQHLIR-----------WCLALRPSDRPTF 269

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 81
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 140
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 182

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 95
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 196

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 81
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 140
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 189
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 246
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 247 SSECQHLIR-----------WCLALRPSDRPTF 268

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 67
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 126
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 175
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 232
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 233 SSECQHLIR-----------WCLALRPSDRPTF 254

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 95
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 196

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 94
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 195

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 82
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 141
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 183

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 82
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 141
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 183

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 109
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 168
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 217
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 274
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 275 SSECQHLIR-----------WCLALRPSDRPTF 296

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 101
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 160
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 209
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 266
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 267 SSECQHLIR-----------WCLALRPSDRPTF 288

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 95
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 196

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 114
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 115 KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 173
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 215

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K+ ++  E K+ + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKN-KIKREIKILENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 67
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 126
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 175
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 232
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 233 SSECQHLIR-----------WCLALRPSDRPTF 254

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
           KY+   KIG G+FGE+F A H  T + VA+K   +EN     P   L E K+ ++L+  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 64  GIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
            +  I+        Y        LV D     L  L      KF+L  +  +   ++  +
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            Y+H    LHRD+K  N L+    +   + + DFGLA+ +
Sbjct: 139 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 175

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 94
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 195

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 95
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 154
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 196

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 94
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 195

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 94
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 153
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 195

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 66
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 125
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 174
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 231
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 232 SSECQHLIR-----------WCLALRPSDRPTF 253

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 109
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 168
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 67
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 126
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 175
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 232
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 233 SSECQHLIR-----------WCLALRPSDRPTF 254

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQL-------LYEAKVYKI 58
           +Y+LG  +G G FG +F    +     VA+K+   N       L       L  A ++K+
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 59  LQGGSGIPNI----KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK--TVLMLADQM 112
             GG G P +     W+    E  +LVL+   P+ +DLF Y   K  L          Q+
Sbjct: 92  GAGG-GHPGVIRLLDWFETQ-EGFMLVLERPLPA-QDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
           +A I++ HSRG +HRDIK +N L+ L R   +  +IDFG
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAK--LIDFG 185

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 62
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 121
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 163

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
            +IG GSFGE+F      T ++VA+KI +      ++    +   +L         K+YG
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 73  --VDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
             + G    ++++ L  G +L+ L      +F + T+L    +++  ++Y+HS   +HRD
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRD 145
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           IK  N L+    +   V + DFG+A +  D    R+          GT  + +      I
Sbjct: 146 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---I 192
Query: 189 EQSRRD---DLESLGYVLLYFLRGSLP 212
           +QS  D   D+ SLG   +   +G  P
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 65
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 66  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 124
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 173
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 230
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 231 SSECQHLIR-----------WCLALRPSDRPTF 252

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 42/273 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 62
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 121
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D             +  
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT---------DFD 170
Query: 175 GTARYASCN-THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y+            R   + SLG +L   + G +P++  +   + Q + +   ++V
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---QRV 227
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
           S+  + L +           +C +L    RP +
Sbjct: 228 SSECQHLIR-----------WCLALRPSDRPTF 249

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
           KY+   KIG G+FGE+F A H  T + VA+K   +EN     P   L E K+ ++L+  +
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 64  GIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
            +  I+        Y        LV D     L  L      KF+L  +  +   ++  +
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            Y+H    LHRD+K  N L+    +   + + DFGLA+ +
Sbjct: 138 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 174

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 89
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 90  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 148
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 190

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
           KY+   KIG G+FGE+F A H  T + VA+K   +EN     P   L E K+ ++L+  +
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 64  GIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
            +  I+        Y        LV D     L  L      KF+L  +  +   ++  +
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            Y+H    LHRD+K  N L+    +   + + DFGLA+ +
Sbjct: 139 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAF 175

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    G   P+  L EA+V K L+       +
Sbjct: 188 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQEAQVMKKLRHEK---LV 243
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  E+ + ++      G  L+ L     +   L  ++ +A Q+ + + YV    ++
Sbjct: 244 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 303
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+G         + DFGL +   D   N +   +  K  +  TA  A+   
Sbjct: 304 HRDLRAANILVGENLVCK---VADFGLGRLIED---NEYTARQGAKFPIKWTAPEAALYG 357
Query: 185 HLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C  
Sbjct: 358 RFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC-- 407
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P         C     ++RP + +L+    D F+
Sbjct: 408 -PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 441

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 84/164 (51%), Gaps = 18/164 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN----------SGTKHPQLLYEAKVY 56
           +Y++G  +GSG FG ++    V  N  VA+K +E           +GT+ P  +   K  
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-- 62
Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIA 114
           K+  G SG+  +  +    +  VL+L+   P ++DLF +   + +L+  L  +   Q++ 
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEP-VQDLFDFITERGALQEELARSFFWQVLE 121
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            + + H+ G LHRDIK +N L+ L R   ++ +IDFG     +D
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALLKD 163

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + LA    +   VAVK+ +    +  +LL+ E  + +  Q  + +   K Y
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  VL+  L G +L D+    R   + + +  + + ++  + Y+H++G +HRDIK 
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+ L     +V + DFG   +      ++ +P R  K L GT  + +         +
Sbjct: 170 DSILLTLD---GRVKLSDFGFCAQ-----ISKDVPKR--KXLVGTPYWMAPEVISRSLYA 219
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPY 241

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           Y+L  ++G G+F  +     V   +  A KI N    S   H +L  EA++ ++L+    
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH--- 80
Query: 65  IPNI-KWYGVDGED--NVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
            PNI + +    E+  + L+ DL+  G   ED  +  R  +S         Q++  + + 
Sbjct: 81  -PNIVRLHDSISEEGHHYLIFDLVTGGELFED--IVAREYYSEADASHCIQQILEAVLHC 137
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H  G +HRD+KP+N L+    K   V + DFGLA +             E +   G   +
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEG----------EQQAWFG---F 184
Query: 180 ASCNTHLGIEQSRRD------DLESLGYVLLYFLRGSLPW 213
           A    +L  E  R+D      DL + G +L   L G  P+
Sbjct: 185 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 19/227 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQL-LYEAKVYKILQGGSG 64
           KY    KIG G++G ++ A  ++ +T  +  +++E      P   + E  + K L+  + 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN- 61
Query: 65  IPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
              +K Y V       VLV + L   L+ L   C       T      Q++  I Y H R
Sbjct: 62  --IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             LHRD+KP N L+    +  ++ I DFGLA+ +        IP R+  +   T  Y + 
Sbjct: 120 RVLHRDLKPQNLLIN---REGELKIADFGLARAF-------GIPVRKYTHEVVTLWYRAP 169
Query: 183 NTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228
           +  +G ++ S   D+ S+G +    + G+  + G+  A +  +  +I
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 19/227 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQL-LYEAKVYKILQGGSG 64
           KY    KIG G++G ++ A  ++ +T  +  +++E      P   + E  + K L+  + 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN- 61
Query: 65  IPNIKWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
              +K Y V    +  VLV + L   L+ L   C       T      Q++  I Y H R
Sbjct: 62  --IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             LHRD+KP N L+    +  ++ I DFGLA+ +        IP R+  +   T  Y + 
Sbjct: 120 RVLHRDLKPQNLLIN---REGELKIADFGLARAF-------GIPVRKYTHEVVTLWYRAP 169
Query: 183 NTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228
           +  +G ++ S   D+ S+G +    + G+  + G+  A +  +  +I
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRI 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 19/227 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQL-LYEAKVYKILQGGSG 64
           KY    KIG G++G ++ A  ++ +T  +  +++E      P   + E  + K L+  + 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN- 61
Query: 65  IPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
              +K Y V       VLV + L   L+ L   C       T      Q++  I Y H R
Sbjct: 62  --IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             LHRD+KP N L+    +  ++ I DFGLA+ +        IP R+  +   T  Y + 
Sbjct: 120 RVLHRDLKPQNLLIN---REGELKIADFGLARAF-------GIPVRKYTHEIVTLWYRAP 169
Query: 183 NTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228
           +  +G ++ S   D+ S+G +    + G+  + G+  A +  +  +I
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
            KIG GSFGE+F      T ++VA+KI +      ++    +   +L         K+YG
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 73  VDGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              +D  L            LDLL P   D       +  + T+L    +++  ++Y+HS
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHS 122
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+    +  +V + DFG+A +  D    R+          GT  + +
Sbjct: 123 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 172
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
                 I+QS  D   D+ SLG   +   RG  P
Sbjct: 173 PEV---IKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
           +Y+L   IG G+F  +     + T    A KI N    S   H +L  EA++ ++L+  S
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH-S 63
Query: 64  GIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            I  +     +   + LV DL+  G   ED+    R  +S         Q++  + + H 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQ 121
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
            G +HRD+KP+N L+    K   V + DFGLA
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLA 153

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
            KIG GSFGE+F      T ++VA+KI +      ++    +   +L         K+YG
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 73  VDGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              +D  L            LDLL P   D       +  + T+L    +++  ++Y+HS
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHS 137
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+    +  +V + DFG+A +  D    R+          GT  + +
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------XFVGTPFWMA 187
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
                 I+QS  D   D+ SLG   +   RG  P
Sbjct: 188 PEV---IKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 99/218 (45%), Gaps = 15/218 (6%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           +GSG+F E+FL     T ++ A+K   ++   +   L  E  V K ++  + +     Y 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 73  VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132
                 +++  + G  L D  +  R  ++ K   ++  Q+++ ++Y+H  G +HRD+KP+
Sbjct: 77  STTHYYLVMQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE 135
Query: 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR 192
           N L     + +++ I DFGL+K  ++   +            GT  Y +         S+
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQNGIMS---------TACGTPGYVAPEVLAQKPYSK 186
Query: 193 RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
             D  S+G +    L G  P+      T+ + ++KI E
Sbjct: 187 AVDCWSIGVITYILLCGYPPFY---EETESKLFEKIKE 221

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           + +  K+G GS+G ++ A H +T +IVA+K     +   +++ E     I+Q       +
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKE---ISIMQQCDSPHVV 87
Query: 69  KWYG--VDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K+YG      D  +V++  G  S+ D+     +  +   +  +    +  +EY+H    +
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           HRDIK  N L+     A    + DFG+A +  D    R+        + GT  + +    
Sbjct: 148 HRDIKAGNILLNTEGHAK---LADFGVAGQLTDXMAKRN-------XVIGTPFWMAPEVI 197
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPW 213
             I  +   D+ SLG   +    G  P+
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 9   YKLGRKIGSGSFGEIFLAS---HVDTNEIVAVKIENSGTKHP-QLLYEAKVYKILQGGSG 64
           +K+  KIG G+F  ++LA+    V   E +A+K     T HP ++  E +   +  G   
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALK-HLIPTSHPIRIAAELQCLTVAGGQDN 81
Query: 65  IPNIKWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           +  +K Y     D+V++     P LE + F+      S + V      +   ++ +H  G
Sbjct: 82  VMGVK-YCFRKNDHVVIA---MPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG 137
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            +HRD+KP NFL    R+  +  ++DFGLA+   D
Sbjct: 138 IVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTHD 170

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 27/236 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQGGS 63
           Y L   IG GS+GE+ +A    T      +I  +  K P+   E      +  +I++   
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 64  GIPNIKWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
               I+ Y    D  D  LV++L  G  L +  V+ +R F       +   +++ + Y H
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCH 123
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
                HRD+KP+NFL       + + +IDFGLA +++        P +  +   GT  Y 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--------PGKMMRTKVGTPYYV 175
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
           S     G+     D+  S G ++   L G  P+    A T  +   KI E   + P
Sbjct: 176 SPQVLEGLYGPECDEW-SAGVMMYVLLCGYPPFS---APTDXEVMLKIREGTFTFP 227

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
            KIG GSFGE+F      T ++VA+KI +      ++    +   +L         K+YG
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 73  VDGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              +D  L            LDLL P   D       +  + T+L    +++  ++Y+HS
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHS 122
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+    +  +V + DFG+A +  D    R+          GT  + +
Sbjct: 123 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------XFVGTPFWMA 172
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
                 I+QS  D   D+ SLG   +   RG  P
Sbjct: 173 PEV---IKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 27/236 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQGGS 63
           Y L   IG GS+GE+ +A    T      +I  +  K P+   E      +  +I++   
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 64  GIPNIKWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
               I+ Y    D  D  LV++L  G  L +  V+ +R F       +   +++ + Y H
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCH 140
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
                HRD+KP+NFL       + + +IDFGLA +++        P +  +   GT  Y 
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--------PGKMMRTKVGTPYYV 192
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
           S     G+     D+  S G ++   L G  P+    A T  +   KI E   + P
Sbjct: 193 SPQVLEGLYGPECDEW-SAGVMMYVLLCGYPPFS---APTDXEVMLKIREGTFTFP 244

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
            KIG GSFGE+F      T ++VA+KI +      ++    +   +L         K+YG
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 73  VDGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              +D  L            LDLL P   D       +  + T+L    +++  ++Y+HS
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHS 142
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+    +  +V + DFG+A +  D    R+          GT  + +
Sbjct: 143 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 192
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
                 I+QS  D   D+ SLG   +   RG  P
Sbjct: 193 PEV---IKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+L + IGSG+FG   L     +NE+VAVK    G K   +    K   I       PN
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEK---IAANVKREIINHRSLRHPN 76
Query: 68  IKWYGVDGEDNVLVLDLLGPSLE-----DLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
           I  +    ++ +L    L   +E     +LF  +    +FS         Q+I+ + Y H
Sbjct: 77  IVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           +    HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y 
Sbjct: 133 AMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKSTVGTPAYI 183
Query: 181 SCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 214
           +    L  E   +  D+ S G  L   L G+ P++
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++  N     K   ++ E  V +  +  + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             +  Y V  E  V++  L G SL D+    C  +  +  V     + +  +E++HS   
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRDIK DN L+G+      V + DFG   +     + R         + GT  + +   
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                   + D+ SLG + +  + G  P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 41/284 (14%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGSGIP 66
           LG +IG G+FGE+F       N +VAVK     T  P L    L EA++ K        P
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKAKFLQEARILKQYSH----P 172
Query: 67  NI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSR 122
           NI +  GV  +   + + +      D   + R    +  +KT+L +     A +EY+ S+
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN-----RHIPYRENK-NLTGT 176
             +HRD+   N L+    + N + I DFG++++  D         R +P +         
Sbjct: 233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
            RY+S             D+ S G +L   F  G+ P+  L      Q+  +  EK    
Sbjct: 290 GRYSS-----------ESDVWSFGILLWETFSLGASPYPNL----SNQQTREFVEKGGRL 334
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
           P   LC   P         C +    QRP +  + +    +  R
Sbjct: 335 PCPELC---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++  N     K   ++ E  V +  +  + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             +  Y V  E  V++  L G SL D+    C  +  +  V     + +  +E++HS   
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRDIK DN L+G+      V + DFG   +     + R         + GT  + +   
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------SEMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                   + D+ SLG + +  + G  P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 111/275 (40%), Gaps = 34/275 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGGS 63
           +++ +KIG G F E++ A+ +     VA+K                + E  + K L    
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-- 91
Query: 64  GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
             PN IK+Y    EDN L + L      DL      F   +R    +TV     Q+ + +
Sbjct: 92  --PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           E++HSR  +HRDIKP N F+   G     V + D GL + +   TT  H       +L G
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVG 198
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
           T  Y S         + + D+ SLG +L        P+ G      K     +C+K    
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEQC 253
Query: 236 PIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFL 269
               L   H   E     + C +   ++RPD  ++
Sbjct: 254 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++  N     K   ++ E  V +  +  + +
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             +  Y V  E  V++  L G SL D+    C  +  +  V     + +  +E++HS   
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRDIK DN L+G+      V + DFG   +     + R         + GT  + +   
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------SXMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                   + D+ SLG + +  + G  P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 24/177 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y L RK+G G F  ++LA  +  N  VA+KI      + +   +    K+LQ  +   N
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE--IKLLQRVNDADN 77
Query: 68  IK-----------------WYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLA 109
            K                   G +G   V+V ++LG +L  L   Y  R   L  V  ++
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 110 DQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKAN---QVYIIDFGLAKKYRDPTTN 162
            Q++  ++Y+H R G +H DIKP+N LM +        Q+ I D G A  Y +  TN
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++  N     K   ++ E  V +  +  + +
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             +  Y V  E  V++  L G SL D+    C  +  +  V     + +  +E++HS   
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 138
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRDIK DN L+G+      V + DFG   +     + R         + GT  + +   
Sbjct: 139 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------SXMVGTPYWMAPEV 188
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                   + D+ SLG + +  + G  P+
Sbjct: 189 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 24/177 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y L RK+G G F  ++LA  +  N  VA+KI      + +   +    K+LQ  +   N
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE--IKLLQRVNDADN 77
Query: 68  IK-----------------WYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLA 109
            K                   G +G   V+V ++LG +L  L   Y  R   L  V  ++
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 110 DQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKAN---QVYIIDFGLAKKYRDPTTN 162
            Q++  ++Y+H R G +H DIKP+N LM +        Q+ I D G A  Y +  TN
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 110/259 (42%), Gaps = 53/259 (20%)
Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG--------TKHPQ-- 48
           E+I    ++L R +G G +G++F    V   +T +I A+K+            T H +  
Sbjct: 12  EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 49  --LLYEAK-------VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 99
             +L E K       +Y    GG      K Y        L+L+ L  S  +LF+   R+
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGG------KLY--------LILEYL--SGGELFMQLERE 115
Query: 100 --FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
             F   T      ++   + ++H +G ++RD+KP+N ++        V + DFGL K+  
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESI 172
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
              T  H          GT  Y +    +    +R  D  SLG ++   L G+ P+ G  
Sbjct: 173 HDGTVTH-------TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-- 223
Query: 218 AATKKQKYDKICEKKVSTP 236
              +K+  DKI + K++ P
Sbjct: 224 -ENRKKTIDKILKCKLNLP 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +K+G+G FGE+++A++ + +  VAVK    G+   +  L EA V K LQ       +
Sbjct: 191 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK---LV 246
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K + V  ++ + ++      G  L+ L      K  L  ++  + Q+   + ++  R ++
Sbjct: 247 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 307 HRDLRAANILVSASLVCK---IADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFG 360
Query: 185 HLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L+  +  G +P+ G+       +  +  E+    P    C  
Sbjct: 361 SFTI----KSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENC-- 410
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P E  +    C     ++RP + +++ +  D ++
Sbjct: 411 -PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 15/154 (9%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
           Y+L  ++G G+F  +         +  A KI N    S   H +L  EA++ ++L+    
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH--- 89
Query: 65  IPNI-KWYGVDGED--NVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
            PNI + +    E+  + LV DL+  G   ED  +  R  +S         Q++  + ++
Sbjct: 90  -PNIVRLHDSISEEGFHYLVFDLVTGGELFED--IVAREYYSEADASHCIHQILESVNHI 146
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           H    +HRD+KP+N L+    K   V + DFGLA
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA 180

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 41/284 (14%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGSGIP 66
           LG +IG G+FGE+F       N +VAVK     T  P L    L EA++ K        P
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKAKFLQEARILKQYSH----P 172
Query: 67  NI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSR 122
           NI +  GV  +   + + +      D   + R    +  +KT+L +     A +EY+ S+
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN-----RHIPYRENK-NLTGT 176
             +HRD+   N L+    + N + I DFG++++  D         R +P +         
Sbjct: 233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
            RY+S             D+ S G +L   F  G+ P+  L      Q+  +  EK    
Sbjct: 290 GRYSS-----------ESDVWSFGILLWETFSLGASPYPNL----SNQQTREFVEKGGRL 334
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
           P   LC   P         C +    QRP +  + +    +  R
Sbjct: 335 PCPELC---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 29/193 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYK 57
           +Y+   K+G G++GE++ A    TNE VA+K          +  +  +   LL E +   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIAR 115
           I++  S I            N  +  +   +  DL  Y  +    S++ +     Q+I  
Sbjct: 95  IIELKSVI----------HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPT---TNRHIP--YR 168
           + + HSR  LHRD+KP N L+ +   +    + I DFGLA+ +  P    T+  I   YR
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204
Query: 169 ENKNLTGTARYAS 181
             + L G+  Y++
Sbjct: 205 PPEILLGSRHYST 217

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+L + IGSG+FG   L     +NE+VAVK    G K  +     K   I       PN
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE---NVKREIINHRSLRHPN 75
Query: 68  IKWYGVDGEDNVLVLDLLGPSLE-----DLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
           I    V  ++ +L    L   +E     +LF  +    +FS         Q+I+ + Y H
Sbjct: 76  I----VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           +    HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y 
Sbjct: 132 AMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKSTVGTPAYI 182
Query: 181 SCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 214
           +    L  E   +  D+ S G  L   L G+ P++
Sbjct: 183 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 110/259 (42%), Gaps = 53/259 (20%)
Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG--------TKHPQ-- 48
           E+I    ++L R +G G +G++F    V   +T +I A+K+            T H +  
Sbjct: 12  EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 49  --LLYEAK-------VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK 99
             +L E K       +Y    GG      K Y        L+L+ L  S  +LF+   R+
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGG------KLY--------LILEYL--SGGELFMQLERE 115
Query: 100 --FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
             F   T      ++   + ++H +G ++RD+KP+N ++        V + DFGL K+  
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKESI 172
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
              T  H          GT  Y +    +    +R  D  SLG ++   L G+ P+ G  
Sbjct: 173 HDGTVTH-------XFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-- 223
Query: 218 AATKKQKYDKICEKKVSTP 236
              +K+  DKI + K++ P
Sbjct: 224 -ENRKKTIDKILKCKLNLP 241

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 24  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 79
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 80  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 139
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 140 HRDLRAANILVS---DTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINY 192
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++           V   
Sbjct: 193 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPD 241
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 242 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 277

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D          E      T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD----------EMAGFVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 25  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 80
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 81  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 140
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 141 HRDLRAANILVS---DTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINY 193
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++           V   
Sbjct: 194 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPD 242
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 243 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 278

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 26  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 81
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 82  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 141
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 142 HRDLRAANILVS---DTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYG 195
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   +  G +P+ G+      Q  ++           V   +
Sbjct: 196 TFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPDN 244
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P E       C     + RP + +L+ +  D F+
Sbjct: 245 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 279

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 22  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 77
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 78  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 138 HRDLRAANILVS---DTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINY 190
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++           V   
Sbjct: 191 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPD 239
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 275

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 110/226 (48%), Gaps = 31/226 (13%)
Query: 5   IGVK-YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKI--------ENSGTKHPQLLYE 52
           +G++ ++L + +G+G++G++FL   +   DT ++ A+K+        +   T+H +   E
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT--E 108
Query: 53  AKVYKILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYC--RRKFSLKTVLMLA 109
            +V + ++    +  +  Y    E  + L+LD +     +LF +   R +F+   V +  
Sbjct: 109 RQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGG--ELFTHLSQRERFTEHEVQIYV 165
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
            +++  +E++H  G ++RDIK +N L+        V + DFGL+K++    T R      
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETER------ 216
Query: 170 NKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPW 213
             +  GT  Y + +   G +    +  D  SLG ++   L G+ P+
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 7/208 (3%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           +G G+   +    ++ T++  AVKI  +  G    ++  E ++    QG   +  +  + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 73  VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132
            + +   LV + +        ++ RR F+     ++   + + ++++H++G  HRD+KP+
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS- 191
           N L     + + V I DFGL    +       I   E     G+A Y +        +  
Sbjct: 141 NILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 192 ----RRDDLESLGYVLLYFLRGSLPWQG 215
               +R DL SLG +L   L G  P+ G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 44/257 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +      +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHI-PYRENKNLTGTARYASCNTHLGIEQSRRD 194
           +   +    + I+DFGLA   R   TN  + PY        T  Y +    LG+  +   
Sbjct: 159 V---KSDCTLKILDFGLA---RTACTNFMMTPY------VVTRYYRAPEVILGMGYAANV 206
Query: 195 DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY 254
           D+ S+G ++   ++G + +QG        +++K+ E ++ TP         AEF +    
Sbjct: 207 DIWSVGCIMGELVKGCVIFQG---TDHIDQWNKVIE-QLGTP--------SAEFMAALQP 254
Query: 255 CQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTN 314
                 + RP Y  +K  F +LF           DW      +  K K+      +R   
Sbjct: 255 TVRNYVENRPKYPGIK--FEELFP----------DWIFPSESERDKIKTSQ----ARDLL 298
Query: 315 SRVMPMRTDKLKGVNDA 331
           S+++ +  DK   V++A
Sbjct: 299 SKMLVIDPDKRISVDEA 315

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 16  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 71
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 72  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 132 HRDLRAANILVS---DTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINY 184
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++           V   
Sbjct: 185 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPD 233
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    IGSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 28  RYQNLSPIGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 143
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 144 KYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT----------GYVAT 190
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 246
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 247 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 275

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 22  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 77
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 78  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 137
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 138 HRDLRAANILVS---DTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYG 191
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      +
Sbjct: 192 TFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----DN 240
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P E       C     + RP + +L+ +  D F+
Sbjct: 241 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 275

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 18  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 73
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 74  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 133
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 134 HRDLRAANILVS---DTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINY 186
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      
Sbjct: 187 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----D 235
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 236 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 271

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 144
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    + +++ I+DFGLA+   D  T              T
Sbjct: 145 KYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLARHTDDEMT----------GYVAT 191
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 247
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 248 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 276

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 118/273 (43%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 140
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    + +++ I+DFGLA+   D  T              T
Sbjct: 141 KYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLARHTDDEMT----------GYVAT 187
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 243
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 244 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 272

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 44/257 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +      +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 100 QDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 156
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHI-PYRENKNLTGTARYASCNTHLGIEQSRRD 194
           +   +    + I+DFGLA   R  +TN  + PY        T  Y +    LG+      
Sbjct: 157 V---KSDCTLKILDFGLA---RTASTNFMMTPY------VVTRYYRAPEVILGMGYKENV 204
Query: 195 DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY 254
           D+ S+G ++   ++GS+ +QG        +++K+ E ++ TP         AEF +    
Sbjct: 205 DIWSVGCIMGELVKGSVIFQG---TDHIDQWNKVIE-QLGTP--------SAEFMAALQP 252
Query: 255 CQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTN 314
                 + RP Y  +   F +LF           DW      +  K K+      +R   
Sbjct: 253 TVRNYVENRPAYPGIA--FEELFP----------DWIFPSESERDKIKTSQ----ARDLL 296
Query: 315 SRVMPMRTDKLKGVNDA 331
           S+++ +  DK   V++A
Sbjct: 297 SKMLVIDPDKRISVDEA 313

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 21  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 76
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 77  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 136
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 137 HRDLRAANILVS---DTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYG 190
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      +
Sbjct: 191 TFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----DN 239
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P E       C     + RP + +L+ +  D F+
Sbjct: 240 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 274

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 31/229 (13%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------ENSGTKHPQL 49
           IG  Y   RK+GSG++GE+ L    + +   A+K+               +N    H ++
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 50  LYEAKVYKILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVL 106
             E  + K L      PNI K + V  +     L        +LF  +  R KF      
Sbjct: 94  YNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
            +  Q+++ I Y+H    +HRDIKP+N L+        + I+DFGL+  +      R   
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR--- 206
Query: 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                +  GTA Y +    L  + + + D+ S G ++   L G  P+ G
Sbjct: 207 -----DRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGG 249

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   + ++VAVK ++    +  +LL+ E  + +  Q  + +     Y
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R        + LA  ++  +  +H++G +HRDIK 
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLQALSVLHAQGVIHRDIKS 275
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       +V + DFG   +      ++ +P R  K L GT  + +      +   
Sbjct: 276 DSILLT---HDGRVKLSDFGFCAQ-----VSKEVPRR--KXLVGTPYWMAPELISRLPYG 325
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 105/273 (38%), Gaps = 78/273 (28%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----------------------TK 45
           KY L   IG GS+G + +A    T  I A+KI N                          
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 46  HPQL--LYEAK--------VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSL------ 89
           HP +  LYE          V ++  GG  +  +  + +D       +D++   +      
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF-IDDSTGKCAMDVVKTQICPCPEC 145
Query: 90  ------------EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137
                        +   + +R+   K +  +  Q+ + + Y+H++G  HRDIKP+NFL  
Sbjct: 146 NEEAINGSIHGFRESLDFVQRE---KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 138 LGRKANQVYIIDFGLAK--------KYRDPTTNRHIPY---RENKNLTGTARYASCNTHL 186
              K+ ++ ++DFGL+K        +Y   TT    PY    E  N T  +    C    
Sbjct: 203 TN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC---- 257
Query: 187 GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
                   D  S G +L   L G++P+ G+  A
Sbjct: 258 --------DAWSAGVLLHLLLMGAVPFPGVNDA 282

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
           Y LG  +G G+FG++ +  H  T   VAVKI N   K   L    K+ + +Q      + 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 68  --IKWYGVDGEDNVLVLDLLGPSLEDLFVY-CRR-KFSLKTVLMLADQMIARIEYVHSRG 123
             IK Y V        + +   S  +LF Y C+  +        L  Q+++ ++Y H   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
            +HRD+KP+N L+     A    I DFGL+    D    R        +  G+  YA+  
Sbjct: 132 VVHRDLKPENVLLDAHMNAK---IADFGLSNMMSDGEFLR--------DSCGSPNYAAPE 180
Query: 184 THLG-IEQSRRDDLESLGYVLLYFLRGSLPW 213
              G +      D+ S G +L   L G+LP+
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 17  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 72
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 73  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 132
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 133 HRDLRAANILVS---DTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINY 185
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      
Sbjct: 186 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----D 234
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 235 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 270

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 22/234 (9%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGI 65
           +++ + IG G+FGE+ +    + +++ A+KI N      +     +  +   ++ G S  
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 66  PNIKWYGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
                Y    ++N+ LV+D  +G  L  L      +   +       +M+  I+ VH   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
           ++HRDIKPDN LM +      + + DFG   K  +  T       ++    GT  Y S  
Sbjct: 196 YVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT------VQSSVAVGTPDYISPE 246
Query: 184 THLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
               +E  +       D  SLG  +   L G  P+    A +  + Y KI   K
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 297

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 16  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 71
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 72  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 132 HRDLRAANILVS---DTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYG 185
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      +
Sbjct: 186 TFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----DN 234
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P E       C     + RP + +L+ +  D F+
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 16  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 71
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 72  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 132 HRDLRAANILVS---DTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINY 184
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      
Sbjct: 185 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----D 233
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
           +Y+L  ++G G+F  +     V   +  A  I N    S   H +L  EA++ ++L+   
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-- 69
Query: 64  GIPNI-KWYGVDGED--NVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
             PNI + +    E+  + L+ DL+  G   ED  +  R  +S         Q++  + +
Sbjct: 70  --PNIVRLHDSISEEGHHYLIFDLVTGGELFED--IVAREYYSEADASHCIQQILEAVLH 125
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
            H  G +HR++KP+N L+    K   V + DFGLA +             E +   G   
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG----------EQQAWFG--- 172
Query: 179 YASCNTHLGIEQSRRD------DLESLGYVLLYFLRGSLPW 213
           +A    +L  E  R+D      DL + G +L   L G  P+
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 11  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 66
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 67  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 126
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 127 HRDLRAANILVS---DTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYG 180
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      +
Sbjct: 181 TFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----DN 229
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P E       C     + RP + +L+ +  D F+
Sbjct: 230 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 264

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 18/211 (8%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
           Y LG  +G G+FG++ +  H  T   VAVKI N   K   L    K+ + +Q      + 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 68  --IKWYGVDGEDNVLVLDLLGPSLEDLFVY-CRR-KFSLKTVLMLADQMIARIEYVHSRG 123
             IK Y V        + +   S  +LF Y C+  +        L  Q+++ ++Y H   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
            +HRD+KP+N L+     A    I DFGL+    D    R           G+  YA+  
Sbjct: 132 VVHRDLKPENVLLDAHMNAK---IADFGLSNMMSDGEFLR--------TSCGSPNYAAPE 180
Query: 184 THLG-IEQSRRDDLESLGYVLLYFLRGSLPW 213
              G +      D+ S G +L   L G+LP+
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++  N     K   ++ E  V +  +  + +
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
             +  Y V  E  V++  L G SL D+    C  +  +  V     + +  +E++HS   
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 138
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HR+IK DN L+G+      V + DFG   +     + R         + GT  + +   
Sbjct: 139 IHRNIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 188
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                   + D+ SLG + +  + G  P+
Sbjct: 189 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 28  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 143
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 144 KYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT----------GYVAT 190
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 246
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 247 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 275

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 34  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 149
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 150 KYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT----------GYVAT 196
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 252
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 253 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 281

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 118/273 (43%), Gaps = 27/273 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +K+G+G FGE+++A++ + +  VAVK    G+   +  L EA V K LQ       +
Sbjct: 18  KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL---V 73
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K + V  ++ + ++      G  L+ L      K  L  ++  + Q+   + ++  R ++
Sbjct: 74  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 133
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HRD++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 134 HRDLRAANILVSASLVCK---IADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFG 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L+  +  G +P+ G+       +  +  E+    P    C  
Sbjct: 188 SFTI----KSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENC-- 237
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
            P E  +    C     ++RP + +++ +  D 
Sbjct: 238 -PEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 144
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 145 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 191
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 247
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 248 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 276

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGX----------VAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   T + VAVK ++    +  +LL+ E  + +     + +     Y
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R   + + +  +   ++  + Y+H++G +HRDIK 
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 169
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       ++ + DFG   +      ++ +P R  K L GT  + +      +   
Sbjct: 170 DSILLT---SDGRIKLSDFGFCAQ-----VSKEVPKR--KXLVGTPYWMAPEVISRLPYG 219
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPY 241

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   + ++VAVK ++    +  +LL+ E  + +  Q  + +     Y
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R        + LA  ++  +  +H++G +HRDIK 
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLQALSVLHAQGVIHRDIKS 198
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       +V + DFG   +      ++ +P R  K L GT  + +      +   
Sbjct: 199 DSILLT---HDGRVKLSDFGFCAQ-----VSKEVPRR--KXLVGTPYWMAPELISRLPYG 248
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPPY 270

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 35  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKH 92
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 150
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 151 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 197
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 253
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 254 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 282

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIP 66
           Y +   IG GS+ E     H  TN   AVK+ +   + P      ++  +L+ G    I 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS----EEIEILLRYGQHPNII 84
Query: 67  NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGF 124
            +K    DG+   LV +L+ G  L D  +  R+KF S +    +   +   +EY+HS+G 
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKIL--RQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 125 LHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
           +HRD+KP N L +        + I DFG AK+ R           EN  L      A+  
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMTPCYTANFV 192
Query: 184 THLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
               +++   D   D+ SLG +L   L G  P+    + T ++   +I   K +
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFT 246

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   + ++VAVK ++    +  +LL+ E  + +  Q  + +     Y
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R        + LA  ++  +  +H++G +HRDIK 
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLQALSVLHAQGVIHRDIKS 155
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       +V + DFG   +      ++ +P R  K L GT  + +      +   
Sbjct: 156 DSILLT---HDGRVKLSDFGFCAQ-----VSKEVPRR--KXLVGTPYWMAPELISRLPYG 205
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPPY 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 35  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 150
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 151 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 197
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 253
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 254 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 282

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   + ++VAVK ++    +  +LL+ E  + +  Q  + +     Y
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R        + LA  ++  +  +H++G +HRDIK 
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLQALSVLHAQGVIHRDIKS 153
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       +V + DFG   +      ++ +P R  K L GT  + +      +   
Sbjct: 154 DSILLT---HDGRVKLSDFGFCAQ-----VSKEVPRR--KXLVGTPYWMAPELISRLPYG 203
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPPY 225

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 35  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 150
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 151 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 197
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 253
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 254 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 282

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 15/211 (7%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP-- 66
           Y +  ++GSG+FG +       T  +   K  N  T +P   Y  K    +      P  
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 67  -NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            N+     D  + VL+L+ L G  L D       K S   V+    Q    ++++H    
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +H DIKP+N +M   +KA+ V IIDFGLA K          P    K  T TA +A+   
Sbjct: 171 VHLDIKPEN-IMCETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFAAPEI 221
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                     D+ ++G +    L G  P+ G
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 42  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 157
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 158 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 204
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 260
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 261 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 289

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 24/242 (9%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           M  +    Y +   IG GS+ E     H  TN   AVK+ +   + P      ++  +L+
Sbjct: 21  MNLVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDP----SEEIEILLR 76
Query: 61  GGS--GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIARI 116
            G    I  +K    DG+   LV +L+ G  L D  +  R+KF S +    +   +   +
Sbjct: 77  YGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL--RQKFFSEREASFVLHTIGKTV 134
Query: 117 EYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           EY+HS+G +HRD+KP N L +        + I DFG AK+ R           EN  L  
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR----------AENGLLMT 184
Query: 176 TARYASCNTHLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
               A+      +++   D   D+ SLG +L   L G  P+    + T ++   +I   K
Sbjct: 185 PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGK 244
Query: 233 VS 234
            +
Sbjct: 245 FT 246

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 97/250 (38%), Gaps = 51/250 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG 62
           +Y  GR +G G F + +  + +DT E+ A K+          +  ++  E  ++K L   
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL--- 83
Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY-----CRRKFSLK-----------TVL 106
                         DN  V+   G   +D FVY     CRR+  L+              
Sbjct: 84  --------------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR 129
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
               Q I  ++Y+H+   +HRD+K  N  +        V I DFGLA K           
Sbjct: 130 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKI-------EFD 179
Query: 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226
               K+L GT  Y +         S   D+ SLG +L   L G  P++    +  K+ Y 
Sbjct: 180 GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYI 236
Query: 227 KICEKKVSTP 236
           +I + + S P
Sbjct: 237 RIKKNEYSVP 246

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 140
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 141 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 187
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 243
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 244 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 272

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 145
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 146 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEMT----------GYVAT 192
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 248
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 249 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 277

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 34  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 149
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 150 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 196
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 252
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 253 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 281

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 97/250 (38%), Gaps = 51/250 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG 62
           +Y  GR +G G F + +  + +DT E+ A K+          +  ++  E  ++K L   
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL--- 99
Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY-----CRRKFSLK-----------TVL 106
                         DN  V+   G   +D FVY     CRR+  L+              
Sbjct: 100 --------------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR 145
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
               Q I  ++Y+H+   +HRD+K  N  +        V I DFGLA K           
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKI-------EFD 195
Query: 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226
               K+L GT  Y +         S   D+ SLG +L   L G  P++    +  K+ Y 
Sbjct: 196 GERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYI 252
Query: 227 KICEKKVSTP 236
           +I + + S P
Sbjct: 253 RIKKNEYSVP 262

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 145
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 146 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEMT----------GYVAT 192
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 248
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 249 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 277

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 20  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 136 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 182
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 238
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 239 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 267

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 21  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 78
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 136
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 137 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 183
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 239
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 240 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 268

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 46  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 103
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 161
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 162 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 208
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 264
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 265 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 293

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 144
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 145 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 191
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 247
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 248 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 276

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 145
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 146 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTADEMT----------GYVAT 192
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 248
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 249 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 277

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 140
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 141 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 187
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 243
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 244 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 272

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 28  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 143
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 144 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 190
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 246
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 247 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   + ++VAVK ++    +  +LL+ E  + +  Q  + +     Y
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R        + LA  ++  +  +H++G +HRDIK 
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLQALSVLHAQGVIHRDIKS 148
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       +V + DFG   +      ++ +P R  K L GT  + +      +   
Sbjct: 149 DSILLT---HDGRVKLSDFGFCAQ-----VSKEVPRR--KXLVGTPYWMAPELISRLPYG 198
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPY 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 43  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 158
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 159 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 205
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 261
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 262 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 290

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 140
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 141 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 187
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 243
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 244 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 272

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 20  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 136 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 182
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 238
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 239 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 267

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 135 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 181
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 237
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 238 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 266

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 145
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 146 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 192
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 248
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 249 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 277

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 28  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 143
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 144 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 190
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 246
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 247 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 275

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 22  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 79
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 137
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 138 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 184
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 185 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 240
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 241 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 269

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           R +GSG++G +  A      + VAVK          L++  + Y+ L+    + +    G
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 73  V-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           +           D  +  LV  L+G  L ++ V C+   S + V  L  Q++  ++Y+HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNI-VKCQ-ALSDEHVQFLVYQLLRGLKYIHS 149
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            G +HRD+KP N  +    + +++ I+DFGLA++  +  T
Sbjct: 150 AGIIHRDLKPSNVAVN---EDSELRILDFGLARQADEEMT 186

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
           KIG GS G + +A+   + ++VAVK ++    +  +LL+ E  + +  Q  + +     Y
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
            V  E  V++  L G +L D+  + R        + LA  ++  +  +H++G +HRDIK 
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLQALSVLHAQGVIHRDIKS 144
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           D+ L+       +V + DFG   +      ++ +P R  K L GT  + +      +   
Sbjct: 145 DSILLT---HDGRVKLSDFGFCAQ-----VSKEVPRR--KXLVGTPYWMAPELISRLPYG 194
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
              D+ SLG +++  + G  P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 109
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 170 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 206

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 109
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 170 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 206

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 56  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 111
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 172 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 208

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 48  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 103
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 164 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 200

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIP 66
           +Y+L + IG+G+FG   L      NE+VAVK    G K    + E    +I+   S   P
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEK----IDENVKREIINHRSLRHP 75
Query: 67  NIKWYGVDGEDNVLVLDLLGPSLE-----DLF--VYCRRKFSLKTVLMLADQMIARIEYV 119
           NI    V  ++ +L    L   +E     +LF  +    +FS         Q+I+ + Y 
Sbjct: 76  NI----VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H+    HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y
Sbjct: 132 HAMQVAHRDLKLENTLLD-GSPAPRLKIADFGYSKA--------SVLHSQPKSAVGTPAY 182
Query: 180 ASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 214
            +    L  E   +  D+ S G  L   L G+ P++
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D          E      T
Sbjct: 135 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD----------EMAGFVAT 181
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 237
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 238 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 266

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  ++    K+ +L    ++ + L   + 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL----QIMRKLDHCNI 75
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 136 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 46  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 103
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 161
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D          E      T
Sbjct: 162 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD----------EMXGYVAT 208
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 264
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 265 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 293

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 58  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 113
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 174 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 210

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 40/242 (16%)
Query: 9   YKLGRKIGSGSFGEIFL----------ASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI 58
           +++ R +G+GSFG + L          A  V   EIV    +   T   +L+     +  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 59  LQGGSGIPNIKWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIA 114
           +        I+ +G   D +   +++D +     +LF   R+  +F        A ++  
Sbjct: 68  I--------IRMWGTFQDAQQIFMIMDYIEGG--ELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            +EY+HS+  ++RD+KP+N L+    K   + I DFG AK   D T            L 
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------XLC 164
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
           GT  Y +         ++  D  S G ++   L G  P+     +   + Y+KI   ++ 
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 221
Query: 235 TP 236
            P
Sbjct: 222 FP 223

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 96/250 (38%), Gaps = 51/250 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG 62
           +Y  GR +G G F + +  + +DT E+ A K+          +  ++  E  ++K L   
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL--- 99
Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY-----CRRKFSLK-----------TVL 106
                         DN  V+   G   +D FVY     CRR+  L+              
Sbjct: 100 --------------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR 145
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
               Q I  ++Y+H+   +HRD+K  N  +        V I DFGLA K           
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKI-------EFD 195
Query: 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226
               K L GT  Y +         S   D+ SLG +L   L G  P++    +  K+ Y 
Sbjct: 196 GERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYI 252
Query: 227 KICEKKVSTP 236
           +I + + S P
Sbjct: 253 RIKKNEYSVP 262

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  ++    K+ +L    ++ + L   + 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL----QIMRKLDHCNI 75
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 136 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 73  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 132
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA        +R     + + L+G+  + +     
Sbjct: 133 RDLKSNNIFL---HEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 32  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 88  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 147
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA +      +R     + + L+G+  + +     
Sbjct: 148 RDLKSNNIFL---HEDLTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 112/261 (42%), Gaps = 21/261 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 96  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 155
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA +      +R     + + L+G+  + +     
Sbjct: 156 RDLKSNNIFL---HEDLTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
             ++   S + D+ + G VL   + G LP+  +    + Q    +    +S  +  +  +
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDLSKVRSN 265
Query: 244 HPAEFASYFHYCQSLTFDQRP 264
            P         C     D+RP
Sbjct: 266 CPKAMKRLMAECLKKKRDERP 286

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D          E      T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD----------EMAGFVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 270

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 99  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 154
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 215 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 251

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 25  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 80
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 141 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 177

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKILQGGSGI 65
           + Y   + IG+GSFG +F A  V+++E+   K+ ++   K+ +L    ++ +I++  + +
Sbjct: 40  IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL----QIMRIVKHPNVV 95
Query: 66  PNIKWYGVDGE--DNVLVLDLLGPSLEDLFVYCRRKFSLK-TVLMLAD-----QMIARIE 117
               ++  +G+  D V +  +L    E ++   R    LK T+ ML       Q++  + 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           Y+HS G  HRDIKP N L  L   +  + +IDFG AK
Sbjct: 156 YIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAK 190

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 33  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 88
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 149 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 185

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  ++    K+ +L    ++ + L   + 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL----QIMRKLDHCNI 75
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 136 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 27/275 (9%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 12  KLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 67
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 68  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 127
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
           HR+++  N L+          I DFGLA+   D   N +      K  +  TA  A    
Sbjct: 128 HRNLRAANILVS---DTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYG 181
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
              I    + D+ S G +L   +  G +P+ G+      Q  ++    ++  P      +
Sbjct: 182 TFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--GYRMVRP-----DN 230
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            P E       C     + RP + +L+ +  D F+
Sbjct: 231 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 265

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 87
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 148 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 184

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 68  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA +      +R     + + L+G+  + +     
Sbjct: 128 RDLKSNNIFL---HEDLTVKIGDFGLATE-----KSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 14  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 70  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 129
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA        +R     + + L+G+  + +     
Sbjct: 130 RDLKSNNIFL---HEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 12  GRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
           G  +G G FG+    +H +T E++ +K  I          L E KV + L+     PN+ 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH----PNVL 70
Query: 69  KWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K+ GV   D   N +   + G +L  +      ++     +  A  + + + Y+HS   +
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
           HRD+   N L+   R+   V + DFGLA+   D  T 
Sbjct: 131 HRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 39  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 95  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 154
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA        +R     + + L+G+  + +     
Sbjct: 155 RDLKSNNIFL---HEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 28  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 83
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 144 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 180

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 96  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 155
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA        +R     + + L+G+  + +     
Sbjct: 156 RDLKSNNIFL---HEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 144
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 145 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 191
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 247
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 248 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 276

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 32  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 87
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 148 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 184

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 39  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 94
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 155 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 191

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 68  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA        +R     + + L+G+  + +     
Sbjct: 128 RDLKSNNIFL---HEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +  + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 73  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 132
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA        +R     + + L+G+  + +     
Sbjct: 133 RDLKSNNIFL---HEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 157
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 158 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 204
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 260
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 261 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 289

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 96/250 (38%), Gaps = 51/250 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG 62
           +Y  GR +G G F + +  + +DT E+ A K+          +  ++  E  ++K L   
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSL--- 99
Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVY-----CRRKFSLK-----------TVL 106
                         DN  V+   G   +D FVY     CRR+  L+              
Sbjct: 100 --------------DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEAR 145
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
               Q I  ++Y+H+   +HRD+K  N  +        V I DFGLA K           
Sbjct: 146 YFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN---DDMDVKIGDFGLATKI-------EFD 195
Query: 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226
               K L GT  Y +         S   D+ SLG +L   L G  P++    +  K+ Y 
Sbjct: 196 GERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE---TSCLKETYI 252
Query: 227 KICEKKVSTP 236
           +I + + S P
Sbjct: 253 RIKKNEYSVP 262

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 21  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 76
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 137 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 173

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 158
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D          E      T
Sbjct: 159 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDD----------EMXGXVAT 205
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 261
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 262 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 290

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 117/274 (42%), Gaps = 35/274 (12%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +K+G+G FGE+++A++ + +  VAVK    G+   +  L EA V K LQ       +
Sbjct: 185 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK---LV 240
Query: 69  KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K + V  ++ + ++      G  L+ L      K  L  ++  + Q+   + ++  R ++
Sbjct: 241 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 300
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           HRD++  N L+          I DFGLA+           P      +  TA  A     
Sbjct: 301 HRDLRAANILVSASLVCK---IADFGLAR------VGAKFP------IKWTAPEAINFGS 345
Query: 186 LGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
             I    + D+ S G +L+  +  G +P+ G+       +  +  E+    P    C   
Sbjct: 346 FTI----KSDVWSFGILLMEIVTYGRIPYPGM----SNPEVIRALERGYRMPRPENC--- 394
Query: 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           P E  +    C     ++RP + +++ +  D ++
Sbjct: 395 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 428

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 75
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 136 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 158
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 159 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 205
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 261
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 262 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 290

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+L + IGSG+FG   L     +NE+VAVK    G K  +     K   I       PN
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE---NVKREIINHRSLRHPN 76
Query: 68  IKWYGVDGEDNVLVLDLLGPSLE-----DLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
           I  +    ++ +L    L   +E     +LF  +    +FS         Q+I+ + Y H
Sbjct: 77  IVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           +    HRD+K +N L+  G  A ++ I  FG +K          + + + K+  GT  Y 
Sbjct: 133 AMQVCHRDLKLENTLLD-GSPAPRLKICAFGYSKS--------SVLHSQPKDTVGTPAYI 183
Query: 181 SCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 214
           +    L  E   +  D+ S G  L   L G+ P++
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 75
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 136 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 135 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 181
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 237
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 238 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 266

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 75
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 136 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 270

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    ++ + L   + 
Sbjct: 24  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL----QIMRKLDHCNI 79
Query: 65  IPNIKWYGVDGE--DNV---LVLDLLGPSLEDLFV-YCRRKFSLKTVL--MLADQMIARI 116
           +    ++   GE  D V   LVLD +  ++  +   Y R K +L  +   +   Q+   +
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 140 AYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 176

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 90
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 148
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 149 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 195
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 251
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 252 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 280

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L +  +   +K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKXQKLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDXELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           R +GSG++G +  A      + VAVK          L++  + Y+ L+    + +    G
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 73  V-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           +           D  +  LV  L+G  L ++ V C+   S + V  L  Q++  ++Y+HS
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNI-VKCQ-ALSDEHVQFLVYQLLRGLKYIHS 141
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            G +HRD+KP N  +    +  ++ I+DFGLA++  +  T
Sbjct: 142 AGIIHRDLKPSNVAVN---EDCELRILDFGLARQADEEMT 178

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+L + IGSG+FG   L     +NE+VAVK    G K  +     K   I       PN
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE---NVKREIINHRSLRHPN 76
Query: 68  IKWYGVDGEDNVLVLDLLGPSLE-----DLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
           I  +    ++ +L    L   +E     +LF  +    +FS         Q+I+ + Y H
Sbjct: 77  IVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           +    HRD+K +N L+  G  A ++ I  FG +K          + + + K+  GT  Y 
Sbjct: 133 AMQVCHRDLKLENTLLD-GSPAPRLKICAFGYSKS--------SVLHSQPKSTVGTPAYI 183
Query: 181 SCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ 214
           +    L  E   +  D+ S G  L   L G+ P++
Sbjct: 184 APEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQ--GGSGIPNIK 69
           RK+G G+FG + L  H+D  +  AVK+  +  K+ +    EA + K +Q    +    +K
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 70  WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLH 126
           ++G  +  +   L+ + LGPSL ++        F ++ + +   +++  + Y+      H
Sbjct: 101 YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTH 160
Query: 127 RDIKPDNFLMG--------------LGRKANQVY--------IIDFGLAKKYRDPTTNRH 164
            D+KP+N L+                  K  Q+Y        +IDFG A    D      
Sbjct: 161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------ 214
Query: 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL 211
                + ++  T +Y +    L +      D+ S G VL     GSL
Sbjct: 215 ----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 32/255 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
           +++ + IG G+FGE+ +    +T  I A+KI N      ++L  A+     +    + N 
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKW----EMLKRAETACFREERDVLVNG 147
Query: 68  -IKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             +W     Y    E+++ LV+D  +G  L  L      K           +M+  I+ +
Sbjct: 148 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H   ++HRDIKPDN L+ +      + + DFG   K  D  T       ++    GT  Y
Sbjct: 208 HQLHYVHRDIKPDNVLLDVN---GHIRLADFGSCLKMNDDGT------VQSSVAVGTPDY 258
Query: 180 ASCNTHLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC--EKK 232
            S      +E          D  SLG  +   L G  P+    A +  + Y KI   E++
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHEER 315
Query: 233 VSTPIEVLCKSHPAE 247
              P  V   S  A+
Sbjct: 316 FQFPSHVTDVSEEAK 330

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           +G++IGSGSFG ++    H D    VAVK+ N     PQ L   K    +L+    +  +
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G      + ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 68  LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +    +   V I DFGLA        +R     + + L+G+  + +     
Sbjct: 128 RDLKSNNIFL---HEDLTVKIGDFGLAT-----VKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPWQGL 216
             ++   S + D+ + G VL   + G LP+  +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENS---GTKHPQLLYEAKVYKILQ 60
           +G +Y++   IG+G++G +  A    T + VA+K I N+    T   + L E K+ K  +
Sbjct: 53  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 112
Query: 61  GGSGI-------PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
             + I       P +  YG + +   +VLDL+   L  + ++  +  +L+ V     Q++
Sbjct: 113 HDNIIAIKDILRPTVP-YG-EFKSVYVVLDLMESDLHQI-IHSSQPLTLEHVRYFLYQLL 169
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             ++Y+HS   +HRD+KP N L+    +  ++ I DFG+A+
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDFGMAR 207

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 104/255 (40%), Gaps = 32/255 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
           +++ + IG G+FGE+ +    +T  I A+KI N      ++L  A+     +    + N 
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKW----EMLKRAETACFREERDVLVNG 131
Query: 68  -IKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             +W     Y    E+++ LV+D  +G  L  L      K           +M+  I+ +
Sbjct: 132 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H   ++HRDIKPDN L+ +      + + DFG   K  D  T       ++    GT  Y
Sbjct: 192 HQLHYVHRDIKPDNVLLDVN---GHIRLADFGSCLKMNDDGT------VQSSVAVGTPDY 242
Query: 180 ASCNTHLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC--EKK 232
            S      +E          D  SLG  +   L G  P+    A +  + Y KI   E++
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHEER 299
Query: 233 VSTPIEVLCKSHPAE 247
              P  V   S  A+
Sbjct: 300 FQFPSHVTDVSEEAK 314

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+D+GLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDYGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 77  DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF- 134
           D VL+L+L+ G  L D F+  +   S +       Q++  + Y+H++   H D+KP+N  
Sbjct: 89  DVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT----HLGIEQ 190
           L+        + +IDFGLA +  D          E KN+ GT  + +        LG+E 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS 250
               D+ S+G +    L G+ P+ G    TK++    I    VS   +    SH +E A 
Sbjct: 200 ----DMWSIGVITYILLSGASPFLG---DTKQETLANIT--SVSYDFDEEFFSHTSELAK 250
Query: 251 YF 252
            F
Sbjct: 251 DF 252

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 50/230 (21%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGS 63
           KY+   KIG GS+G +F   + DT +IVA+K        P +    L E ++ K L+   
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-- 61
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYC-----------RRKFSLKTVLMLADQM 112
             PN+         N+L +      L  +F YC           +R      V  +  Q 
Sbjct: 62  --PNLV--------NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-------KYRDPTTNRHI 165
           +  + + H    +HRD+KP+N L+    K + + + DFG A+        Y D    R  
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRW- 167
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            YR  + L G  +Y               D+ ++G V    L G   W G
Sbjct: 168 -YRSPELLVGDTQYGP-----------PVDVWAIGCVFAELLSGVPLWPG 205

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 7/208 (3%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           +G G+   +    ++ T++  AVKI  +  G    ++  E ++    QG   +  +  + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 73  VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132
            + +   LV + +        ++ RR F+     ++   + + ++++H++G  HRD+KP+
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS- 191
           N L     + + V I DF L    +       I   E     G+A Y +        +  
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 192 ----RRDDLESLGYVLLYFLRGSLPWQG 215
               +R DL SLG +L   L G  P+ G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSG 64
           V Y   + IG+GSFG ++ A   D+ E+VA+K  +++   K+ +L    K+         
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL-----DHCN 74
Query: 65  IPNIKW--YGVDGEDNVLVLDLLGPSLEDLFV-----YCRRKFSLKTVL--MLADQMIAR 115
           I  +++  Y    + +V+ L+L+   + +        Y R K +L  +   +   Q+   
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           + Y+HS G  HRDIKP N L  L      + + DFG AK+
Sbjct: 135 LAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 172

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 24/234 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIP 66
           Y++   IG GS+       H  TN   AVKI +   + P      ++  +L+ G    I 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEIEILLRYGQHPNII 79
Query: 67  NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGF 124
            +K    DG+   +V +L+ G  L D  +  R+KF S +    +   +   +EY+H++G 
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 125 LHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
           +HRD+KP N L +        + I DFG AK+ R           EN  L      A+  
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLMTPCYTANFV 187
Query: 184 THLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
               +E+   D   D+ SLG +L   L G  P+      T ++   +I   K S
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/265 (20%), Positives = 113/265 (42%), Gaps = 28/265 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +++  ++G G+FG+++ A + +T  + A K+  + ++     Y  ++ +IL        +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI-EILATCDHPYIV 79
Query: 69  KWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K  G    DG+  +++    G +++ + +   R  +   + ++  QM+  + ++HS+  +
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 139
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---- 181
           HRD+K  N LM L      + + DFG++ K       R        +  GT  + +    
Sbjct: 140 HRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKR-------DSFIGTPYWMAPEVV 189
Query: 182 -CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
            C T        + D+ SLG  L+   +   P   L       K  K      S P  +L
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------SDPPTLL 243
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPD 265
               P++++  F     +  D+ P+
Sbjct: 244 T---PSKWSVEFRDFLKIALDKNPE 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 113/276 (40%), Gaps = 29/276 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G  GE+++  + + +  VAVK    G+  P   L EA + K LQ       +
Sbjct: 16  KLVERLGAGQAGEVWMG-YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR---LV 71
Query: 69  KWYGVDGEDNVLVLD--LLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           + Y V  ++ + ++   +   SL D        K ++  +L +A Q+   + ++  R ++
Sbjct: 72  RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI 131
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN--LTGTARYASCN 183
           HRD++  N L+          I DFGLA+   D         RE     +  TA  A   
Sbjct: 132 HRDLRAANILVS---DTLSCKIADFGLARLIEDAEXTA----REGAKFPIKWTAPEAINY 184
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               I    + D+ S G +L   +  G +P+ G+      Q  ++           V   
Sbjct: 185 GTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------VRPD 233
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
           + P E       C     + RP + +L+ +  D F+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 23/281 (8%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +Y   + IGSG+FG   L     T E+VAVK IE        +  E   ++ L+     P
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH----P 76
Query: 67  NI-KWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           NI ++  V      L + +   S  +L+  +    +FS         Q+++ + Y HS  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
             HRD+K +N L+  G  A ++ I DFG +K          + + + K+  GT  Y +  
Sbjct: 137 ICHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKSTVGTPAYIAPE 187
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVSTPIEVLC 241
             L  E   +  D+ S G  L   L G+ P++  +     +K   +I   K S P ++  
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYG----FLKRLFHDLFS 278
                   S        T    P+      FLK L  DL +
Sbjct: 248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMN 288

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L +  +   +K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKXQKLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 84/161 (52%), Gaps = 17/161 (10%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENS---GTKHPQLLYEAKVYKILQ 60
           +G +Y++   IG+G++G +  A    T + VA+K I N+    T   + L E K+ K  +
Sbjct: 52  VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK 111
Query: 61  GGSGI-------PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
             + I       P +  YG + +   +VLDL+   L  + ++  +  +L+ V     Q++
Sbjct: 112 HDNIIAIKDILRPTVP-YG-EFKSVYVVLDLMESDLHQI-IHSSQPLTLEHVRYFLYQLL 168
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             ++Y+HS   +HRD+KP N L+    +  ++ I DFG+A+
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIGDFGMAR 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/265 (20%), Positives = 113/265 (42%), Gaps = 28/265 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +++  ++G G+FG+++ A + +T  + A K+  + ++     Y  ++ +IL        +
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI-EILATCDHPYIV 71
Query: 69  KWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K  G    DG+  +++    G +++ + +   R  +   + ++  QM+  + ++HS+  +
Sbjct: 72  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII 131
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---- 181
           HRD+K  N LM L      + + DFG++ K       R        +  GT  + +    
Sbjct: 132 HRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKR-------DSFIGTPYWMAPEVV 181
Query: 182 -CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
            C T        + D+ SLG  L+   +   P   L       K  K      S P  +L
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------SDPPTLL 235
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPD 265
               P++++  F     +  D+ P+
Sbjct: 236 T---PSKWSVEFRDFLKIALDKNPE 257

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
           R+    Y++ + IG G+FGE+ L  H  T ++ A+K+    E          +E +    
Sbjct: 65  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 59  LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
                 +  + +   D     +V++ + P  + + +        K       +++  ++ 
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYM-PGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +HS GF+HRD+KPDN L+    K+  + + DFG   K
Sbjct: 184 IHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 217

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 114/273 (41%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C  K +   V  L  Q++  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCA-KLTDDHVQFLIYQILRGL 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T              T
Sbjct: 135 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT----------GYVAT 181
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 237
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSL   Q P   F
Sbjct: 238 PGAELLKKISSESAR--NYIQSLA--QMPKMNF 266

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
           R+    Y++ + IG G+FGE+ L  H  T ++ A+K+    E          +E +    
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 59  LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
                 +  + +   D     +V++ + P  + + +        K       +++  ++ 
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYM-PGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +HS GF+HRD+KPDN L+    K+  + + DFG   K
Sbjct: 189 IHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 222

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 77  DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF- 134
           D VL+L+L+ G  L D F+  +   S +       Q++  + Y+H++   H D+KP+N  
Sbjct: 89  DVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT----HLGIEQ 190
           L+        + +IDFGLA +  D          E KN+ GT  + +        LG+E 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS 250
               D+ S+G +    L G+ P+ G    TK++    I    VS   +    SH +E A 
Sbjct: 200 ----DMWSIGVITYILLSGASPFLG---DTKQETLANIT--SVSYDFDEEFFSHTSELAK 250
Query: 251 YF 252
            F
Sbjct: 251 DF 252

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           ++    +G+G+F E+ LA    T ++ AVK        P+   + K   I    + +  I
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKC------IPKKALKGKESSIENEIAVLRKI 77
Query: 69  KWYGVDGEDNV--------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
           K   +   +++        LV+ L+ G  L D  V  +  ++ K    L  Q++  + Y+
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVE-KGFYTEKDASTLIRQVLDAVYYL 136
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           H  G +HRD+KP+N L     + +++ I DFGL+K
Sbjct: 137 HRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 38/281 (13%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           ++GSG+ G+++      T  ++AVK +  SG K         +  +L+       ++ +G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 73  --VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDI 129
             +   D  + ++L+G   E L    +     + +  +   ++  + Y+  + G +HRD+
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
           KP N L+    +  Q+ + DFG++ +  D                   R A C  ++  E
Sbjct: 152 KPSNILLD---ERGQIKLCDFGISGRLVDDKAK--------------DRSAGCAAYMAPE 194
Query: 190 Q-----------SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
           +             R D+ SLG  L+    G  P++  K  T  +   K+ +++   P+ 
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--TDFEVLTKVLQEE--PPLL 250
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
                   +F S+   C +    +RP Y   K L H    R
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYN--KLLEHSFIKR 289

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 77  DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF- 134
           D VL+L+L+ G  L D F+  +   S +       Q++  + Y+H++   H D+KP+N  
Sbjct: 89  DVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT----HLGIEQ 190
           L+        + +IDFGLA +  D          E KN+ GT  + +        LG+E 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS 250
               D+ S+G +    L G+ P+ G    TK++    I    VS   +    SH +E A 
Sbjct: 200 ----DMWSIGVITYILLSGASPFLG---DTKQETLANIT--SVSYDFDEEFFSHTSELAK 250
Query: 251 YF 252
            F
Sbjct: 251 DF 252

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           R +GSG++G +  A      + VAVK          L++  + Y+ L+    + +    G
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 73  V-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           +           D  +  LV  L+G  L +  +   +  S + V  L  Q++  ++Y+HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNN--IVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            G +HRD+KP N  +    + +++ I+DFGLA++  +  T
Sbjct: 150 AGIIHRDLKPSNVAVN---EDSELRILDFGLARQADEEMT 186

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
           R+    Y++ + IG G+FGE+ L  H  T ++ A+K+    E          +E +    
Sbjct: 70  RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 59  LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
                 +  + +   D     +V++ + P  + + +        K       +++  ++ 
Sbjct: 130 FANSPWVVQLFYAFQDDRYLYMVMEYM-PGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           +HS GF+HRD+KPDN L+    K+  + + DFG   K
Sbjct: 189 IHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 222

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSG 64
           + + R IG G FGE++     DT ++ A+K ++    K  Q   L    ++   L     
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 65  IPNIKW--YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            P I    Y     D +  +LDL+     DL  +  +   FS   +   A ++I  +E++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H+R  ++RD+KP N L+    +   V I D GLA  +     +  +         GT  Y
Sbjct: 309 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 356
Query: 180 ASCNT-HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
            +      G+      D  SLG +L   LRG  P++  K   K +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSG 64
           + + R IG G FGE++     DT ++ A+K ++    K  Q   L    ++   L     
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 65  IPNIKW--YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            P I    Y     D +  +LDL+     DL  +  +   FS   +   A ++I  +E++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H+R  ++RD+KP N L+    +   V I D GLA  +     +  +         GT  Y
Sbjct: 309 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 356
Query: 180 ASCNT-HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
            +      G+      D  SLG +L   LRG  P++  K   K +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSG 64
           + + R IG G FGE++     DT ++ A+K ++    K  Q   L    ++   L     
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 65  IPNIKW--YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            P I    Y     D +  +LDL+     DL  +  +   FS   +   A ++I  +E++
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H+R  ++RD+KP N L+    +   V I D GLA  +     +  +         GT  Y
Sbjct: 308 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 355
Query: 180 ASCNT-HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
            +      G+      D  SLG +L   LRG  P++  K   K +
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 400

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L +  +   +K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKSQKLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    + +++ I+DFGL +   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDSELKILDFGLCRHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSG 64
           + + R IG G FGE++     DT ++ A+K ++    K  Q   L    ++   L     
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 65  IPNIKW--YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
            P I    Y     D +  +LDL+     DL  +  +   FS   +   A ++I  +E++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H+R  ++RD+KP N L+    +   V I D GLA  +     +  +         GT  Y
Sbjct: 309 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 356
Query: 180 ASCNT-HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
            +      G+      D  SLG +L   LRG  P++  K   K +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 39/214 (18%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG----------GS 63
           +IG GSFGE++      T E+VA+KI +      ++    +   +L            GS
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 64  GIPNIK-WYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            + + K W  ++       LDLL P  LE+ ++         T+L    +++  ++Y+HS
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI--------ATILR---EILKGLDYLHS 134
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +HRDIK  N L+    +   V + DFG+A +  D    R+          GT  + +
Sbjct: 135 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------XFVGTPFWMA 184
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
                 I+QS  D   D+ SLG   +   +G  P
Sbjct: 185 PEV---IKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A    T   VAVK          +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+DF LA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFYLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G FGE++       +  VAVK     T    + L EA V K 
Sbjct: 8   MERTDITMKHKLG----GGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ S   +L +A Q+ 
Sbjct: 64  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTXTAH 167

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 15  IGSGSFGEIFLASHV--DTN-EIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY 71
           +G G FG +F A +   D N  I  +++ N      +++ E K    L+   GI  ++++
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-PGI--VRYF 69
Query: 72  GVDGEDNVLVLDLLGPSLEDLFVYCR----RKFSLK---------------TVLMLADQM 112
               E N    + L PS   +++Y +    RK +LK                 L +  Q+
Sbjct: 70  NAWLEKNTT--EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA----KKYRDPTTNRHIP-Y 167
              +E++HS+G +HRD+KP N    +    + V + DFGL     +   + T    +P Y
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
             +    GT  Y S     G   S + D+ SLG +L   L
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 24/234 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIP 66
           Y++   IG GS+       H  TN   AVKI +   + P      ++  +L+ G    I 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPT----EEIEILLRYGQHPNII 79
Query: 67  NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGF 124
            +K    DG+   +V +L  G  L D  +  R+KF S +    +   +   +EY+H++G 
Sbjct: 80  TLKDVYDDGKYVYVVTELXKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 125 LHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
           +HRD+KP N L +        + I DFG AK+ R           EN  L      A+  
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----------AENGLLXTPCYTANFV 187
Query: 184 THLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
               +E+   D   D+ SLG +L   L G  P+      T ++   +I   K S
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFS 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 32/225 (14%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASH-VDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
           +++  G+ +K    IGSG FG++F A H +D    V  +++ +  K  +   E K    L
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKL 61
Query: 60  QGGSGIP-NIKWYGVDGEDNVLVLDLLGPSLEDLFV---YC-----------RRKFSLKT 104
              + +  N  W G D +      +      + LF+   +C           RR   L  
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 105 VLMLA--DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
           VL L   +Q+   ++Y+HS+  ++RD+KP N  +       QV I DFGL    ++    
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDG-- 176
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
                 +     GT RY S       +  +  DL +LG +L   L
Sbjct: 177 ------KRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 72  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 129 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 178
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 179 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 218

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 13/204 (6%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-ENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYG 72
           +G G FG++       T   +A KI +  G K   ++  E  V   L   + I     + 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 73  VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
               D VLV++ + G  L D  +      +    ++   Q+   I ++H    LH D+KP
Sbjct: 157 -SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
           +N L  + R A Q+ IIDFGLA++Y+        P  + K   GT  + +         S
Sbjct: 216 ENILC-VNRDAKQIKIIDFGLARRYK--------PREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 192 RRDDLESLGYVLLYFLRGSLPWQG 215
              D+ S+G +    L G  P+ G
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLG 290

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RKFSL   ++++ A Q+   + 
Sbjct: 71  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTALA 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 126 YLESKRFVHRDIAARNVLVS---ATDCVKLGDFGLSRYMEDST 165

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 72  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 129 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 178
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 179 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 218

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 8   MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    +++  +   +L D    C R++ S   +L +A Q+ 
Sbjct: 64  IKH----PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTXTAH 167

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 44/224 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-------------IENS-----GTKHPQLL 50
           Y     +G+G+F E+ LA    T ++VA+K             +EN        KHP ++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 51  YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
               +Y+                 G    L++ L+ G  L D  V  +  ++ +    L 
Sbjct: 80  ALDDIYE----------------SGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLI 122
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
            Q++  ++Y+H  G +HRD+KP+N L     + +++ I DFGL+ K  DP +        
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVL------ 175
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                GT  Y +         S+  D  S+G +    L G  P+
Sbjct: 176 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 20/212 (9%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y     +G+G+F E+ LA    T ++VA+K    E    K   +  E  V   ++  + +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV----YCRRKFSLKTVLMLADQMIARIEYVHS 121
                Y   G   +++  + G  L D  V    Y  R  S      L  Q++  ++Y+H 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-----RLIFQVLDAVKYLHD 134
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            G +HRD+KP+N L     + +++ I DFGL+ K  DP +             GT  Y +
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVL-------STACGTPGYVA 186
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                    S+  D  S+G +    L G  P+
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 20/212 (9%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y     +G+G+F E+ LA    T ++VA+K    E    K   +  E  V   ++  + +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV----YCRRKFSLKTVLMLADQMIARIEYVHS 121
                Y   G   +++  + G  L D  V    Y  R  S      L  Q++  ++Y+H 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-----RLIFQVLDAVKYLHD 134
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            G +HRD+KP+N L     + +++ I DFGL+ K  DP +             GT  Y +
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVL-------STACGTPGYVA 186
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                    S+  D  S+G +    L G  P+
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y++G ++GSG F  +       T +  A K            G    ++  E  + + ++
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 61  GGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIAR 115
                PNI   + +  +  D VL+L+L+     +LF +   K SL          Q++  
Sbjct: 74  H----PNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESLTEDEATQFLKQILDG 127
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
           + Y+HS+   H D+KP+N ++      N ++ +IDFG+A K             E KN+ 
Sbjct: 128 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--------EFKNIF 179
Query: 175 GTARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+ FGLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILGFGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 13  RKIGSGSFGEIFLASHV----DTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           R +G G FG++ L  +     +T E VAVK     SG  H   L   K  +IL+      
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL--KKEIEILRNLYHEN 84
Query: 67  NIKWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            +K+ G+  ED      L+++ L   SL++     + K +LK  L  A Q+   ++Y+ S
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           R ++HRD+   N L+      +QV I DFGL K
Sbjct: 145 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTK 174

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 20/212 (9%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y     +G+G+F E+ LA    T ++VA+K    E    K   +  E  V   ++  + +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV----YCRRKFSLKTVLMLADQMIARIEYVHS 121
                Y   G   +++  + G  L D  V    Y  R  S      L  Q++  ++Y+H 
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-----RLIFQVLDAVKYLHD 134
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            G +HRD+KP+N L     + +++ I DFGL+ K  DP +             GT  Y +
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVL-------STACGTPGYVA 186
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
                    S+  D  S+G +    L G  P+
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+D GLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDAGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 31/184 (16%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQ--LLYEAKVYKILQGGSGIPNI-- 68
           +G GS+G +    + DT  IVA+K  +E+   K  +   + E K+ K L+  + +  +  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 69  -----KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
                +WY        LV + +  ++ D           + V     Q+I  I + HS  
Sbjct: 93  CKKKKRWY--------LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-------YRDPTTNRHIPYRENKNLTGT 176
            +HRDIKP+N L+    ++  V + DFG A+        Y D    R   YR  + L G 
Sbjct: 145 IIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRW--YRAPELLVGD 199
Query: 177 ARYA 180
            +Y 
Sbjct: 200 VKYG 203

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 13  RKIGSGSFGEIFLASHV----DTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           R +G G FG++ L  +     +T E VAVK     SG  H   L   K  +IL+      
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL--KKEIEILRNLYHEN 72
Query: 67  NIKWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            +K+ G+  ED      L+++ L   SL++     + K +LK  L  A Q+   ++Y+ S
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           R ++HRD+   N L+      +QV I DFGL K
Sbjct: 133 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTK 162

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y++G ++GSG F  +       T +  A K            G    ++  E  + + ++
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 61  GGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIAR 115
                PNI   + +  +  D VL+L+L+     +LF +   K SL          Q++  
Sbjct: 67  H----PNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
           + Y+HS+   H D+KP+N ++      N ++ +IDFG+A K             E KN+ 
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--------EFKNIF 172
Query: 175 GTARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 213

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y++G ++GSG F  +       T +  A K            G    ++  E  + + ++
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 61  GGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLADQMIAR 115
                PNI   + +  +  D VL+L+L+     +LF +   K SL          Q++  
Sbjct: 88  H----PNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESLTEDEATQFLKQILDG 141
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
           + Y+HS+   H D+KP+N ++      N ++ +IDFG+A K             E KN+ 
Sbjct: 142 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--------EFKNIF 193
Query: 175 GTARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           GT  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 194 GTPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RKFSL   ++++ A Q+   + 
Sbjct: 451 ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 506 YLESKRFVHRDIAARNVLVS---ATDCVKLGDFGLSRYMEDST 545

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 19/145 (13%)
Query: 77  DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF- 134
           D VL+L+L+ G  L D F+  +   S +       Q++  + Y+H++   H D+KP+N  
Sbjct: 89  DVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT----HLGIEQ 190
           L+        + +IDFGLA +  D          E KN+ GT  + +        LG+E 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 191 SRRDDLESLGYVLLYFLRGSLPWQG 215
               D+ S+G +    L G+ P+ G
Sbjct: 200 ----DMWSIGVITYILLSGASPFLG 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 19/145 (13%)
Query: 77  DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF- 134
           D VL+L+L+ G  L D F+  +   S +       Q++  + Y+H++   H D+KP+N  
Sbjct: 89  DVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT----HLGIEQ 190
           L+        + +IDFGLA +  D          E KN+ GT  + +        LG+E 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 191 SRRDDLESLGYVLLYFLRGSLPWQG 215
               D+ S+G +    L G+ P+ G
Sbjct: 200 ----DMWSIGVITYILLSGASPFLG 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 19/145 (13%)
Query: 77  DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF- 134
           D VL+L+L+ G  L D F+  +   S +       Q++  + Y+H++   H D+KP+N  
Sbjct: 89  DVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT----HLGIEQ 190
           L+        + +IDFGLA +  D          E KN+ GT  + +        LG+E 
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 191 SRRDDLESLGYVLLYFLRGSLPWQG 215
               D+ S+G +    L G+ P+ G
Sbjct: 200 ----DMWSIGVITYILLSGASPFLG 220

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 10  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 59  LQGGSGIPN-IKWYGVDGED---NVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    +++  +   +L D    C R++ S   +L +A Q+ 
Sbjct: 66  IKH----PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 169

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 10  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    +++  +   +L D    C R++ S   +L +A Q+ 
Sbjct: 66  IKH----PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 169

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 18/166 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RKFSL   ++++ A Q+   + 
Sbjct: 71  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTALA 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T  +
Sbjct: 126 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTXXK 168

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPAFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N ++ L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 20/158 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSG 64
           Y +   IG GS+G ++LA   +T + VA+K  N   +      ++L E  +   L+    
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 65  IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY------ 118
           I   + Y +   D++L  D L   LE      ++ F  KT + L ++ I  I Y      
Sbjct: 88  I---RLYDLIIPDDLLKFDELYIVLEIADSDLKKLF--KTPIFLTEEHIKTILYNLLLGE 142
Query: 119 --VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             +H  G +HRD+KP N L+    +   V + DFGLA+
Sbjct: 143 NFIHESGIIHRDLKPANCLLN---QDCSVKVCDFGLAR 177

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 114 HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+         +  GT  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 221
Query: 179 YASCNTHLGIEQSRRD-----------DLESLGYVLLYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+L+L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILILELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+D GLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDRGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/220 (21%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYKILQGGSGIPN 67
           ++L   +G+G++G+++   HV T ++ A+K+ + +G +  ++  E  + K       I  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 68  IKWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCR-RKFSLKTVLMLADQMIARIE 117
             +YG        G D+   LV++  G  S+ DL    +      + +  +  +++  + 
Sbjct: 86  --YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           ++H    +HRDIK  N L+    +  +V ++DFG++ +  D T  R           GT 
Sbjct: 144 HLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGR------RNTFIGTP 193
Query: 178 RYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
            +      +C+ +       + DL SLG   +    G+ P
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE+++      +  VAVK     T    + L EA V K 
Sbjct: 29  MERTDITMKHKLG----GGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 84
Query: 59  LQGGSGIPN-IKWYGV-DGEDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLM-LADQMI 113
           ++     PN ++  GV   E    ++    P  +L D    C R+     VL+ +A Q+ 
Sbjct: 85  IKH----PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQIS 140
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 141 SAMEYLEKKNFIHRDLAARNCLVG---ENHVVKVADFGLSRLMTGDTYTAH 188

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++   IG GS+G ++LA   + N+ VA+K  N   +    L + K  +IL+  + +  +
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFED---LIDCK--RILREITILNRL 84
Query: 69  KW-YGVDGEDNVLVLDLLGPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEY---- 118
           K  Y +   D ++  DLL    ++L++         K   KT + L +Q +  I Y    
Sbjct: 85  KSDYIIRLHDLIIPEDLL--KFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLL 142
Query: 119 ----VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
               +H  G +HRD+KP N L+    +   V I DFGLA+
Sbjct: 143 GEKFIHESGIIHRDLKPANCLLN---QDCSVKICDFGLAR 179

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSGIP 66
           Y +  ++G+G+FG +   +   T    A K  +    +    +  E +   +L+  + + 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV- 111
Query: 67  NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           N+     D  + V++ + + G  L +       K S    +    Q+   + ++H   ++
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           H D+KP+N +M   +++N++ +IDFGL        T    P +  K  TGTA +A+    
Sbjct: 172 HLDLKPEN-IMFTTKRSNELKLIDFGL--------TAHLDPKQSVKVTTGTAEFAAPEVA 222
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            G       D+ S+G +    L G  P+ G
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSGLSPFGG 252

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 114 HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+         +  GT  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 221
Query: 179 YASCNTHLGIEQSRRD-----------DLESLGYVLLYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +  A   DT   + V ++        +++  + Y+ L+    + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 138
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +Y+HS   +HRD+KP N  +    +  ++ I+D GLA+   D  T              T
Sbjct: 139 KYIHSADIIHRDLKPSNLAVN---EDCELKILDGGLARHTDDEMT----------GYVAT 185
Query: 177 ARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y +    L  +  ++  D+ S+G ++   L G   + G    T      K+  + V T
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLILRLVGT 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268
           P   L K   +E A   +Y QSLT  Q P   F
Sbjct: 242 PGAELLKKISSESAR--NYIQSLT--QMPKMNF 270

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           +Y+    +GSG++G +   S  D    + + ++        +++  + Y+ L+    + +
Sbjct: 52  RYQTLSPVGSGAYGSV--CSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 109
Query: 68  IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
               G+           +  D  LV  L+G  L ++ V C+ K +   V  L  Q++  +
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIYQILRGL 167
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
           +Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T
Sbjct: 168 KYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 209

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  +V++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYIVMELMDANLSQV---IQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDATLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   ++G + + G        +++K+ E ++ TP          EF       
Sbjct: 208 IWSVGVIMGEMIKGGVLFPG---TDHIDQWNKVIE-QLGTP--------SPEFMKKLQPT 255
Query: 256 QSLTFDQRPDY-GF-LKRLFHDLF 277
                + RP Y G+  ++LF D+ 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVL 279

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKHPQLLYEAK-VYKILQGGSGIPNI 68
           L  +IGSGSFG ++    H D    VAVKI       P+     +    +L+    +  +
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGD----VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL 95
Query: 69  KWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
            + G   +DN+ ++     G SL         KF +  ++ +A Q    ++Y+H++  +H
Sbjct: 96  LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL 186
           RD+K +N  +  G     V I DFGLA        +R    ++ +  TG+  + +     
Sbjct: 156 RDMKSNNIFLHEGLT---VKIGDFGLAT-----VKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 187 GIEQ---SRRDDLESLGYVLLYFLRGSLPW 213
             +    S + D+ S G VL   + G LP+
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RKFSL   ++++ A Q+   + 
Sbjct: 451 ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 506 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 545

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+D           L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP+N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPENLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPN 67
           +G G F  ++ A   +TN+IVA+K    G +       +   L E K+ + L   + I  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 68  IKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
           +  +G   + N+ LV D +   LE +        +   +       +  +EY+H    LH
Sbjct: 78  LDAFG--HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 135
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           RD+KP+N L+    +   + + DFGLAK +  P
Sbjct: 136 RDLKPNNLLLD---ENGVLKLADFGLAKSFGSP 165

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y+L   IGSG+   +  A      E VA+K   +E   T   +LL E +           
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH---- 67
Query: 66  PNIKWY---GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLK-------TVLMLADQMIA 114
           PNI  Y    V  ++  LV+ LL G S+ D+  +   K   K       T+  +  +++ 
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR---DPTTNRHIPYRENK 171
            +EY+H  G +HRD+K  N L+G   +   V I DFG++       D T N     +  K
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRN-----KVRK 179
Query: 172 NLTGTARYASCNTHLGIEQSR----RDDLESLGYVLLYFLRGSLPW 213
              GT  + +      +EQ R    + D+ S G   +    G+ P+
Sbjct: 180 TFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  +V++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYIVMELMDANLSQV---IQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDATLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   ++G + + G        +++K+ E ++ TP          EF       
Sbjct: 208 IWSVGVIMGEMIKGGVLFPG---TDHIDQWNKVIE-QLGTP--------SPEFMKKLQPT 255
Query: 256 QSLTFDQRPDYG--FLKRLFHDLF 277
                + RP Y     ++LF D+ 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVL 279

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y+L   IGSG+   +  A      E VA+K   +E   T   +LL E +           
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH---- 72
Query: 66  PNIKWY---GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLK-------TVLMLADQMIA 114
           PNI  Y    V  ++  LV+ LL G S+ D+  +   K   K       T+  +  +++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR---DPTTNRHIPYRENK 171
            +EY+H  G +HRD+K  N L+G   +   V I DFG++       D T N     +  K
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRN-----KVRK 184
Query: 172 NLTGTARYASCNTHLGIEQSR----RDDLESLGYVLLYFLRGSLPW 213
              GT  + +      +EQ R    + D+ S G   +    G+ P+
Sbjct: 185 TFVGTPCWMAPEV---MEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 98/242 (40%), Gaps = 37/242 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQG 61
           Y+L   IG G+F  +    + +T +  AVKI        + G     L  EA +  +L+ 
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 62  GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-----FSLKTVLMLADQMIARI 116
              +  ++ Y  DG   ++   + G  L   F   +R      +S         Q++  +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
            Y H    +HRD+KP+N L+     +  V + DFG+A +  +              L   
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE------------SGLVAG 191
Query: 177 ARYASCNTHLGIEQSRRD------DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
            R  + +  +  E  +R+      D+   G +L   L G LP+ G    TK++ ++ I +
Sbjct: 192 GRVGTPH-FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG----TKERLFEGIIK 246
Query: 231 KK 232
            K
Sbjct: 247 GK 248

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 67
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+D           L  +     Q++  + + HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 180 ASC 182
           ++ 
Sbjct: 185 STA 187

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G     +  E  + K L      PNI
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNH----PNI 66
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+D           L  +     Q++  + + HS   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 127 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 180 ASC 182
           ++ 
Sbjct: 184 STA 186

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 67  HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+         +  GT  
Sbjct: 124 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 174
Query: 179 YASCNTHLGIEQSRRD-----------DLESLGYVLLYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSGIP 66
           Y +  ++G+G+FG +   +   T    A K  +    +    +  E +   +L+  + + 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV- 217
Query: 67  NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           N+     D  + V++ + + G  L +       K S    +    Q+   + ++H   ++
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           H D+KP+N +M   +++N++ +IDFGL        T    P +  K  TGTA +A+    
Sbjct: 278 HLDLKPEN-IMFTTKRSNELKLIDFGL--------TAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
            G       D+ S+G +    L G  P+ G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 11  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 66
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    +++  +   +L D    C R++ +   +L +A Q+ 
Sbjct: 67  IKH----PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTXTAH 170

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LI 87
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK----------------- 99
             G  +  +   G     G   +++++       +L  Y R K                 
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKEAPEDLYKD 145
Query: 100 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YR 157
             +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+
Sbjct: 146 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYK 202
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
           DP       Y    +     ++ +  T      + + D+ S G VLL+  F  G+ P+ G
Sbjct: 203 DPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYPG 255
Query: 216 LK 217
           +K
Sbjct: 256 VK 257

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 54/246 (21%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LI 85
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK----------------- 99
             G  +  +   G     G   +++++       +L  Y R K                 
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 100 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YR 157
             +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYK 200
Query: 158 DPTTNRHIPYRENKNLTGTAR----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSL 211
           DP   R           G AR    + +  T      + + D+ S G VLL+  F  G+ 
Sbjct: 201 DPDXVR----------KGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGAS 249
Query: 212 PWQGLK 217
           P+ G+K
Sbjct: 250 PYPGVK 255

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 10  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ S   +L +A Q+ 
Sbjct: 66  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 169

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 15  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 70
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ S   +L +A Q+ 
Sbjct: 71  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 174

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 89
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 90  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 177

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 35  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 90
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 91  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 138
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 139 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 178

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 86  HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+         +  GT  
Sbjct: 143 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 193
Query: 179 YASCNTHLGIEQSRRD-----------DLESLGYVLLYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LI 85
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK----------------- 99
             G  +  +   G     G   +++++       +L  Y R K                 
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 100 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YR 157
             +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYK 200
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
           DP       Y    +     ++ +  T      + + D+ S G VLL+  F  G+ P+ G
Sbjct: 201 DPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYPG 253
Query: 216 LK 217
           +K
Sbjct: 254 VK 255

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 11  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 69
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 70  HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 126
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+         +  GT  
Sbjct: 127 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 177
Query: 179 YASCNTHLGIEQSRRD-----------DLESLGYVLLYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 178 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 226

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 97/239 (40%), Gaps = 47/239 (19%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASH-VDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
           +++  G+ +K    IGSG FG++F A H +D    V  +++ +  K  +   E K    L
Sbjct: 6   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER---EVKALAKL 62
Query: 60  QGGSGIP-NIKWYGVDGE----DNVLVLDLLGPS---------LEDLFV---YC------ 96
              + +  N  W G D +    D+ L      P           + LF+   +C      
Sbjct: 63  DHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 97  -----RRKFSLKTVLMLA--DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
                RR   L  VL L   +Q+   ++Y+HS+  +HRD+KP N  +       QV I D
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV---DTKQVKIGD 179
Query: 150 FGLAKKYR-DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
           FGL    + D    R           GT RY S       +  +  DL +LG +L   L
Sbjct: 180 FGLVTSLKNDGKRTRS---------KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGPNI 88
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 89  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 136
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 176

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 10  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 59  LQGGSGIPN-IKWYGVDGED---NVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ S   +L +A Q+ 
Sbjct: 66  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 169

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 8   MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 63
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ S   +L +A Q+ 
Sbjct: 64  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTFTAH 167

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           R+IG GSFG ++ A  V  +E+VA+K      + S  K   ++ E +  + L+     PN
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH----PN 115
Query: 68  -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            I++ G    ++   LV++    S  DL    ++      +  +    +  + Y+HS   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           +HRD+K  N L+    +   V + DFG A
Sbjct: 176 IHRDVKAGNILLS---EPGLVKLGDFGSA 201

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 65  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LI 122
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK----------------- 99
             G  +  +   G     G   +++++       +L  Y R K                 
Sbjct: 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKVAPEDLYKD 180
Query: 100 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YR 157
             +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+
Sbjct: 181 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYK 237
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
           DP       Y    +     ++ +  T      + + D+ S G VLL+  F  G+ P+ G
Sbjct: 238 DPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYPG 290
Query: 216 LK 217
           +K
Sbjct: 291 VK 292

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 88
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 89  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 136
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 176

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 128
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 129 ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 176
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 177 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 224
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 97/240 (40%), Gaps = 47/240 (19%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------------ENSGT 44
           +Y L  +IG GS+G + LA + + N   A+K+                          G 
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 45  KHP-----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV-LVLDLL--GPSLEDLFVYC 96
             P     Q+  E  + K L   + +  ++      ED++ +V +L+  GP +E   V  
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME---VPT 130
Query: 97  RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            +  S          +I  IEY+H +  +HRDIKP N L+G   +   + I DFG++ ++
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEF 187
Query: 157 RDPTTNRHIPYRENKNLTGTARYA---SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           +              N  GT  +    S +    I   +  D+ ++G  L  F+ G  P+
Sbjct: 188 KGSDALL-------SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 42/238 (17%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           +  LG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI--LI 85
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK--------------FSL 102
             G  +  +   G     G   +++++       +L  Y R K               +L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTT 161
           + ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+DP  
Sbjct: 144 EHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD- 199
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLK 217
                Y    +     ++ +  T      + + D+ S G VLL+  F  G+ P+ G+K
Sbjct: 200 -----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYPGVK 251

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 28/231 (12%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW-- 70
           + IG GSFG++ LA H       AVK+     K   L  + + + + +    + N+K   
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 71  -----YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSR 122
                +     D +  VLD +     +LF + +R+  F        A ++ + + Y+HS 
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             ++RD+KP+N L+        + + DFGL K+  +  +             GT  Y + 
Sbjct: 159 NIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNST-------TSTFCGTPEYLAP 208
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
                    R  D   LG VL   L G  P+     A   + YD I  K +
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPL 256

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL-LYEAKVYKILQGGSG-- 64
           +Y + RK+G G F  ++L+  +   + VA+K+  S   + +  L E ++ K ++      
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 65  ---------IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
                    + + K  GV+G    +V ++LG  L    +    +   L  V  +  Q++ 
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 115 RIEYVHSRG-FLHRDIKPDNFLMGLGRKANQVYI 147
            ++Y+H++   +H DIKP+N L+ +    N+ YI
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSV----NEQYI 187

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 73
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RK+SL   ++++ A Q+   + 
Sbjct: 74  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTALA 128
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 129 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 168

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 54  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGPNI 109
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 110 ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 157
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 158 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 197

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGPNI 89
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 90  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 137
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 138 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 177

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 105/265 (39%), Gaps = 34/265 (12%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKV 55
           ++R+    +     +G GSFG++ LA    T E+ A+KI               + E +V
Sbjct: 13  LDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRV 72
Query: 56  YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMI 113
             +L     +  +       +    V++ +     DL  + ++  KF     +  A ++ 
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGG--DLMYHIQQVGKFKEPQAVFYAAEIS 130
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIPYRENKN 172
             + ++H RG ++RD+K DN ++        + I DFG+ K++  D  T R         
Sbjct: 131 IGLFFLHKRGIIYRDLKLDNVMLD---SEGHIKIADFGMCKEHMMDGVTTR--------E 179
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
             GT  Y +          +  D  + G +L   L G  P+ G     + + +  I E  
Sbjct: 180 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG---EDEDELFQSIMEHN 236
Query: 233 VSTPIEV------LCKS----HPAE 247
           VS P  +      +CK     HPA+
Sbjct: 237 VSYPKSLSKEAVSICKGLMTKHPAK 261

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL-LYEAKVYKILQGGSG-- 64
           +Y + RK+G G F  ++L+  +   + VA+K+  S   + +  L E ++ K ++      
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 65  ---------IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIA 114
                    + + K  GV+G    +V ++LG  L    +    +   L  V  +  Q++ 
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 141
Query: 115 RIEYVHSRG-FLHRDIKPDNFLMGLGRKANQVYI 147
            ++Y+H++   +H DIKP+N L+ +    N+ YI
Sbjct: 142 GLDYLHTKCRIIHTDIKPENILLSV----NEQYI 171

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 72
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RK+SL   ++++ A Q+   + 
Sbjct: 73  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTALA 127
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 128 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 167

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RK+SL   ++++ A Q+   + 
Sbjct: 76  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 131 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 170

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 88/233 (37%), Gaps = 42/233 (18%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           KY   +KIG GSFG+  L    +      +K  N      +   E++    +      PN
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 68  IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI-------ARIE 117
           I  Y    E+N    +V+D       DLF   +R  + K VL   DQ++         ++
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGG--DLF---KRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----------------YRDPTT 161
           +VH R  LHRDIK  N  +    K   V + DFG+A+                 Y  P  
Sbjct: 140 HVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 162 NRHIPYRENKNL--TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             + PY    ++   G   Y  C      E        S+  ++L  + GS P
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGSFP 243

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 114 HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN----------RHIPYR 168
           +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+           ++P  
Sbjct: 171 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216
             K+++ +      N     + S + D+ SLG +L Y   G  P+Q +
Sbjct: 227 AIKDMSSSRE----NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 28/204 (13%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  +V++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDATLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   ++G + + G        +++K+ E ++ TP          EF       
Sbjct: 208 IWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE-QLGTP--------SPEFMKKLQPT 255
Query: 256 QSLTFDQRPDYG--FLKRLFHDLF 277
                + RP Y     ++LF D+ 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVL 279

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGPNI 88
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 89  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 136
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 176

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 14/143 (9%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL-LYEAKVYKILQGGSG-- 64
           +Y + RK+G G F  ++L   +     VA+K+  S   + +  L E K+ K ++      
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 65  ---------IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
                    I + K  G++G    +V ++LG  L    +    +   ++ V  +  Q++ 
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQ 151
Query: 115 RIEYVHSRG-FLHRDIKPDNFLM 136
            ++Y+HS+   +H DIKP+N LM
Sbjct: 152 GLDYLHSKCKIIHTDIKPENILM 174

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 83/209 (39%), Gaps = 26/209 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV 73
           ++G GSFGE+       T    AVK      K    ++ A+      G +    +  YG 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVK------KVRLEVFRAEELMACAGLTSPRIVPLYGA 134
Query: 74  DGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
             E    N+ +  L G SL  L V  +        L    Q +  +EY+HSR  LH D+K
Sbjct: 135 VREGPWVNIFMELLEGGSLGQL-VKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKY------RDPTTNRHIPYRENKNLTGTARYASCNT 184
            DN L  L    +   + DFG A         +D  T  +IP        GT  + +   
Sbjct: 194 ADNVL--LSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP--------GTETHMAPEV 243
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            LG     + D+ S   ++L+ L G  PW
Sbjct: 244 VLGRSCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 144 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 203
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 204 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 233

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 88
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 89  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 136
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 176

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 194
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 195 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RK+SL   ++++ A Q+   + 
Sbjct: 68  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 123 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 162

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 193
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 194 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 223

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 98
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RK+SL   ++++ A Q+   + 
Sbjct: 99  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTALA 153
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 154 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 193

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 15  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 70
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    +++  +   +L D    C R++ +   +L +A Q+ 
Sbjct: 71  IKH----PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 174

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLXGGPNI 88
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 89  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 136
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 176

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           R+IG GSFG ++ A  V  +E+VA+K      + S  K   ++ E +  + L+     PN
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH----PN 76
Query: 68  -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            I++ G    ++   LV++    S  DL    ++      +  +    +  + Y+HS   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           +HRD+K  N L+    +   V + DFG A
Sbjct: 137 IHRDVKAGNILLS---EPGLVKLGDFGSA 162

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  +V++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDATLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   ++G + + G        +++K+ E ++ TP          EF       
Sbjct: 208 IWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE-QLGTP--------SPEFMKKLQPT 255
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL----KYQQTQKTKSQDLLPASR 311
                + RP Y              GY F+ +F   +     ++ + + ++++DLL    
Sbjct: 256 VRTYVENRPKYA-------------GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 312 VTNS 315
           V ++
Sbjct: 303 VIDA 306

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 129 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 188
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 189 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 187
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 188 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 217

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG+ I  +
Sbjct: 40  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKIL-ENLRGGTNIIKL 98
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--------QMIARIEYVH 120
               +D      V D +  +   +F Y       +   +L D        +++  ++Y H
Sbjct: 99  ----IDT-----VKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCH 149
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           S+G +HRD+KP N ++   +K  ++ +ID+GLA+ Y
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFY 183

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 190 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  +V++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDATLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   ++G + + G        +++K+ E ++ TP          EF       
Sbjct: 208 IWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE-QLGTP--------SPEFMKKLQPT 255
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL----KYQQTQKTKSQDLLPASR 311
                + RP Y              GY F+ +F   +     ++ + + ++++DLL    
Sbjct: 256 VRTYVENRPKYA-------------GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 312 VTNS 315
           V ++
Sbjct: 303 VIDA 306

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 195
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 196 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 225

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 7   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 65
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 66  HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 122
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+         +  GT  
Sbjct: 123 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTS-----VVKDSQVGTVN 173
Query: 179 YASCNTHLGIEQSRRD-----------DLESLGYVLLYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RK+SL   ++++ A Q+   + 
Sbjct: 71  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTALA 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 126 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 165

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++   N  +AV I+      S +   + L EA   +    
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 62  GSGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSL--KTVLMLADQMIARIE 117
               P+I K  GV  E+ V ++  L  +L +L  + + RK+SL   ++++ A Q+   + 
Sbjct: 71  ----PHIVKLIGVITENPVWIIMELC-TLGELRSFLQVRKYSLDLASLILYAYQLSTALA 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           Y+ S+ F+HRDI   N L+      + V + DFGL++   D T
Sbjct: 126 YLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 165

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 42/238 (17%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           +  LG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI--LI 85
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK--------------FSL 102
             G  +  +   G     G   +++++       +L  Y R K               +L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTT 161
           + ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+DP  
Sbjct: 144 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKIXDFGLARDIYKDPD- 199
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLK 217
                Y    +     ++ +  T      + + D+ S G VLL+  F  G+ P+ G+K
Sbjct: 200 -----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYPGVK 251

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +K+G+G FGE+++  + ++ + VAVK    GT   Q  L EA + K LQ       +
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 70
Query: 69  KWYG-VDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           + Y  V  E+ + ++      G  L+ L      K  L  ++  + Q+   + Y+  + +
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 130
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           +HRD++  N L+    ++    I DFGLA+   D
Sbjct: 131 IHRDLRAANVLVS---ESLMCKIADFGLARVIED 161

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 180 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 239
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 240 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 269

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 40/239 (16%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+   +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FS 101
                + N+          ++V+        +L  Y R K                   +
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFC-KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPT 160
           L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+DP 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 194
Query: 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLK 217
                 Y    +     ++ +  T      + + D+ S G VLL+  F  G+ P+ G+K
Sbjct: 195 ------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYPGVK 246

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 40/239 (16%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+   +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FS 101
                + N+          ++V+        +L  Y R K                   +
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFC-KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPT 160
           L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+  Y+DP 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 194
Query: 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLK 217
                 Y    +     ++ +  T      + + D+ S G VLL+  F  G+ P+ G+K
Sbjct: 195 ------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYPGVK 246

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 234 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 263

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/283 (21%), Positives = 119/283 (42%), Gaps = 42/283 (14%)
Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL +++G+G FGE+++  + ++ + VAVK    GT   Q  L EA + K LQ       +
Sbjct: 16  KLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 71
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRR----KFSLKTVLMLADQMIARIEYVHSRGF 124
           + Y V   +  + +     +   L  + +     K  L  ++  + Q+   + Y+  + +
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 131
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD-PTTNRHIPYRENKNLTGTARYASCN 183
           +HRD++  N L+    ++    I DFGLA+   D   T R       K     A    C 
Sbjct: 132 IHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 188
Query: 184 THLGIEQSRRDDLESLGYVLLYFL--RGSLPWQG------LKAATKKQKYDKICEKKVST 235
           T        + D+ S G +LLY +   G +P+ G      + A ++  +  ++       
Sbjct: 189 TI-------KSDVWSFG-ILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV------- 233
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
                 ++ P E       C     ++RP + +L+ +  D ++
Sbjct: 234 ------ENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDFYT 270

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 190 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 219

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 32/162 (19%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y++ RK+G G + E+F   +V+ NE    K      K  +     +  KILQ   G PNI
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNE----KCIIKILKPVKKKKIKREIKILQNLMGGPNI 88
Query: 69  KWYGVDGEDNVLVLDLL------GPSLEDLFVYCRRKFSLKTVLMLAD--------QMIA 114
                     V +LD++       PSL  +F Y            L D        +++ 
Sbjct: 89  ----------VKLLDIVRDQHSKTPSL--IFEYVNNTDFKVLYPTLTDYDIRYYIYELLK 136
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            ++Y HS+G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 137 ALDYCHSQGIMHRDVKPHNVM--IDHELRKLRLIDWGLAEFY 176

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +++  ++G G+FG+++ A + +T+ + A K+ +  TK  + L +  V   +      PNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNI 96
Query: 69  KWYGVDG---EDNVLVLD--LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
               +D    E+N+ +L     G +++ + +   R  +   + ++  Q +  + Y+H   
Sbjct: 97  V-KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS-- 181
            +HRD+K  N L  L      + + DFG++ K       R I  R+  +  GT  + +  
Sbjct: 156 IIHRDLKAGNILFTLD---GDIKLADFGVSAK-----NTRXIQRRD--SFIGTPYWMAPE 205
Query: 182 ---CNTHLGIEQSRRDDLESLGYVLL 204
              C T        + D+ SLG  L+
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLI 231

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 93
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 94  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 141
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 189
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 66
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 67  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 114
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 162
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G G+FG++ L     T    A+KI  +       ++ +     ++LQ      +  +K 
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 74
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           Y     D +  +       E  F   R R F+ +       ++++ +EY+HSR  ++RDI
Sbjct: 75  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 134
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           K +N ++    K   + I DFGL K+   D  T         K   GT  Y +       
Sbjct: 135 KLENLMLD---KDGHIKITDFGLCKEGISDGAT--------MKTFCGTPEYLAPEVLEDN 183
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +  R  D   LG V+   + G LP+
Sbjct: 184 DYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/244 (21%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  +V++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYIVMELMDANLSQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   ++G + + G        +++K+ E ++ TP          EF       
Sbjct: 208 IWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE-QLGTP--------SPEFMKKLQPT 255
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL----KYQQTQKTKSQDLLPASR 311
                + RP Y              GY F+ +F   +     ++ + + ++++DLL    
Sbjct: 256 VRTYVENRPKYA-------------GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 312 VTNS 315
           V ++
Sbjct: 303 VIDA 306

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 66
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 67  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 114
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 162
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 15  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 70
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLM-LADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R+     VL+ +A Q+ 
Sbjct: 71  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTXTAH 174

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +++  ++G G+FG+++ A + +T+ + A K+ +  TK  + L +  V   +      PNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNI 96
Query: 69  KWYGVDG---EDNVLVLD--LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
               +D    E+N+ +L     G +++ + +   R  +   + ++  Q +  + Y+H   
Sbjct: 97  V-KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS-- 181
            +HRD+K  N L  L      + + DFG++ K       R I  R+  +  GT  + +  
Sbjct: 156 IIHRDLKAGNILFTLD---GDIKLADFGVSAK-----NTRTIQRRD--SFIGTPYWMAPE 205
Query: 182 ---CNTHLGIEQSRRDDLESLGYVLL 204
              C T        + D+ SLG  L+
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLI 231

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G G+FG++ L     T    A+KI  +       ++ +     ++LQ      +  +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           Y     D +  +       E  F   R R F+ +       ++++ +EY+HSR  ++RDI
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           K +N ++    K   + I DFGL K+   D  T         K   GT  Y +       
Sbjct: 132 KLENLMLD---KDGHIKITDFGLCKEGISDGAT--------MKTFCGTPEYLAPEVLEDN 180
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +  R  D   LG V+   + G LP+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE VAVKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N L  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVL--IDHEHRKLRLIDWGLAEFY 182

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 66
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 67  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 114
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 162
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG+ I  +
Sbjct: 45  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKIL-ENLRGGTNIIKL 103
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--------QMIARIEYVH 120
               +D      V D +  +   +F Y       +   +L D        +++  ++Y H
Sbjct: 104 ----IDT-----VKDPVSKTPALVFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCH 154
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           S+G +HRD+KP N ++   +K  ++ +ID+GLA+ Y
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFY 188

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 69
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 70  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 117
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N  +       
Sbjct: 118 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDEMANEFV------- 167
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 168 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G G+FG++ L     T    A+KI  +       ++ +     ++LQ      +  +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           Y     D +  +       E  F   R R F+ +       ++++ +EY+HSR  ++RDI
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           K +N ++    K   + I DFGL K+   D  T         K   GT  Y +       
Sbjct: 132 KLENLMLD---KDGHIKITDFGLCKEGISDGAT--------MKTFCGTPEYLAPEVLEDN 180
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +  R  D   LG V+   + G LP+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 21/234 (8%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQG--GSGIPNI 68
           R +G G FGE+F      T ++ A K  N      +  Y+  +   KIL       I ++
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGF 124
            +      D  LV+ ++        +Y   +    F     +    Q+++ +E++H R  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           ++RD+KP+N L+        V I D GLA + +   T       + K   GT  + +   
Sbjct: 311 IYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQT-------KTKGYAGTPGFMAPEL 360
Query: 185 HLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            LG E     D  +LG  L   +  RG    +G K   K+ K  ++ E+ V+ P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRVLEQAVTYP 413

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 92/209 (44%), Gaps = 40/209 (19%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+     T+   +P+   
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG--TSFMMVPF--- 187
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
                T  Y +    LG+      D+ S+G ++   ++G + + G        +++K+ E
Sbjct: 188 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE 241
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
            ++ TP     K       +Y         + RP Y              GY F+ +F  
Sbjct: 242 -QLGTPCPEFMKKLQPTVRTY--------VENRPKYA-------------GYSFEKLFPD 279
Query: 291 TIL----KYQQTQKTKSQDLLPASRVTNS 315
            +     ++ + + ++++DLL    V ++
Sbjct: 280 VLFPADSEHNKLKASQARDLLSKMLVIDA 308

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 21/234 (8%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQG--GSGIPNI 68
           R +G G FGE+F      T ++ A K  N      +  Y+  +   KIL       I ++
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGF 124
            +      D  LV+ ++        +Y   +    F     +    Q+++ +E++H R  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           ++RD+KP+N L+        V I D GLA + +   T       + K   GT  + +   
Sbjct: 311 IYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQT-------KTKGYAGTPGFMAPEL 360
Query: 185 HLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            LG E     D  +LG  L   +  RG    +G K   K+ K  ++ E+ V+ P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRVLEQAVTYP 413

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 85
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 86  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 133
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 134 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 181
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 18/158 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+  + +GSG++G +   S VD      V I+         L+  + Y+ L+    + + 
Sbjct: 27  YRDLQPVGSGAYGAV--CSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 69  KWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
              G+           D  D  LV+  +G  L  L  +   K     +  L  QM+  + 
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 142
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           Y+H+ G +HRD+KP N  +    +  ++ I+DFGLA++
Sbjct: 143 YIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 177

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G G+FG++ L     T    A+KI  +       ++ +     ++LQ      +  +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           Y     D +  +       E  F   R R F+ +       ++++ +EY+HSR  ++RDI
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           K +N ++    K   + I DFGL K+   D  T         K   GT  Y +       
Sbjct: 132 KLENLMLD---KDGHIKITDFGLCKEGISDGAT--------MKXFCGTPEYLAPEVLEDN 180
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +  R  D   LG V+   + G LP+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 217 MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 272
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ S   +L +A Q+ 
Sbjct: 273 IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 328
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HR++   N L+G   + + V + DFGL++     T   H
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 376

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 21/234 (8%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQG--GSGIPNI 68
           R +G G FGE+F      T ++ A K  N      +  Y+  +   KIL       I ++
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGF 124
            +      D  LV+ ++        +Y   +    F     +    Q+++ +E++H R  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           ++RD+KP+N L+        V I D GLA + +   T       + K   GT  + +   
Sbjct: 311 IYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQT-------KTKGYAGTPGFMAPEL 360
Query: 185 HLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            LG E     D  +LG  L   +  RG    +G K   K+ K  ++ E+ V+ P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRVLEQAVTYP 413

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 21/234 (8%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQG--GSGIPNI 68
           R +G G FGE+F      T ++ A K  N      +  Y+  +   KIL       I ++
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGF 124
            +      D  LV+ ++        +Y   +    F     +    Q+++ +E++H R  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           ++RD+KP+N L+        V I D GLA + +   T       + K   GT  + +   
Sbjct: 311 IYRDLKPENVLLD---DDGNVRISDLGLAVELKAGQT-------KTKGYAGTPGFMAPEL 360
Query: 185 HLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            LG E     D  +LG  L   +  RG    +G K   K+ K  ++ E+ V+ P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRVLEQAVTYP 413

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 66
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 67  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 114
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 162
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +F  SH  +  ++A K         I N   +  Q+L+E     I      
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 66
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +         LK    + +Q++ ++     
Sbjct: 67  ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 114
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +G          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 162
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y S     G   S + D+ S+G  L+    G  P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/255 (21%), Positives = 112/255 (43%), Gaps = 31/255 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           + L   +G G+   +F   H  T ++ A+K+ N+ +    +  + + +++L+  +    +
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 69  KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHS 121
           K + ++ E      VL+++     SL  +       + L     L++   ++  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
            G +HR+IKP N +  +G     VY + DFG A++  D          +  +L GT  Y 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------EQFVSLYGTEEYL 182
Query: 181 SCNTHLGIEQS--RRD---------DLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKI 228
             + +   E++  R+D         DL S+G    +   GSLP++  +   + K+   KI
Sbjct: 183 HPDMY---ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 229 CEKKVSTPIEVLCKS 243
              K S  I  + K+
Sbjct: 240 ITGKPSGAISGVQKA 254

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 59/128 (46%), Gaps = 13/128 (10%)
Query: 90  EDLFVYCRRKFSLK-----TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144
           E+L  +  R+ SL+       L +  Q+   +E++HS+G +HRD+KP N    +    + 
Sbjct: 146 ENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DV 202
Query: 145 VYIIDFGLA----KKYRDPTTNRHIP-YRENKNLTGTARYASCNTHLGIEQSRRDDLESL 199
           V + DFGL     +   + T    +P Y  +    GT  Y S     G   S + D+ SL
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
Query: 200 GYVLLYFL 207
           G +L   L
Sbjct: 263 GLILFELL 270

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 91/209 (43%), Gaps = 40/209 (19%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+     T+    PY   
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG--TSFMMTPY--- 186
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
                T  Y +    LG+      D+ S+G ++   ++G + + G        +++K+ E
Sbjct: 187 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE 240
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
            ++ TP     K       +Y         + RP Y              GY F+ +F  
Sbjct: 241 -QLGTPCPEFMKKLQPTVRTY--------VENRPKYA-------------GYSFEKLFPD 278
Query: 291 TIL----KYQQTQKTKSQDLLPASRVTNS 315
            +     ++ + + ++++DLL    V ++
Sbjct: 279 VLFPADSEHNKLKASQARDLLSKMLVIDA 307

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 10  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 59  LQGGSGIPN-IKWYGVDGED---NVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 66  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 169

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G G+FG++ L     T    A+KI  +       ++ +     ++LQ      +  +K 
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 76
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           Y     D +  +       E  F   R R F+ +       ++++ +EY+HSR  ++RDI
Sbjct: 77  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 136
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           K +N ++    K   + I DFGL K+   D  T         K   GT  Y +       
Sbjct: 137 KLENLMLD---KDGHIKITDFGLCKEGISDGAT--------MKXFCGTPEYLAPEVLEDN 185
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +  R  D   LG V+   + G LP+
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 67
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP+N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 128 LHRDLKPENLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 180 ASC 182
           ++ 
Sbjct: 185 STA 187

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 47/234 (20%)
Query: 11  LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLY------EAKVYKIL 59
           L R++G G+FG++FLA     S      +VAVK      K P L        EA++   L
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 74
Query: 60  QGGSGIPNIKWYGV--DGEDNVLVLDLL------------GPSLEDLF----VYCRRKFS 101
           Q       +K+YGV  DG+  ++V + +            GP    L        + +  
Sbjct: 75  QHEH---IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPT 160
           L  +L +A Q+ + + Y+ S+ F+HRD+   N L+G    AN  V I DFG++   RD  
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGDFGMS---RDVY 184
Query: 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPW 213
           +  +  YR   +     R+    + +  + +   D+ S G +L   F  G  PW
Sbjct: 185 STDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 15  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 70
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 71  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 174

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G G+FG++ L     T    A+KI  +       ++ +     ++LQ      +  +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           Y     D +  +       E  F   R R F+ +       ++++ +EY+HSR  ++RDI
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           K +N ++    K   + I DFGL K+   D  T         K   GT  Y +       
Sbjct: 132 KLENLMLD---KDGHIKITDFGLCKEGISDGAT--------MKXFCGTPEYLAPEVLEDN 180
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +  R  D   LG V+   + G LP+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 91/209 (43%), Gaps = 40/209 (19%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+     T+    PY   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG--TSFMMTPY--- 185
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
                T  Y +    LG+      D+ S+G ++   ++G + + G        +++K+ E
Sbjct: 186 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE 239
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
            ++ TP     K       +Y         + RP Y              GY F+ +F  
Sbjct: 240 -QLGTPCPEFMKKLQPTVRTY--------VENRPKYA-------------GYSFEKLFPD 277
Query: 291 TIL----KYQQTQKTKSQDLLPASRVTNS 315
            +     ++ + + ++++DLL    V ++
Sbjct: 278 VLFPADSEHNKLKASQARDLLSKMLVIDA 306

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 15  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 70
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 71  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 174

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW 70
           +G G+FG++ L     T    A+KI  +       ++ +     ++LQ      +  +K 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           Y     D +  +       E  F   R R F+ +       ++++ +EY+HSR  ++RDI
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
           K +N ++    K   + I DFGL K+   D  T         K   GT  Y +       
Sbjct: 132 KLENLMLD---KDGHIKITDFGLCKEGISDGAT--------MKXFCGTPEYLAPEVLEDN 180
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
           +  R  D   LG V+   + G LP+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 65
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP+N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 126 LHRDLKPENLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 180 ASC 182
           ++ 
Sbjct: 183 STA 185

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +++  ++G G+FG+++ A + +T+ + A K+ +  TK  + L +  V   +      PNI
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNI 96
Query: 69  KWYGVDG---EDNVLVLD--LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
               +D    E+N+ +L     G +++ + +   R  +   + ++  Q +  + Y+H   
Sbjct: 97  V-KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS-- 181
            +HRD+K  N L  L      + + DFG++ K       R I  R+     GT  + +  
Sbjct: 156 IIHRDLKAGNILFTLD---GDIKLADFGVSAK-----NTRXIQRRD--XFIGTPYWMAPE 205
Query: 182 ---CNTHLGIEQSRRDDLESLGYVLL 204
              C T        + D+ SLG  L+
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLI 231

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 81/203 (39%), Gaps = 14/203 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV 73
           ++G GSFGE+       T    AVK      K    ++ A+      G +    +  YG 
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVK------KVRLEVFRAEELMACAGLTSPRIVPLYGA 153
Query: 74  DGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
             E    N+ +  L G SL  L V  +        L    Q +  +EY+HSR  LH D+K
Sbjct: 154 VREGPWVNIFMELLEGGSLGQL-VKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
            DN L  L    +   + DFG A   +     + +       + GT  + +    LG   
Sbjct: 213 ADNVL--LSSDGSHAALCDFGHAVCLQPDGLGKSL--LTGDYIPGTETHMAPEVVLGRSC 268
Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
             + D+ S   ++L+ L G  PW
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 23  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 78
Query: 59  LQGGSGIPN-IKWYGVDGED---NVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 79  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 134
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 135 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 182

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 12  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 67
Query: 59  LQGGSGIPN-IKWYGVDGED---NVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 68  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 171

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 12  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 67
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 68  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 171

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 14  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 70  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 125
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 173

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 11  LGRKIGSGSFGEIFLASHVDT-----NEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
           L R++G G+FG++FLA   +        +VAVK   + S         EA++   LQ   
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR---------------RKFSLKTVLML 108
               +K+YGV  E + L++        DL  + R                + +   +L +
Sbjct: 77  ---IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
           A Q+ A + Y+ S+ F+HRD+   N L+G   +   V I DFG++   RD  +  +  YR
Sbjct: 134 AQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY--YR 185
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
              +     R+    + +  + +   D+ SLG VL   F  G  PW  L
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNIINL--LGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKHPQLL--YEAKVYKILQGGSGIP 66
           R +G G FG++ L  +  TN    E+VAVK    G   PQL   ++ ++ +IL+      
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCG-PQLRSGWQREI-EILRTLYHEH 72
Query: 67  NIKWYGV---DGEDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            +K+ G     GE +V ++    P  SL D     R    L  +L+ A Q+   + Y+H+
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP--RHCVGLAQLLLFAQQICEGMAYLHA 130
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++HR +   N L+   R    V I DFGLAK
Sbjct: 131 QHYIHRALAARNVLLDNDR---LVKIGDFGLAK 160

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/255 (21%), Positives = 111/255 (43%), Gaps = 31/255 (12%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           + L   +G G+   +F   H  T ++ A+K+ N+ +    +  + + +++L+  +    +
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 69  KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHS 121
           K + ++ E      VL+++     SL  +       + L     L++   ++  + ++  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
            G +HR+IKP N +  +G     VY + DFG A++  D          +   L GT  Y 
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------EQFVXLYGTEEYL 182
Query: 181 SCNTHLGIEQS--RRD---------DLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKI 228
             + +   E++  R+D         DL S+G    +   GSLP++  +   + K+   KI
Sbjct: 183 HPDMY---ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 229 CEKKVSTPIEVLCKS 243
              K S  I  + K+
Sbjct: 240 ITGKPSGAISGVQKA 254

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 10  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 59  LQGGSGIPN-IKWYGVDGED---NVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 66  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++     T   H
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 169

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 34/224 (15%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
           Y  G ++GSG F  +       T    A K            G     +  E  + K +Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEY 118
             + I   + Y  +  D +L+ +L+     +LF +   K SL  +       Q++  + Y
Sbjct: 73  HPNVITLHEVYE-NKTDVILIGELVAGG--ELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPY-RENKNLTG 175
           +HS    H D+KP+N +M L R   +  + IIDFGLA K         I +  E KN+ G
Sbjct: 130 LHSLQIAHFDLKPEN-IMLLDRNVPKPRIKIIDFGLAHK---------IDFGNEFKNIFG 179
Query: 176 TARYASCNT----HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
           T  + +        LG+E     D+ S+G +    L G+ P+ G
Sbjct: 180 TPEFVAPEIVNYEPLGLEA----DMWSIGVITYILLSGASPFLG 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 40/209 (19%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+     T+    PY   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG--TSFMMTPY--- 185
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
                T  Y +    LG+      D+ S+G ++   ++G + + G        +++K+ E
Sbjct: 186 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE 239
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDW 290
            ++ TP          EF            + RP Y              GY F+ +F  
Sbjct: 240 -QLGTP--------SPEFMKKLQPTVRTYVENRPKYA-------------GYSFEKLFPD 277
Query: 291 TIL----KYQQTQKTKSQDLLPASRVTNS 315
            +     ++ + + ++++DLL    V ++
Sbjct: 278 VLFPADSEHNKLKASQARDLLSKMLVIDA 306

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKHPQLL--YEAKVYKILQGGSGIP 66
           R +G G FG++ L  +  TN    E+VAVK    G   PQL   ++ ++ +IL+      
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCG-PQLRSGWQREI-EILRTLYHEH 71
Query: 67  NIKWYGV---DGEDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            +K+ G     GE +V ++    P  SL D     R    L  +L+ A Q+   + Y+H+
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP--RHCVGLAQLLLFAQQICEGMAYLHA 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++HR +   N L+   R    V I DFGLAK
Sbjct: 130 QHYIHRALAARNVLLDNDR---LVKIGDFGLAK 159

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 66
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP+N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 127 LHRDLKPENLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 180 ASC 182
           ++ 
Sbjct: 184 STA 186

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 52/244 (21%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKI--LI 87
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK----------------F 100
             G  +  +   G     G   +++++       +L  Y R K                 
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKPEDLYKDFL 145
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDP 159
           +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+   +DP
Sbjct: 146 TLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EKNVVKICDFGLARDIXKDP 202
Query: 160 TTNRHIPYRENKNLTGTAR----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPW 213
              R           G AR    + +  T      + + D+ S G VLL+  F  G+ P+
Sbjct: 203 DXVR----------KGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPY 251
Query: 214 QGLK 217
            G+K
Sbjct: 252 PGVK 255

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 52/222 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK------------IENSGTKHPQL--LYEAK----- 54
           ++G GSFGE+       T    AVK            +  +G   P++  LY A      
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 124
Query: 55  ---VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
                ++L+GGS    IK  G   ED  L    LG +LE L                   
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYY--LGQALEGL------------------- 163
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
                EY+H+R  LH D+K DN L  L    ++  + DFG A   +     + +      
Sbjct: 164 -----EYLHTRRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSL--LTGD 214
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            + GT  + +    +G     + D+ S   ++L+ L G  PW
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 52/222 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK------------IENSGTKHPQL--LYEAK----- 54
           ++G GSFGE+       T    AVK            +  +G   P++  LY A      
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 140
Query: 55  ---VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
                ++L+GGS    IK  G   ED  L    LG +LE L                   
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYY--LGQALEGL------------------- 179
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
                EY+H+R  LH D+K DN L  L    ++  + DFG A   +     + +      
Sbjct: 180 -----EYLHTRRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSL--LTGD 230
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            + GT  + +    +G     + D+ S   ++L+ L G  PW
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 8/162 (4%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIP 66
           +++ + IG G+F E+ +     T ++ A+KI N     K  ++    +   +L  G    
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 67  NIKWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
             + +    ++N L L +   +G  L  L      +   +       +++  I+ VH  G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
           ++HRDIKPDN L+    +   + + DFG   K R   T R +
Sbjct: 183 YVHRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVRSL 221

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 65
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP+N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 126 LHRDLKPENLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 180 ASC 182
           ++ 
Sbjct: 183 STA 185

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           I   ++L   +G G++G +  A+H  T EIVA+K      K    L   +  KIL+    
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 65  IPNIKWYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
              I  + +   D+        ++ +L+   L    V   +  S   +     Q +  ++
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR--VISTQMLSDDHIQYFIYQTLRAVK 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--- 174
            +H    +HRD+KP N L+        + + DFGLA+   +   +   P  +   +T   
Sbjct: 127 VLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 175 GTARYASCNTHL-GIEQSRRDDLESLGYVL--LYFLRGSLP 212
            T  Y +    L   + SR  D+ S G +L  L+  R   P
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL-----------FVYC-------RRKFSL 102
               I N+   G   +D  L + +   S  +L             YC         + S 
Sbjct: 77  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 191
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 192 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 240
Query: 216 L 216
           +
Sbjct: 241 V 241

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           I   ++L   +G G++G +  A+H  T EIVA+K      K    L   +  KIL+    
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 65  IPNIKWYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
              I  + +   D+        ++ +L+   L    V   +  S   +     Q +  ++
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR--VISTQMLSDDHIQYFIYQTLRAVK 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--- 174
            +H    +HRD+KP N L+        + + DFGLA+   +   +   P  +   +T   
Sbjct: 127 VLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 175 GTARYASCNTHL-GIEQSRRDDLESLGYVL--LYFLRGSLP 212
            T  Y +    L   + SR  D+ S G +L  L+  R   P
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 14  KIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           ++G G+FG + L  +     +T  +VAVK +++SG    Q  ++ ++ +IL+       +
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREI-QILKALHSDFIV 87
Query: 69  KWYGVD---GEDNV-LVLDLLGPS--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           K+ GV    G  ++ LV++ L PS  L D     R +     +L+ + Q+   +EY+ SR
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYL-PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             +HRD+   N L+        V I DFGLAK
Sbjct: 147 RCVHRDLAARNILV---ESEAHVKIADFGLAK 175

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 14  KIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           ++G G+FG + L  +     +T  +VAVK +++SG    Q  ++ ++ +IL+       +
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREI-QILKALHSDFIV 74
Query: 69  KWYGVD---GEDNV-LVLDLLGPS--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           K+ GV    G  ++ LV++ L PS  L D     R +     +L+ + Q+   +EY+ SR
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYL-PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             +HRD+   N L+        V I DFGLAK
Sbjct: 134 RCVHRDLAARNILV---ESEAHVKIADFGLAK 162

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 17/152 (11%)
Query: 14  KIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           ++G G+FG + L  +     +T  +VAVK +++SG    Q  ++ ++ +IL+       +
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREI-QILKALHSDFIV 75
Query: 69  KWYGVD---GEDNV-LVLDLLGPS--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           K+ GV    G  ++ LV++ L PS  L D     R +     +L+ + Q+   +EY+ SR
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYL-PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             +HRD+   N L+        V I DFGLAK
Sbjct: 135 RCVHRDLAARNILV---ESEAHVKIADFGLAK 163

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGS 63
           +Y++   IG+GS+G +  A       +VA+K    +        ++L E  +   L    
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 64  GIPNIKWY---GVDGEDNV-LVLDLLGPSLEDLF---VYCRRKFSLKTVLMLADQMIARI 116
            +  +       V+  D + +VL++     + LF   VY   +  +KT+L     ++  +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT-ELHIKTLLY---NLLVGV 169
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT-NRHIP 166
           +YVHS G LHRD+KP N L+    +   V + DFGLA+    P   N  +P
Sbjct: 170 KYVHSAGILHRDLKPANCLVN---QDCSVKVCDFGLARTVDYPENGNSQLP 217

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 22/56 (39%), Positives = 36/56 (64%), Gaps = 3/56 (5%)
Query: 99  KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           KFS + +  L  QM+  ++Y+HS G +HRD+KP N  +    +  ++ I+DFGLA+
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLAR 174

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F   R+  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 11  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 66
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R++ +   +L +A Q+ 
Sbjct: 67  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSR 160

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMRIADFGLARDINNI 210
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 18/161 (11%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 12  MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 67
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLM-LADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R+     VL+ +A Q+ 
Sbjct: 68  IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + +EY+  + F+HRD+   N L+G   + + V + DFGL++
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSR 161

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL-----------FVYC-------RRKFSL 102
               I N+   G   +D  L + +   S  +L             YC         + S 
Sbjct: 92  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 206
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 207 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 255
Query: 216 L 216
           +
Sbjct: 256 V 256

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 1   MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKI 58
           MER  I +K+KLG     G +GE++       +  VAVK     T    + L EA V K 
Sbjct: 256 MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 311
Query: 59  LQGGSGIPN-IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLM-LADQMI 113
           ++     PN ++  GV   +    ++   +   +L D    C R+     VL+ +A Q+ 
Sbjct: 312 IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 367
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           + +EY+  + F+HR++   N L+G   + + V + DFGL++     T   H
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 415

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYK-----ILQ 60
           KY     IG G    +    H  T    AVKI     +   P+ L E +        IL+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 61  GGSGIPNIKWYGVDGEDN----VLVLDLLGPSLEDLFVYCRRKFSL--KTVLMLADQMIA 114
             +G P+I    +D  ++     LV DL+     +LF Y   K +L  K    +   ++ 
Sbjct: 155 QVAGHPHIITL-IDSYESSSFMFLVFDLMRKG--ELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + ++H+   +HRD+KP+N L+       Q+ + DFG +            P  + + L 
Sbjct: 212 AVSFLHANNIVHRDLKPENILLD---DNMQIRLSDFGFSCHLE--------PGEKLRELC 260
Query: 175 GTARYAS-----CN---THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           GT  Y +     C+   TH G    +  DL + G +L   L GS P+
Sbjct: 261 GTPGYLAPEILKCSMDETHPGY--GKEVDLWACGVILFTLLAGSPPF 305

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 12/176 (6%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           K+G G++  ++      T+ +VA+K   +E+        + E  + K L+  + I  +  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN-IVTLHD 67
Query: 71  YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
                +   LV + L   L+     C    ++  V +   Q++  + Y H +  LHRD+K
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYRENKNLTGTARYAS 181
           P N L+    +  ++ + DFGLA+    PT         + YR    L G+  Y++
Sbjct: 128 PQNLLIN---ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 52/222 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK------------IENSGTKHPQL--LYEAK----- 54
           ++G GSFGE+       T    AVK            +  +G   P++  LY A      
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPW 138
Query: 55  ---VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
                ++L+GGS    IK  G   ED  L    LG +LE L                   
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYY--LGQALEGL------------------- 177
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
                EY+H+R  LH D+K DN L  L    ++  + DFG A   +     + +      
Sbjct: 178 -----EYLHTRRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSL--LTGD 228
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            + GT  + +    +G     + D+ S   ++L+ L G  PW
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL--FVYCRR----------------KFSL 102
               I N+   G   +D  L + +   S  +L  ++  RR                + S 
Sbjct: 84  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 198
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 199 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 247
Query: 216 L 216
           +
Sbjct: 248 V 248

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL--FVYCRR----------------KFSL 102
               I N+   G   +D  L + +   S  +L  ++  RR                + S 
Sbjct: 81  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 195
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 196 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 244
Query: 216 L 216
           +
Sbjct: 245 V 245

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 66
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 127 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 180 ASC 182
           ++ 
Sbjct: 184 STA 186

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDXTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 259
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 260 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 306
Query: 309 ASRVT 313
           A R++
Sbjct: 307 AKRIS 311

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL--FVYCRR----------------KFSL 102
               I N+   G   +D  L + +   S  +L  ++  RR                + S 
Sbjct: 92  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 206
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 207 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 255
Query: 216 L 216
           +
Sbjct: 256 V 256

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G     +  E  + K L      PNI
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNH----PNI 65
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 126 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 180 ASC 182
           ++ 
Sbjct: 183 STA 185

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 67
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 180 ASC 182
           ++ 
Sbjct: 185 STA 187

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  R++G G+FG + +  +     +T E+VAVK     T+     +E ++ +IL+     
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHD 74
Query: 66  PNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             +K+ GV    G  N+ L+++ L   SL +     + +     +L    Q+   +EY+ 
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 135 TKRYIHRDLATRNILV---ENENRVKIGDFGLTK 165

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 67
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 180 ASC 182
           ++ 
Sbjct: 185 STA 187

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 66
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 127 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 180 ASC 182
           ++ 
Sbjct: 184 STA 186

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 71
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 132 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 180 ASC 182
           ++ 
Sbjct: 189 STA 191

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 67
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 180 ASC 182
           ++ 
Sbjct: 185 STA 187

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 71
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 132 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 180 ASC 182
           ++ 
Sbjct: 189 STA 191

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 43/103 (41%), Gaps = 8/103 (7%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           Q++  + Y+H  G +HRD+KP+N L         + I DFGL+K                
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--------M 207
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           K + GT  Y +     G       D+ S+G +    L G  P+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNIINL--LGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 65
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 126 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 180 ASC 182
           ++ 
Sbjct: 183 STA 185

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 84
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 85  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 199
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 200 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 248
Query: 213 WQGL 216
           + G+
Sbjct: 249 YPGI 252

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G     +  E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 68
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 129 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 180 ASC 182
           ++ 
Sbjct: 186 STA 188

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G     +  E  + K L      PNI
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNH----PNI 65
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 126 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 180 ASC 182
           ++ 
Sbjct: 183 STA 185

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   T   + PY     
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE 187
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 188 VLGPEKYDKSC------------DMWSLGVIMYILLCGYPPF 217

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL--FVYCRR----------------KFSL 102
               I N+   G   +D  L + +   S  +L  ++  RR                + S 
Sbjct: 85  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 199
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 200 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 248
Query: 216 L 216
           +
Sbjct: 249 V 249

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 54/246 (21%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LI 85
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK----------------- 99
             G  +  +   G     G   +++++       +L  Y R K                 
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 100 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-R 157
             +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+   +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXK 200
Query: 158 DPTTNRHIPYRENKNLTGTAR----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSL 211
           DP   R           G AR    + +  T      + + D+ S G VLL+  F  G+ 
Sbjct: 201 DPDXVR----------KGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGAS 249
Query: 212 PWQGLK 217
           P+ G+K
Sbjct: 250 PYPGVK 255

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DYYKNTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G     +  E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G     +  E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 26/251 (10%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
           Y + + IG G+FGE+ L  H  + ++ A+K+    E          +E +          
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 136
Query: 65  IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           +  +     D +   +V++ + P  + + +        K       +++  ++ +HS G 
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYM-PGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 195
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS--- 181
           +HRD+KPDN L+    K   + + DFG   K  D T   H          GT  Y S   
Sbjct: 196 IHRDVKPDNMLLD---KHGHLKLADFGTCMKM-DETGMVHC-----DTAVGTPDYISPEV 246
Query: 182 CNTHLGIEQSRRD-DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             +  G     R+ D  S+G  L   L G  P+    A +    Y KI + K S     L
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY---ADSLVGTYSKIMDHKNS-----L 298
Query: 241 CKSHPAEFASY 251
           C    AE + +
Sbjct: 299 CFPEDAEISKH 309

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 63
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 180 ASC 182
           ++ 
Sbjct: 181 STA 183

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 63
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 180 ASC 182
           ++ 
Sbjct: 181 STA 183

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 68
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 129 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 180 ASC 182
           ++ 
Sbjct: 186 STA 188

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 87
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 88  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 202
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 203 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 251
Query: 213 WQGL 216
           + G+
Sbjct: 252 YPGI 255

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 63
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 180 ASC 182
           ++ 
Sbjct: 181 STA 183

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 82
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 83  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV---TENNVMKIADFGLARDINNI 197
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 198 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 246
Query: 213 WQGL 216
           + G+
Sbjct: 247 YPGI 250

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 54/246 (21%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+  ++
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--LI 76
Query: 60  QGGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRK----------------- 99
             G  +  +   G     G   +++++       +L  Y R K                 
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVIVEFC--KFGNLSTYLRSKRNEFVPYKVAPEDLYKD 134
Query: 100 -FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-R 157
             +L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+   +
Sbjct: 135 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXK 191
Query: 158 DPTTNRHIPYRENKNLTGTAR----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSL 211
           DP   R           G AR    + +  T      + + D+ S G VLL+  F  G+ 
Sbjct: 192 DPDXVR----------KGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGAS 240
Query: 212 PWQGLK 217
           P+ G+K
Sbjct: 241 PYPGVK 246

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RKFSL 102
               I N+   G   +D  L + +   S  +L  Y +                   + S 
Sbjct: 92  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 206
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 207 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 255
Query: 216 L 216
           +
Sbjct: 256 V 256

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 64
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 125 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 180 ASC 182
           ++ 
Sbjct: 182 STA 184

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 63
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + L   L+            L  +     Q++  + + HS   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 124 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 180 ASC 182
           ++ 
Sbjct: 181 STA 183

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL--FVYCRR----------------KFSL 102
               I N+   G   +D  L + +   S  +L  ++  RR                + S 
Sbjct: 133 KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+      Y 
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 247
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 248 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 296
Query: 216 L 216
           +
Sbjct: 297 V 297

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 28  HVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87
           HV+ + I       +GT+ P  +   K  K+  G SG+  +  +    +  VL+L+   P
Sbjct: 83  HVEKDRISDWGELPNGTRVPMEVVLLK--KVSSGFSGVIRLLDWFERPDSFVLILERPEP 140
Query: 88  SLEDLFVYCRRKFSLKTVLMLA--DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145
            ++DLF +   + +L+  L  +   Q++  + + H+ G LHRDIK +N L+ L R   ++
Sbjct: 141 -VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GEL 197
Query: 146 YIIDFGLAKKYRD 158
            +IDFG     +D
Sbjct: 198 KLIDFGSGALLKD 210

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 95  QDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV 151
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 152 V---KSDXTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 200
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 252
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 253 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 299
Query: 309 ASRVT 313
           A R++
Sbjct: 300 AKRIS 304

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDXTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 259
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 260 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 306
Query: 309 ASRVT 313
           A R++
Sbjct: 307 AKRIS 311

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 79
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 80  ---IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 136
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 137 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 169

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYLVMELMDANLXQVI---QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDXTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 259
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 260 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 306
Query: 309 ASRVT 313
           A R++
Sbjct: 307 AKRIS 311

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 142 MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDINNI 256
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 257 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 305
Query: 213 WQGL 216
           + G+
Sbjct: 306 YPGI 309

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 140 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 197 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 245
Query: 196 LESLGYVLLYFLRGSLPWQG 215
           + S+G ++   +R  + + G
Sbjct: 246 IWSVGCIMGEMVRHKILFPG 265

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 14  KIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           ++G G+FG + L  +     +T  +VAVK +++SG    Q  ++ ++ +IL+       +
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREI-QILKALHSDFIV 71
Query: 69  KWYGVD---GEDNV-LVLDLLGPS--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           K+ GV    G   + LV++ L PS  L D     R +     +L+ + Q+   +EY+ SR
Sbjct: 72  KYRGVSYGPGRPELRLVMEYL-PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
             +HRD+   N L+        V I DFGLAK
Sbjct: 131 RCVHRDLAARNILV---ESEAHVKIADFGLAK 159

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 27/166 (16%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           +++  ++G+G FG +    H DT E VA+K    E S     +   E ++ K L      
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH---- 72
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV--YCR----RKF--------SLKT--VLMLA 109
           PN+    V   +    L  L P+   L    YC     RK+         LK   +  L 
Sbjct: 73  PNV----VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 128
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
             + + + Y+H    +HRD+KP+N ++  G +     IID G AK+
Sbjct: 129 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 174

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 71
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
            +   K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 72  IV---KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 128
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 129 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 161

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  +++G G+FG + +  +     +T E+VAVK     T+     +E ++ +IL+     
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHD 76
Query: 66  PNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY+ 
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 137 TKRYIHRDLATRNILV---ENENRVKIGDFGLTK 167

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 27/166 (16%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           +++  ++G+G FG +    H DT E VA+K    E S     +   E ++ K L      
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH---- 71
Query: 66  PNIKWYGVDGEDNVLVLDLLGPSLEDLFV--YCR----RKF--------SLKT--VLMLA 109
           PN+    V   +    L  L P+   L    YC     RK+         LK   +  L 
Sbjct: 72  PNV----VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
             + + + Y+H    +HRD+KP+N ++  G +     IID G AK+
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 104 ---IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 161 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 193

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  +++G G+FG + +  +     +T E+VAVK     T+     +E ++ +IL+     
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHD 74
Query: 66  PNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY+ 
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 135 TKRYIHRDLATRNILV---ENENRVKIGDFGLTK 165

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 91  ---IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 148 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 180

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I  I   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNI--ITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
            +   K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 73  IV---KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 130 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 162

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           ++IGSG FG + L   ++ +++    I          + EA+V   L   S    ++ YG
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL---SHPKLVQLYG 69
Query: 73  VDGEDN--VLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           V  E     LV + +    L D     R  F+ +T+L +   +   + Y+     +HRD+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 130 KPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
              N L+G     NQV  + DFG+ +   D        Y  +       ++AS       
Sbjct: 130 AARNCLVG----ENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFS 179
Query: 189 EQSRRDDLESLGYVLLY--FLRGSLPWQ 214
             S + D+ S G VL++  F  G +P++
Sbjct: 180 RYSSKSDVWSFG-VLMWEVFSEGKIPYE 206

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 70
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
            +   K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 71  IV---KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 127
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 128 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 160

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 76
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
            +   K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 77  IV---KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 133
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 134 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 166

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 53/124 (42%), Gaps = 11/124 (8%)
Query: 93  FVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152
           F+   R   +  + +   Q+   + ++HS G  HRDIKP N L+    K N + + DFG 
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--NSKDNTLKLCDFGS 188
Query: 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSL 211
           AKK         IP   +     +  Y +    LG  E +   DL S+G V    + G  
Sbjct: 189 AKKL--------IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 212 PWQG 215
            + G
Sbjct: 241 LFSG 244

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 16/102 (15%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKN 172
           I+Y+HS    HRD+KP+N L    R    + + DFG AK+   +   TT  + PY     
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 173 LTGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           + G  +Y  SC            D  SLG +    L G  P+
Sbjct: 234 VLGPEKYDKSC------------DXWSLGVIXYILLCGYPPF 263

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  +++G G+FG + +  +     +T E+VAVK     T+     +E ++ +IL+     
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHD 71
Query: 66  PNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY+ 
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 132 TKRYIHRDLATRNILV---ENENRVKIGDFGLTK 162

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 73  ---IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 130 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 162

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  +++G G+FG + +  +     +T E+VAVK     T+     +E ++ +IL+     
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHD 77
Query: 66  PNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY+ 
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 138 TKRYIHRDLATRNILV---ENENRVKIGDFGLTK 168

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 140 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 197 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 245
Query: 196 LESLGYVLLYFLRGSLPWQG 215
           + S+G ++   +R  + + G
Sbjct: 246 IWSVGCIMGEMVRHKILFPG 265

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 13  RKIGSGSFGEIFLASHVDTN----EIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           R +G G FG++ L  +  TN    E+VAVK    ++G +H +  ++ ++  IL+      
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-RSGWKQEI-DILRTLYHEH 94
Query: 67  NIKWYGVDGEDNVLVLDL------LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
            IK+ G   +     L L      LG SL D     R    L  +L+ A Q+   + Y+H
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLG-SLRDYLP--RHSIGLAQLLLFAQQICEGMAYLH 151
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HRD+   N L+   R    V I DFGLAK
Sbjct: 152 AQHYIHRDLAARNVLLDNDR---LVKIGDFGLAK 182

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 35/248 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +Y++   IG GSFG++  A      E VA+K I+N      Q   E ++ +++       
Sbjct: 36  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD--T 93
Query: 67  NIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEY 118
            +K+Y V  + +        LV ++L  +L DL      R  SL      A QM   + +
Sbjct: 94  EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 153
Query: 119 VHS--RGFLHRDIKPDNFLMGLGRKANQVYIIDFG----LAKKYRDPTTNRHIPYRENKN 172
           + +     +H D+KP+N L+    K + + I+DFG    L ++      +R         
Sbjct: 154 LATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF-------- 204
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                 Y S    LG+      D+ SLG +L+    G   + G   A +  + +KI E  
Sbjct: 205 ------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG---ANEVDQMNKIVEVL 255
Query: 233 VSTPIEVL 240
              P  +L
Sbjct: 256 GIPPAHIL 263

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K  +++G G+FG + +  +     +T E+VAVK +++S  +H +    E ++ K LQ  +
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 64  GIPNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY
Sbjct: 91  ---IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 148 LGTKRYIHRDLATRNILV---ENENRVKIGDFGLTK 180

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 101/243 (41%), Gaps = 48/243 (19%)
Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+   +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FS 101
                + N+          ++V+        +L  Y R K                   +
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFC-KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPT 160
           L+ ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+   +DP 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIXKDPD 194
Query: 161 TNRHIPYRENKNLTGTAR----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
             R           G AR    + +  T      + + D+ S G VLL+  F  G+ P+ 
Sbjct: 195 XVR----------KGDARLPLKWMAPETIFDRVYTIQSDVWSFG-VLLWEIFSLGASPYP 243
Query: 215 GLK 217
           G+K
Sbjct: 244 GVK 246

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/56 (37%), Positives = 36/56 (64%), Gaps = 3/56 (5%)
Query: 99  KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +FS + +  L  QM+  ++Y+HS G +HRD+KP N  +    +  ++ I+DFGLA+
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILDFGLAR 192

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I  I   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNI--IHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
            Y   TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 35/248 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +Y++   IG GSFG++  A      E VA+K I+N      Q   E ++ +++       
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD--T 112
Query: 67  NIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEY 118
            +K+Y V  + +        LV ++L  +L DL      R  SL      A QM   + +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 119 VHS--RGFLHRDIKPDNFLMGLGRKANQVYIIDFG----LAKKYRDPTTNRHIPYRENKN 172
           + +     +H D+KP+N L+    K + + I+DFG    L ++      +R         
Sbjct: 173 LATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSSCQLGQRIYQXIQSRF-------- 223
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                 Y S    LG+      D+ SLG +L+    G   + G   A +  + +KI E  
Sbjct: 224 ------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG---ANEVDQMNKIVEVL 274
Query: 233 VSTPIEVL 240
              P  +L
Sbjct: 275 GIPPAHIL 282

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 15/101 (14%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT--TNRHIPYRENKNL 173
           I+++HS    HRD+KP+N L     K   + + DFG AK+       T  + PY     +
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 200
Query: 174 TGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 201 LGPEKYDKSC------------DMWSLGVIMYILLCGFPPF 229

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 18/221 (8%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           I   ++L   +G G++G +  A+H  T EIVA+K      K    L   +  KIL+    
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 65  IPNIKWYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
              I  + +   D+        ++ +L+   L    V   +  S   +     Q +  ++
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR--VISTQMLSDDHIQYFIYQTLRAVK 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL---T 174
            +H    +HRD+KP N L+        + + DFGLA+   +   +   P  +   +    
Sbjct: 127 VLHGSNVIHRDLKPSNLLIN---SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 175 GTARYASCNTHL-GIEQSRRDDLESLGYVL--LYFLRGSLP 212
            T  Y +    L   + SR  D+ S G +L  L+  R   P
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP 224

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD- 158
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+   + 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 159 ----PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
                TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DXXKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           ++IGSG FG + L   ++ +++    I          + EA+V   L   S    ++ YG
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL---SHPKLVQLYG 72
Query: 73  VDGEDN--VLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           V  E     LV + +    L D     R  F+ +T+L +   +   + Y+     +HRD+
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 130 KPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
              N L+G     NQV  + DFG+ +   D        Y  +       ++AS       
Sbjct: 133 AARNCLVG----ENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFS 182
Query: 189 EQSRRDDLESLGYVLLY--FLRGSLPWQ 214
             S + D+ S G VL++  F  G +P++
Sbjct: 183 RYSSKSDVWSFG-VLMWEVFSEGKIPYE 209

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDXTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 259
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 260 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 306
Query: 309 ASRVT 313
           A R++
Sbjct: 307 AKRIS 311

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYE-----AKVYKILQ 60
           G  Y + ++IGSG   ++F   + +  +I A+K  N      Q L       A + K+ Q
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
               I  I+ Y  +  D  + + +   ++ DL  + ++K S+      +    M+  +  
Sbjct: 86  HSDKI--IRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H  G +H D+KP NFL+  G     + +IDFG+A + + P     +      +  GT  
Sbjct: 143 IHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQ-PDXXXVV----KDSQVGTVN 193
Query: 179 YASCNTHLGIEQSRRD-----------DLESLGYVLLYFLRGSLPWQGL 216
           Y        +  SR +           D+ SLG +L Y   G  P+Q +
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           ++IGSG FG + L   ++ +++    I          + EA+V   L   S    ++ YG
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL---SHPKLVQLYG 69
Query: 73  VDGEDN--VLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           V  E     LV + +    L D     R  F+ +T+L +   +   + Y+     +HRD+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 130 KPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
              N L+G     NQV  + DFG+ +   D        Y  +       ++AS       
Sbjct: 130 AARNCLVG----ENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFS 179
Query: 189 EQSRRDDLESLGYVLLY--FLRGSLPWQ 214
             S + D+ S G VL++  F  G +P++
Sbjct: 180 RYSSKSDVWSFG-VLMWEVFSEGKIPYE 206

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 15/101 (14%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT--TNRHIPYRENKNL 173
           I+++HS    HRD+KP+N L     K   + + DFG AK+       T  + PY     +
Sbjct: 122 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV 181
Query: 174 TGTARY-ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
            G  +Y  SC            D+ SLG ++   L G  P+
Sbjct: 182 LGPEKYDKSC------------DMWSLGVIMYILLCGFPPF 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTN----EIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           R +G G FG++ L  +  TN    E+VAVK    + G +H +  ++ ++  IL+      
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH-RSGWKQEI-DILRTLYHEH 77
Query: 67  NIKWYGV---DGEDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            IK+ G     GE ++ ++    P  SL D     R    L  +L+ A Q+   + Y+HS
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++HR++   N L+   R    V I DFGLAK
Sbjct: 136 QHYIHRNLAARNVLLDNDR---LVKIGDFGLAK 165

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 51/244 (20%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
           K  LG+ +G G+FG++ +A  V  ++        VAVK +++  T+     L+ E ++ K
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR------------------RK 99
           ++     I N+   G   +D  L + +   S  +L  Y R                   +
Sbjct: 96  MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD- 158
            + K ++    Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+   + 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNI 210
Query: 159 ----PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
                TTN  +P    K +   A +    TH       + D+ S G VL++  F  G  P
Sbjct: 211 DXXKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 259
Query: 213 WQGL 216
           + G+
Sbjct: 260 YPGI 263

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           M R+   +++  + +G G+FG++ L     T    A+KI     K   ++ + +V   L 
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLT 58
Query: 61  GGSGIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQM 112
               + N +        Y     D +  +       E  F   R R FS         ++
Sbjct: 59  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 118
Query: 113 IARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYREN 170
           ++ ++Y+HS +  ++RD+K +N ++    K   + I DFGL K+  +D  T         
Sbjct: 119 VSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT--------M 167
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
           K   GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 103 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 160 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 208
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 209 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 260
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 261 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 307
Query: 309 ASRVT 313
           A R++
Sbjct: 308 AKRIS 312

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           ++IGSG FG + L   ++ +++    I          + EA+V   L   S    ++ YG
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL---SHPKLVQLYG 67
Query: 73  VDGEDN--VLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           V  E     LV + +    L D     R  F+ +T+L +   +   + Y+     +HRD+
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 130 KPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
              N L+G     NQV  + DFG+ +   D        Y  +       ++AS       
Sbjct: 128 AARNCLVG----ENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFS 177
Query: 189 EQSRRDDLESLGYVLLY--FLRGSLPWQ 214
             S + D+ S G VL++  F  G +P++
Sbjct: 178 RYSSKSDVWSFG-VLMWEVFSEGKIPYE 204

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 101 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 157
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 158 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 206
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 207 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 258
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 259 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 305
Query: 309 ASRVT 313
           A R++
Sbjct: 306 AKRIS 310

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 96  QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 152
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 153 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 201
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 202 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 253
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 254 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 300
Query: 309 ASRVT 313
           A R++
Sbjct: 301 AKRIS 305

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 259
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 260 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 306
Query: 309 ASRVT 313
           A R++
Sbjct: 307 AKRIS 311

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           ++IGSG FG + L   ++ +++    I+         + EA+V   L   S    ++ YG
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKL---SHPKLVQLYG 89
Query: 73  VDGEDN--VLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           V  E     LV + +    L D     R  F+ +T+L +   +   + Y+     +HRD+
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 130 KPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
              N L+G     NQV  + DFG+ +   D        Y  +       ++AS       
Sbjct: 150 AARNCLVG----ENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFS 199
Query: 189 EQSRRDDLESLGYVLLY--FLRGSLPWQ 214
             S + D+ S G VL++  F  G +P++
Sbjct: 200 RYSSKSDVWSFG-VLMWEVFSEGKIPYE 226

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL-LYEAKVYKILQGGSGIPNI- 68
           KIG G++G ++ A +  T E+VA   ++++      P   + E  + K L      PNI 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH----PNIV 65
Query: 69  KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K   V   +N   LV + L   L+            L  +     Q++  + + HS   L
Sbjct: 66  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 125
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARYA 180
           HRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y+
Sbjct: 126 HRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 181 SC 182
           + 
Sbjct: 183 TA 184

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL-LYEAKVYKILQGGSGIPNI- 68
           KIG G++G ++ A +  T E+VA   ++++      P   + E  + K L      PNI 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH----PNIV 64
Query: 69  KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           K   V   +N   LV + L   L+            L  +     Q++  + + HS   L
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARYA 180
           HRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y+
Sbjct: 125 HRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 181 SC 182
           + 
Sbjct: 182 TA 183

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 103 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 159
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 160 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 208
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 209 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 260
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 261 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 307
Query: 309 ASRVT 313
           A R++
Sbjct: 308 AKRIS 312

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 35/248 (14%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +Y++   IG GSFG++  A      E VA+K I+N      Q   E ++ +++       
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD--T 112
Query: 67  NIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEY 118
            +K+Y V  + +        LV ++L  +L DL      R  SL      A QM   + +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 119 VHS--RGFLHRDIKPDNFLMGLGRKANQVYIIDFG----LAKKYRDPTTNRHIPYRENKN 172
           + +     +H D+KP+N L+    K   + I+DFG    L ++      +R         
Sbjct: 173 LATPELSIIHCDLKPENILL-CNPKRXAIKIVDFGSSCQLGQRIYQXIQSRF-------- 223
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
                 Y S    LG+      D+ SLG +L+    G   + G   A +  + +KI E  
Sbjct: 224 ------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG---ANEVDQMNKIVEVL 274
Query: 233 VSTPIEVL 240
              P  +L
Sbjct: 275 GIPPAHIL 282

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 102 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 159 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 207
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 259
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 260 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 306
Query: 309 ASRVT 313
           A R++
Sbjct: 307 AKRIS 311

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 95  QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 152 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 200
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 252
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 253 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 299
Query: 309 ASRVT 313
           A R++
Sbjct: 300 AKRIS 304

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 21/191 (10%)
Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK-IL 59
           ++R I  + ++ ++IG G +GE+++       E VAVK+  + T+      E ++Y+ +L
Sbjct: 31  VQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT-TEEASWFRETEIYQTVL 87
Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLED--LFVYCRR-KFSLKTVLMLADQMIARI 116
                I       + G  +   L L+    E+  L+ Y +      K++L LA   ++ +
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGL 147
Query: 117 EYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
            ++H+  F         HRD+K  N L+   +K     I D GLA K+   T    IP  
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP-- 202
Query: 169 ENKNLTGTARY 179
                 GT RY
Sbjct: 203 -PNTRVGTKRY 212

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/112 (22%), Positives = 54/112 (48%), Gaps = 6/112 (5%)
Query: 48  QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLK 103
           ++L+E  V ++ +    + N+     +  + +L+L+       ++F  C  +     S  
Sbjct: 74  EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG--EIFSLCLPELAEMVSEN 131
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
            V+ L  Q++  + Y+H    +H D+KP N L+        + I+DFG+++K
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 42/245 (17%)
Query: 76  EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
           +D  LV++L+  +L  +    + +   + +  L  QM+  I+++HS G +HRD+KP N +
Sbjct: 96  QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 152
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
           +   +    + I+DFGLA+     T+    PY        T  Y +    LG+      D
Sbjct: 153 V---KSDCTLKILDFGLARTAG--TSFMMTPY------VVTRYYRAPEVILGMGYKENVD 201
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
           + S+G ++   +R  + + G        +++K+ E ++ TP     K       +Y    
Sbjct: 202 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 253
Query: 256 QSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQKTKSQDLL-------P 308
                + RP Y  L   F  LF    +  D        ++ + + ++++DLL       P
Sbjct: 254 ----VENRPKYAGLT--FPKLFPDSLFPADS-------EHNKLKASQARDLLSKMLVIDP 300
Query: 309 ASRVT 313
           A R++
Sbjct: 301 AKRIS 305

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
           ++IGSG FG + L   ++ +++    I          + EA+V   L   S    ++ YG
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL---SHPKLVQLYG 70
Query: 73  VDGEDN--VLVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
           V  E     LV + +    L D     R  F+ +T+L +   +   + Y+     +HRD+
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 130 KPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
              N L+G     NQV  + DFG+ +   D        Y  +       ++AS       
Sbjct: 131 AARNCLVG----ENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEVFSFS 180
Query: 189 EQSRRDDLESLGYVLLY--FLRGSLPWQ 214
             S + D+ S G VL++  F  G +P++
Sbjct: 181 RYSSKSDVWSFG-VLMWEVFSEGKIPYE 207

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  +++G G+FG + +  +     +T E+VAVK     T+     +E ++ +IL+     
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHD 74
Query: 66  PNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             +K+ GV    G  N+ L+++ L   SL D       +     +L    Q+   +EY+ 
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 135 TKRYIHRDLATRNILV---ENENRVKIGDFGLTK 165

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 18/153 (11%)
Query: 13  RKIGSGSFGEIFLASHVDTN----EIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           R +G G FG++ L  +  TN    E+VAVK    + G +H +  ++ ++  IL+      
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQH-RSGWKQEI-DILRTLYHEH 77
Query: 67  NIKWYGV---DGEDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            IK+ G     GE ++ ++    P  SL D     R    L  +L+ A Q+   + Y+H+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + ++HR++   N L+   R    V I DFGLAK
Sbjct: 136 QHYIHRNLAARNVLLDNDR---LVKIGDFGLAK 165

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 13/103 (12%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-----TTNRHI 165
           Q++  + Y+HS+G +HRD+KP N  +   R    V I DFGLAK            ++++
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 166 PYRENKNLT---GTARYASCNTHLGI-EQSRRDDLESLGYVLL 204
           P   + NLT   GTA Y +     G    + + D+ SLG +  
Sbjct: 181 P-GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 18/78 (23%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+                
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 195
Query: 156 YRDPTTNRHIPYRENKNL 173
           YR P     + Y+EN +L
Sbjct: 196 YRAPEVILGMGYKENVDL 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEA-KVYKILQGGSGIPNIKWYG 72
           +G G++G ++    +     +A+K I    +++ Q L+E   ++K L+  + +  +  + 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 73  VDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
            +G   + +  + G SL  L    +   K + +T+     Q++  ++Y+H    +HRDIK
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
            DN L  +   +  + I DFG +K+    +P T         +  TGT +Y +      I
Sbjct: 150 GDNVL--INTYSGVLKISDFGTSKRLAGINPCT---------ETFTGTLQYMAPEI---I 195
Query: 189 EQSRRD-----DLESLGYVLLYFLRGSLPWQGL 216
           ++  R      D+ SLG  ++    G  P+  L
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 18/78 (23%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+                
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 184
Query: 156 YRDPTTNRHIPYRENKNL 173
           YR P     + Y+EN +L
Sbjct: 185 YRAPEVILGMGYKENVDL 202

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 65/285 (22%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNI-K 69
           +IG G++G +    H  + +I+AVK   S     +  QLL +  V   +   S  P I +
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQ 85
Query: 70  WYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL--MLADQMIARIEYVHSRGF 124
           +YG    +G D  + ++L+  S +  + Y      + +VL  ++ ++++ +I     +  
Sbjct: 86  FYGALFREG-DCWICMELMSTSFDKFYKY------VYSVLDDVIPEEILGKITLATVKAL 138
Query: 125 ---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
                    +HRDIKP N L+    ++  + + DFG++ +  D                 
Sbjct: 139 NHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDS--------------IA 181
Query: 176 TARYASCNTHLGIEQ-----SR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225
             R A C  ++  E+     SR     R D+ SLG  L     G  P+    +      +
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----F 236
Query: 226 DKICEKKVSTPIEVLCKSHPAEFASYF----HYCQSLTFDQRPDY 266
           D++ +     P + L  S   EF+  F    + C +    +RP Y
Sbjct: 237 DQLTQVVKGDPPQ-LSNSEEREFSPSFINFVNLCLTKDESKRPKY 280

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 13/103 (12%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-----TTNRHI 165
           Q++  + Y+HS+G +HRD+KP N  +   R    V I DFGLAK            ++++
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 166 PYRENKNLT---GTARYASCNTHLGI-EQSRRDDLESLGYVLL 204
           P   + NLT   GTA Y +     G    + + D+ SLG +  
Sbjct: 181 P-GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 25/169 (14%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+     T+    P    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG--TSFMMTPE--- 185
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
                T  Y +    LG+      D+ S+G ++   ++G + + G        +++K+ E
Sbjct: 186 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG---TDHIDQWNKVIE 239
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG--FLKRLFHDLF 277
            ++ TP     K       +Y         + RP Y     ++LF D+ 
Sbjct: 240 -QLGTPCPEFMKKLQPTVRTY--------VENRPKYAGYSFEKLFPDVL 279

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 18/78 (23%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+                
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 156 YRDPTTNRHIPYRENKNL 173
           YR P     + Y+EN +L
Sbjct: 191 YRAPEVILGMGYKENVDL 208

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
           Q++  I Y+H+   LHRD+KP N L MG G +  +V I D G A+ +  P
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 96
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 155
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 156 VKPHNVM--IDHEHRKLRLIDWGLAEFY 181

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 44  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 102
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 103 ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 161
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 162 VKPHNVM--IDHEHRKLRLIDWGLAEFY 187

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 22/183 (12%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 67
Query: 69  -KWYGVDGEDN--VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K   V   +N   LV + +   L+            L  +     Q++  + + HS   
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTARY 179
           LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   Y
Sbjct: 128 LHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 180 ASC 182
           ++ 
Sbjct: 185 STA 187

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 96
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 155
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 156 VKPHNVM--IDHEHRKLRLIDWGLAEFY 181

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 97
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 156
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 157 VKPHNVM--IDHEHRKLRLIDWGLAEFY 182

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 51/241 (21%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTKH---PQLLYEAKVYKILQ 60
           LG+ +G G+FG++ LA  +  ++        VAVK+  S         L+ E ++ K++ 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDL--FVYCRR----------------KFSL 102
               I N+   G   +D  L + +   S  +L  ++  RR                + S 
Sbjct: 92  KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----- 157
           K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+        
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDXX 206
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
             TTN  +P    K +   A +    TH       + D+ S G VLL+  F  G  P+ G
Sbjct: 207 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 255
Query: 216 L 216
           +
Sbjct: 256 V 256

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           Y+L RK+G G + E+F A ++  NE V VKI     K         + + L+GG  I  +
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL-ENLRGGPNIITL 95
Query: 69  KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
                D       L     +  D F    +  +   +     +++  ++Y HS G +HRD
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTD-FKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRD 154
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKY 156
           +KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 155 VKPHNVM--IDHEHRKLRLIDWGLAEFY 180

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 24/184 (13%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           KIG G++G ++ A +  T E+VA+K      E  G      + E  + K L      PNI
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELNH----PNI 63
Query: 69  -KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRG 123
            K   V   +N L L +     +DL  +          L  +     Q++  + + HS  
Sbjct: 64  VKLLDVIHTENKLYL-VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNLTGTAR 178
            LHRD+KP N L+        + + DFGLA+ +  P  T  H    + YR  + L G   
Sbjct: 123 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 179 YASC 182
           Y++ 
Sbjct: 180 YSTA 183

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 30/277 (10%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNEIVAVKIENS--GTKHPQLLYEAKVYKILQGGSGIPNI 68
           +  KIG+GSFG +  A    ++  V + +E      +  + L E  + K L+     PNI
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH----PNI 96
Query: 69  KWY--GVDGEDNVLVLD--LLGPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSR 122
             +   V    N+ ++   L   SL  L      R +   +  L +A  +   + Y+H+R
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 123 G--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
               +HRD+K  N L+    K   V + DFGL++        +   +  +K   GT  + 
Sbjct: 157 NPPIVHRDLKSPNLLVD---KKYTVKVCDFGLSRL-------KASXFLXSKXAAGTPEWM 206
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           +         + + D+ S G +L        PW  L  A         C++     +E+ 
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-----LEIP 261
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
              +P + A+    C +    +RP +  +  L   L 
Sbjct: 262 RNLNP-QVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 10  KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
           K  +++G G+FG + +  +     +T E+VAVK     T+     +E ++ +IL+     
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHD 72
Query: 66  PNIKWYGV---DGEDNV-LVLDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             +K+ GV    G  N+ L+++ L   SL D     + +     +L    Q+   +EY+ 
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           ++ ++HR++   N L+      N+V I DFGL K
Sbjct: 133 TKRYIHRNLATRNILV---ENENRVKIGDFGLTK 163

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
           R+   +++  + +G G+FG++ L     T    A+KI     K   ++ + +V   L   
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTEN 202
Query: 63  SGIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
             + N +        Y     D +  +       E  F   R R FS         ++++
Sbjct: 203 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 262
Query: 115 RIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKN 172
            ++Y+HS +  ++RD+K +N ++    K   + I DFGL K+  +D  T         K 
Sbjct: 263 ALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT--------MKT 311
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
             GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 52  EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT--VLMLA 109
           EA+    LQ    +P   +  +DG+   L +D    +  DL    RR+  L     + + 
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQ---LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIV 140
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
            Q+ + ++  H+ G  HRD+KP+N L+     A   Y++DFG+A      TT+  +   +
Sbjct: 141 RQIGSALDAAHAAGATHRDVKPENILVSADDFA---YLVDFGIASA----TTDEKL--TQ 191
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
             N  GT  Y +         + R D+ +L  VL   L GS P+QG
Sbjct: 192 LGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 38/252 (15%)
Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQLLYEAKVYKILQGGSG 64
           ++K   K+G+G++  ++   +  T   VA   VK+++        + E  + K L+  + 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN- 64
Query: 65  IPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCR------RKFSLKTVLMLADQMIARI 116
              ++ Y V   +N   LV + +   L+  ++  R      R   L  V     Q++  +
Sbjct: 65  --IVRLYDVIHTENKLTLVFEFMDNDLKK-YMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN-----RHIPYRENK 171
            + H    LHRD+KP N L+    K  Q+ + DFGLA+ +  P          + YR   
Sbjct: 122 AFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
            L G+  Y++             D+ S G +L   + G    + L   T  ++  K+   
Sbjct: 179 VLMGSRTYSTS-----------IDIWSCGCILAEMITG----KPLFPGTNDEEQLKLIFD 223
Query: 232 KVSTPIEVLCKS 243
            + TP E L  S
Sbjct: 224 IMGTPNESLWPS 235

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
           R+   +++  + +G G+FG++ L     T    A+KI     K   ++ + +V   L   
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTEN 199
Query: 63  SGIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
             + N +        Y     D +  +       E  F   R R FS         ++++
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 115 RIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKN 172
            ++Y+HS +  ++RD+K +N ++    K   + I DFGL K+  +D  T         K 
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT--------MKT 308
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
             GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/220 (21%), Positives = 88/220 (40%), Gaps = 51/220 (23%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++G+G+ G +    H  +  I+A K         I N   +  Q+L+E     I      
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 76
Query: 65  IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              + +YG    DGE ++ +  + G SL+ +    +R         + ++++ ++     
Sbjct: 77  ---VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVL 124
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           RG          +HRD+KP N L+       ++ + DFG++ +  D   N         +
Sbjct: 125 RGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---------S 172
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
             GT  Y +     G   S + D+ S+G  L+    G  P
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 27/231 (11%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIK 69
           +G G F + F  S  DT E+ A KI          +  ++  E  +++ L        + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV---VG 81
Query: 70  WYG-VDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
           ++G  +  D V V+  L      L ++ RRK  +         Q++   +Y+H    +HR
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY--RENKNLTGTARYASCNTH 185
           D+K  N  +    +  +V I DFGLA K         + Y     K L GT  Y +    
Sbjct: 142 DLKLGNLFLN---EDLEVKIGDFGLATK---------VEYDGERKKTLCGTPNYIAPEVL 189
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                S   D+ S+G ++   L G  P++    +  K+ Y +I + + S P
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIP 237

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKIL--QG 61
           +  +Y++ + IG GSFG++  A     ++ VA+K + N    H Q   E ++ + L  Q 
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 62  GSGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMI 113
                N+    +   +N        +  +LL  +L +L    + + FSL  V   A  ++
Sbjct: 155 KDNTMNV----IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
             ++ +H    +H D+KP+N L+    ++  + +IDFG
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFG 247

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEA-KVYKILQGGSGIPNIKWYG 72
           +G G++G ++    +     +A+K I    +++ Q L+E   ++K L+  + +  +  + 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 73  VDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
            +G   + +  + G SL  L    +   K + +T+     Q++  ++Y+H    +HRDIK
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
            DN L  +   +  + I DFG +K+    +P T         +  TGT +Y +      I
Sbjct: 136 GDNVL--INTYSGVLKISDFGTSKRLAGINPCT---------ETFTGTLQYMAPEI---I 181
Query: 189 EQSRRD-----DLESLGYVLLYFLRGSLPWQGL 216
           ++  R      D+ SLG  ++    G  P+  L
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
           R+   +++  + +G G+FG++ L     T    A+KI     K   ++ + +V   L   
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTEN 61
Query: 63  SGIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
             + N +        Y     D +  +       E  F   R R FS         ++++
Sbjct: 62  RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 121
Query: 115 RIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKN 172
            ++Y+HS +  ++RD+K +N ++    K   + I DFGL K+  +D  T         K 
Sbjct: 122 ALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT--------MKX 170
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
             GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKIL--QG 61
           +  +Y++ + IG GSFG++  A     ++ VA+K + N    H Q   E ++ + L  Q 
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 62  GSGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMI 113
                N+    +   +N        +  +LL  +L +L    + + FSL  V   A  ++
Sbjct: 155 KDNTMNV----IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
             ++ +H    +H D+KP+N L+    ++  + +IDFG
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFG 247

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 63/292 (21%), Positives = 124/292 (42%), Gaps = 48/292 (16%)
Query: 14  KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
           ++G G++G +    HV + +I+AVK      +  +  +LL +  +   ++       + +
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS--MRTVDCPFTVTF 115
Query: 71  YGV---DGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVL-MLADQMIARIEYVHSR-G 123
           YG    +G D  + ++L+  SL+  +  V  + +   + +L  +A  ++  +E++HS+  
Sbjct: 116 YGALFREG-DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 174
Query: 124 FLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
            +HRD+KP N L+  LG    QV + DFG++    D                     A C
Sbjct: 175 VIHRDVKPSNVLINALG----QVKMCDFGISGYLVDSVAK--------------TIDAGC 216
Query: 183 NTHLGIEQ----------SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
             ++  E+          S + D+ SLG  ++       P+      T  Q+  ++ E+ 
Sbjct: 217 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW--GTPFQQLKQVVEE- 273
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG-FLKRLFHDLFSREGYD 283
             +P ++      AEF  +   C      +RP Y   ++  F  L   +G D
Sbjct: 274 -PSP-QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTD 323

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 71/306 (23%), Positives = 113/306 (36%), Gaps = 55/306 (17%)
Query: 8   KYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSG---TKHPQLLYEAKVYKIL 59
           +   G+ +G+G+FG++  A+       D    VAVK+       T+   L+ E KV   L
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 106
Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKT--VLM------ 107
                I N+      G   +++ +       DL  + RRK       KT   +M      
Sbjct: 107 GNHMNIVNLLGACTIGGPTLVITEYC--CYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 108 --------LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
                    + Q+   + ++ S+  +HRD+   N L+  GR      I DFGLA      
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK---ICDFGLA------ 215
Query: 160 TTNRHIPYRENKNLTGTAR----YASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQ 214
              RHI    N  + G AR    + +  +      +   D+ S G  L   F  GS P+ 
Sbjct: 216 ---RHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 272
Query: 215 GLKAATKKQKYDKICEKKVSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRLF 273
           G+   +K         K +     +L   H PAE       C      +RP +  + +L 
Sbjct: 273 GMPVDSKFY-------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325
Query: 274 HDLFSR 279
               S 
Sbjct: 326 EKQISE 331

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 27/231 (11%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIK 69
           +G G F + F  S  DT E+ A KI          +  ++  E  +++ L        + 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH---VVG 85
Query: 70  WYG-VDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
           ++G  +  D V V+  L      L ++ RRK  +         Q++   +Y+H    +HR
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 145
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY--RENKNLTGTARYASCNTH 185
           D+K  N  +    +  +V I DFGLA K         + Y     K L GT  Y +    
Sbjct: 146 DLKLGNLFLN---EDLEVKIGDFGLATK---------VEYDGERKKTLCGTPNYIAPEVL 193
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
                S   D+ S+G ++   L G  P++    +  K+ Y +I + + S P
Sbjct: 194 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIP 241

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 23/229 (10%)
Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIK 69
           +G G F + F  S  DT E+ A KI          +  ++  E  +++ L        + 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV---VG 81
Query: 70  WYG-VDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
           ++G  +  D V V+  L      L ++ RRK  +         Q++   +Y+H    +HR
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+K  N  +    +  +V I DFGLA K       +       K L GT  Y +      
Sbjct: 142 DLKLGNLFLN---EDLEVKIGDFGLATKVEYDGERK-------KTLCGTPNYIAPEVLSK 191
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              S   D+ S+G ++   L G  P++    +  K+ Y +I + + S P
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFE---TSCLKETYLRIKKNEYSIP 237

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
           R+   +++  + +G G+FG++ L     T    A+KI     K   ++ + +V   L   
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTEN 59
Query: 63  SGIPNIKW-------YGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
             + N +        Y     D +  +       E  F   R R FS         ++++
Sbjct: 60  RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 119
Query: 115 RIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKN 172
            ++Y+HS +  ++RD+K +N ++    K   + I DFGL K+  +D  T         K 
Sbjct: 120 ALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGAT--------MKX 168
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
             GT  Y +       +  R  D   LG V+   + G LP+
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 18/78 (23%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
           QM+  I+++HS G +HRD+KP N ++   +    + I+DFGLA+                
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMEPEVVTRY 190
Query: 156 YRDPTTNRHIPYRENKNL 173
           YR P     + Y+EN ++
Sbjct: 191 YRAPEVILGMGYKENVDI 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/277 (21%), Positives = 110/277 (39%), Gaps = 30/277 (10%)
Query: 11  LGRKIGSGSFGEIFLASHVDTNEIVAVKIENS--GTKHPQLLYEAKVYKILQGGSGIPNI 68
           +  KIG+GSFG +  A    ++  V + +E      +  + L E  + K L+     PNI
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH----PNI 96
Query: 69  KWY--GVDGEDNVLVLD--LLGPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVHSR 122
             +   V    N+ ++   L   SL  L      R +   +  L +A  +   + Y+H+R
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 123 G--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
               +HR++K  N L+    K   V + DFGL++        +   +  +K+  GT  + 
Sbjct: 157 NPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRL-------KASTFLSSKSAAGTPEWM 206
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           +         + + D+ S G +L        PW  L  A         C++     +E+ 
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-----LEIP 261
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
              +P + A+    C +    +RP +  +  L   L 
Sbjct: 262 RNLNP-QVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	423
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	0.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	0.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	0.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	0.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-173
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-165
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-159
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-22
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-21
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-21
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-20
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-20
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-20
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-20
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-20
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-19
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-19
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-18
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-18
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-18
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-18
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-18
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-17
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-16
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-16
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-16
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-15
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-15
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-14
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-14
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-14
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-14
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-14
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-14
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-14
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-13
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-13
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-13
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-12
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-12
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-12
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-12
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-12
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-12
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-12
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-11
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-11
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-04
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-11
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-11
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-11
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-11
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-11
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-11
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-10
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-10
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-10
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-10
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-10
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-09
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-09
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-09
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-09
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-09
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-08
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-08
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-04

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score =  549 bits (1415), Expect = 0.0
 Identities = 245/421 (58%), Positives = 296/421 (70%), Gaps = 1/421 (0%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G K++LGRKIGSGSFGEI+L +++ TNE VA+K+EN  TKHPQLLYE+K+Y+ILQ
Sbjct: 1   MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG+GIPN++W+GV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI R+E+VH
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD +T++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKY+KI EKKV+T IE L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK 300
           C+ +P EFASYFHYC+SL FD +PDY +LKRLF DLF REG+ FD+VFDWTILKYQQ+Q 
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300

Query: 301 TKSQDLLPASRVTNSRVMPMRTDKLKGVNDASCSAEVLECRGSYNRTRPDADMQHRPSVA 360
             +           S + P      +                      P A +       
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQK 360

Query: 361 EKMSSDHHFGKHSMGNAS-IPSASFVLPSTFNRNFQKPEGPDEAANIGRGHGNKTGASSS 419
             + +D  F K  + +AS     S         +  +   P + +   R         + 
Sbjct: 361 APVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGAF 420

Query: 420 W 420
            
Sbjct: 421 R 421

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score =  540 bits (1394), Expect = 0.0
 Identities = 165/317 (52%), Positives = 226/317 (71%), Gaps = 3/317 (0%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
             ++G  +++G+KIG G+FGE+ L  ++ TNE VA+K+E   ++ PQL  E + YK L  
Sbjct: 4   VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS 63

Query: 62  GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           G GIP + ++G  G+ N +VL+LLGPSLEDLF  C R FSLKTVLM+A Q+I+R+EYVHS
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 122 RGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           +  ++RD+KP+NFL+G    +    ++IIDF LAK+Y DP T +HIPYRE+K+LTGTARY
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
            S NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEV
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243

Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
           LC++ P E A+Y  Y + L F ++PDY +L++LF DLF R+GY FD+ +DW   +     
Sbjct: 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPV 302

Query: 300 KTKSQDLLPASRVTNSR 316
               QD   +S     +
Sbjct: 303 GAVQQDPALSSNREAHQ 319

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score =  538 bits (1388), Expect = 0.0
 Identities = 205/294 (69%), Positives = 255/294 (86%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 3   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK 294
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score =  534 bits (1378), Expect = 0.0
 Identities = 166/295 (56%), Positives = 212/295 (71%), Gaps = 2/295 (0%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
              ++GV YK+GR+IG GSFG IF  +++  N+ VA+K E   +  PQL  E + YK+L 
Sbjct: 4   QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           G +GIPN+ ++G +G  NVLV+DLLGPSLEDL   C RKFS+KTV M A QM+AR++ +H
Sbjct: 64  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 121 SRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
            +  ++RDIKPDNFL+G    + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
           Y S NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+ 
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243

Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
            LC   P EF  Y HY ++L FD  PDY +L+ LF  +  R     D  FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score =  488 bits (1258), Expect = e-173
 Identities = 83/330 (25%), Positives = 145/330 (43%), Gaps = 29/330 (8%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKHPQLLYEAKV 55
           +  +    +K+G  IG G FG I+LA       V ++    VK+E S   +  L  E K 
Sbjct: 29  ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS--DNGPLFTELKF 86

Query: 56  YKILQ--------------GGSGIPNIKWYGVDGED----NVLVLDLLGPSLEDLFVYCR 97
           Y+                    G+P     G+  ++      +++D  G  L+ ++    
Sbjct: 87  YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146

Query: 98  RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
           ++FS KTVL L+ +++  +EY+H   ++H DIK  N L+      +QVY++D+GLA +Y 
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYRYC 205

Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
               ++       +   GT  + S + H G+  SRR DLE LGY ++ +L G LPW+   
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265

Query: 218 AATKKQKYDKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
              K  +  KI  ++    +   C    + P E A Y    + L + ++P Y  L+ +  
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325

Query: 275 DLFSREGYDFDFVFDWTILKYQQTQKTKSQ 304
                 G   D   D ++++    +     
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTIT 355

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score =  467 bits (1204), Expect = e-165
 Identities = 89/316 (28%), Positives = 142/316 (44%), Gaps = 33/316 (10%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQLLYEAKVYK 57
           ++ + G ++ LG+KIGSG FG I+LA   +  E  A   VK+E    ++  L  E K Y+
Sbjct: 31  LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY--QENGPLFSELKFYQ 88

Query: 58  ILQGGS--------------GIPNIKWYGV----DGEDNVLVLDLLGPSLEDLFVYCRRK 99
            +                  GIP     G+          +V++ LG  L+ +       
Sbjct: 89  RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-T 147

Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           F   TVL L  +M+  +EY+H   ++H DIK  N L+G     +QVY+ D+GL+ +Y   
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLSYRYCPN 206

Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--- 216
             ++       K   GT  + S + H G+  SRR D+E LGY +L +L G LPW+     
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266

Query: 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
             A +  K + + E   S        S   E A +     SL +D++P+Y  LK++ +  
Sbjct: 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326

Query: 277 FSREGYDFDFVFDWTI 292
               G       D++ 
Sbjct: 327 GIPLGP-----LDFST 337

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score =  451 bits (1162), Expect = e-159
 Identities = 68/317 (21%), Positives = 121/317 (38%), Gaps = 33/317 (10%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGT----------- 44
             G ++KL       + G ++ A+   T         +  ++K++               
Sbjct: 39  KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98

Query: 45  --KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED-NVLVLDLLGPSLEDLFVYC-RRKF 100
             K  Q+    K+Y        IP    +GV  +    LVL  LG SL+       +   
Sbjct: 99  AAKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156

Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           S ++VL +A +++  +E++H   ++H ++  +N  +    + +QV +  +G A +Y    
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCP-- 213

Query: 161 TNRHIPYRENKN--LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
           + +H+ Y E       G   + S + H G   SRR DL+SLGY +L +L G LPW     
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273

Query: 219 ATKKQKYDKICEKKVSTPIEVLCK---SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
            T+     K        P    C            Y     +LT++++P Y  L+     
Sbjct: 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333

Query: 276 LFSREGYDFDFVFDWTI 292
           L               +
Sbjct: 334 LLQDLRVSPYDPIGLPM 350

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (297), Expect = 2e-30
 Identities = 53/258 (20%), Positives = 92/258 (35%), Gaps = 43/258 (16%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
            + G  Y + ++IGSG   ++F   + +  +I A+K     E           E      
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82

Query: 59  LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
           LQ      +   I+ Y  +  D    +V++     L       ++             M+
Sbjct: 83  LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 137

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             +  +H  G +H D+KP NFL+  G     + +IDFG+A + +  TT+         + 
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQ 188

Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
            GT  Y              N     + S + D+ SLG   Y + Y   G  P+Q +   
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 243

Query: 220 TKKQKYDKICEKKVSTPI 237
            +  K   I +       
Sbjct: 244 NQISKLHAIIDPNHEIEF 261

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  117 bits (295), Expect = 6e-30
 Identities = 53/256 (20%), Positives = 91/256 (35%), Gaps = 39/256 (15%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
            + G  Y + ++IGSG   ++F   + +  +I A+K     E           E      
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63

Query: 59  LQGGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
           LQ  S    I + Y  +  D    +V++     L       ++             M+  
Sbjct: 64  LQQHS--DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEA 120

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           +  +H  G +H D+KP NFL+        + +IDFG+A + +  TT+         +  G
Sbjct: 121 VHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQVG 171

Query: 176 TARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAATK 221
           T  Y              N     + S + D+ SLG   Y + Y   G  P+Q +    +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--NQ 226

Query: 222 KQKYDKICEKKVSTPI 237
             K   I +       
Sbjct: 227 ISKLHAIIDPNHEIEF 242

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  116 bits (291), Expect = 5e-29
 Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 43/258 (16%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
            + G  Y + ++IGSG   ++F   + +  +I A+K     E           E      
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 59  LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
           LQ      +   I+ Y  +  D    +V++     L       ++             M+
Sbjct: 111 LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 165

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             +  +H  G +H D+KP NFL+        + +IDFG+A + +  TT+         + 
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQ 216

Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
            G   Y              N     + S + D+ SLG   Y + Y   G  P+Q +   
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 271

Query: 220 TKKQKYDKICEKKVSTPI 237
            +  K   I +       
Sbjct: 272 NQISKLHAIIDPNHEIEF 289

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (288), Expect = 1e-28
 Identities = 35/272 (12%), Positives = 72/272 (26%), Gaps = 45/272 (16%)

Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
                 G  +G         A+  +T E   V +             Q+  E    ++L+
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 61  GG---------------------SGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLFV 94
           G                           +    +D  D        +   +  +L+    
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 95  Y------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
                    +       L L  Q+I  +  +H  G +H  ++P + ++    +   V++ 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLT 248

Query: 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FL 207
            F    +      +      E   L       S +       +   D  +LG +++Y   
Sbjct: 249 GFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIW 307

Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
              LP             + I     + P  V
Sbjct: 308 CADLPITK---DAALGGSEWIFRSCKNIPQPV 336

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 1e-28
 Identities = 45/269 (16%), Positives = 76/269 (28%), Gaps = 52/269 (19%)

Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
             K KL   +  G    +FL   V+  E  A+K+     ENS ++  +L         L 
Sbjct: 61  ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120

Query: 61  G--------------------GSGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLF-- 93
           G                        P         +D      +L++      LE LF  
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180

Query: 94  ----VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
                  R    +  + +L  Q+I     + S+G +H    PDN  +       ++ + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGD 237

Query: 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYAS--CNTHLGIEQSRRDDLESLGYVLLYFL 207
                K                  +    YA            +   +   LG  +    
Sbjct: 238 VSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              LP+ GL     K  + +   +   T 
Sbjct: 288 CLFLPF-GLVTPGIKGSWKRPSLRVPGTD 315

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  112 bits (281), Expect = 1e-27
 Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 50/305 (16%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
           +      + L   +G G+   +F   H  T ++ A+K+    +        + E +V K 
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 59  LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
           L       NI K + ++ E      VL+++     SL  +       + L     L++  
Sbjct: 64  LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
            ++  + ++   G +HR+IKP N +  +G     VY + DFG A++  D           
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168

Query: 170 NKNLT---GTARYAS--------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
           ++      GT  Y                 +     DL S+G V  Y    GSLP++  +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227

Query: 218 AA-TKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
                K+   KI   K S  I  +   ++ P +++       SL+         L+ L  
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-------RGLQVLLT 280

Query: 275 DLFSR 279
            + + 
Sbjct: 281 PVLAN 285

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  111 bits (278), Expect = 1e-27
 Identities = 56/277 (20%), Positives = 102/277 (36%), Gaps = 41/277 (14%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
           +      + L   +G G+   +F   H  T ++ A+K+    +        + E +V K 
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 59  LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
           L       NI K + ++ E      VL+++     SL  +       + L     L++  
Sbjct: 64  LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
            ++  + ++   G +HR+IKP N +  +G     VY + DFG A++  D           
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168

Query: 170 NKNLT---GTARYAS----CNTHLGIEQSRRDDLE----SLGYVLLY-FLRGSLPWQGLK 217
           ++      GT  Y          L  +  ++        S+G V  Y    GSLP++  +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227

Query: 218 AA-TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH 253
                K+   KI   K S  I  + K+          
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 7e-27
 Identities = 34/286 (11%), Positives = 76/286 (26%), Gaps = 61/286 (21%)

Query: 1   MERIIGVKYKL---GRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYE 52
           +E  +G + +    G  +G         A+  +T E   V +             Q+  E
Sbjct: 69  VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128

Query: 53  AKVYKILQG---------------------GSGIPNIKWYGVDGEDN-----VLVLDLLG 86
               ++L+G                           +    +D  D        +   + 
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188

Query: 87  PSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140
            +L+                     L L  Q+I  +  +H  G +H  ++P + ++    
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--- 245

Query: 141 KANQVYIIDFGLAKKYRDPT-TNRHIPYRENKNLTGTARYASCNTHLGIEQ-----SRRD 194
           +   V++  F    +      +     +             +       +      +   
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAF 298

Query: 195 DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
           D  +LG + +Y+     LP             + I     + P  V
Sbjct: 299 DTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPV 340

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (265), Expect = 6e-26
 Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 70/266 (26%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
           E     +Y+LG  +G G FG +F    +     VA+K+         +  +       E 
Sbjct: 27  EAFEA-EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85

Query: 54  KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRK 99
            +   +  G G P + +        E  +LVL+   P+ +DLF Y            R  
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA-QDLFDYITEKGPLGEGPSRCF 144

Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           F          Q++A I++ HSRG +HRDIK +N L  +  +     +IDFG      D 
Sbjct: 145 FG---------QVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHD- 192

Query: 160 TTNRHIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 210
                      +  T   GT  Y+     S + +  +       + SLG +LLY +  G 
Sbjct: 193 -----------EPYTDFDGTRVYSPPEWISRHQYHALPA----TVWSLG-ILLYDMVCGD 236

Query: 211 LPWQGLKAATKKQKYDKICEKKVSTP 236
           +P++            +I E ++  P
Sbjct: 237 IPFER---------DQEILEAELHFP 253

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  103 bits (260), Expect = 2e-25
 Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 32/199 (16%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
            ++    +G G+FG++  A +   +   A+K I ++  K   +L E  +   L       
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH----Q 62

Query: 67  NI-KWYGVDGEDNV---------------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
            + ++Y    E                  + ++     +L DL               L 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP--- 166
            Q++  + Y+HS+G +HRD+KP N  +    ++  V I DFGLAK          +    
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 167 -YRENKNLT---GTARYAS 181
               + NLT   GTA Y +
Sbjct: 180 LPGSSDNLTSAIGTAMYVA 198

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  104 bits (261), Expect = 2e-25
 Identities = 47/251 (18%), Positives = 89/251 (35%), Gaps = 29/251 (11%)

Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGS 63
              Y   +K+G G F  + L   +      A+K      +    +   EA ++++     
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85

Query: 64  GIPNI-KWYGV-----DGEDNV-LVLDL-LGPSLEDLFVYCRRK---FSLKTVLMLADQM 112
             PNI +           +    L+L      +L +     + K    +   +L L   +
Sbjct: 86  --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH--IPYREN 170
              +E +H++G+ HRD+KP N L+G      Q  ++D G   +           +  ++ 
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 171 KNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD 226
                T  Y +    +         R D+ SLG  +LY +  G  P+       K     
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDM--VFQKGDSVA 257

Query: 227 KICEKKVSTPI 237
              + ++S P 
Sbjct: 258 LAVQNQLSIPQ 268

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (254), Expect = 1e-24
 Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 34/242 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
            +K+G  +G GSF  ++ A  + T   VA+K+        +G    ++  E K++  L+ 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLKH 70

Query: 62  GSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
               P+I + Y   +  + V LVL++     +        + FS         Q+I  + 
Sbjct: 71  ----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
           Y+HS G LHRD+   N L+    +   + I DFGLA + + P    +         T  G
Sbjct: 127 YLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHY---------TLCG 174

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
           T  Y S             D+ SLG  + Y  L G  P+      T K   +K+      
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVVLADYE 230

Query: 235 TP 236
            P
Sbjct: 231 MP 232

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  103 bits (258), Expect = 2e-24
 Identities = 42/225 (18%), Positives = 84/225 (37%), Gaps = 20/225 (8%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           +  +  + +     +G G+ G I     +  N  VAVK             E +   +L+
Sbjct: 18  VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-ECFSFADREVQ---LLR 72

Query: 61  GGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
                PN+ +++          + ++L   +L++              + L  Q  + + 
Sbjct: 73  ESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           ++HS   +HRD+KP N L+ +     +    I DFGL KK      +    +     + G
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPG 188

Query: 176 TARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQG 215
           T  + +    +       +   D+ S G  + Y++   GS P+  
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  103 bits (259), Expect = 4e-24
 Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 39/257 (15%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
            +  G  +++  ++G+G FG +    H DT E VA+K    E S     +   E ++ K 
Sbjct: 10  TQTCG-PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 59  LQGGSGIPNI---------KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSL--KTVL 106
           L      PN+                +  +L ++   G  L            L    + 
Sbjct: 69  LNH----PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
            L   + + + Y+H    +HRD+KP+N ++  G +     IID G AK+           
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------- 176

Query: 167 YRENKNLT---GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKK 222
               +  T   GT +Y +       + +   D  S G  L +    G  P+       + 
Sbjct: 177 ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG-TLAFECITGFRPFLP---NWQP 229

Query: 223 QKYDKICEKKVSTPIEV 239
            ++     +K +  I V
Sbjct: 230 VQWHGKVREKSNEHIVV 246

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (256), Expect = 5e-24
 Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 37/239 (15%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
           E+ +       + +G GS G +           VAVK           L E K   +L  
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-FCDIALMEIK---LLTE 64

Query: 62  GSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQM 112
               PN+ ++Y     +  + + L+L   +L+DL           +       + L  Q+
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 113 IARIEYVHSRGFLHRDIKPDNFL----------MGLGRKANQVYIIDFGLAKKYRDPTTN 162
            + + ++HS   +HRD+KP N L             G +  ++ I DFGL KK       
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS---G 181

Query: 163 RHIPYRENKNLTGTARYA-------SCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLP 212
           +        N +GT+ +        S N       +R  D+ S+G  + Y++  +G  P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =   99 bits (250), Expect = 5e-24
 Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 45/247 (18%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
           +Y  GR +G G F + F  S  DT E+ A KI           +  ++  E  +++ L  
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAH 74

Query: 62  GSGIPNI-KWYGV-DGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
                ++  ++G  +  D V +VL+L    SL +L    R+  +         Q++   +
Sbjct: 75  ----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQ 129

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
           Y+H    +HRD+K  N    L      V I DFGLA K       +             G
Sbjct: 130 YLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VLCG 177

Query: 176 TARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKIC 229
           T  Y      S   H     S   D+ S+G  ++Y  L G  P++    +  K+ Y +I 
Sbjct: 178 TPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLRIK 228

Query: 230 EKKVSTP 236
           + + S P
Sbjct: 229 KNEYSIP 235

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 35/241 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
            +++GR +G G FG ++LA    +  I+A+K      +E +G +H QL  E ++   L+ 
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH 68

Query: 62  GSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARI 116
               PNI + YG   D     L+L+     L  ++   ++  KF  +       ++   +
Sbjct: 69  ----PNILRLYGYFHDATRVYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANAL 122

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
            Y HS+  +HRDIKP+N L+G    A ++ I DFG +          H P     +L GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGT 170

Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y       G     + DL SLG VL Y FL G  P++   A T ++ Y +I   + + 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYKRISRVEFTF 226

Query: 236 P 236
           P
Sbjct: 227 P 227

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 54/257 (21%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
           E +   +Y++G  +GSG FG ++    V  N  VA+K                 ++  E 
Sbjct: 39  EPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97

Query: 54  KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL--ML 108
            + K +   SG   + +        +  VL+L+   P  +DLF +   + +L+  L    
Sbjct: 98  VLLKKVS--SGFSGVIRLLDWFERPDSFVLILERPEPV-QDLFDFITERGALQEELARSF 154

Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
             Q++  + + H+ G LHRDIK +N L  +     ++ +IDFG     +D          
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKD---------- 202

Query: 169 ENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAA 219
                T   GT  Y+       + + G        + SLG +LLY +  G +P++     
Sbjct: 203 --TVYTDFDGTRVYSPPEWIRYHRYHGRSA----AVWSLG-ILLYDMVCGDIPFEH---- 251

Query: 220 TKKQKYDKICEKKVSTP 236
                 ++I   +V   
Sbjct: 252 -----DEEIIRGQVFFR 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 45/249 (18%)

Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKIL 59
             +Y  GR +G G F + F  S  DT E+ A KI           +  ++  E  +++ L
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSL 98

Query: 60  QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
                  ++  ++G  +  D V +VL+L    SL +L    R+  +         Q++  
Sbjct: 99  AH----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLG 153

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT- 174
            +Y+H    +HRD+K  N    L      V I DFGLA K       +            
Sbjct: 154 CQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VL 201

Query: 175 -GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDK 227
            GT  Y      S   H     S   D+ S+G  ++Y  L G  P++    +  K+ Y +
Sbjct: 202 CGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLR 252

Query: 228 ICEKKVSTP 236
           I + + S P
Sbjct: 253 IKKNEYSIP 261

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (254), Expect = 1e-23
 Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 37/248 (14%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQ 60
           +   Y+  +K+GSG++GE+ L     T+   A+KI      S + + +LL E  V K+L 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94

Query: 61  GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
                PNI K Y   + + N  LV++   G  L D  ++ R KF+     ++  Q+++ +
Sbjct: 95  H----PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGV 149

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
            Y+H    +HRD+KP+N L+    K   + I+DFGL+  +           ++ K   GT
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--------NQKKMKERLGT 201

Query: 177 ARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICE 230
           A Y +       E  R+      D+ S+G V+L+  L G  P+ G    T ++   K+ +
Sbjct: 202 AYYIA------PEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILRKVEK 251

Query: 231 KKVSTPIE 238
            K +    
Sbjct: 252 GKYTFDSP 259

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 13/154 (8%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
            ++   ++G GS+GE+F     +   + AVK   S  + P+     L E       +   
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG---SHEKVG 114

Query: 64  GIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             P   +      E  +L    +L GPSL+              V       +  + ++H
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           S+G +H D+KP N  +G      +  + DFGL  
Sbjct: 175 SQGLVHLDVKPANIFLG---PRGRCKLGDFGLLV 205

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (250), Expect = 4e-23
 Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 38/249 (15%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKIL 59
              +YK  R +G GSFGE+ L     T +  AVK+         T    LL E ++ K L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83

Query: 60  QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
                 PNI K Y   + +    LV ++  G  L D  +  R++FS      +  Q+++ 
Sbjct: 84  DH----PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSG 138

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           I Y+H    +HRD+KP+N L+    K   + IIDFGL+  +           ++ K+  G
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIG 190

Query: 176 TARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKIC 229
           TA Y +       E          D+ S G V+LY  L G  P+ G   A +     K+ 
Sbjct: 191 TAYYIA------PEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILKKVE 240

Query: 230 EKKVSTPIE 238
           + K +  + 
Sbjct: 241 KGKYTFELP 249

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 97.3 bits (243), Expect = 5e-23
 Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 39/243 (16%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
            + +GR +G G FG ++LA       I+A+K      +E  G +H QL  E ++   L+ 
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH 73

Query: 62  GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRR--KFSLKTVLMLADQMIA 114
               PNI + Y    D +   L+L+    G    +L+   ++  +F  +      +++  
Sbjct: 74  ----PNILRMYNYFHDRKRIYLMLEFAPRG----ELYKELQKHGRFDEQRSATFMEELAD 125

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + Y H R  +HRDIKP+N LMG      ++ I DFG +          H P    + + 
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRRTMC 173

Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKV 233
           GT  Y       G     + DL   G VL Y FL G  P+    + +  + + +I    +
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETHRRIVNVDL 229

Query: 234 STP 236
             P
Sbjct: 230 KFP 232

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 96.5 bits (241), Expect = 9e-23
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 48/247 (19%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
           I   +   RK+GSG+FG++ L     +     +K    + S     Q+  E +V K L  
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79

Query: 62  GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLAD 110
               PNI K + V  D  +  +V++    G    +L           +  S   V  L  
Sbjct: 80  ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           QM+  + Y HS+  +H+D+KP+N L       + + IIDFGLA+ ++            +
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--------SDEHS 183

Query: 171 KNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLP-W----QGLKAA 219
            N  GTA Y +       E  +RD     D+ S G V++YF L G LP      + ++  
Sbjct: 184 TNAAGTALYMA------PEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQK 236

Query: 220 TKKQKYD 226
              ++ +
Sbjct: 237 ATYKEPN 243

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 24/167 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
           +Y + + +GSG+ GE+ LA    T + VA+KI                   +  E ++ K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 58  ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
            L      P I K       ++  +VL+L+  G    +LF  V   ++    T  +   Q
Sbjct: 71  KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 122

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           M+  ++Y+H  G +HRD+KP+N L+    +   + I DFG +K   +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
           +Y + + +GSG+ GE+ LA    T + VA++I                   +  E ++ K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 58  ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
            L      P I K       ++  +VL+L+  G    +LF  V   ++    T  +   Q
Sbjct: 196 KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 247

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           M+  ++Y+H  G +HRD+KP+N L+    +   + I DFG +K   +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 54/262 (20%), Positives = 90/262 (34%), Gaps = 75/262 (28%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----------SGTKHPQLLYEAKVYK 57
           KY     +GSG+FG ++ A   + N+ V VK                K  ++  E  +  
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 58  ILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRKFSLK 103
            ++      NI K   +  +     LV++  G  L+ LF +               F   
Sbjct: 85  RVEH----ANIIKVLDIFENQGFFQLVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFR-- 137

Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
                  Q+++ + Y+  +  +HRDIK +N +  +      + +IDFG A          
Sbjct: 138 -------QLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER----- 182

Query: 164 HIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214
                  K      GT  Y        N + G E     ++ SLG V LY L     P+ 
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLG-VTLYTLVFEENPFC 231

Query: 215 GLKAATKKQKYDKICEKKVSTP 236
                      ++  E  +  P
Sbjct: 232 E---------LEETVEAAIHPP 244

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 43/251 (17%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
              +Y +   +G GSFGE+       T +  AVK+ N           +L E ++ K L 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 61  GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
                PNI K + + +   +  +V +L  G  L D  +  R++FS      +  Q+ + I
Sbjct: 80  H----PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGI 134

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-- 174
            Y+H    +HRD+KP+N L+    K   + IIDFGL+             +++N  +   
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-----------FQQNTKMKDR 183

Query: 175 -GTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDK 227
            GTA Y +       E  R       D+ S G V+LY  L G+ P+ G     +     +
Sbjct: 184 IGTAYYIA------PEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDILKR 233

Query: 228 ICEKKVSTPIE 238
           +   K +  + 
Sbjct: 234 VETGKYAFDLP 244

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 19/165 (11%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
              +Y +   +G GSFGE+       T +  AVK+ N           +L E ++ K L 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 61  GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
                PNI K + + +   +  +V +L   G    +LF  +  R++FS      +  Q+ 
Sbjct: 80  H----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVF 131

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           + I Y+H    +HRD+KP+N L+    K   + IIDFGL+  ++ 
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.0 bits (244), Expect = 3e-22
 Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 20/206 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
            Y +  ++G+G+FG +   +   T    A K       +    +  E +   +L+     
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH---- 213

Query: 66  PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           P +   +    D  + V++ + + G  L +       K S    +    Q+   + ++H 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
             ++H D+KP+N +    +++N++ +IDFGL             P +  K  TGTA +A+
Sbjct: 274 NNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVTTGTAEFAA 324

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL 207
                G       D+ S+G VL Y L
Sbjct: 325 PEVAEGKPVGYYTDMWSVG-VLSYIL 349

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 53/256 (20%), Positives = 101/256 (39%), Gaps = 46/256 (17%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVY 56
           ++IG KY +G  +G GS+G++      +T    AVKI               +  E ++ 
Sbjct: 2   KLIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60

Query: 57  KILQGGSGIPNI-KWYGVDGEDN----VLVLDLLGPSLEDLFVY-CRRKFSLKTVLMLAD 110
           + L+      N+ +   V   +      +V++     ++++      ++F +        
Sbjct: 61  RRLRH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           Q+I  +EY+HS+G +H+DIKP N L  L      + I   G+A            P+  +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVA--------EALHPFAAD 165

Query: 171 KNLT---GTARYAS------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAAT 220
                  G+  +         +T  G +     D+ S G V LY    G  P++G     
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAG-VTLYNITTGLYPFEG---DN 217

Query: 221 KKQKYDKICEKKVSTP 236
             + ++ I +   + P
Sbjct: 218 IYKLFENIGKGSYAIP 233

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.8 bits (236), Expect = 7e-22
 Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 32/227 (14%)

Query: 6   GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
            ++ ++ R +  G F  ++ A  V +    A+K    N   K+  ++ E    K L G  
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH- 85

Query: 64  GIPNI----------KWYGVDGEDNVLVL-DLLGPSLEDLFVYCRRK--FSLKTVLMLAD 110
             PNI          K     G+   L+L +L    L +       +   S  TVL +  
Sbjct: 86  --PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 111 QMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
           Q    ++++H +    +HRD+K +N L+        + + DFG A              R
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200

Query: 169 -----ENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
                E      T  Y +    + +       + D+ +LG  +LY L
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLL 246

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 17/163 (10%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
           I   Y L   IG GS+GE+ +A    T    A K I     +       E ++ K L   
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH- 65

Query: 63  SGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR 115
              PNI + Y   +   ++ LV++L   G    +LF  V  +R F       +   +++ 
Sbjct: 66  ---PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           + Y H     HRD+KP+NFL       + + +IDFGLA +++ 
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 70/262 (26%), Positives = 102/262 (38%), Gaps = 62/262 (23%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
              +   + L + +G G++GE+ LA +  T E VAVKI +   +          E  + K
Sbjct: 3   VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60

Query: 58  ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
           +L       N+ K+YG   E N+  L      LE     +LF              +R F
Sbjct: 61  MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111

Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
                     Q++A + Y+H  G  HRDIKP+N L  L  + N + I DFGLA  +R   
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159

Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQ 214
             R +       + GT  Y                    D+ S G ++L   L G LPW 
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCG-IVLTAMLAGELPWD 209

Query: 215 GLKAATKKQKYDKICEKKVSTP 236
               +   Q+Y    EKK    
Sbjct: 210 Q--PSDSCQEYSDWKEKKTYLN 229

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 33/182 (18%), Positives = 75/182 (41%), Gaps = 18/182 (9%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGS 63
           +  KY +   +G G FG +       + +    K ++  GT    +  E  +  I +   
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-- 60

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
              NI   +      E+ V++ + + G  + +       + + + ++    Q+   ++++
Sbjct: 61  --RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS    H DI+P+N +    R+++ + II+FG A++ +        P    + L     Y
Sbjct: 119 HSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLFTAPEY 169

Query: 180 AS 181
            +
Sbjct: 170 YA 171

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 57/259 (22%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY 56
            +  IG  Y+L + IG G+F ++ LA H+ T   VA+KI +    + T   +L  E ++ 
Sbjct: 10  EQPHIG-NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68

Query: 57  KILQGGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVY-----------CRRKFSL 102
           KIL      PNI K + V + E  + L+++    S  ++F Y            R KF  
Sbjct: 69  KILNH----PNIVKLFEVIETEKTLYLIMEYA--SGGEVFDYLVAHGRMKEKEARSKFR- 121

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
                   Q+++ ++Y H +  +HRD+K +N L  L    N + I DFG + ++      
Sbjct: 122 --------QIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV---- 166

Query: 163 RHIPYRENKNLT---GTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLK 217
                     L    G   YA+     G +      D+ SLG V+LY L  GSLP+ G  
Sbjct: 167 -------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG-VILYTLVSGSLPFDG-- 216

Query: 218 AATKKQKYDKICEKKVSTP 236
               K+  +++   K   P
Sbjct: 217 -QNLKELRERVLRGKYRIP 234

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 19/162 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
            Y +  ++G G+F  +    H  T    A KI N    S     +L  EA++ + LQ   
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-- 64

Query: 64  GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
             PNI + +     E    LV DL+  G    +LF  +  R  +S         Q++  I
Sbjct: 65  --PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESI 118

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            Y HS G +HR++KP+N L+    K   V + DFGLA +  D
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 94.4 bits (235), Expect = 9e-22
 Identities = 44/175 (25%), Positives = 64/175 (36%), Gaps = 22/175 (12%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGI 65
                ++G GSFGE+       T    AVK   +E    +      E      L      
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSS---- 109

Query: 66  PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           P I   YG   E   +   ++LL G SL  L             L    Q +  +EY+H+
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT 168

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           R  LH D+K DN L  L    ++  + DFG A   +     + +       + GT
Sbjct: 169 RRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 33/200 (16%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
            ++  + +G G FG +F A +   +   A+K   + N      +++ E K    L+    
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH--- 62

Query: 65  IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFV---YCRRK--------------FSLKTVL 106
            P I +++    E N             L++    CR++                    L
Sbjct: 63  -PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
            +  Q+   +E++HS+G +HRD+KP N         + V + DFGL              
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 162 NRHIPYRENKNLTGTARYAS 181
                Y  +    GT  Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 22/166 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY-------KIL 59
            Y+    +G G    +    H  T +  AVK I+ +G          ++         IL
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 60  QGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQM 112
           +  SG PNI +     +      LV DL+  G    +LF  +  +   S K    +   +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRKIMRAL 133

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           +  I  +H    +HRD+KP+N L  L    N + + DFG + +   
Sbjct: 134 LEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 19/164 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
           +Y+L  ++G G+F  +     V   +  A  I N    S   H +L  EA++ ++L+   
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-- 69

Query: 64  GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
             PNI + +     E +  L+ DL+  G    +LF  +  R  +S         Q++  +
Sbjct: 70  --PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQILEAV 123

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
            + H  G +HR++KP+N L+    K   V + DFGLA +     
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 48/255 (18%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------ENSGTKHPQL 49
           IG  Y   RK+GSG++GE+ L    + +   A+K+               +N    H ++
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93

Query: 50  LYEAKVYKILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTV 105
             E  + K L      PNI K + V + +    LV +   G  L +  +  R KF     
Sbjct: 94  YNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDA 148

Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
             +  Q+++ I Y+H    +HRDIKP+N L+        + I+DFGL+  +         
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-------- 200

Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAA 219
              + ++  GTA Y +       E  ++      D+ S G V++Y  L G  P+ G    
Sbjct: 201 KDYKLRDRLGTAYYIA------PEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG---Q 250

Query: 220 TKKQKYDKICEKKVS 234
             +    K+ + K  
Sbjct: 251 NDQDIIKKVEKGKYY 265

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 21/168 (12%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY---K 57
              KY     IG G    +    H  T    AVKI        +                
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151

Query: 58  ILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLAD 110
           IL+  +G P+I       +    + LV DL+  G    +LF  +  +   S K    +  
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            ++  + ++H+   +HRD+KP+N L  L      + + DFG +     
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEP 252

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 19/165 (11%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
               Y +  ++G G+F  +    H  T    A KI N    S     +L  EA++ + LQ
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86

Query: 61  GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
                PNI + +     E    LV DL+  G    +LF  +  R  +S         Q++
Sbjct: 87  H----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQIL 138

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
             I Y HS G +HR++KP+N L+    K   V + DFGLA +  D
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 17/160 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
            +     +GSG+F E+FL     T ++ A+K   ++   +   L  E  V K ++     
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH---- 65

Query: 66  PNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
            NI     + +   +  LV+ L+  G    +LF  +  R  ++ K   ++  Q+++ ++Y
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVLSAVKY 121

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           +H  G +HRD+KP+N L     + +++ I DFGL+K  ++
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 91.5 bits (228), Expect = 8e-21
 Identities = 43/188 (22%), Positives = 77/188 (40%), Gaps = 32/188 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
            Y +G ++GSG F  +       T    A K            G    ++  E  + + +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
                  N+   + V  +  D VL+L+L+  G    +LF +  +K SL  +       Q+
Sbjct: 73  LH----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124

Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
           +  + Y+H++   H D+KP+N ++         + +IDFGLA +             E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176

Query: 172 NLTGTARY 179
           N+ GT  +
Sbjct: 177 NIFGTPEF 184

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 21/173 (12%)

Query: 12  GRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
              +G G++G ++    +     +A+K   E        L  E  ++K L+      NI 
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82

Query: 69  KWYGVDGEDNVL--VLDLL-GPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           ++ G   E+  +   ++ + G SL  L    +   K + +T+     Q++  ++Y+H   
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
            +HRDIK DN L  +   +  + I DFG +K+               +  TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPCT-------ETFTGT 186

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.6 bits (228), Expect = 9e-21
 Identities = 70/262 (26%), Positives = 102/262 (38%), Gaps = 62/262 (23%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
              +   + L + +G G++GE+ LA +  T E VAVKI +   +          E  + K
Sbjct: 3   VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60

Query: 58  ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
           +L       N+ K+YG   E N+  L      LE     +LF              +R F
Sbjct: 61  MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111

Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
                     Q++A + Y+H  G  HRDIKP+N L  L  + N + I DFGLA  +R   
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159

Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQ 214
             R +       + GT  Y                    D+ S G ++L   L G LPW 
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCG-IVLTAMLAGELPWD 209

Query: 215 GLKAATKKQKYDKICEKKVSTP 236
               +   Q+Y    EKK    
Sbjct: 210 Q--PSDSCQEYSDWKEKKTYLN 229

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 45/223 (20%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
           +K    IGSG FG++F A H    +   +K      +  +   E K    L       NI
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAEREVKALAKLDH----VNI 66

Query: 69  -----KWYGVDGEDNVLVLDLLGPSLEDLFV---YC-------------RRKFSLKTVLM 107
                 W G D +      +      + LF+   +C               K      L 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           L +Q+   ++Y+HS+  ++RD+KP N  +       QV I DFGL    ++         
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDG------- 176

Query: 168 RENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
            +     GT RY S    +     +  +  DL +LG ++L  L
Sbjct: 177 -KRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALG-LILAEL 214

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 47/250 (18%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQ 60
            Y+L   IG G F  +    + +T +  AVKI        + G     L  EA +  +L+
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 61  GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLA 109
                P+I +       +  + +V + +       DL             +S        
Sbjct: 85  H----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYM 136

Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
            Q++  + Y H    +HRD+KP   L+     +  V +  FG+A +  +           
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLV 189

Query: 170 NKNLTGTARYAS----CNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQK 224
                GT  + +         G       D+   G V+L+  L G LP+ G    TK++ 
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFYG----TKERL 240

Query: 225 YDKICEKKVS 234
           ++ I + K  
Sbjct: 241 FEGIIKGKYK 250

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 32/188 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
            Y++G ++GSG F  +       T +  A K            G    ++  E  + + +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
           +     PNI   + +  +  D VL+L+L+  G    +LF +   +   +         Q+
Sbjct: 66  RH----PNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQI 117

Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
           +  + Y+HS+   H D+KP+N ++        ++ +IDFG+A K             E K
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--------AGNEFK 169

Query: 172 NLTGTARY 179
           N+ GT  +
Sbjct: 170 NIFGTPEF 177

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 47/234 (20%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----------E 52
           +II  +YK+  K+G G    ++LA     N  VA+K                       E
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFERE 61

Query: 53  AKVYKILQGGSGIPNI-KWY--GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLML 108
                 L       NI        + +   LV++ + GP+L +  +      S+ T +  
Sbjct: 62  VHNSSQLSH----QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEY-IESHGPLSVDTAINF 116

Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
            +Q++  I++ H    +HRDIKP N L+        + I DFG+AK   + +        
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLT------ 167

Query: 169 ENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQG 215
           +  ++ GT +Y S       EQ++        D+ S+G ++LY  L G  P+ G
Sbjct: 168 QTNHVLGTVQYFS------PEQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 38/274 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP----QLLYEAKVYKILQGG 62
            +++ +KIG G F E++ A+ +     VA+K ++             + E  + K L   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH- 91

Query: 63  SGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIAR 115
              PN+ K+Y    EDN L  VL+L     L  +  + +++      +TV     Q+ + 
Sbjct: 92  ---PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 116 IEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
           +E++HSR  +HRDIKP N F+         V + D GL + +   TT          +L 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAA-------HSLV 197

Query: 175 GTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
           GT  Y S    +       + + D+ SLG +L        P+ G           KI + 
Sbjct: 198 GTPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQC 253

Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
               P+     S   E     + C +   ++RPD
Sbjct: 254 DYP-PLPSDHYS--EELRQLVNMCINPDPEKRPD 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 29/278 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYKILQGGSGI 65
            +G++IGSGSFG ++       +  VAVK+ N     PQ L     E  V +  +     
Sbjct: 27  TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH---- 79

Query: 66  PNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHS 121
            NI  + G      + +V     G SL         KF +K ++ +A Q  AR ++Y+H+
Sbjct: 80  VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ-TARGMDYLHA 138

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           +  +HRD+K +N  +    + N V I DFGLA        +R     + + L+G+  + +
Sbjct: 139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLSGSILWMA 190

Query: 182 ---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
                       S + D+ + G VL   + G LP+  +      Q  + +    +S  + 
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSLSPDLS 248

Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
            +  + P         C     D+RP +  +     +L
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 89.0 bits (221), Expect = 7e-20
 Identities = 46/275 (16%), Positives = 94/275 (34%), Gaps = 40/275 (14%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
           ++G  IG G FG+++          VA+++ +    +   L     E   Y+  +     
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH---- 88

Query: 66  PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVH 120
            N+  + G         ++  L  G +L  +    +    +     +A + I + + Y+H
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE-IVKGMGYLH 147

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTGTARY 179
           ++G LH+D+K  N     G+    V I DFGL           R    R      G   +
Sbjct: 148 AKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQ---NGWLCH 200

Query: 180 ---------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
                    +       +  S+  D+ +LG +         P++   A        ++  
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIWQMGT 257

Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
                  ++       E +    +C +   ++RP 
Sbjct: 258 GMKPNLSQIGM---GKEISDILLFCWAFEQEERPT 289

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.9 bits (221), Expect = 8e-20
 Identities = 67/251 (26%), Positives = 97/251 (38%), Gaps = 56/251 (22%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
            Y++   IG GS+       H  TN   AVKI +          E    +IL      PN
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID--KSKRDPTEEI---EILLRYGQHPN 77

Query: 68  I-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
           I     V D    V +V +L+  G    +L   +  ++ FS +    +   +   +EY+H
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKTVEYLH 133

Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT---GT 176
           ++G +HRD+KP N L          + I DFG AK+ R           EN  L     T
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLMTPCYT 183

Query: 177 ARY------------ASCNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQ 223
           A +            A+C            D+ SLG VLLY  L G  P+      T ++
Sbjct: 184 ANFVAPEVLERQGYDAAC------------DIWSLG-VLLYTMLTGYTPFANGPDDTPEE 230

Query: 224 KYDKICEKKVS 234
              +I   K S
Sbjct: 231 ILARIGSGKFS 241

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 89.4 bits (222), Expect = 9e-20
 Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 19/180 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
            Y +  ++GSG+FG +       T  +   K  N         +  E  +   L      
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH---- 107

Query: 66  PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           P +   +    D  + VL+L+ L G  L D       K S   V+    Q    ++++H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +H DIKP+N +    +KA+ V IIDFGLA K          P    K  T TA +A+
Sbjct: 168 HSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFAA 218

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 88.2 bits (219), Expect = 9e-20
 Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 18/183 (9%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP-QLLYEAKVYKILQGGSGIPN 67
             G  +G G FG+    +H +T E++ +K +     +     L E KV + L+     PN
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH----PN 68

Query: 68  I-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVL-MLADQMIAR-IEYVHS 121
           + K+ GV  +D  L  + + + G +L  +      ++     +    D  IA  + Y+HS
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD--IASGMAYLHS 126

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
              +HRD+   N L+    +   V + DFGLA+   D  T      R  K      RY  
Sbjct: 127 MNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGL-RSLKKPDRKKRYTV 182

Query: 182 CNT 184
              
Sbjct: 183 VGN 185

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 37/186 (19%), Positives = 66/186 (35%), Gaps = 31/186 (16%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY---------EAKVYKILQ 60
           +  ++IG G FG +     V    +VA+K    G    +            E  +   L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 61  GGSGIPNI-KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
                PNI K YG+      +V++ +    L    +           L L    IA  IE
Sbjct: 82  H----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD-IALGIE 136

Query: 118 YVHSRG--FLHRDIKPDNFLMGLGRKANQVY--IIDFGLAKKYRDPTTNRHIPYRENKNL 173
           Y+ ++    +HRD++  N  +    +   V   + DFGL+++     +            
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL---------- 186

Query: 174 TGTARY 179
            G  ++
Sbjct: 187 LGNFQW 192

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 71/252 (28%), Positives = 106/252 (42%), Gaps = 45/252 (17%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVY 56
           +R IG  Y +   +G GSFG++ LA+H  T + VA+K  +         H ++  E    
Sbjct: 5   KRHIG-PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 57  KILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
           K+L+     P+I K Y V     D V+V++  G  L D  V  +++ +         Q+I
Sbjct: 64  KLLRH----PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQII 118

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             IEY H    +HRD+KP+N L  L    N V I DFGL+    D              L
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTD-----------GNFL 164

Query: 174 T---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK 224
               G+  YA     +   + G E     D+ S G ++LY  L G LP+           
Sbjct: 165 KTSCGSPNYAAPEVINGKLYAGPEV----DVWSCG-IVLYVMLVGRLPFDD---EFIPNL 216

Query: 225 YDKICEKKVSTP 236
           + K+       P
Sbjct: 217 FKKVNSCVYVMP 228

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 42/231 (18%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLY----EAKVYK 57
              G  Y+L R +G G  G+++ A       IVA+K+ +   +  P        EA+   
Sbjct: 31  TQFG-PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG 89

Query: 58  ILQGGSGIPNIKW---YGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
            LQ     P++     +G       + + L+ G  L  + +  +   +    + +  Q+ 
Sbjct: 90  RLQE----PHVVPIHDFGEIDGQLYVDMRLINGVDLAAM-LRRQGPLAPPRAVAIVRQIG 144

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIPYREN 170
           + ++  H+ G  HRD+KP+N L+      +  Y++DFG+A    D               
Sbjct: 145 SALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLG-------- 193

Query: 171 KNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLYFLRGSLPWQG 215
            N  GT  Y +       E+        R D+ +L  VL   L GS P+QG
Sbjct: 194 -NTVGTLYYMA------PERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 41/201 (20%), Positives = 67/201 (33%), Gaps = 41/201 (20%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
           ++    KIGSG FG +F         I A+K      +G+   Q  L E   + +L    
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL---G 68

Query: 64  GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARI 116
              ++ +++    ED+ +    +   G SL D      R    F    +  L  Q+   +
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYII---------------DFGLAKKYRDPT 160
            Y+HS   +H DIKP N F+                            D G   +   P 
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188

Query: 161 TNRHIPYRENKNLTGTARYAS 181
                         G +R+ +
Sbjct: 189 V-----------EEGDSRFLA 198

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 59/273 (21%), Positives = 99/273 (36%), Gaps = 70/273 (25%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGI 65
           +Y L  +IG GS+G + LA + + N   A+K+ +     +                  G 
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 66  ----------------------PNI-KWYGV---DGEDNV-LVLDLL-----------GP 87
                                 PN+ K   V     ED++ +V +L+            P
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 88  SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147
             ED     R  F           +I  IEY+H +  +HRDIKP N L+G   +   + I
Sbjct: 134 LSEDQ---ARFYFQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKI 178

Query: 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLL 204
            DFG++ +++              N  GT  + +    +    I   +  D+ ++G V L
Sbjct: 179 ADFGVSNEFKGSDALLS-------NTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTL 230

Query: 205 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
           Y F+ G  P+           + KI  + +  P
Sbjct: 231 YCFVFGQCPFMD---ERIMCLHSKIKSQALEFP 260

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 32/188 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
            Y +G ++GSG F  +       T    A K            G    ++  E  + + +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
                 PNI   + V  +  D VL+L+L+  G    +LF +  +K SL  +       Q+
Sbjct: 73  LH----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124

Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
           +  + Y+H++   H D+KP+N ++         + +IDFGLA +             E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176

Query: 172 NLTGTARY 179
           N+ GT  +
Sbjct: 177 NIFGTPEF 184

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 69/281 (24%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYK 57
           +  KY L   IG GS+G + +A    T  I A+KI       + +     ++  E ++ K
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83

Query: 58  ILQGGSGIPNIKW-YGV-DGEDNV-LVLDLL----------------------------- 85
            L      PNI   Y V + E  + LV++L                              
Sbjct: 84  KLHH----PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139

Query: 86  -----------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134
                        S+             K +  +  Q+ + + Y+H++G  HRDIKP+NF
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199

Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQS 191
           L     K+ ++ ++DFGL+K++       +          GT  + +    NT       
Sbjct: 200 LF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNT-TNESYG 254

Query: 192 RRDDLESLGYVLLYF-LRGSLP-W----QGLKAATKKQKYD 226
            + D  S G VLL+  L G++P          +    +K  
Sbjct: 255 PKCDAWSAG-VLLHLLLMGAVPFPGVNDADTISQVLNKKLC 294

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 19/213 (8%)

Query: 8   KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
            Y+L    +G G+   +    ++ T++  AVKI      H +     +V ++L    G  
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV-EMLYQCQGHR 71

Query: 67  NI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYV 119
           N+ +     + ED   LV + +  G     +   ++ RR F+     ++   + + ++++
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEASVVVQDVASALDFL 127

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H++G  HRD+KP+N L     + + V I DF L    +       I   E     G+A Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 180 AS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
            +       +       +R DL SLG V+LY L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 21/175 (12%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKHPQLLYEAKVYK 57
           ++      +   +G G+F +++ A+  D N     +   +K++       +     ++ +
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGTQLME 119

Query: 58  ILQGGSGIPNIKWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSLKTVLMLAD 110
            L+       +K+Y      N  VLV +L    +L +     +    +      V+  A 
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--------VYIIDFGLAKKYR 157
           +M+  IE VH    +H DIKPDNF++G G             + +ID G +   +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 32/188 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
            Y  G ++GSG F  +       T    A K            G     +  E  + K +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
           Q     PN+   + V  +  D +L+L+L+  G    +LF +   +   + +       Q+
Sbjct: 72  QH----PNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQI 123

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
           +  + Y+HS    H D+KP+N ++        ++ IIDFGLA K             E K
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------FGNEFK 175

Query: 172 NLTGTARY 179
           N+ GT  +
Sbjct: 176 NIFGTPEF 183

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 29/186 (15%)

Query: 8   KYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
            Y L  +++G G F  +       T +  A K             ++L+E     +L+  
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA---VLELA 85

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK----FSLKTVLMLADQMI 113
              P +   + V  +  + +L+L+    G    ++F  C  +     S   V+ L  Q++
Sbjct: 86  KSCPRVINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQIL 141

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             + Y+H    +H D+KP N L+        + I+DFG+++K             E + +
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREI 193

Query: 174 TGTARY 179
            GT  Y
Sbjct: 194 MGTPEY 199

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 15/162 (9%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
             II       + +G G  G++    +  T E  A+K+       P+   E    ++   
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 66

Query: 62  GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
            S  P+I +   V      G   + +V++ L  G     +     + F+ +    +   +
Sbjct: 67  ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
              I+Y+HS    HRD+KP+N L    R    + + DFG AK
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 44/256 (17%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVY 56
           M       Y++   IG+GS+G           +I+  K  + G+        L+ E  + 
Sbjct: 1   MPSRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59

Query: 57  KILQGGSGIPNI-KWYG--VDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLM 107
           + L+     PNI ++Y   +D  +  L  V++   G  L  +     ++      + VL 
Sbjct: 60  RELKH----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115

Query: 108 LADQMIARIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
           +  Q+   ++  H R       LHRD+KP N  +        V + DFGLA+     T+ 
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSF 172

Query: 163 RHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKA 218
                   K   GT  Y S    N    +  + + D+ SLG  LLY L     P+    A
Sbjct: 173 A-------KTFVGTPYYMSPEQMN---RMSYNEKSDIWSLG-CLLYELCALMPPFT---A 218

Query: 219 ATKKQKYDKICEKKVS 234
            ++K+   KI E K  
Sbjct: 219 FSQKELAGKIREGKFR 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 87.6 bits (217), Expect = 1e-18
 Identities = 44/231 (19%), Positives = 85/231 (36%), Gaps = 46/231 (19%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-ENSGTKHPQ--LLYEAKVY 56
            I+  +Y++   I  G  G I+LA  +D N     V +K   +SG    Q   + E +  
Sbjct: 76  DIVAGQYEVKGCIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL 133

Query: 57  KILQGGSGIPNIKWYGVDGEDNV-----LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLAD 110
             +     I  I  +    + +      +V++ + G SL+       +K  +   +    
Sbjct: 134 AEVVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLL 189

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
           +++  + Y+HS G ++ D+KP+N ++       Q+ +ID G   +               
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGY--------- 236

Query: 171 KNLTGTARYASCNTHLGIEQSR-----RDDLESLGYVLLY-FLRGSLPWQG 215
             L GT  + +       E  R       D+ ++G   L           G
Sbjct: 237 --LYGTPGFQA------PEIVRTGPTVATDIYTVG-RTLAALTLDLPTRNG 278

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 19/160 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
           +Y   + IGSG+FG   L     T E+VAVK    G    + +  E   ++ L+     P
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH----P 76

Query: 67  NI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY--CRRKFSLKTVLMLADQMIARIEY 118
           NI ++  V      L +      +E     +L+       +FS         Q+++ + Y
Sbjct: 77  NIVRFKEVILTPTHLAI-----IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            HS    HRD+K +N L+  G  A ++ I DFG +K    
Sbjct: 132 CHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 42/221 (19%)

Query: 5   IGVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
               Y L    + +G GSF       H  +N+  AVKI +   K  +   + ++   L+ 
Sbjct: 6   FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEI-TALKL 61

Query: 62  GSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
             G PNI K + V   + +  LV++LL  G    +LF  +  ++ FS      +  ++++
Sbjct: 62  CEGHPNIVKLHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVS 117

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            + ++H  G +HRD+KP+N L        ++ IIDFG A+              +N+ L 
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLK 167

Query: 175 ---GTARYAS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
               T  YA+      N +         DL SLG V+LY +
Sbjct: 168 TPCFTLHYAAPELLNQNGY-----DESCDLWSLG-VILYTM 202

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)

Query: 8   KYKLGRK--IGSGSFGEIFLASHVDTNEIVAVK-IENSGTK-HPQLLYEAKVYKILQGGS 63
            Y + +   +G G FG++       T   +A K I+  G K   ++  E  V   L    
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-- 145

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
              N+ + Y       D VLV++ + G  L D  +      +    ++   Q+   I ++
Sbjct: 146 --ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H    LH D+KP+N L  + R A Q+ IIDFGLA++Y+        P  + K   GT  +
Sbjct: 204 HQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREKLKVNFGTPEF 254

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 41/162 (25%), Positives = 64/162 (39%), Gaps = 26/162 (16%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
           KY   +KIG GSFG+  L    +      +K  N          +   E  V   ++   
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-- 82

Query: 64  GIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCRRK----FSLKTVLMLADQMI 113
             PNI ++     E+  L +      ++     DLF     +    F    +L    Q+ 
Sbjct: 83  --PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
             +++VH R  LHRDIK  N  +    K   V + DFG+A+ 
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARV 174

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 27/178 (15%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
           ++   +G G+FG +  A      + VA+K   S ++    + E +    +      PNI 
Sbjct: 11  EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH----PNIV 64

Query: 69  KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIAR-IEYVHSR-- 122
           K YG       LV++   G SL ++         ++    +    Q  ++ + Y+HS   
Sbjct: 65  KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ-CSQGVAYLHSMQP 123

Query: 123 -GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
              +HRD+KP N L  L      + I DFG A   +   TN            G+A +
Sbjct: 124 KALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMTNN----------KGSAAW 169

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 52/299 (17%), Positives = 101/299 (33%), Gaps = 58/299 (19%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKILQGGSGI- 65
            Y++ R +  G F +I L      N+  A+K  E S  +  +   ++   KI        
Sbjct: 32  DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 66  -------------PNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRR-------KFS 101
                               G+    D V ++ + +   S+     Y             
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 102 LKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           ++ +  +   ++    Y+H+ +   HRD+KP N LM    K  +V + DFG ++      
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESE------ 200

Query: 161 TNRHIPYRENKNLT---GTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
                 Y  +K +    GT  +      +         + D+ SLG + LY      +P+
Sbjct: 201 ------YMVDKKIKGSRGTYEFMPPEFFSNESSY-NGAKVDIWSLG-ICLYVMFYNVVPF 252

Query: 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272
                 +  + ++ I  K +  P++     +P            L+ +      FLK  
Sbjct: 253 SL--KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI---DFLKLF 306

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 15/161 (9%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           +   +++  ++G G+   ++      T +  A+K+         +  E  V   L     
Sbjct: 51  LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH--- 107

Query: 65  IPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIE 117
            PNI K   + +    + LVL+L+  G    +LF  +  +  +S +       Q++  + 
Sbjct: 108 -PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEAVA 162

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           Y+H  G +HRD+KP+N L         + I DFGL+K    
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.0 bits (206), Expect = 6e-18
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 16/161 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
           KY+   KIG GS+G +F   + DT +IVA+K      ++   K    L E ++ K L+  
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKH- 61

Query: 63  SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
              PN+     V        LV +    ++       +R      V  +  Q +  + + 
Sbjct: 62  ---PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           H    +HRD+KP+N L+    K + + + DFG A+    P+
Sbjct: 119 HKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPS 156

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 16/162 (9%)

Query: 8   KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
            Y+L ++ +G G  G++    H  T +  A+K+       P+   E          SG P
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQEVD---HHWQASGGP 82

Query: 67  NI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
           +I     V      G+  + ++++ +  G     +     + F+ +    +   +   I+
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           ++HS    HRD+KP+N L     K   + + DFG AK+    
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 69/282 (24%), Positives = 107/282 (37%), Gaps = 53/282 (18%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
           +R I     L   IG G FGE++        E VAVKI +S  +      EA++Y+ +  
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVML 93

Query: 62  GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
                NI  +   D +DN       LV D     SL D     R   +++ ++ LA    
Sbjct: 94  RH--ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS-T 148

Query: 114 AR-IEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           A  + ++H             HRD+K  N L+   +K     I D GLA ++   T    
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID 205

Query: 165 IPYRENKNLTGTARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGS------ 210
           I      +  GT RY        +    H   E  +R D+ ++G V     R        
Sbjct: 206 IA---PNHRVGTKRYMAPEVLDDSINMKHF--ESFKRADIYAMGLVFWEIARRCSIGGIH 260

Query: 211 ----LPWQGLKA--ATKKQKYDKICEKKVSTPIEVLCKSHPA 246
               LP+  L     + ++    +CE+K+   I    +S  A
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 302

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 82.8 bits (205), Expect = 8e-18
 Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 23/160 (14%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           Y+L   IGSG+   +  A      E VA+K    E   T   +LL E +           
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH---- 72

Query: 66  PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
           PNI  +Y   V  ++  LV+ LL G S+ D+  +   K   K+ ++     IA I     
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVL 131

Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
              EY+H  G +HRD+K  N L+G   +   V I DFG++
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVS 168

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 66/251 (26%), Positives = 98/251 (39%), Gaps = 53/251 (21%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGG 62
            Y LG  +G G+FG++ +  H  T   VAVKI N     S     ++  E +  K+ +  
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH- 70

Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYC--RRKFSLKTVLMLADQMIA 114
              P+I K Y V        +      +E     +LF Y     +        L  Q+++
Sbjct: 71  ---PHIIKLYQVISTPTDFFM-----VMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            ++Y H    +HRD+KP+N L  L    N   I DFGL+    D            + L 
Sbjct: 123 AVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD-----------GEFLR 168

Query: 175 ---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225
              G+  YA     S   + G E     D+ S G V+LY L  G+LP+           +
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEV----DIWSCG-VILYALLCGTLPFDD---EHVPTLF 220

Query: 226 DKICEKKVSTP 236
            KI       P
Sbjct: 221 KKIRGGVFYIP 231

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 31/195 (15%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
           +R I  + ++ ++IG G +GE+++       E VAVK+  +  +      E ++Y+ +  
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTVLM 88

Query: 62  GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
                NI  +   D +         L+ D     SL D           K++L LA    
Sbjct: 89  RH--ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYS-S 143

Query: 114 AR-IEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
              + ++H+  F         HRD+K  N L+   +K     I D GLA K+   T    
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVD 200

Query: 165 IPYRENKNLTGTARY 179
           IP        GT RY
Sbjct: 201 IP---PNTRVGTKRY 212

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 55/241 (22%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTKHPQLLY--------- 51
             +  +Y+LG  +G G   E+ LA   D   +  VAVK+         L           
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLA--RDLRDHRDVAVKV-----LRADLARDPSFYLRFR 60

Query: 52  -EAKVYKILQGGSGIPNI-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFS 101
            EA+    L      P I   Y   GE          +V++ + G +L D+ V+     +
Sbjct: 61  REAQNAAALNH----PAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMT 114

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            K  + +       + + H  G +HRD+KP N ++      N V ++DFG+A+   D   
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN 171

Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQ 214
                  +   + GTA+Y S       EQ+R      R D+ SLG  +LY  L G  P+ 
Sbjct: 172 ----SVTQTAAVIGTAQYLS------PEQARGDSVDARSDVYSLG-CVLYEVLTGEPPFT 220

Query: 215 G 215
           G
Sbjct: 221 G 221

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 16/160 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
           KY+    +G GS+G +    + DT  IVA+K      ++   K    + E K+ K L+  
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRH- 83

Query: 63  SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
               N+     V  +     LV + +  ++ D           + V     Q+I  I + 
Sbjct: 84  ---ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           HS   +HRDIKP+N L+    ++  V + DFG A+    P
Sbjct: 141 HSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP 177

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 15/166 (9%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
             II       + +G G  G++    +  T E  A+K+       P+   E    ++   
Sbjct: 57  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 110

Query: 62  GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
            S  P+I +   V      G   + +V++ L  G     +     + F+ +    +   +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
              I+Y+HS    HRD+KP+N L    R    + + DFG AK+   
Sbjct: 171 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 40/167 (23%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
            Y+L RK+G G + E+F A ++  NE V VKI     K  ++  E K+ + L+GG   PN
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGG---PN 92

Query: 68  IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD----------------- 110
           I          + + D++   +            +   +   D                 
Sbjct: 93  I----------ITLADIVKDPVSRTPAL------VFEHVNNTDFKQLYQTLTDYDIRFYM 136

Query: 111 -QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
            +++  ++Y HS G +HRD+KP N +  +  +  ++ +ID+GLA+ Y
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFY 181

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYK 57
           +R   V Y   + IG+GSFG ++ A   D+ E+VA+K      K  Q       E ++ +
Sbjct: 49  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMR 102

Query: 58  ILQGGSGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLML 108
            L       NI   +++     + +D V   LVLD +    E ++   R     K  L +
Sbjct: 103 KLDH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPV 155

Query: 109 AD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
                   Q+   + Y+HS G  HRDIKP N L  L      + + DFG AK+      N
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLVRGEPN 213

Query: 163 RH 164
             
Sbjct: 214 VS 215

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 20/172 (11%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKIL- 59
           E     +Y L RK+G G F  ++LA  +  N  VA+KI             E K+ + + 
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73

Query: 60  ------QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTV 105
                 +   G  +I          G +G   V+V ++LG +L  L      R   L  V
Sbjct: 74  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133

Query: 106 LMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRK---ANQVYIIDFGLA 153
             ++ Q++  ++Y+H R G +H DIKP+N LM +        Q+ I D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.9 bits (198), Expect = 6e-17
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
           KY+   KIG G++G +F A + +T+EIVA+K      ++ G      L E  + K L+  
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKH- 60

Query: 63  SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
               NI + + V   D    LV +     L+  F  C      + V     Q++  + + 
Sbjct: 61  ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           HSR  LHRD+KP N L+    +  ++ + +FGLA+ +  P 
Sbjct: 118 HSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPV 155

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 48/181 (26%), Positives = 71/181 (39%), Gaps = 34/181 (18%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGT--------------KHPQ 48
           KY+   KIG G+FGE+F A H  T + VA+K      E  G               KH  
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77

Query: 49  L--LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL 106
           +  L E    K         +I  Y        LV D     L  L      KF+L  + 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSI--Y--------LVFDFCEHDLAGLLSNVLVKFTLSEIK 127

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
            +   ++  + Y+H    LHRD+K  N L+    +   + + DFGLA+ +     ++   
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 167 Y 167
           Y
Sbjct: 185 Y 185

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 44/176 (25%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKIL 59
           IG  Y LG  +G G+FG++ +  H  T   VAVKI N     S     ++  E +  K+ 
Sbjct: 15  IG-HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73

Query: 60  QGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKFSL 102
           +     P+I K Y V    + + +      +E     +LF Y            RR F  
Sbjct: 74  RH----PHIIKLYQVISTPSDIFM-----VMEYVSGGELFDYICKNGRLDEKESRRLFQ- 123

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
                   Q+++ ++Y H    +HRD+KP+N L  L    N   I DFGL+    D
Sbjct: 124 --------QILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 41/175 (23%), Positives = 81/175 (46%), Gaps = 32/175 (18%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           ++L   +G+G++G+++   HV T ++ A+K ++ +G +  ++  E     +L+  S   N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSHHRN 82

Query: 68  I-KWYG------VDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
           I  +YG        G D+ L  V++     S+ DL    +          L ++ IA I 
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYIC 135

Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
                   ++H    +HRDIK  N L+    +  +V ++DFG++ +       R+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRN 187

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 67/258 (25%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
           +K G+ +G GSF  + LA  + T+   A+KI                 E    S   HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 48  --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
             +L +    + K+Y  L           Y  +GE               L  Y R+   
Sbjct: 92  FVKLYFTFQDDEKLYFGLS----------YAKNGE---------------LLKYIRKIGS 126

Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           F          ++++ +EY+H +G +HRD+KP+N L+    +   + I DFG AK     
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE 183

Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
           +           +  GTA+Y S          +  DL +LG  ++Y  + G  P+   +A
Sbjct: 184 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF---RA 234

Query: 219 ATKKQKYDKICEKKVSTP 236
             +   + KI + +   P
Sbjct: 235 GNEYLIFQKIIKLEYDFP 252

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 74/259 (28%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI------------EN--------SGTKHP---QL 49
           R IG GSFG++ +    DT ++ A+K              N         G +HP    L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 50  LY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFS 101
            Y    E  ++                       +V+DLL  G    DL  + ++   F 
Sbjct: 81  WYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQQNVHFK 113

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            +TV +   +++  ++Y+ ++  +HRD+KPDN L+    +   V+I DF +A      T 
Sbjct: 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQ 170

Query: 162 NRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
                      + GT  Y +    ++  G   S   D  SLG V  Y  LRG  P+    
Sbjct: 171 --------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRRPYHIRS 221

Query: 218 AATKKQKYDKICEKKVSTP 236
           + + K+         V+ P
Sbjct: 222 STSSKEIVHTFETTVVTYP 240

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 42/223 (18%), Positives = 75/223 (33%), Gaps = 40/223 (17%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI--PN 67
           KL   IG G +G ++  S       VAVK+ +   +    + E  +Y++      +   N
Sbjct: 16  KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ-NFINEKNIYRV----PLMEHDN 68

Query: 68  I-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
           I ++   D            LV++     SL              +   LA  +   + Y
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAY 126

Query: 119 VHS---------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIPYR 168
           +H+             HRD+   N L+   +      I DFGL+ +   +          
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183

Query: 169 ENKNLTGTARY-------ASCNTHLGIEQSRRDDLESLGYVLL 204
              +  GT RY        + N        ++ D+ +LG +  
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 15/154 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
            +   R+IG GSFG ++ A  V  +E+VA+K      + S  K   ++ E +  + L+  
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113

Query: 63  SGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
              PN  ++ G  +      LV++    S  DL    ++      +  +    +  + Y+
Sbjct: 114 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
           HS   +HRD+K  N L+    +   V + DFG A
Sbjct: 171 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
           +Y+    +G G F  ++ A   +TN+IVA   +K+ +       +    L E K+ + L 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 61  GGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTV--LMLADQMIAR 115
                PNI       G  +   LV D +   LE +        +   +   ML    +  
Sbjct: 71  H----PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML--MTLQG 124

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           +EY+H    LHRD+KP+N L+    +   + + DFGLAK +  P 
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPN 166

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 46/195 (23%), Positives = 71/195 (36%), Gaps = 29/195 (14%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           M+R +     L   +G G +GE++  S     E VAVKI +S  +      E ++Y  + 
Sbjct: 2   MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEK-SWFRETELYNTVM 58

Query: 61  GGSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM 112
                 NI  +   D           L+       SL D            + L +   +
Sbjct: 59  LRH--ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSI 114

Query: 113 IARIEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
            + + ++H   F         HRD+K  N L+   +K  Q  I D GLA  +   T    
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLD 171

Query: 165 IPYRENKNLTGTARY 179
           +    N    GT RY
Sbjct: 172 VG---NNPRVGTKRY 183

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 45/189 (23%), Positives = 71/189 (37%), Gaps = 37/189 (19%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGS 63
            L   IG G FG+++ A  +     VAVK                +  EAK++ +L+   
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-- 65

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEY 118
             PNI    GV     +  LV++   G  L  +     ++     ++  A Q IAR + Y
Sbjct: 66  --PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQ-IARGMNY 120

Query: 119 VHSRG---FLHRDIKPDNFLMGLGRKANQVY-----IIDFGLAKKYRDPTTNRHIPYREN 170
           +H       +HRD+K  N L+    +   +      I DFGLA         R       
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---------REWHRTTK 171

Query: 171 KNLTGTARY 179
            +  G   +
Sbjct: 172 MSAAGAYAW 180

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.9 bits (190), Expect = 9e-16
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
            Y    K+G G++  ++      T+ +VA+K   +E+        + E  + K L+    
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH--- 59

Query: 65  IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
             NI   + +   +    LV + L   L+     C    ++  V +   Q++  + Y H 
Sbjct: 60  -ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNR 163
           +  LHRD+KP N L+    +  ++ + DFGLA+    PT    N 
Sbjct: 119 QKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNE 160

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 37/209 (17%), Positives = 83/209 (39%), Gaps = 14/209 (6%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQ-- 60
           +   +Y + RK+G G F  ++L+  +   + VA+K+  S   + +  L E ++ K ++  
Sbjct: 34  LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93

Query: 61  -----GGSGIPNI----KWYGVDGEDNVLVLDLLGPSLEDL-FVYCRRKFSLKTVLMLAD 110
                    +  +    K  GV+G    +V ++LG  L         +   L  V  +  
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 111 QMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
           Q++  ++Y+H++   +H DIKP+N L+ +  +  +    +    ++   P  +       
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLES 198
                          +    + +  DL +
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGN 242

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 66/278 (23%), Positives = 104/278 (37%), Gaps = 54/278 (19%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
            +  KIG+GSFG +  A        VAVKI      H + +     E  + K L+     
Sbjct: 40  NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH---- 93

Query: 66  PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR-IEY 118
           PNI  + G      +  +V + L   SL  L      R +   +  L +A   +A+ + Y
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD-VAKGMNY 152

Query: 119 VHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTG 175
           +H+R    +HR++K  N L+    K   V + DFGL++ K     +        +K+  G
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLS--------SKSAAG 201

Query: 176 TARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
           T  +           N     E+S   D+ S G +L        PW  L  A   Q    
Sbjct: 202 TPEWMAPEVLRDEPSN-----EKS---DVYSFGVILWELATLQQPWGNLNPA---QVVAA 250

Query: 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
           +  K     I         + A+    C +    +RP 
Sbjct: 251 VGFKCKRLEIPRNL---NPQVAAIIEGCWTNEPWKRPS 285

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 37/159 (23%), Positives = 75/159 (47%), Gaps = 12/159 (7%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
            +  +Y++ + IG GSFG++  A     ++ VA+K + N    H Q   E ++ + L+  
Sbjct: 94  HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ 153

Query: 63  SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
               +     +   +N        +  +LL  +L +L    + + FSL  V   A  ++ 
Sbjct: 154 D--KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
            ++ +H    +H D+KP+N L+   +  + + +IDFG +
Sbjct: 212 CLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS 249

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 60/245 (24%), Positives = 92/245 (37%), Gaps = 46/245 (18%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGI 65
           R IG G FGE++     DT ++ A+K           G      L E  +  ++  G   
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDC- 251

Query: 66  PNIK--WYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
           P I    Y     D +  +LDL+  G    DL   +     FS   +   A ++I  +E+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGG----DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H+R  ++RD+KP N L+    +   V I D GLA  +     +            GT  
Sbjct: 308 MHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH---------ASVGTHG 355

Query: 179 Y------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEK 231
           Y           +         D  SLG  +L+  LRG  P++  K   K +        
Sbjct: 356 YMAPEVLQKGVAY-----DSSADWFSLG-CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409

Query: 232 KVSTP 236
            V  P
Sbjct: 410 AVELP 414

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 16/163 (9%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           +    KIG GSFGE+F      T ++VA+KI   E +  +   +  E  V          
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79

Query: 66  PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           P + K+YG  +      ++++ L G S  DL            +  +  +++  ++Y+HS
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL--LEPGPLDETQIATILREILKGLDYLHS 137

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
              +HRDIK  N L+    +  +V + DFG+A +  D    R+
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN 177

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 56/234 (23%), Positives = 81/234 (34%), Gaps = 44/234 (18%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
             +L      G FG ++ A     NE VAVKI     K      E +VY +     G+  
Sbjct: 25  PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQ-SWQNEYEVYSL----PGMKH 77

Query: 66  PNI-KWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
            NI ++ G +     + +DL          SL D         S   +  +A+ M   + 
Sbjct: 78  ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLA 135

Query: 118 YVHSRGF----------LHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP 166
           Y+H               HRDIK  N L+    K N    I DFGLA K+    +     
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTACIADFGLALKFEAGKS----- 186

Query: 167 YRENKNLTGTARY-----ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
             +     GT RY          +   +   R D+ ++G VL           G
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 11/161 (6%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
            + +  K+G GS+G ++ A H +T +IVA+K     +   +++ E  + +        P+
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS----PH 85

Query: 68  I-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           + K+YG      D  +V++     S+ D+     +  +   +  +    +  +EY+H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
            +HRDIK  N L+          + DFG+A +  D    R+
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRN 183

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 50/162 (30%), Positives = 72/162 (44%), Gaps = 19/162 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHP-QLLYEAKVYKILQG 61
           KY    KIG G++G ++ A + +  E  A+K      E+ G   P   + E  + K L+ 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGI--PSTTIREISILKELKH 59

Query: 62  GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
                NI K Y V       VLV + L   L+ L   C       T      Q++  I Y
Sbjct: 60  ----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
            H R  LHRD+KP N L+    +  ++ I DFGLA+ +  P 
Sbjct: 116 CHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPV 154

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 19/163 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHP-QLLYEAKVYKILQG 61
            ++   KIG G++G ++ A +  T E+VA+K      E  G   P   + E  + K L  
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELNH 61

Query: 62  GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIE 117
               PNI K   V   +N   LV + L   L+            L  +     Q++  + 
Sbjct: 62  ----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           + HS   LHRD+KP N L+        + + DFGLA+ +  P 
Sbjct: 118 FCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPV 157

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.1 bits (183), Expect = 6e-15
 Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 17/161 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
           KY+   K+G G++G ++ A       IVA+K      E+ G      + E  + K L   
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHH- 78

Query: 63  SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
              PNI     V   +    LV + +   L+ +    +       + +   Q++  + + 
Sbjct: 79  ---PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
           H    LHRD+KP N L+        + + DFGLA+ +  P 
Sbjct: 136 HQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPV 173

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQ-LLYEAKVYKILQG 61
           +Y+   K+G G++GE++ A    TNE VA+K      E  G   P   + E  + K LQ 
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQH 92

Query: 62  GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
                NI +   V   ++   L+ +     L+          S++ +     Q+I  + +
Sbjct: 93  ----RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNF 147

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKAN--QVYIIDFGLAKKYRDPT 160
            HSR  LHRD+KP N L+ +   +    + I DFGLA+ +  P 
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 33/163 (20%), Positives = 74/163 (45%), Gaps = 13/163 (7%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
            +++  ++G G+FG+++ A + +T  + A K+    S  +    + E ++          
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH---- 75

Query: 66  PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           P I K  G         ++++   G +++ + +   R  +   + ++  QM+  + ++HS
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
           +  +HRD+K  N LM L      + + DFG++ K       R 
Sbjct: 136 KRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRD 175

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 38/189 (20%), Positives = 65/189 (34%), Gaps = 36/189 (19%)

Query: 8   KYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLY-EAKVYKILQG 61
            Y+L   IG G      + LA +  T E V V+    E    +    L  E  V K+   
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85

Query: 62  GSGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM--LADQMIAR 115
               PNI  +    +   +  +V   +   S +DL         + T  M  + +  IA 
Sbjct: 86  ----PNIVPYRATFIADNELWVVTSFMAYGSAKDL---------ICTHFMDGMNELAIAY 132

Query: 116 I--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
           I        +Y+H  G++HR +K  + L+       +VY+               + + +
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 168 RENKNLTGT 176
              K     
Sbjct: 190 DFPKYSVKV 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 20/170 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
           +Y+   +IG G++G ++ A    +   VA   V++ N G     L    + E  + + L+
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 61  GGSGIPNI-------KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQ 111
                PN+            D E  V LV + +   L              +T+  L  Q
Sbjct: 70  AFEH-PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            +  ++++H+   +HRD+KP+N L+        V + DFGLA+ Y     
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMA 175

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 31/171 (18%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++  N     K   ++ E  V +  +     
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---- 76

Query: 66  PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
           PNI  +    + G++  +V++ L G SL D+               + +  IA +     
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECL 126

Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
              E++HS   +HRDIK DN L+G+      V + DFG   +     + R 
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRS 174

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 37/239 (15%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
           IG G+FGE+ L  H  T ++ A+K+        +++  +          I+   +   + 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132

Query: 67  NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG 123
            + +   D     +V++ +  G    DL           K       +++  ++ +HS G
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGG----DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS-- 181
           F+HRD+KPDN L+    K+  + + DFG   K       R           GT  Y S  
Sbjct: 189 FIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVR------CDTAVGTPDYISPE 239

Query: 182 --CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
              +        R  D  S+G V LY  L G  P+    A +    Y KI   K S   
Sbjct: 240 VLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTPF---YADSLVGTYSKIMNHKNSLTF 294

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 24/159 (15%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
           K  R +G G FG++ L     ++  T E+VAVK    ++G +H      E  + + L   
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH- 92

Query: 63  SGIPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIAR- 115
               +I K+ G     G  ++ LV++ +   L  L  Y  R    L  +L+ A Q I   
Sbjct: 93  ---EHIIKYKGCCEDAGAASLQLVMEYV--PLGSLRDYLPRHSIGLAQLLLFAQQ-ICEG 146

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           + Y+H++ ++HRD+   N L+        V I DFGLAK
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 34/196 (17%), Positives = 64/196 (32%), Gaps = 46/196 (23%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------------------------- 38
           KY LG+ +G+GSFG +     +++ +  A+K                             
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67

Query: 39  -----IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDL 92
                 +             K+     G +               + ++++ +    + L
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DTL 124

Query: 93  FVYCRRKFSLKTVLMLAD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
               +        + +        Q+   + ++HS G  HRDIKP N L  +  K N + 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTLK 182

Query: 147 IIDFGLAKKYRDPTTN 162
           + DFG AKK      +
Sbjct: 183 LCDFGSAKKLIPSEPS 198

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 27/170 (15%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
            K   +IG GSF  ++     +T   VA       + + ++  +   EA++ K LQ    
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84

Query: 65  IPNI-----KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIA 114
            PNI      W         +  V +L+   +L+    Y +R     +K +     Q++ 
Sbjct: 85  -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILK 140

Query: 115 RIEYVHSRG--FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            ++++H+R    +HRD+K DN F+ G       V I D GLA   R    
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFA 187

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 18/164 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++K   K+G+G++  ++   +  T   VA+K   +++        + E  + K L+    
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH--- 62

Query: 65  IPNI-KWYGVDGEDN--VLVLDLLGPSLEDL-----FVYCRRKFSLKTVLMLADQMIARI 116
             NI + Y V   +N   LV + +   L+            R   L  V     Q++  +
Sbjct: 63  -ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
            + H    LHRD+KP N L+    K  Q+ + DFGLA+ +  P 
Sbjct: 122 AFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPV 162

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 19/171 (11%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGSGIP 66
            LG +IG G+FGE+F       N +VAVK              L EA++ K        P
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH----P 172

Query: 67  NI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           NI +  GV    +   +V++L+ G            +  +KT+L +     A +EY+ S+
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYR 168
             +HRD+   N L+    + N + I DFG++++  D           +P +
Sbjct: 233 CCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 31/171 (18%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
                 KIG GS G + LA    +   VAVK+ +     +   L  E  + +  Q     
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH---- 101

Query: 66  PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
            N+ + Y   + GE+  ++++ L G +L D+           + + L ++ IA +     
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----------SQVRLNEEQIATVCEAVL 151

Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
               Y+H++G +HRDIK D+ L+ L     +V + DFG   +       R 
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRK 199

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 35/177 (19%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
           + Y   + IG+GSFG +F A  V+++E VA+K      K  Q       E ++ +I++  
Sbjct: 40  IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK------KVLQDKRFKNRELQIMRIVKH- 91

Query: 63  SGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--- 110
              PN+   K +     D +D V   LVL+ +    E ++   R    LK  + +     
Sbjct: 92  ---PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKL 145

Query: 111 ---QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
              Q++  + Y+HS G  HRDIKP N L  L   +  + +IDFG AK       N  
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 24/160 (15%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
           K  R +G G FG++ L        +T E VAVK     SG  H   L  E ++ + L   
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH- 82

Query: 63  SGIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
               NI K+ G+   DG + + L+++ L  G SL++     + K +LK  L  A Q I +
Sbjct: 83  ---ENIVKYKGICTEDGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQLKYAVQ-ICK 137

Query: 116 -IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            ++Y+ SR ++HRD+   N L+      +QV I DFGL K
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 22/175 (12%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVD--TNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
           ER+  +    G K+G G++G ++ A   D   ++  A+K IE +G        E  + + 
Sbjct: 16  ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRE 74

Query: 59  LQGGSGIPNI-KWYGV---DGEDNV-LVLD--------LLGPSLEDLFVYCRRKFSLKTV 105
           L+     PN+     V     +  V L+ D        ++             +     V
Sbjct: 75  LKH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
             L  Q++  I Y+H+   LHRD+KP N L MG G +  +V I D G A+ +  P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 23/159 (14%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
           K  +++G G+FG + +        +T E+VAVK    ++         E ++ K LQ   
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 70

Query: 64  GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
              NI K+ GV    G  N+ L+++ L  G SL D     + +     +L    Q I + 
Sbjct: 71  --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 126

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +EY+ ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 127 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 23/159 (14%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGGS 63
           K  +++G G+FG + +        +T E+VAVK     T+        E ++ K LQ   
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 101

Query: 64  GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
              NI K+ GV    G  N+ L+++ L  G SL D     + +     +L    Q I + 
Sbjct: 102 --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 157

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +EY+ ++ ++HRD+   N L+      N+V I DFGL K
Sbjct: 158 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 30/149 (20%), Positives = 70/149 (46%), Gaps = 13/149 (8%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
           ++GSG+ G+++      T  ++AVK      +  ++ ++L +     ++      P I +
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSHDCPYIVQ 88

Query: 70  WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLH 126
            +G  +   D  + ++L+G   E L    +     + +  +   ++  + Y+    G +H
Sbjct: 89  CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148

Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           RD+KP N L+    +  Q+ + DFG++ +
Sbjct: 149 RDVKPSNILLD---ERGQIKLCDFGISGR 174

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 40/242 (16%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
           IG G+FGE+ +    + +++ A+KI        ++L  A+         +L  G    I 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREERDVLVNGDSKWIT 137

Query: 67  NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHS 121
            + +   D  +  LV+D    G    DL     +   +   +       +M+  I+ VH 
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGG----DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
             ++HRDIKPDN LM        + + DFG   K  +  T +      +    GT  Y S
Sbjct: 194 LHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYIS 244

Query: 182 CNTHLGIEQSRRD-----DLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
                 +E  +       D  SLG V +Y  L G  P+    A +  + Y KI   K   
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYGETPFY---AESLVETYGKIMNHKERF 300

Query: 236 PI 237
             
Sbjct: 301 QF 302

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 23/159 (14%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
           K   ++G G+FG + L        +T  +VAVK +++SG    +    E ++ K L    
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-- 83

Query: 64  GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
               I K+ GV    G  ++ LV++ L  G  L D     R +     +L+ + Q I + 
Sbjct: 84  --DFIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQ-ICKG 139

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +EY+ SR  +HRD+   N L+        V I DFGLAK
Sbjct: 140 MEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 54/245 (22%), Positives = 86/245 (35%), Gaps = 44/245 (17%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
           IG G+F E+ +     T ++ A+K       ++           E     +L  G    I
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC--FREERD---VLVNGDRRWI 123

Query: 66  PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
             + +   D     LV++    G    DL     +   +   +       +++  I+ VH
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGG----DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY- 179
             G++HRDIKPDN L+    +   + + DFG   K R   T R      +    GT  Y 
Sbjct: 180 RLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVR------SLVAVGTPDYL 230

Query: 180 ------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKK 232
                 A              D  +LG V  Y    G  P+    A +  + Y KI   K
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMFYGQTPFY---ADSTAETYGKIVHYK 286

Query: 233 VSTPI 237
               +
Sbjct: 287 EHLSL 291

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 40/175 (22%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK-----ILQG 61
            ++++ R  G G+FG + L     T   VA+K      K    + +   ++     I+Q 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------K----VIQDPRFRNRELQIMQD 72

Query: 62  GSGI--PNI---KWY----GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA 109
            + +  PNI   + Y    G     ++   +V++ +    + L   CR  +  +      
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPI 129

Query: 110 D------QMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
                  Q+I  I  +H  S    HRDIKP N L  +      + + DFG AKK 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 14/161 (8%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
               +Y++   IG GSFG++  A      E VA+K I+N      Q   E ++ +++   
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110

Query: 63  SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIA 114
                +K+Y V  + +        LV ++L  +L DL      R  SL      A QM  
Sbjct: 111 D--TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168

Query: 115 RIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
            + ++ +     +H D+KP+N L+    K + + I+DFG +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSS 208

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 72/258 (27%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
           +   + +G+GSFG + L  H ++    A+KI                 E         P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 48  --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
             +L +     + +Y +++  +G          GE               +F + RR  +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAG----------GE---------------MFSHLRRIGR 137

Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
           FS       A Q++   EY+HS   ++RD+KP+N L+    +   + + DFG AK+ +  
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR 194

Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
           T            L GT    +    L    ++  D  +LG VL+Y    G  P+    A
Sbjct: 195 T----------WTLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF---FA 240

Query: 219 ATKKQKYDKICEKKVSTP 236
               Q Y+KI   KV  P
Sbjct: 241 DQPIQIYEKIVSGKVRFP 258

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 21/168 (12%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
           KL + IG G FG++ L  +      VAVK   +       L EA V   L+      N+ 
Sbjct: 24  KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 77

Query: 69  KWYGV--DGEDNV-LVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIAR-IEYVH 120
           +  GV  + +  + +V + +  +   L  Y R           +L  +   +   +EY+ 
Sbjct: 78  QLLGVIVEEKGGLYIVTEYM--AKGSLVDYLRSRGRSVLGGDCLLKFSLD-VCEAMEYLE 134

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
              F+HRD+   N L+    + N   + DFGL K+         +P +
Sbjct: 135 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 34/178 (19%), Positives = 71/178 (39%), Gaps = 38/178 (21%)

Query: 8   KYKLGRKIGSGSFGEIFLASHV-DTNEIVA---VKIEN-------------------SGT 44
           +Y+   +IG G++G++F A  + +    VA   V+++                       
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71

Query: 45  KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF-SLK 103
           +HP ++   +++ +          K          LV + +   L              +
Sbjct: 72  EHPNVV---RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTE 120

Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
           T+  +  Q++  ++++HS   +HRD+KP N L+     + Q+ + DFGLA+ Y     
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMA 175

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 17/157 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
            +  K+G G +GE++       +  VAVK     T   +  L EA V K ++     PN 
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 71

Query: 68  IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK-FSLKTVLMLADQMIAR-IEYVHS 121
           ++  GV        ++ + +  G +L D    C R+  S   +L +A Q I+  +EY+  
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEK 129

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           + F+HRD+   N L+G   + + V + DFGL++    
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.3 bits (168), Expect = 6e-13
 Identities = 55/271 (20%), Positives = 95/271 (35%), Gaps = 98/271 (36%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
           +++ R +G+GSFG + L          A+K+                 E    S   HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 48  --QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 98
             ++        +++ I+   +GG                            +LF   R+
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGG----------------------------ELFSLLRK 99

Query: 99  --KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
             +F        A ++   +EY+HS+  ++RD+KP+N L+    K   + I DFG AK  
Sbjct: 100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYV 156

Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY----------VLLY- 205
            D T            L GT  Y      +  E      + +  Y          +L+Y 
Sbjct: 157 PDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWSFGILIYE 195

Query: 206 FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            L G  P+     +   + Y+KI   ++  P
Sbjct: 196 MLAGYTPFY---DSNTMKTYEKILNAELRFP 223

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 67.2 bits (165), Expect = 9e-13
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 13/154 (8%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
              ++IGSG FG + L   ++ ++ VA+K    G    +  + EA+V   L      P +
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PKL 65

Query: 69  -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            + YGV  +     LV + +    L D     R  F+ +T+L +   +   + Y+     
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           +HRD+   N L+G   +   + + DFG+ +   D
Sbjct: 126 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD 156

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 17/166 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
           KL + IG G FG++ L  +      VAVK   +       L EA V   L+      N+ 
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 249

Query: 69  KWYGV---DGEDNVLVLDLL--GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           +  GV   +     +V + +  G SL D L    R       +L  +  +   +EY+   
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
            F+HRD+   N L+    + N   + DFGL K+         +P +
Sbjct: 309 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 62/203 (30%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQL----LYEAKV 55
           I   ++L   +G G++G +  A+H  T EIVA+K      K      P      L E K+
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKI 62

Query: 56  YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--- 110
            K  +      NI          + + ++  P   + F  VY      +   LM  D   
Sbjct: 63  LKHFKH----ENI----------ITIFNIQRPDSFENFNEVY------IIQELMQTDLHR 102

Query: 111 -----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGL 152
                            Q +  ++ +H    +HRD+KP N L+     +N  + + DFGL
Sbjct: 103 VISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGL 158

Query: 153 AKKYRDPTTNRHIPYRENKNLTG 175
           A+   +   +   P  +   +  
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVE 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 17/168 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
              +++G+G FG +         + VA+K+   G+      + EAKV   L        +
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSH----EKL 81

Query: 69  -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            + YGV        ++ + +    L +     R +F  + +L +   +   +EY+ S+ F
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
           LHRD+   N L+        V + DFGL++   D           P R
Sbjct: 142 LHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 19/170 (11%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
            +  K+G G +GE++       +  VAVK     T   +  L EA V K ++     PN 
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 278

Query: 68  IKWYGV--DGEDNVLVLDLL--GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           ++  GV        ++ + +  G +L D L    R++ S   +L +A Q+ + +EY+  +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
            F+HR++   N L+G   + + V + DFGL++               P +
Sbjct: 338 NFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 21/157 (13%)

Query: 10  KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
           K  + +GSG+FG ++        +  +I VA+K     T       +L EA V   +   
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76

Query: 63  SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
              P++ +  G+     V L+  L   G  L D     +     + +L    Q IA+ + 
Sbjct: 77  ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           Y+  R  +HRD+   N L+        V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 32/153 (20%), Positives = 67/153 (43%), Gaps = 25/153 (16%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
           +IG G++G +    H  + +I+AVK         +  QLL +     ++   S  P I +
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85

Query: 70  WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
           +YG      D  + ++L+  S +  +    +        ++ ++++ +I         ++
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
                 +HRDIKP N L+    ++  + + DFG
Sbjct: 142 KENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 36/168 (21%), Positives = 65/168 (38%), Gaps = 17/168 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
            L +++GSG FG + L       + VAVK+   G+        EA+    L      P +
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSH----PKL 65

Query: 69  -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            K+YGV        +V + +    L +      +      +L +   +   + ++ S  F
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
           +HRD+   N L+    +   V + DFG+ +   D           P +
Sbjct: 126 IHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 26/157 (16%)

Query: 14  KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
           ++G G++G +    HV + +I+AVK      +  +  +LL +     I       P    
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDCPFTVT 70

Query: 70  WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
           +YG      D  + ++L+  SL+  +     K  +     + + ++ +I        E++
Sbjct: 71  FYGALFREGDVWICMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
           HS    +HRD+KP N L+       QV + DFG++  
Sbjct: 126 HSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGY 159

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 43/185 (23%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
           +G +Y   + +G G  G +F A   D ++ VA+K I  +  +  +    E K+ + L   
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH- 67

Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------- 110
               NI          V V ++LGPS   L         L +V      M  D       
Sbjct: 68  ---DNI----------VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114

Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
                        Q++  ++Y+HS   LHRD+KP N    +  +   + I DFGLA+   
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLARIMD 172

Query: 158 DPTTN 162
              ++
Sbjct: 173 PHYSH 177

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 27/219 (12%), Positives = 52/219 (23%), Gaps = 47/219 (21%)

Query: 3   RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYK 57
           RI   +Y+L    G     + + A     +  VA+   +     P       L       
Sbjct: 27  RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86

Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
            +    G+  +          ++V + + G SL+++        S    +     + A  
Sbjct: 87  RIDK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAA 142

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           +  H  G       P    +        V +                             
Sbjct: 143 DAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDAN--------------- 180

Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
                           +DD+  +G  L   L    P   
Sbjct: 181 ---------------PQDDIRGIGASLYALLVNRWPLPE 204

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 64.9 bits (159), Expect = 5e-12
 Identities = 19/184 (10%), Positives = 45/184 (24%), Gaps = 36/184 (19%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
               K+     GE++          + VK+        +       E    +I       
Sbjct: 13  NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH---- 66

Query: 66  PNI-KWYGV----DGEDNVLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIAR-IE 117
           PN+    G           L+   +   SL + L             +  A   +AR + 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD-MARGMA 125

Query: 118 YVHSRGF--LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           ++H+         +   + ++    +     I    +                ++     
Sbjct: 126 FLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF------------SFQSPGRMY 170

Query: 176 TARY 179
              +
Sbjct: 171 APAW 174

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.7 bits (161), Expect = 5e-12
 Identities = 61/263 (23%), Positives = 98/263 (37%), Gaps = 84/263 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
           +G GSFG++FLA    TN+  A+K                  E        +HP    + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 51  Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFS 101
                +  ++ +++   GG                            DL   +    KF 
Sbjct: 85  CTFQTKENLFFVMEYLNGG----------------------------DLMYHIQSCHKFD 116

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
           L      A ++I  ++++HS+G ++RD+K DN L+    K   + I DFG+ K+    D 
Sbjct: 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDA 173

Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
            TN           T  GT  Y +    LG + +   D  S G VLLY  L G  P+ G 
Sbjct: 174 KTN-----------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLIGQSPFHG- 220

Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
               +++ +  I       P  +
Sbjct: 221 --QDEEELFHSIRMDNPFYPRWL 241

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 34/181 (18%), Positives = 62/181 (34%), Gaps = 42/181 (23%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
            +  +Y++   +G G+FG++     H      VA+K I N G        E     +L+ 
Sbjct: 16  WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VLK- 71

Query: 62  GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
                 IK    + +                 +  +LLG +  +       + + L  V 
Sbjct: 72  -----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 126

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
            +A Q+   + ++H     H D+KP+N L                     K   + + DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 151 G 151
           G
Sbjct: 187 G 187

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 21/157 (13%)

Query: 10  KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
           +  + +GSG FG +         ++ +I V +K+  + SG +  Q +         L   
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH- 74

Query: 63  SGIPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
               +I +  G+  G    LV     LG SL D     R     + +L    Q IA+ + 
Sbjct: 75  ---AHIVRLLGLCPGSSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLLNWGVQ-IAKGMY 129

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           Y+   G +HR++   N L+      +QV + DFG+A 
Sbjct: 130 YLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 55/292 (18%), Positives = 107/292 (36%), Gaps = 38/292 (13%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
           ++   ++G+G+ G +F  SH  +  ++A K+   E       Q++ E +V          
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS---- 90

Query: 66  PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           P I  +YG      +  + ++ + G SL+ +     R    + +  ++  +I  + Y+  
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 149

Query: 122 RG-FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           +   +HRD+KP N L+       ++ + DFG++ +  D   N  +         GT  Y 
Sbjct: 150 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 197

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S     G   S + D+ S+G  L+    G  P     A   +  +    E   +      
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 241 CKSHPAEFASYFHYCQSLTF--------DQRPDYGFLKRLFHDLFSREGYDF 284
                            +          ++ P      +L   +FS E  DF
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-----PKLPSGVFSLEFQDF 304

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 82/259 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
           +G GSFG++ L+    T+E+ AVKI                 E        K P   QL 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 51  Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
                  ++Y                        V++ +  G    DL  + ++  +F  
Sbjct: 88  SCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQVGRFKE 120

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
              +  A ++   + ++ S+G ++RD+K DN ++        + I DFG+ K+  +   T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGVT 177

Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
           T            T  GT  Y +          +  D  + G VLLY  L G  P++G  
Sbjct: 178 TK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG-- 223

Query: 218 AATKKQKYDKICEKKVSTP 236
              + + +  I E  V+ P
Sbjct: 224 -EDEDELFQSIMEHNVAYP 241

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.3 bits (160), Expect = 8e-12
 Identities = 54/262 (20%), Positives = 94/262 (35%), Gaps = 82/262 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
           +G GSFG++ LA   +T ++ AVK+                 E         HP   QL 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 51  Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLF--VYCRRKFSL 102
                  +++                        V++ +  G    DL   +   R+F  
Sbjct: 91  CCFQTPDRLF-----------------------FVMEFVNGG----DLMFHIQKSRRFDE 123

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
                 A ++I+ + ++H +G ++RD+K DN L+          + DFG+ K+      T
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICNGVT 180

Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
           T            T  GT  Y +      +      D  ++G VLLY  L G  P++   
Sbjct: 181 TA-----------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEMLCGHAPFEA-- 226

Query: 218 AATKKQKYDKICEKKVSTPIEV 239
              +   ++ I   +V  P  +
Sbjct: 227 -ENEDDLFEAILNDEVVYPTWL 247

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)

Query: 10  KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
           +LGR IG G FG++      S  +    VA+K   + T        L EA   +      
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 75

Query: 64  GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYV 119
             P+I K  GV       ++++L     L       +    L ++++ A Q ++  + Y+
Sbjct: 76  --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ-LSTALAYL 132

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            S+ F+HRDI   N L+      + V + DFGL++   D
Sbjct: 133 ESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 168

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 64.9 bits (159), Expect = 9e-12
 Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 83/262 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
           +G G+FG++ L     T    A+KI                 E+     T+HP    L Y
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 52  ----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSL 102
                 ++  +++   GG                            +LF  +   R F+ 
Sbjct: 73  AFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFTE 104

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
           +       ++++ +EY+HSR  ++RDIK +N ++    K   + I DFGL K+      T
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGAT 161

Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
                        T  GT  Y +       +  R  D   LG V++Y  + G LP+    
Sbjct: 162 MK-----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN-- 207

Query: 218 AATKKQKYDKICEKKVSTPIEV 239
               ++ ++ I  +++  P  +
Sbjct: 208 -QDHERLFELILMEEIRFPRTL 228

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 61/201 (30%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY------- 56
           +  KY+L +K+G G++G ++ +    T E+VAVK I +         ++           
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFRE 58

Query: 57  -KILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLAD---- 110
             IL   SG  NI          V +L++L   +  D+++            M  D    
Sbjct: 59  IMILTELSGHENI----------VNLLNVLRADNDRDVYLV--------FDYMETDLHAV 100

Query: 111 ----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
                           Q+I  I+Y+HS G LHRD+KP N L+     A   V + DFGL+
Sbjct: 101 IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156

Query: 154 KKYRDPTTNRHIPYRENKNLT 174
           + + +     +         T
Sbjct: 157 RSFVNIRRVTNNIPLSINENT 177

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 60/263 (22%), Positives = 91/263 (34%), Gaps = 84/263 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
           IG GSFG++ LA H       AVK+                 E +      KHP    L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 51  Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
           +      K+Y +L    GG                            +LF + +R   F 
Sbjct: 106 FSFQTADKLYFVLDYINGG----------------------------ELFYHLQRERCFL 137

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
                  A ++ + + Y+HS   ++RD+KP+N L+        + + DFGL K+    + 
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNS 194

Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
           TT+           T  GT  Y +          R  D   LG  +LY  L G  P+   
Sbjct: 195 TTS-----------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLYGLPPFYS- 241

Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
                 + YD I  K +     +
Sbjct: 242 --RNTAEMYDNILNKPLQLKPNI 262

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 12/104 (11%)

Query: 86  GPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKA 142
             +L+D                L +  Q+   +E++HS+G +HRD+KP N F        
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 200

Query: 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-----GTARYAS 181
           + V + DFGL          + +        T     GT  Y S
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 15/67 (22%), Positives = 28/67 (41%), Gaps = 7/67 (10%)

Query: 8  KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
           ++  + +G G FG +F A +   +   A+K   + N      +++ E K    L+    
Sbjct: 7  DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 62

Query: 65 IPNIKWY 71
           P I  Y
Sbjct: 63 HPGIVRY 69

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 241

Query: 69  -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
            + Y V  E+ + +V + +   SL D       K+     L+    M A+I     YV  
Sbjct: 242 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 298

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
             ++HRD++  N L+G   +     + DFGLA+   D           P +       TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349

Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             A+         + + D+ S G +LL     +G +P+ G+     ++  D++ E+    
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 400

Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
           P    C   P         C     ++RP + +L+    D F+  
Sbjct: 401 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 57/250 (22%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
           +G G FGE+F      T ++ A K        +  G +    + E K   IL       I
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG--AMVEKK---ILAKVHSRFI 247

Query: 66  PNIKWYGVDGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLADQMIARI 116
            ++  Y  + + ++ LV+ ++  G    D+             F     +    Q+++ +
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGG----DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
           E++H R  ++RD+KP+N L+        V I D GLA +            +  +  T  
Sbjct: 303 EHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVE-----------LKAGQTKTKG 348

Query: 177 ARYASCNTH--------LGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YD 226
                  T         LG E     D  +LG V LY  +    P++      + ++   
Sbjct: 349 ----YAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEMIAARGPFRARGEKVENKELKQ 403

Query: 227 KICEKKVSTP 236
           ++ E+ V+ P
Sbjct: 404 RVLEQAVTYP 413

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 52/269 (19%), Positives = 99/269 (36%), Gaps = 87/269 (32%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
           IG GS+ ++ L     T+ I A+K+                 E       + HP    L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 51  Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
                E++++ +++   GG                            DL  + +R  K  
Sbjct: 77  SCFQTESRLFFVIEYVNGG----------------------------DLMFHMQRQRKLP 108

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
            +     + ++   + Y+H RG ++RD+K DN L+        + + D+G+ K+      
Sbjct: 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGD 165

Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
           TT+           T  GT  Y +     G +     D  +LG VL++  + G  P+  +
Sbjct: 166 TTS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIV 213

Query: 217 KAA------TKKQKYDKICEKKVSTPIEV 239
            ++      T+   +  I EK++  P  +
Sbjct: 214 GSSDNPDQNTEDYLFQVILEKQIRIPRSL 242

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 21/170 (12%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           KL  ++G+G FGE+++  +    + VAVK    G+  P   L EA + K LQ       +
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQH----QRL 70

Query: 69  -KWYGV-DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSR 122
            + Y V   E   ++ + +      L  + +     K ++  +L +A Q+   + ++  R
Sbjct: 71  VRLYAVVTQEPIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
            ++HRD++  N L+          I DFGLA+   D           P +
Sbjct: 129 NYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 38/239 (15%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
           +G G FGE+       T ++ A K        +  G      L E +   IL+  +   +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQ---ILEKVNSRFV 246

Query: 66  PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYV 119
            ++ +     +   LVL L+  G    DL  +     +  F     +  A ++   +E +
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGG----DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           H    ++RD+KP+N L+        + I D GLA    +  T +           GT  Y
Sbjct: 303 HRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIK--------GRVGTVGY 351

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YDKICEKKVSTP 236
            +         +   D  +LG  LLY  + G  P+Q  K   K+++    + E      
Sbjct: 352 MAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
           +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+       +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 324

Query: 69  -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
            + Y V  E+ + +V + +   SL D       K+     L+    M A+I     YV  
Sbjct: 325 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 381

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
             ++HRD++  N L+G   +     + DFGLA+   D           P +       TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432

Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             A+         + + D+ S G +LL     +G +P+ G+     ++  D++ E+    
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 483

Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
           P    C   P         C     ++RP + +L+    D F+  
Sbjct: 484 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 51/268 (19%), Positives = 99/268 (36%), Gaps = 85/268 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
           IG GS+ ++ L     T+ I A+++                 E       + HP    L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 51  Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
                E++++                        V++ +  G    DL  + +R  K   
Sbjct: 120 SCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQRQRKLPE 152

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
           +     + ++   + Y+H RG ++RD+K DN L+        + + D+G+ K+      T
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDT 209

Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
           T+           T  GT  Y +     G +     D  +LG VL++  + G  P+  + 
Sbjct: 210 TS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVG 257

Query: 218 AA------TKKQKYDKICEKKVSTPIEV 239
           ++      T+   +  I EK++  P  +
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRSL 285

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 25/172 (14%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
           +   Y     +GSG++G +  A    + E VA+K +          +  Y E  + K +Q
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 61  GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
                 N+              +  D  LV+  +     DL      KFS + +  L  Q
Sbjct: 82  H----ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQ 134

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
           M+  ++Y+HS G +HRD+KP N  +      + ++ I+DFGLA+      T 
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMTG 182

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 50/221 (22%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
           I  +Y++   IG+GS+G +  A       +VA+K I          + +  E  +   L 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF---SLKTVLM----LAD- 110
                 ++          V VLD++ P   + F  +Y   +      K +      L + 
Sbjct: 111 H----DHV----------VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156

Query: 111 -------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
                   ++  ++YVHS G LHRD+KP N L+      +  V + DFGLA         
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCDFGLA--------- 203

Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL-GYV 202
           R + Y EN N          + +L      ++    L G+V
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 34/160 (21%), Positives = 67/160 (41%), Gaps = 18/160 (11%)

Query: 10  KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
              + IG+G FGE++      S       VA+K   +G    Q    L EA +       
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH- 105

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               NI +  GV    +  +++ + +   +L+        +FS+  ++ +   + A ++Y
Sbjct: 106 ---HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
           + +  ++HRD+   N L+          + DFGL++   D
Sbjct: 163 LANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 21/157 (13%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
           K  + +GSG+FG ++    +   E     VA+K     T       +L EA V   +   
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76

Query: 63  SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
              P++ +  G+     V L+  L   G  L D     +     + +L    Q IA+ + 
Sbjct: 77  ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           Y+  R  +HRD+   N L+        V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 17/159 (10%)

Query: 10  KLGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
            + + IGSG  GE+           +  VA+K   +G    Q    L EA +        
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-- 109

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             PNI +  GV   G   ++V + +   SL+        +F++  ++ +   + A + Y+
Sbjct: 110 --PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
              G++HRD+   N L+          + DFGL++   D
Sbjct: 168 SDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 38/187 (20%), Positives = 71/187 (37%), Gaps = 50/187 (26%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG 62
           ++   + + RK+G G+FG + L  H+D  +  AVK+  +  K       EA + K +Q  
Sbjct: 32  LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91

Query: 63  SGIPNIKWYGVDGEDN---------------VLVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
                      D  +N                L+ + LGPSL ++        F ++ + 
Sbjct: 92  -----------DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------------GLGRKANQ 144
           +   +++  + Y+      H D+KP+N L+                          K+  
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 145 VYIIDFG 151
           + +IDFG
Sbjct: 201 IKLIDFG 207

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 36/177 (20%), Positives = 65/177 (36%), Gaps = 52/177 (29%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
           +   Y +   IG GS+G ++LA   +T + VA+K +          + +  E  +   L+
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
                  I          + + DL+ P     F  +Y      +   +  +D        
Sbjct: 84  S----DYI----------IRLYDLIIPDDLLKFDELY------IVLEIADSDLKKLFKTP 123

Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
                         ++    ++H  G +HRD+KP N L+      +  V + DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFGLA 176

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 56/263 (21%), Positives = 97/263 (36%), Gaps = 84/263 (31%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
           +G GSFG++ L+    T+E+ AVKI                 E        K P   QL 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 51  Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
                  ++Y +++   GG                            DL  + ++  +F 
Sbjct: 409 SCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQQVGRFK 440

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
               +  A ++   + ++ S+G ++RD+K DN ++        + I DFG+ K+  +   
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGV 497

Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
           TT            T  GT  Y +          +  D  + G VLLY  L G  P++G 
Sbjct: 498 TTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG- 544

Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
               + + +  I E  V+ P  +
Sbjct: 545 --EDEDELFQSIMEHNVAYPKSM 565

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 36/159 (22%), Positives = 67/159 (42%), Gaps = 17/159 (10%)

Query: 10  KLGRKIGSGSFGEIFLA--SHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
            + + +G+G FGE+           EI VA+K    G    Q    L EA +        
Sbjct: 48  SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-- 105

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
             PNI +  GV    +  ++V + +   SL+        +F++  ++ +   + + ++Y+
Sbjct: 106 --PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
              G++HRD+   N L+          + DFGL +   D
Sbjct: 164 SDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 61.8 bits (151), Expect = 6e-11
 Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 18/155 (11%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
            L R +G G FGE++   + +       VAVK              + EA + K L    
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-- 72

Query: 64  GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYV 119
             P+I K  G+ + E   ++++L     L       +    + T+++ + Q I + + Y+
Sbjct: 73  --PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ-ICKAMAYL 129

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            S   +HRDI   N L+        V + DFGL++
Sbjct: 130 ESINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 50/184 (27%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN-SGTKHPQLLY-EAKVYKILQG 61
           +G +Y     IG G++G +  A        VA+K I       + Q    E K+    + 
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84

Query: 62  GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
                NI          + + D++     +    VY      +   LM  D         
Sbjct: 85  ----ENI----------IGINDIIRAPTIEQMKDVY------IVQDLMETDLYKLLKTQH 124

Query: 111 -----------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRD 158
                      Q++  ++Y+HS   LHRD+KP N L+         + I DFGLA+    
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLARVADP 180

Query: 159 PTTN 162
              +
Sbjct: 181 DHDH 184

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 42/181 (23%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLA-SHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
           ++  +Y++   +G G+FG++     H      VAVK ++N          E +V + L  
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70

Query: 62  GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLF-VYCRRKFSLKTVL 106
                       +                   +V +LLG S  D         F L  + 
Sbjct: 71  ---------TDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
            +A Q+   + ++HS    H D+KP+N L                         + ++DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 151 G 151
           G
Sbjct: 182 G 182

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
           +LGR IG G FG++    ++        VA+K   + T        L EA   +      
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 450

Query: 64  GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             P+I K  GV  E+ V ++++L     L       +    L ++++ A Q+   + Y+ 
Sbjct: 451 --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
           S+ F+HRDI   N L+      + V + DFGL++   D      +   +P +
Sbjct: 509 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 56/188 (29%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
           +  +Y+    +GSG++G +  A    T   VAVK  +   +          E ++ K ++
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
                 N+          + +LD+  P        D+++         T LM AD     
Sbjct: 87  H----ENV----------IGLLDVFTPARSLEEFNDVYLV--------THLMGADLNNIV 124

Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
                          Q++  ++Y+HS   +HRD+KP N  +      + ++ I+DFGLA+
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLAR 180

Query: 155 KYRDPTTN 162
              D  T 
Sbjct: 181 HTADEMTG 188

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 25/166 (15%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
           +  +Y+  + IGSG+ G +  A     +  VA+K +        H +  Y E  + K + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 61  GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
                 NI         +    + +D  LV++L+     +L    + +   + +  L  Q
Sbjct: 120 H----KNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQ 172

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156
           M+  I+++HS G +HRD+KP N ++    K++  + I+DFGLA+  
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.0 bits (149), Expect = 1e-10
 Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 85/261 (32%)

Query: 15  IGSGSFGEIFLASHV---DTNEIVAVKI----------------EN---SGTKHP---QL 49
           +G GSFG++FL   +   D  ++ A+K+                E        HP   +L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 50  LY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF 100
            Y    E K+Y IL   +GG                            DLF  +     F
Sbjct: 92  HYAFQTEGKLYLILDFLRGG----------------------------DLFTRLSKEVMF 123

Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRD 158
           + + V     ++   ++++HS G ++RD+KP+N L+    +   + + DFGL+K+    +
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHE 180

Query: 159 PTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
                          +  GT  Y +         ++  D  S G VL++  L G+LP+QG
Sbjct: 181 KKAY-----------SFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGTLPFQG 228

Query: 216 LKAATKKQKYDKICEKKVSTP 236
                +K+    I + K+  P
Sbjct: 229 ---KDRKETMTMILKAKLGMP 246

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 19/154 (12%)

Query: 11  LGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKHPQL----LYEAKVYKILQGGSG 64
             +++GSG+FG +    +     +  VAVKI  +    P L    L EA V + L     
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77

Query: 65  IPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
            P I +  G+ + E  +LV+++  LG  L   ++   R    K ++ L  Q+   ++Y+ 
Sbjct: 78  -PYIVRMIGICEAESWMLVMEMAELG-PLNK-YLQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
              F+HRD+   N L+      +   I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 44/158 (27%), Positives = 65/158 (41%), Gaps = 22/158 (13%)

Query: 10  KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQG 61
           +L  K+G GSFG +      +       VAVK                + E      L  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 62  GSGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-I 116
                N+ + YGV     + +V +L  LG SL D     +  F L T+   A Q +A  +
Sbjct: 81  ----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQ-VAEGM 134

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            Y+ S+ F+HRD+   N L+      + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 17/168 (10%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
           KL +K+G+G FGE+++A++    + VAVK    G+   +  L EA V K LQ        
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQH----DKL 245

Query: 68  IKWYGVDGEDNVLVLDLLGP--SLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           +K + V  ++ + ++       SL D L      K  L  ++  + Q+   + ++  R +
Sbjct: 246 VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
           +HRD++  N L+     +    I DFGLA+   D           P +
Sbjct: 306 IHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 32/163 (19%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNE---IVAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
              R IG G FG ++   ++D  +     A+K     +  +  +  L E  + + L    
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-- 81

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
             PN+    G+    E    VL      L      DL  +    +R  ++K ++    Q 
Sbjct: 82  --PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ- 132

Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
           +AR +EY+  + F+HRD+   N ++    ++  V + DFGLA+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLAR 172

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 38/176 (21%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
            L R++G G+FG++FLA   + +      +VAVK     T   +     EA++   LQ  
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH- 76

Query: 63  SGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLK 103
               +I K+YGV  DG+  ++V       DL              ++      + +  L 
Sbjct: 77  ---EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
            +L +A Q IA  + Y+ S+ F+HRD+   N L+G       V I DFG++   RD
Sbjct: 134 QMLHIASQ-IASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---RD 182

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 27/182 (14%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
            L R +G G+FGE++        +  +   VAVK   E    +     L EA +      
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 62  GSGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----- 112
                NI +  GV        ++++L+ G  L+      R + S  + L + D +     
Sbjct: 93  ----QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148

Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIP 166
           IA   +Y+    F+HRDI   N L+          I DFG+A+      Y        +P
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208

Query: 167 YR 168
            +
Sbjct: 209 VK 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 80/261 (30%)

Query: 15  IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
           +G G+FG++ L     T    A+KI                 EN     ++HP    L Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 52  ----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSL 102
                 ++  ++    GG                            +LF +  R   FS 
Sbjct: 216 SFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFSE 247

Query: 103 KTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
                   ++++ ++Y+HS +  ++RD+K +N ++    K   + I DFGL K+      
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGA 304

Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
           T              GT  Y +       +  R  D   LG V++Y  + G LP+     
Sbjct: 305 TMK---------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN--- 351

Query: 219 ATKKQKYDKICEKKVSTPIEV 239
              ++ ++ I  +++  P  +
Sbjct: 352 QDHEKLFELILMEEIRFPRTL 372

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.5 bits (145), Expect = 5e-10
 Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 87/266 (32%)

Query: 15  IGSGSFGEIFLASHV---DTNEIVAVKI------------------ENS---GTKHP--- 47
           +G G +G++F    V   +T +I A+K+                  E +     KHP   
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 48  QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR-- 98
            L+Y      K+Y IL    GG                            +LF+   R  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGG----------------------------ELFMQLEREG 116

Query: 99  KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--Y 156
            F   T      ++   + ++H +G ++RD+KP+N ++        V + DFGL K+  +
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKESIH 173

Query: 157 RDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
               T+           T  GT  Y +    +    +R  D  SLG  L+Y  L G+ P+
Sbjct: 174 DGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMYDMLTGAPPF 221

Query: 214 QGLKAATKKQKYDKICEKKVSTPIEV 239
            G     +K+  DKI + K++ P  +
Sbjct: 222 TG---ENRKKTIDKILKCKLNLPPYL 244

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 39/184 (21%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
                IG G FG ++  + +D +      AVK  N  T   +    L E  + K      
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVYCR---RKFSLKTVLMLADQM 112
             PN+    G+    E + LV+      L      DL  + R      ++K ++    Q 
Sbjct: 86  --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 136

Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR-DPTTNRH 164
           +A+ ++Y+ S+ F+HRD+   N ++    +   V + DFGLA+       Y     T   
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 165 IPYR 168
           +P +
Sbjct: 194 LPVK 197

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 27/169 (15%), Positives = 61/169 (36%), Gaps = 26/169 (15%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEI-------VAVKIENSGTKHPQ--LLYEAKVYKILQ 60
                +G G+F +IF     +  +        V +K+ +   ++        A +   L 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 61  GGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIA 114
                 ++   YGV   G++N+LV + +      L  Y ++     ++   L +A Q+ A
Sbjct: 71  H----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQLAA 124

Query: 115 RIEYVHSRGFLHRDIKPDNFL-----MGLGRKANQVYIIDFGLAKKYRD 158
            + ++     +H ++   N L              + + D G++     
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 56/188 (29%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
           +   Y+  + +GSG++G +  A    T   VA+K +          +  Y E ++ K ++
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
                 N+          + +LD+  P        D ++            M  D     
Sbjct: 83  H----ENV----------IGLLDVFTPDETLDDFTDFYLV--------MPFMGTDLGKLM 120

Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
                          QM+  + Y+H+ G +HRD+KP N  +      + ++ I+DFGLA+
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLAR 176

Query: 155 KYRDPTTN 162
           +     T 
Sbjct: 177 QADSEMTG 184

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 44/195 (22%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
             G+ +G+G+FG++  A        D    VAVK+   ++     + L+ E KV   L  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-- 83

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL------DLL------------GPSLEDLFVYCRRKF 100
                NI    G    G   +++       DLL              +   +        
Sbjct: 84  -GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
            L+ +L  + Q +A+ + ++ S+  +HRD+   N L+          I DFGLA+     
Sbjct: 143 DLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKND 198

Query: 156 --YRDPTTNRHIPYR 168
             Y     N  +P +
Sbjct: 199 SNYV-VKGNARLPVK 212

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 25/163 (15%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
           +  +Y+  + IGSG+ G +  A        VA+K +        H +  Y E  + K + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 61  GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
                 NI         +    + +D  +V++L+     +L    + +   + +  L  Q
Sbjct: 83  H----KNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQ 135

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
           M+  I+++HS G +HRD+KP N ++    K++  + I+DFGLA
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 41/191 (21%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
            L  ++G G+FG++FLA            +VAVK     ++  +     EA++  +LQ  
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH- 102

Query: 63  SGIPNI-KWYGV--DGEDNVLVL------DLL---------GPSLEDLFVYCRRKFSLKT 104
               +I +++GV  +G   ++V       DL             L            L  
Sbjct: 103 ---QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR 157
           +L +A Q +A  + Y+    F+HRD+   N L+G G     V I DFG+++       YR
Sbjct: 160 LLAVASQ-VAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYR 215

Query: 158 DPTTNRHIPYR 168
                  +P R
Sbjct: 216 -VGGRTMLPIR 225

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 35/177 (19%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
                IG G FG ++  + +D +      AVK  N  T   +    L E  + K      
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
             PN+    G+    E + LV+      L      DL  +        ++K ++    Q 
Sbjct: 150 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 200

Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
           +A+ ++++ S+ F+HRD+   N ++    +   V + DFGLA   RD          
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDMYDKEFDSVH 251

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 44/187 (23%), Positives = 70/187 (37%), Gaps = 37/187 (19%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
            L R +G G+FGE++        +  +   VAVK   E    +     L EA +      
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 62  GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRR---------KFSLKTVLM 107
                NI +  GV        ++L+L+  G    DL  + R            ++  +L 
Sbjct: 134 ----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 108 LADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
           +A   IA   +Y+    F+HRDI   N L+          I DFG+A+      Y     
Sbjct: 186 VARD-IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244

Query: 162 NRHIPYR 168
              +P +
Sbjct: 245 CAMLPVK 251

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 38/188 (20%), Positives = 61/188 (32%), Gaps = 63/188 (33%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL------------L 50
            +   Y + R I SGS+G +           VA+K + N+ +    +            L
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 51  YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLML 108
            E ++          PNI          + + D+     E     +Y      L T LM 
Sbjct: 78  REIRLLNHFHH----PNI----------LGLRDIFVHFEEPAMHKLY------LVTELMR 117

Query: 109 AD----------------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QV 145
            D                       ++  +  +H  G +HRD+ P N L+      N  +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDI 173

Query: 146 YIIDFGLA 153
            I DF LA
Sbjct: 174 TICDFNLA 181

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 16/154 (10%)

Query: 10  KLGR-KIGSGSFGEIFLAS-HVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
            +   ++G G+FG +      +   +I VA+K+  + +     + ++ EA++   L    
Sbjct: 12  LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-- 69

Query: 64  GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             P I +  GV   E  +LV+++  G  L    V  R +  +  V  L  Q+   ++Y+ 
Sbjct: 70  --PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            + F+HRD+   N L+      +   I DFGL+K
Sbjct: 128 EKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 15/152 (9%)

Query: 11  LGRKIGSGSFGEIFLAS-HVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGSGI 65
              ++G G+FG +      +   +I VA+K+   GT+      ++ EA++   L      
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395

Query: 66  PNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           P I +  GV   E  +LV+++  G  L    V  R +  +  V  L  Q+   ++Y+  +
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
            F+HR++   N L+      +   I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 35/177 (19%), Positives = 61/177 (34%), Gaps = 39/177 (22%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
           +   ++G   FG+++       +  +  + VA+K      + P      +EA +   LQ 
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSL 102
               PN+    GV    +   ++       DL                D     +     
Sbjct: 72  ----PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 103 KTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
              + L  Q IA  +EY+ S   +H+D+   N L+        V I D GL    R+
Sbjct: 128 PDFVHLVAQ-IAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---RE 177

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 41/189 (21%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
            + R++G GSFG ++        +      VA+K  N      +    L EA V K    
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL------DLL------GPSLEDLFVYCRRKFSLKTVL 106
                ++ +  GV   G+  ++++      DL        P++ +  V      SL  ++
Sbjct: 88  ----HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV--LAPPSLSKMI 141

Query: 107 MLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDP 159
            +A + IA  + Y+++  F+HRD+   N ++        V I DFG+ +       YR  
Sbjct: 142 QMAGE-IADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYR-K 196

Query: 160 TTNRHIPYR 168
                +P R
Sbjct: 197 GGKGLLPVR 205

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 43/194 (22%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
           KLG+ +G G+FG++  A         T   VAVK+   G  H +   L+ E K+   +  
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI-- 87

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL-------DLL----------GPSLEDLFVYCRRKFS 101
                N+    G        ++V+       +L            P         +   +
Sbjct: 88  -GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 102 LKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----- 155
           L+ ++  + Q +A+ +E++ SR  +HRD+   N L+    + N V I DFGLA+      
Sbjct: 147 LEHLICYSFQ-VAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 202

Query: 156 -YRDPTTNRHIPYR 168
            Y     +  +P +
Sbjct: 203 DYV-RKGDARLPLK 215

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 43/190 (22%), Positives = 76/190 (40%), Gaps = 38/190 (20%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
           + G+ +G+G+FG++  A+     +      VAVK+  S     +   L+ E K+   L  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL-- 106

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL------DLL--------GPSLEDLFVYCRRKFSLKT 104
                NI    G    G   +++       DLL            +  F       S + 
Sbjct: 107 -GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDP--- 159
           +L  + Q +A+ + ++ S+  +HRD+   N L+  G   +   I DFGLA+    D    
Sbjct: 166 LLHFSSQ-VAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMNDSNYI 221

Query: 160 -TTNRHIPYR 168
              N  +P +
Sbjct: 222 VKGNARLPVK 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 89/271 (32%)

Query: 15  IGSGSFGEIFLASHV---DTNEIVAVKI------------------EN----SGTKHP-- 47
           +G+G++G++FL   +   DT ++ A+K+                  E        + P  
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 48  -QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCR 97
             L Y    E K++ IL    GG                            +LF  +  R
Sbjct: 122 VTLHYAFQTETKLHLILDYINGG----------------------------ELFTHLSQR 153

Query: 98  RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAK 154
            +F+   V +   +++  +E++H  G ++RDIK +N L+   G       V + DFGL+K
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLTDFGLSK 207

Query: 155 KYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQ--SRRDDLESLGYVLLY-FLRG 209
                     +     +     GT  Y + +   G +    +  D  SLG VL+Y  L G
Sbjct: 208 --------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG-VLMYELLTG 258

Query: 210 SLPWQGL-KAATKKQKYDKICEKKVSTPIEV 239
           + P+    +  ++ +   +I + +   P E+
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 44/195 (22%)

Query: 10  KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
            LG+ +G G+FG++ +A               VAVK+            L+ E ++ K++
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
                  NI    G         +++      +L                D+      + 
Sbjct: 98  ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
           + K ++    Q +AR +EY+ S+  +HRD+   N L+        + I DFGLA+     
Sbjct: 155 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 210

Query: 156 --YRDPTTNRHIPYR 168
             Y+  TTN  +P +
Sbjct: 211 DYYK-KTTNGRLPVK 224

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.7 bits (133), Expect = 9e-09
 Identities = 39/212 (18%), Positives = 61/212 (28%), Gaps = 59/212 (27%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------------------- 39
           K +   KIG G FGE+F       +  VA+KI                            
Sbjct: 21  KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 40  ------ENSGTKH----------------PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77
                      +                 P LL +A  +     GS      ++  D   
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 78  NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLM 136
            VL  +  G  LE       +  SL T   +  Q+ A +    +   F HRD+   N L+
Sbjct: 139 IVLEFEFGGIDLEQ---MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
              +K +   +      K    P+    +   
Sbjct: 196 ---KKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 41/187 (21%), Positives = 62/187 (33%), Gaps = 36/187 (19%)

Query: 10  KLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
           K    IG G+FG++  A           A+K                E +V   L     
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH-- 85

Query: 65  IPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLKTV 105
            PNI    G         L +      +LL                +        S + +
Sbjct: 86  -PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 106 LMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
           L  A   +AR ++Y+  + F+HRD+   N L+G         I DFGL++    Y    T
Sbjct: 145 LHFAAD-VARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVYV-KKT 199

Query: 162 NRHIPYR 168
              +P R
Sbjct: 200 MGRLPVR 206

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 44/195 (22%)

Query: 10  KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
            LG+ +G G+FG++ LA          +    VAVK+  S         L+ E ++ K++
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
                  NI    G         +++      +L                +       + 
Sbjct: 132 ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
           S K ++  A Q +AR +EY+ S+  +HRD+   N L+        + I DFGLA+     
Sbjct: 189 SSKDLVSCAYQ-VARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLARDIHHI 244

Query: 156 --YRDPTTNRHIPYR 168
             Y+  TTN  +P +
Sbjct: 245 DYYK-KTTNGRLPVK 258

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 45/192 (23%), Positives = 70/192 (36%), Gaps = 46/192 (23%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
            LGR +G G FG +  A     +     VAVK+  +           L EA   K     
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH- 84

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL--------GPSLEDLFVYCR--------RKFSLK 103
              P++ K  GV         +   +        G    DL  +              L+
Sbjct: 85  ---PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG----DLHAFLLASRIGENPFNLPLQ 137

Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------Y 156
           T++      IA  +EY+ SR F+HRD+   N ++    +   V + DFGL++K      Y
Sbjct: 138 TLVRFMVD-IACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYY 193

Query: 157 RDPTTNRHIPYR 168
           R       +P +
Sbjct: 194 R-QGCASKLPVK 204

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 47/187 (25%), Positives = 70/187 (37%), Gaps = 37/187 (19%)

Query: 10  KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
            LG+ +G G FG +   +    +     VAVK         +     L EA   K     
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH- 95

Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCR--------RKFSLKTVLML 108
              PN+ +  GV  E +   +      L      DL  Y          +   L+T+L  
Sbjct: 96  ---PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 109 ADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDPTT 161
               IA  +EY+ +R FLHRD+   N ++        V + DFGL+KK      YR    
Sbjct: 153 MVD-IALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ-GR 207

Query: 162 NRHIPYR 168
              +P +
Sbjct: 208 IAKMPVK 214

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 44/195 (22%)

Query: 10  KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
            LG+ +G G FG++ +A               VAVK+            L+ E ++ K++
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
                  NI    G         +++      +L                D+      + 
Sbjct: 144 GKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
           + K ++    Q +AR +EY+ S+  +HRD+   N L+        + I DFGLA+     
Sbjct: 201 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 256

Query: 156 --YRDPTTNRHIPYR 168
             Y+  TTN  +P +
Sbjct: 257 DYYK-KTTNGRLPVK 270

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 51/201 (25%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
            LG+ +G G FG++  A             VAVK+        +   LL E  V K +  
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
               P++ K YG        +L++       L                     +   L  
Sbjct: 86  ----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141

Query: 95  YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
              R  ++  ++  A Q I++ ++Y+     +HRD+   N L+  G    ++ I DFGL+
Sbjct: 142 PDERALTMGDLISFAWQ-ISQGMQYLAEMKLVHRDLAARNILVAEG---RKMKISDFGLS 197

Query: 154 KK------YRDPTTNRHIPYR 168
           +       Y    +   IP +
Sbjct: 198 RDVYEEDSYV-KRSQGRIPVK 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 49/201 (24%), Positives = 70/201 (34%), Gaps = 51/201 (25%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
           +  R IG G+FG +F A        +   +VAVK+               EA +      
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
               PNI K  GV   G+   L+       DL                     +   +  
Sbjct: 110 ----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165

Query: 95  YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
                 S    L +A Q +A  + Y+  R F+HRD+   N L+G       V I DFGL+
Sbjct: 166 PGPPPLSCAEQLCIARQ-VAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLS 221

Query: 154 KK------YRDPTTNRHIPYR 168
           +       Y+    N  IP R
Sbjct: 222 RNIYSADYYK-ADGNDAIPIR 241

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 43/200 (21%), Positives = 70/200 (35%), Gaps = 49/200 (24%)

Query: 10  KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
           + G+ +GSG+FG++  A     S    +  VAVK+        +   L+ E K+   L  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL-- 105

Query: 62  GSGIPNI-KWYGV--DGEDNVLVL------DLL-----------------GPSLEDLFVY 95
                NI    G         L+       DLL                           
Sbjct: 106 -GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 96  CRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
                + + +L  A Q +A+ +E++  +  +HRD+   N L+        V I DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQ-VAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 220

Query: 155 K------YRDPTTNRHIPYR 168
                  Y     N  +P +
Sbjct: 221 DIMSDSNYV-VRGNARLPVK 239

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 4e-07
 Identities = 48/310 (15%), Positives = 96/310 (30%), Gaps = 106/310 (34%)

Query: 28  HVDT---NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP----NIKWYGVDGEDNVL 80
           HV+      I+   +        + +++     +    + IP    ++ W+ V   D ++
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTILLSLIWFDVIKSDVMV 406

Query: 81  VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI--KPDNFLMGL 138
           V++ L             K+SL     +  Q       + S   ++ ++  K +N    L
Sbjct: 407 VVNKL------------HKYSL-----VEKQPKESTISIPS---IYLELKVKLEN-EYAL 445

Query: 139 GRKANQVYIID-FGLAKKY--RDPTTNR-------HIPYRENKNLTGTARYASCNTHL-G 187
            R      I+D + + K +   D            HI +                 HL  
Sbjct: 446 HRS-----IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKN 483

Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247
           IE   R  L  + ++   FL             +K ++D        + +  L      +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLE------------QKIRHDSTAWNASGSILNTL-----QQ 526

Query: 248 FASYFHYCQSLTFDQRPDY--------GFLKRLFHDLFSREGYDF---------DFVFDW 290
              Y  Y      D  P Y         FL ++  +L   +  D          + +F+ 
Sbjct: 527 LKFYKPY----ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582

Query: 291 TILKYQQTQK 300
               ++Q Q+
Sbjct: 583 A---HKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 2e-04
 Identities = 55/443 (12%), Positives = 107/443 (24%), Gaps = 145/443 (32%)

Query: 22  EIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWY--GVDGE 76
            I     +D   I+  K   SGT       L  + ++ +         N K+    +  E
Sbjct: 44  SILSKEEID--HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101

Query: 77  DNVLVLDLLGPSLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNF 134
                     PS+   +++  R +       + A   ++R++     R  L   ++P   
Sbjct: 102 QR-------QPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-LRPAKN 152

Query: 135 L----M-GLG----------------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
           +    + G G                +   +++ ++            N + P    + L
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLK----------NCNSPETVLEML 202

Query: 174 TGTARYASCNTHLGIEQSR--RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY------ 225
                    N     + S   +  + S+   L   L             K + Y      
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL-------------KSKPYENCLLV 249

Query: 226 -DKICEKKVSTPIEVLCK-------SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
              +   K      + CK           +F S       ++ D              L 
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH-ISLDHHSM-TLTPDEVKSLL 307

Query: 278 SREGYDFDFVFDWTILKYQQTQKTKSQDLLPASRVTNS-----------RVMPMRTDKLK 326
            +          +           + QDL P   +T +           R      D  K
Sbjct: 308 LK----------YL--------DCRPQDL-PREVLTTNPRRLSIIAESIRDGLATWDNWK 348

Query: 327 GVN--------------------------------DASCSAEVLE---CRGSYNRTRPDA 351
            VN                                 A     +L         +      
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV 408

Query: 352 DMQHRPSVAEKMSSDHHFGKHSM 374
           +  H+ S+ EK   +      S+
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSI 431

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 8/87 (9%)

Query: 87  PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
              E      +   +L+ ++  + Q+   +E++ SR  +HRD+   N L+        V 
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233

Query: 147 IIDFGLAKK-YRDP----TTNRHIPYR 168
           I DFGLA+  Y+DP      +  +P +
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLK 260

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 15/93 (16%)

Query: 63  SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            GIP    + VD ++  +++  + G   +D+            +     +++ ++   H 
Sbjct: 399 FGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE------DNLDIAYKIGEIVGKL---HK 449

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
              +H D+   NF+         +YIIDFGL K
Sbjct: 450 NDVIHNDLTTSNFIFD-----KDLYIIDFGLGK 477

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	423
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.16
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.65
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.5
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.42
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.4
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.17
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.95
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.92
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.71
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.34
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.29
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.28
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.84
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.43
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.12
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.07

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-57  Score=463.42  Aligned_cols=300  Identities=78%  Similarity=1.322  Sum_probs=275.8

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      |+.+++++|++.+.||+|+||.||+|++..+++.||||++.......++.+|+++++.|.++++++.+..++.+....+|
T Consensus         1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            78899999999999999999999999999999999999998888788899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||++++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+.++..+.+||+|||+++.+....
T Consensus        81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            99999999999999878889999999999999999999999999999999999999655578899999999999988776


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .....++.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.......+.+.++.........+.+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL  240 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence            66666677777889999999999999999999999999999999999999999998777777888888888888888888


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecccchhhh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQK  300 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~  300 (423)
                      +..+|.++.+||..||..+|++||++++|++.|++++.+.++.++..|||+.+++++.+.
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~  300 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI  300 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-----
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccc
Confidence            899999999999999999999999999999999999999999999999999887665443

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-57  Score=434.29  Aligned_cols=267  Identities=22%  Similarity=0.325  Sum_probs=224.8

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      .++|++++.||+|+||+||+|+++.+++.||||++..     ......+.+|+++++.|+| ++|..++.++.+.+..||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence            3579999999999999999999999999999999863     2345668999999999986 667777777788899999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||| ||+|.+++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+...
T Consensus       110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence            99999 8899999976 4679999999999999999999999999999999999999   57899999999999987543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ....     .....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+.   .+.+.++....+..|   
T Consensus       186 ~~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~~p---  254 (311)
T 4aw0_A          186 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKIIKLEYDFP---  254 (311)
T ss_dssp             TTCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC---
T ss_pred             CCcc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC---
Confidence            3211     22367899999999999999999999999999999999999999987543   355666766666554   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                        ..+++++++||.+||..||++||+++++... ..+   ..+.|...+||+.+.
T Consensus       255 --~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i---~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          255 --EKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENLH  303 (311)
T ss_dssp             --TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTGG
T ss_pred             --cccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH---HCCCCcCCCCHHHhc
Confidence              4568999999999999999999999987442 112   235666678897653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.4e-56  Score=419.26  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=201.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||+||+|+++.+++.||||++....     ....+.+|+++++.++| ++|..+..++.+.+..|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEEE
Confidence            58999999999999999999999999999999886432     23458999999999986 6677777777888999999


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||||+|+|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.......
T Consensus        92 mEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            99999999999876 5679999999999999999999999999999999999999   5789999999999987654322


Q ss_pred             CCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                              ....+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+.+.   .+.+..+.......|    
T Consensus       168 --------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~~~~~~p----  232 (275)
T 3hyh_A          168 --------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISNGVYTLP----  232 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC----
T ss_pred             --------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCC----
Confidence                    235689999999999999886 5899999999999999999999987443   345555655555443    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                       ..+++++++||.+||+.||++|||++++++  +.+|+
T Consensus       233 -~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k  267 (275)
T 3hyh_A          233 -KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK  267 (275)
T ss_dssp             -TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence             456899999999999999999999999977  55554

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.4e-56  Score=429.98  Aligned_cols=260  Identities=22%  Similarity=0.219  Sum_probs=214.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++.+..   ..+|+.+++.|+| ++|..++.++.+.+..||||||| 
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSS-PRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCC-TTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeccC
Confidence            568999999999999999999999999999999876543   3579999999987 56667777778889999999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC-cEEEeeccceeeecCCCCCCc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~  164 (423)
                      ||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||++   .++ .+||+|||+|+.+........
T Consensus       134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--------
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCcccc
Confidence            8999999976 45799999999999999999999999999999999999994   555 699999999998754332111


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                        ......++||+.|||||++.+..|+.++|||||||+||||++|+.||.+....   +.+.++....  .+...+...+
T Consensus       210 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~--~~~~~~~~~~  282 (336)
T 4g3f_A          210 --LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKIASEP--PPIREIPPSC  282 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHHHHSC--CGGGGSCTTS
T ss_pred             --eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHcCC--CCchhcCccC
Confidence              11223568999999999999999999999999999999999999999875443   3333444332  2333455678


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      |+++.+||.+||..||++||++.||++.|..++.+.+
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            9999999999999999999999999999999887655

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-56  Score=430.20  Aligned_cols=247  Identities=19%  Similarity=0.269  Sum_probs=209.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|++.++||+|+||+||+|+++.+|+.||||++...  ...+.+.+|+.+|+.|+| ++|..++.++.+.+..||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeC
Confidence            5699999999999999999999999999999987533  344568999999999986 6677777777889999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      | +|+|.+++..  ..+++.++..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+...... 
T Consensus       153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~-  226 (346)
T 4fih_A          153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR-  226 (346)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC-
T ss_pred             CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCc-
Confidence            9 8899998864  569999999999999999999999999999999999999   57899999999999987554321 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..   +.+..+..... .. ......
T Consensus       227 ------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~~-~~-~~~~~~  295 (346)
T 4fih_A          227 ------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP-PR-LKNLHK  295 (346)
T ss_dssp             ------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSSC-CC-CSCGGG
T ss_pred             ------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCCC-CC-CCcccc
Confidence                  23678999999999999999999999999999999999999999875443   33444433221 11 112345


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +++++++||.+||..||++||+++++++
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            7899999999999999999999998865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.9e-55  Score=416.19  Aligned_cols=294  Identities=70%  Similarity=1.243  Sum_probs=259.8

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      |+..++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+++++.+.|+++++.+..++......++
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            45678899999999999999999999999999999999988777777899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++......
T Consensus        83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            99999999999998777889999999999999999999999999999999999999544578899999999999887766


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .....++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+.......+....
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence            55555556666789999999999999999999999999999999999999999987666666667777777778888888


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                      +..+|+++.++|..||+.||++||++++|++.|++++.+.+..++..+||+.++
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~  296 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK  296 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence            888999999999999999999999999999999999999999999999998653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-56  Score=434.07  Aligned_cols=252  Identities=21%  Similarity=0.217  Sum_probs=207.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++++.||+|+||+||+|+++.+++.||||++.....    ...+.+|+++++.|+| ++|..++.++.+.+..||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEE
Confidence            589999999999999999999999999999999876543    2358899999999987 66667777778899999999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||| ||+|.+++...+ ..+++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+....
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence            999 899999997644 357999999999999999999999999999999999999   478999999999998764321


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .       .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..   +.+.++.......    .
T Consensus       180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~----~  245 (350)
T 4b9d_A          180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKIISGSFPP----V  245 (350)
T ss_dssp             H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTCCCC----C
T ss_pred             c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCCCCC----C
Confidence            1       112568999999999999999999999999999999999999999875443   4555565554432    2


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ...+|+++.+||.+||+.||++||++++|++  +.++.
T Consensus       246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~  281 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE--KGFIA  281 (350)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHH
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHHhh
Confidence            2456899999999999999999999999866  34443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-54  Score=413.90  Aligned_cols=293  Identities=70%  Similarity=1.244  Sum_probs=265.3

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      |+..++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.|+++++.+..++......++
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            45678899999999999999999999999999999999988877778899999999999999999999988889999999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++......
T Consensus        83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            99999999999998777789999999999999999999999999999999999999655578899999999999887766


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .....++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+.......+...+
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence            55555555566788999999999999999999999999999999999999999986665556666777777777788888


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      +..+|+++.++|..||+.||++||++++|++.|++++.+.+...+..|||+.+
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~  295 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML  295 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence            88899999999999999999999999999999999999999999999999865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.7e-56  Score=422.12  Aligned_cols=263  Identities=23%  Similarity=0.327  Sum_probs=215.5

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      +.|-.++|.+.+.||+|+||+||+|++.     .++..||||+++....  .+++.+|++++..|+| ++|..+..++.+
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~   86 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVE   86 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEee
Confidence            3455678999999999999999999875     3578899999876432  3458999999999986 667777777778


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      .+..+|||||| +|+|.+++...+            ..+++.+++.|+.||+.||+|||+++||||||||+|||+   +.
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~  163 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GE  163 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CC
Confidence            88999999999 899999997532            469999999999999999999999999999999999999   57


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhh
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT  220 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~  220 (423)
                      ++.+||+|||+|+........     .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.. 
T Consensus       164 ~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-  237 (299)
T 4asz_A          164 NLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-  237 (299)
T ss_dssp             GGCEEECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred             CCcEEECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            889999999999865433221     12234579999999999999999999999999999999998 99999986554 


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                        +.+..+...... +   .+..+|+++.+||.+||+.||++||++++|.+.|+++.+..
T Consensus       238 --~~~~~i~~~~~~-~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          238 --EVIECITQGRVL-Q---RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             --HHHHHHHHTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             --HHHHHHHcCCCC-C---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence              344444443321 1   12456999999999999999999999999999999887654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.2e-55  Score=433.79  Aligned_cols=247  Identities=19%  Similarity=0.269  Sum_probs=209.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|++.++||+|+||.||+|+++.+|+.||||++...  ...+.+.+|+.+|+.|+| ++|..++.++.+.+..||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEECCEEEEEEeC
Confidence            5699999999999999999999999999999988643  344568999999999987 6677777777888999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      | ||+|.+++..  ..+++..+..|+.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.+...... 
T Consensus       230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~-  303 (423)
T 4fie_A          230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPR-  303 (423)
T ss_dssp             CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCC-
T ss_pred             CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCcc-
Confidence            9 8899998864  569999999999999999999999999999999999999   47899999999999887554321 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....   +.+..+..... .. ......
T Consensus       304 ------~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~~-~~-~~~~~~  372 (423)
T 4fie_A          304 ------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNLP-PR-LKNLHK  372 (423)
T ss_dssp             ------BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCC-CC-CSCTTS
T ss_pred             ------ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCCC-CC-Cccccc
Confidence                  23678999999999999999999999999999999999999999875543   33334433221 11 112346


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +++++++||.+||..||++||++++|++
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            7899999999999999999999999865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-54  Score=418.73  Aligned_cols=285  Identities=57%  Similarity=1.033  Sum_probs=258.5

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .+++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.|.++++++.+..++.+....++||
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            36789999999999999999999999999999999999877777789999999999977788989988888999999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc-----EEEeeccceeeec
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-----VYIIDFGLAKKYR  157 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~-----vkL~DFGla~~~~  157 (423)
                      ||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++   .++.     +||+|||+++.+.
T Consensus        85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred             EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence            9999999999987777899999999999999999999999999999999999995   4444     9999999999887


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ........+++......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+.......+.
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            76665555666667889999999999999999999999999999999999999999987766666777777777777787


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceece
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT  291 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~  291 (423)
                      ..++..+| ++.++|..||+.||.+||++++|.+.|++++.+.++..+..+||.
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            88888888 999999999999999999999999999999999999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.6e-54  Score=408.24  Aligned_cols=291  Identities=57%  Similarity=0.993  Sum_probs=260.4

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.+++++|++.+.||+|+||.||+|.+..+++.||||++........+.+|+.++..+.++++++.+..++.+....++|
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            46789999999999999999999999999999999999987777778999999999998888999998889999999999


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec--CCCCcEEEeeccceeeecCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~--~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+  +....+||+|||+++.....
T Consensus        85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            9999999999998777779999999999999999999999999999999999999522  12234999999999988776


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ......++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+.......+...
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  244 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence            55555555556678899999999999999999999999999999999999999998766666667777777777777777


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceecee
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTI  292 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~  292 (423)
                      .+..+|+++.++|..||+.||++||++++|++.|++++.+.+...+..|||+.
T Consensus       245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  297 (298)
T 1csn_A          245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL  297 (298)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred             HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence            78889999999999999999999999999999999999999999999999974

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-55  Score=418.01  Aligned_cols=257  Identities=23%  Similarity=0.296  Sum_probs=203.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      |-.++|++.++||+|+||+||+|++.   ..||||+++....    .+.+.+|+.+++.|+|++ |..+..++. .+..+
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpN-IV~l~g~~~-~~~~~  107 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN-ILLFMGYMT-KDNLA  107 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEEC-SSSCE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEE-CCeEE
Confidence            34578899999999999999999863   3599999875432    235889999999998855 445555543 45689


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |||||| +|+|.+++......+++.+++.|+.||+.||+|||+++||||||||+|||++   +++.+||+|||+|+....
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC---
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceeccc
Confidence            999999 8999999987667899999999999999999999999999999999999994   788999999999987644


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc-C
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-S  234 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~  234 (423)
                      .....     .....+||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+.+...   .+..+..... .
T Consensus       185 ~~~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~---~~~~~~~~~~~~  256 (307)
T 3omv_A          185 WSGSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGRGYAS  256 (307)
T ss_dssp             --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHTTCCC
T ss_pred             CCcce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCCC
Confidence            32211     22356899999999999753   58999999999999999999999998765432   2222333333 2


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +........+|+++.+||.+||+.||++||++.+|++.|+.+
T Consensus       257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            223344566799999999999999999999999999998765

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=419.35  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=207.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      |-..+|.+.++||+|+||+||+|++.     .+++.||||+++....  .+.|.+|+++|..|+| ++|..+..++.+..
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~  116 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEGR  116 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence            44567999999999999999999875     3578899999876432  3458999999999986 56667777777888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      ..||||||| +|+|.+++....              ..+++.+++.|+.||+.||+|||+++||||||||+|||++   .
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---Q  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---T
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---C
Confidence            999999999 999999986432              3589999999999999999999999999999999999994   8


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhh
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT  220 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~  220 (423)
                      ++.+||+|||+|+........     .......||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+.. 
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-  267 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-  267 (329)
T ss_dssp             TTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-
T ss_pred             CCcEEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-
Confidence            899999999999876443321     12235679999999999999999999999999999999999 99999986554 


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                        +.+..+.... ..+.   +..+|+++.+||.+||+.||++||++++|++.|+.+.+.
T Consensus       268 --~~~~~i~~g~-~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          268 --EAIDCITQGR-ELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --HHHHHHHHTC-CCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --HHHHHHHcCC-CCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence              3334443332 2221   245699999999999999999999999999999988654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-54  Score=412.09  Aligned_cols=247  Identities=21%  Similarity=0.259  Sum_probs=198.8

Q ss_pred             CCce-EEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeee----CC
Q 014527            6 GVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD----GE   76 (423)
Q Consensus         6 ~~~y-~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~   76 (423)
                      .++| ++.++||+|+||+||+|.+..+++.||||++.....    ...+.+|+++++.|+|++ |..+..++.+    ..
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-IV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN-IVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTT-BCCEEEEEEEEETTEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEeeccCCCc
Confidence            4555 888999999999999999999999999998764332    235889999999998755 4445443332    34


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEeeccce
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ..||||||| +|+|.+++.. .+.+++..+..|+.||+.||+|||++|  ||||||||+|||++  +.++.+||+|||+|
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla  179 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred             EEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence            579999999 8999999976 567999999999999999999999999  99999999999994  24689999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      +......         ....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+....  ...+..+.....
T Consensus       180 ~~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~~~~  247 (290)
T 3fpq_A          180 TLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVK  247 (290)
T ss_dssp             GGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCC
T ss_pred             EeCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHcCCC
Confidence            7543221         236689999999999876 5999999999999999999999999764332  233333333322


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +   .......++++.+||.+||..||++||++++|++
T Consensus       248 ~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2   1233456889999999999999999999999865

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-55  Score=420.24  Aligned_cols=265  Identities=23%  Similarity=0.344  Sum_probs=208.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +-.++|++++.||+|+||+||+|++.   .+++.||||+++...    ....+.+|+++++.|+| ++|..++.++.+.+
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~   99 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEETT
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECC
Confidence            33468999999999999999999985   467899999886532    23357889999999986 56667777778889


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..||||||| ||+|.+++.. .+.+++.++..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEeccccccee
Confidence            999999999 8999999976 4579999999999999999999999999999999999999   5789999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......       .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..   +.+..+.......
T Consensus       176 ~~~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~  245 (304)
T 3ubd_A          176 SIDHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMILKAKLGM  245 (304)
T ss_dssp             -----C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCC
T ss_pred             ccCCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHHHcCCCCC
Confidence            544332       123678999999999999999999999999999999999999999875443   4555666655554


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      |     ..+|+++.+||.+||+.||++||++..-  .+++++   .+.|...+||..+
T Consensus       246 p-----~~~s~~~~~li~~~L~~dP~~R~ta~~~--~~~eil---~Hp~f~~idw~~l  293 (304)
T 3ubd_A          246 P-----QFLSPEAQSLLRMLFKRNPANRLGAGPD--GVEEIK---RHSFFSTIDWNKL  293 (304)
T ss_dssp             C-----TTSCHHHHHHHHHHTCSSGGGSTTCSTT--THHHHH---TSGGGTTCCHHHH
T ss_pred             C-----CcCCHHHHHHHHHHcccCHHHCCCCCcC--CHHHHH---cCccccCCCHHHH
Confidence            4     4568999999999999999999986310  112221   2445556788654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-54  Score=416.03  Aligned_cols=258  Identities=18%  Similarity=0.221  Sum_probs=211.1

Q ss_pred             cccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      .|--..+++.++||+|+||+||+|++.     .+++.||||+++...   ..+.|.+|+.++..|+| ++|..+..++.+
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~  100 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLGVVTK  100 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcceEEEE
Confidence            344578899999999999999999864     357889999987543   23569999999999987 556666667777


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL  138 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~  138 (423)
                      ....+|||||| +|+|.+++...               ...+++..++.|+.||+.||+|||+++||||||||+|||+  
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--  178 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--  178 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--
Confidence            88899999999 89999999643               2358999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                       ++++.+||+|||+|+........     .......||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+
T Consensus       179 -~~~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          179 -YDKLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             -CGGGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             -CCCCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence             57889999999999876443221     12335689999999999999999999999999999999998 899999876


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ..   +.+..+.... ..+.   +..+|+++.+||.+||+.||++||++.+|++.|+.+
T Consensus       253 ~~---~~~~~i~~~~-~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 NQ---DVVEMIRNRQ-VLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HH---HHHHHHHTTC-CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HH---HHHHHHHcCC-CCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            54   3333343332 2222   245699999999999999999999999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-54  Score=422.70  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=215.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee-C
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD-G   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~-~   75 (423)
                      -.++|++++.||+|+||+||+|++..+     ++.||||++......   ..+.+|++++..+.|+++|..+..++.. .
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            346899999999999999999998654     367999998765443   3488999999999998888777665544 5


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG  139 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~  139 (423)
                      ...+|||||| +|+|.+++....               ..+++..++.|+.|||.||+|||+++||||||||+|||+   
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---
Confidence            6789999999 899999997532               348999999999999999999999999999999999999   


Q ss_pred             CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchh
Q 014527          140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA  218 (423)
Q Consensus       140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~  218 (423)
                      ++++.+||+|||+|+.+......     .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+...
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             CCCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            47889999999999876543321     12235679999999999999999999999999999999998 9999987643


Q ss_pred             hhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      .   +.+.+........+.+   ..+|+++.+||..||+.||++||++.+|++.|+.+++..
T Consensus       294 ~---~~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          294 D---EEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             S---HHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             H---HHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            3   2222333333333222   345899999999999999999999999999999988653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=413.42  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=207.4

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeee------e
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV------D   74 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~------~   74 (423)
                      ++++|++++.||+|+||+||+|+++.+|+.||||+++.....    ..+.+|+++|+.|+|+ +|..+..+..      +
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD-NIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCT-TBCCEEEECCCSSCTTT
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCC-CcceEeeeeeccccccc
Confidence            567899999999999999999999999999999998765432    3478899999999875 4555544432      3


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....|||||||+|+|.+++.. .+.+++..+..|+.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+
T Consensus       131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR  206 (398)
T ss_dssp             CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred             CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence            367899999999999998864 5679999999999999999999999999999999999999   588999999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh--
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--  231 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--  231 (423)
                      .+........   ......+||+.|||||++.+.. ++.++||||||||+|||++|+.||.+.+..+....+......  
T Consensus       207 ~~~~~~~~~~---~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~  283 (398)
T 4b99_A          207 GLCTSPAEHQ---YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS  283 (398)
T ss_dssp             CC-------C---CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ecccCccccc---cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            7644321111   1234678999999999998764 699999999999999999999999986554433333222111  


Q ss_pred             ---------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          232 ---------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       232 ---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                                           ....+.......+++++.+||.+||..||++|||++++++  +.+|+
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~  349 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR--HPFLA  349 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--CHhhC
Confidence                                 0111223344567889999999999999999999998866  44443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-52  Score=401.90  Aligned_cols=266  Identities=23%  Similarity=0.242  Sum_probs=196.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHH--HHHHHcCCCCCCeEEEeeeeC----Cee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAK--VYKILQGGSGIPNIKWYGVDG----EDN   78 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~--~l~~l~~~~~i~~i~~~~~~~----~~~   78 (423)
                      |.++|.+.+.||+|+||+||+|++  +|+.||||+++... ...+.+|.+  .+..++|++ |..+..++.+.    ...
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpN-Iv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHEN-ILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTT-BCCEEEEEEEECSSSEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCC-CCcEEEEEEecCCCceEE
Confidence            457899999999999999999998  68899999987543 333444444  445667654 44454444332    257


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcccccccCCceEEeecCCCCcEEEee
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                      ||||||| +|+|.+++..  ..+++..++.++.|++.||+|||++        +||||||||+|||+   +.++.+||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~D  151 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD  151 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred             EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEe
Confidence            9999999 8999999974  5699999999999999999999987        99999999999999   5889999999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCC------CCCccchHHHHHHHHHHHHhCCCCCCCc-------
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGL-------  216 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~~sDIwSlGvil~elltG~~Pf~~~-------  216 (423)
                      ||+|+..........   ......+||+.|||||++.+.      .++.++|||||||+||||+||..||...       
T Consensus       152 FGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             CCCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            999988765432211   112346899999999999765      3678999999999999999997765431       


Q ss_pred             ---hhh--hhHHHHHHHHhhhcCCcHHHhh--ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          217 ---KAA--TKKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       217 ---~~~--~~~~~~~~i~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                         ...  ...+....+......++.+...  ...+..+.+|+.+||+.||++|||+.+|++.|+++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i  301 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence               111  1122233333444433322221  12356899999999999999999999999999999877664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-51  Score=394.54  Aligned_cols=253  Identities=20%  Similarity=0.254  Sum_probs=184.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC--------
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--------   75 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--------   75 (423)
                      ++|++++.||+|+||+||+|+++.+++.||||+++....   .+.+.+|+++++.|+|++.+..+..+....        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            469999999999999999999999999999998865443   245889999999998755444444333222        


Q ss_pred             ---CeeEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEee
Q 014527           76 ---EDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        76 ---~~~~lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                         ...||||||| +|+|.+++.....  ..+...++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEcc
Confidence               2469999999 8999999874321  24567789999999999999999999999999999999   4788999999


Q ss_pred             ccceeeecCCCCCCcc-----cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHH
Q 014527          150 FGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK  224 (423)
Q Consensus       150 FGla~~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~  224 (423)
                      ||+|+.+.........     ........+||+.|||||++.+..|+.++|||||||+||||++   ||....  +....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence            9999887654322110     1112235689999999999999999999999999999999996   887532  22233


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +..+.....  |  ......++.+.+||.+||+.||++||++.+|++
T Consensus       237 ~~~~~~~~~--p--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 LTDVRNLKF--P--PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHTTCC--C--HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCC--C--CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            333333222  2  112223567889999999999999999999865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.8e-51  Score=400.14  Aligned_cols=261  Identities=21%  Similarity=0.286  Sum_probs=203.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.++|++.+.||+|+||+||+|+++   .+++.||||++.......++.+|+++++.+.+|++|..+..++.+.+..|||
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            5688999999999999999999875   4678899999887777778999999999998788888888888899999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||| +++|.+++.    .+++.++..++.||+.||+|||++||+||||||+|||++  .+.+.+||+|||+|+......
T Consensus        99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCS
T ss_pred             EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCcc
Confidence            9999 789998873    599999999999999999999999999999999999995  344799999999998765432


Q ss_pred             CCCcc---------------------cccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchh
Q 014527          161 TNRHI---------------------PYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKA  218 (423)
Q Consensus       161 ~~~~~---------------------~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~  218 (423)
                      .....                     ........+||+.|+|||++.+.. |+.++||||+||++|||++|+.||...+.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence            11000                     001123457999999999998764 89999999999999999999999965332


Q ss_pred             -hhhHHHHHHHHhh-----------------------------------hcCCc-----------HHHhhccChHHHHHH
Q 014527          219 -ATKKQKYDKICEK-----------------------------------KVSTP-----------IEVLCKSHPAEFASY  251 (423)
Q Consensus       219 -~~~~~~~~~i~~~-----------------------------------~~~~~-----------~~~~~~~~~~~l~~l  251 (423)
                       .+....+..+...                                   ....|           ....+..+++++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence             1111111111100                                   00000           001124568899999


Q ss_pred             HHHHhcCCCCCCCChHHHHH
Q 014527          252 FHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       252 i~~cl~~dP~~RPt~~~l~~  271 (423)
                      |.+||..||++|||++++++
T Consensus       333 l~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHCcCChhHCcCHHHHhc
Confidence            99999999999999999865

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.6e-50  Score=395.14  Aligned_cols=285  Identities=29%  Similarity=0.529  Sum_probs=223.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCC-----CcEEEEEEecCCCCchhHHHHHHHHHHHcC--------------CCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKHPQLLYEAKVYKILQG--------------GSG   64 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-----~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~--------------~~~   64 (423)
                      +..++|++.+.||+|+||.||+|.+..+     ++.||||++....  ..+.+|++++..+.+              |++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            4556999999999999999999998764     5789999987643  356677777766655              567


Q ss_pred             CCeEEEeeeeC----CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC
Q 014527           65 IPNIKWYGVDG----EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR  140 (423)
Q Consensus        65 i~~i~~~~~~~----~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~  140 (423)
                      ++.+..++...    ...+|||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++. +
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~  188 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K  188 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence            77776655543    457999999999999999876678999999999999999999999999999999999999942 1


Q ss_pred             CCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh
Q 014527          141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT  220 (423)
Q Consensus       141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~  220 (423)
                      ..+.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            57899999999998775443322222222345679999999999999999999999999999999999999998643221


Q ss_pred             hHHHHHHHHhhhcCCcHHHh---h---ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          221 KKQKYDKICEKKVSTPIEVL---C---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~---~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                      ...   .............+   +   ..+|.++.++|..||..+|.+||++.+|++.|++++.+.+...+..+||....
T Consensus       269 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~  345 (364)
T 3op5_A          269 KYV---RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE  345 (364)
T ss_dssp             HHH---HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred             HHH---HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence            111   11111111111111   1   56699999999999999999999999999999999999999999999998654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-50  Score=418.24  Aligned_cols=260  Identities=24%  Similarity=0.334  Sum_probs=215.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCee
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~   78 (423)
                      -++|++++.||+|+||+||+|+++.+|+.||||++...     .....+..|..++..+.  +|++|..++..+.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            46899999999999999999999999999999998632     23334566666666554  357777888888899999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ||||||| ||+|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence            9999999 8999999976 4679999999999999999999999999999999999999   588999999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ....         ...+||+.|||||++. +..|+.++|||||||+||||++|..||.+....+..+....+.......|
T Consensus       344 ~~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p  414 (689)
T 3v5w_A          344 KKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP  414 (689)
T ss_dssp             SCCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred             CCCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence            4332         3578999999999997 45799999999999999999999999987555444455555555554444


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCC-----hHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                           ..+++++++||.+||..||.+|++     +++|+          .+.|...+||..+
T Consensus       415 -----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~----------~HpfF~~idW~~l  461 (689)
T 3v5w_A          415 -----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK----------ESPFFRSLDWQMV  461 (689)
T ss_dssp             -----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT----------TSGGGTTCCHHHH
T ss_pred             -----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh----------cCccccCCCHHHH
Confidence                 456899999999999999999998     45553          3556666788764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.2e-50  Score=413.83  Aligned_cols=251  Identities=18%  Similarity=0.260  Sum_probs=213.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.....  .+.+.+|+.+|+.|+| ++|..+..++.+....||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEee
Confidence            689999999999999999999999999999998876542  3458899999999987 5666777777889999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      | ||+|.+++......+++.++..++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+|+.+.....  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~--  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS--  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc--
Confidence            9 88999998765667999999999999999999999999999999999999952 2347999999999998754322  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            ....+||+.|||||++.+..|+.++|||||||+||||++|..||.+....   +.+..+.......+ ......
T Consensus       313 ------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~  382 (573)
T 3uto_A          313 ------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWNMD-DSAFSG  382 (573)
T ss_dssp             ------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTCCCCC-SGGGTT
T ss_pred             ------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhCCCCCC-cccccC
Confidence                  22568999999999999999999999999999999999999999875543   44555555544433 233456


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +++++++||.+||..||.+||++.++++
T Consensus       383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          383 ISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            7999999999999999999999998865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=374.08  Aligned_cols=282  Identities=22%  Similarity=0.362  Sum_probs=221.8

Q ss_pred             CCceEEeceeeecCceeEEEEEECCC--------CcEEEEEEecCCCCchhHHHHHHHHHHHcCCC--------------
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--------------   63 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~--------~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~--------------   63 (423)
                      +++|++.+.||+|+||.||+|++..+        ++.||||++...   ..+.+|+++++.++|++              
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            68999999999999999999999873        789999998754   46889999999998733              


Q ss_pred             CCCeEEEeeee-CCeeEEEEeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           64 GIPNIKWYGVD-GEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        64 ~i~~i~~~~~~-~~~~~lv~e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      +++.+..++.. ....++||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~  194 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---P  194 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---T
T ss_pred             CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---C
Confidence            23335555554 7788999999999999999864 36799999999999999999999999999999999999995   5


Q ss_pred             CC--cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh
Q 014527          142 AN--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA  219 (423)
Q Consensus       142 ~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~  219 (423)
                      ++  .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            55  8999999999876543322111111223558999999999999999999999999999999999999999875321


Q ss_pred             h--hHHHHHHHHhhhcCCcH-HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          220 T--KKQKYDKICEKKVSTPI-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       220 ~--~~~~~~~i~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      .  .......+......... ......+|.++.+||..||..||++||++++|++.|+.++.+.+...+..+||+..
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~~  351 (352)
T 2jii_A          275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMV  351 (352)
T ss_dssp             HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC-
T ss_pred             HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcCC
Confidence            1  11111111111111000 00113468999999999999999999999999999999999999999999999753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-47  Score=364.73  Aligned_cols=267  Identities=23%  Similarity=0.332  Sum_probs=216.9

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +++++.++|++.+.||+|+||.||+|++..+++.||||++.....     ...+.+|+.++..++| ++++.+..++.+.
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~   83 (294)
T 4eqm_A            5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDVDEED   83 (294)
T ss_dssp             CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEEEECS
T ss_pred             hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEeeeeC
Confidence            578899999999999999999999999999999999998754332     2347889999999986 5666777777888


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      +..++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAK  159 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSST
T ss_pred             CeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcc
Confidence            8999999999 7899999876 4579999999999999999999999999999999999999   478899999999997


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   ....+.......
T Consensus       160 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~  230 (294)
T 4eqm_A          160 ALSETSLT------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV---SIAIKHIQDSVP  230 (294)
T ss_dssp             TC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH---HHHHHHHSSCCC
T ss_pred             cccccccc------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhhccCC
Confidence            65433211      123457999999999999999999999999999999999999999875443   222333344444


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHHHhcC
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSREG  281 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~l~~~L~~~~~~~~  281 (423)
                      .........+|+.+.++|.+||..||.+|| +++++.+.|+.++.+..
T Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            444455567899999999999999999999 88999888887665443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.7e-47  Score=369.63  Aligned_cols=261  Identities=19%  Similarity=0.287  Sum_probs=213.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +--++|++.+.||+|+||.||+|++..+++.||||++...     .....+..|..++..+.+|++++.+..++.+....
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            4457899999999999999999999999999999988643     33445788999999987778888888888899999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus       100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence            9999999 7899998876 4679999999999999999999999999999999999999   578999999999997543


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....       .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..   +.+..+.......| 
T Consensus       176 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p-  244 (353)
T 3txo_A          176 CNGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDEVVYP-  244 (353)
T ss_dssp             C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred             cCCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence            2221       123568999999999999989999999999999999999999999875443   45556666655544 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCCh------HHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY------GFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                          ..+++.+.+||.+||..||.+||++      ++|++          +.|...+||..+
T Consensus       245 ----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~----------hp~f~~~~w~~l  292 (353)
T 3txo_A          245 ----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR----------HPFFKEIDWAQL  292 (353)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT----------SGGGTTCCHHHH
T ss_pred             ----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh----------CCcccCCCHHHH
Confidence                3458899999999999999999998      55533          344455678654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.7e-46  Score=368.67  Aligned_cols=266  Identities=20%  Similarity=0.304  Sum_probs=216.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      --++|++++.||+|+||.||+|+++.+++.||||+++..     .....+..|..++..+.++++++.+..++.+....|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            346899999999999999999999999999999998643     223458899999999877788888888888899999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+....
T Consensus       130 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeeccc
Confidence            999999 8899988875 4679999999999999999999999999999999999999   5889999999999986333


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh------hhHHHHHHHHhhh
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKK  232 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~------~~~~~~~~i~~~~  232 (423)
                      ...       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......      .....+..+....
T Consensus       206 ~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  278 (396)
T 4dc2_A          206 PGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  278 (396)
T ss_dssp             TTC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred             CCC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence            221       223678999999999999999999999999999999999999999653211      1223444555555


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChH---HHHHHHHHHHHhcCCCCCcceeceec
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG---FLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~---~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      ...|     ..++.++.+||.+||+.||.+||++.   .+.+.+       .+.|...+||..+
T Consensus       279 ~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~-------~Hpff~~i~w~~l  330 (396)
T 4dc2_A          279 IRIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ-------GHPFFRNVDWDMM  330 (396)
T ss_dssp             CCCC-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHH-------HSTTTTTCCHHHH
T ss_pred             cCCC-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHh-------cCccccCCCHHHH
Confidence            5444     34689999999999999999999963   222222       2456666788754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-46  Score=358.40  Aligned_cols=248  Identities=22%  Similarity=0.308  Sum_probs=206.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...  .....+.+|+.+++.+.| +++..+..++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEECCEEEEEEE
Confidence            47899999999999999999999999999999987533  344568899999999987 566677777778889999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.........
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  172 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK  172 (297)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccc
Confidence            99 8999999874  469999999999999999999999999999999999999   47889999999999876544321


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+........   .+.......  .....
T Consensus       173 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~--~~~~~  240 (297)
T 3fxz_A          173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPE--LQNPE  240 (297)
T ss_dssp             -------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHHCSCC--CSCGG
T ss_pred             -------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhCCCCC--CCCcc
Confidence                   235679999999999999999999999999999999999999998755432222   222221111  11124


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++..+.+||.+||+.||++||+++++++
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            56899999999999999999999999865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.4e-46  Score=365.64  Aligned_cols=252  Identities=20%  Similarity=0.287  Sum_probs=213.0

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++.....        ...+.+|+.+++.+.| +++..+..++.+
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEEe
Confidence            3567889999999999999999999999999999998865432        3468899999999986 566677777778


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC----cEEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID  149 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~----~vkL~D  149 (423)
                      ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+.   ..+    .+||+|
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~D  162 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID  162 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEe
Confidence            88999999999 8999998864 55799999999999999999999999999999999999995   333    799999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      ||+++.......        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.
T Consensus       163 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i~  231 (361)
T 2yab_A          163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT  231 (361)
T ss_dssp             CSSCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred             cCCceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence            999987654322        23567999999999999999999999999999999999999999875433   4445555


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......+ ...+..+++.+.+||.+||..||.+||++.++++
T Consensus       232 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          232 AVSYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            5555444 3344677899999999999999999999998864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-46  Score=363.03  Aligned_cols=246  Identities=23%  Similarity=0.343  Sum_probs=208.4

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      .-++|++.+.||+|+||.||+|++..+++.||||++.....    ...+.+|+++++.++| +++..+..+.......++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEE
Confidence            45789999999999999999999999999999999865432    2347899999999986 666677777778889999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        92 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred             EEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence            99999 8899999876 4579999999999999999999999999999999999999   57889999999999765433


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ..        ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..   +....+.......|  
T Consensus       168 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~p--  234 (328)
T 3fe3_A          168 GK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRERVLRGKYRIP--  234 (328)
T ss_dssp             CG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC--
T ss_pred             Cc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC--
Confidence            21        2356899999999999988875 8999999999999999999999875543   34444555555444  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                         ..+++++.+||.+||..||.+||+++++++
T Consensus       235 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          235 ---FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ---TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ---CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               235889999999999999999999998865

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-46  Score=355.70  Aligned_cols=260  Identities=17%  Similarity=0.228  Sum_probs=203.6

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHc--CCCCCCeEEEe
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQ--GGSGIPNIKWY   71 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-------~~~~~~~E~~~l~~l~--~~~~i~~i~~~   71 (423)
                      ++.++.++|++.+.||+|+||+||+|++..+++.||||++....       ....+.+|+.+++.+.  .|+++..+..+
T Consensus         3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            46788999999999999999999999999999999999876322       2346788999988887  24566666555


Q ss_pred             eeeCC-----eeEEEEeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcE
Q 014527           72 GVDGE-----DNVLVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV  145 (423)
Q Consensus        72 ~~~~~-----~~~lv~e~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~v  145 (423)
                      +....     ..++||||++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~  159 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTV  159 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCE
T ss_pred             eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCE
Confidence            44433     5799999999999999875432 39999999999999999999999999999999999999   478899


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHH
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY  225 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~  225 (423)
                      ||+|||+++.......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+
T Consensus       160 kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  231 (308)
T 3g33_A          160 KLADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI  231 (308)
T ss_dssp             EECSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred             EEeeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999976543322        23567899999999999999999999999999999999999999876554433333


Q ss_pred             HHHHhhh-------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          226 DKICEKK-------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       226 ~~i~~~~-------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .......                   ...+.......+++.+.+||.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            2221110                   111223344567899999999999999999999998865

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-46  Score=364.87  Aligned_cols=261  Identities=19%  Similarity=0.223  Sum_probs=214.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .++.++|++.+.||+|+||.||+|.+..+++.||||++...       .....+.+|+.+++.++| +++..+..++.+.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~   98 (351)
T 3c0i_A           20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSD   98 (351)
T ss_dssp             CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET
T ss_pred             CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence            35678999999999999999999999999999999987521       234568999999999986 5666676677788


Q ss_pred             CeeEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                      ...|+||||+ +++|.+.+...   ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            8999999999 78998887643   2358999999999999999999999999999999999999644344569999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      +++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..    ...+..+...
T Consensus       179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~  247 (351)
T 3c0i_A          179 VAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKG  247 (351)
T ss_dssp             TCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHT
T ss_pred             ceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcC
Confidence            9987754332       1225579999999999999999999999999999999999999998743    2344445454


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ....+. ..+..+++++.+||.+||..||++||++.++++  +.++.
T Consensus       248 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~  291 (351)
T 3c0i_A          248 KYKMNP-RQWSHISESAKDLVRRMLMLDPAERITVYEALN--HPWLK  291 (351)
T ss_dssp             CCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred             CCCCCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Chhhc
Confidence            444432 334567899999999999999999999999876  34443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.4e-46  Score=360.39  Aligned_cols=260  Identities=21%  Similarity=0.311  Sum_probs=215.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +--++|++++.||+|+||.||+|++..+++.||||+++..     .....+.+|+.+++.++| +++..+..++.+.+..
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEE
Confidence            3457899999999999999999999999999999988642     344568899999999876 6677777777888899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        81 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcc
Confidence            9999999 7899988875 4679999999999999999999999999999999999999   578999999999998643


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....       .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+....   ..+..+.......| 
T Consensus       157 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p-  225 (337)
T 1o6l_A          157 SDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP-  225 (337)
T ss_dssp             CTTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred             cCCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence            3221       123568999999999999999999999999999999999999999875433   44445555544443 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                          ..+++++.+||.+||..||.+||     ++++|++          +.|...+||..+
T Consensus       226 ----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~----------h~~f~~~~~~~~  272 (337)
T 1o6l_A          226 ----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME----------HRFFLSINWQDV  272 (337)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHH
T ss_pred             ----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc----------CCCcCCCCHHHH
Confidence                35689999999999999999999     7777754          334445677543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-46  Score=361.10  Aligned_cols=259  Identities=17%  Similarity=0.237  Sum_probs=216.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++| +++..+..++.+....++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC-CCCCeEeEEEecCCEEEEEEE
Confidence            56899999999999999999999999999999998875432 3347899999999986 566677777778899999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +.++.+||+|||+++....... 
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~-  159 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN-  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc-
Confidence            99 78999998755557999999999999999999999999999999999999951 1278999999999987654321 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......+. ..+.
T Consensus       160 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~-~~~~  228 (321)
T 1tki_A          160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFDE-EAFK  228 (321)
T ss_dssp             -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCCH-HHHT
T ss_pred             -------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCCCCCCh-hhhc
Confidence                   12457899999999999988999999999999999999999999875443   444555555554443 3446


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .+|.++.+||.+||..||.+||++.++++  +.++.+
T Consensus       229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~  263 (321)
T 1tki_A          229 EISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ  263 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhcc
Confidence            77999999999999999999999999977  555543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.8e-46  Score=355.88  Aligned_cols=257  Identities=19%  Similarity=0.245  Sum_probs=208.0

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +.+.++|++.+.||+|+||+||+|++. +++.||||++.....    ...+.+|+++++.++| +++..+..++.+....
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCSSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccCCEE
Confidence            456789999999999999999999985 488999998865432    2457899999999986 5666676777788899


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTS
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCC
Confidence            9999999989999988766679999999999999999999999999999999999999   4788999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC---
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS---  234 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---  234 (423)
                      ...       ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+......   
T Consensus       172 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          172 PVR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW  244 (311)
T ss_dssp             CCC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred             Ccc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence            322       1224578999999999987 45899999999999999999999999886655444444333222111   


Q ss_pred             -------------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 -------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 -------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                         .+.......+++++.+||.+||..||++||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                               1122333456789999999999999999999999876

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.7e-46  Score=364.93  Aligned_cols=261  Identities=20%  Similarity=0.309  Sum_probs=214.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEEC-------CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~-------~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ..++|++.+.||+|+||.||+|++.       .++..||||+++.....   ..+.+|+.+++.+.+|+++..+..++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4578999999999999999999975       34567999998765432   3478999999999656778888777788


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL  138 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~  138 (423)
                      ....|+||||+ +++|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||+  
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE--
Confidence            88999999999 789999998643               348999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                       +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       237 -~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          237 -TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             -CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence             47889999999999876543321     12234567889999999999999999999999999999999 999998765


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ...   .+..+... ....   ....++.++.++|..||+.||++||++.+|++.|+.++...
T Consensus       311 ~~~---~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          311 VEE---LFKLLKEG-HRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             GGG---HHHHHHTT-CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHH---HHHHHhcC-CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            432   22222222 2111   12355889999999999999999999999999999988643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.2e-46  Score=357.06  Aligned_cols=259  Identities=23%  Similarity=0.296  Sum_probs=202.9

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      .+..++|++.+.||+|+||.||+|++  +++.||||++......    ..+.+|+++++.++| +++..+..++.+....
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTTCC
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCce
Confidence            35578999999999999999999987  6888999998765432    347889999999986 5666777777788889


Q ss_pred             EEEEecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEeeccce
Q 014527           79 VLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ++||||+ +++|.+++....  ..+++..++.++.||+.||+|||++|  |+||||||+|||+   +.++.+||+|||++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC--
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCC
Confidence            9999999 789999987432  13999999999999999999999999  9999999999999   47889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      +.......       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....   ....+.....
T Consensus       187 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~~~~  256 (309)
T 3p86_A          187 RLKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGFKCK  256 (309)
T ss_dssp             ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHHSCC
T ss_pred             cccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCC
Confidence            76443321       1235679999999999999999999999999999999999999998765432   2222221111


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..   .....+++++.+||.+||..||.+||++.+|++.|+.+++..
T Consensus       257 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          257 RL---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            11   123456899999999999999999999999999999987643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.4e-46  Score=360.56  Aligned_cols=263  Identities=19%  Similarity=0.271  Sum_probs=213.5

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~---~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      .+..++|++.+.||+|+||.||+|++..+++   .||||++......   ..+.+|+.+++.++| ++++.+..++.+..
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~  123 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTRGR  123 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECGGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCC
Confidence            4667899999999999999999999986554   5999998765432   358899999999976 66667777777888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence            899999999 889999997666789999999999999999999999999999999999999   5788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .........    ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....   ....+... ..
T Consensus       201 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~~-~~  272 (325)
T 3kul_A          201 LEDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVEEG-YR  272 (325)
T ss_dssp             CC----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTT-CC
T ss_pred             cccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcC-CC
Confidence            754332111    1223456789999999999899999999999999999999 999998765442   22222222 22


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      .+.   ...+|+.+.+||..||..||.+||++.+|++.|+.++...
T Consensus       273 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          273 LPA---PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             CCC---CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            221   2356899999999999999999999999999999988643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=353.69  Aligned_cols=249  Identities=19%  Similarity=0.211  Sum_probs=204.7

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +.++.++|++.++||+|+||+||+|++..+++.||||++......    .....|+..+..+.+++++..+..++.+...
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            345668899999999999999999999999999999987654322    2355666777777667888888888889999


Q ss_pred             eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      .++||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecc
Confidence            99999999999999998877789999999999999999999999999999999999999   478899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....        .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+...      ...+.....   .
T Consensus       209 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~~~~~~~---~  270 (311)
T 3p1a_A          209 TAGA--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------WQQLRQGYL---P  270 (311)
T ss_dssp             --------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------HHHHTTTCC---C
T ss_pred             cCCC--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHhccCC---C
Confidence            4322        124569999999999987 789999999999999999999777654321      222222221   2


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......+++++.+||..||+.||++||++++|++
T Consensus       271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            2344667999999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.2e-46  Score=364.04  Aligned_cols=254  Identities=24%  Similarity=0.295  Sum_probs=212.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+.+++.++| +++..+..++.+....+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEE
Confidence            345789999999999999999999999999999999876543    2357899999999986 66777777777888999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++.....
T Consensus       105 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             EEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            999999 7899888864 45699999999999999999999999999999999999996443456799999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ...        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   ..+..+.......+..
T Consensus       184 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~  252 (362)
T 2bdw_A          184 SEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDYPSP  252 (362)
T ss_dssp             CCS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCTT
T ss_pred             Ccc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCcc
Confidence            321        12567999999999999999999999999999999999999999875433   4444555555444432


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       .+..+++++.+||.+||..||++||++.++++
T Consensus       253 -~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          253 -EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             -GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             23567899999999999999999999999876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=356.60  Aligned_cols=264  Identities=19%  Similarity=0.271  Sum_probs=212.6

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....  ....+.+|+++++.++| +++..+..++.+....++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEEE
Confidence            589999999999999999999999999999999875533  23458899999999986 667777777778899999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccccc
Confidence            99 889999998777789999999999999999999999999999999999999   47889999999999876543321


Q ss_pred             Ccc-------cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhH--HHHHHHHhhhc
Q 014527          163 RHI-------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK--QKYDKICEKKV  233 (423)
Q Consensus       163 ~~~-------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~~~~~  233 (423)
                      ...       .........||+.|+|||++.+..++.++|||||||++|+|++|..||.........  .........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence            100       001112567999999999999999999999999999999999999999764322111  111111111  


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                           .....+|+.+.++|.+||+.||++||++.+|++.|+.+....
T Consensus       243 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          243 -----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             -----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                 112456889999999999999999999999999999887653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=371.37  Aligned_cols=255  Identities=22%  Similarity=0.261  Sum_probs=213.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+.+++.++| ++|..+..++.+....+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEECCEEE
Confidence            456789999999999999999999999999999999876543    2347899999999976 56667777777889999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++.....
T Consensus        87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            999999 8899998876 56799999999999999999999999999999999999996444568899999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ....       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   ..+..+.......+.+
T Consensus       166 ~~~~-------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~  235 (444)
T 3soa_A          166 EQQA-------WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIKAGAYDFPSP  235 (444)
T ss_dssp             TCCB-------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTCCCCCTT
T ss_pred             CCce-------eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhCCCCCCcc
Confidence            3321       23568999999999999999999999999999999999999999875433   4445555555544432


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       .+..+++++.+||.+||..||.+||++.++++
T Consensus       236 -~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 -EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             23467899999999999999999999999977

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.5e-45  Score=361.29  Aligned_cols=257  Identities=22%  Similarity=0.333  Sum_probs=208.8

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHc----CCCCCCeEEEeeeeCC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQ----GGSGIPNIKWYGVDGE   76 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~----~~~~i~~i~~~~~~~~   76 (423)
                      +.++.++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.+.    .++++..+..++...+
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            5678999999999999999999999999999999999987532 2344778999999998    3567777777788889


Q ss_pred             eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec----------------
Q 014527           77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----------------  139 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~----------------  139 (423)
                      ..++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..                
T Consensus       110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~  189 (360)
T 3llt_A          110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK  189 (360)
T ss_dssp             EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred             eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence            999999999999999998644 359999999999999999999999999999999999999421                


Q ss_pred             ------CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 014527          140 ------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW  213 (423)
Q Consensus       140 ------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf  213 (423)
                            ...+.+||+|||+|+......          ....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          190 KIQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             EEEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                  127889999999998644322          2557899999999999999999999999999999999999999


Q ss_pred             CCchhhhhHHHHHHHHhhhcCCcHHHh-----------------------------------------hccChHHHHHHH
Q 014527          214 QGLKAATKKQKYDKICEKKVSTPIEVL-----------------------------------------CKSHPAEFASYF  252 (423)
Q Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~-----------------------------------------~~~~~~~l~~li  252 (423)
                      .+.........+..+   ....+....                                         ....++.+.+||
T Consensus       260 ~~~~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          260 RTHEHMEHLAMMESI---IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CCSSHHHHHHHHHHH---TCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCCcHHHHHHHHHHh---cCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            876554333333222   111111110                                         011236788999


Q ss_pred             HHHhcCCCCCCCChHHHHH
Q 014527          253 HYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       253 ~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+||+.||++||+++++++
T Consensus       337 ~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          337 YSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCChhhCCCHHHHhc
Confidence            9999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-45  Score=359.71  Aligned_cols=272  Identities=21%  Similarity=0.308  Sum_probs=216.7

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      ..+--++|++.+.||+|+||.||+|++..+++.||||++.....     ...+.+|..++..+.+|+++..+..++.+..
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            45556899999999999999999999999999999999875422     2347789999998866788888888888889


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..|+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBC
T ss_pred             EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEecccccc
Confidence            999999999 8899998875 4579999999999999999999999999999999999999   5788999999999986


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchh------hhhHHHHHHHH
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA------ATKKQKYDKIC  229 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~------~~~~~~~~~i~  229 (423)
                      ......       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+..+.
T Consensus       160 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~  232 (345)
T 3a8x_A          160 GLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  232 (345)
T ss_dssp             SCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred             ccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence            432221       12356899999999999999999999999999999999999999975321      11223344444


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      ......|     ..++.++.+||.+||..||.+||++... .-+.++   ..+.|...+||..+
T Consensus       233 ~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~-~~~~~i---~~hp~f~~~~w~~~  287 (345)
T 3a8x_A          233 EKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQ-TGFADI---QGHPFFRNVDWDMM  287 (345)
T ss_dssp             HCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTT-THHHHH---HTSGGGTTCCHHHH
T ss_pred             cCCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCc-CCHHHH---hcCCccCCCCHHHH
Confidence            4444433     3568999999999999999999996310 001112   23455566788654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.8e-46  Score=362.10  Aligned_cols=262  Identities=21%  Similarity=0.297  Sum_probs=217.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ++--++|++.+.||+|+||.||+|++..+++.||||++...     .....+..|..++..+.+++++..+..++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            34567899999999999999999999999999999987643     3445578899999888778889999888888899


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .|+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccc
Confidence            99999999 8899999875 4569999999999999999999999999999999999999   57899999999999864


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .....       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.   .+.+..+.......|
T Consensus       172 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~p  241 (353)
T 2i0e_A          172 IWDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYP  241 (353)
T ss_dssp             CCTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC
T ss_pred             ccCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHHHhCCCCCC
Confidence            32221       12366899999999999999999999999999999999999999987543   345556666555544


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCCh-----HHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDY-----GFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                           ..+++++.+||.+||..||.+||++     ++|+          .+.|...+||..+
T Consensus       242 -----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~----------~h~~f~~~~w~~l  288 (353)
T 2i0e_A          242 -----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK----------EHAFFRYIDWEKL  288 (353)
T ss_dssp             -----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH----------TSGGGTTCCHHHH
T ss_pred             -----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh----------cCccccCCCHHHH
Confidence                 3568999999999999999999965     3332          2345556788654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.4e-46  Score=363.14  Aligned_cols=260  Identities=23%  Similarity=0.246  Sum_probs=216.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+|++++..+.+|+++..+..++.+....|+||||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            46789999999999999999999999999999999876543  3568999999997778888888888889999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC-CCCcEEEeeccceeeecCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~-~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      + +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||+++........
T Consensus        98 ~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~  176 (342)
T 2qr7_A           98 MKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL  176 (342)
T ss_dssp             CCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence            9 8899998874 55799999999999999999999999999999999999985221 2246999999999876544321


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+..+.......+. ..+.
T Consensus       177 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~~~  248 (342)
T 2qr7_A          177 -------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG-GYWN  248 (342)
T ss_dssp             -------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-TTTT
T ss_pred             -------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-cccc
Confidence                   22557899999999999888999999999999999999999999875444455556666555544332 2335


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      .+++++.+||.+||..||++||++.++++  +.++
T Consensus       249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~  281 (342)
T 2qr7_A          249 SVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWI  281 (342)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCee
Confidence            67899999999999999999999999866  4444

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-45  Score=360.75  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=216.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +.-++|++.+.||+|+||.||+|+++.+++.||||+++..     .....+..|..++..+.+|+++..+..++.+....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            4458999999999999999999999999999999988642     34456788999999886678888888888888999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence            9999999 8899999876 4579999999999999999999999999999999999999   578899999999997643


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....       .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..   +.+..+.......+ 
T Consensus       170 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p-  238 (345)
T 1xjd_A          170 LGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP-  238 (345)
T ss_dssp             CTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred             cCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCCCCC-
Confidence            2221       123668999999999999999999999999999999999999999875443   44445544444333 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChH-HHHHHHHHHHHhcCCCCCcceeceec
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYG-FLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                          ..+++++.+||.+||..||++||++. +|++          +.|...+||..+
T Consensus       239 ----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~----------hp~f~~~~w~~l  281 (345)
T 1xjd_A          239 ----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ----------HPLFREINWEEL  281 (345)
T ss_dssp             ----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG----------SGGGTTCCHHHH
T ss_pred             ----cccCHHHHHHHHHHhcCCHhHcCCChHHHHc----------CccccCCCHHHH
Confidence                34689999999999999999999986 5532          344455678654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=355.87  Aligned_cols=255  Identities=19%  Similarity=0.244  Sum_probs=210.7

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++....        ....+.+|+.+++.++| +++..+..++.+
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEe
Confidence            345678999999999999999999999999999999876543        23568899999999986 566677777778


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC-CCCcEEEeeccc
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGL  152 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~-~~~~vkL~DFGl  152 (423)
                      ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++... ....+||+|||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            88999999999 8899998864 56799999999999999999999999999999999999995211 122899999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      ++.......        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+....
T Consensus       165 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~~~~  233 (326)
T 2y0a_A          165 AHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVN  233 (326)
T ss_dssp             CEECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHTC
T ss_pred             CeECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHhcC
Confidence            987653321        12457999999999999999999999999999999999999999875433   3333444444


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...+ ......++..+.+||.+||..||++||++.++++
T Consensus       234 ~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 YEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            4333 3344567899999999999999999999999866

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-45  Score=349.98  Aligned_cols=251  Identities=22%  Similarity=0.286  Sum_probs=204.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++.+.||+|+||+||+|++..+++.||||++......    ..+.+|+.+++.++| +++..+..++.+....++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeCCEEEEEE
Confidence            5899999999999999999999999999999988754332    457889999999986 56677777777889999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+++++.+.+......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus        81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred             ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence            999999999988777889999999999999999999999999999999999999   4788999999999987654322 


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCC-CchhhhhHHHHHHHHhhhcCCc----
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDKICEKKVSTP----  236 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~-~~~~~~~~~~~~~i~~~~~~~~----  236 (423)
                            ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||. +....   ..+..+.......+    
T Consensus       157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~  227 (292)
T 3o0g_A          157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTC
T ss_pred             ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhh
Confidence                  223567899999999998766 7999999999999999999888854 33222   22333322111111    


Q ss_pred             --------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 --------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          .......+++.+.+||.+||+.||++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                                01112346889999999999999999999999866

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=364.06  Aligned_cols=269  Identities=30%  Similarity=0.489  Sum_probs=198.8

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECC---CCcEEEEEEecCCCC-------------chhHHHHHHHHHHHcCCCCCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK-------------HPQLLYEAKVYKILQGGSGIP   66 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~---~~~~vaiKi~~~~~~-------------~~~~~~E~~~l~~l~~~~~i~   66 (423)
                      .+.+++|++.+.||+|+||.||+|.+..   ++..||||+......             ...+.+|+.++..+.| ++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h-~ni~  111 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY-LGIP  111 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC-CCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc-cCcc
Confidence            4567899999999999999999999987   788899998876532             1224456666666666 5566


Q ss_pred             eEEEeeee----CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           67 NIKWYGVD----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        67 ~i~~~~~~----~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      .+..++..    ....++||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++   .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~  187 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YK  187 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SS
T ss_pred             eeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cC
Confidence            66555555    67889999999999999887533 799999999999999999999999999999999999995   34


Q ss_pred             C--cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh
Q 014527          143 N--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT  220 (423)
Q Consensus       143 ~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~  220 (423)
                      +  .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            4  99999999998775432221111112245689999999999999999999999999999999999999996532211


Q ss_pred             h-HHHHHHHHhhhcCCcHHHhhc--cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          221 K-KQKYDKICEKKVSTPIEVLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       221 ~-~~~~~~i~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      . .....................  .+|.++.++|..||..||++||++++|++.|+.+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1 111111111111111112212  6789999999999999999999999999888753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.1e-46  Score=363.60  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=211.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEE-----CCCCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeEEEeeee-
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVD-   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~-----~~~~~~vaiKi~~~~~~~~---~~~~E~~~l~~l~~~~~i~~i~~~~~~-   74 (423)
                      +..++|++.+.||+|+||.||+|++     ..+++.||||++.......   .+.+|++++..+.+|+++..+..++.+ 
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            4568999999999999999999994     4567899999997654433   488999999999777777777666554 


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcC-------------------------------------------------------
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRR-------------------------------------------------------   98 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~-------------------------------------------------------   98 (423)
                      ....++||||+ +++|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            45589999999 7899999875432                                                       


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccccc
Q 014527           99 ----------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR  168 (423)
Q Consensus        99 ----------~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  168 (423)
                                .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++........     .
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~-----~  250 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----V  250 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC-----E
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc-----h
Confidence                      18999999999999999999999999999999999999   47889999999999866443221     1


Q ss_pred             CCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHH
Q 014527          169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE  247 (423)
Q Consensus       169 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (423)
                      ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....   .+..........+.   ...++++
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~  324 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLKEGTRMRA---PDYTTPE  324 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHHHTCCCCC---CTTCCHH
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHHHHcCCCCCC---CCCCCHH
Confidence            2235678999999999999999999999999999999998 999998754332   22222222222221   2345889


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +.++|..||+.||++||++.+|++.|+.++..
T Consensus       325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5e-46  Score=367.55  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=213.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -.++|++.+.||+|+||.||+|++..+++.||||++......   ..+.+|+++++.++| +++..+..++......++|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSSSSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecCCCcEEE
Confidence            457899999999999999999999989999999998755332   357889999999986 5666676677777889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCc
Confidence            9999 899999998766679999999999999999999999999999999999999   478899999999998654321


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..     .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.......+    ........+.+ 
T Consensus       268 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~----~~~~~~~~~~~-  337 (377)
T 3cbl_A          268 YA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE----FVEKGGRLPCP-  337 (377)
T ss_dssp             EE-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH----HHHTTCCCCCC-
T ss_pred             ee-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCC-
Confidence            11     01122346788999999998889999999999999999998 999998865443222    22222222222 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                        ..+|+++.+||..||+.||++||++++|++.|+++.++.
T Consensus       338 --~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          338 --ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence              345899999999999999999999999999999987653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-45  Score=359.97  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=215.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .-++|++++.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.+.| +++..+..++.+....|
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEEE
Confidence            457899999999999999999999999999999987542     334568889999999866 66777777777888999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       118 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccC
Confidence            999999 8899999876 4569999999999999999999999999999999999999   5788999999999987643


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ..          ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...   .+.+..+.......|  
T Consensus       194 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~p--  258 (350)
T 1rdq_E          194 RT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFP--  258 (350)
T ss_dssp             CB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC--
T ss_pred             Cc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHHHHHHcCCCCCC--
Confidence            22          256899999999999999999999999999999999999999987543   345555655555444  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCC-----hHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                         ..++.++.++|.+||..||.+||+     +++|++          +.|....||..+
T Consensus       259 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~----------h~~f~~~~w~~~  305 (350)
T 1rdq_E          259 ---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAI  305 (350)
T ss_dssp             ---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHH
T ss_pred             ---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh----------CcCcCCCCHHHH
Confidence               356899999999999999999998     666643          344556788654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8.8e-46  Score=362.05  Aligned_cols=255  Identities=20%  Similarity=0.234  Sum_probs=196.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.| +++..+..++......++|||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC-TTBCCEEEEEECSSEEEEEEC
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC-CCCcceeeeEecCCeEEEEEE
Confidence            4567899999999999999999999999999999999877666778899999999987 566667777778889999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++....... 
T Consensus       129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  206 (349)
T 2w4o_A          129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-  206 (349)
T ss_dssp             CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence            99 7899998864 45699999999999999999999999999999999999996434588999999999986543321 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....  ...+..+.......+ .....
T Consensus       207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~~~~~-~~~~~  276 (349)
T 2w4o_A          207 -------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCEYYFI-SPWWD  276 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTCCCCC-TTTTT
T ss_pred             -------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCCCccC-Cchhh
Confidence                   12567999999999999999999999999999999999999999764432  223444444433322 22335


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .++.++.+||.+||..||++||++.++++
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            67899999999999999999999998866

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.4e-46  Score=373.46  Aligned_cols=267  Identities=22%  Similarity=0.283  Sum_probs=217.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||+||+|++..+++.||||++..     ......+..|..++..+.| +++..+..++.+....
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS-KWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCEE
Confidence            446799999999999999999999999999999998764     2233448899999998865 6677777778888999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ +|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence            9999999 999999998656789999999999999999999999999999999999999   588999999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      .....      .....+||+.|+|||++.     +..++.++|||||||++|||++|+.||.+.+..   +.+.++....
T Consensus       227 ~~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~  297 (437)
T 4aw2_A          227 EDGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHK  297 (437)
T ss_dssp             TTSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHH
T ss_pred             cCCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhcc
Confidence            43321      122468999999999997     456899999999999999999999999875443   4444454432


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCC--CCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      .....+.....+++++.+||.+||..+|++  ||++++|++          +.|...+||..+
T Consensus       298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~----------Hpff~~i~w~~l  350 (437)
T 4aw2_A          298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK----------HPFFSGIDWDNI  350 (437)
T ss_dssp             HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT----------SGGGTTCCTTTG
T ss_pred             ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC----------CCccCCCCHHHH
Confidence            222222223456899999999999998888  999988854          344455688765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-45  Score=364.41  Aligned_cols=263  Identities=23%  Similarity=0.274  Sum_probs=197.4

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeee--
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD--   74 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--   74 (423)
                      |++.+.++|++++.||+|+||.||+|.+..+++.||||++....    ....+.+|+.++..+.+|+++..+..+...  
T Consensus         3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~   82 (388)
T 3oz6_A            3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN   82 (388)
T ss_dssp             -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred             ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence            45667899999999999999999999999999999999876432    223477899999999866777777665543  


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....|+||||++++|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR  157 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence            346899999999999998874  579999999999999999999999999999999999999   578899999999998


Q ss_pred             eecCCCCCCc--------------ccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhh
Q 014527          155 KYRDPTTNRH--------------IPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA  219 (423)
Q Consensus       155 ~~~~~~~~~~--------------~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~  219 (423)
                      .+........              .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            7643211100              00111235689999999999987 56899999999999999999999999886554


Q ss_pred             hhHHHHHHHHhhhcCCcHHHh------------------------------------------hccChHHHHHHHHHHhc
Q 014527          220 TKKQKYDKICEKKVSTPIEVL------------------------------------------CKSHPAEFASYFHYCQS  257 (423)
Q Consensus       220 ~~~~~~~~i~~~~~~~~~~~~------------------------------------------~~~~~~~l~~li~~cl~  257 (423)
                      .....   +......++.+.+                                          ...+++++.+||.+||.
T Consensus       238 ~~~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQLER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            33333   2221111111000                                          11567899999999999


Q ss_pred             CCCCCCCChHHHHH
Q 014527          258 LTFDQRPDYGFLKR  271 (423)
Q Consensus       258 ~dP~~RPt~~~l~~  271 (423)
                      .||++||+++++++
T Consensus       315 ~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          315 FNPNKRISANDALK  328 (388)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             cCcccCCCHHHHhC
Confidence            99999999998865

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-45  Score=349.90  Aligned_cols=253  Identities=24%  Similarity=0.305  Sum_probs=202.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++.+.||+|+||.||+|++ .+++.||||++....    ....+.+|+.+++.++| +++..+..++......++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccCCeEEEEE
Confidence            5899999999999999999998 678899999886543    23568899999999986 56666767777788999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      ||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....... 
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred             EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-
Confidence            999889999998766789999999999999999999999999999999999999   4788999999999986643221 


Q ss_pred             CcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc--------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--------  233 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------  233 (423)
                            ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.+......        
T Consensus       156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence                  11245789999999999764 589999999999999999999999987655433333322211110        


Q ss_pred             -------------CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 -------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   ..+.......+++++.+||.+||..||++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                         01112233557899999999999999999999999865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-45  Score=353.75  Aligned_cols=256  Identities=22%  Similarity=0.310  Sum_probs=214.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      --++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|..++..+.| +++..+..++.+....|
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC-CCCceEeEEEEeCCEEE
Confidence            347899999999999999999999999999999987643     334557889999998876 66777777777888999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus        83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred             EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC
Confidence            999999 7899999875 5579999999999999999999999999999999999999   5789999999999987543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ..          ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+...   ...+..+.......+  
T Consensus       159 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~p--  223 (318)
T 1fot_A          159 VT----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILNAELRFP--  223 (318)
T ss_dssp             CB----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHCCCCCC--
T ss_pred             cc----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC--
Confidence            22          256899999999999999999999999999999999999999987543   344555655555444  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                         ..+++++.++|.+||..||.+||     ++++|++          +.|...++|..+
T Consensus       224 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~----------hp~f~~~~~~~~  270 (318)
T 1fot_A          224 ---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN----------HPWFKEVVWEKL  270 (318)
T ss_dssp             ---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT----------SGGGSSCCHHHH
T ss_pred             ---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc----------CccccCCCHHHH
Confidence               34588999999999999999999     7777643          344445677643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.5e-45  Score=351.90  Aligned_cols=266  Identities=21%  Similarity=0.256  Sum_probs=207.0

Q ss_pred             ccCCceEEe-ceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            4 IIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         4 i~~~~y~i~-~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      .+.++|++. +.||+|+||.||+|++..+++.||||++....  ....+.+|+.++..+.+|+++..+..++.+.+..++
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            467889995 78999999999999999999999999986543  345689999999997767888888888888999999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999 7899999876 457999999999999999999999999999999999999963333345999999999865432


Q ss_pred             CCCCcccccCCCcccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCchhhh------------hH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------KK  222 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~------------~~  222 (423)
                      ...............||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.....            ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            2111111111224569999999999975     457899999999999999999999998643211            22


Q ss_pred             HHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+..+.......+.. ....+++.+.+||.+||..||++||++.++++
T Consensus       248 ~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhccCcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            3344454555544432 33567899999999999999999999999866

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.1e-46  Score=353.50  Aligned_cols=267  Identities=21%  Similarity=0.253  Sum_probs=206.4

Q ss_pred             CcccCCceEEeceeeecCceeEEEEE----ECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeEEEeee--
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGV--   73 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~----~~~~~~~vaiKi~~~~~~~--~~~~~E~~~l~~l~~~~~i~~i~~~~~--   73 (423)
                      +.+..++|++.+.||+|+||.||+|+    +..+++.||||++......  ..+.+|+.+++.++|+ ++..+..++.  
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~   83 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD-NIVKYKGVCYSA   83 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEecC
Confidence            35778999999999999999999998    4568899999998765432  4578999999999874 4545544332  


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      .....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCcc
Confidence            345689999999 8899999987666799999999999999999999999999999999999995   778999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-----------
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-----------  221 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-----------  221 (423)
                      ++........    ........++..|+|||++.+..++.++|||||||++|+|++|..||........           
T Consensus       161 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          161 TKVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  236 (295)
T ss_dssp             CC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred             cccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence            9876543221    1122345678889999999999999999999999999999999999975322100           


Q ss_pred             -HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          222 -KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       222 -~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       ..............+   ....+|+++.+||..||+.||++||++.+|++.|+.+...
T Consensus       237 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          237 IVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence             001111111111111   1245689999999999999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=370.01  Aligned_cols=266  Identities=23%  Similarity=0.308  Sum_probs=214.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||.||+|+++.+++.||||+++..     .....+.+|..++..+.| +++..+..++.+.+..
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR-RWITQLHFAFQDENYL  136 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEeeCCEE
Confidence            4468899999999999999999999999999999998642     123347889999998865 6777787788888999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence            9999999 899999998766689999999999999999999999999999999999999   588999999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCccccc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHL-------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      .....      .....+||+.|+|||++.       +..++.++|||||||++|||++|+.||.+.+..   +.+.++..
T Consensus       214 ~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~  284 (412)
T 2vd5_A          214 ADGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVH  284 (412)
T ss_dssp             TTSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT
T ss_pred             CCCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence            43321      122468999999999997       356899999999999999999999999875443   34444544


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCC---CChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR---PDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      .......+.....+|+++++||.+||. +|.+|   |++++|++          +.|...+||..+
T Consensus       285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~----------Hpff~~i~w~~l  339 (412)
T 2vd5_A          285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT----------HPFFFGLDWDGL  339 (412)
T ss_dssp             HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT----------SGGGTTCCSTTS
T ss_pred             cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc----------CCCcCCCCHHHH
Confidence            322111122235679999999999999 99998   57777743          445556788765

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-46  Score=364.21  Aligned_cols=264  Identities=18%  Similarity=0.251  Sum_probs=212.3

Q ss_pred             cccCCceEEeceeeecCceeEEEEEE-----CCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~-----~~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      .+..++|++.+.||+|+||.||+|++     ..+++.||||++......   ..+.+|+.++..++| +++..+..++..
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~  145 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSLQ  145 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEEec
Confidence            45678999999999999999999994     456778999998654332   347889999999976 566667667777


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEE
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI  147 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL  147 (423)
                      ....++||||+ +++|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.......+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            88889999999 889999998654      35899999999999999999999999999999999999954334557999


Q ss_pred             eeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHH
Q 014527          148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD  226 (423)
Q Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~  226 (423)
                      +|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....   +.+.
T Consensus       226 ~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~  297 (367)
T 3l9p_A          226 GDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE  297 (367)
T ss_dssp             CCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH
T ss_pred             CCCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence            999999865332211     12235578999999999999999999999999999999998 99999875543   2333


Q ss_pred             HHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .+.......    ....+|..+.+||..||+.||++||++.+|++.|+.+...
T Consensus       298 ~i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          298 FVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHcCCCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            333322111    1245688999999999999999999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=353.33  Aligned_cols=265  Identities=20%  Similarity=0.248  Sum_probs=208.6

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC--Ce
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--ED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~   77 (423)
                      .+++++|++.+.||+|+||.||+|++..+++.||||++...   .....+.+|+++++.++| +++..+..++...  ..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCcceEEEEeecCCCce
Confidence            46789999999999999999999999999999999998653   234557899999999987 4555555444443  37


Q ss_pred             eEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec-CCCCcEEEeeccce
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLA  153 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~-~~~~~vkL~DFGla  153 (423)
                      .++||||+ +++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            79999999 7899999975433  39999999999999999999999999999999999998432 35667999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCccccc--------CCCCCccchHHHHHHHHHHHHhCCCCCCCchhh-hhHHH
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQK  224 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~  224 (423)
                      +.......        .....||+.|+|||++.        +..++.++|||||||++|||++|+.||...... ...+.
T Consensus       164 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  235 (319)
T 4euu_A          164 RELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (319)
T ss_dssp             EECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred             eecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence            87655432        12457999999999987        567899999999999999999999999754332 22334


Q ss_pred             HHHHHhhhcCC-------------------c-HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          225 YDKICEKKVST-------------------P-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       225 ~~~i~~~~~~~-------------------~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +.++.......                   + ...+...++..+.++|.+||+.||++||+++++++...+.
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            44444332211                   0 0012234477899999999999999999999998876653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=361.63  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=215.7

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .+..++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.+.| ++++.+..++.+...
T Consensus        11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCE
Confidence            45668999999999999999999999999999999987532     334568899999999976 667777777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+..
T Consensus        90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML  165 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence            99999999 8899988874 5679999999999999999999999999999999999999   58899999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .....        .....||+.|+|||++.+   ..++.++|||||||++|+|++|..||.........+.+..+.....
T Consensus       166 ~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  237 (384)
T 4fr4_A          166 PRETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV  237 (384)
T ss_dssp             CTTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred             cCCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence            54322        235689999999999974   4589999999999999999999999987555544555555544444


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCC-hHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      ..+     ..++..+.+||.+||..||.+||+ +++|++          +.|...+||..+
T Consensus       238 ~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~----------hp~f~~~~w~~~  283 (384)
T 4fr4_A          238 TYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN----------FPYMNDINWDAV  283 (384)
T ss_dssp             CCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT----------SGGGTTCCHHHH
T ss_pred             CCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc----------ChhhhcCCHHHH
Confidence            433     345899999999999999999998 555432          344445667543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=358.89  Aligned_cols=265  Identities=20%  Similarity=0.300  Sum_probs=218.1

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCC-------CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYG   72 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-------~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~   72 (423)
                      .+..++|++.+.||+|+||.||+|++..+       +..||||++......   ..+.+|+++++.+..++++..+..++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            35678999999999999999999997543       357999998766443   34789999999996667788887788


Q ss_pred             eeCCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEE
Q 014527           73 VDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM  136 (423)
Q Consensus        73 ~~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl  136 (423)
                      ......++||||+ +++|.+++....               ..+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            8888899999999 789999998654               359999999999999999999999999999999999999


Q ss_pred             eecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 014527          137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG  215 (423)
Q Consensus       137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~  215 (423)
                         +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       225 ---~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          225 ---TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             ---CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ---cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence               47889999999999876543321     12234567899999999999999999999999999999999 9999987


Q ss_pred             chhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                      .....   ....+... ....   ....+++++.+||..||+.||++||++.+|++.|+.++.....
T Consensus       297 ~~~~~---~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          297 VPVEE---LFKLLKEG-HRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             CCHHH---HHHHHHTT-CCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             CCHHH---HHHHHHcC-CCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            55432   22222222 1111   1245689999999999999999999999999999999876653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.6e-45  Score=367.76  Aligned_cols=254  Identities=20%  Similarity=0.281  Sum_probs=209.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +..++|++.+.||+|+||.||+|.+  .++.||||+++.......+.+|+.+++.++|++.+..+..+.......++|||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4457899999999999999999998  47799999998887778899999999999875544444444444457899999


Q ss_pred             cc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++...... +++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++...... 
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc-
Confidence            99 78999999865543 7999999999999999999999999999999999999   478899999999998543221 


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                               ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+........   .+.. ....+.   
T Consensus       344 ---------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i~~-~~~~~~---  407 (450)
T 1k9a_A          344 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEK-GYKMDA---  407 (450)
T ss_dssp             ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---HHHT-TCCCCC---
T ss_pred             ---------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc-CCCCCC---
Confidence                     13357889999999999999999999999999999998 999998865543322   2222 222221   


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...+|+.+.+||..||..||++||++.+|++.|+++...
T Consensus       408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            245689999999999999999999999999999988754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.1e-46  Score=360.28  Aligned_cols=253  Identities=26%  Similarity=0.301  Sum_probs=208.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ...-++|++.+.||+|+||.||+|.+..+++.||||++..     ......+.+|+.+++.++| +++..+..++.....
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTPTD   83 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCE
Confidence            3455889999999999999999999999999999998753     2344568999999999986 566677777778889


Q ss_pred             eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      .++||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        84 ~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           84 IVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTT
T ss_pred             EEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceecc
Confidence            999999999999998876 4579999999999999999999999999999999999999   578899999999997654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ....        ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........   .+......  
T Consensus       160 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~--  226 (336)
T 3h4j_B          160 DGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---KVNSCVYV--  226 (336)
T ss_dssp             TSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---CCCSSCCC--
T ss_pred             CCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---HHHcCCCC--
Confidence            3321        235679999999999998876 789999999999999999999998643322111   11111111  


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                         ....+++++.+||.+||..||.+||++++|++  +.++.
T Consensus       227 ---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~  263 (336)
T 3h4j_B          227 ---MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFN  263 (336)
T ss_dssp             ---CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHH
T ss_pred             ---CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhc
Confidence               22446899999999999999999999999976  45554

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.5e-45  Score=365.35  Aligned_cols=259  Identities=19%  Similarity=0.186  Sum_probs=201.1

Q ss_pred             CceEEe-ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeee----CCeeEEE
Q 014527            7 VKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLV   81 (423)
Q Consensus         7 ~~y~i~-~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~~~~lv   81 (423)
                      ++|.+. +.||+|+||.||+|.+..+++.||||++..   ...+.+|+.++..+.+|+++..+..++..    ....|||
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            456665 799999999999999999999999999863   35688999998777777777777655443    5678999


Q ss_pred             Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++.....
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            9999 789999987532 35999999999999999999999999999999999999963333789999999999875432


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~  238 (423)
                      ..        ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... ......+....+..+..
T Consensus       218 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          218 NS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             -----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             Cc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            21        1256789999999999999999999999999999999999999987543221 11223343444433322


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       .+..++.++.+||.+||..||++||++.+|++  +.++..
T Consensus       290 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~  327 (400)
T 1nxk_A          290 -EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ  327 (400)
T ss_dssp             -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred             -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccC
Confidence             23457899999999999999999999999977  455543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.4e-45  Score=349.75  Aligned_cols=264  Identities=21%  Similarity=0.322  Sum_probs=217.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEE-----CCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~-----~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +..++|++.+.||+|+||.||+|++     ..+++.||||++.....   ...+.+|+.++..+..|+++..+..++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            4568999999999999999999986     35678899999876543   245889999999996567788887777888


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEe
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRR-----------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG  137 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~  137 (423)
                      ...++||||+ +++|.+++.....                 .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence            8999999999 7799999986543                 489999999999999999999999999999999999994


Q ss_pred             ecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCc
Q 014527          138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL  216 (423)
Q Consensus       138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~  216 (423)
                         .++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       180 ---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          180 ---HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             ---TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ---CCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence               7889999999999876544321     12234567889999999999999999999999999999999 99999875


Q ss_pred             hhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      ....   .+............   ...+|..+.++|..||..||.+||++.+|++.|++++.+..
T Consensus       252 ~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          252 PVDS---KFYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             CSSH---HHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             cchh---HHHHHhccCCCCCC---cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            4332   22222232222221   23458999999999999999999999999999999987654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-45  Score=352.86  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=192.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+|+.+++.++| +++..+..++...+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEECCeEEEEE
Confidence            478999999999999999999999999999999886543   33568899999999986 56667777777888999999


Q ss_pred             eccCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           83 DLLGPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        83 e~~~~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ||+.++|.+++....     ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred             EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence            999999999987543     458999999999999999999999999999999999999   478899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC-
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST-  235 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-  235 (423)
                      ....       ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.......... 
T Consensus       160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            3322       12245789999999999874 58999999999999999999999998865543333332222110000 


Q ss_pred             --------------------c-----HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 --------------------P-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 --------------------~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          .     .......++.++.+||.+||+.||++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                                0     00111246889999999999999999999998865

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.5e-45  Score=355.29  Aligned_cols=257  Identities=24%  Similarity=0.280  Sum_probs=193.2

Q ss_pred             cCCceEEe---ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~---~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.++|++.   +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+.+|+++..+..++.+....++|
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            34678886   7899999999999999999999999998653 3456889999999999778888888888888999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           85 MELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             ECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             EEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            9999 7899999876 5679999999999999999999999999999999999999643334489999999998654432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh----hhHHHHHHHHhhhcCCc
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTP  236 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~  236 (423)
                      ..       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....    ...+.+..+.......+
T Consensus       164 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          164 QP-------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred             Cc-------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence            21       22557899999999999999999999999999999999999999864331    22344444544444333


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      . ..+..+++++.+||..||..||.+||+++++++
T Consensus       237 ~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          237 G-EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             S-HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             c-ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            2 233567899999999999999999999998854

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=356.49  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=203.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCC-CCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGG-SGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~-~~i~~i~~~~~~~~~~   78 (423)
                      +.+++|++.+.||+|+||.||+|.+. +++.||||++......    ..+.+|+.++..+.|+ +++..+..++......
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            56889999999999999999999874 5889999998755432    3478899999999864 7788888888889999


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++|||+.+++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||+++....
T Consensus        85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred             EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence            99999889999999986 56799999999999999999999999999999999999993    67899999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      .....     ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||......  ...+..
T Consensus       160 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~  232 (343)
T 3dbq_A          160 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA  232 (343)
T ss_dssp             ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH
T ss_pred             ccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHH
Confidence            32211     1235579999999999975           66899999999999999999999999864322  222333


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      +........   .....+.++.+||..||..||.+||++.++++  +.++.
T Consensus       233 ~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--hp~~~  278 (343)
T 3dbq_A          233 IIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ  278 (343)
T ss_dssp             HHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred             HhcCCcccC---CcccCCHHHHHHHHHHcCCChhHCCCHHHHHh--Ccccc
Confidence            332222221   12334788999999999999999999999976  44444

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-44  Score=342.13  Aligned_cols=261  Identities=24%  Similarity=0.285  Sum_probs=214.7

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++.....    ...+.+|+.+++.++| +++..+..++......
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH   80 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEE
Confidence            3568999999999999999999999999999999999865432    2357889999999986 6677777777788889


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++....
T Consensus        81 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999 7799888875 4579999999999999999999999999999999999999644445569999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   .....+.......+.
T Consensus       160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~  228 (284)
T 3kk8_A          160 DSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDYPS  228 (284)
T ss_dssp             SSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCT
T ss_pred             cCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHHHhccccCCc
Confidence            4332        12467999999999999999999999999999999999999999875443   333344444443332


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      . ....+++++.+||..||+.||++||+++++++  +.++..
T Consensus       229 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~  267 (284)
T 3kk8_A          229 P-EWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICN  267 (284)
T ss_dssp             T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHS
T ss_pred             h-hhcccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccC
Confidence            2 23456899999999999999999999999977  455543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.1e-45  Score=361.93  Aligned_cols=257  Identities=21%  Similarity=0.298  Sum_probs=204.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~i~~~~~~~~~~   78 (423)
                      +.+.+|++.+.||+|+||.||+|.+.. ++.||||++......    ..+.+|+.++..|.+ ++++..+..++......
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            345679999999999999999999765 889999998765432    457899999999986 67888888888888899


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |+|||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+    .++.+||+|||+++.+..
T Consensus       132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC--
T ss_pred             EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccC
Confidence            99999779999999876 4579999999999999999999999999999999999999    357899999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      .....     ......||+.|+|||++.+           ..++.++|||||||+||||++|+.||......  ...+..
T Consensus       207 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~  279 (390)
T 2zmd_A          207 DTTSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA  279 (390)
T ss_dssp             ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHH
T ss_pred             CCccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHH
Confidence            32211     1235579999999999976           36889999999999999999999999864321  223333


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      +.......+.   ....+.++.+||..||..||.+||++.+|++  +.++.
T Consensus       280 ~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~~~  325 (390)
T 2zmd_A          280 IIDPNHEIEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ  325 (390)
T ss_dssp             HHCTTSCCCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred             HhCccccCCC---CccchHHHHHHHHHHcccChhhCCCHHHHhh--CcCcc
Confidence            4333332222   1234788999999999999999999999976  34443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.3e-45  Score=350.38  Aligned_cols=264  Identities=22%  Similarity=0.282  Sum_probs=203.0

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeEEEeee----e
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWYGV----D   74 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~--l~~~~~i~~i~~~~~----~   74 (423)
                      |++++.++|++.+.||+|+||+||+|++  +++.||||++... ....+..|.+++..  ++| +++..+..++.    .
T Consensus         2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h-~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRH-ENILGFIASDMTSRHS   77 (301)
T ss_dssp             --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCC-TTBCCEEEEEEEEETT
T ss_pred             ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccC-cCeeeEEEeeccccCC
Confidence            6789999999999999999999999988  6889999998653 34456778888877  555 45555544322    2


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcccccccCCceEEeecCCCCcE
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQV  145 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~giiHrDIKp~NILl~~~~~~~~v  145 (423)
                      ....++||||+ +++|.+++.  ...+++..++.++.||+.||.|||        ++||+||||||+|||+   +.++.+
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~  152 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQC  152 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCE
T ss_pred             CceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCE
Confidence            34579999999 789999985  467999999999999999999999        9999999999999999   478899


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCC------CCCccchHHHHHHHHHHHHhC----------
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRG----------  209 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~~sDIwSlGvil~elltG----------  209 (423)
                      ||+|||+|+...........   ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDV---GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             EECCCTTCEEEETTTTEEEC---CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             EEeeCCCeeecccccccccc---cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            99999999876654332111   12345799999999999887      455799999999999999999          


Q ss_pred             CCCCCCchhhh-hHHHHHHHHh-h--hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          210 SLPWQGLKAAT-KKQKYDKICE-K--KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       210 ~~Pf~~~~~~~-~~~~~~~i~~-~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ..||....... ....+..... .  ....+........++.+.+||..||+.||++||++.+|++.|+++
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            88987643221 1122222221 1  122222222334578899999999999999999999999999865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.2e-45  Score=343.52  Aligned_cols=258  Identities=19%  Similarity=0.283  Sum_probs=213.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+.. ++.||+|++.... ....+.+|+++++.++| +++..+..++.+....++||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCceEEEE
Confidence            346799999999999999999999874 6779999987654 45568999999999986 66667777777888899999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred             EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc
Confidence            999 789999998766779999999999999999999999999999999999999   4778999999999976543211


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                            .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....   +....+... ....   .
T Consensus       162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~~~~-~~~~---~  228 (269)
T 4hcu_A          162 ------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG-FRLY---K  228 (269)
T ss_dssp             ------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-CCCC---C
T ss_pred             ------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhcC-ccCC---C
Confidence                  11224567889999999999999999999999999999999 99999875543   233333222 1111   1


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ....++.+.+++..||+.||++||++.++++.|+++.+.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            234588999999999999999999999999999988653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.7e-45  Score=343.53  Aligned_cols=258  Identities=16%  Similarity=0.210  Sum_probs=213.0

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+..++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+|++++..++| ++++.+..++.+....++|
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH-PKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCceEEE
Confidence            356789999999999999999999876 46779999987654 45568999999999986 6666777777788889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTC
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhh
Confidence            9999 889999998766779999999999999999999999999999999999999   578899999999998765433


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.......   ....+........   
T Consensus       159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~~---  226 (268)
T 3sxs_A          159 YV------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLKVSQGHRLYR---  226 (268)
T ss_dssp             EE------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHHTTCCCCC---
T ss_pred             hh------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHHHHHcCCCCCC---
Confidence            21      1224456788999999999889999999999999999999 999998755432   2222222221111   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                       ....++.+.++|..||+.||++||++.+|++.|+.+..
T Consensus       227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          227 -PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence             13348899999999999999999999999999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-45  Score=355.49  Aligned_cols=256  Identities=27%  Similarity=0.319  Sum_probs=206.2

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      |..-+.++|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+.+++.++| +++..+..++.+...
T Consensus         1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~   79 (323)
T 3tki_A            1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI   79 (323)
T ss_dssp             -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred             CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCe
Confidence            445567899999999999999999999999999999998865432   3568899999999986 566677777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++.+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence            99999999 7799888753 4469999999999999999999999999999999999999   47889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .......     ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......  ..+..........
T Consensus       156 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~  228 (323)
T 3tki_A          156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL  228 (323)
T ss_dssp             EETTEEC-----CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHHTTCTTS
T ss_pred             ccCCccc-----ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcccccC
Confidence            4332211     1235689999999999988775 789999999999999999999998754322  2222222222221


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +   ....++..+.+||.+||..||++||++++|++
T Consensus       229 ~---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          229 N---PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             T---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C---ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1   12456899999999999999999999998854

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.9e-45  Score=345.42  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=200.6

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      .+..++|++.+.||+|+||.||+|.+..+   +..||||+......   ...+.+|+.+++.++|+ ++..+..+. ..+
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~-~~~   88 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP-HIVKLIGVI-TEN   88 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCT-TBCCEEEEE-CSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCC-ccceEEEEE-ccC
Confidence            35678999999999999999999998753   45699998875433   23578899999999874 455554444 456


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY  165 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccccccc
Confidence            789999999 6799999987666799999999999999999999999999999999999995   678999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .......      ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+......   +..+..... 
T Consensus       166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~~-  235 (281)
T 1mp8_A          166 MEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGER-  235 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCC-
T ss_pred             cCccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCCC-
Confidence            6543221      1224457889999999998899999999999999999997 9999987654432   223322221 


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      .+   ....+|+.+.++|..||..||++||++.+|++.|++++.++
T Consensus       236 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          236 LP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            11   22456899999999999999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.9e-45  Score=347.03  Aligned_cols=259  Identities=19%  Similarity=0.292  Sum_probs=211.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+|++++..+.| +++..+..++.+....++||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC-CCEeeEEEEEecCCCeEEEE
Confidence            45679999999999999999999876 57789999987654 45668999999999986 56667777777888899999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc
Confidence            999 889999998666779999999999999999999999999999999999999   4788999999999976543211


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                            .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.......   ....+.... ....   
T Consensus       176 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~-~~~~---  242 (283)
T 3gen_A          176 ------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQGL-RLYR---  242 (283)
T ss_dssp             ------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHHTTC-CCCC---
T ss_pred             ------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHHHhccc-CCCC---
Confidence                  11224457889999999998899999999999999999998 999998765443   222332221 1111   


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ....++.+.++|..||+.||++||++.+|++.|.+++.++
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            1344889999999999999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.3e-45  Score=345.92  Aligned_cols=253  Identities=17%  Similarity=0.288  Sum_probs=203.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc---------hhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---------PQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---------~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      .+..++|++.+.||+|+||.||+|++..+++.||||++......         ..+.+|+.+++.++| +++..+..+. 
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-   92 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH-PNIVKLYGLM-   92 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC-TTBCCEEEEE-
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC-CCchhhheee-
Confidence            46689999999999999999999999999999999987654321         568899999999976 4555554443 


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCc-----E
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQ-----V  145 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~-----v  145 (423)
                       ....++||||+ +++|.+.+......+++..++.++.||+.||.|||++|  |+||||||+|||++   ..+.     +
T Consensus        93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~~~~  168 (287)
T 4f0f_A           93 -HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAPVCA  168 (287)
T ss_dssp             -TTTTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCSCCE
T ss_pred             -cCCCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCceeE
Confidence             33447999999 78999988766678999999999999999999999999  99999999999995   3443     9


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHH
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ  223 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~  223 (423)
                      ||+|||+++.....          .....||+.|+|||++.  +..++.++|||||||++|+|++|+.||........ .
T Consensus       169 kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~  237 (287)
T 4f0f_A          169 KVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-K  237 (287)
T ss_dssp             EECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-H
T ss_pred             EeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-H
Confidence            99999999754322          12457899999999994  44578999999999999999999999987543322 2


Q ss_pred             HHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      ....+........   ....+|+++.++|..||+.||.+||++++|++.|++
T Consensus       238 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          238 FINMIREEGLRPT---IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHhccCCCCC---CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            2222223222222   234568999999999999999999999999998874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.2e-44  Score=339.88  Aligned_cols=252  Identities=24%  Similarity=0.271  Sum_probs=212.0

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +.++|++.+.||+|+||.||+|.+..++..||+|++...  .....+.+|+++++.++| ++++.+..++.+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEEE
Confidence            567899999999999999999999999999999987643  345678999999999976 66777777777888999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++........
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            999 7899998875 45699999999999999999999999999999999999996555788999999999987654332


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                              .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||......   +....+.......+. ...
T Consensus       165 --------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~  231 (277)
T 3f3z_A          165 --------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKIREGTFTFPE-KDW  231 (277)
T ss_dssp             --------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCH-HHH
T ss_pred             --------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCc-hhh
Confidence                    2255799999999998765 899999999999999999999999875443   344444454444443 333


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+++.+.++|.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          232 LNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            467899999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-45  Score=354.94  Aligned_cols=263  Identities=19%  Similarity=0.265  Sum_probs=211.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +-.++|++.+.||+|+||.||+|++.     .++..||||++....   ....+.+|+.++..+..|++++.+..++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            34578999999999999999999973     356789999987542   3456899999999996567788887777788


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCC
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRR----------------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD  132 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~  132 (423)
                      +..++||||+ +++|.+++.....                      .+++..++.++.||+.||.|||++||+||||||+
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~  201 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  201 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            8999999999 8899999975432                      3789999999999999999999999999999999


Q ss_pred             ceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCC
Q 014527          133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL  211 (423)
Q Consensus       133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~  211 (423)
                      |||++   .++.+||+|||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       202 NIll~---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          202 NVLVT---HGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             GEEEE---TTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             hEEEc---CCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence            99994   7889999999999876543321     11234567889999999999899999999999999999998 999


Q ss_pred             CCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ||.+....   ..+..+.......+.   ...+|+++.+||..||..||.+||++.+|++.|+.++...
T Consensus       274 p~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          274 PYPGIPVD---ANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             SSTTCCCS---HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcccCCcH---HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            99875433   222233333332222   2345899999999999999999999999999999886543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=354.96  Aligned_cols=254  Identities=19%  Similarity=0.252  Sum_probs=201.5

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||++......   ..+.+|+.+++.++| +++..+..++......++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeCCEEEEEec
Confidence            5799999999999999999999999999999988654322   235679999999986 566677777778889999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~--  155 (324)
T 3mtl_A           81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK--  155 (324)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred             ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence            99999999998877789999999999999999999999999999999999999   4788999999999986543322  


Q ss_pred             cccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC-------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST-------  235 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-------  235 (423)
                           ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..........       
T Consensus       156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence                 1224578999999999987 568999999999999999999999998866554444333332211110       


Q ss_pred             ---------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 ---------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ---------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                     ........+++++.+||.+||+.||.+||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                           111222356889999999999999999999999876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-45  Score=348.99  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=200.2

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .+|.+++|++.+.||+|+||.||+|++.   ..||||+++.....    ..+.+|+.+++.++|++ +..+..+. ....
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~-~~~~   93 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN-ILLFMGYS-TAPQ   93 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEE-CSSS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc-EEEEEeec-cCCc
Confidence            4688999999999999999999999863   35999998765433    34789999999998755 44454444 4566


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEK  170 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC-----
T ss_pred             cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceecccc
Confidence            89999999 7899998876567799999999999999999999999999999999999995   7889999999999765


Q ss_pred             cCCCCCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .......     ......||+.|+|||++.   +..++.++|||||||++|+|++|+.||.+.....  .....+.....
T Consensus       171 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~  243 (289)
T 3og7_A          171 SRWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSL  243 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHTSC
T ss_pred             ccccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccccc
Confidence            4322111     123457999999999997   5668899999999999999999999998754432  22333334444


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ..........+|+.+.+||.+||..||.+||++.+|++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            44444455677999999999999999999999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.8e-45  Score=356.25  Aligned_cols=259  Identities=24%  Similarity=0.289  Sum_probs=200.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| +++..+..++.+....++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC-CCCCcEEEEEeeCCEEEEEEE
Confidence            4689999999999999999999999999999999887543 34668999999999986 566677777778889999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++......  
T Consensus        97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~--  172 (361)
T 3uc3_A           97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS--  172 (361)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccC--
Confidence            99 8899998875 456999999999999999999999999999999999999941 123359999999997533222  


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCcc-chHHHHHHHHHHHHhCCCCCCCchhhh-hHHHHHHHHhhhcCCcHHHh
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRR-DDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDIwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~~  240 (423)
                            ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... ....+..+.......+..  
T Consensus       173 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  244 (361)
T 3uc3_A          173 ------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--  244 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--
T ss_pred             ------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--
Confidence                  1235579999999999998887655 899999999999999999998754322 223333444434333322  


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       ..+++++.+||.+||..||.+||++.+|++  +.+|.+
T Consensus       245 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~  280 (361)
T 3uc3_A          245 -IRISPECCHLISRIFVADPATRISIPEIKT--HSWFLK  280 (361)
T ss_dssp             -SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHT
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHh--Ccchhc
Confidence             245889999999999999999999999976  555543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.1e-45  Score=361.14  Aligned_cols=264  Identities=22%  Similarity=0.296  Sum_probs=208.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHH-HHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVY-KILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l-~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +..++|++++.||+|+||.||+|+++.+++.||||++....     ....+..|..++ +.+. |+++..+..++.+.+.
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADK  113 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCE
Confidence            34578999999999999999999999999999999886532     223355666653 3344 5777778788888899


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .|+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus       114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGG
T ss_pred             EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCcccccc
Confidence            99999999 7899998875 4579999999999999999999999999999999999999   57899999999999864


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .....       .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.   .+.+..+.......+
T Consensus       190 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~  259 (373)
T 2r5t_A          190 IEHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKPLQLK  259 (373)
T ss_dssp             BCCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHHHSCCCCC
T ss_pred             ccCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcccCCC
Confidence            33221       12366899999999999999999999999999999999999999987543   345555655544433


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                           ..++.++.+||.+||..||.+||++.+..   .++   ..+.|...+||..+
T Consensus       260 -----~~~~~~~~~li~~lL~~dp~~R~~~~~~~---~~i---~~h~~f~~~~w~~l  305 (373)
T 2r5t_A          260 -----PNITNSARHLLEGLLQKDRTKRLGAKDDF---MEI---KSHVFFSLINWDDL  305 (373)
T ss_dssp             -----SSSCHHHHHHHHHHTCSSGGGSTTTTTTH---HHH---HTSGGGTTCCHHHH
T ss_pred             -----CCCCHHHHHHHHHHcccCHHhCCCCCCCH---HHH---hCCccccCCCHHHH
Confidence                 45689999999999999999999985322   222   23455566788654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-44  Score=360.74  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=205.8

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCC-----CCCCeEEEeeeeCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG-----SGIPNIKWYGVDGE   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~-----~~i~~i~~~~~~~~   76 (423)
                      ..+..+|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+.+.     +++..+..++....
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            4567899999999999999999999999999999999876432 34578899999999754     35566666777888


Q ss_pred             eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc--EEEeeccce
Q 014527           77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLA  153 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~--vkL~DFGla  153 (423)
                      ..++||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++   .++.  +||+|||+|
T Consensus       173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTC
T ss_pred             eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccc
Confidence            999999999999999998654 3599999999999999999999999999999999999994   5554  999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      +......          ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.....   
T Consensus       250 ~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~---  316 (429)
T 3kvw_A          250 CYEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG---  316 (429)
T ss_dssp             EETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC---
T ss_pred             eecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC---
Confidence            7644322          245789999999999999999999999999999999999999988655433333222211   


Q ss_pred             CCcHH------------------------------------------------------HhhccChHHHHHHHHHHhcCC
Q 014527          234 STPIE------------------------------------------------------VLCKSHPAEFASYFHYCQSLT  259 (423)
Q Consensus       234 ~~~~~------------------------------------------------------~~~~~~~~~l~~li~~cl~~d  259 (423)
                      ..+..                                                      .+....++.+.+||.+||..|
T Consensus       317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d  396 (429)
T 3kvw_A          317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD  396 (429)
T ss_dssp             CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence            11100                                                      111223678999999999999


Q ss_pred             CCCCCChHHHHH
Q 014527          260 FDQRPDYGFLKR  271 (423)
Q Consensus       260 P~~RPt~~~l~~  271 (423)
                      |++|||++++++
T Consensus       397 P~~Rpta~e~L~  408 (429)
T 3kvw_A          397 PAVRMTPGQALR  408 (429)
T ss_dssp             TTTSCCHHHHHT
T ss_pred             hhhCCCHHHHhC
Confidence            999999999866

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-44  Score=358.85  Aligned_cols=260  Identities=18%  Similarity=0.227  Sum_probs=204.3

Q ss_pred             cCCceEEeceeeec--CceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            5 IGVKYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G--~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      .+++|++.+.||+|  +||.||+|++..+++.||||++......    ..+.+|+.+++.++| ++|..+..++.+....
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEEEECCEE
Confidence            46899999999999  9999999999999999999998754322    347789999999987 5666677777788999


Q ss_pred             EEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           79 VLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence            9999999 88999998764 2569999999999999999999999999999999999999   57889999999998765


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ..................||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+........   .+......
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~  255 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL---EKLNGTVP  255 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH---HC------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHhcCCCC
Confidence            4432222111222334589999999999988  578999999999999999999999998754332111   11111100


Q ss_pred             -----------------------------------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 -----------------------------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 -----------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                                               .+.......+++.+.+||.+||+.||++||+++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                     0011123456889999999999999999999999865

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.7e-45  Score=361.57  Aligned_cols=261  Identities=20%  Similarity=0.299  Sum_probs=202.5

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcC-------CCCCCeEEEee
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG-------GSGIPNIKWYG   72 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~-------~~~i~~i~~~~   72 (423)
                      ++.++.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.+       ++++..+..++
T Consensus        31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            357888999999999999999999999999999999999875432 3457899999999974       23344444433


Q ss_pred             e----eCCeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecC------
Q 014527           73 V----DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGR------  140 (423)
Q Consensus        73 ~----~~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~------  140 (423)
                      .    .....++||||++++|.+.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++      
T Consensus       111 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             eecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence            3    455789999999999998887643 5699999999999999999999999 999999999999995211      


Q ss_pred             ----------------------------------------CCCcEEEeeccceeeecCCCCCCcccccCCCccccccccc
Q 014527          141 ----------------------------------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA  180 (423)
Q Consensus       141 ----------------------------------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~  180 (423)
                                                              ....+||+|||+++......          ....||+.|+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~  260 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYR  260 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGC
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCccc
Confidence                                                    11379999999998764332          2457899999


Q ss_pred             CcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh---hHHHHHHHHhhhcCCcHHH------------------
Q 014527          181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT---KKQKYDKICEKKVSTPIEV------------------  239 (423)
Q Consensus       181 aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~~~------------------  239 (423)
                      |||++.+..++.++|||||||++|+|++|+.||.+.....   ....+..+.......+...                  
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            9999999999999999999999999999999997644221   1112222222111111110                  


Q ss_pred             -------------------hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 -------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 -------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                         .....+..+.+||.+||..||++||+++++++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                               01223567999999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-44  Score=349.06  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=198.8

Q ss_pred             cccCCceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      .+..++|++.+.||+|+||.||+|++.   .+++.||||++....      ....+.+|+.+++.++| +++..+..++.
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~   91 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYAFQ   91 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEEEE
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEEEE
Confidence            456789999999999999999999985   688999999987542      23447789999999986 56666667777


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      ..+..|+||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~  167 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL  167 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence            888999999999 7899998875 4569999999999999999999999999999999999999   4788999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      ++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   ..+..+....
T Consensus       168 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~  237 (327)
T 3a62_A          168 CKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILKCK  237 (327)
T ss_dssp             C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTC
T ss_pred             ccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCC
Confidence            976433221       122567999999999999999999999999999999999999999875433   3444555544


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      ...+     ..++.++.+||.+||..||.+||     +++++++
T Consensus       238 ~~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 LNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            4433     34589999999999999999999     5556544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4e-45  Score=351.33  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=198.5

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCC-
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE-   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~-   76 (423)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++......     ..+.+|+.++..++|+ ++..+..++.... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~   86 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP-AIVAVYDTGEAETP   86 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCT-TBCCEEEEEEEEET
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCC-CcceEEEeeeccCC
Confidence            45789999999999999999999999999999999998765322     2477899988888774 4555544443332 


Q ss_pred             ---eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           77 ---DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        77 ---~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                         ..|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~  162 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGI  162 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCSC
T ss_pred             CCcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeeccC
Confidence               349999999 7899999875 45799999999999999999999999999999999999994   788999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      ++.........    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....   .........
T Consensus       163 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~~~~~~~~  235 (311)
T 3ork_A          163 ARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VAYQHVRED  235 (311)
T ss_dssp             C----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHCC
T ss_pred             ccccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhcCC
Confidence            98765432211    12235679999999999999999999999999999999999999998755432   222222222


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHH-HHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK-RLFHD  275 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~-~~L~~  275 (423)
                       ..+.......+|.++.++|.+||+.||++||+..+++ ..|..
T Consensus       236 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          236 -PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             -CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence             3334445567899999999999999999999765543 34433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6e-45  Score=352.74  Aligned_cols=259  Identities=21%  Similarity=0.280  Sum_probs=203.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcE----EEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~----vaiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .+..++|++.+.||+|+||.||+|++..+++.    ||+|.+...   .....+.+|+.++..++| +++..+..++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecC
Confidence            35578999999999999999999999877765    577776533   234568999999999987 5566665555554


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                       ..+++++++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHH
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCccee
Confidence             467788888 8999999988777899999999999999999999999999999999999994   77899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .........     ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+........    ......
T Consensus       166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~~  236 (327)
T 3poz_A          166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE  236 (327)
T ss_dssp             HHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTC
T ss_pred             EccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH----HHHcCC
Confidence            765443221     1224467889999999999999999999999999999999 999998765443222    222222


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ..+.   ...++..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       237 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 RLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2222   13358899999999999999999999999999988764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.3e-45  Score=384.15  Aligned_cols=266  Identities=21%  Similarity=0.291  Sum_probs=221.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +.-++|++++.||+|+||.||+|++..+++.||||+++.     ......+..|..++..+.+++++..+..++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            345789999999999999999999999999999998763     234456788999999888889999998888889999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ||||||+ +++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+...
T Consensus       418 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECC
T ss_pred             EEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccc
Confidence            9999999 8899998876 4579999999999999999999999999999999999999   588999999999998644


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....       .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+.   .+.+..+.......| 
T Consensus       494 ~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~p-  562 (674)
T 3pfq_A          494 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYP-  562 (674)
T ss_dssp             CTTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHSSCCCCC-
T ss_pred             cCCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHHhCCCCCC-
Confidence            3322       12367899999999999999999999999999999999999999987543   355666666665555 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                          ..+++++.+||..||..||++||++..  ...+++   ..+.|...+||..+
T Consensus       563 ----~~~s~~~~~li~~lL~~dP~~R~~~~~--~~~~ei---~~h~ff~~i~w~~l  609 (674)
T 3pfq_A          563 ----KSMSKEAVAICKGLMTKHPGKRLGCGP--EGERDI---KEHAFFRYIDWEKL  609 (674)
T ss_dssp             ----TTSCHHHHHHHHHHSCSSSTTCTTCST--THHHHH---HSSGGGSSCCHHHH
T ss_pred             ----ccCCHHHHHHHHHHccCCHHHCCCCCC--CcHHHH---hcCccccCCCHHHH
Confidence                456899999999999999999999721  011122   23455566788765

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.2e-44  Score=347.71  Aligned_cols=252  Identities=20%  Similarity=0.284  Sum_probs=210.8

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++....        ....+.+|+.+++.+.| +++..+..++.+
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEec
Confidence            446688999999999999999999999999999999876543        23458899999999987 556667677778


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC----cEEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID  149 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~----~vkL~D  149 (423)
                      ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++    .+||+|
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~D  162 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID  162 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEcc
Confidence            88999999999 8899998874 55799999999999999999999999999999999999995   444    799999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      ||++........        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.
T Consensus       163 fg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~  231 (321)
T 2a2a_A          163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT  231 (321)
T ss_dssp             CTTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred             CccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH
Confidence            999987654322        12457999999999999999999999999999999999999999875433   3334444


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......+ ......++..+.+||.+||..||++||++.++++
T Consensus       232 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          232 SVSYDFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TTCCCCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hcccccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            4333333 3344667899999999999999999999998866

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.9e-45  Score=361.55  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=208.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||.||+|++..+++.||||++..     ......+.+|+.++..++| +++..+..++.+....
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEE
Confidence            345789999999999999999999999999999998754     2334458899999998876 6677777777888999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ +|+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus       145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeec
Confidence            9999999 8899998864  469999999999999999999999999999999999999   588999999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCC----CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh-
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-  232 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-  232 (423)
                      .....      .....+||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+..   ..+.++.... 
T Consensus       220 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~  290 (410)
T 3v8s_A          220 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN  290 (410)
T ss_dssp             TTSEE------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHH
T ss_pred             cCCcc------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhccc
Confidence            43211      123568999999999998765    789999999999999999999999875443   4444454432 


Q ss_pred             -cCCcHHHhhccChHHHHHHHHHHhcCCCCC--CCChHHHHH
Q 014527          233 -VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR  271 (423)
Q Consensus       233 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~l~~  271 (423)
                       ...|.   ...+++++++||.+||..+|.+  ||++++|++
T Consensus       291 ~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 SLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence             22222   1356899999999999999988  999998865

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-44  Score=342.82  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.++|++.+.||+|+||.||+|++..++..||+|++....   ....+.+|+++++.++| +++..+..++.+....++|
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecCCeEEEE
Confidence            5678999999999999999999999999999999876543   34568999999999987 5666677777788899999


Q ss_pred             Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |||+ +++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++....
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999 78999988643   3679999999999999999999999999999999999999644456889999999997655


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......   ...+........ 
T Consensus       179 ~~~~--------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~-  245 (285)
T 3is5_A          179 SDEH--------STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---QQKATYKEPNYA-  245 (285)
T ss_dssp             ----------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCCCCC-
T ss_pred             Cccc--------CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---HhhhccCCcccc-
Confidence            4322        225578999999999864 689999999999999999999999987554322   222222222221 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ..+..+++++.+||.+||+.||++||++.+|++
T Consensus       246 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 -VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             122446889999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=343.56  Aligned_cols=255  Identities=22%  Similarity=0.286  Sum_probs=199.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -++|++.+.||+|+||.||+|++..+++.||||++......    ..+.+|+.+++.++| +++..+..++.+....++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecCCeEEEE
Confidence            47899999999999999999999999999999988665443    346789999999986 5666777777788899999


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |||+.+.+...+....+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCccc
Confidence            9999555444444446779999999999999999999999999999999999999   4788999999999987654332


Q ss_pred             CCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc-------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------  233 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------  233 (423)
                      .       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+......       
T Consensus       158 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          158 Y-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             c-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence            1       124578999999999986 5689999999999999999999999988665543333332221100       


Q ss_pred             ----------------CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 ----------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                      ..+.......++..+.+||..||..||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                            01122233567889999999999999999999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-44  Score=353.37  Aligned_cols=245  Identities=20%  Similarity=0.307  Sum_probs=204.9

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ..+|++.+.||+|+||.||+|++..+++.||||++......     ..+.+|+++++.++| +++..+..++......++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCeEEE
Confidence            35699999999999999999999999999999998754322     347899999999986 556667777778889999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||+.|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..... 
T Consensus       132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB-
T ss_pred             EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCceecCCC-
Confidence            999999999999987778899999999999999999999999999999999999994   7889999999999765322 


Q ss_pred             CCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                                ....||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.....   .+..+........ 
T Consensus       208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~~~~~~~~~~~-  273 (348)
T 1u5q_A          208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPAL-  273 (348)
T ss_dssp             ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCCCCC-
T ss_pred             ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCC-
Confidence                      2457999999999985   4568999999999999999999999998755432   2223333222211 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                        ....+++.+.+||..||+.||++||++++|++
T Consensus       274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence              12356899999999999999999999999876

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=347.21  Aligned_cols=249  Identities=20%  Similarity=0.285  Sum_probs=198.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----------------------------chhHHHHHHH
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------------------HPQLLYEAKV   55 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------------------------~~~~~~E~~~   55 (423)
                      +..++|++.+.||+|+||.||+|++..+++.||||++.....                            .+.+.+|+++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            446899999999999999999999999999999998765421                            2458899999


Q ss_pred             HHHHcCCCCCCeEEEeeee--CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCC
Q 014527           56 YKILQGGSGIPNIKWYGVD--GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD  132 (423)
Q Consensus        56 l~~l~~~~~i~~i~~~~~~--~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~  132 (423)
                      ++.++|+ ++..+..+..+  ....++||||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+
T Consensus        90 l~~l~h~-~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           90 LKKLDHP-NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             HHTCCCT-TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHhCCCC-CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            9999874 45555444443  56789999999 677777543  457999999999999999999999999999999999


Q ss_pred             ceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCC---CCccchHHHHHHHHHHHHhC
Q 014527          133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRG  209 (423)
Q Consensus       133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDIwSlGvil~elltG  209 (423)
                      |||+   +.++.+||+|||+++........       .....||+.|+|||++.+..   ++.++|||||||++|+|++|
T Consensus       167 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          167 NLLV---GEDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             GEEE---CTTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             HEEE---CCCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            9999   47889999999999876543221       12457999999999998765   37889999999999999999


Q ss_pred             CCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..||.+....   .....+.......+.   ...+++++.+||.+||+.||++||++.+|++
T Consensus       237 ~~pf~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          237 QCPFMDERIM---CLHSKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCSSCCSSHH---HHHHHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccHH---HHHHHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9999875433   223333333333221   2356899999999999999999999999865

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-44  Score=347.53  Aligned_cols=262  Identities=18%  Similarity=0.288  Sum_probs=213.5

Q ss_pred             cccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ++..++|++.+.||+|+||.||+|.+.     .+++.||||++......   ..+.+|+++++.++| +++..+..++.+
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~   97 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH-PHVIKLYGACSQ   97 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CceeeEEEEEec
Confidence            345689999999999999999999984     45588999998765432   347889999999976 666667677777


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCccccccc
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK  130 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIK  130 (423)
                      ....++||||+ +++|.+++....                       ..+++..++.++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            88899999999 799999998643                       238999999999999999999999999999999


Q ss_pred             CCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-C
Q 014527          131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G  209 (423)
Q Consensus       131 p~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G  209 (423)
                      |+|||++   .++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus       178 p~NIli~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          178 ARNILVA---EGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             GGGEEEE---TTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             hheEEEc---CCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence            9999994   7889999999999876543321     12234567889999999999889999999999999999999 9


Q ss_pred             CCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..||.+......   ...+.. .....   ....+++++.++|..||+.||++||++.+|++.|++++.+.
T Consensus       250 ~~p~~~~~~~~~---~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          250 GNPYPGIPPERL---FNLLKT-GHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             CCSSTTCCGGGH---HHHHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCCCCHHHH---HHHhhc-CCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence            999987654322   222222 21111   22456899999999999999999999999999999998753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6e-44  Score=345.68  Aligned_cols=257  Identities=19%  Similarity=0.250  Sum_probs=207.1

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEE-CCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCC-----CCCeEEEeeee
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASH-VDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWYGVD   74 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~-~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~-----~i~~i~~~~~~   74 (423)
                      +.++.++|++.+.||+|+||.||+|.+ ..+++.||||++..... ...+.+|+.+++.+.|.+     ++..+..++..
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            578899999999999999999999998 56789999999875432 345889999999998754     35566677778


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC------------
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK------------  141 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~------------  141 (423)
                      ....++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..+.            
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            88999999999999999997644 36899999999999999999999999999999999999952111            


Q ss_pred             ----CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCch
Q 014527          142 ----ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK  217 (423)
Q Consensus       142 ----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~  217 (423)
                          .+.+||+|||+++......          ....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                5689999999998644322          24578999999999999999999999999999999999999998765


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHH---------------------------------------hhccChHHHHHHHHHHhcC
Q 014527          218 AATKKQKYDKICEKKVSTPIEV---------------------------------------LCKSHPAEFASYFHYCQSL  258 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~---------------------------------------~~~~~~~~l~~li~~cl~~  258 (423)
                      .......+..+..   ..+...                                       .....++.+.+||.+||..
T Consensus       239 ~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          239 SKEHLAMMERILG---PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             HHHHHHHHHHHHC---SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             hHHHHHHHHHHhC---CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            5443333333221   111100                                       0012257899999999999


Q ss_pred             CCCCCCChHHHHH
Q 014527          259 TFDQRPDYGFLKR  271 (423)
Q Consensus       259 dP~~RPt~~~l~~  271 (423)
                      ||.+||++.++++
T Consensus       316 dP~~Rpt~~ell~  328 (339)
T 1z57_A          316 DPAKRITLREALK  328 (339)
T ss_dssp             STTTSCCHHHHTT
T ss_pred             CcccccCHHHHhc
Confidence            9999999999865

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6e-45  Score=360.80  Aligned_cols=253  Identities=23%  Similarity=0.231  Sum_probs=209.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+|+.+++.+.| +++..+..++.+....++||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeCCEEEEEE
Confidence            34689999999999999999999999999999999876532  3358899999999976 56667777777888999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc
Confidence            999 88999988755557999999999999999999999999999999999999941 1356899999999987654322


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                              .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......+ ....
T Consensus       207 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~  274 (387)
T 1kob_A          207 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWEFD-EDAF  274 (387)
T ss_dssp             --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCCCC-SSTT
T ss_pred             --------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-cccc
Confidence                    12457899999999999999999999999999999999999999875443   33333433333322 2223


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+++++.+||.+||..||.+||++.++++
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            467899999999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-45  Score=353.53  Aligned_cols=260  Identities=21%  Similarity=0.326  Sum_probs=211.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +..++|++.+.||+|+||.||+|++.     .+++.||||++.....   ...+.+|+.+++.++| +++..+..++.+.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~  122 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVG  122 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEccC
Confidence            45689999999999999999999987     3458899999876543   2357899999999976 6676777777778


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccC
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP  131 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp  131 (423)
                      ...++||||+ +++|.+++....                       ..+++.+++.++.||+.||.|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            8899999999 789999997642                       5699999999999999999999999999999999


Q ss_pred             CceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CC
Q 014527          132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GS  210 (423)
Q Consensus       132 ~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~  210 (423)
                      +|||+   +.++.+||+|||+++.......     +.......+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       203 ~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          203 RNCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             GGEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ceEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence            99999   4788999999999986543221     112235578999999999999899999999999999999999 99


Q ss_pred             CCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          211 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .||.+....   +....+......    .....+|..+.++|..||+.||++||++.+|++.|+++..+
T Consensus       275 ~p~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          275 QPYYGMAHE---EVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CTTTTSCHH---HHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CcCCCCChH---HHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            999875543   233333333221    12245689999999999999999999999999999987644

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-44  Score=349.21  Aligned_cols=263  Identities=19%  Similarity=0.298  Sum_probs=214.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCc-----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~-----~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +..++|++.+.||+|+||.||+|.+..+++     .||+|++.....   ...+.+|+.++..+..|+++..+..++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            446789999999999999999999976654     799999876543   245789999999996567788887777888


Q ss_pred             CeeEEEEecc-CCCHHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCC
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYC-------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK  141 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~  141 (423)
                      ...++||||+ +++|.+++...             ...+++..++.++.||+.||.|||++||+||||||+|||++   .
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---N  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---G
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---C
Confidence            8999999999 77999998753             24589999999999999999999999999999999999994   7


Q ss_pred             CCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhh
Q 014527          142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT  220 (423)
Q Consensus       142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~  220 (423)
                      ++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             CCeEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            789999999999876543321     12234567889999999999899999999999999999998 999998754332


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                         .+..+.......+.   ....|+.+.++|..||+.||.+||++.+|++.|+++..+.
T Consensus       275 ---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          275 ---KFYKLVKDGYQMAQ---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             ---HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence               22233333332222   1335889999999999999999999999999999887653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.4e-44  Score=347.89  Aligned_cols=258  Identities=18%  Similarity=0.237  Sum_probs=207.2

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCC-cEEEEEEecCCCC-chhHHHHHHHHHHHcCCCC-----CCeEEEeee
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGV   73 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~-~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~i~~~~~   73 (423)
                      ++.++.++|++.+.||+|+||.||+|.+..++ +.||||++..... ...+.+|+.+++.+.|.+.     +..+..+..
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            46788999999999999999999999998776 6899999875432 3457889999999986543     445566677


Q ss_pred             eCCeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec-------------
Q 014527           74 DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-------------  139 (423)
Q Consensus        74 ~~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~-------------  139 (423)
                      .....++||||++++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||+...             
T Consensus        93 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           93 FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            888999999999999999887644 469999999999999999999999999999999999999422             


Q ss_pred             ---CCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Q 014527          140 ---RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL  216 (423)
Q Consensus       140 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~  216 (423)
                         +..+.+||+|||+++......          ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence               257899999999998644322          2457999999999999999999999999999999999999999876


Q ss_pred             hhhhhHHHHHHHHhhhcCCcHHHh---------------------------------------hccChHHHHHHHHHHhc
Q 014527          217 KAATKKQKYDKICEKKVSTPIEVL---------------------------------------CKSHPAEFASYFHYCQS  257 (423)
Q Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~---------------------------------------~~~~~~~l~~li~~cl~  257 (423)
                      ........+.++..   ..|....                                       ....+.++.+||.+||.
T Consensus       243 ~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          243 ENREHLVMMEKILG---PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             SHHHHHHHHHHHHC---CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CHHHHHHHHHHHcC---CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            55443333333221   1111100                                       01124689999999999


Q ss_pred             CCCCCCCChHHHHH
Q 014527          258 LTFDQRPDYGFLKR  271 (423)
Q Consensus       258 ~dP~~RPt~~~l~~  271 (423)
                      .||++||++.++++
T Consensus       320 ~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          320 FDPAQRITLAEALL  333 (355)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999998864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5e-45  Score=359.86  Aligned_cols=263  Identities=17%  Similarity=0.281  Sum_probs=202.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      .+..++|++.+.||+|+||.||+|++.   .++..||||+++....   ...+.+|+.++..++| +++..+..++.+..
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  119 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKSK  119 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCC
Confidence            345678999999999999999999876   4577899999876533   2358899999999976 56777777777888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence            899999999 889999998666679999999999999999999999999999999999999   5788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .........    ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.....   ....+.. ...
T Consensus       197 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~~-~~~  268 (373)
T 2qol_A          197 LEDDPEAAY----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVDE-GYR  268 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHHT-TEE
T ss_pred             cccCCccce----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCC
Confidence            654322110    1123345788999999999999999999999999999998 999998765432   2222222 222


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      .+.   ...+|..+.++|..||+.||++||++.+|++.|+.++...
T Consensus       269 ~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          269 LPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             CCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            221   1345899999999999999999999999999999987643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.3e-44  Score=350.62  Aligned_cols=259  Identities=23%  Similarity=0.258  Sum_probs=203.5

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeee-------
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------   74 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~-------   74 (423)
                      -++|++.+.||+|+||.||+|++..+++.||||++.....    ...+.+|+.+++.++|++ +..+..++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN-VVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTT-BCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCC-cccHhheeecccccccc
Confidence            3789999999999999999999999999999998765432    335789999999998754 4445444333       


Q ss_pred             -CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           75 -GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        75 -~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                       ....++||||+.++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLA  171 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhc
Confidence             45689999999999999988766789999999999999999999999999999999999999   47889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +.+........   .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus       172 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          172 RAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             EECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            87654322211   12235678999999999986 458999999999999999999999999866554444433332211


Q ss_pred             cCCcHHHh------------------------hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTPIEVL------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~~~~~------------------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ........                        ....++.+.+||.+||..||++||+++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11100000                        0012677999999999999999999998876

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-44  Score=365.97  Aligned_cols=250  Identities=20%  Similarity=0.239  Sum_probs=192.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeee-----C
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD-----G   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~-----~   75 (423)
                      +.++|++++.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++|++.+..+..+...     .
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            4588999999999999999999999999999999986532    234578999999999875544444443322     2


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...|+||||++++|.+.+.   ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.
T Consensus       140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART  213 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred             CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence            4579999999888877763   459999999999999999999999999999999999999   5788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....   +.......
T Consensus       214 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~---i~~~lg~p  282 (464)
T 3ttj_A          214 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---VIEQLGTP  282 (464)
T ss_dssp             ---CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCSC
T ss_pred             cCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCC
Confidence            654321        2356899999999999999999999999999999999999999988654433322   22211111


Q ss_pred             cH-------------------------HHhh------------ccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PI-------------------------EVLC------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~-------------------------~~~~------------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..                         +...            ...++++.+||.+||..||++||+++++++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            10                         0000            011567999999999999999999998866

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-44  Score=365.46  Aligned_cols=248  Identities=21%  Similarity=0.303  Sum_probs=199.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++| +++..+..++...+..
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEETTEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeCCEE
Confidence            4557899999999999999999999999999999987632     233457789999888876 5677777777888899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ++||||+ +++|.+++.. .+.+++..+..++.||+.||+|||+ +||+||||||+|||+   +.++.+||+|||+|+..
T Consensus       224 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTT
T ss_pred             EEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceec
Confidence            9999999 7899888875 4579999999999999999999998 999999999999999   47889999999999754


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .....       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....   ..+..+.......+
T Consensus       300 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p  369 (446)
T 4ejn_A          300 IKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP  369 (446)
T ss_dssp             CC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred             cCCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCC
Confidence            33221       123568999999999999999999999999999999999999999875443   34444544444433


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                           ..+++++.+||.+||..||.+||     ++++|++
T Consensus       370 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          370 -----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                 34689999999999999999999     8888754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.6e-44  Score=352.44  Aligned_cols=255  Identities=23%  Similarity=0.280  Sum_probs=205.3

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCC-----CCeEEEeeeeCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGVDGE   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~-----i~~i~~~~~~~~   76 (423)
                      ..+.++|++.+.||+|+||+||+|++..+++.||||++..... ...+..|+.++..+.++++     +..+..++....
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            4567899999999999999999999999999999999875432 3457789999999986664     666677777889


Q ss_pred             eeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ..++||||++++|.+++.... ..+++..++.++.||+.||.|||  +.||+||||||+|||++. +..+.+||+|||+|
T Consensus       130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTC
T ss_pred             ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCc
Confidence            999999999999999998654 56999999999999999999999  579999999999999942 24678999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      +......          ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+........   .+.....
T Consensus       209 ~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~---~i~~~~~  275 (382)
T 2vx3_A          209 CQLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN---KIVEVLG  275 (382)
T ss_dssp             EETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHC
T ss_pred             eeccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhC
Confidence            8764322          24578999999999999999999999999999999999999998765443332   2322211


Q ss_pred             CCcHHHh---------hcc--------------------------------------------------ChHHHHHHHHH
Q 014527          234 STPIEVL---------CKS--------------------------------------------------HPAEFASYFHY  254 (423)
Q Consensus       234 ~~~~~~~---------~~~--------------------------------------------------~~~~l~~li~~  254 (423)
                      ..+....         ...                                                  ..+++.+||.+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            1111100         000                                                  01478999999


Q ss_pred             HhcCCCCCCCChHHHHH
Q 014527          255 CQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       255 cl~~dP~~RPt~~~l~~  271 (423)
                      ||..||++|||++++++
T Consensus       356 mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             HTCSCTTTSCCHHHHTT
T ss_pred             hcCCChhhCCCHHHHhc
Confidence            99999999999999865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.7e-45  Score=352.02  Aligned_cols=257  Identities=19%  Similarity=0.264  Sum_probs=209.6

Q ss_pred             cccCCceEEe-ceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         3 ~i~~~~y~i~-~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +.+.++|.+. +.||+|+||.||+|.+..+++.||||++....    ....+.+|+.++..+.++++++.+..++.+...
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3467889988 89999999999999999999999999876532    245688999999999988999999888888999


Q ss_pred             eEEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           78 NVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      .++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||+++.
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            99999999 77998887532 35699999999999999999999999999999999999995323368999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......
T Consensus       184 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~  252 (327)
T 3lm5_A          184 IGHACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNISQVNVDY  252 (327)
T ss_dssp             C-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCC
T ss_pred             cCCccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHhccccc
Confidence            654322        12457999999999999999999999999999999999999999875543   3333333333332


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      + ......+++.+.+||..||..||++||++++|++
T Consensus       253 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          253 S-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             C-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             C-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            2 2233567899999999999999999999998864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-44  Score=347.57  Aligned_cols=264  Identities=21%  Similarity=0.314  Sum_probs=211.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee-
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD-   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~-   74 (423)
                      +..++|++.+.||+|+||.||+|++.     .+++.||||++......   ..+.+|+.++..+.+++++..+..++.. 
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            45689999999999999999999853     46789999998765443   3478999999999777777777665544 


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRK---------------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL  138 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~---------------l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~  138 (423)
                      ....++||||+ +++|.+++......               +++..++.++.||+.||.|||++||+||||||+|||+  
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--  181 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  181 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence            45689999999 78999998754322               8899999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                       +.++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus       182 -~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          182 -SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -CCCCCEEECCCccccccccCccc-----eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence             47789999999999866443221     11234567899999999999999999999999999999998 999998754


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      ...  .....+ ......+   ....+++++.++|..||+.||.+||++.+|++.|+.++....
T Consensus       256 ~~~--~~~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          256 IDE--EFCRRL-KEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CSH--HHHHHH-HHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hhH--HHHHHh-ccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            322  112222 2221111   123458899999999999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-44  Score=346.04  Aligned_cols=246  Identities=20%  Similarity=0.290  Sum_probs=203.6

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      .|+..+.||+|+||.||+|++..+++.||||++....  ....+.+|+.+++.++| +++..+..++......++||||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-FNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEecC
Confidence            4888899999999999999999899999999886543  34558899999999987 55666666677788999999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCc
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH  164 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~  164 (423)
                       +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.........  
T Consensus       125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~--  197 (321)
T 2c30_A          125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK--  197 (321)
T ss_dssp             CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC--
T ss_pred             CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc--
Confidence             889999875  4569999999999999999999999999999999999999   47889999999999876543221  


Q ss_pred             ccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....   +.+..+.......  ......+
T Consensus       198 -----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~--~~~~~~~  267 (321)
T 2c30_A          198 -----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRDSPPPK--LKNSHKV  267 (321)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSSCCC--CTTGGGS
T ss_pred             -----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCCCC--cCccccC
Confidence                 23567999999999999999999999999999999999999999875443   2233332222111  1122456


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ++.+.++|.+||..||++||++++|++
T Consensus       268 ~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          268 SPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            889999999999999999999999866

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=343.68  Aligned_cols=259  Identities=19%  Similarity=0.288  Sum_probs=207.9

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++........+.+|+.+++.+.| +++..+..+.......++||
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEEe
Confidence            44678899999999999999999999999999999999887777889999999999976 56666766677788999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc
Confidence            999 679999998667789999999999999999999999999999999999999   4788999999999987654322


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                             ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...+.....  +.....
T Consensus       181 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~--~~~~~~  248 (314)
T 3com_A          181 -------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---IFMIPTNPP--PTFRKP  248 (314)
T ss_dssp             -------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCC--CCCSSG
T ss_pred             -------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHhcCCC--cccCCc
Confidence                   12355789999999999999999999999999999999999999987544322   212211111  111112


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..++..+.+||..||..||.+||++.++++  +.++..
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~  284 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRS  284 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhc
Confidence            345889999999999999999999999976  455543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-44  Score=365.59  Aligned_cols=260  Identities=24%  Similarity=0.339  Sum_probs=214.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +.++|++.+.||+|+||+||+|++..+++.||||++..    ......+.+|+++++.++| ++++.+..++.+....++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcCCEEEE
Confidence            56789999999999999999999999999999998753    3345678999999999976 566677777778889999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.....
T Consensus        99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            99999 8899998876 457999999999999999999999999999999999999964445678999999999765443


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....   +.+..+.......+.+ 
T Consensus       178 ~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~-  244 (486)
T 3mwu_A          178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFDLP-  244 (486)
T ss_dssp             ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCSCSG-
T ss_pred             Cc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCCc-
Confidence            21        225579999999999987 5999999999999999999999999875443   4444555555444333 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      .+..+++++.+||.+||..||.+||++.++++  +.++....
T Consensus       245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~  284 (486)
T 3mwu_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYS  284 (486)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCc
Confidence            23567899999999999999999999999977  55565443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-44  Score=343.40  Aligned_cols=262  Identities=19%  Similarity=0.322  Sum_probs=217.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+..++|++.+.||+|+||.||+|.+..++..||||++..... ...+.+|+.+++.++| +++..+..++.+....++|
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCEEEE
Confidence            4567899999999999999999999999999999999876543 3568899999999986 5666676677788889999


Q ss_pred             Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCC
Confidence            9999 689999997643 459999999999999999999999999999999999999   47789999999999866543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ...      ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......+.   + .......  
T Consensus       165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~-~~~~~~~--  232 (288)
T 3kfa_A          165 TYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---L-EKDYRME--  232 (288)
T ss_dssp             SSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---H-HTTCCCC--
T ss_pred             ccc------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-hccCCCC--
Confidence            221      1224567889999999999999999999999999999999 9999987654432222   2 2222221  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                       ....+|+.+.+||..||..||.+||++.+|++.|+.++.+..
T Consensus       233 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence             124568999999999999999999999999999999987654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-44  Score=345.78  Aligned_cols=264  Identities=22%  Similarity=0.255  Sum_probs=208.1

Q ss_pred             cccCCceEEeceeeecCceeEEEEE----ECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~----~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .+..++|++.+.||+|+||.||+|+    +..+++.||||++....   ....+.+|+.+++.++| +++..+..++...
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTED   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC-TTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC-CCeeeeeeEEecC
Confidence            4456789999999999999999999    45688999999987543   33568899999999987 4555554444433


Q ss_pred             --CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           76 --EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        76 --~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                        ...++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~  172 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGL  172 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccc
Confidence              6689999999 7899999977777899999999999999999999999999999999999995   678999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh-----------hh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-----------TK  221 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-----------~~  221 (423)
                      +.........    +.......||..|+|||++.+..++.++|||||||++|+|++|..||......           ..
T Consensus       173 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (302)
T 4e5w_A          173 TKAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT  248 (302)
T ss_dssp             CEECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred             cccccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence            9877554321    11233557889999999999989999999999999999999999987542110           11


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ...+..........+   ....+|+.+.+||.+||..||.+||++.+|++.|+.++
T Consensus       249 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          249 VTRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111111112111111   22456899999999999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.8e-44  Score=347.25  Aligned_cols=263  Identities=19%  Similarity=0.311  Sum_probs=213.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC-------CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~-------~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      +..++|++.+.||+|+||.||+|++.       .++..||||++......   ..+.+|+.+++.+..++++..+..++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            45689999999999999999999986       35678999998765433   347899999999966677888877777


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEe
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG  137 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~  137 (423)
                      .....++||||+ +++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||+ 
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-  190 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-  190 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE-
Confidence            888999999999 789999987543               248999999999999999999999999999999999999 


Q ss_pred             ecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCc
Q 014527          138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL  216 (423)
Q Consensus       138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~  216 (423)
                        +.++.+||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       191 --~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          191 --TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             --CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             --cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence              47889999999999876543221     12234567889999999998889999999999999999999 99999875


Q ss_pred             hhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      ....   ....+.... ..+   ....++.++.++|..||..||.+||++.+|++.|+.++....
T Consensus       264 ~~~~---~~~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          264 PVEE---LFKLLKEGH-RMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             CHHH---HHHHHHHTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CHHH---HHHHHhcCC-CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            4432   222222221 111   124568999999999999999999999999999999987543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-44  Score=351.28  Aligned_cols=258  Identities=22%  Similarity=0.221  Sum_probs=198.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      .-++|++.+.||+|+||+||+|++..+++.||||++.....    ...+.+|+.+++.++| +++..+..+..+....++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEEE
Confidence            45789999999999999999999999999999999875433    2346789999999976 667777777788899999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec--CCCCcEEEeeccceeeecC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~--~~~~~vkL~DFGla~~~~~  158 (423)
                      ||||+.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+  +..+.+||+|||+++....
T Consensus       111 v~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          111 IFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            999999899999876 4569999999999999999999999999999999999999532  2345699999999987643


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC---
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS---  234 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---  234 (423)
                      ...       ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.........   
T Consensus       190 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          190 PIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            322       122457899999999998754 899999999999999999999999876544332222221110000   


Q ss_pred             -------------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 -------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 -------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                         .....+...+++++.+||.+||..||.+||+++++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                               0011122336789999999999999999999999865

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-44  Score=349.86  Aligned_cols=262  Identities=20%  Similarity=0.332  Sum_probs=192.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCc---EEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~---~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +..++|++.+.||+|+||.||+|++..++.   .||||++....    ....+.+|+++++.++| +++..+..++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC-TTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC-Cceehhhceeeccc
Confidence            457889999999999999999999877665   79999987542    23458899999999976 55555555544444


Q ss_pred             ee------EEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc
Q 014527           77 DN------VLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ  144 (423)
Q Consensus        77 ~~------~lv~e~~-~~sL~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~  144 (423)
                      ..      ++||||+ +++|.+++....     ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCC
Confidence            33      9999999 789999987533     159999999999999999999999999999999999999   47889


Q ss_pred             EEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 014527          145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ  223 (423)
Q Consensus       145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~  223 (423)
                      +||+|||+++........     .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.....   
T Consensus       176 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---  247 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---  247 (323)
T ss_dssp             EEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---
T ss_pred             EEEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---
Confidence            999999999876443321     12234467889999999999999999999999999999999 999998765443   


Q ss_pred             HHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      .+..+.......    ....+++++.+||.+||+.||++||++.+|++.|++++....
T Consensus       248 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          248 IYNYLIGGNRLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHHHHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHhcCCCCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            233333322111    124568999999999999999999999999999999987653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=351.66  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=195.4

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----   75 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+++++.++|++.+..+..+....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            46889999999999999999999999999999999865432    234789999999998755444444433221     


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...|+||||++++|.+++..  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccc
Confidence            34699999999999999875  569999999999999999999999999999999999999   4788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .....          ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+......   .+......
T Consensus       178 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~  244 (367)
T 1cm8_A          178 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTGT  244 (367)
T ss_dssp             CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCC
T ss_pred             ccccc----------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCC
Confidence            54322          24578999999999987 679999999999999999999999998765443322   22221111


Q ss_pred             Cc--------------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 TP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 ~~--------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+                          ........++.+.+||.+||..||++||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            11                          12223456889999999999999999999999876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-44  Score=350.13  Aligned_cols=264  Identities=22%  Similarity=0.246  Sum_probs=200.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeC----CeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDG----EDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~----~~~~   79 (423)
                      -.++|++.+.||+|+||.||+|++.  ++.||||++..... .....+|+.++..++|++ +..+..++...    ...+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHEN-ILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTT-BCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCC-chhhcceeccCCCCCceEE
Confidence            3578999999999999999999874  78999999865432 223566888888888754 54554444432    3479


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CcccccccCCceEEeecCCCCcEEEe
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR----------GFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      +||||+ +++|.+++..  ..+++..++.++.||+.||.|||++          ||+||||||+|||+   +.++.+||+
T Consensus        99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~  173 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIA  173 (322)
T ss_dssp             EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEEC
T ss_pred             EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEc
Confidence            999999 7899999974  4599999999999999999999999          99999999999999   478899999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCchhhh---
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT---  220 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~---  220 (423)
                      |||+++.........     ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+.....   
T Consensus       174 DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          174 DFGLALKFEAGKSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CCTTCEEECTTSCCC-----CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             cCCcccccccccCcc-----ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999998776543221     22346799999999999873     45678899999999999999999997643211   


Q ss_pred             ----------hHHHHHHHHhhhcCCcHHHhh--ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          221 ----------KKQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       221 ----------~~~~~~~i~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                                .......+............+  ...++++.+||.+||+.||++||++.+|++.|+.+.+..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~~  321 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN  321 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence                      111111122222222111111  1225679999999999999999999999999999876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.1e-44  Score=349.54  Aligned_cols=257  Identities=21%  Similarity=0.228  Sum_probs=203.6

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeC----Cee
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG----EDN   78 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~----~~~   78 (423)
                      +++|++++.||+|+||.||+|.+..+++.||||++......   ..+.+|++++..++|++.+..+..+....    ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            58999999999999999999999999999999998754432   45789999999998755444434333222    468


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++||||++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       106 ~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          106 YIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCG
T ss_pred             EEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCC
Confidence            99999999999998874  569999999999999999999999999999999999999   4788999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh------
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------  231 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------  231 (423)
                      .....    .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......      
T Consensus       181 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          181 DHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             GGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             CCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            32211    112356899999999987654 4899999999999999999999999876554433333222111      


Q ss_pred             -----------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 -----------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 -----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                       ....+.......+++++.+||.+||..||.+||++.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                             1111223344567889999999999999999999999876

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-44  Score=337.80  Aligned_cols=253  Identities=23%  Similarity=0.362  Sum_probs=197.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      ++-.++|++.+.||+|+||.||+|.+  +++.||||++....      ....+.+|+++++.++| +++..+..++.+..
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~   79 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKEP   79 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC-
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecCC
Confidence            45578999999999999999999998  48889999876532      23458899999999986 66667777777788


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---cccccccCCceEEeecC-----CCCcEEE
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGR-----KANQVYI  147 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDIKp~NILl~~~~-----~~~~vkL  147 (423)
                      ..++||||+ +++|.+++.  .+.+++..++.++.||+.||.|||++|   |+||||||+|||++...     ..+.+||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            899999999 788988875  567999999999999999999999999   89999999999995211     2678999


Q ss_pred             eeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      +|||++........         ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+....   .....
T Consensus       158 ~Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~  225 (271)
T 3dtc_A          158 TDFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---AVAYG  225 (271)
T ss_dssp             CCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHH
T ss_pred             ccCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHh
Confidence            99999986544322         2457899999999999999999999999999999999999999875543   22222


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      +.......+.   ...+|+.+.++|.+||+.||.+||++.++++.|++
T Consensus       226 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          226 VAMNKLALPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HHTSCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hhcCCCCCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            3333322222   24568999999999999999999999999998874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=349.23  Aligned_cols=260  Identities=21%  Similarity=0.282  Sum_probs=201.9

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEE----EEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV----AVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~v----aiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .+..++|++.+.||+|+||.||+|++..+++.|    |+|.+...   .....+.+|+.+++.++| +++..+..++...
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB-TTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEecC
Confidence            355789999999999999999999998877755    66665433   244568899999999987 4555555555444


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                       ..+++++++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus        90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK  165 (327)
T ss_dssp             -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC--
T ss_pred             -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCccee
Confidence             477788888 8999999988777899999999999999999999999999999999999994   77899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .........     ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+........    ......
T Consensus       166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----~~~~~~  236 (327)
T 3lzb_A          166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE  236 (327)
T ss_dssp             -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTC
T ss_pred             EccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCC
Confidence            765433221     1224457889999999999999999999999999999999 999998765543222    222222


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..+.   ...++.++.++|..||..||.+||++.+|++.|+.+...
T Consensus       237 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 RLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2222   234588999999999999999999999999999988743

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-43  Score=363.97  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=213.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---------------CchhHHHHHHHHHHHcCCCCCCeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------------KHPQLLYEAKVYKILQGGSGIPNI   68 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---------------~~~~~~~E~~~l~~l~~~~~i~~i   68 (423)
                      .+.++|++++.||+|+||+||+|++..+++.||||++....               ....+.+|+.+++.+.| ++++.+
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~  111 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIKL  111 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCCE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCeE
Confidence            46789999999999999999999999999999999876532               23468899999999986 667777


Q ss_pred             EEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEE
Q 014527           69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI  147 (423)
Q Consensus        69 ~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL  147 (423)
                      ..++.+....++||||| +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            77777888999999999 7899998876 467999999999999999999999999999999999999963323347999


Q ss_pred             eeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      +|||+++.......        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....   +.+..
T Consensus       191 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~  258 (504)
T 3q5i_A          191 VDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKK  258 (504)
T ss_dssp             CCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred             EECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence            99999987654322        225579999999999875 6899999999999999999999999875543   44455


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      +.......+.. .+..+++++.+||..||..||.+||+++++++  +.++++..
T Consensus       259 i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~  309 (504)
T 3q5i_A          259 VEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKYA  309 (504)
T ss_dssp             HHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHTC
T ss_pred             HHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhch
Confidence            55555544433 34577999999999999999999999999976  55665543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-45  Score=347.45  Aligned_cols=257  Identities=18%  Similarity=0.254  Sum_probs=205.3

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCC-------cEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEee
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYG   72 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~-------~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~   72 (423)
                      .++..++|++.+.||+|+||.||+|++..++       ..||+|++....  ..+.+.+|+.+++.++| +++..+..++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~   81 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGVC   81 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEE
Confidence            5678899999999999999999999998776       469999886432  33458899999999986 5666777777


Q ss_pred             eeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc-------
Q 014527           73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-------  144 (423)
Q Consensus        73 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~-------  144 (423)
                      .+....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.       
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~  158 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPP  158 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCC
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccc
Confidence            7788899999999 7899999987666699999999999999999999999999999999999996   3443       


Q ss_pred             -EEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhC-CCCCCCchhhhh
Q 014527          145 -VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK  221 (423)
Q Consensus       145 -vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG-~~Pf~~~~~~~~  221 (423)
                       +||+|||++......           ....||+.|+|||++.+ ..++.++|||||||++|+|++| ..||....... 
T Consensus       159 ~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-  226 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-  226 (289)
T ss_dssp             EEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred             eeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-
Confidence             999999998643221           24568899999999998 6799999999999999999995 55555433221 


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                         ...........+     ...++++.+||..||+.||++||++.+|++.|++++...+.
T Consensus       227 ---~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          227 ---KLQFYEDRHQLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             ---HHHHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             ---HHHHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence               112222222222     33477899999999999999999999999999988765543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-44  Score=363.19  Aligned_cols=268  Identities=21%  Similarity=0.268  Sum_probs=188.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeee-----e
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----D   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~   74 (423)
                      .+.++|++++.||+|+||.||+|++..+++.||||++.....    ...+.+|+++++.++|+ +|..+..++.     .
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD-HVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCT-TBCCEEEECCCSCTTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCC-CCCceEEEEecCCccc
Confidence            356899999999999999999999999999999998865432    24578999999999874 4555544442     2


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....|+||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+
T Consensus       129 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          129 FDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLAR  204 (458)
T ss_dssp             CCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred             CceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence            256899999999999998864 5579999999999999999999999999999999999999   578899999999998


Q ss_pred             eecCCCCCCcc-c-------------------ccCCCcccccccccCcccc-cCCCCCccchHHHHHHHHHHHHh-----
Q 014527          155 KYRDPTTNRHI-P-------------------YRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLR-----  208 (423)
Q Consensus       155 ~~~~~~~~~~~-~-------------------~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDIwSlGvil~ellt-----  208 (423)
                      ........... +                   .......+||+.|+|||++ .+..++.++||||||||||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            76533211100 0                   0122356789999999986 45669999999999999999999     


Q ss_pred             ------CCCCCCCchhh-----------------hhHHHHHHHHhhhcC--------------------------CcHHH
Q 014527          209 ------GSLPWQGLKAA-----------------TKKQKYDKICEKKVS--------------------------TPIEV  239 (423)
Q Consensus       209 ------G~~Pf~~~~~~-----------------~~~~~~~~i~~~~~~--------------------------~~~~~  239 (423)
                            |+.+|.+....                 .....+..+....-.                          .....
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  67777653310                 001111222111111                          11122


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      .....++++.+||.+||..||++||+++++++  +.+|.
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~  401 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFK  401 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGT
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhh
Confidence            23455889999999999999999999999876  44443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.4e-44  Score=336.76  Aligned_cols=254  Identities=19%  Similarity=0.281  Sum_probs=208.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      ++.++|++.+.||+|+||.||+|++..+++.||+|++....        ....+.+|+.+++.+.| +++..+..++.+.
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~   80 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENK   80 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCC
Confidence            56789999999999999999999999999999999876432        24568999999999986 6677777777788


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC-CCCcEEEeeccce
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLA  153 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~-~~~~vkL~DFGla  153 (423)
                      ...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+. ....+||+|||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            8999999999 7999999875 45799999999999999999999999999999999999995211 1238999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      ........        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+....   +.+..+.....
T Consensus       160 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~  228 (283)
T 3bhy_A          160 HKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNISAVNY  228 (283)
T ss_dssp             EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCC
T ss_pred             eeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhHhccc
Confidence            87654322        12456899999999999999999999999999999999999999875433   33333333333


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..+ ......++..+.++|.+||..||++||++.++++
T Consensus       229 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 DFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            333 3344677899999999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.3e-44  Score=358.76  Aligned_cols=263  Identities=18%  Similarity=0.244  Sum_probs=196.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC----
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG----   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~----   75 (423)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++.....    ...+.+|+++++.++|++ +..+..+....    
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY-IIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTT-BCCEEEECCCSCTTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCC-cceEEEEEecCCCCc
Confidence            367899999999999999999999999999999999875432    245789999999998754 55554444333    


Q ss_pred             -CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 -~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                       ...|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+
T Consensus       102 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          102 FDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLAR  177 (432)
T ss_dssp             CCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             CCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcc
Confidence             56899999999999998864 4569999999999999999999999999999999999999   578899999999998


Q ss_pred             eecCCCCCCcc---------------cccCCCcccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCC-----
Q 014527          155 KYRDPTTNRHI---------------PYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLRGSLPW-----  213 (423)
Q Consensus       155 ~~~~~~~~~~~---------------~~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDIwSlGvil~elltG~~Pf-----  213 (423)
                      ...........               ........+||+.|+|||++ .+..++.++|||||||++|||++|..||     
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            76543221000               00112466899999999986 4566999999999999999999854444     


Q ss_pred             ------CCchh--------------hhhHHHHHHHHhhh--------------------------cCCcHHHhhccChHH
Q 014527          214 ------QGLKA--------------ATKKQKYDKICEKK--------------------------VSTPIEVLCKSHPAE  247 (423)
Q Consensus       214 ------~~~~~--------------~~~~~~~~~i~~~~--------------------------~~~~~~~~~~~~~~~  247 (423)
                            .+...              ......+..+....                          ...+.......++++
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence                  33210              00111111121111                          111222333567899


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHH
Q 014527          248 FASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       248 l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +.+||.+||..||++||+++++++
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhc
Confidence            999999999999999999998866

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-44  Score=341.01  Aligned_cols=254  Identities=20%  Similarity=0.274  Sum_probs=200.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +..++|++.+.||+|+||.||+|.+  +++.||||++......+.+.+|+.+++.++|++.+..+..+.......++|||
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            4468999999999999999999987  58899999998877777899999999999875554444444445567899999


Q ss_pred             cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc-
Confidence            99 6699999875432 38999999999999999999999999999999999999   478899999999997654322 


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                               ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   ....+... ...   ..
T Consensus       172 ---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~-~~~---~~  235 (278)
T 1byg_A          172 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG-YKM---DA  235 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTT-CCC---CC
T ss_pred             ---------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcC-CCC---CC
Confidence                     13467889999999999899999999999999999998 999998754432   22222221 111   12


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...+|+.+.++|..||..||++||++.+|++.|+.+...
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            245689999999999999999999999999999988654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=361.93  Aligned_cols=269  Identities=19%  Similarity=0.240  Sum_probs=211.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC--Ce
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--ED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~   77 (423)
                      .+++++|++.+.||+|+||.||+|++..+++.||||++...   .....+.+|+++++.++| +++..+..++.+.  ..
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCC
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCCCeEEEeeccCCCCe
Confidence            46789999999999999999999999999999999998653   234557899999999987 4555555444443  36


Q ss_pred             eEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec-CCCCcEEEeeccce
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLA  153 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~-~~~~~vkL~DFGla  153 (423)
                      .++||||+ +++|.+++.....  .+++..++.++.||+.||+|||++||+||||||+|||+..+ +..+.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            79999999 7899999875332  39999999999999999999999999999999999998432 35567999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccC--------CCCCccchHHHHHHHHHHHHhCCCCCCCchh-hhhHHH
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-ATKKQK  224 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~-~~~~~~  224 (423)
                      +.......        .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||..... ....+.
T Consensus       164 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~  235 (396)
T 4eut_A          164 RELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV  235 (396)
T ss_dssp             EECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred             eEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence            87654321        224579999999999875        4578899999999999999999999975433 222333


Q ss_pred             HHHHHhhhcCCc--------------------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          225 YDKICEKKVSTP--------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       225 ~~~i~~~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      +.++........                    ...+...++..+.++|..||..||++||+++++++.+++++.+.
T Consensus       236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            444443322110                    00112334778999999999999999999999999999988654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-44  Score=364.76  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=213.7

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +.+..++|++++.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.++| +++..+..+.....
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~   89 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVISTPS   89 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEECSS
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence            356678999999999999999999999999999999987643     234568899999999986 56666767777888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhh
Confidence            999999999 8899998864 4579999999999999999999999999999999999999   5788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ......        ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....   ..+.++......
T Consensus       166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~  234 (476)
T 2y94_A          166 MSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKICDGIFY  234 (476)
T ss_dssp             CCTTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHHTTCCC
T ss_pred             cccccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCcC
Confidence            654321        125579999999999998775 78999999999999999999999875433   444555555444


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .+     ..+++++.+||.+||..||.+||++++|++  +.++..
T Consensus       235 ~p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~~  272 (476)
T 2y94_A          235 TP-----QYLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFKQ  272 (476)
T ss_dssp             CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHHT
T ss_pred             CC-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhhh
Confidence            33     345889999999999999999999999977  455554

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=354.58  Aligned_cols=253  Identities=22%  Similarity=0.237  Sum_probs=205.3

Q ss_pred             cCCceEE--eceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKL--GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i--~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +...|.+  .+.||+|+||.||+|.+..+++.||||++....  ....+.+|+.+++.++| ++++.+..++.+.+..++
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEE
Confidence            3455666  678999999999999999999999999987653  33458899999999976 566677777778889999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||+++.....
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCc
Confidence            99999 78999988766667999999999999999999999999999999999999942 24678999999999876543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   +.+..+.......+. .
T Consensus       243 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~-~  310 (373)
T 2x4f_A          243 EK--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNNILACRWDLED-E  310 (373)
T ss_dssp             CB--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCSCS-G
T ss_pred             cc--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCCh-h
Confidence            22        12457999999999999989999999999999999999999999875543   344445554443332 2


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....+++++.+||.+||..||.+||++.++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            33567899999999999999999999999977

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-43  Score=347.21  Aligned_cols=251  Identities=20%  Similarity=0.221  Sum_probs=210.0

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      +.++|++.+.||+|+||.||+|++..+|+.||||++.....          ...+.+|+.++..+..++++..+..++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            34689999999999999999999998999999999875432          23477899999999666778888888888


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS  247 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence            89999999999 7799998875 4579999999999999999999999999999999999999   57889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccC------CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      ..+.....        .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||.+....   ..+..
T Consensus       248 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~  316 (365)
T 2y7j_A          248 CHLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRM  316 (365)
T ss_dssp             EECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred             cccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHH
Confidence            87654332        125679999999999864      35788999999999999999999999875433   33444


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +.......+.+ .+..++..+.++|.+||..||++||+++++++
T Consensus       317 i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          317 IMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            44444444433 33567889999999999999999999999876

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-44  Score=367.79  Aligned_cols=260  Identities=26%  Similarity=0.355  Sum_probs=216.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .++.++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.+++.+.| ++++.+..++.+...
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~  100 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCE
Confidence            45678999999999999999999999999999999997643     234568999999999976 666677777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++.+
T Consensus       101 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999 8899998875 567999999999999999999999999999999999999964446789999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      .....        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....   +.+..+.......+
T Consensus       180 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~  247 (484)
T 3nyv_A          180 EASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVEKGKYTFE  247 (484)
T ss_dssp             CCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred             ccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC
Confidence            54321        124579999999999987 6999999999999999999999999875543   44445555544443


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .+ .+..+++++.+||.+||..||.+||++.++++  +.++..
T Consensus       248 ~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~  287 (484)
T 3nyv_A          248 LP-QWKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQT  287 (484)
T ss_dssp             SG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHH
T ss_pred             Cc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhcc
Confidence            32 23567899999999999999999999999976  455543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7e-44  Score=341.28  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=211.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .+.++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+|+.+++.++| +++..+..++.+....++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccCCEEEEE
Confidence            35689999999999999999999999999999999887543  33458899999999986 5566676777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           85 MQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             ECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             EEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            9999 7899998875 4579999999999999999999999999999999999999544567899999999987543211


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                               .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....   ..+..+.......+ ...
T Consensus       164 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~-~~~  230 (304)
T 2jam_A          164 ---------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGYYEFE-SPF  230 (304)
T ss_dssp             ---------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCCCCCC-TTT
T ss_pred             ---------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC-ccc
Confidence                     12456899999999999999999999999999999999999999875433   33344444433322 223


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...+|+++.++|..||..||++||+++++++  +.++..
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~  267 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDG  267 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccC
Confidence            3567899999999999999999999999876  455543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-44  Score=345.35  Aligned_cols=263  Identities=17%  Similarity=0.255  Sum_probs=206.9

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCC----cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~----~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      .+...+|++.+.||+|+||.||+|.+..++    ..||||++......   ..+.+|+.++..+.| +++..+..++...
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~  118 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY  118 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecC
Confidence            466789999999999999999999987543    35999998765432   347889999999976 5666676777778


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence            8899999999 679999998766789999999999999999999999999999999999999   478899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      ..........    ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....   +....+... .
T Consensus       196 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~-~  267 (333)
T 1mqb_A          196 VLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDG-F  267 (333)
T ss_dssp             -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-C
T ss_pred             hhcccccccc----ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHCC-C
Confidence            7654322110    1123456889999999999999999999999999999999 99999875543   223333222 2


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..+.   ...+|..+.++|.+||+.||++||++.+|++.|++++...
T Consensus       268 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          268 RLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             cCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            2221   2356899999999999999999999999999999988654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=349.24  Aligned_cols=253  Identities=21%  Similarity=0.243  Sum_probs=201.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....       ....+.+|+++++.+.| +++..+..++.+...
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEeeCCc
Confidence            3578999999999999999999999999999999876432       13457899999999986 566666666677888


Q ss_pred             eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      .++||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred             eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence            99999999889999887655679999999999999999999999999999999999999   478899999999998764


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC--
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS--  234 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--  234 (423)
                      ....       ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......   +..+......  
T Consensus       164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~  233 (346)
T 1ua2_A          164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPT  233 (346)
T ss_dssp             SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC
T ss_pred             CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence            4322       12355789999999999765 489999999999999999999999987654433   3333322111  


Q ss_pred             ---------------------CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 ---------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 ---------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                           .+.......+++++.+||.+||..||++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                                 1222334566789999999999999999999998866

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.3e-44  Score=364.32  Aligned_cols=252  Identities=24%  Similarity=0.354  Sum_probs=207.4

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +.++|++++.||+|+||.||+|++..++..||||++...    .....+.+|+.+++.+.| ++|..+..++.+....++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence            345799999999999999999999999999999987653    234568999999999986 566677777778889999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||| +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.....
T Consensus       114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            99999 8899988875 457999999999999999999999999999999999999964444667999999999876543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....   +.+..+.......+.+ 
T Consensus       193 ~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~-  259 (494)
T 3lij_A          193 KK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEKGKYTFDSP-  259 (494)
T ss_dssp             BC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCSG-
T ss_pred             cc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCch-
Confidence            32        225579999999999874 6899999999999999999999999875543   4444555554444322 


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+..+++.+.+||.+||..||.+||++.++++
T Consensus       260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            23567899999999999999999999999976

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-44  Score=341.87  Aligned_cols=255  Identities=21%  Similarity=0.273  Sum_probs=199.4

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ..+-.++|++.+.||+|+||.||+|++  .++.||||++........+.+|+++++.++|+ ++..+..+.  .+..++|
T Consensus         3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~--~~~~~lv   77 (307)
T 2eva_A            3 HMIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHP-NIVKLYGAC--LNPVCLV   77 (307)
T ss_dssp             CBCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCT-TBCCEEEBC--TTTTEEE
T ss_pred             CcCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCC-CcCeEEEEE--cCCcEEE
Confidence            345568999999999999999999988  47889999998776667799999999999874 454454433  3568999


Q ss_pred             Eecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---cCcccccccCCceEEeecCCCC-cEEEeecccee
Q 014527           82 LDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS---RGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK  154 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDIKp~NILl~~~~~~~-~vkL~DFGla~  154 (423)
                      |||+ +++|.+++.....  .++...++.++.||+.||.|||+   +||+||||||+|||++   .++ .+||+|||++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTAC  154 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC--
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEccccccc
Confidence            9999 7899999874332  47899999999999999999999   8999999999999995   445 48999999997


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ......          ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....+.... .
T Consensus       155 ~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~-~  222 (307)
T 2eva_A          155 DIQTHM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHNGT-R  222 (307)
T ss_dssp             --------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHHHTTC-C
T ss_pred             cccccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHHhcCC-C
Confidence            654322          134689999999999999999999999999999999999999986433211 1111221111 1


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                         ......+|..+.++|.+||+.||++||++++|++.|+.+...
T Consensus       223 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          223 ---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             ---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             ---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence               112345689999999999999999999999999999988643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-44  Score=352.04  Aligned_cols=256  Identities=20%  Similarity=0.269  Sum_probs=199.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee----------
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV----------   73 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~----------   73 (423)
                      ...++|++.+.||+|+||.||+|++..+++.||||++..+..  ...+|+.+++.++|++.+..+..+..          
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            456899999999999999999999999999999998865433  23489999999987555544444322          


Q ss_pred             ---------------------------eCCeeEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014527           74 ---------------------------DGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRG  123 (423)
Q Consensus        74 ---------------------------~~~~~~lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g  123 (423)
                                                 .....++||||+.++|.+.+..   ....+++..++.++.||+.||.|||++|
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                       2334789999999898888763   3467999999999999999999999999


Q ss_pred             cccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHH
Q 014527          124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYV  202 (423)
Q Consensus       124 iiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvi  202 (423)
                      |+||||||+|||++  ..++.+||+|||+|+.......        .....||+.|+|||++.+.. ++.++|||||||+
T Consensus       162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            99999999999994  3578999999999987654332        12557899999999998754 8999999999999


Q ss_pred             HHHHHhCCCCCCCchhhhhHHHHHHHHhhhc---------------------CCcHHHhhccChHHHHHHHHHHhcCCCC
Q 014527          203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKV---------------------STPIEVLCKSHPAEFASYFHYCQSLTFD  261 (423)
Q Consensus       203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~  261 (423)
                      +|+|++|+.||.+....+....+.+......                     ..-...+....|+++.+||.+||..||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999998655433333222211100                     0001112344688999999999999999


Q ss_pred             CCCChHHHHH
Q 014527          262 QRPDYGFLKR  271 (423)
Q Consensus       262 ~RPt~~~l~~  271 (423)
                      +||++.++++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.8e-44  Score=344.96  Aligned_cols=262  Identities=22%  Similarity=0.292  Sum_probs=204.6

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -++|++.+.||+|+||.||+|++..+++.||||++......    ..+.+|+.+++.++| ++++.+..++.+....++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEEE
Confidence            47899999999999999999999999999999987655433    236789999999986 6677777777788999999


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      |||+.+.+...+......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.......
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCcc
Confidence            9999666555555556779999999999999999999999999999999999999   4788999999999986654322


Q ss_pred             CCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh---------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---------  231 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---------  231 (423)
                             ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......         
T Consensus       180 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          180 -------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             -------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence                   12245789999999999876 6899999999999999999999999876544332222211110         


Q ss_pred             --------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          232 --------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       232 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                                    ....+.......+++.+.+||.+||..||++||++.+|++  +.+|+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~  313 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQMD  313 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc--CchhccC
Confidence                          0111222333467899999999999999999999999977  5666544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.1e-44  Score=346.79  Aligned_cols=268  Identities=18%  Similarity=0.237  Sum_probs=194.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEee--------e
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYG--------V   73 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~--------~   73 (423)
                      +.+.+|++.+.||+|+||.||+|++..+++.||||++....  ....+.+|+.++..+..|+++..+..+.        .
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            34668999999999999999999999999999999875433  2345789999999998556666665554        2


Q ss_pred             eCCeeEEEEeccCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEee
Q 014527           74 DGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        74 ~~~~~~lv~e~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                      .....+++|||++++|.+++...  ...+++..++.++.||+.||.|||++|  |+||||||+|||+   +.++.+||+|
T Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~D  181 (337)
T 3ll6_A          105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCD  181 (337)
T ss_dssp             SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCC
T ss_pred             CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEec
Confidence            34457999999999999998753  456999999999999999999999999  9999999999999   4788999999


Q ss_pred             ccceeeecCCCCCCcc-----cccCCCcccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh
Q 014527          150 FGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK  221 (423)
Q Consensus       150 FGla~~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~---~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~  221 (423)
                      ||+++...........     .........||+.|+|||++   .+..++.++|||||||++|+|++|+.||......  
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--  259 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--  259 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence            9999876543321100     00112245689999999998   5667899999999999999999999999763321  


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCC
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF  284 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~  284 (423)
                           .+.......+..   ...+..+.+||..||+.||.+||++.++++.|+.+....+.+.
T Consensus       260 -----~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~  314 (337)
T 3ll6_A          260 -----RIVNGKYSIPPH---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP  314 (337)
T ss_dssp             -----------CCCCTT---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred             -----HhhcCcccCCcc---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence                 122222222221   3446789999999999999999999999999999987765443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-44  Score=348.74  Aligned_cols=257  Identities=18%  Similarity=0.222  Sum_probs=204.3

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcE----EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~----vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ..++|++.+.||+|+||.||+|++..+++.    ||+|++....   ....+.+|+.++..++| +++..+..++. ...
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH-AHIVRLLGLCP-GSS   88 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC-TTBCCEEEEEC-BSS
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEc-CCc
Confidence            367999999999999999999999887775    7778765432   23457889999999987 45555555543 566


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccccc
Confidence            88999999 899999987655679999999999999999999999999999999999999   57889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .......     ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+.........   +... ...
T Consensus       166 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~-~~~  236 (325)
T 3kex_A          166 PPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKG-ERL  236 (325)
T ss_dssp             CCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH---HHTT-CBC
T ss_pred             Ccccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH---HHcC-CCC
Confidence            5443221     1234567889999999999999999999999999999999 9999987654432222   2222 111


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      +..   ..++.++.++|.+||..||.+||++.+|++.|+.+..
T Consensus       237 ~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          237 AQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111   2347789999999999999999999999999988753

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-44  Score=368.92  Aligned_cols=258  Identities=19%  Similarity=0.319  Sum_probs=214.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +-..+|++.+.||+|+||.||+|.+..++..||||++.... ....+.+|+.+++.++| +++..+..++......+|||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC-CCEeeEEEEEecCCcEEEEE
Confidence            34567999999999999999999999889999999987654 34568999999999986 56666766777788899999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCc
Confidence            999 799999998643 459999999999999999999999999999999999999   478899999999998764432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      .      .......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.......+   . .......+.  
T Consensus       373 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~---~-~~~~~~~~~--  440 (495)
T 1opk_A          373 Y------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---L-LEKDYRMER--  440 (495)
T ss_dssp             E------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---H-HHTTCCCCC--
T ss_pred             e------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---H-HHcCCCCCC--
Confidence            1      12234456789999999998889999999999999999999 999998865443222   2 222222221  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                       ...+|+.+.+||..||+.||++||++.+|++.|+.++.
T Consensus       441 -~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          441 -PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             24568999999999999999999999999999987654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.1e-45  Score=349.96  Aligned_cols=260  Identities=20%  Similarity=0.294  Sum_probs=211.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      ++..++|++.+.||+|+||.||+|.+.     .+++.||||++......   ..+.+|+.+++.+.| +++..+..++.+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCEeeeEEEEcc
Confidence            456789999999999999999999876     35778999998765432   247889999999986 566667667777


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ  144 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~  144 (423)
                      ....++||||+ +++|.+++....         ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCe
Confidence            88899999999 789999987532         457999999999999999999999999999999999999   47889


Q ss_pred             EEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHH
Q 014527          145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ  223 (423)
Q Consensus       145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~  223 (423)
                      +||+|||+++........     .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....   +
T Consensus       177 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~  248 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---Q  248 (322)
T ss_dssp             EEECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---H
T ss_pred             EEECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---H
Confidence            999999999765433211     12234567899999999999899999999999999999999 89999875443   2


Q ss_pred             HHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ....+.......    ....+|..+.++|..||..||.+||++.++++.|++++.
T Consensus       249 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            333333322211    224568999999999999999999999999999887654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.7e-44  Score=333.97  Aligned_cols=256  Identities=18%  Similarity=0.269  Sum_probs=211.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      -.++|++.+.||+|+||.||+|.+. +++.||+|++.... ..+.+.+|+++++.++| +++..+..++.+....++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSCEEEEC
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCeEEEEe
Confidence            3578999999999999999999986 57789999987654 34568999999999976 666677777777888999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++........ 
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccccc-
Confidence            99 789999998766779999999999999999999999999999999999999   4778999999999976543211 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                           .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......   +....+.... ...   ..
T Consensus       160 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i~~~~-~~~---~~  227 (267)
T 3t9t_A          160 -----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTGF-RLY---KP  227 (267)
T ss_dssp             -----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTTC-CCC---CC
T ss_pred             -----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHHhcCC-cCC---CC
Confidence                 11224567889999999998899999999999999999999 99999875433   2233332221 111   12


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ...+..+.+++.+||..||++||++.++++.|+++.+
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3458899999999999999999999999999998875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.3e-44  Score=345.79  Aligned_cols=266  Identities=17%  Similarity=0.256  Sum_probs=209.4

Q ss_pred             CcccCCceEEeceeeecCceeEEEEE-----ECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~-----~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      ..+..++|++.+.||+|+||.||+|+     +..+++.||||++.....   ...+.+|+.+++.+.| +++..+..++.
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~  103 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSL  103 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC-CCCCeEEEEEc
Confidence            46778999999999999999999999     456788999999865432   2357889999999966 66767777777


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEE
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY  146 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vk  146 (423)
                      .....++||||+ +++|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++..+....+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            788899999999 889999998654      3489999999999999999999999999999999999996443566799


Q ss_pred             EeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHH
Q 014527          147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY  225 (423)
Q Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~  225 (423)
                      |+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......   +..
T Consensus       184 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL  255 (327)
T ss_dssp             ECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH
T ss_pred             ECcccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHH
Confidence            9999999865433221     12234568899999999999899999999999999999998 99999875433   222


Q ss_pred             HHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..+.......    ....+|..+.++|..||+.||.+||++.+|++.|+.+....
T Consensus       256 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          256 EFVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            2232222111    12456899999999999999999999999999999876543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.5e-44  Score=356.20  Aligned_cols=255  Identities=22%  Similarity=0.246  Sum_probs=197.3

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeee-----CCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD-----GEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~-----~~~~~   79 (423)
                      ...+|++.+.||+|+||.||+|++..+++.||||++.....  ...+|+++++.|+|++.+..+..+...     ....+
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            34579999999999999999999999999999998865432  345799999999876555444443322     12367


Q ss_pred             EEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      +||||+.++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++  .+.+.+||+|||+++.+
T Consensus       130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred             eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhc
Confidence            9999998888887653   346799999999999999999999999999999999999995  24567899999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh---
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---  232 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---  232 (423)
                      .....        .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+....+....+.+.....   
T Consensus       208 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          208 VRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             CTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            54322        1245789999999999875 68999999999999999999999998865443322222211100   


Q ss_pred             -----------cCC------cH-HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 -----------VST------PI-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 -----------~~~------~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                 +..      +. ..+....++++.+||.+||..||.+||++.++++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                       000      00 1122356889999999999999999999998865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-43  Score=338.50  Aligned_cols=263  Identities=22%  Similarity=0.280  Sum_probs=200.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....     ....+.+|+.+++.++| +++..+..++...+..
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNEL  107 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCcE
Confidence            44578999999999999999999999999999999987532     12347889999999976 5666677777788899


Q ss_pred             EEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           79 VLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ++||||+ +++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC----
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecccee
Confidence            9999999 67999988642   4569999999999999999999999999999999999999   478899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .......       ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+... ........+......
T Consensus       185 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~  256 (310)
T 2wqm_A          185 FFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP  256 (310)
T ss_dssp             ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSC
T ss_pred             eecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCC
Confidence            6644322       11245789999999999999999999999999999999999999976432 122222233222222


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                      ..   ....+++++.++|..||..||++||++.+|++.|+++.....
T Consensus       257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            11   124568999999999999999999999999999999876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.1e-44  Score=359.56  Aligned_cols=254  Identities=26%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....          ....+.+|+.+++.++|++ +..+..+. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~-  209 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC-IIKIKNFF-  209 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTT-BCCCCEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCC-EeeEEEEE-
Confidence            34678999999999999999999999999999999876421          1234789999999998754 55554444 


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      .....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||+
T Consensus       210 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             ESSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ecCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            456689999999 8899887754 46799999999999999999999999999999999999996444556799999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      |+.......        .....||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......  .....+.
T Consensus       289 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~  358 (419)
T 3i6u_A          289 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT  358 (419)
T ss_dssp             TTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH
T ss_pred             ceecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh
Confidence            987643321        235679999999999864   567889999999999999999999998643321  1222233


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...... ....+..+++.+.+||.+||+.||.+||+++++++
T Consensus       359 ~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          359 SGKYNF-IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TTCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCC-CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            333332 34445677999999999999999999999998866

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.7e-44  Score=341.78  Aligned_cols=259  Identities=22%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      -++|++.+.||+|+||.||+|++..+++.||||++.....     ...+.+|+.++..++| +++..+..++......++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeCCeEEE
Confidence            4789999999999999999999999999999999865422     2457889999999976 666677777778889999


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccccc
Confidence            99999 6799999875 4579999999999999999999999999999999999999   47889999999999766543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ...      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....    .+......... ....
T Consensus       188 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~-~~~~  256 (309)
T 2h34_A          188 KLT------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIP-RPST  256 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCC-CGGG
T ss_pred             ccc------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCC-Cccc
Confidence            211      122457899999999999999999999999999999999999999875432    22222222222 2233


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHHHhc
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSRE  280 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RP-t~~~l~~~L~~~~~~~  280 (423)
                      ....+|.++.++|.+||..||++|| +++++++.|+.++...
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            4466799999999999999999999 9999999998776443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-43  Score=335.72  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=207.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ..-++|++.+.||+|+||.||+|.+..+++.||||++...     .....+.+|+.+++.++| ++++.+..++.+....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCEE
Confidence            3457899999999999999999999999999999987532     234568899999999986 6677777777788899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        85 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCC
Confidence            9999999 6899998876 4569999999999999999999999999999999999999   478899999999986543


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ...         .....||+.|+|||++.+..++.++||||||+++|+|++|..||......   ..+..+.......+ 
T Consensus       161 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~-  227 (279)
T 3fdn_A          161 SSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEFTFP-  227 (279)
T ss_dssp             ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCC-
T ss_pred             ccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHHHHHhCCCCCC-
Confidence            322         12457899999999999999999999999999999999999999875443   33333333333332 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                          ..+++.+.+||.+||+.||.+||++++|++  +.++...
T Consensus       228 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~  264 (279)
T 3fdn_A          228 ----DFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN  264 (279)
T ss_dssp             ----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHH
T ss_pred             ----CcCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCC
Confidence                345889999999999999999999999987  4555543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.9e-44  Score=336.18  Aligned_cols=250  Identities=18%  Similarity=0.199  Sum_probs=204.1

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      |...+.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+..+..+.+++++..+..++.+.+
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            34456789999999999999999999999999999999887543    23357889999999866678888888888899


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC------------
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR------------  140 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~------------  140 (423)
                      ..++||||+ +++|.+++....   ..+++..++.++.||+.||.|||++||+||||||+|||++.+.            
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999 779999987542   5699999999999999999999999999999999999995322            


Q ss_pred             ----CCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 014527          141 ----KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQG  215 (423)
Q Consensus       141 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~  215 (423)
                          ....+||+|||++.......           ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             cccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                44589999999998765432           34589999999999876 567899999999999999999988764


Q ss_pred             chhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...      ...+......    .....+++++.++|..||..||++||++.++++
T Consensus       234 ~~~------~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          234 GDQ------WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SHH------HHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH------HHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            321      2223232221    223456899999999999999999999999865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8e-44  Score=339.62  Aligned_cols=262  Identities=18%  Similarity=0.252  Sum_probs=206.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~---~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ..+|++.+.||+|+||.||+|++..++   ..||+|.+......   ..+.+|+.+++.++|++.+..+..+.......+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            457999999999999999999976433   35899988765432   347899999999987655555555566677889


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence            999999 779999998666779999999999999999999999999999999999999   4788999999999986643


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....   ........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||.+.......   ..+.......  
T Consensus       181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~--  252 (298)
T 3f66_A          181 KEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGRRLL--  252 (298)
T ss_dssp             GGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHHTTCCCC--
T ss_pred             cchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhcCCCCC--
Confidence            32111   112335567889999999999999999999999999999999 66777664443222   2222222211  


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                        ....+|+.+.++|..||+.||++||++.+|++.|+.++...
T Consensus       253 --~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          253 --QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             --CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence              12345889999999999999999999999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.4e-44  Score=350.96  Aligned_cols=261  Identities=20%  Similarity=0.307  Sum_probs=209.6

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ++.+..++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+|+.+++.++| +++..+..++.+...
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTE
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCE
Confidence            356788999999999999999999999999999999999876543   2357899999999976 667777777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      .++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||++..
T Consensus       106 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHH
T ss_pred             EEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcc
Confidence            99999999 7799999876 45699999999999999999999996 99999999999999   4788999999999976


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHH----------
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY----------  225 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~----------  225 (423)
                      .....         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+          
T Consensus       182 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          182 LIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             HHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             ccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            54322         12457899999999999999999999999999999999999999875433221111          


Q ss_pred             -----------------------------HHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          226 -----------------------------DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       226 -----------------------------~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                                                   ..+......   ......++.++.+||..||..||++||+++++++  +.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~  327 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP---KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAF  327 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCC---CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHH
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC---CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh--ChH
Confidence                                         111111000   0011235889999999999999999999999977  455


Q ss_pred             HHhc
Q 014527          277 FSRE  280 (423)
Q Consensus       277 ~~~~  280 (423)
                      ++..
T Consensus       328 ~~~~  331 (360)
T 3eqc_A          328 IKRS  331 (360)
T ss_dssp             HHHH
T ss_pred             hhcc
Confidence            5543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-43  Score=333.04  Aligned_cols=258  Identities=19%  Similarity=0.221  Sum_probs=205.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC---CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~---~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +..++|++.+.||+|+||.||+|++..   ++..||||++.....   ...+.+|+.+++.++|+ ++..+..+.. ...
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~-~~~   86 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP-HIVKLIGIIE-EEP   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCT-TBCCEEEEEC-SSS
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCC-CcceEEEEEc-CCC
Confidence            456899999999999999999998754   344699999876532   34588999999999874 4555544443 456


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCccc
Confidence            78999999 7899999987777799999999999999999999999999999999999995   6789999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......      ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........   +... ...
T Consensus       164 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---~~~~-~~~  233 (281)
T 3cc6_A          164 EDEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKG-DRL  233 (281)
T ss_dssp             ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---HHHT-CCC
T ss_pred             cccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---HhcC-CCC
Confidence            543221      1224467889999999998899999999999999999998 9999986554433222   2221 111


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +.   ...+|+.+.++|.+||..||++||++.+|++.|++++..
T Consensus       234 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          234 PK---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            11   134589999999999999999999999999999998764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-43  Score=341.80  Aligned_cols=253  Identities=20%  Similarity=0.284  Sum_probs=200.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeee--CCeeEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GEDNVLV   81 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--~~~~~lv   81 (423)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.. .....+.+|+.+++.+.+++++..+..+..+  ....++|
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            346889999999999999999999999999999999875 3456789999999999977888888776665  6678999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.    .+++..++.++.||+.||.|||++||+||||||+|||++  .+...+||+|||+++......
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTC
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCC
Confidence            9999 788888763    489999999999999999999999999999999999995  234489999999998765433


Q ss_pred             CCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHH----------
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKI----------  228 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i----------  228 (423)
                      .        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+...          
T Consensus       186 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          186 E--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             C--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             c--------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence            2        124578999999999987 56899999999999999999999999543221 111111111          


Q ss_pred             HhhhcCCcH-------------------HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          229 CEKKVSTPI-------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       229 ~~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .........                   ......+++++.+||.+||..||.+||+++++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000                   0011226899999999999999999999999876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.4e-44  Score=348.26  Aligned_cols=264  Identities=22%  Similarity=0.259  Sum_probs=208.7

Q ss_pred             CCceEEeceeeecCceeEEEEEE----CCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeEEEeee--eCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGV--DGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~----~~~~~~vaiKi~~~~~~~--~~~~~E~~~l~~l~~~~~i~~i~~~~~--~~~~   77 (423)
                      .++|++.+.||+|+||.||+|++    ..+++.||||++......  ..+.+|+++++.+.| +++..+..+..  +...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC-CceeEEEEEEecCCCce
Confidence            58999999999999999999994    567899999998765432  348899999999976 45555544433  5667


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGCEEC
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccceec
Confidence            89999999 8999999987667799999999999999999999999999999999999994   7889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-----------HHHH
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-----------KQKY  225 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-----------~~~~  225 (423)
                      .......    .......||+.|+|||++.+..++.++|||||||++|+|++|..||........           ...+
T Consensus       178 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          178 PLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            5433211    122345688999999999998899999999999999999999999976432110           0111


Q ss_pred             HHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       226 ~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..........+   ....+|+.+.+||..||..||.+||++.+|++.|+.++...
T Consensus       254 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          254 LELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            11112222221   12456899999999999999999999999999999886544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-43  Score=334.43  Aligned_cols=252  Identities=20%  Similarity=0.261  Sum_probs=206.9

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee-------
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-------   73 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-------   73 (423)
                      ++..++++|++.+.||+|+||.||+|++..+++.||||++....  ..+.+|+++++.++|++.+..+..+..       
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            45678899999999999999999999999899999999987643  568899999999987554444433321       


Q ss_pred             --------eCCeeEEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC
Q 014527           74 --------DGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN  143 (423)
Q Consensus        74 --------~~~~~~lv~e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~  143 (423)
                              .....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++   .++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~  159 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTK  159 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETT
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---CCC
Confidence                    244579999999 67999999764 35799999999999999999999999999999999999994   778


Q ss_pred             cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHH
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ  223 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~  223 (423)
                      .+||+|||++........        .....||+.|+|||++.+..++.++|||||||++|+|++|..||....     .
T Consensus       160 ~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~  226 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K  226 (284)
T ss_dssp             EEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H
T ss_pred             CEEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H
Confidence            999999999987654332        124578999999999999999999999999999999999999985321     2


Q ss_pred             HHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ....+.....       ...++..+.++|.+||..||.+||++.++++.|..+.
T Consensus       227 ~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          227 FFTDLRDGII-------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHHHTTCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHHHhhcccc-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2222222211       1345889999999999999999999999999988764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=348.61  Aligned_cols=259  Identities=16%  Similarity=0.201  Sum_probs=205.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEE-----ECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC--CCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~-----~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~--~~~i~~i~~~~~~~~   76 (423)
                      +..++|++.+.||+|+||.||+|.     +..+++.||||++... ....+..|++++..+.+  ++++..+..++...+
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            346789999999999999999994     6678899999998754 45578899999998874  344555666677788


Q ss_pred             eeEEEEecc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee--------cCCCC
Q 014527           77 DNVLVLDLL-GPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL--------GRKAN  143 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~--------~~~~~  143 (423)
                      ..++||||+ +++|.+++...    ...+++..++.|+.||+.||+|||++||+||||||+|||++.        .+..+
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence            899999999 89999999753    456999999999999999999999999999999999999952        11178


Q ss_pred             cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHH
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ  223 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~  223 (423)
                      .+||+|||+|+.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--  293 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--  293 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred             CEEEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence            99999999998764322211     12356799999999999999999999999999999999999999965332110  


Q ss_pred             HHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCC-CChHHHHHHHHHHHHhc
Q 014527          224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR-PDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       224 ~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~~l~~~L~~~~~~~  280 (423)
                              ........  ...++.+.+++..||+.+|.+| |++.+|.+.|++++...
T Consensus       294 --------~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 --------KPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             --------EECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             --------eechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                    00000000  1236789999999999999998 58899999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.6e-44  Score=362.76  Aligned_cols=258  Identities=22%  Similarity=0.382  Sum_probs=208.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+.. +..||||+++... ..+.+.+|+.+++.++|++ +..+..+.. .+..++||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK-LVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTT-BCCEEEEEC-SSSCEEEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCC-EeeEEEEEe-CCccEEEE
Confidence            456789999999999999999999854 6789999987643 4456899999999998754 555544443 66789999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCc
Confidence            999 88999998743 2468999999999999999999999999999999999999   478899999999998654321


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                            +.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.......   ..+.. ....+.  
T Consensus       339 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~-~~~~~~--  406 (454)
T 1qcf_A          339 ------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALER-GYRMPR--  406 (454)
T ss_dssp             ------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHH-TCCCCC--
T ss_pred             ------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc-CCCCCC--
Confidence                  111224456889999999998899999999999999999999 99999886554332   22222 222222  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                       ...+|+++.+||.+||..||++||++++|++.|++++...
T Consensus       407 -~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          407 -PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence             2356899999999999999999999999999998776443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-44  Score=348.68  Aligned_cols=251  Identities=21%  Similarity=0.314  Sum_probs=204.0

Q ss_pred             CCceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      .++|++.+.||+|+||.||+|++.   .+++.||||+++..      .....+.+|+.++..+.+++++..+..++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            479999999999999999999985   57899999987642      234557789999999987888888888888889


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence            999999999 7899999876 4579999999999999999999999999999999999999   5788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHHhhh
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKK  232 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~  232 (423)
                      +......      ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||........ ......+....
T Consensus       209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  282 (355)
T 1vzo_A          209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE  282 (355)
T ss_dssp             CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred             cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence            6433221      12245799999999999863  478999999999999999999999976433222 22222333222


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                      ...     ...++..+.+||.+||..||.+||     ++++|++
T Consensus       283 ~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          283 PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            222     245688999999999999999999     7777755

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.2e-44  Score=351.30  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=185.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeee-----eC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~   75 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+.+++.++|++.+..+..+..     ..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            46899999999999999999999999999999999865432    2357899999999987554444444332     12


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++|||+++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH  181 (367)
T ss_dssp             CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred             CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence            56799999999999998864  579999999999999999999999999999999999999   4788999999999986


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh---
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---  231 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---  231 (423)
                      .....          ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.+....   
T Consensus       182 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          182 TADEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ccccC----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            54321          24578999999999987 67899999999999999999999999886554333332222111   


Q ss_pred             --------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 --------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          ....+........++.+.+||.+||..||++||++.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                                0111223334456889999999999999999999998865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-43  Score=338.11  Aligned_cols=259  Identities=20%  Similarity=0.299  Sum_probs=206.0

Q ss_pred             cCCceEEec-eeeecCceeEEEEEE--CCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            5 IGVKYKLGR-KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         5 ~~~~y~i~~-~Lg~G~fg~Vy~a~~--~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      ..++|++.+ .||+|+||.||+|.+  ..+++.||||++.....    ...+.+|+.+++.++| +++..+..++ ..+.
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGIC-EAES   91 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-ESSS
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEE-CCCC
Confidence            357899998 999999999999955  45678899999876532    3458899999999986 4555555554 5677


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceee
Confidence            89999999 7899999876 56699999999999999999999999999999999999995   6789999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .......    .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.....   ....+.... ..
T Consensus       168 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~-~~  239 (291)
T 1xbb_A          168 RADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGE-RM  239 (291)
T ss_dssp             CTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTC-CC
T ss_pred             ccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-CC
Confidence            5433211    11223456789999999998889999999999999999999 999998765432   222222221 11


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      .   ....+|+.+.++|..||+.||++||++.+|++.|++++...
T Consensus       240 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          240 G---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            1   22456899999999999999999999999999999998653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.2e-44  Score=345.86  Aligned_cols=260  Identities=19%  Similarity=0.225  Sum_probs=211.0

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEE--EEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIV--AVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~v--aiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      -.++|++.+.||+|+||.||+|++..++..+  |||.+...   .....+.+|++++..+.+++++..+..++.+....+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            3478999999999999999999998888765  99987643   234468899999999966688888888888899999


Q ss_pred             EEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCC
Q 014527           80 LVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN  143 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~  143 (423)
                      +||||+ +++|.+++....               ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence            999999 789999987532               369999999999999999999999999999999999999   4778


Q ss_pred             cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhH
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK  222 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~  222 (423)
                      .+||+|||+++......        ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....   
T Consensus       180 ~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---  248 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---  248 (327)
T ss_dssp             CEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred             eEEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---
Confidence            99999999997432211        1224467889999999998889999999999999999998 99999875543   


Q ss_pred             HHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                      +.+..+... ....   ....+++.+.+||.+||..||.+||+++++++.|+.++.+...
T Consensus       249 ~~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          249 ELYEKLPQG-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             HHHHHGGGT-CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             HHHHHhhcC-CCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            222222222 1111   1234588999999999999999999999999999999887653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-44  Score=345.75  Aligned_cols=269  Identities=23%  Similarity=0.320  Sum_probs=203.9

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHc-CCCCCCeEEEeeeeC----Ce
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ-GGSGIPNIKWYGVDG----ED   77 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~-~~~~i~~i~~~~~~~----~~   77 (423)
                      +.+.++|++.+.||+|+||.||+|++  +++.||||++.... .....+|.+++..+. +|+++..+..++...    ..
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            45678999999999999999999998  48899999886432 344566666665542 446666666665555    67


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CcccccccCCceEEeecCCCCcEEEe
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      .++||||+ +++|.+++..  ..+++..++.++.||+.||.|||++        ||+||||||+|||+   +.++.+||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEE
Confidence            89999999 7799999964  4699999999999999999999999        99999999999999   478899999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCcc------chHHHHHHHHHHHHhC----------CCC
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR------DDLESLGYVLLYFLRG----------SLP  212 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~------sDIwSlGvil~elltG----------~~P  212 (423)
                      |||+++.+.........   ......||+.|+|||++.+...+..      +|||||||++|||++|          ..|
T Consensus       185 Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             CCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             eCCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999876544322111   1235579999999999988776655      9999999999999999          778


Q ss_pred             CCCchhhhh-HHHHHHHH-hhhc--CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          213 WQGLKAATK-KQKYDKIC-EKKV--STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       213 f~~~~~~~~-~~~~~~i~-~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                      |........ ........ ....  ..+.......+++++.+||..||+.||++||++.+|++.|+.+.+..+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  335 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI  335 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred             HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence            765432211 11122211 1111  1122112234578899999999999999999999999999999887654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-43  Score=342.94  Aligned_cols=255  Identities=20%  Similarity=0.237  Sum_probs=193.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeC------
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG------   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~------   75 (423)
                      +-++|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+++++.++|++.+..+..+....      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            34789999999999999999999999999999999875432   345889999999998755444443332211      


Q ss_pred             --------------------------------------------------CeeEEEEecc-CCCHHHHHHHhc--CCCCH
Q 014527           76 --------------------------------------------------EDNVLVLDLL-GPSLEDLFVYCR--RKFSL  102 (423)
Q Consensus        76 --------------------------------------------------~~~~lv~e~~-~~sL~~~l~~~~--~~l~~  102 (423)
                                                                        ...++||||+ +++|.+++....  ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                              1379999999 889999987532  23566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc-----cccCCCcccccc
Q 014527          103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-----PYRENKNLTGTA  177 (423)
Q Consensus       103 ~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~  177 (423)
                      ..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...........     .+.......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            7799999999999999999999999999999999   47889999999999887654321110     012234567999


Q ss_pred             cccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhc
Q 014527          178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQS  257 (423)
Q Consensus       178 ~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~  257 (423)
                      .|+|||++.+..++.++|||||||++|+|++|..|+..     .......+.....  +  ......++++.+||.+||+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~--~--~~~~~~~~~~~~li~~~l~  311 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKF--P--LLFTQKYPQEHMMVQDMLS  311 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCC--C--HHHHHHCHHHHHHHHHHHC
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCC--C--cccccCChhHHHHHHHHcc
Confidence            99999999999999999999999999999998777532     1122222222221  1  2223346788999999999


Q ss_pred             CCCCCCCChHHHHH
Q 014527          258 LTFDQRPDYGFLKR  271 (423)
Q Consensus       258 ~dP~~RPt~~~l~~  271 (423)
                      .||.+||+++++++
T Consensus       312 ~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          312 PSPTERPEATDIIE  325 (332)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCCCcCCCHHHHhh
Confidence            99999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=347.90  Aligned_cols=240  Identities=20%  Similarity=0.237  Sum_probs=201.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      +.++|++.+.||+|+||.||+|++..+++.||||++....          ....+.+|+.+++.++| +++..+..++.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEee
Confidence            4578999999999999999999999999999999887653          23357889999999976 667777777778


Q ss_pred             CCeeEEEEecc-CC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           75 GEDNVLVLDLL-GP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        75 ~~~~~lv~e~~-~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      ....++||||+ ++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~  176 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS  176 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence            88999999998 44 88888764 5579999999999999999999999999999999999999   4788999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      ++.......        .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......         ...
T Consensus       177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~  239 (335)
T 3dls_A          177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEA  239 (335)
T ss_dssp             CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTT
T ss_pred             ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hhh
Confidence            987654332        124579999999999998876 88999999999999999999999864321         111


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....+     ..+++++.+||..||..||++||++++|++
T Consensus       240 ~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          240 AIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             CCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22222     335889999999999999999999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-43  Score=334.55  Aligned_cols=258  Identities=21%  Similarity=0.351  Sum_probs=209.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+|+++++.++|+ ++..+..+.. .+..++||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~-~~~~~~v~   86 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-RLVRLYAVVT-QEPIYIIT   86 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEEC-SSSCEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCc-CcceEEEEEc-CCCcEEEE
Confidence            55789999999999999999999975 46789999887654 445689999999999875 4555544443 45689999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCcc
Confidence            999 889999886422 369999999999999999999999999999999999999   478899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      .      .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.....   .+..+... ....   
T Consensus       164 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~-~~~~---  230 (279)
T 1qpc_A          164 Y------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERG-YRMV---  230 (279)
T ss_dssp             E------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT-CCCC---
T ss_pred             c------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHHhcc-cCCC---
Confidence            1      11234467889999999998889999999999999999999 999998755432   22222222 1111   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ....+|.++.+++..||..||++||++++|++.|++++...
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            12456899999999999999999999999999999998764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.6e-43  Score=335.92  Aligned_cols=253  Identities=20%  Similarity=0.277  Sum_probs=189.5

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchh---HHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~---~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ++..++|++.+.||+|+||.||+|++..+++.||||++........   ...|...+....+++++..+..++.+....+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            4667899999999999999999999999999999999876543322   3334443333334577777777777888999


Q ss_pred             EEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      +||||++++|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+|||+   +..+.+||+|||+++.
T Consensus        83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred             EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence            9999998899888764   356799999999999999999999998 99999999999999   4788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      ......        .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||......  ...+......
T Consensus       160 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~  229 (290)
T 3fme_A          160 LVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEE  229 (290)
T ss_dssp             ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHHHHS
T ss_pred             cccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHHhcc
Confidence            654322        1234789999999996    5667899999999999999999999999753322  1222222222


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....   ....+++++.++|..||+.||++||++.++++
T Consensus       230 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 PSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            22111   12356899999999999999999999999977

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=336.38  Aligned_cols=261  Identities=18%  Similarity=0.240  Sum_probs=204.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~---~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      .|++.+.||+|+||.||+|.+..+++   .||+|++......   ..+.+|+.+++.++|++.+..+..+.......+++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46677999999999999999765544   7999998765443   34789999999998755444444444444455999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCc
Confidence            9999 899999998666779999999999999999999999999999999999999   478899999999997654322


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP-WQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..   .........+|+.|+|||.+.+..++.++|||||||++|+|++|..| |.......   ....+... ...+.  
T Consensus       179 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~-~~~~~--  249 (298)
T 3pls_A          179 YY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQG-RRLPQ--  249 (298)
T ss_dssp             GG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTT-CCCCC--
T ss_pred             cc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcC-CCCCC--
Confidence            11   11123356789999999999999999999999999999999995554 55433322   22222222 22211  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                       ...+++.+.++|..||+.||.+||++.+|++.|+++++...
T Consensus       250 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          250 -PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence             23458899999999999999999999999999999988754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-44  Score=347.15  Aligned_cols=264  Identities=24%  Similarity=0.317  Sum_probs=206.3

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++...       .....+.+|+++++.++| +++..+..++.+...
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~  102 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence            457899999999999999999999999999999987532       233568899999999986 667777777788889


Q ss_pred             eEEEEecc-CCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHH
Q 014527           78 NVLVLDLL-GPSLEDLFVYC---------------------------------------RRKFSLKTVLMLADQMIARIE  117 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~aL~  117 (423)
                      .++||||+ +++|.+++...                                       ...+++..++.++.||+.||.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999 89999987410                                       111367788999999999999


Q ss_pred             HHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC--CCCCccch
Q 014527          118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDD  195 (423)
Q Consensus       118 yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sD  195 (423)
                      |||++||+||||||+|||++. +....+||+|||+++.+........   .......||+.|+|||++.+  ..++.++|
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEY---YGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCcccc---ccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999999941 1223899999999987654332211   12235679999999999975  67899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       196 IwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      ||||||++|+|++|+.||.+....   +.+..+.......+.+ ....+++.+.+||.+||..||.+||++.++++  +.
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~--hp  332 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDA---DTISQVLNKKLCFENP-NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ--HP  332 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCTTSG-GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH--SH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcccccCCc-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Ch
Confidence            999999999999999999876544   3334444444433322 22456899999999999999999999999976  45


Q ss_pred             HHHh
Q 014527          276 LFSR  279 (423)
Q Consensus       276 ~~~~  279 (423)
                      +++.
T Consensus       333 ~~~~  336 (345)
T 3hko_A          333 WISQ  336 (345)
T ss_dssp             HHHT
T ss_pred             hhcc
Confidence            5543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=340.62  Aligned_cols=266  Identities=20%  Similarity=0.238  Sum_probs=202.5

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEee-------
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG-------   72 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~-------   72 (423)
                      +..++++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+++++.++|++.+..+..+.       
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            34678999999999999999999999999999999998765432  245789999999998755544444332       


Q ss_pred             ------eeCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEE
Q 014527           73 ------VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY  146 (423)
Q Consensus        73 ------~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vk  146 (423)
                            .+....++||||+.++|.+++.  .+.+++..++.++.||+.||+|||++||+||||||+|||++  ..++.+|
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~k  161 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLK  161 (320)
T ss_dssp             C----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEE
T ss_pred             cccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEE
Confidence                  2446789999999889999885  46799999999999999999999999999999999999995  3467999


Q ss_pred             EeeccceeeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHH
Q 014527          147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY  225 (423)
Q Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~  225 (423)
                      |+|||+++.........    .......+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+........  
T Consensus       162 l~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--  235 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ--  235 (320)
T ss_dssp             ECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred             EccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence            99999998764322111    11234567999999999876 678999999999999999999999998765433222  


Q ss_pred             HHHHhhh-------------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          226 DKICEKK-------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       226 ~~i~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                       .+....                         ...+.......++.++.+||.+||+.||++||+++++++  +.++...
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~  312 (320)
T 2i6l_A          236 -LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSIY  312 (320)
T ss_dssp             -HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTT
T ss_pred             -HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--Ccccccc
Confidence             222111                         112233444567999999999999999999999999976  5666543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.3e-43  Score=343.42  Aligned_cols=263  Identities=20%  Similarity=0.230  Sum_probs=203.4

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeee-----
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD-----   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~-----   74 (423)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++.....   ...+.+|+.+++.++|+ ++..+..+...     
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE-NIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCT-TBCCEEEECCCSCSTT
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCC-CcCCeeeeecccccCc
Confidence            4567899999999999999999999999999999999865433   23467899999999874 45555444333     


Q ss_pred             CCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        75 ~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ....++||||++++|.+++..  ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus        86 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           86 FNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred             cceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccccc
Confidence            267899999999999998874  569999999999999999999999999999999999999   478899999999998


Q ss_pred             eecCCCCCCccc---ccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          155 KYRDPTTNRHIP---YRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       155 ~~~~~~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      ...........+   ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            765432211100   011224578999999998765 6789999999999999999999999987654332222222111


Q ss_pred             hh------------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 KK------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 ~~------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..                        ...+.......+++++.+||.+||..||++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            10                        111233344577899999999999999999999999866

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=336.70  Aligned_cols=264  Identities=20%  Similarity=0.285  Sum_probs=211.7

Q ss_pred             ccCCceEEec-eeeecCceeEEEEEEC--CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~-~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +-.++|.+.+ .||+|+||.||+|.+.  .++..||||++.....   ...+.+|+++++.++| +++..+..++ ..+.
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVC-QAEA   83 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE-ESSS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEe-cCCC
Confidence            3456788887 9999999999999865  4678899999876543   2347899999999976 5555555554 5567


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeee
Confidence            89999999 6799999876566799999999999999999999999999999999999995   7789999999999877


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .......    .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.....   ....+.... ..
T Consensus       161 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~~-~~  232 (287)
T 1u59_A          161 GADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-RM  232 (287)
T ss_dssp             TTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC-CC
T ss_pred             ccCccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcCC-cC
Confidence            5433211    12234467899999999998889999999999999999998 999998755432   222232222 11


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCC
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD  283 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  283 (423)
                         .....+|+++.++|..||..||++||++.+|++.|+.++.+.+-.
T Consensus       233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence               122456899999999999999999999999999999998766543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.3e-43  Score=338.63  Aligned_cols=256  Identities=19%  Similarity=0.248  Sum_probs=203.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEEC-CCCcEEEEEEecCC----CCchhHHHHHHHHHHHc--CCCCCCeEEEeee----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSG----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGV----   73 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~-~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~----   73 (423)
                      ..++|++.+.||+|+||.||+|++. .+++.||||++...    .....+.+|+.+++.+.  .|+++..+..++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4689999999999999999999995 67889999987532    22346789999998884  4466666655443    


Q ss_pred             -eCCeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           74 -DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        74 -~~~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                       .....++||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg  165 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  165 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecCc
Confidence             456789999999999999988643 349999999999999999999999999999999999999   478899999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      +++......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......
T Consensus       166 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          166 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            997654221        122567899999999999999999999999999999999999999876544332222221110


Q ss_pred             h-------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 K-------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ~-------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .                   ...+.......++..+.+||.+||..||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0                   011223344567899999999999999999999998865

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.3e-43  Score=345.76  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=192.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----   75 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+.+|+.+++.++|++ +..+..+....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN-IIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTT-BCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCC-ccceEEeecccccccc
Confidence            45799999999999999999999999999999999875432    234788999999998754 54554444333     


Q ss_pred             -CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 -~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                       ...++||||+.++|.+++.   ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       102 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          102 FQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR  175 (371)
T ss_dssp             CCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC--
T ss_pred             ccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeeccc
Confidence             3689999999889988874   469999999999999999999999999999999999999   478899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...   .+..+......
T Consensus       176 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~  244 (371)
T 2xrw_A          176 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGT  244 (371)
T ss_dssp             ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCC
T ss_pred             ccccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC
Confidence            6543221        124578999999999999999999999999999999999999998755432   22222221111


Q ss_pred             CcH-------------------------HH------------hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          235 TPI-------------------------EV------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       235 ~~~-------------------------~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ...                         ..            .....+.++.+||.+||..||++||+++++++  +.++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~  322 (371)
T 2xrw_A          245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYI  322 (371)
T ss_dssp             CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHH
T ss_pred             CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC--Ccch
Confidence            000                         00            00112578999999999999999999999976  5665


Q ss_pred             H
Q 014527          278 S  278 (423)
Q Consensus       278 ~  278 (423)
                      .
T Consensus       323 ~  323 (371)
T 2xrw_A          323 N  323 (371)
T ss_dssp             H
T ss_pred             h
Confidence            4

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.6e-43  Score=330.47  Aligned_cols=255  Identities=24%  Similarity=0.323  Sum_probs=202.6

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +++..++|++.+.||+|+||.||+|.+..+++.||||++...     .....+.+|+.+++.++| +++..+..+.....
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVISTPT   84 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCC
Confidence            456779999999999999999999999989999999987532     234468899999999986 56666767777888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM  160 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred             eEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence            999999999 7899999876 4569999999999999999999999999999999999999   4788999999999976


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ......        .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......   ..+..+......
T Consensus       161 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~  229 (276)
T 2h6d_A          161 MSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRGGVFY  229 (276)
T ss_dssp             CCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCC
T ss_pred             cCCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcCccc
Confidence            644321        124578999999999998775 68999999999999999999999875433   333333333332


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .+     ..++..+.++|.+||+.||++||++++|++  +.++++
T Consensus       230 ~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~  267 (276)
T 2h6d_A          230 IP-----EYLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQ  267 (276)
T ss_dssp             CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHT
T ss_pred             Cc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHh--Chhhcc
Confidence            22     345889999999999999999999999977  455544

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.6e-43  Score=343.86  Aligned_cols=254  Identities=25%  Similarity=0.319  Sum_probs=210.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....     ....+.+|+.+++.+.| +++..+..++.+.+..
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCeE
Confidence            34678999999999999999999999999999999876542     23457889999999976 5666777777788899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       117 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence            9999999 6899998775 4679999999999999999999999999999999999999   478899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   +.+..+.......+ 
T Consensus       193 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~-  261 (335)
T 2owb_A          193 YDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKKNEYSIP-  261 (335)
T ss_dssp             STTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCC-
T ss_pred             cCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHhcCCCCCC-
Confidence            33221       23567999999999999999999999999999999999999999875433   33333433333332 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                          ..+++.+.+||.+||+.||++||++++|++  +.++..
T Consensus       262 ----~~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~  297 (335)
T 2owb_A          262 ----KHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTS  297 (335)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred             ----ccCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccC
Confidence                345889999999999999999999999976  455543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-43  Score=362.30  Aligned_cols=264  Identities=21%  Similarity=0.288  Sum_probs=215.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||.||+|+++.+++.||||++...     .....+.+|+.++..+.| +++..+..++.+....
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCEE
Confidence            4457899999999999999999999999999999987542     234568899999999976 6677777777788899


Q ss_pred             EEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           79 VLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      |+||||+ +++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV  337 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence            9999999 88999988753   2369999999999999999999999999999999999999   578999999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh-hhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-TKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~  233 (423)
                      ........       ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ...+....+.....
T Consensus       338 ~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~  410 (543)
T 3c4z_A          338 ELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV  410 (543)
T ss_dssp             ECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred             eccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence            76543321       22458999999999999999999999999999999999999999875322 22334444544444


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCCh-----HHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY-----GFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      ..+     ..+++++.+||.+||..||.+||++     ++|+          .+.|...++|..+
T Consensus       411 ~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~----------~Hpff~~i~w~~l  460 (543)
T 3c4z_A          411 TYP-----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR----------THPLFRDISWRQL  460 (543)
T ss_dssp             CCC-----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH----------TSGGGTTCCHHHH
T ss_pred             CCC-----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH----------cCccccCCCHHHH
Confidence            433     4568999999999999999999976     4443          2344455678644

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.8e-43  Score=333.01  Aligned_cols=251  Identities=19%  Similarity=0.175  Sum_probs=209.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----------chhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....           ...+.+|+.+++.+.+++++..+..++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            46899999999999999999999999999999999875431           2347789999999986688888888888


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      .....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence            889999999999 7899999875 4579999999999999999999999999999999999999   4788999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD  226 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~  226 (423)
                      +........        .....||+.|+|||++.      ...++.++|||||||++|+|++|..||......   ....
T Consensus       171 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~  239 (298)
T 1phk_A          171 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR  239 (298)
T ss_dssp             CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred             hhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH
Confidence            987654322        12457899999999985      446789999999999999999999999875433   3333


Q ss_pred             HHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+.......+.+ ....++..+.++|.+||..||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            444444433322 23456899999999999999999999998865

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.7e-43  Score=332.86  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=209.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||.||+|++..+++.||||++..     ......+.+|+++++.++| +++..+..++.+....
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcCCEE
Confidence            445899999999999999999999999999999998753     2334568899999999986 5666777777788899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred             EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence            9999999 7799998876 4569999999999999999999999999999999999999   478899999999997654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ...         .....|++.|+|||++.+..++.++||||||+++|+|++|..||......   .....+.......+ 
T Consensus       166 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~-  232 (284)
T 2vgo_A          166 SLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHRRIVNVDLKFP-  232 (284)
T ss_dssp             SSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC-
T ss_pred             ccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHHHHhccccCCC-
Confidence            322         12457899999999999999999999999999999999999999875433   23333433333322 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                          ..++..+.++|..||..||.+||++++|++  +.++..
T Consensus       233 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~  268 (284)
T 2vgo_A          233 ----PFLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKA  268 (284)
T ss_dssp             ----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHH
T ss_pred             ----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHh
Confidence                346889999999999999999999999976  444443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-43  Score=336.06  Aligned_cols=253  Identities=25%  Similarity=0.321  Sum_probs=210.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+.+|+.+++.+.| +++..+..++.+.+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccCCEE
Confidence            45689999999999999999999999999999999876542     22357889999999976 5666677777788899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecc
Confidence            9999999 6899988765 4579999999999999999999999999999999999999   478899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....       .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......   +.+..+.......+ 
T Consensus       167 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~-  235 (294)
T 2rku_A          167 YDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKKNEYSIP-  235 (294)
T ss_dssp             STTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC-
T ss_pred             cCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhhccCCCc-
Confidence            33221       22457899999999999988999999999999999999999999875433   33333433333332 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                          ..+++.+.++|.+||+.||++||+++++++  +.++.
T Consensus       236 ----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~  270 (294)
T 2rku_A          236 ----KHINPVAASLIQKMLQTDPTARPTINELLN--DEFFT  270 (294)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHH
T ss_pred             ----cccCHHHHHHHHHHcccChhhCcCHHHHhh--Chhee
Confidence                355889999999999999999999999976  45554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.6e-44  Score=336.36  Aligned_cols=246  Identities=23%  Similarity=0.320  Sum_probs=182.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.++..++| +++..+..++.+....++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccCCeEEEE
Confidence            5799999999999999999999999999999987532     233568899999999986 5666777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCCC
Confidence            9999 789999988655779999999999999999999999999999999999999   478899999999998765332


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      ..       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......   ..+..+......     .
T Consensus       167 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-----~  231 (278)
T 3cok_A          167 EK-------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---NTLNKVVLADYE-----M  231 (278)
T ss_dssp             --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCC-----C
T ss_pred             Cc-------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH---HHHHHHhhcccC-----C
Confidence            21       12457899999999999989999999999999999999999999864432   122222211221     1


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...++.++.++|.+||..||++||+++++++
T Consensus       232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            2346889999999999999999999998865

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.3e-44  Score=343.70  Aligned_cols=255  Identities=25%  Similarity=0.321  Sum_probs=200.5

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeEEEee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYG   72 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~i~~~~   72 (423)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++....          ....+.+|+.+++.+.|+ ++..+..+.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~   84 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP-CIIKIKNFF   84 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCT-TBCCEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCC-CCceEeeEE
Confidence            346689999999999999999999999999999999876432          123478999999999874 455555554


Q ss_pred             eeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        73 ~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                      .. ...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||
T Consensus        85 ~~-~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           85 DA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             ES-SSEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             cC-CceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            43 3489999999 7799888764 5679999999999999999999999999999999999999643344569999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (423)
                      +++.......        .....||+.|+|||++.   +..++.++|||||||++|+|++|..||.......  .....+
T Consensus       163 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~  232 (322)
T 2ycf_A          163 HSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI  232 (322)
T ss_dssp             TCEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH
T ss_pred             cceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH
Confidence            9987643211        12456899999999974   4568999999999999999999999998644321  122223


Q ss_pred             HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...... ..+..+..++..+.+||.+||..||++||++.++++
T Consensus       233 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 TSGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCccc-cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            333332 233445677999999999999999999999998865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.2e-43  Score=345.79  Aligned_cols=250  Identities=21%  Similarity=0.287  Sum_probs=196.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe---
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED---   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~---   77 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++......    ..+.+|+.+++.++|++ +..+..++.....   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN-VIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTT-BCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCC-chhhhhheeccCCccc
Confidence            568999999999999999999999999999999998765432    35788999999998754 4444444443333   


Q ss_pred             ---eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           78 ---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        78 ---~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                         .++||||+.++|.+++   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       119 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          119 FYDFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR  192 (371)
T ss_dssp             CCCCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC-
T ss_pred             ceeEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCccc
Confidence               3999999998887776   4569999999999999999999999999999999999999   478899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh--
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--  231 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--  231 (423)
                      ......          ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......  
T Consensus       193 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          193 HADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            654332          24578999999999987 67899999999999999999999999876544332222211110  


Q ss_pred             ---------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 ---------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                           ............+++.+.+||.+||+.||++||++.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                                 0111122233456899999999999999999999998865

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.3e-43  Score=341.89  Aligned_cols=265  Identities=23%  Similarity=0.301  Sum_probs=208.0

Q ss_pred             cccCCce-EEeceeeecCceeEEEEEEC----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            3 RIIGVKY-KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         3 ~i~~~~y-~i~~~Lg~G~fg~Vy~a~~~----~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      .++.++| ++++.||+|+||.||+|.+.    .+++.||||++.....   ...+.+|+++++.++| +++..+..++.+
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~  104 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCED  104 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC-cchhhEEEEEec
Confidence            4567777 99999999999999888653    4788999999886643   2347899999999997 555555555544


Q ss_pred             --CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           75 --GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        75 --~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                        ....++||||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg  179 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG  179 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred             CCCceEEEEEecccCCcHHHHHh--hCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence              46789999999 789999886  3459999999999999999999999999999999999999   478899999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh-----------
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-----------  220 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~-----------  220 (423)
                      ++.........    ........+|..|+|||++.+..++.++|||||||++|+|++|..||.......           
T Consensus       180 ~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  255 (318)
T 3lxp_A          180 LAKAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM  255 (318)
T ss_dssp             GCEECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred             ccccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence            99877543321    112235568889999999999889999999999999999999999997633210           


Q ss_pred             hHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ....+..........+   ....+|+++.+||..||+.||.+||++.+|++.|+.+.++.
T Consensus       256 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          256 TVLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            0111112222222222   22456899999999999999999999999999999987653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.7e-43  Score=364.42  Aligned_cols=263  Identities=19%  Similarity=0.224  Sum_probs=213.2

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +..++|++.+.||+|+||.||+|++..+++.||||++...     .....+.+|+.++..++| +++..+..++.+.+..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeCCEE
Confidence            5568899999999999999999999999999999987532     334557899999999976 5666777777788899


Q ss_pred             EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      |+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+..
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceec
Confidence            9999999 899999887533 349999999999999999999999999999999999999   57899999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~  235 (423)
                      .....        ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ......+.......
T Consensus       337 ~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~  408 (576)
T 2acx_A          337 PEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY  408 (576)
T ss_dssp             CTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC
T ss_pred             ccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC
Confidence            54322        1245899999999999998999999999999999999999999987543222 22233333322222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      +     ..+++++.+||.+||..||.+||     ++++|++          +.|...+||..+
T Consensus       409 p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~----------HpfF~~i~w~~l  456 (576)
T 2acx_A          409 S-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE----------HPLFKKLNFKRL  456 (576)
T ss_dssp             C-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT----------SGGGTTCCHHHH
T ss_pred             C-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh----------ChhhccCCHHHH
Confidence            2     45689999999999999999999     5666643          344445677654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-43  Score=359.28  Aligned_cols=259  Identities=22%  Similarity=0.357  Sum_probs=204.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      +..++|++.+.||+|+||.||+|.+.. +..||||+++... ..+.+.+|+.+++.++|++ +..+..+..+ +..++||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECS-SSCEEEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCC-EeeEEEEEcC-CceEEEe
Confidence            456789999999999999999999865 4669999987654 3456899999999998754 5455444433 6789999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred             hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCc
Confidence            999 78999999743 3569999999999999999999999999999999999999   477899999999998765332


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      .      .......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.....   .+..+.. ....+.  
T Consensus       335 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~-~~~~~~--  402 (452)
T 1fmk_A          335 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER-GYRMPC--  402 (452)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT-TCCCCC--
T ss_pred             e------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCCCCC--
Confidence            1      11224457889999999998899999999999999999999 999998865443   2222222 222222  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                       ...+|+.+.+||.+||..||++||++++|++.|++++....
T Consensus       403 -~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          403 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence             23568999999999999999999999999999998775543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=338.33  Aligned_cols=257  Identities=19%  Similarity=0.317  Sum_probs=201.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCCCCCeEEEeeee------CC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSGIPNIKWYGVD------GE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~------~~   76 (423)
                      ...++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.+.+++++..+..++..      ..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            3568999999999999999999999999999999988654 3456789999999999666777777666554      46


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence            789999999 669999998643 569999999999999999999999999999999999999   478899999999997


Q ss_pred             eecCCCCCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      .......       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.....   .+..+.
T Consensus       178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~  247 (326)
T 2x7f_A          178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIP  247 (326)
T ss_dssp             --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH
T ss_pred             ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhh
Confidence            6543221       122457899999999997     5568999999999999999999999998754432   222222


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ......   .....++..+.+||..||..||.+||++++|++  +.++.
T Consensus       248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~  291 (326)
T 2x7f_A          248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIR  291 (326)
T ss_dssp             HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHH
T ss_pred             cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHh
Confidence            222111   122456899999999999999999999999976  44554

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-43  Score=344.78  Aligned_cols=261  Identities=18%  Similarity=0.210  Sum_probs=179.0

Q ss_pred             ccCCceEEec-eeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeee----CCee
Q 014527            4 IIGVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDN   78 (423)
Q Consensus         4 i~~~~y~i~~-~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~~~   78 (423)
                      .+.++|++.+ .||+|+||.||+|++..+++.||||++...   ....+|+..+..+..+++++.+..++..    ....
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4678999965 699999999999999999999999998653   3445555555455555666666554443    4457


Q ss_pred             EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++..
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            9999999 779999997543 36999999999999999999999999999999999999964444677999999999865


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHH-HHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~  235 (423)
                      .....         ....||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...+.......
T Consensus       182 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (336)
T 3fhr_A          182 TQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF  252 (336)
T ss_dssp             -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred             ccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence            43321         245789999999999988899999999999999999999999976543322111 11111122222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +. .....+++++.+||..||..||.+||+++++++  +.++..
T Consensus       253 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~  293 (336)
T 3fhr_A          253 PN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQ  293 (336)
T ss_dssp             CT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred             Cc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Cccccc
Confidence            21 122456899999999999999999999999977  455543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-44  Score=350.60  Aligned_cols=262  Identities=18%  Similarity=0.247  Sum_probs=198.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~---~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ..|++.+.||+|+||.||+|++..++   ..||||+++....   ...+.+|+.+++.++|++.+..+..+.......++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            35889999999999999999976432   4689998865433   24578999999999875555444444555678899


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccccc
Confidence            99999 789999998666679999999999999999999999999999999999999   47889999999999866443


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      ....   ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+........   .+...... .  
T Consensus       246 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~~~~-~--  316 (373)
T 3c1x_A          246 EFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRL-L--  316 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTTCCC-C--
T ss_pred             cccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcCCCC-C--
Confidence            2111   111234567889999999999999999999999999999999 788887755433222   22222211 1  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                       ....+|..+.++|.+||..||++||++.+|++.|+.++....
T Consensus       317 -~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          317 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence             123458999999999999999999999999999999987543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.7e-43  Score=332.20  Aligned_cols=260  Identities=24%  Similarity=0.339  Sum_probs=211.1

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++...    .....+.+|+++++.++| +++..+..+..+....
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCCCeE
Confidence            34668999999999999999999999999999999987543    234568899999999976 5666676777788899


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999 8899888875 4579999999999999999999999999999999999999644445689999999997654


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....        .....||+.|+|||.+.+. ++.++||||||+++|+|++|..||.+....   .....+.......+.
T Consensus       176 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~  243 (287)
T 2wei_A          176 QNTK--------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETGKYAFDL  243 (287)
T ss_dssp             CCSS--------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCS
T ss_pred             CCCc--------cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCCc
Confidence            3321        1244689999999998764 899999999999999999999999875443   333344444433332


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      + ....+++++.++|..||..||++||++.++++  +.++.+
T Consensus       244 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~~  282 (287)
T 2wei_A          244 P-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQK  282 (287)
T ss_dssp             G-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHH
T ss_pred             h-hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHhc
Confidence            2 22456899999999999999999999999977  344443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-44  Score=344.10  Aligned_cols=266  Identities=16%  Similarity=0.207  Sum_probs=208.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ..++|++.+.||+|+||.||+|++. +++.||||+......  ...+.+|+.+++.++| +++..+..++......++||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECCCTTCCEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEE
Confidence            4578999999999999999999964 688999998765433  3458899999999986 56666777777888999999


Q ss_pred             ecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           83 DLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||+ +++|.+++....   ..+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence            999 789998875432   248999999999999999999999999999999999999   5788999999999987543


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH----HHhhhcC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK----ICEKKVS  234 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----i~~~~~~  234 (423)
                      .....     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+............    .....+.
T Consensus       192 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          192 LDQTH-----LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             SSCCC-----CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             ccccc-----cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            32211     12345689999999999988999999999999999999999999976443221111110    0011110


Q ss_pred             C-----cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          235 T-----PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       235 ~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      .     .........+..+.+++.+||+.||++||++.+|++.|+.++...
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            0     011112234778999999999999999999999999999887643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=368.71  Aligned_cols=265  Identities=20%  Similarity=0.286  Sum_probs=206.9

Q ss_pred             CCceEEec-eeeecCceeEEEEEEC--CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            6 GVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~-~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ..+|.+.+ .||+|+||.||+|.+.  .++..||||+++...   ....+.+|+++++.++| +++..+..++.. +..+
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC-TTBCCEEEEEES-SSEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEecc-CCeE
Confidence            34566666 8999999999999876  356679999987643   34568999999999987 455555555543 5689


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+++....
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC-
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccccC
Confidence            999999 8899999876566799999999999999999999999999999999999994   788999999999987643


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ....    +.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.....   .+..+.... ..+ 
T Consensus       489 ~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~-~~~-  559 (613)
T 2ozo_A          489 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-RME-  559 (613)
T ss_dssp             -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHHTTC-CCC-
T ss_pred             CCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC-CCC-
Confidence            3211    111223456789999999999899999999999999999998 999999866543   233332222 111 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCc
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDF  286 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~  286 (423)
                        ....+|+++.+||..||..||++||++.+|++.|+.++...+...+.
T Consensus       560 --~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~  606 (613)
T 2ozo_A          560 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  606 (613)
T ss_dssp             --CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCC
Confidence              12356899999999999999999999999999999998877655443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.7e-43  Score=348.25  Aligned_cols=257  Identities=21%  Similarity=0.266  Sum_probs=196.3

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeC-----C
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----E   76 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~-----~   76 (423)
                      +.....+|++.+.||+|+||.||+|++..+++ ||+|.+.....  ...+|+++++.++|++.+..+..+....     .
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            34566789999999999999999999987666 77776654332  2347999999998755444444443322     2


Q ss_pred             eeEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           77 DNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ..++||||+.+++...+..   ....+++..++.++.||+.||.|||++||+||||||+|||++  ..++.+||+|||+|
T Consensus       112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred             EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCc
Confidence            3789999998887766543   256799999999999999999999999999999999999994  36889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +.......        .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.+.....
T Consensus       190 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          190 KILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             EECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            87654332        1255789999999999775 48999999999999999999999999865543333222211100


Q ss_pred             --------------------cCCcH-HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 --------------------VSTPI-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 --------------------~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          ...+. ..+...+++++.+||.+||..||.+||++.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                                00011 1122346889999999999999999999998865

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.2e-43  Score=336.61  Aligned_cols=257  Identities=21%  Similarity=0.300  Sum_probs=201.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~-~~~i~~i~~~~~~~~~~   78 (423)
                      +.+++|++.+.||+|+||.||+|.+. +++.||||++......    ..+.+|+.++..+.+ ++++..+..++......
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            55788999999999999999999975 4888999998754432    457899999999986 67788888888888899


Q ss_pred             EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ++|||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||+++....
T Consensus       104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC---
T ss_pred             EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccC
Confidence            99999889999999886 56799999999999999999999999999999999999994    58999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK  227 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (423)
                      .....     ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||......  ...+..
T Consensus       179 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~  251 (313)
T 3cek_A          179 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA  251 (313)
T ss_dssp             ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH
T ss_pred             ccccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHHHH
Confidence            32211     1224578999999999976           46888999999999999999999999864322  122233


Q ss_pred             HHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       228 i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      +........   .....+.++.++|.+||..||.+||++.+|++  +.++.
T Consensus       252 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~  297 (313)
T 3cek_A          252 IIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ  297 (313)
T ss_dssp             HHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred             HHhcccccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhc--Ccccc
Confidence            333222221   12344789999999999999999999999876  34444

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4e-43  Score=337.28  Aligned_cols=261  Identities=20%  Similarity=0.314  Sum_probs=197.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC---CCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~---~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +..++|++.+.||+|+||.||+|.+..   +++.||||++......    ..+.+|+.+++.++|++ +..+..++.+..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN-VIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTT-BCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCC-eeeeeEEEeecc
Confidence            446899999999999999999998865   4568999998755432    34788999999998755 444444433322


Q ss_pred             -----eeEEEEecc-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcE
Q 014527           77 -----DNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV  145 (423)
Q Consensus        77 -----~~~lv~e~~-~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~v  145 (423)
                           ..++||||+ +++|.+++...     ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcE
Confidence                 459999999 78999998643     3469999999999999999999999999999999999999   478899


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHH
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK  224 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~  224 (423)
                      ||+|||+++........     .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.....   .
T Consensus       187 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~  258 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M  258 (313)
T ss_dssp             EECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred             EEeecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H
Confidence            99999999876543211     12234567889999999999999999999999999999999 999998765443   2


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ...+......    .....+++.+.++|..||..||.+||++.+|++.|++++...
T Consensus       259 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          259 YDYLLHGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHHHTTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHcCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            2223222211    112456899999999999999999999999999999998653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-43  Score=331.59  Aligned_cols=250  Identities=10%  Similarity=0.118  Sum_probs=201.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeC--Ce
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--ED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~--~~   77 (423)
                      +..++|++.+.||+|+||.||+|++  .++.||||++......    ..+.+|+.+++.++| +++..+..+..+.  ..
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH-PNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSC-TTEECEEEEECTTTSSS
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CchhheEEEEccCCCCC
Confidence            4568999999999999999999998  4888999998765422    347889999998876 4555555555444  67


Q ss_pred             eEEEEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEeeccce
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      .++||||+ +++|.+++..... .+++..++.++.||+.||.|||++|  |+||||||+|||+   +.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence            89999999 7899999975433 4899999999999999999999999  9999999999999   47889999999887


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCc---cchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR---RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      .....            ....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||.+.....   ....+..
T Consensus       161 ~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~  225 (271)
T 3kmu_A          161 FSFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGMKVAL  225 (271)
T ss_dssp             CTTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HHHHHHH
T ss_pred             eeecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HHHHHHh
Confidence            54221            2447899999999999876544   7999999999999999999998765432   2223333


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      ......   ....+|+++.++|..||+.||++||++++|++.|+.+.
T Consensus       226 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          226 EGLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             SCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            322222   23456899999999999999999999999999998874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.4e-44  Score=354.52  Aligned_cols=251  Identities=16%  Similarity=0.111  Sum_probs=188.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcC-CCCCCe-EE------Eeee
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQG-GSGIPN-IK------WYGV   73 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~-~~~i~~-i~------~~~~   73 (423)
                      ..|++.+.||+|+||.||+|++..+++.||||++.....     ...+.+|+.++..|.+ |+++.. +.      .+..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            359999999999999999999999999999999887553     2346788877888873 233222 21      1111


Q ss_pred             eC-----------------CeeEEEEeccCCCHHHHHHHhcCCCCHHHH------HHHHHHHHHHHHHHHhcCccccccc
Q 014527           74 DG-----------------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTV------LMLADQMIARIEYVHSRGFLHRDIK  130 (423)
Q Consensus        74 ~~-----------------~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~giiHrDIK  130 (423)
                      ..                 ...|+||||+.++|.+++......+....+      +.++.||+.||+|||++||+|||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            11                 347999999999999999876555666666      7888999999999999999999999


Q ss_pred             CCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHh
Q 014527          131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLR  208 (423)
Q Consensus       131 p~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~ellt  208 (423)
                      |+|||+   +.++.+||+|||+|+......          ....+|+.|+|||++.+  ..++.++|||||||++|+|++
T Consensus       222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            999999   478899999999998654221          13456799999999987  679999999999999999999


Q ss_pred             CCCCCCCchhhhhHHHHHHH--HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          209 GSLPWQGLKAATKKQKYDKI--CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       209 G~~Pf~~~~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      |+.||.+....... .+...  ............+..+|+.+.+||.+||+.||++||++.++++
T Consensus       289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999875332110 00000  0000000111123467899999999999999999999999976

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.1e-43  Score=333.26  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=208.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ....|++.+.||+|+||.||+|++..+++.||||++....   ....+.+|+.++..+.| +++..+..++.+....++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEE
Confidence            3567999999999999999999999999999999987543   33568899999999976 6666777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A           99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred             EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence            9999 679999875  4679999999999999999999999999999999999999   478899999999998765433


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+.....    ...
T Consensus       174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~----~~~  239 (303)
T 3a7i_A          174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIPKNNP----PTL  239 (303)
T ss_dssp             C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCC----CCC
T ss_pred             c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhhcCCC----CCC
Confidence            2       1235578999999999999999999999999999999999999998754432   2222222111    122


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...++..+.+||..||..||.+||++.+|++  +.++..
T Consensus       240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~  276 (303)
T 3a7i_A          240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFILR  276 (303)
T ss_dssp             CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT--CHHHHH
T ss_pred             ccccCHHHHHHHHHHcCCChhhCcCHHHHhh--Chhhhc
Confidence            3466899999999999999999999999977  344443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.8e-43  Score=342.62  Aligned_cols=256  Identities=16%  Similarity=0.191  Sum_probs=194.4

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-------------chhHHHHHHHHHHHcCCCCCCeEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------------HPQLLYEAKVYKILQGGSGIPNIKW   70 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-------------~~~~~~E~~~l~~l~~~~~i~~i~~   70 (423)
                      .+.++|++.+.||+|+||.||+|.+.. ++.||||++.....             ...+.+|+++++.++|++.+..+..
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            457899999999999999999999765 88999998754321             1568899999999987554444444


Q ss_pred             eee----eCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEE
Q 014527           71 YGV----DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY  146 (423)
Q Consensus        71 ~~~----~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vk  146 (423)
                      +..    .....++||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~k  174 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDIT  174 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCEE
Confidence            332    223679999999999999998666679999999999999999999999999999999999999   4788999


Q ss_pred             EeeccceeeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHH
Q 014527          147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY  225 (423)
Q Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~  225 (423)
                      |+|||+++.......        .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+
T Consensus       175 l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          175 ICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             EEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999975443322        224578999999999987 66899999999999999999999999876544333222


Q ss_pred             HHHHhhh------------------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          226 DKICEKK------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       226 ~~i~~~~------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .......                        ............++.+.+||.+||..||.+||++.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            2211100                        011122333456888999999999999999999999866

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.9e-43  Score=336.15  Aligned_cols=252  Identities=17%  Similarity=0.302  Sum_probs=200.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+|+.++..+.| +++..+..++......++|
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC-CEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeCCeEEEE
Confidence            45789999999999999999999999999999999876543  34568899999999976 5666666666677889999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence            9999 789999888767789999999999999999999999999999999999999   478899999999976432211


Q ss_pred             CCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .       ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.......   .+..+.......
T Consensus       172 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~  241 (302)
T 2j7t_A          172 Q-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKIAKSDPPT  241 (302)
T ss_dssp             H-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSCCCC
T ss_pred             c-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHHhccCCcc
Confidence            0       112457899999999984     6678999999999999999999999998755432   222232222111


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                        ......++..+.++|..||..||++||++.+|++
T Consensus       242 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 --LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              1122456889999999999999999999998865

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.5e-43  Score=345.57  Aligned_cols=258  Identities=25%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcC----------CCCCCeEEEee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQG----------GSGIPNIKWYG   72 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~----------~~~i~~i~~~~   72 (423)
                      +..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.+          ++++..+..++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            44689999999999999999999999999999999987543 23457889999999884          24555554444


Q ss_pred             eeC----CeeEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeec---CCCC
Q 014527           73 VDG----EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLG---RKAN  143 (423)
Q Consensus        73 ~~~----~~~~lv~e~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~---~~~~  143 (423)
                      ...    ...++|||+++++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++..   +..+
T Consensus        96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            332    2789999999999999998643 4599999999999999999999998 99999999999999532   2334


Q ss_pred             cEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh---
Q 014527          144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT---  220 (423)
Q Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~---  220 (423)
                      .+||+|||+++......          ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   
T Consensus       176 ~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          176 QIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             EEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             eEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence            89999999998765432          24578999999999999999999999999999999999999998643211   


Q ss_pred             hHHHHHHHHhhhcCCcHHH-------------------------------------hhccChHHHHHHHHHHhcCCCCCC
Q 014527          221 KKQKYDKICEKKVSTPIEV-------------------------------------LCKSHPAEFASYFHYCQSLTFDQR  263 (423)
Q Consensus       221 ~~~~~~~i~~~~~~~~~~~-------------------------------------~~~~~~~~l~~li~~cl~~dP~~R  263 (423)
                      ....+..+.......|...                                     .....+.++.+||.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence            1112222222111111100                                     112336789999999999999999


Q ss_pred             CChHHHHH
Q 014527          264 PDYGFLKR  271 (423)
Q Consensus       264 Pt~~~l~~  271 (423)
                      |++++|++
T Consensus       326 pt~~ell~  333 (373)
T 1q8y_A          326 ADAGGLVN  333 (373)
T ss_dssp             BCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999866

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.7e-44  Score=354.08  Aligned_cols=239  Identities=14%  Similarity=0.112  Sum_probs=184.6

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcC--CCCCCeEE-------Ee
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQG--GSGIPNIK-------WY   71 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~~--~~~i~~i~-------~~   71 (423)
                      .++|++.+.||+|+||+||+|++..+++.||||++...     ...+.+.+|+.+++.+..  |+++..+.       .+
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            57899999999999999999999889999999997632     223558899966666652  23333322       22


Q ss_pred             eeeCC-----------------eeEEEEeccCCCHHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhcCcccc
Q 014527           72 GVDGE-----------------DNVLVLDLLGPSLEDLFVYCRRKFS-------LKTVLMLADQMIARIEYVHSRGFLHR  127 (423)
Q Consensus        72 ~~~~~-----------------~~~lv~e~~~~sL~~~l~~~~~~l~-------~~~~~~i~~qi~~aL~yLH~~giiHr  127 (423)
                      ..+.+                 ..|+||||++|+|.+++.... .++       +..++.|+.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            22221                 378999999999999998642 233       48888999999999999999999999


Q ss_pred             cccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCC-----------CCCccchH
Q 014527          128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----------EQSRRDDL  196 (423)
Q Consensus       128 DIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~~sDI  196 (423)
                      ||||+|||+   +.++.+||+|||+|+.....          .....| +.|+|||++.+.           .++.++||
T Consensus       231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CCCHHHEEE---cCCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            999999999   47889999999999863321          124567 999999999987           89999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          197 ESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       197 wSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      |||||++|||++|+.||.+.........       ..     ..+..+|+++.+||.+||..||++||++.++++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~~-------~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSEW-------IF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSGG-------GG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchhh-------hh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999999999976443211111       11     112466899999999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.1e-43  Score=332.59  Aligned_cols=256  Identities=27%  Similarity=0.316  Sum_probs=205.3

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      |..-+.++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+|+.+++.++| +++..+..++.+...
T Consensus         1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~   79 (276)
T 2yex_A            1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI   79 (276)
T ss_dssp             -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTE
T ss_pred             CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcCCE
Confidence            34445678999999999999999999999999999999876432   23458899999999976 566677777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCcccc
Confidence            99999999 6799888753 4569999999999999999999999999999999999999   47889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .......     ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......  ..+..+.......
T Consensus       156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~  228 (276)
T 2yex_A          156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL  228 (276)
T ss_dssp             EETTEEC-----CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHHHHTTCTTS
T ss_pred             CCCcchh-----cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhhccccc
Confidence            4332111     1235678999999999988775 789999999999999999999998754322  1222222222211


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +   ....+++.+.++|..||+.||++||++++|++
T Consensus       229 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 N---PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             T---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1   12456899999999999999999999998865

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=339.22  Aligned_cols=266  Identities=21%  Similarity=0.244  Sum_probs=207.7

Q ss_pred             cccCCceEEeceeeecCceeEEEEEE----CCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeEEEeee--e
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGV--D   74 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~----~~~~~~vaiKi~~~~~~~--~~~~~E~~~l~~l~~~~~i~~i~~~~~--~   74 (423)
                      .+..++|++++.||+|+||.||+|++    ..+++.||||++......  ..+.+|+.+++.++|++ +..+..+..  .
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~  115 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN-IVKYKGVCYSAG  115 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTT-BCCEEEEECC--
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEecC
Confidence            34567899999999999999999984    567899999998765432  35889999999998754 444443332  3


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLT  192 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcch
Confidence            34789999999 7899999987667799999999999999999999999999999999999994   6789999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhh------------h
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------K  221 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~------------~  221 (423)
                      ..........    .......++..|+|||++.+..++.++|||||||++|+|++|..||.......            .
T Consensus       193 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          193 KVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  268 (326)
T ss_dssp             EECCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred             hhcccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence            8765433211    11224467888999999998889999999999999999999999987532110            0


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...+..........+   ....+|+++.++|..||+.||++||++.+|++.|+.+..+
T Consensus       269 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          269 VFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            001111112111111   1245689999999999999999999999999999988654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.3e-43  Score=338.72  Aligned_cols=244  Identities=23%  Similarity=0.332  Sum_probs=204.3

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCeEEEee
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYG   72 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~i~~~~   72 (423)
                      ...+.++|++.+.||+|+||.||+|++..+++.||||++....        ....+.+|+.+++.+.+ ++++..+..++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3567899999999999999999999999999999999876542        22457889999999985 67788888888


Q ss_pred             eeCCeeEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeec
Q 014527           73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF  150 (423)
Q Consensus        73 ~~~~~~~lv~e~~~--~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DF  150 (423)
                      ...+..++|||++.  ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++  .+.+.+||+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Df  194 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF  194 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeC
Confidence            88889999999994  899999876 46799999999999999999999999999999999999994  25789999999


Q ss_pred             cceeeecCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      |+++.......         ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....         +.
T Consensus       195 g~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~  256 (320)
T 3a99_A          195 GSGALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II  256 (320)
T ss_dssp             TTCEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH
T ss_pred             ccccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hh
Confidence            99987654321         24578999999999987665 7889999999999999999999976321         12


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ......     ...+++++.+||.+||..||++||++++|++
T Consensus       257 ~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 RGQVFF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HCCCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222221     2456899999999999999999999998865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-43  Score=335.31  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=198.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC-CCc--EEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD-TNE--IVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-~~~--~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +..++|++.+.||+|+||.||+|++.. +++  .||||++....     ....+.+|+++++.++| +++..+..+....
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~   93 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLTP   93 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEccC
Confidence            457899999999999999999998653 333  68999876432     23457899999999986 5555555555443


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                       ..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR  169 (291)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCE
T ss_pred             -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEccccccc
Confidence             488999999 7899999987667799999999999999999999999999999999999994   67899999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .........    .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....   +.+..+.....
T Consensus       170 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~  242 (291)
T 1u46_A          170 ALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKIDKEGE  242 (291)
T ss_dssp             ECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTSCC
T ss_pred             cccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHHHccCC
Confidence            765433211    11234567889999999998889999999999999999999 99999876543   33333333322


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ..+   ....+|.++.++|..||..||++||++.+|++.|+++..
T Consensus       243 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 RLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            222   124568999999999999999999999999999987643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.8e-42  Score=339.13  Aligned_cols=253  Identities=19%  Similarity=0.176  Sum_probs=186.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC------ee
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE------DN   78 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~------~~   78 (423)
                      -++|++.+.||+|+||.||+|++..+++.||||++.... .......|++.+..+.|++.+..+..+.....      ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            368999999999999999999999999999999875543 34457778888888887554444444333221      27


Q ss_pred             EEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH--hcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           79 VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        79 ~lv~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ++||||+.++|...+..   ....+++..++.++.||+.||.|||  ++||+||||||+|||++  ..++.+||+|||++
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence            89999998888776653   3456899999999999999999999  99999999999999995  23789999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........   +....
T Consensus       180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~---~~~~~  248 (360)
T 3e3p_A          180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE---IVRVL  248 (360)
T ss_dssp             BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHH
T ss_pred             eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH---HHHHc
Confidence            87654332        12557899999999997655 89999999999999999999999988654433332   22211


Q ss_pred             cCCcH-----------------------HHh----hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTPI-----------------------EVL----CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~~-----------------------~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...+.                       ...    ....++++.+||.+||+.||.+||++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11111                       111    1124788999999999999999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-42  Score=328.92  Aligned_cols=249  Identities=21%  Similarity=0.254  Sum_probs=198.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeee---eCCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV---DGED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~---~~~~   77 (423)
                      .+..|++.+.||+|+||.||+|.+..++..||+|++.....    ...+.+|+.+++.++|++.+..+..+..   ....
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            35679999999999999999999999999999998765432    2347889999999987554444443332   2456


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEeecccee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      .++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|  |+||||||+|||++  +..+.+||+|||++.
T Consensus       104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence            89999999 7899999875 467999999999999999999999999  99999999999994  367899999999996


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      ......         .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......  ...+..+......
T Consensus       181 ~~~~~~---------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~  248 (290)
T 1t4h_A          181 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVKP  248 (290)
T ss_dssp             GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCCC
T ss_pred             cccccc---------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhccCCc
Confidence            543321         124578999999998875 5899999999999999999999999864432  2223233222211


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                         .......++++.+||..||..||.+||++.+|++
T Consensus       249 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               2233455789999999999999999999999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=350.10  Aligned_cols=269  Identities=17%  Similarity=0.202  Sum_probs=190.0

Q ss_pred             ccCCceEE-eceeeecCceeEEEEEEC--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEee-eeCCeeE
Q 014527            4 IIGVKYKL-GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i-~~~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~-~~~~~~~   79 (423)
                      .+.+.|++ +++||+|+||.||+|++.  .+++.||||++........+.+|+.+++.|+|++.+..+..+. ......+
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            45567887 458999999999999976  4688999999987777778999999999999755444443332 3467889


Q ss_pred             EEEeccCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec-CCCCcEEEeec
Q 014527           80 LVLDLLGPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDF  150 (423)
Q Consensus        80 lv~e~~~~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~-~~~~~vkL~DF  150 (423)
                      +||||++++|.+++....        ..+++..++.|+.||+.||.|||++||+||||||+|||+... +..+.+||+||
T Consensus        97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            999999999999886432        249999999999999999999999999999999999999532 35689999999


Q ss_pred             cceeeecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhh------hHH
Q 014527          151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------KKQ  223 (423)
Q Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~------~~~  223 (423)
                      |+|+.+......    ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....      ...
T Consensus       177 g~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          177 GFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             CCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999876543211    1122356899999999999875 48999999999999999999999997643210      012


Q ss_pred             HHHHHHhhhcCCcHH---------------------------------HhhccChHHHHHHHHHHhcCCCCCCCChHHHH
Q 014527          224 KYDKICEKKVSTPIE---------------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK  270 (423)
Q Consensus       224 ~~~~i~~~~~~~~~~---------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~  270 (423)
                      .+..+.......+..                                 ......++.+.+||.+||..||.+|||+++++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            222222111100000                                 00011266889999999999999999999986


Q ss_pred             HHHHHHHH
Q 014527          271 RLFHDLFS  278 (423)
Q Consensus       271 ~~L~~~~~  278 (423)
                      +  +.+|.
T Consensus       333 ~--hp~f~  338 (405)
T 3rgf_A          333 Q--DPYFL  338 (405)
T ss_dssp             T--SGGGT
T ss_pred             c--Chhhc
Confidence            6  44443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.4e-43  Score=340.86  Aligned_cols=268  Identities=25%  Similarity=0.301  Sum_probs=208.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeEEEeeeeCC----
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWYGVDGE----   76 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~--l~~~~~i~~i~~~~~~~~----   76 (423)
                      +.+.++|++.+.||+|+||.||+|++  +++.||||++... ....+.+|++++..  ++| +++..+..++....    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h-~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCC-TTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCC-CcEEEEEeeecccCCccc
Confidence            45678999999999999999999998  5889999998653 34567889999888  455 55666655555443    


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCcccccccCCceEEeecCCCCcEEE
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQVYI  147 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~giiHrDIKp~NILl~~~~~~~~vkL  147 (423)
                      ..++||||+ +++|.+++..  ..+++..++.++.||+.||.|||        ++||+||||||+|||+   +.++.+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL  188 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCI  188 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEE
T ss_pred             eeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEE
Confidence            789999999 6799999974  46999999999999999999999        8999999999999999   47889999


Q ss_pred             eeccceeeecCCCCCCcccccCCCcccccccccCcccccCCC------CCccchHHHHHHHHHHHHhC----------CC
Q 014527          148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRG----------SL  211 (423)
Q Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~~sDIwSlGvil~elltG----------~~  211 (423)
                      +|||++...........   .......||+.|+|||++.+..      ++.++|||||||++|||++|          ..
T Consensus       189 ~Dfg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             CCCTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EECCCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            99999987765432110   0123557999999999998763      34689999999999999999          88


Q ss_pred             CCCCchhhh--hHHHHHHHHhhhcCCcHHH--hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCC
Q 014527          212 PWQGLKAAT--KKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGY  282 (423)
Q Consensus       212 Pf~~~~~~~--~~~~~~~i~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  282 (423)
                      ||.......  .......+.........+.  .....+..+.+||.+||+.||++||++.+|++.|+.+..+.+.
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~  340 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  340 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence            997643221  1222222333332222211  1123467899999999999999999999999999999887664

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=364.03  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=208.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      |..++|++.+.||+|+||.||+|.+.. +..||||+++... ..+.+.+|+++++.|+|++ +..+..+..+ ...+|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECS-SSCEEEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCC-EeeEEEEEee-ccceEee
Confidence            456789999999999999999999865 4669999987654 3456899999999998755 4455444433 6789999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus       341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH
T ss_pred             ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc
Confidence            999 78999999743 3569999999999999999999999999999999999999   477899999999997654321


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                            +.......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.....   .+..+. .....+.  
T Consensus       418 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i~-~~~~~~~--  485 (535)
T 2h8h_A          418 ------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVE-RGYRMPC--  485 (535)
T ss_dssp             ------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHHH-TTCCCCC--
T ss_pred             ------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-cCCCCCC--
Confidence                  111224457889999999998899999999999999999999 999998765443   222222 2222221  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                       ...+|..+.+||.+||..||++||++++|++.|++++....
T Consensus       486 -~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          486 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             -CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence             23568999999999999999999999999999998765443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=338.57  Aligned_cols=265  Identities=18%  Similarity=0.235  Sum_probs=199.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeee---eCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGV---DGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~---~~~~~   78 (423)
                      +.+++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+|+.+++.+.|++.+..+..+..   .....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            45789999999999999999999999999999999875432  23458899999999987554444443332   23477


Q ss_pred             EEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           79 VLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ++||||+ +++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcch
Confidence            9999999 77999998763   4669999999999999999999999999999999999999   478899999999987


Q ss_pred             eecCCCCCCc--ccccCCCcccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          155 KYRDPTTNRH--IPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       155 ~~~~~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      ..........  ..........||+.|+|||++.+..   ++.++|||||||++|+|++|+.||........  ......
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~  260 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAV  260 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHh
Confidence            6432111000  0000011345799999999998654   68899999999999999999999965322111  111111


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ......+.   ...++.++.++|.+||+.||.+||++.+|++.|+.+
T Consensus       261 ~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          261 QNQLSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             HCC--CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hccCCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            22222221   235688999999999999999999999999998865

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=330.28  Aligned_cols=256  Identities=18%  Similarity=0.297  Sum_probs=202.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeEEEee--eeCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYG--VDGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~--~~~~   76 (423)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++...      .....+.+|+.+++.++|++ +..+..+.  .+..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN-VIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTT-BCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCC-eeEEEEEEEcCCCC
Confidence            458899999999999999999999999999999987643      23456889999999998744 55554443  4556


Q ss_pred             eeEEEEeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           77 DNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ..++||||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA  158 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence            78999999977788888754 3569999999999999999999999999999999999999   4788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      ........     ......||+.|+|||++.+..  ++.++|||||||++|+|++|..||.+....   +.+..+.....
T Consensus       159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~~~~  230 (305)
T 2wtk_C          159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGKGSY  230 (305)
T ss_dssp             CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCC
T ss_pred             cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhcCCC
Confidence            65332211     112456899999999998754  378999999999999999999999875433   33334434333


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..+     ..+++.+.++|.+||..||.+||++++|++  +.++..
T Consensus       231 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~  269 (305)
T 2wtk_C          231 AIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRK  269 (305)
T ss_dssp             CCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHS
T ss_pred             CCC-----CccCHHHHHHHHHHccCChhhCCCHHHHhc--Cccccc
Confidence            322     456889999999999999999999999976  455543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.3e-43  Score=330.05  Aligned_cols=249  Identities=22%  Similarity=0.255  Sum_probs=199.7

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEee--eeCCeeE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~--~~~~~~~   79 (423)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....    ...+.+|+.+++.++|+ ++..+..+.  ......+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP-NIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCC-CCCeEEEEEecCCCceEE
Confidence            4789999999999999999999999999999999875442    23478999999999874 455554433  3467889


Q ss_pred             EEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC-----cccccccCCceEEeecCCCCcEEEeec
Q 014527           80 LVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDF  150 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDIKp~NILl~~~~~~~~vkL~DF  150 (423)
                      +||||+ +++|.+++....   ..+++..++.++.||+.||.|||++|     |+||||||+|||+   +.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecC
Confidence            999999 679999987532   34999999999999999999999999     9999999999999   47889999999


Q ss_pred             cceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh
Q 014527          151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE  230 (423)
Q Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~  230 (423)
                      |+++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .....+..
T Consensus       161 g~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~  230 (279)
T 2w5a_A          161 GLARILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE  230 (279)
T ss_dssp             CHHHHC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred             chheeeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHhh
Confidence            99976543221       112456899999999999999999999999999999999999999876443   22333333


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL  272 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  272 (423)
                      ....    .+...++.++.++|.+||+.||.+||++++|++.
T Consensus       231 ~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (279)
T 2w5a_A          231 GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  268 (279)
T ss_dssp             TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            3321    1224568999999999999999999999998763

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.2e-43  Score=342.93  Aligned_cols=261  Identities=16%  Similarity=0.214  Sum_probs=202.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +..++|++.+.||+|+||.||+|++ .+++.||||++....   ....+.+|++++..+.| +++..+..++......++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEECCSSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEEecCCceEE
Confidence            4578999999999999999999985 458899999887543   23368999999999986 566666666777888899


Q ss_pred             EEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           81 VLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ||||+ +++|.+++....   ..+++..++.++.||+.||.|||++   ||+||||||+|||+   +.++.+||+|||++
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA  181 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccc
Confidence            99999 789999987532   2499999999999999999999999   99999999999999   47889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhh-HHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~  232 (423)
                      +........      ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...........
T Consensus       182 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          182 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             EECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            876543321      12245699999999999988899999999999999999999999963211110 00011111110


Q ss_pred             cCCc----------HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          233 VSTP----------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       233 ~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      ....          ........+..+.+++..||+.||.+||++.+|++.|+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            0000          001112235789999999999999999999999998874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=338.13  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=194.4

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCC----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE----   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~----   76 (423)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||++......    ..+.+|+.+++.++|++ +..+..+.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN-VIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTT-BCCCSEEECSCSSGGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCC-cccHhheEeccccccc
Confidence            468999999999999999999999999999999998764332    34788999999998754 444444333332    


Q ss_pred             --eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           77 --DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        77 --~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                        ..++||||+.++|.+++   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++
T Consensus       101 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          101 FYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR  174 (353)
T ss_dssp             CCCCEEEEECCSEEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTT
T ss_pred             ceeEEEEeccccCCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccccc
Confidence              35999999998888776   3469999999999999999999999999999999999999   478899999999997


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh--
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--  231 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--  231 (423)
                      ......          ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+....  
T Consensus       175 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          175 HADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             CCCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            654321          24578999999999987 67899999999999999999999999876543322222111100  


Q ss_pred             ---------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 ---------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                           ............+++++.+||.+||..||++||+++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                 0001111223456899999999999999999999998865

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.7e-42  Score=328.75  Aligned_cols=257  Identities=24%  Similarity=0.296  Sum_probs=200.5

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      |...+.||+|+||.||+|.+  +++.||||++....      ....+.+|+.+++.++| +++..+..++.+....++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CCeEEEEEEEecCCceEEEE
Confidence            44458999999999999986  68899999876432      23458899999999986 66777777777788899999


Q ss_pred             ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           83 DLL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        83 e~~-~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence            999 89999998743  3459999999999999999999999999999999999999   47889999999999876543


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC----
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST----  235 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----  235 (423)
                      ....     ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..........    
T Consensus       187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            2211     1234578999999999876 48899999999999999999999998754332222221111111000    


Q ss_pred             ---cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          236 ---PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       236 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                         .........+..+.+++..||..||.+||++.+|++.|+++.
T Consensus       261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence               000111223678999999999999999999999999998763

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-42  Score=363.99  Aligned_cols=254  Identities=21%  Similarity=0.328  Sum_probs=199.2

Q ss_pred             eEEe-ceeeecCceeEEEEEEC--CCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            9 YKLG-RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         9 y~i~-~~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.+. +.||+|+||.||+|.+.  .+++.||||+++....    ...+.+|++++..++| +++..+..++. .+..++|
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~-~~~~~lv  447 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICE-AESWMLV  447 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC-TTBCCEEEEEE-SSSEEEE
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCCEEEE
Confidence            3443 47999999999999654  5678899999875432    3568999999999987 45555555553 4568999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+.+....
T Consensus       448 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC--
T ss_pred             EEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCc
Confidence            9999 8899999875 56799999999999999999999999999999999999995   77899999999998765433


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..    +.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.......+   .+.. ....+   
T Consensus       524 ~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---~i~~-~~~~~---  592 (635)
T 4fl3_A          524 NY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEK-GERMG---  592 (635)
T ss_dssp             ---------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHT-TCCCC---
T ss_pred             cc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc-CCCCC---
Confidence            21    112224457889999999999999999999999999999998 999998866543222   2222 22221   


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ....+|+++.+||..||+.||++||++++|++.|++++.+
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            1245689999999999999999999999999999998764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=330.45  Aligned_cols=256  Identities=21%  Similarity=0.332  Sum_probs=187.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCch---hHHHHHH-HHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAK-VYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~---~~~~E~~-~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      -++|++.+.||+|+||.||+|++..+++.||||++.......   .+..|.. +++.+ .++++..+..++.+....++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Confidence            368999999999999999999999999999999987654432   2333443 34444 457777777777888899999


Q ss_pred             EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||++.......
T Consensus       103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred             EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCc
Confidence            99998888887776677899999999999999999999996 99999999999999   478899999999997664432


Q ss_pred             CCCcccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .        .....||+.|+|||++.     +..++.++|||||||++|+|++|+.||.....  ..+.+..+.......
T Consensus       180 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~  249 (318)
T 2dyl_A          180 A--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPL  249 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCC
T ss_pred             c--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCC
Confidence            2        12457899999999995     45688999999999999999999999986332  123333333322211


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .  .....++.++.++|..||..||.+||++++|++  +.++..
T Consensus       250 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~  289 (318)
T 2dyl_A          250 L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE--HSFIKR  289 (318)
T ss_dssp             C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHH
T ss_pred             C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh--CHHHHh
Confidence            1  111346899999999999999999999999977  344443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.4e-42  Score=325.14  Aligned_cols=245  Identities=22%  Similarity=0.243  Sum_probs=193.9

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCC
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS   88 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~s   88 (423)
                      ...||+|+||.||+|.+..+++.||||++....  ....+.+|+.+++.+.| +++..+..++......++||||+ +++
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            348999999999999999999999999876543  24568899999999976 55666666777888999999999 889


Q ss_pred             HHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCccc
Q 014527           89 LEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP  166 (423)
Q Consensus        89 L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~  166 (423)
                      |.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||++  ..++.+||+|||++........     
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~-----  178 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP-----  178 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--------
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC-----
Confidence            9999886533  467899999999999999999999999999999999995  2378999999999987654321     


Q ss_pred             ccCCCcccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          167 YRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       167 ~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                        ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........  ............   .+...+
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~---~~~~~~  251 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKVGMFKVHP---EIPESM  251 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHHHHHHCCCC---CCCTTS
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHhhccccccc---cccccC
Confidence              122457899999999998654  88999999999999999999999976432211  111111111111   123456


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ++++.++|.+||..||++||+++++++
T Consensus       252 ~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          252 SAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            899999999999999999999998865

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.2e-43  Score=334.85  Aligned_cols=259  Identities=22%  Similarity=0.258  Sum_probs=185.7

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +..++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+|+.++..+.| +++..+..++...+..++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEESSSCEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEeecCCcEE
Confidence            55789999999999999999999998889999999876432   34457889998888876 566677777777888999


Q ss_pred             EEecc-CCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           81 VLDLL-GPSLEDLFVYC-------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      ||||+ +++|.+++...       ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccc
Confidence            99999 88999998752       3459999999999999999999999999999999999999   4788999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      +...........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........   .......
T Consensus       168 ~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~  242 (303)
T 2vwi_A          168 SAFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LMLTLQN  242 (303)
T ss_dssp             HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHTS
T ss_pred             hheeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHHHhcc
Confidence            976543221110  111235579999999999876 5689999999999999999999999987544322   1122221


Q ss_pred             hcCC-----cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 KVST-----PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....     ........++.++.++|.+||..||.+||++.+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1111     111223567889999999999999999999999866

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=336.76  Aligned_cols=268  Identities=17%  Similarity=0.211  Sum_probs=192.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHH--HHcCCCCCCeEEEeee----eCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK--ILQGGSGIPNIKWYGV----DGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~--~l~~~~~i~~i~~~~~----~~~~   77 (423)
                      +.-++|++.+.||+|+||.||+|++  +++.||||++.... ...+..|.+++.  .+.|++.+..+..+..    ....
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            4568999999999999999999987  68999999986532 334455555543  3555444443332221    2335


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CcccccccCCceEEeecCCCCcEEE
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDIKPDNFLMGLGRKANQVYI  147 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------giiHrDIKp~NILl~~~~~~~~vkL  147 (423)
                      .++||||+ +++|.+++..  ...++..++.++.||+.||.|||++         ||+||||||+|||+   +.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEE
Confidence            68999999 8899999964  4568999999999999999999999         99999999999999   47789999


Q ss_pred             eeccceeeecCCCCCCc-ccccCCCcccccccccCcccccC-------CCCCccchHHHHHHHHHHHHhCCCCCCCchhh
Q 014527          148 IDFGLAKKYRDPTTNRH-IPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA  219 (423)
Q Consensus       148 ~DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~  219 (423)
                      +|||+++.+........ ..........||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987654322110 00112235579999999999987       45677999999999999999997776432211


Q ss_pred             hh--------------HHHHHHH-HhhhcCCcHHHhh---ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          220 TK--------------KQKYDKI-CEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       220 ~~--------------~~~~~~i-~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..              ...+... .........+..+   ...++.+.+||.+||..||++||++.++++.|++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            10              0011111 1111111111111   11356899999999999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-42  Score=334.89  Aligned_cols=255  Identities=19%  Similarity=0.291  Sum_probs=181.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~---~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      +..++|++.+.||+|+||.||+|.+..+++.||||++.......   .+..|+..+.....++++..+..++...+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            44689999999999999999999999999999999987654322   355566544444455777778777778889999


Q ss_pred             EEeccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           81 VLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ||||+.++|.+++...    ...+++..+..++.|++.||.|||++ ||+||||||+|||++   .++.+||+|||+++.
T Consensus        99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSCC
T ss_pred             EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCCCcee
Confidence            9999988998888642    46799999999999999999999999 999999999999994   788999999999977


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      ......        .....||+.|+|||++    .+..++.++|||||||++|+|++|..||.+....  .+.+..+...
T Consensus       176 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~  245 (327)
T 3aln_A          176 LVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKG  245 (327)
T ss_dssp             --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCS
T ss_pred             cccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcC
Confidence            644321        1234789999999999    4666899999999999999999999999864321  1111111111


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ............+++.+.+||..||..||++||++.+|++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111111122356899999999999999999999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=338.13  Aligned_cols=273  Identities=16%  Similarity=0.230  Sum_probs=200.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      .+..++|++.+.||+|+||.||+|.+..   .||+|++....    ....+.+|+.+++.++| +++..+..++.+....
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC-TTBCCCCEEEECSSCE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCCce
Confidence            3556899999999999999999999843   49999876532    23457789999999986 5566666666777889


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      ++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++    ++.+||+|||+++...
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISG  180 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC---
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccccc
Confidence            9999999 7899999876555799999999999999999999999999999999999993    6799999999987653


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccC---------CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLG---------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (423)
                      .......  ........||+.|+|||++.+         ..++.++|||||||++|+|++|..||......   .....+
T Consensus       181 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~  255 (319)
T 2y4i_B          181 VLQAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIWQM  255 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHHHH
T ss_pred             ccccccc--ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHh
Confidence            2221110  112234568999999999975         34788999999999999999999999875443   222222


Q ss_pred             HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceece
Q 014527          229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWT  291 (423)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~  291 (423)
                      ........   ....+|.++.++|..||..||++||++.+|++.|+.+..+...-.+....|.
T Consensus       256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~  315 (319)
T 2y4i_B          256 GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK  315 (319)
T ss_dssp             HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred             ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence            22221111   1134688999999999999999999999999999988776654444444453

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-42  Score=328.56  Aligned_cols=243  Identities=23%  Similarity=0.330  Sum_probs=193.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHc---CCCCCCeEEEe
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQ---GGSGIPNIKWY   71 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--------~~~~~~E~~~l~~l~---~~~~i~~i~~~   71 (423)
                      ..+.++|++.+.||+|+||.||+|++..+++.||||++.....        ...+.+|+.++..+.   .++++..+..+
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            4577899999999999999999999999999999999865432        234668999999994   45677777777


Q ss_pred             eeeCCeeEEEEec-c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEee
Q 014527           72 GVDGEDNVLVLDL-L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        72 ~~~~~~~~lv~e~-~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                      +...+..++|||+ + +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++  ..++.+||+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d  183 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID  183 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence            7777889999998 4 7899999876 45699999999999999999999999999999999999994  2678999999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI  228 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (423)
                      ||++........         ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....         .+
T Consensus       184 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~  245 (312)
T 2iwi_A          184 FGSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EI  245 (312)
T ss_dssp             CSSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH
T ss_pred             cchhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HH
Confidence            999987654321         24578999999999987665 458999999999999999999997632         12


Q ss_pred             HhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .......+     ..++..+.++|.+||..||++||+++++++
T Consensus       246 ~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHTCCCCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhccCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22222222     446889999999999999999999999865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-41  Score=358.32  Aligned_cols=259  Identities=22%  Similarity=0.316  Sum_probs=207.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCC---CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~---~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +..++|++.+.||+|+||.||+|.+..+   +..||||+.......   ..+.+|+.+++.++|++ +..+..+. ..+.
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~-~~~~  464 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH-IVKLIGVI-TENP  464 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTT-BCCEEEEE-CSSS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCC-CCeEEEEE-ecCc
Confidence            4567899999999999999999998653   457999987754332   45889999999998754 55554444 3456


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++..
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCSC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCeec
Confidence            89999999 7899999987666799999999999999999999999999999999999995   7889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......      ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.....   .+..+.... ..
T Consensus       542 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~~~-~~  611 (656)
T 2j0j_A          542 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGE-RL  611 (656)
T ss_dssp             CC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHHTC-CC
T ss_pred             CCCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcCC-CC
Confidence            443221      1224467889999999999899999999999999999997 999998765443   233332222 11


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      +   ....+|+.+.+||.+||..||++||++.+|++.|++++.++
T Consensus       612 ~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          612 P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            1   22456899999999999999999999999999999998764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.1e-42  Score=325.87  Aligned_cols=258  Identities=19%  Similarity=0.228  Sum_probs=192.8

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeee----------
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV----------   73 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~----------   73 (423)
                      +.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++.+..+..+..          
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            4578999999999999999999999999999999885432 23457889999999987554444333322          


Q ss_pred             --eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeec
Q 014527           74 --DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF  150 (423)
Q Consensus        74 --~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DF  150 (423)
                        .....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeC
Confidence              245679999999 789999998766678899999999999999999999999999999999999   47889999999


Q ss_pred             cceeeecCCCCCCc-------ccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhH
Q 014527          151 GLAKKYRDPTTNRH-------IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK  222 (423)
Q Consensus       151 Gla~~~~~~~~~~~-------~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~  222 (423)
                      |++...........       ..........||+.|+|||++.+. .++.++|||||||++|+|++   ||....  ...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~~  235 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ERV  235 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hHH
Confidence            99986543211000       001122355789999999999865 68999999999999999998   665422  222


Q ss_pred             HHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....+.......+ .......+..+.++|..||+.||.+||++.+|++
T Consensus       236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          236 NILKKLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHSTTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccccccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            33333333222222 2233456788999999999999999999998865

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.8e-41  Score=341.00  Aligned_cols=260  Identities=21%  Similarity=0.189  Sum_probs=193.4

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++.+.+.|.+.+.||+|+||+||.+. ..+++.||||++..+ ....+.+|+.++..+.+|+++..+..++.+....++|
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            56778889999999999999998764 457899999987653 2345789999999886668888888888888899999


Q ss_pred             EeccCCCHHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeec----------CCCCcE
Q 014527           82 LDLLGPSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----------RKANQV  145 (423)
Q Consensus        82 ~e~~~~sL~~~l~~~~~~------l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~----------~~~~~v  145 (423)
                      ||||+++|.+++......      .++..++.++.||+.||+|||++||+||||||+|||++..          +....+
T Consensus        88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            999988999998743211      1233467899999999999999999999999999999632          234589


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                      ||+|||+++..........   .......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.+..
T Consensus       168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            9999999988754332110   01224579999999999976       568999999999999999999 999997643


Q ss_pred             hhhhHHHHHHHHhhhcCCcHH--HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          218 AATKKQKYDKICEKKVSTPIE--VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...     ..+.......+..  .....+++++.+||.+||+.||.+||++.+|++
T Consensus       245 ~~~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THH-----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH-----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            221     1222222222110  011234688999999999999999999999865

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.1e-42  Score=334.31  Aligned_cols=252  Identities=16%  Similarity=0.230  Sum_probs=203.2

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----c--------------hhHHHHHHHHHHHcCCC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----H--------------PQLLYEAKVYKILQGGS   63 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~--------------~~~~~E~~~l~~l~~~~   63 (423)
                      .+..++|++.+.||+|+||.||+|.+  +++.||||++.....     .              ..+.+|+.++..++| +
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~  103 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN-E  103 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC-T
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC-C
Confidence            45668999999999999999999998  899999998753211     1              678999999999986 5


Q ss_pred             CCCeEEEeeeeCCeeEEEEecc-CCCHHHH------HHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCce
Q 014527           64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDL------FVYC-RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNF  134 (423)
Q Consensus        64 ~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~------l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NI  134 (423)
                      ++..+..++.+.+..++||||+ +++|.++      +... ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            6666666677788999999999 6699887      4321 4569999999999999999999999 9999999999999


Q ss_pred             EEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCC-CCCc-cchHHHHHHHHHHHHhCCCC
Q 014527          135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSR-RDDLESLGYVLLYFLRGSLP  212 (423)
Q Consensus       135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-~sDIwSlGvil~elltG~~P  212 (423)
                      |+   +.++.+||+|||++.......         .....||+.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus       184 l~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          184 LM---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             EE---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EE---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            99   478899999999998764431         1245789999999999987 5666 99999999999999999999


Q ss_pred             CCCchhhhhHHHHHHHHhhhcCCcHH--------------HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          213 WQGLKAATKKQKYDKICEKKVSTPIE--------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       213 f~~~~~~~~~~~~~~i~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      |......  .+.+..+.......+..              .....++.++.+||..||..||.+||++.++++
T Consensus       252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9875431  23344444433333311              111456899999999999999999999999866

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=340.97  Aligned_cols=255  Identities=18%  Similarity=0.173  Sum_probs=191.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      ..+|.+.+.||+|+||+||.. ...+++.||||++... ....+.+|+++++.+..|++|..+..++.+....|+|||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE-CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTT-TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            346999999999999997643 3457899999988653 33457899999999966677888888888889999999999


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC--CCCcEEEeeccceeeecCCCCCC
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      +++|.+++......+....++.++.||+.||.|||++||+||||||+|||++..+  ....+||+|||+|+........ 
T Consensus       101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~-  179 (432)
T 3p23_A          101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-  179 (432)
T ss_dssp             SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred             CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc-
Confidence            9999999986555566677889999999999999999999999999999995332  2346889999999876543211 


Q ss_pred             cccccCCCcccccccccCccccc---CCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          164 HIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                         +.......||+.|+|||++.   +..++.++|||||||++|||++ |..||.......    ...+ ..........
T Consensus       180 ---~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~-~~~~~~~~~~  251 (432)
T 3p23_A          180 ---FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANIL-LGACSLDCLH  251 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHH-TTCCCCTTSC
T ss_pred             ---eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHH-hccCCccccC
Confidence               11223567999999999998   4567889999999999999999 999997533221    1111 1111111111


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....+..+.+||.+||+.||.+||++++|++
T Consensus       252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11223567899999999999999999999874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.3e-42  Score=342.20  Aligned_cols=239  Identities=15%  Similarity=0.122  Sum_probs=186.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCC----------------
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGI----------------   65 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i----------------   65 (423)
                      ..|++.+.||+|+||+||+|++..+++.||||++....     ..+.+.+|+.++..+.|..++                
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            35889999999999999999999999999999987332     245688999999888763221                


Q ss_pred             -----CeEEEeee-----eCCeeEEEEeccCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccc
Q 014527           66 -----PNIKWYGV-----DGEDNVLVLDLLGPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI  129 (423)
Q Consensus        66 -----~~i~~~~~-----~~~~~~lv~e~~~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDI  129 (423)
                           +.+..+..     .....+++|++++++|.+++...      ...+++..++.++.||+.||+|||++||+||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                 10101111     13356899999999999998643      334778899999999999999999999999999


Q ss_pred             cCCceEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccc----------cCCCCCccchHHHH
Q 014527          130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH----------LGIEQSRRDDLESL  199 (423)
Q Consensus       130 Kp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~~sDIwSl  199 (423)
                      ||+|||+   +.++.+||+|||+++......          ....| +.|+|||++          .+..++.++|||||
T Consensus       238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~~----------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          238 RPVDIVL---DQRGGVFLTGFEHLVRDGASA----------VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             CGGGEEE---CTTCCEEECCGGGCEETTEEE----------CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             ccceEEE---ecCCeEEEEeccceeecCCcc----------ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence            9999999   478889999999998654321          24567 999999999          55568899999999


Q ss_pred             HHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          200 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       200 Gvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ||++|||++|+.||.+.........   +    +     ..+..+|+++.+||..||..||++||++.++++
T Consensus       304 Gvil~elltg~~Pf~~~~~~~~~~~---~----~-----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          304 GLAIYWIWCADLPNTDDAALGGSEW---I----F-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHHSSCCCCTTGGGSCSGG---G----G-----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHCCCCCCCcchhhhHHH---H----H-----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999999987543221111   1    1     112456899999999999999999999888865

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-40  Score=316.48  Aligned_cols=238  Identities=21%  Similarity=0.231  Sum_probs=184.0

Q ss_pred             CceEEe-ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeee----CCeeEEE
Q 014527            7 VKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLV   81 (423)
Q Consensus         7 ~~y~i~-~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~~~~lv   81 (423)
                      ++|.+. +.||+|+||.||+|.+..+++.||||++..   ...+.+|+.++..+.+++++..+..++..    ....++|
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            556666 889999999999999999999999999864   45688999998777666777777665554    6678999


Q ss_pred             Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      |||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++....  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            9999 779999998643 369999999999999999999999999999999999999633337899999999986532  


Q ss_pred             CCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHH-HHHHhhhcCCcHH
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVSTPIE  238 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~  238 (423)
                                                 +..++.++|||||||++|+|++|..||.+.......... ..+.......+ .
T Consensus       172 ---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~  223 (299)
T 3m2w_A          172 ---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP-N  223 (299)
T ss_dssp             ---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC-H
T ss_pred             ---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC-c
Confidence                                       124677899999999999999999999764432111000 01111112222 2


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      .....+++++.+||.+||+.||.+||++.++++  +.++..
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~  262 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ  262 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHT
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhcc
Confidence            223567899999999999999999999999976  455543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-40  Score=316.21  Aligned_cols=232  Identities=13%  Similarity=0.080  Sum_probs=189.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      +++++|++.+.||+|+||.||+|++..+++.||||++......     ..+.+|+.++..+.| +++..+..++.+.+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceeeEEEEECCcE
Confidence            7889999999999999999999999999999999998765432     458899999998876 5677777778888999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||+ +++|.+++.   ......++..|+.||+.||+|||++||+||||||+|||++   .++.+||+++|.     
T Consensus       107 ~lv~e~~~g~~L~~~l~---~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~~-----  175 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPAT-----  175 (286)
T ss_dssp             EEEEECCCEEEHHHHHT---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCCC-----
T ss_pred             EEEEEecCCCCHHHHHh---cCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEeccc-----
Confidence            9999999 789999884   2356778999999999999999999999999999999995   788899985542     


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                                            ++       .++.++|||||||++|+|++|+.||.+...........+... ....+.
T Consensus       176 ----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~  225 (286)
T 3uqc_A          176 ----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEP  225 (286)
T ss_dssp             ----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCH
T ss_pred             ----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCCh
Confidence                                  22       368899999999999999999999987544321100001111 112233


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ......+|+++.++|.+||+.||++| ++.++++.|+.+..
T Consensus       226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            44556789999999999999999999 99999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.2e-40  Score=347.72  Aligned_cols=243  Identities=16%  Similarity=0.217  Sum_probs=191.4

Q ss_pred             CcccCCceEEeceeeecCceeEEEEEECC-CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         2 ~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +.++.++|++.+.||+|+||.||+|.+.. +++.||||++......   ..+.+|+.++..++| ++|+.+..++...+.
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PSIVQIFNFVEHTDR  153 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEEECT
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC-CCcCeEeeeEeecCC
Confidence            45788999999999999999999999976 7899999988654332   347889999999987 555556555544433


Q ss_pred             -----eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           78 -----NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        78 -----~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                           .||||||+ +++|.+++.   ..+++..++.|+.||+.||.|||++||+||||||+|||++    .+.+||+|||
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~~~~kl~DFG  226 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLG  226 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSCEEECCCT
T ss_pred             CCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----CCcEEEEecc
Confidence                 69999999 788887654   3799999999999999999999999999999999999994    3489999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      +++.....           ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.......         
T Consensus       227 ~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------  285 (681)
T 2pzi_A          227 AVSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------  285 (681)
T ss_dssp             TCEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------
T ss_pred             cchhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc---------
Confidence            99876432           2457999999999998754 88999999999999999999998753211100         


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHHH
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFS  278 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~l~~~L~~~~~  278 (423)
                       ...+.    ...++.+.+||.+||..||.+|| +++++...|..++.
T Consensus       286 -~~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          286 -EDDPV----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             -TTCHH----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             -ccccc----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence             00011    11257899999999999999999 56777777766654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.7e-40  Score=344.29  Aligned_cols=264  Identities=18%  Similarity=0.233  Sum_probs=196.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeee------CC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD------GE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~------~~   76 (423)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....   ...+.+|+++++.++| +++..+..+...      ..
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH-PNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB-TTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCceeeeecccccccCCC
Confidence            4889999999999999999999999999999998875433   2347889999999986 455555444332      66


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ..++||||+ +++|.+++.....  .+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            789999999 8899999875332  5899999999999999999999999999999999999974434456999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhH------HHHHH
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK------QKYDK  227 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~------~~~~~  227 (423)
                      ........        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......      .....
T Consensus       172 ~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          172 KELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH  243 (676)
T ss_dssp             CBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred             cccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence            87654332        12567999999999999999999999999999999999999999753211000      00000


Q ss_pred             H-----HhhhcC-----CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHH-----HHHHHHHHH
Q 014527          228 I-----CEKKVS-----TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL-----KRLFHDLFS  278 (423)
Q Consensus       228 i-----~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l-----~~~L~~~~~  278 (423)
                      +     ......     .....+...+++.+.++|..||..||++||++.++     .+.+++++.
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0     000000     00111233468899999999999999999999884     455555554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.4e-39  Score=311.90  Aligned_cols=242  Identities=20%  Similarity=0.148  Sum_probs=182.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHc--------CCCCCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQ--------GGSGIP   66 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------~~~~~~E~~~l~~l~--------~~~~i~   66 (423)
                      ..++|++.+.||+|+||+||+|++  +++.||||++.....          ...+.+|+.+++.++        .|+++.
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999998  689999998875432          266899999999997        344554


Q ss_pred             eEEEeee------------------------------eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 014527           67 NIKWYGV------------------------------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR  115 (423)
Q Consensus        67 ~i~~~~~------------------------------~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~a  115 (423)
                      .+.....                              .....||||||+ +|++.+.+.  ++.+++..++.++.||+.|
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHH
Confidence            4433211                              267899999999 675665553  3668999999999999999


Q ss_pred             HHHHH-hcCcccccccCCceEEeecC-----------------CCCcEEEeeccceeeecCCCCCCcccccCCCcccccc
Q 014527          116 IEYVH-SRGFLHRDIKPDNFLMGLGR-----------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA  177 (423)
Q Consensus       116 L~yLH-~~giiHrDIKp~NILl~~~~-----------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~  177 (423)
                      |.||| ++||+||||||+|||++..+                 ....+||+|||+|+.....            ...||+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt~  241 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECCC
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEee
Confidence            99999 99999999999999996221                 0128999999999876532            347999


Q ss_pred             cccCcccccCCCCCccchHHHHHHH-HHHHHhCCCCCCCchhhhhHHHHHHHHhhh-c-CCcHHHhhccChHHHHHHHHH
Q 014527          178 RYASCNTHLGIEQSRRDDLESLGYV-LLYFLRGSLPWQGLKAATKKQKYDKICEKK-V-STPIEVLCKSHPAEFASYFHY  254 (423)
Q Consensus       178 ~Y~aPE~~~~~~~s~~sDIwSlGvi-l~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~-~~~~~~~~~~~~~~l~~li~~  254 (423)
                      .|+|||++.+.. +.++||||||++ .+++++|..||.+...  .......+.... . ..+.......+++++.+||.+
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~  318 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRT  318 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHH
Confidence            999999999876 899999998777 7788999999964211  011122222111 1 111122334568899999999


Q ss_pred             HhcCCCCCCCChHHHH
Q 014527          255 CQSLTFDQRPDYGFLK  270 (423)
Q Consensus       255 cl~~dP~~RPt~~~l~  270 (423)
                      ||..|     ++++++
T Consensus       319 ~L~~d-----sa~e~l  329 (336)
T 2vuw_A          319 MLNFS-----SATDLL  329 (336)
T ss_dssp             GGGSS-----SHHHHH
T ss_pred             HhccC-----CHHHHH
Confidence            99976     888776

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.1e-33  Score=286.40  Aligned_cols=186  Identities=16%  Similarity=0.112  Sum_probs=132.0

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCC------------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~------------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ...++.|++|.+..++....|+.|++|++....            ...++.+|+++|+++.++++++.+..++.+....|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            344667888888877777789999999987542            12348899999999988899999999999999999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |||||+ |++|.+++.. .+.++..   .|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+....
T Consensus       319 LVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC-
T ss_pred             EEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCC
Confidence            999999 8999999975 4567764   478999999999999999999999999999   4789999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP  212 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~P  212 (423)
                      ...       .....+||+.|||||++.+. +..++|+||+|+++++|.++..+
T Consensus       392 ~~~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            432       22367899999999999874 56789999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=5.2e-28  Score=249.00  Aligned_cols=187  Identities=19%  Similarity=0.178  Sum_probs=140.7

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ..+.||+|+||.||+|..  .++.+++|.......          .+.+.+|+++++.++| ++++.+..++...+..||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-FGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-GTCCCCCEEEEETTTTEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-CCcCceEEEEEeCCccEE
Confidence            456899999999999954  577899997554321          1236899999999987 455544555567788899


Q ss_pred             EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCC
Q 014527           81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP  159 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (423)
                      ||||+ +++|.+++..         ++.++.||+.||.|||++||+||||||+|||++   .  .+||+|||+|+.....
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence            99999 7999998753         678999999999999999999999999999994   3  9999999999987543


Q ss_pred             CCCCcccccCCCcccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 014527          160 TTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQ  214 (423)
Q Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDIwSlGvil~elltG~~Pf~  214 (423)
                      .......+.......||+.|+|||++.+  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2111000111236689999999999987  557888999999999998888877774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=4.1e-25  Score=209.09  Aligned_cols=144  Identities=20%  Similarity=0.286  Sum_probs=113.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------HPQLLYEAKVYKILQGGSGI   65 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--------------------~~~~~~E~~~l~~l~~~~~i   65 (423)
                      +..|.+.+.||+|+||.||+|.+ .+++.||||+++....                    ...+.+|+.+++.+.+   +
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~  164 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---L  164 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---S
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---C
Confidence            34566779999999999999999 7899999999864321                    2347899999999983   3


Q ss_pred             CeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCc
Q 014527           66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ  144 (423)
Q Consensus        66 ~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~  144 (423)
                      .....+.  .+..++||||+ +++|.+ +.       ......++.||+.||.|||++||+||||||+|||+   + ++.
T Consensus       165 ~v~~~~~--~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~  230 (282)
T 1zar_A          165 AVPKVYA--WEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEG  230 (282)
T ss_dssp             SSCCEEE--EETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTE
T ss_pred             CcCeEEe--ccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCc
Confidence            3333332  25569999999 778877 31       13456799999999999999999999999999999   4 789


Q ss_pred             EEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccC
Q 014527          145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG  187 (423)
Q Consensus       145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  187 (423)
                      +||+|||+|+.                    +..|+|||.+.+
T Consensus       231 vkl~DFG~a~~--------------------~~~~~a~e~l~r  253 (282)
T 1zar_A          231 IWIIDFPQSVE--------------------VGEEGWREILER  253 (282)
T ss_dssp             EEECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred             EEEEECCCCeE--------------------CCCCCHHHHHHH
Confidence            99999999853                    345788988753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.6e-22  Score=187.36  Aligned_cols=136  Identities=22%  Similarity=0.291  Sum_probs=107.1

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcE--EEEEEecCCCCc--------------------------hhHHHHHHHHHHH
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKH--------------------------PQLLYEAKVYKIL   59 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~--vaiKi~~~~~~~--------------------------~~~~~E~~~l~~l   59 (423)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++.....                          ..+.+|+.++..|
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998778888  999987543211                          2478899999999


Q ss_pred             cCCC-CCCeEEEeeeeCCeeEEEEeccC--C----CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCcccccccC
Q 014527           60 QGGS-GIPNIKWYGVDGEDNVLVLDLLG--P----SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKP  131 (423)
Q Consensus        60 ~~~~-~i~~i~~~~~~~~~~~lv~e~~~--~----sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDIKp  131 (423)
                      .++. .+|.+..+    ...+|||||++  |    .|.++..    ..++..+..++.||+.||.||| +.||+||||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            8753 23444332    35789999994  3    6666532    1335578899999999999999 99999999999


Q ss_pred             CceEEeecCCCCcEEEeeccceeee
Q 014527          132 DNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus       132 ~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      +|||++   .  .++|+|||+|...
T Consensus       200 ~NILl~---~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYI---D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEES---S--SEEECCCTTCEET
T ss_pred             HHEEEc---C--cEEEEECcccccC
Confidence            999994   3  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=5.8e-18  Score=165.15  Aligned_cols=137  Identities=22%  Similarity=0.296  Sum_probs=98.3

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----------------chh--------HHHHHHHHHHHcCCC
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HPQ--------LLYEAKVYKILQGGS   63 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----------------~~~--------~~~E~~~l~~l~~~~   63 (423)
                      -|++++.||.|+||.||+|.+. +|+.||||+++....                ...        ..+|...|.+|.+ .
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-E  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-T
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-c
Confidence            3899999999999999999975 589999998753210                000        2457777888854 3


Q ss_pred             CCCeEEEeeeeCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        64 ~i~~i~~~~~~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      +++....+...  ..+|||||+ |..|..+       ........++.||+.+|.+||+.|||||||||.|||++.+.+.
T Consensus       174 gv~vp~p~~~~--~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          174 GFPVPEPIAQS--RHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             TCSCCCEEEEE--TTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCCCCeeeecc--CceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence            34333333322  348999999 5555432       1223456788999999999999999999999999999632211


Q ss_pred             -------CcEEEeeccceee
Q 014527          143 -------NQVYIIDFGLAKK  155 (423)
Q Consensus       143 -------~~vkL~DFGla~~  155 (423)
                             ..++|+||+-+..
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEE
T ss_pred             ccccccccceEEEEeCCccc
Confidence                   1489999998765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=1.2e-12  Score=121.66  Aligned_cols=137  Identities=17%  Similarity=0.189  Sum_probs=108.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|++...++.|+.+.||++..  .++.+++|+....  .....+.+|+.+++.|.....+|.+..++.+....|+|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            4589999999999999999974  3678999987642  23346999999999997666688888888888899999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------  121 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------------  121 (423)
                      + |.+|.+.+      .+......++.+++.+|..||+                                          
T Consensus        92 i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            9 66776542      1223345788999999999998                                          


Q ss_pred             -----------------cCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          122 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       122 -----------------~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                                       ..++|+|++|.|||++   +...+.|+||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence                             4589999999999994   44445699999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=9.8e-12  Score=114.74  Aligned_cols=134  Identities=18%  Similarity=0.130  Sum_probs=98.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeEEEeeeeCCeeEEEEecc
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLL   85 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~-i~~i~~~~~~~~~~~lv~e~~   85 (423)
                      ..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+... +|.+..++...+..++|||++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            3466655555667799999964 45677999997654 34568999999999987644 676777777777889999999


Q ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 014527           86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG-----------------------------------------  123 (423)
Q Consensus        86 -~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----------------------------------------  123 (423)
                       |.+| + .   . ..+   ...++.+++..|..||+..                                         
T Consensus        98 ~G~~l-~-~---~-~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDL-L-S---S-HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEET-T-T---S-CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCccc-C-c---C-cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence             5555 2 1   1 112   2356777888888888643                                         


Q ss_pred             -----------------cccccccCCceEEeecCCCCcEEEeecccee
Q 014527          124 -----------------FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       124 -----------------iiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                                       ++|+|++|.|||++   ++..+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence                             99999999999994   44455699999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.16  E-value=2.5e-11  Score=115.28  Aligned_cols=191  Identities=15%  Similarity=0.172  Sum_probs=121.2

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC--CCeEEEeeeeCC---eeEEEEecc-
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG--IPNIKWYGVDGE---DNVLVLDLL-   85 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~--i~~i~~~~~~~~---~~~lv~e~~-   85 (423)
                      .+.++.|....||++.     ..+++|+.........+.+|+++++.+.....  +|.+..++....   ..|+||+++ 
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999863     45899986644334568999999999965433  445544443333   348899999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS--------------------------------------------  121 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------------------------------------------  121 (423)
                      |.++.+...   ..++..+...++.|++..|..||+                                            
T Consensus       100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A          100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            555554322   247788888899999999999986                                            


Q ss_pred             --------------cCcccccccCCceEEeecCC-CCcEEEeeccceeeecCCCCCCccccc---CC----Ccccccccc
Q 014527          122 --------------RGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPTTNRHIPYR---EN----KNLTGTARY  179 (423)
Q Consensus       122 --------------~giiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~---~~----~~~~gt~~Y  179 (423)
                                    ..++|+|++|.||+++  ++ ...+.|+||+.+...............   ..    ..+.....+
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~--~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFD--TEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEE--TTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEe--CCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1369999999999995  22 456789999998764221100000000   00    000000011


Q ss_pred             cC-cccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 014527          180 AS-CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ  214 (423)
Q Consensus       180 ~a-PE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~  214 (423)
                      .. |+.....  ....+.|++|.++|.+.+|..+|-
T Consensus       255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11 2211111  123689999999999999988774

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=2e-10  Score=111.72  Aligned_cols=137  Identities=15%  Similarity=0.214  Sum_probs=99.8

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEec--CCC---CchhHHHHHHHHHHHcCCC-CCCeEEEeeeeC---CeeEEE
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGT---KHPQLLYEAKVYKILQGGS-GIPNIKWYGVDG---EDNVLV   81 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~--~~~---~~~~~~~E~~~l~~l~~~~-~i~~i~~~~~~~---~~~~lv   81 (423)
                      -.+.|+.|.++.||++...  +..+++|+..  ...   ....+.+|+.+++.|.... .+|.+..++.+.   ...|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4677899999999999753  4678899765  322   2346889999999998632 256666665554   347999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS---------------------------------------  121 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---------------------------------------  121 (423)
                      ||++ |..+.+.   .-..++......++.+++..|..||+                                       
T Consensus       120 me~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999 4444321   12347788889999999999999997                                       


Q ss_pred             -------------------cCcccccccCCceEEeecCCC--CcEEEeeccceee
Q 014527          122 -------------------RGFLHRDIKPDNFLMGLGRKA--NQVYIIDFGLAKK  155 (423)
Q Consensus       122 -------------------~giiHrDIKp~NILl~~~~~~--~~vkL~DFGla~~  155 (423)
                                         ..++|+|++|.|||++   .+  ..+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence                               3689999999999994   33  2368999999864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=1.2e-07  Score=90.10  Aligned_cols=136  Identities=22%  Similarity=0.249  Sum_probs=91.4

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCeEEEeee-eCCeeEEEEecc-CC
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIPNIKWYGV-DGEDNVLVLDLL-GP   87 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~--~i~~i~~~~~-~~~~~~lv~e~~-~~   87 (423)
                      .+.++.|....||++     +..+++|+.........+.+|+++++.|.++.  .+|.+..++. ..+..+++|+++ |.
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            456788888899988     45688998643333456889999999998642  3566666653 445678999999 54


Q ss_pred             CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 014527           88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------------------------------------------  122 (423)
Q Consensus        88 sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------------------------------------------  122 (423)
                      .+.+..   -..++......++.+++..|..||+.                                             
T Consensus        99 ~l~~~~---~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           99 ILGEDG---MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             ECHHHH---HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             ECchhh---hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            554421   12345555555566666666655532                                             


Q ss_pred             ---------------CcccccccCCceEEeecCCCCc-EEEeeccceee
Q 014527          123 ---------------GFLHRDIKPDNFLMGLGRKANQ-VYIIDFGLAKK  155 (423)
Q Consensus       123 ---------------giiHrDIKp~NILl~~~~~~~~-vkL~DFGla~~  155 (423)
                                     .++|+|++|.|||++.++..+. +.|+||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           3589999999999952111345 58999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.65  E-value=3.6e-07  Score=84.65  Aligned_cols=132  Identities=17%  Similarity=0.156  Sum_probs=95.4

Q ss_pred             eeeecCce-eEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CCCHHH
Q 014527           14 KIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLED   91 (423)
Q Consensus        14 ~Lg~G~fg-~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~sL~~   91 (423)
                      .+..|..+ .||+......+..+++|+.... ....+.+|+..|+.|...--+|.+..++.+.+..++|||++ |.++.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            34445544 6999887777778999986543 34468899999999987655788888888889999999999 556665


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------------
Q 014527           92 LFVYCRRKFSLKTVLMLADQMIARIEYVHSR-------------------------------------------------  122 (423)
Q Consensus        92 ~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-------------------------------------------------  122 (423)
                      ....     .......++.+++..|..||+.                                                 
T Consensus       110 ~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          110 VLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             cccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            5432     1223345566666666666631                                                 


Q ss_pred             ---------CcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          123 ---------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       123 ---------giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                               .++|+|+.+.|||++   +.+.+-|+||+.+.
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~  222 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG  222 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence                     168999999999994   45556699999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.47  E-value=8.5e-07  Score=87.13  Aligned_cols=75  Identities=16%  Similarity=0.177  Sum_probs=51.3

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCC---------CchhHHHHHHHHHHHcCC--CCCCeEEEeeeeCCeeE
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNV   79 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---------~~~~~~~E~~~l~~l~~~--~~i~~i~~~~~~~~~~~   79 (423)
                      -.+.||.|.++.||++....+++.|+||......         ....+..|.++++.+...  ..+|.+..+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3567899999999999765567789999754321         234568899999998753  345555544  455678


Q ss_pred             EEEeccCC
Q 014527           80 LVLDLLGP   87 (423)
Q Consensus        80 lv~e~~~~   87 (423)
                      +|||++.+
T Consensus       112 lvmE~l~g  119 (397)
T 2olc_A          112 TVMEDLSH  119 (397)
T ss_dssp             EEECCCTT
T ss_pred             EEEEeCCC
Confidence            99999954

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.40  E-value=5.5e-07  Score=87.02  Aligned_cols=79  Identities=11%  Similarity=0.280  Sum_probs=54.5

Q ss_pred             eEEecee-eecCceeEEEEEEC---C---CCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCC--CCCCeEEEeeee
Q 014527            9 YKLGRKI-GSGSFGEIFLASHV---D---TNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG--SGIPNIKWYGVD   74 (423)
Q Consensus         9 y~i~~~L-g~G~fg~Vy~a~~~---~---~~~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~--~~i~~i~~~~~~   74 (423)
                      ....+.| +.|....+|++...   .   +++.+++|+.....     ....+.+|+.+++.|...  -.+|.+..++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445677 88888999998753   0   15679999865433     135688999999999764  346666666544


Q ss_pred             C---CeeEEEEeccCC
Q 014527           75 G---EDNVLVLDLLGP   87 (423)
Q Consensus        75 ~---~~~~lv~e~~~~   87 (423)
                      .   ...++|||++.|
T Consensus       102 ~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             STTTSSCEEEEECCCC
T ss_pred             CCccCCceEEEEecCC
Confidence            4   346899999943

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.17  E-value=1.6e-05  Score=75.76  Aligned_cols=72  Identities=15%  Similarity=0.139  Sum_probs=43.8

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCCeEEE------eeeeCCeeEEEEec
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-SGIPNIKW------YGVDGEDNVLVLDL   84 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~-~~i~~i~~------~~~~~~~~~lv~e~   84 (423)
                      .+.|+.|..+.||++...  +..+++|+...  ....+..|..+++.|... -.+|.+..      +....+..+++|++
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHR--PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECS--CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            345666778999999763  34589998875  234566778888777632 12344432      22356678999999


Q ss_pred             cCC
Q 014527           85 LGP   87 (423)
Q Consensus        85 ~~~   87 (423)
                      +.|
T Consensus       113 i~G  115 (346)
T 2q83_A          113 IEG  115 (346)
T ss_dssp             CCC
T ss_pred             ecC
Confidence            944

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.95  E-value=6.6e-05  Score=70.56  Aligned_cols=68  Identities=19%  Similarity=0.164  Sum_probs=48.5

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-CC
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP   87 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-~~   87 (423)
                      .+.|+.|....+|++      +.+++|+...... ......|+.+++.+......|.+..+  +.+..++++||+ +|
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence            678888999999998      4589998765421 22356899999988866555666544  444567899999 55

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.92  E-value=6.3e-05  Score=74.34  Aligned_cols=73  Identities=14%  Similarity=0.329  Sum_probs=46.0

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecC-----CC----CchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeE
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GT----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~----~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~   79 (423)
                      -.+.||.|..+.||++..  +++.++||....     ..    .......|.+++..+.  .+..+|.+..++  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            456789999999999964  567899993221     11    1123344555444432  234466666554  56789


Q ss_pred             EEEecc-CC
Q 014527           80 LVLDLL-GP   87 (423)
Q Consensus        80 lv~e~~-~~   87 (423)
                      +|||++ ++
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 76

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.89  E-value=0.00014  Score=67.75  Aligned_cols=80  Identities=16%  Similarity=0.113  Sum_probs=57.8

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      ++.|.+..-.+.+|.|..+.||+++. .+|+.|++|+......  ...+..|+..|+.|.....++.-..+..+  ..++
T Consensus        11 ~l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~~l   87 (288)
T 3f7w_A           11 ELTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DRTL   87 (288)
T ss_dssp             HHHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TTEE
T ss_pred             HhcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--CceE
Confidence            45677888889999999999999985 4588899998654332  23578999999999754334333333333  3478


Q ss_pred             EEecc
Q 014527           81 VLDLL   85 (423)
Q Consensus        81 v~e~~   85 (423)
                      |||++
T Consensus        88 v~e~l   92 (288)
T 3f7w_A           88 AMEWV   92 (288)
T ss_dssp             EEECC
T ss_pred             EEEee
Confidence            99998

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=9e-05  Score=70.22  Aligned_cols=73  Identities=25%  Similarity=0.302  Sum_probs=57.1

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCeEEEeeeeCCeeEEEEeccC
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLVLDLLG   86 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~--~~i~~i~~~~~~~~~~~lv~e~~~   86 (423)
                      -.+.|+.|....+|++..  ++..+++|+.... ....+..|+..|+.|...  ..+|.+..++...+..++|||++.
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            456789999999999974  4677899987643 245688999999999753  557777777777788999999993

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.71  E-value=0.00037  Score=65.89  Aligned_cols=139  Identities=17%  Similarity=0.200  Sum_probs=78.3

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeEEEe------eeeCCeeEEEEe
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY------GVDGEDNVLVLD   83 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~-i~~i~~~------~~~~~~~~lv~e   83 (423)
                      -.+.|+.|....+|++...  +..+++|+.........+..|+.++..|..... +|.+...      ....+..+++|+
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            3456777888999999763  336889988764445568889999998875322 3443211      123456789999


Q ss_pred             ccCC-CH-----H------HHH---HHhcCCC--------CHHHHHH---------------HHHHHHHHHHHHHh----
Q 014527           84 LLGP-SL-----E------DLF---VYCRRKF--------SLKTVLM---------------LADQMIARIEYVHS----  121 (423)
Q Consensus        84 ~~~~-sL-----~------~~l---~~~~~~l--------~~~~~~~---------------i~~qi~~aL~yLH~----  121 (423)
                      ++.| .+     .      ..+   ......+        .......               +...+...++++..    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9944 21     1      111   1111111        1110000               00113444555552    


Q ss_pred             ---cCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          122 ---RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       122 ---~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                         .+++|+|+.+.|||+.   ++..+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence               4699999999999994   34445799999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.55  E-value=0.0016  Score=57.66  Aligned_cols=139  Identities=12%  Similarity=0.095  Sum_probs=88.8

Q ss_pred             CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        87 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      .+|.+++...+.+++++++|.++.|.+.+|.-+- .+.-..+=+.|..|++.   .+|.|-+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence            4799999988999999999999999999987762 11112233446788884   677776653 1110           


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccCh
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP  245 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (423)
                              .....+.|||... ...+.+.=|||||+++|..+-=..|=..                         ...++
T Consensus        98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e-------------------------E~eLS  143 (229)
T 2yle_A           98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE-------------------------ERELS  143 (229)
T ss_dssp             -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE-------------------------EECCC
T ss_pred             --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc-------------------------chhhC
Confidence                    1123456777753 2346788999999999998863232110                         13347


Q ss_pred             HHHHHHHHHHhcCC-------------------------CCCCCChHHHHHHHH
Q 014527          246 AEFASYFHYCQSLT-------------------------FDQRPDYGFLKRLFH  274 (423)
Q Consensus       246 ~~l~~li~~cl~~d-------------------------P~~RPt~~~l~~~L~  274 (423)
                      +.+.+||..|..-.                         +..|+++++|++...
T Consensus       144 ~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          144 PPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             HHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence            78888998887652                         356777777766554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.0005  Score=65.42  Aligned_cols=140  Identities=16%  Similarity=0.118  Sum_probs=72.4

Q ss_pred             eceeeecCcee-EEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeEEEeeeeCCeeEEEEeccCC-C
Q 014527           12 GRKIGSGSFGE-IFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP-S   88 (423)
Q Consensus        12 ~~~Lg~G~fg~-Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~-i~~i~~~~~~~~~~~lv~e~~~~-s   88 (423)
                      .+.|+.|.... +|+... .++..+++|...... ...+..|+.+++.|..... +|.+..+.  ....+++||++++ .
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g~ll~e~l~~~~   98 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEE--HARGLLLIEDLGDAL   98 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTTEEEECCCCSCB
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeec--CCCCEEEEeeCCCcc
Confidence            34565554444 677753 225678888654432 1456788888888875432 55555543  3334789999844 4


Q ss_pred             HHHHHHHh------------------c-------CCCCHHHHH-------H-H------------HHHHHHHHHHH----
Q 014527           89 LEDLFVYC------------------R-------RKFSLKTVL-------M-L------------ADQMIARIEYV----  119 (423)
Q Consensus        89 L~~~l~~~------------------~-------~~l~~~~~~-------~-i------------~~qi~~aL~yL----  119 (423)
                      +.+.+...                  .       ..++.....       . +            ...+...+..|    
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            44332210                  0       012221110       0 0            00111222233    


Q ss_pred             --HhcCcccccccCCceEEeecCC-CCcEEEeeccceee
Q 014527          120 --HSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKK  155 (423)
Q Consensus       120 --H~~giiHrDIKp~NILl~~~~~-~~~vkL~DFGla~~  155 (423)
                        +...++|+|+.+.|||++.+.. .+.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence              2346999999999999941100 26799999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.37  E-value=0.0015  Score=64.59  Aligned_cols=73  Identities=12%  Similarity=0.114  Sum_probs=51.4

Q ss_pred             EeceeeecCceeEEEEEECC-------CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527           11 LGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~-------~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      -.+.|+.|-...||++....       .++.|++|+.........+..|..+++.|......|.+...+  .+  .+|++
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--g~v~e  152 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG--GRLEE  152 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--EEEEC
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--CEEEE
Confidence            34577888889999998753       257899999854222256778999999998766667665443  22  38999


Q ss_pred             ccCC
Q 014527           84 LLGP   87 (423)
Q Consensus        84 ~~~~   87 (423)
                      |+.|
T Consensus       153 ~l~G  156 (429)
T 1nw1_A          153 YIPS  156 (429)
T ss_dssp             CCCE
T ss_pred             EeCC
Confidence            9843

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.34  E-value=0.0026  Score=60.13  Aligned_cols=72  Identities=11%  Similarity=0.019  Sum_probs=47.0

Q ss_pred             eeeecCceeEEEEEECCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCCC-CCeEEEe-----eeeCCeeEEEEeccC
Q 014527           14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSG-IPNIKWY-----GVDGEDNVLVLDLLG   86 (423)
Q Consensus        14 ~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-~~~~~~~~E~~~l~~l~~~~~-i~~i~~~-----~~~~~~~~lv~e~~~   86 (423)
                      .|+ |....||++.. .+|+.+++|+.... .....+..|..++..|..... +|.+...     ....+..+++|++++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            455 77889998864 34567999998743 345567889999998875322 3333221     122456688999995


Q ss_pred             C
Q 014527           87 P   87 (423)
Q Consensus        87 ~   87 (423)
                      |
T Consensus       111 G  111 (328)
T 1zyl_A          111 G  111 (328)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.29  E-value=0.00064  Score=65.72  Aligned_cols=72  Identities=17%  Similarity=0.084  Sum_probs=45.2

Q ss_pred             eceeeecCceeEEEEEECC--------CCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527           12 GRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~--------~~~~vaiKi~~~~~~~-~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .+.|+.|....+|++....        .++.+++|+....... .....|..+++.|......|.+....  .  .++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            4567788888999998643        1267999987543211 13578999999987655466665332  2  47899


Q ss_pred             eccCC
Q 014527           83 DLLGP   87 (423)
Q Consensus        83 e~~~~   87 (423)
                      +|+.|
T Consensus       114 e~i~G  118 (369)
T 3c5i_A          114 EWLYG  118 (369)
T ss_dssp             ECCCS
T ss_pred             EEecC
Confidence            99944

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.28  E-value=0.0016  Score=63.22  Aligned_cols=138  Identities=17%  Similarity=0.184  Sum_probs=80.8

Q ss_pred             ceeeecCceeEEEEEECC-------CCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527           13 RKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~-------~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +.|..|-...+|++....       +++.|++|+..... ....+.+|.++++.|......|.+..++.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            456678888999998642       34789999864322 334577999999999876667777655432    389999


Q ss_pred             cCC-CHH--------------HHHHHhc-------CCCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 014527           85 LGP-SLE--------------DLFVYCR-------RKFS--LKTVLMLADQMIA-------------------RIEYVH-  120 (423)
Q Consensus        85 ~~~-sL~--------------~~l~~~~-------~~l~--~~~~~~i~~qi~~-------------------aL~yLH-  120 (423)
                      +.| .|.              ..+....       +...  +.++..+..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            943 211              1111111       1122  3455556554422                   233332 


Q ss_pred             ---h----cCcccccccCCceEEeec-CCCCcEEEeecccee
Q 014527          121 ---S----RGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAK  154 (423)
Q Consensus       121 ---~----~giiHrDIKp~NILl~~~-~~~~~vkL~DFGla~  154 (423)
                         .    ..++|+|+.+.|||+..+ +..+.+.|+||..|.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               2    259999999999999521 113689999998874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.03  E-value=0.019  Score=57.18  Aligned_cols=72  Identities=11%  Similarity=0.015  Sum_probs=48.5

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEeccC
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG   86 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~~   86 (423)
                      -.+.|+.|-...+|++.....+..+++|+...... .-...+|..++..|......|.+..++  .+  .+||||+.
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~  184 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMD  184 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeC
Confidence            34578888889999998754457899998754321 112368999999998766667776554  22  35999984

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.43  E-value=0.015  Score=55.35  Aligned_cols=64  Identities=6%  Similarity=0.018  Sum_probs=40.0

Q ss_pred             cCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC--CCeEEE------eeeeCCeeEEEEeccCC
Q 014527           18 GSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG--IPNIKW------YGVDGEDNVLVLDLLGP   87 (423)
Q Consensus        18 G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~--i~~i~~------~~~~~~~~~lv~e~~~~   87 (423)
                      |....||++... ++ .+++|+......    ..|+.+++.|.....  +|.+..      +.......+++|+++.|
T Consensus        34 g~~N~vy~v~~~-~g-~~vLK~~~~~~~----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           34 DTNAFAYQADSE-SK-SYFIKLKYGYHD----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             CSSCEEEEEECS-SC-EEEEEEEECSSC----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             ccccceEEEEeC-CC-CEEEEEecCccc----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            336799999743 34 899998766442    467777877764311  233321      12335677999999943

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.12  E-value=0.029  Score=55.19  Aligned_cols=72  Identities=18%  Similarity=0.137  Sum_probs=49.9

Q ss_pred             eceeeecCceeEEEEEECCC-------CcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527           12 GRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~-------~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .+.|..|-...+|++.....       ++.|++|+...... .-...+|..+++.|......|.+....  .  .++||+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            45667788889999987521       57799998654321 223578999999998766677776432  2  378999


Q ss_pred             ccCC
Q 014527           84 LLGP   87 (423)
Q Consensus        84 ~~~~   87 (423)
                      |+.|
T Consensus       151 fI~G  154 (424)
T 3mes_A          151 FIDG  154 (424)
T ss_dssp             CCCS
T ss_pred             EeCC
Confidence            9943

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.07  E-value=0.13  Score=49.92  Aligned_cols=32  Identities=28%  Similarity=0.508  Sum_probs=25.6

Q ss_pred             cccccccCCceEEeec---CCCCcEEEeeccceee
Q 014527          124 FLHRDIKPDNFLMGLG---RKANQVYIIDFGLAKK  155 (423)
Q Consensus       124 iiHrDIKp~NILl~~~---~~~~~vkL~DFGla~~  155 (423)
                      ++|+|+.+.|||+..+   ++...++++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999431   3467899999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	423
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-90
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-89
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-33
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-33
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-32
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-32
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-32
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-31
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-31
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-29
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-29
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-28
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-28
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-27
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-27
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-27
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-26
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-26
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-26
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-26
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-26
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-25
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-25
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-25
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-25
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-25
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-24
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-23
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-23
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-23
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-22
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-22
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-21
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-21
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-20
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-20
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-20
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-19
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-18

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  272 bits (696), Expect = 5e-90
 Identities = 166/292 (56%), Positives = 212/292 (72%), Gaps = 2/292 (0%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           ++GV YK+GR+IG GSFG IF  +++  N+ VA+K E   +  PQL  E + YK+L G +
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           GIPN+ ++G +G  NVLV+DLLGPSLEDL   C RKFS+KTV M A QM+AR++ +H + 
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 124 FLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            ++RDIKPDNFL+G    + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
            NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+  LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL 293
              P EF  Y HY ++L FD  PDY +L+ LF  +  R     D  FDW +L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  271 bits (694), Expect = 1e-89
 Identities = 205/299 (68%), Positives = 258/299 (86%)

Query: 1   MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
           ME  +G +Y+LGRKIGSGSFG+I+L + +   E VA+K+E   TKHPQL  E+K+YK++Q
Sbjct: 1   MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60

Query: 61  GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
           GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD  T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S NTHLGIEQSRRDDLESLGYVL+YF  GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
           CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G+ +D+VFDW +LK+  ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 53/287 (18%), Positives = 105/287 (36%), Gaps = 26/287 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
            ++   ++G+G+ G +F  SH  +  ++A K+   E       Q++ E +V         
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS--- 63

Query: 65  IPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
            P I  +YG      +  + ++ +     D  +    +   + +  ++  +I  + Y+  
Sbjct: 64  -PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 122 R-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           +   +HRD+KP N L+       ++ + DFG++ +  D   N  +         GT  Y 
Sbjct: 123 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 170

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
           S     G   S + D+ S+G  L+    G  P     A   +  +    E   +      
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDY---GFLKRLFHDLFSREGYDF 284
                   +        +   +  DY       +L   +FS E  DF
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 47/259 (18%), Positives = 98/259 (37%), Gaps = 16/259 (6%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
           KY +   +G G FG +       + +    K ++  GT    +  E  +  I +    I 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64

Query: 67  NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
           ++       E+ V++ + + G  + +       + + + ++    Q+   ++++HS    
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
           H DI+P+N +    R+++ + II+FG A++ +     R +             Y +   H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175

Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245
                S   D+ SLG ++   L G  P+      T +Q  + I   + +   E   K   
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYTFDEEAF-KEIS 231

Query: 246 AEFASYFHYCQSLTFDQRP 264
            E   +           R 
Sbjct: 232 IEAMDFVDRLLVKERKSRM 250

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 44/260 (16%), Positives = 94/260 (36%), Gaps = 17/260 (6%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
            Y +  ++G+G+FG +   +   T    A K       +    +  E +   +L+    +
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTL 85

Query: 66  PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            N+     D  + V++ + + G  L +       K S    +    Q+   + ++H   +
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +H D+KP+N +    +++N++ +IDFGL        + +          TGTA +A+   
Sbjct: 146 VHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPEV 196

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
             G       D+ S+G +    L G  P+ G       +    +     +          
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKSCDWNMDDSAF-SGI 252

Query: 245 PAEFASYFHYCQSLTFDQRP 264
             +   +         + R 
Sbjct: 253 SEDGKDFIRKLLLADPNTRM 272

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  123 bits (310), Expect = 2e-32
 Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 17/260 (6%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
            Y +  ++GSG+FG +       T  +   K            +  E  +   L     +
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKL 88

Query: 66  PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            N+     D  + VL+L+ L G  L D       K S   V+    Q    ++++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +H DIKP+N +    +KA+ V IIDFGLA K       +          T TA +A+   
Sbjct: 149 VHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFAAPEI 199

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
                     D+ ++G +    L G  P+ G       +    +         +    S 
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWEFDEDAF-SSV 255

Query: 245 PAEFASYFHYCQSLTFDQRP 264
             E   +          +R 
Sbjct: 256 SPEAKDFIKNLLQKEPRKRL 275

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 4e-32
 Identities = 51/284 (17%), Positives = 105/284 (36%), Gaps = 32/284 (11%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           +++  ++G G+FG+++ A + +T+ + A K+    S  +    + E  +          P
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH----P 69

Query: 67  NI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           NI K       +N   ++++   G +++ + +   R  +   + ++  Q +  + Y+H  
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS- 181
             +HRD+K  N L         + + DFG++ K       R        +  GT  + + 
Sbjct: 130 KIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAP 179

Query: 182 ----CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
               C T        + D+ SLG  L+       P   L      +   KI + +   P 
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE--PPT 234

Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
                   + F  +   C     D R     L +  H   + + 
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVTVDS 276

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 5e-32
 Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 26/262 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
            +++GR +G G FG ++LA    +  I+A+K+             QL  E ++   L+  
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65

Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
             I  +  Y  D     L+L+          +    KF  +       ++   + Y HS+
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             +HRDIKP+N L+G    A ++ I DFG +          H P      L GT  Y   
Sbjct: 126 RVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDYLPP 173

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
               G     + DL SLG +   FL G  P++     T ++ Y +I   + + P  V   
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFPDFV--- 227

Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
                              QRP
Sbjct: 228 --TEGARDLISRLLKHNPSQRP 247

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-31
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 27/268 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
           +  +G++IGSGSFG ++          VAVK+ N     PQ       E  V +  +   
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-- 63

Query: 64  GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
              NI  + G      + +V     G SL         KF +  ++ +A Q    ++Y+H
Sbjct: 64  --VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           ++  +HRD+K +N  +    +   V I DFGLA      + +        + L+G+  + 
Sbjct: 122 AKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILWM 173

Query: 181 S---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
           +            S + D+ + G VL   + G LP+  +    + Q    +    +S  +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDL 231

Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD 265
             +  + P         C     D+RP 
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPL 259

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 5e-31
 Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 25/241 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
            +K G+ +G GSF  + LA  + T+   A+KI          K P +  E  V   L   
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH- 67

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
              P   K Y    D E     L       L   ++     F          ++++ +EY
Sbjct: 68  ---PFFVKLYFTFQDDEKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +H +G +HRD+KP+N L+    +   + I DFG AK     +           +  GTA+
Sbjct: 124 LHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQ 175

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
           Y S          +  DL +LG ++   + G  P++      +   + KI + +   P +
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYDFPEK 232

Query: 239 V 239
            
Sbjct: 233 F 233

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 3e-30
 Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 21/248 (8%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
            + L + +G G++GE+ LA +  T E VAVKI   + +      +  E  + K+L     
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH--- 62

Query: 65  IPNI-KWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
             N+ K+YG   E N+  L L+          +                Q++A + Y+H 
Sbjct: 63  -ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
            G  HRDIKP+N L+    + + + I DFGLA  +R     R +       + GT  Y +
Sbjct: 122 IGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVA 173

Query: 182 CNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
                  E  +   D+ S G VL   L G LPW     +   Q+Y    EKK        
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPWKK 231

Query: 241 CKSHPAEF 248
             S P   
Sbjct: 232 IDSAPLAL 239

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  115 bits (288), Expect = 4e-30
 Identities = 56/269 (20%), Positives = 100/269 (37%), Gaps = 27/269 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
           +Y+LG  +G G   E+ LA  +  +  VAVK+         + + +   EA+    L   
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH- 66

Query: 63  SGIPNI-KWYGVDGEDN------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
              P I   Y     +        +V++ +        V+     + K  + +       
Sbjct: 67  ---PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           + + H  G +HRD+KP N ++      N V ++DFG+A+   D   +      +   + G
Sbjct: 124 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QTAAVIG 176

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
           TA+Y S     G     R D+ SLG VL   L G  P+ G    +      +   +    
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQHVREDP-I 232

Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
           P     +   A+  +      +   + R 
Sbjct: 233 PPSARHEGLSADLDAVVLKALAKNPENRY 261

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 5e-30
 Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 37/284 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
            +   R+IG GSFG ++ A  V  +E+VA+K      + S  K   ++ E +  + L+  
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74

Query: 63  SGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
              PN  ++ G         LV++    S  DL    ++      +  +    +  + Y+
Sbjct: 75  ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HS   +HRD+K  N L+    +   V + DFG A       +             GT  +
Sbjct: 132 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANS-----------FVGTPYW 177

Query: 180 AS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            +          +   + D+ SLG   +       P   +           I + +    
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPAL 234

Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
                      F ++   C       RP    L +  H    RE
Sbjct: 235 QSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRE 273

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 47/269 (17%), Positives = 84/269 (31%), Gaps = 22/269 (8%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------ENSGTKHPQLLYEAKVY 56
            Y+    +G G    +    H  T +  AVKI           E         L E  + 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 57  KILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
           + + G   I  +K          LV DL+    L D ++  +   S K    +   ++  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALLEV 122

Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
           I  +H    +HRD+KP+N L+        + + DFG + +       R +    +     
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
               +  + H G    +  D+ S G ++   L GS P+       +      I       
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNYQF 234

Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
                   +             +   +R 
Sbjct: 235 GSPEW-DDYSDTVKDLVSRFLVVQPQKRY 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 54/277 (19%), Positives = 112/277 (40%), Gaps = 27/277 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
             KL  ++G+G FGE+++  + + +  VAVK ++         L EA + K LQ      
Sbjct: 14  TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH----Q 68

Query: 67  NI-KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
            + + Y V  ++ + ++ + +  G  ++ L      K ++  +L +A Q+   + ++  R
Sbjct: 69  RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
            ++HRD++  N L+          I DFGLA+   D            +      ++ + 
Sbjct: 129 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAP 179

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
                   + + D+ S G +L   +  G +P+ G           ++ +        V  
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGYRMVRP 232

Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
            + P E       C     + RP + +L+ +  D F+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 22/227 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
           +Y++G  +GSG FG ++    V  N  VA+K                 ++  E  + K +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 60  QGG-SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIE 117
             G SG+  +  +    +  VL+L+   P  +       R     +       Q++  + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           + H+ G LHRDIK +N L  +     ++ +IDFG     +D             +  GT 
Sbjct: 125 HCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT---------DFDGTR 173

Query: 178 RYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
            Y+            R   + SLG +L   + G +P++  +   + Q
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 64/289 (22%), Positives = 99/289 (34%), Gaps = 27/289 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQG-- 61
           KY+   KIG G+FGE+F A H  T + VA+K               L E K+ ++L+   
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 62  -----GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
                         Y        LV D     L  L      KF+L  +  +   ++  +
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
            Y+H    LHRD+K  N L+    +   + + DFGLA+ +     ++   Y    N   T
Sbjct: 131 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVVT 184

Query: 177 ARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
             Y      LG        DL   G ++      S   QG    T++ +   I +   S 
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGSI 241

Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
             EV            +   + L   +        RL   +      D 
Sbjct: 242 TPEVW------PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 4e-29
 Identities = 47/237 (19%), Positives = 95/237 (40%), Gaps = 25/237 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
            +   + +G G+FG++ L     T    A+KI       +  +    + E++V +  +  
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH- 64

Query: 63  SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
              P +          + L   +   +  +LF +  R+  F+ +       ++++ +EY+
Sbjct: 65  ---PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           HSR  ++RDIK +N ++    K   + I DFGL K+                   GT  Y
Sbjct: 122 HSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEY 171

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
            +       +  R  D   LG V+   + G LP+        ++ ++ I  +++  P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFP 225

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 9e-29
 Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 22/245 (8%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
           KY    KIG G+ G ++ A  V T + VA++        K   ++ E  V +  +    I
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNI 79

Query: 66  PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            N     + G++  +V++ L G SL D+            +  +  + +  +E++HS   
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRDIK DN L+        V + DFG   +     + R         + GT  + +   
Sbjct: 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPEV 187

Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG------LKAATKKQKYDKICEKKVSTPIE 238
                   + D+ SLG + +  + G  P+        L         +    +K+S    
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247

Query: 239 VLCKS 243
                
Sbjct: 248 DFLNR 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-28
 Identities = 51/268 (19%), Positives = 89/268 (33%), Gaps = 19/268 (7%)

Query: 4   IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
           II       + +G G  G++    +  T E  A+K+       P+   E +++       
Sbjct: 9   IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCP 65

Query: 64  GIPNIKWYGVDGEDN----VLVLDLL-GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIE 117
            I  I     +        ++V++ L G  L         + F+ +    +   +   I+
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           Y+HS    HRD+KP+N L    R    + + DFG AK+     +     Y        T 
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TP 177

Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL-KAATKKQKYDKICEKKVSTP 236
            Y +       +  +  D+ SLG ++   L G  P+      A       +I   +   P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP 264
                     E              QR 
Sbjct: 238 NP-EWSEVSEEVKMLIRNLLKTEPTQRM 264

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 20/234 (8%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
           + L + +G GSFG++FLA    TN+  A+K   ++       +       ++L      P
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 67  NI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
            +   +        L   +    G  L    +    KF L      A ++I  ++++HS+
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYH-IQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
           G ++RD+K DN L+    K   + I DFG+ K+        +          GT  Y + 
Sbjct: 123 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAP 172

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
              LG + +   D  S G +L   L G  P+ G     +++ +  I       P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFYP 223

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  111 bits (278), Expect = 3e-28
 Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 16/278 (5%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
            Y+L RK+G G + E+F A ++  NE V VKI     K  ++  E K+ + L+GG  I  
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIIT 94

Query: 68  IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
           +     D       L     +  D     +   +   +     +++  ++Y HS G +HR
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-LTDYDIRFYMYEILKALDYCHSMGIMHR 153

Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
           D+KP N +  +  +  ++ +ID+GLA+ Y                   +  +      + 
Sbjct: 154 DVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203

Query: 188 IEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246
            +      D+ SLG +L   +    P+          +  +I +   +  +      +  
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
           E    F+        +R +        H + S E  DF
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLV-SPEALDF 298

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (276), Expect = 5e-28
 Identities = 51/261 (19%), Positives = 100/261 (38%), Gaps = 18/261 (6%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
            Y     +G+G+F E+ LA    T ++VA+K    +    K   +  E  V   ++    
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPN 68

Query: 65  IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           I  +      G    L++ L+ G  L D  +  +  ++ +    L  Q++  ++Y+H  G
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFD-RIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
            +HRD+KP+N L     + +++ I DFGL+K     +              GT  Y +  
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYVAPE 179

Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
                  S+  D  S+G +    L G  P+         + +++I + +           
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSPYW-DD 235

Query: 244 HPAEFASYFHYCQSLTFDQRP 264
                  +  +      ++R 
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRF 256

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 1e-27
 Identities = 55/273 (20%), Positives = 95/273 (34%), Gaps = 33/273 (12%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
            Y++   IG+GS+G           +I+  K       +  +   L+ E  + + L+   
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HP 63

Query: 64  GIPNIKWYGVDGEDNV--LVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIE 117
            I       +D  +    +V++   G  L  +     ++      + VL +  Q+   ++
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 118 YVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
             H R       LHRD+KP N  +        V + DFGLA+     T+         K 
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KA 173

Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
             GT  Y S      +  + + D+ SLG +L        P+      ++K+   KI E K
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGK 230

Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
                         E         +L    RP 
Sbjct: 231 FRRIPYRY----SDELNEIITRMLNLKDYHRPS 259

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-27
 Identities = 64/277 (23%), Positives = 119/277 (42%), Gaps = 27/277 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIP 66
             +L  K+G G FGE+++ +   T   VA+K    GT  P+  L EA+V K L+      
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----E 72

Query: 67  NI-KWYGVDGEDNVLVL--DLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSR 122
            + + Y V  E+ + ++   +   SL D       K+  L  ++ +A Q+ + + YV   
Sbjct: 73  KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
            ++HRD++  N L+G   +     + DFGLA+   D        Y   +      ++ + 
Sbjct: 133 NYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAP 183

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
              L    + + D+ S G +L     +G +P+ G+     ++  D++ E+    P    C
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC 239

Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
              P         C     ++RP + +L+    D F+
Sbjct: 240 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  108 bits (270), Expect = 7e-27
 Identities = 54/239 (22%), Positives = 91/239 (38%), Gaps = 20/239 (8%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
           + + R IG G FGE++     DT ++ A+K                L E  +  ++  G 
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 64  --GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              I  + +     +    +LDL+        +     FS   +   A ++I  +E++H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           R  ++RD+KP N L+    +   V I D GLA  +     +  +         GT  Y +
Sbjct: 126 RFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMA 173

Query: 182 CNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
                 G+      D  SLG +L   LRG  P++  K   K +         V  P   
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 1e-26
 Identities = 49/266 (18%), Positives = 94/266 (35%), Gaps = 26/266 (9%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
            K   +IG GSF  ++     +T   VA       + + ++  +   EA++ K LQ  + 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 65  IPNIKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           +     +    +     VLV +L+       ++   +   +K +     Q++  ++++H+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 122 RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
           R    +HRD+K DN    +      V I D GLA   R             K + GT  +
Sbjct: 131 RTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGTPEF 179

Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
            +   +   +     D+ + G  +L       P+         Q Y ++         + 
Sbjct: 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFD- 235

Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPD 265
             K    E       C     D+R  
Sbjct: 236 --KVAIPEVKEIIEGCIRQNKDERYS 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-26
 Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 30/274 (10%)

Query: 4   IIGVK-YKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-----ENSGTKHPQLLYEAK 54
           +IG K  +L  K+G GSFG +        +     VAVK       +        + E  
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 55  VYKILQGGSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQ 111
               L       N+ + YGV     + +V +L    SL D     +  F L T+   A Q
Sbjct: 64  AMHSLDH----RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
           +   + Y+ S+ F+HRD+   N L+      + V I DFGL +       +    Y   +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQE 172

Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICE 230
           +      + +  +      S   D    G  L      G  PW GL      Q   KI +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDK 229

Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
           +    P    C   P +  +    C +   + RP
Sbjct: 230 EGERLPRPEDC---PQDIYNVMVQCWAHKPEDRP 260

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-26
 Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 39/295 (13%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
           +R   V Y   + IG+GSFG ++ A   D+ E+VA+K      +      E ++ + L  
Sbjct: 15  DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDH 72

Query: 62  GSGIPNIKWYGVDGEDN-----VLVLDLLGPS-LEDLFVYCRRK--FSLKTVLMLADQMI 113
            + +    ++   GE        LVLD +  +       Y R K    +  V +   Q+ 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRE 169
             + Y+HS G  HRDIKP N    L      + + DFG AK+        +      YR 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
            + + G   Y           +   D+ S G VL   L G   + G    +   +  +I 
Sbjct: 191 PELIFGATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEII 236

Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
           +   +   E + + +P      F   ++  +          ++F      E    
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPW---------TKVFRPRTPPEAIAL 282

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 5e-26
 Identities = 57/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)

Query: 13  RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIP 66
           +++GSG+FG +    +      + VAVKI  +    P    +LL EA V + L      P
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68

Query: 67  NI-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
            I +  G+ + E  +LV+++      + ++   R    K ++ L  Q+   ++Y+    F
Sbjct: 69  YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+   N L+      +   I DFGL+K  R         Y+   +     ++ +   
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181

Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
               + S + D+ S G ++      G  P++G+K +      +K   +++  P       
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GERMGCPAGC---- 235

Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
            P E     + C +   + RP +  ++    + +
Sbjct: 236 -PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (261), Expect = 6e-26
 Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 28/236 (11%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
           +++ R +G+GSFG + L          A+K+          +      E  +  I+    
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-- 63

Query: 64  GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
             P I + +G   D +   +++D +        +   ++F        A ++   +EY+H
Sbjct: 64  --PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121

Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
           S+  ++RD+KP+N L+    K   + I DFG AK   D T            L GT  Y 
Sbjct: 122 SKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYI 168

Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
           +         ++  D  S G ++   L G  P+     +   + Y+KI   ++  P
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFP 221

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (263), Expect = 6e-26
 Identities = 57/297 (19%), Positives = 114/297 (38%), Gaps = 32/297 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
           ++   + +G+GSFG + L  H ++    A+KI          +    L E ++ + +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100

Query: 63  SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
             +  +++   D  +  +V++ +        +    +FS       A Q++   EY+HS 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             ++RD+KP+N L+        + + DFG AK+ +  T              GT    + 
Sbjct: 161 DLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
              L    ++  D  +LG ++     G  P+         Q Y+KI   KV  P      
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSGKVRFPSHF--- 261

Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQTQ 299
              ++          L  D    +G LK   +D+ + +   +    DW  +  ++ +
Sbjct: 262 --SSDLKDLLRNL--LQVDLTKRFGNLKNGVNDIKNHK---WFATTDWIAIYQRKVE 311

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-25
 Identities = 56/281 (19%), Positives = 109/281 (38%), Gaps = 31/281 (11%)

Query: 13  RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPN 67
            ++G G+FG +    +    +   VA+K+   GT+     +++ EA++   L      P 
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70

Query: 68  I-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
           I +  GV   + + LV+++  G  L    V  R +  +  V  L  Q+   ++Y+  + F
Sbjct: 71  IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130

Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
           +HRD+   N L+      +   I DFGL+K      +                ++ +   
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183

Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
               + S R D+ S G  +   L  G  P++ +      +    I + K           
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGKRMECPPEC--- 237

Query: 244 HPAEFASYFHYCQSLTFDQRPDYG----FLKRLFHDLFSRE 280
            P E  +    C    ++ RPD+      ++  ++ L S+ 
Sbjct: 238 -PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-25
 Identities = 53/289 (18%), Positives = 99/289 (34%), Gaps = 46/289 (15%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEI-----VAVKI---ENSGTKHPQLLYEAKVYKIL 59
             + G+ +GSG+FG++  A+    ++      VAVK+   +   ++   L+ E K+   L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS----------------- 101
                I N+           L+ +      L +     R KFS                 
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 102 -----LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
                 + +L  A Q+   +E++  +  +HRD+   N L+        V I DFGLA+  
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDI 214

Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 215
              +      Y    N     ++ +  +      + + D+ S G +L      G  P+ G
Sbjct: 215 MSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269

Query: 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
           +        + K+ +                E       C +    +RP
Sbjct: 270 I---PVDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRP 312

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-25
 Identities = 57/280 (20%), Positives = 99/280 (35%), Gaps = 33/280 (11%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
           + KL + IG G FG++ L  +      VAVK   +       L EA V   L+      N
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----SN 61

Query: 68  I-KWYGVDGEDN---VLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           + +  GV  E+     +V + +   SL D L    R       +L  +  +   +EY+  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
             F+HRD+   N L+    + N   + DFGL K+                      ++ +
Sbjct: 122 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTA 168

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
                  + S + D+ S G +L      G +P+  +     K    ++ +       +  
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPDGC 225

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
               P         C  L    RP +  L+     + + E
Sbjct: 226 ----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-25
 Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 30/283 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
           + +LGR IG G FG++    ++        VA+K      S +   + L EA   +    
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 62  GSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               P+I K  GV  E+ V ++++L     L       +    L ++++ A Q+   + Y
Sbjct: 68  ----PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           + S+ F+HRDI   N L+      + V + DFGL++   D T      Y +        +
Sbjct: 124 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDST------YYKASKGKLPIK 174

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
           + +  +      +   D+   G  +   L  G  P+QG+       K + +  +  +   
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGER 227

Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
             +  + P    S    C +    +RP +  LK     +   E
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (253), Expect = 5e-25
 Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 25/277 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
              +  K+G G +GE++       +  VAVK ++    +  + L EA V K ++     P
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 73

Query: 67  NI-KWYGVDGEDNVLVLDL----LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
           N+ +  GV   +    +       G  L+ L    R++ S   +L +A Q+ + +EY+  
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           + F+HRD+   N L+G   + + V + DFGL++     T   H   +         ++ +
Sbjct: 134 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTA 184

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
             +    + S + D+ + G +L       +            +  ++ EK         C
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRMERPEGC 241

Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
              P +       C       RP +  + + F  +F 
Sbjct: 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 6e-25
 Identities = 53/269 (19%), Positives = 95/269 (35%), Gaps = 28/269 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
            Y  G ++GSG F  +       T    A K            G     +  E  + K +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
           Q     PN+   + V  +  D +L+L+L+       F+  +   + +       Q++  +
Sbjct: 71  QH----PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 117 EYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
            Y+HS    H D+KP+N ++        ++ IIDFGLA K       ++I         G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178

Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
           T  + +             D+ S+G +    L G+ P+ G    TK++    +       
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVNYEF 235

Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
             E    +  A    +          +R 
Sbjct: 236 EDEYF-SNTSALAKDFIRRLLVKDPKKRM 263

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 8e-25
 Identities = 53/285 (18%), Positives = 101/285 (35%), Gaps = 30/285 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
           +Y+   +IG G++G++F A  + +    VA+K               + E  V + L+  
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 63  SGIPNIKWYGVDGEDNVLVLDLL--------GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
                ++ + V           L              L          +T+  +  Q++ 
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            ++++HS   +HRD+KP N L+     + Q+ + DFGLA+ Y        +         
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV--------V 176

Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
            T  Y +    L    +   DL S+G +     R    ++G   ++   +  KI    + 
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKIL-DVIG 232

Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
            P E       A     FH   +   ++      +  L  DL  +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD--IDELGKDLLLK 275

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 59/291 (20%), Positives = 94/291 (32%), Gaps = 33/291 (11%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
           +G +Y     IG G++G +  A        VA+K        T   + L E K+    + 
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 62  GSGIPNI-KWYGV-------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
                NI     +         +D  LV  L+G  L  L     +  S   +     Q++
Sbjct: 66  ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQIL 119

Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
             ++Y+HS   LHRD+KP N L+        + I DFGLA+       +           
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
              A     N       ++  D+ S+G +L   L     + G        + + I     
Sbjct: 177 WYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGILG 230

Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
           S   E L                 L      +     RLF +    +  D 
Sbjct: 231 SPSQEDL------NCIINLKARNYLLSLPHKNKVPWNRLFPNA-DSKALDL 274

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.8 bits (248), Expect = 2e-24
 Identities = 45/272 (16%), Positives = 98/272 (36%), Gaps = 21/272 (7%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKV 55
           + I     K+ + IG+G FGE+         +    VA+K      +  +    L EA +
Sbjct: 21  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80

Query: 56  YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
                    + +++         +++ + +   SL+        +F++  ++ +   + A
Sbjct: 81  MGQFDH-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            ++Y+    ++HRD+   N L+          + DFGL++   D T++    Y       
Sbjct: 140 GMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGK 194

Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKV 233
              R+ +       + +   D+ S G V+   +  G  P+  +   T +   + I +   
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYR 251

Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
             P        P+        C     + RP 
Sbjct: 252 LPPPM----DCPSALHQLMLDCWQKDRNHRPK 279

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 99.6 bits (247), Expect = 3e-24
 Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 29/281 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
           KY    KIG G++G ++ A + +  E  A+K     +         + E  + K L+  S
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-S 60

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
            I  +       +  VLV + L   L+ L   C       T      Q++  I Y H R 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYRENKNLTGTAR 178
            LHRD+KP N L+    +  ++ I DFGLA+ +  P          + YR    L G+ +
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
           Y           S   D+ S+G +    + G+  + G    ++  +  +I  + + TP  
Sbjct: 178 Y-----------STTIDIWSVGCIFAEMVNGTPLFPG---VSEADQLMRIF-RILGTPNS 222

Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
               +         ++              L     DL S+
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.9 bits (248), Expect = 3e-24
 Identities = 51/265 (19%), Positives = 95/265 (35%), Gaps = 24/265 (9%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQG 61
           +K  + +GSG+FG ++    +   E V + +         S   + ++L EA V   +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 62  GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
              +  +    +     ++   +    L D     +     + +L    Q+   + Y+  
Sbjct: 71  -PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
           R  +HRD+   N L+        V I DFGLAK         H      +      ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181

Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
             + L    + + D+ S G  +   +  GS P+ G+ A     +   I EK    P   +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKGERLPQPPI 237

Query: 241 CKSHPAEFASYFHYCQSLTFDQRPD 265
           C     +       C  +  D RP 
Sbjct: 238 C---TIDVYMIMVKCWMIDADSRPK 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 8e-24
 Identities = 49/263 (18%), Positives = 99/263 (37%), Gaps = 27/263 (10%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
               +++G+G FG +           VA+K I+       + + EAKV   L        
Sbjct: 6   LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH----EK 60

Query: 68  I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           + + YGV        ++ + +    L +     R +F  + +L +   +   +EY+ S+ 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
           FLHRD+   N L+        V + DFGL++   D        Y  +       R++   
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPE 171

Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
             +  + S + D+ + G ++      G +P++     T  +  + I +        +   
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLRLYRPHLA-- 226

Query: 243 SHPAEFASYFHYCQSLTFDQRPD 265
               +  +  + C     D+RP 
Sbjct: 227 --SEKVYTIMYSCWHEKADERPT 247

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 1e-23
 Identities = 49/248 (19%), Positives = 106/248 (42%), Gaps = 23/248 (9%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKI------ENSGTKHPQLLYE 52
           E++    ++L + +G+G++G++FL   +   DT ++ A+K+                  E
Sbjct: 19  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78

Query: 53  AKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
            +V + ++    +  + +         L+LD +        +  R +F+   V +   ++
Sbjct: 79  RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138

Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
           +  +E++H  G ++RDIK +N L+        V + DFGL+K++    T R   +     
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC---- 191

Query: 173 LTGTARYASCNTHLGIEQ--SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
             GT  Y + +   G +    +  D  SLG ++   L G+ P+       +K    +I  
Sbjct: 192 --GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISR 246

Query: 231 KKVSTPIE 238
           + + +   
Sbjct: 247 RILKSEPP 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 97.2 bits (241), Expect = 2e-23
 Identities = 58/302 (19%), Positives = 102/302 (33%), Gaps = 53/302 (17%)

Query: 8   KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
             +  R IG G+FG +F A        +   +VAVK+   E S         EA +    
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------------FVY 95
              + +  +      G+   L+ + +    L +                           
Sbjct: 74  DNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 96  CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
                S    L +A Q+ A + Y+  R F+HRD+   N L+G   +   V I DFGL++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRN 189

Query: 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQ 214
                      Y+ + N     R+    +      +   D+ + G VL      G  P+ 
Sbjct: 190 IYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244

Query: 215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----FLK 270
           G+     ++    + +  +    E    + P E  +    C S     RP +      L+
Sbjct: 245 GM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

Query: 271 RL 272
           R+
Sbjct: 298 RM 299

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 98.2 bits (243), Expect = 3e-23
 Identities = 64/310 (20%), Positives = 106/310 (34%), Gaps = 37/310 (11%)

Query: 2   ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQ 60
           E     +Y L RK+G G F  ++LA  +  N  VA+K +            E K+ + + 
Sbjct: 8   EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67

Query: 61  ----------GGSGIPNIKWYGVDGEDNVLVLDLLG-----PSLEDLFVYCRRKFSLKTV 105
                     G + I  +  +      N + + ++        L  +  Y  R   L  V
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 106 LMLADQMIARIEYV-HSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTT 161
             ++ Q++  ++Y+    G +H DIKP+N LM          Q+ I D G A  Y +  T
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
           N             T  Y S    LG       D+ S   ++   + G   ++  +  + 
Sbjct: 188 NSI----------QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237

Query: 222 KQKYD---KICEKKVSTPIEVLCKSHPAEF----ASYFHYCQSLTFDQRPDYGFLKRLFH 274
            +  D   +I E     P  +L                     L F    D    K  F 
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297

Query: 275 DLFSREGYDF 284
              ++E  DF
Sbjct: 298 KDEAKEISDF 307

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (239), Expect = 3e-23
 Identities = 59/282 (20%), Positives = 101/282 (35%), Gaps = 27/282 (9%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
           KY+   KIG G++G +F A + +T+EIVA+K     ++        L E  + K L+   
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HK 61

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
            I  +       +   LV +     L+  F  C      + V     Q++  + + HSR 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
            LHRD+KP N L+    +  ++ + +FGLA+ +  P                T  Y   +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYS-------AEVVTLWYRPPD 171

Query: 184 THLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
              G +  S   D+ S G +         P           +  +I     +   E    
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEE---- 225

Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
               ++ S         +   P    L  +   L +  G D 
Sbjct: 226 ----QWPSMTKLPDYKPYPMYPATTSLVNVVPKL-NATGRDL 262

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 3e-23
 Identities = 50/284 (17%), Positives = 92/284 (32%), Gaps = 39/284 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
           +   G+ +G+G+FG++  A        D    VAVK+       T+   L+ E KV   L
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 60  QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------FVYCRRKFS 101
                I N+      G   +++ +      L +                           
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
           L+ +L  + Q+   + ++ S+  +HRD+   N L+          I DFGLA+  ++ + 
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSN 200

Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
                Y    N     ++ +  +      +   D+ S G  L                  
Sbjct: 201 -----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPV 253

Query: 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
             K+ K+ ++             PAE       C      +RP 
Sbjct: 254 DSKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPT 294

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 5e-23
 Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 38/261 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
            Y+  + +GSG++G +  A    T   VA+K       S     +   E ++ K ++   
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-- 76

Query: 64  GIPNI-KWYGVDGEDN--------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
              N+     V   D          LV+  +G  L  L      K     +  L  QM+ 
Sbjct: 77  --ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLK 132

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR--HIPYRENKN 172
            + Y+H+ G +HRD+KP N  +    +  ++ I+DFGLA++     T       YR  + 
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189

Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
           +    RY           ++  D+ S+G ++   + G   ++G   +    +  +I +  
Sbjct: 190 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKG---SDHLDQLKEIMKVT 235

Query: 233 VSTPIEVLCKSHPAEFASYFH 253
            + P E + +    E  +Y  
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMK 256

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.5 bits (239), Expect = 8e-23
 Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 43/291 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
           +Y+    +GSG++G +  A    T   VAVK       S     +   E ++ K ++   
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-- 76

Query: 64  GIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
              N+              +  D  LV  L+G  L ++     +K +   V  L  Q++ 
Sbjct: 77  --ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILR 132

Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
            ++Y+HS   +HRD+KP N  +    +  ++ I+DFGLA+   D  T             
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA--------- 180

Query: 175 GTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
            T  Y +    L     ++  D+ S+G ++   L G   + G        +   I     
Sbjct: 181 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVG 236

Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDF 284
           +   E+L K       +Y       +  Q P   F         +    D 
Sbjct: 237 TPGAELLKKISSESARNYIQ-----SLTQMPKMNFANVFIG--ANPLAVDL 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 1e-22
 Identities = 53/277 (19%), Positives = 95/277 (34%), Gaps = 19/277 (6%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
            ++   KIG G++G ++ A +  T E+VA+K       +       + E  + K L    
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61

Query: 64  GIPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSR 122
            I  +           LV + L   L+            L  +     Q++  + + HS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             LHRD+KP N L+        + + DFGLA+ +  P             +      A  
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172

Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
                   S   D+ SLG +    +     + G    ++  +  +I  + + TP EV+  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIF-RTLGTPDEVVWP 228

Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
              +       + +    D       L      L S+
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 2e-22
 Identities = 51/263 (19%), Positives = 99/263 (37%), Gaps = 27/263 (10%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
               ++IGSG FG + L   ++ ++ VA+K I          + EA+V   L      P 
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PK 61

Query: 68  I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
           + + YGV  +     LV + +    L D     R  F+ +T+L +   +   + Y+    
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
            +HRD+   N L+    +   + + DFG+ +   D         +         ++AS  
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPE 172

Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
                  S + D+ S G ++      G +P++     +  +  + I           L  
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDI-STGFRLYKPRLAS 228

Query: 243 SHPAEFASYFHYCQSLTFDQRPD 265
           +H  +  +   +C     + RP 
Sbjct: 229 THVYQIMN---HCWKERPEDRPA 248

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 5e-22
 Identities = 56/290 (19%), Positives = 113/290 (38%), Gaps = 30/290 (10%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
           +Y+  + IGSG+ G +  A     +  VA+K       + T   +   E  + K +   +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 64  -----GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
                 +   +    + +D  LV++L+  +L       + +   + +  L  QM+  I++
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKH 134

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           +HS G +HRD+KP N ++   +    + I+DFGLA+                     T  
Sbjct: 135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VVTRY 183

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
           Y +    LG+      D+ S+G ++   +R  + + G        +++K+ E+  +   E
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTPCPE 240

Query: 239 VLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK--RLFHDLFSREGYDF 284
            + K  P    +         LTF +             + L + +  D 
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 8e-22
 Identities = 56/278 (20%), Positives = 91/278 (32%), Gaps = 30/278 (10%)

Query: 13  RKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQGGSGI 65
             +G G F  ++ A   +TN+IVA+K        E     +   L E K+ + L      
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59

Query: 66  PNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
           PNI       G  +   LV D +   LE +        +   +       +  +EY+H  
Sbjct: 60  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
             LHRD+KP+N L+    +   + + DFGLAK +  P            +   T  Y + 
Sbjct: 120 WILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYT-------HQVVTRWYRAP 169

Query: 183 NTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
               G        D+ ++G +L   L       G    +   +  +I E   +   E   
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWP 226

Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
                     F     +                DL   
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLDLIQG 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 3e-21
 Identities = 44/280 (15%), Positives = 98/280 (35%), Gaps = 30/280 (10%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNE----IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
               + IG+G FGE++      ++      VA+K      +  +    L EA +      
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 62  GSGIPNI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
                NI +  GV  +   +++        +L+        +FS+  ++ +   + A ++
Sbjct: 69  ----HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
           Y+ +  ++HRD+   N L+          + DFGL++   D     +             
Sbjct: 125 YLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPI 177

Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-KVSTP 236
           R+ +       + +   D+ S G V+   +            +  +    I +  ++ TP
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLPTP 235

Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
           ++      P+        C      +RP +  +  +   L
Sbjct: 236 MDC-----PSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.0 bits (225), Expect = 3e-21
 Identities = 49/279 (17%), Positives = 85/279 (30%), Gaps = 40/279 (14%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
            K    IG G+FG++  A        +   I       S   H     E +V   L    
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 64  GIPNIKWYGVDGEDNVLVLDLL-GPSLEDL---------------FVYCRRKFSLKTVLM 107
            I N+           L ++     +L D                        S + +L 
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
            A  +   ++Y+  + F+HRD+   N L+G   +     I DFGL++             
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG-- 186

Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYD 226
                     R+ +  +      +   D+ S G +L   +  G  P+ G+   T  + Y+
Sbjct: 187 ------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYE 237

Query: 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
           K+ +                E       C      +RP 
Sbjct: 238 KLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPS 272

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 2e-20
 Identities = 49/282 (17%), Positives = 101/282 (35%), Gaps = 23/282 (8%)

Query: 7   VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKHP---QLLYEAKVYKILQ 60
           +       IG G FG ++  + +D +      AVK  N  T      Q L E  + K   
Sbjct: 27  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86

Query: 61  GGSGIPNIKWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
               + ++    +  E +  +VL  +    L +         ++K ++    Q+   +++
Sbjct: 87  H-PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
           + S+ F+HRD+   N ++    +   V + DFGLA+   D   +               +
Sbjct: 146 LASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVK 199

Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
           + +  +    + + + D+ S G +L   + RG+ P+  +           + + +     
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQGRRLLQP 256

Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
           E      P         C     + RP +  L      +FS 
Sbjct: 257 EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 3e-20
 Identities = 52/285 (18%), Positives = 103/285 (36%), Gaps = 42/285 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI---ENSGTKHPQLLYEAKVYK 57
           +  LG+ +G G+FG++ LA  +  ++        VAVK+   + +      L+ E ++ K
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 58  ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFS 101
           ++     I N+           ++++     +L +     R                + S
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
            K ++  A Q+   +EY+ S+  +HRD+   N L+    + N + I DFGLA+       
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 190

Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 220
            +        N     ++ +         + + D+ S G +L      G  P+ G+    
Sbjct: 191 YKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---P 242

Query: 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
            ++ +  + E                E       C      QRP 
Sbjct: 243 VEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPT 283

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 3e-20
 Identities = 72/311 (23%), Positives = 105/311 (33%), Gaps = 45/311 (14%)

Query: 5   IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
           I     L   IG G FGE++        E VAVKI +S  +      EA++Y+ +     
Sbjct: 1   IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRH- 56

Query: 65  IPNI-KWYGVDGEDNV------LVLDLL-GPSLED------LFVYCRRKFSLKTVLMLAD 110
             NI  +   D +DN       LV D     SL D      + V    K +L T   LA 
Sbjct: 57  -ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 115

Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
             +  +         HRD+K  N L+    K     I D GLA ++   T    I     
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP--- 169

Query: 171 KNLTGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG--------- 215
            +  GT RY               E  +R D+ ++G V     R                
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229

Query: 216 ---LKAATKKQKYDKICEKKVSTPIEVLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK 270
                  + ++    +CE+K+   I    +S  A    A     C       R     +K
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

Query: 271 RLFHDLFSREG 281
           +    L  +EG
Sbjct: 290 KTLSQLSQQEG 300

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.5 bits (213), Expect = 1e-19
 Identities = 58/295 (19%), Positives = 104/295 (35%), Gaps = 40/295 (13%)

Query: 8   KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
           + KLG+ +G G+FG++  A         T   VAVK+   G  H +        KIL   
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 63  SGIPNIK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
               N+             L++ +      +L  Y R K                   +L
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
           + ++  + Q+   +E++ SR  +HRD+   N L+    + N V I DFGLA+        
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD- 189

Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK 221
               Y    +     ++ +  T      + + D+ S G +L       + P+ G+K    
Sbjct: 190 ----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 243

Query: 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
            +++ +  ++               E       C      QRP +  L     +L
Sbjct: 244 -EEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.1 bits (212), Expect = 2e-19
 Identities = 57/304 (18%), Positives = 109/304 (35%), Gaps = 45/304 (14%)

Query: 8   KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
           K  + R++G GSFG ++          +    VA+K      S  +  + L EA V K  
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 60  QGGSGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRR---------KFSLKTVL 106
                  ++ +  GV   G+  +++++L+    L+      R            SL  ++
Sbjct: 81  NC----HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
            +A ++   + Y+++  F+HRD+   N ++    +   V I DFG+ +   +        
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY----- 188

Query: 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKY 225
           YR+        R+ S  +      +   D+ S G VL         P+QGL   + +Q  
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVL 245

Query: 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG----FLKRLFHDLFSREG 281
             + E  +    +      P         C       RP +      +K      F    
Sbjct: 246 RFVMEGGLLDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301

Query: 282 YDFD 285
           + + 
Sbjct: 302 FYYS 305

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.8 bits (196), Expect = 4e-18
 Identities = 28/183 (15%), Positives = 61/183 (33%), Gaps = 32/183 (17%)

Query: 9   YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------KHPQLLYEAKV- 55
             +G+ +G G    +F     +      VK    G                     A   
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 56  ----YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
               ++ LQ   G+   K Y  +   N +++       E +      +  ++    + D 
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWE--GNAVLM-------ELIDAKELYRVRVENPDEVLDM 111

Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
           ++  +   + RG +H D+   N L+        ++IIDF  + +  +      +  R+ +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREIL-ERDVR 166

Query: 172 NLT 174
           N+ 
Sbjct: 167 NII 169

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	423
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.54
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.25
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.39
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.12
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.11

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-61  Score=462.54  Aligned_cols=297  Identities=69%  Similarity=1.235  Sum_probs=266.9

Q ss_pred             CCcccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEE
Q 014527            1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus         1 ~~~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~l   80 (423)
                      |+.-+|++|++++.||+|+||+||+|++..+++.||||++.......++..|+++++.++|+++++.+..++.+....++
T Consensus         1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            77789999999999999999999999999999999999988877778899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        81 v~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||||++++|.+.+....+.+++..++.++.||+.||+|||++|||||||||+|||++..+.+..+||+|||+|+.+....
T Consensus        81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            99999999999988878889999999999999999999999999999999999999766667889999999999988766


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .....+++......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..........+.+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence            65555666667889999999999999999999999999999999999999999987766666666666666777778888


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecccch
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILKYQQ  297 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~  297 (423)
                      +..+|+++.+||..||+.+|++||++++|.++|++++.+.++.++..|||+.+++..
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~~  297 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGA  297 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGTC
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCCC
Confidence            889999999999999999999999999999999999999999999999999887644

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3e-60  Score=451.13  Aligned_cols=291  Identities=57%  Similarity=0.994  Sum_probs=265.6

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|++++|++++.||+|+||+||+|++..+++.||||++........+.+|++++..|.|+++++.+..++......++||
T Consensus         1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            47899999999999999999999999999999999998877777789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC--CCCcEEEeeccceeeecCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~--~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||++++|.+++......++..++..++.|++.||+|||++||+||||||+|||++...  ..+.+||+|||+|+.+....
T Consensus        81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            9999999999988777899999999999999999999999999999999999996322  35789999999999987766


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .....+.+......||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+.++...+...+...+
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  240 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence            66666666677889999999999999999999999999999999999999999987766666677777777777778888


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                      +..+|+++.+++..||..+|++||+++.|.+.|++++.+.+...+..|||+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~  293 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL  293 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence            88999999999999999999999999999999999999999999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=406.05  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=210.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++++.||+|+||+||+|+++.+++.||||++..     ......+.+|+++++.++| ++|..+..++.+.+..|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEECCEEEEE
Confidence            579999999999999999999999999999998752     3345568899999999987 5677777778888999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||| +|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+......
T Consensus        85 mEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC
T ss_pred             EeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc
Confidence            9999 7899999875 4579999999999999999999999999999999999999   478899999999997654332


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                               .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..   +.+..+.......|    
T Consensus       161 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~p----  224 (263)
T d2j4za1         161 ---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEFTFP----  224 (263)
T ss_dssp             ---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC----
T ss_pred             ---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence                     12568999999999999999999999999999999999999999875433   44555555554443    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ..+|+++.+||.+||+.||++|||++++++
T Consensus       225 -~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 -DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             346899999999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-55  Score=412.68  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=219.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      ...+|++++.||+|+||+||+|+++.+++.||||++..     ......+.+|+++++.++| ++|..+..++.+.+..|
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECSSEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEECCEEE
Confidence            34679999999999999999999999999999998753     2344568999999999987 56667777777889999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||| +|+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+   ++++.+||+|||+|+.+..
T Consensus        85 ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC-
T ss_pred             EEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceeccc
Confidence            999999 7899998775 5679999999999999999999999999999999999999   5788999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                      .....     ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.   .+.+.++.......|  
T Consensus       161 ~~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~~~~p--  230 (288)
T d1uu3a_         161 ESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKIIKLEYDFP--  230 (288)
T ss_dssp             --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTTCCCCC--
T ss_pred             CCccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHHHHHHcCCCCCC--
Confidence            33211     12356799999999999999999999999999999999999999987543   345556665555444  


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCCCCcceeceecc
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYDFDFVFDWTILK  294 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~  294 (423)
                         ..+++++++||.+||+.||++|||++|+... ..+.   .+.|...+||..+.
T Consensus       231 ---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~-~~i~---~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         231 ---EKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPLK---AHPFFESVTWENLH  279 (288)
T ss_dssp             ---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH-HHHH---TSGGGTTCCCTTGG
T ss_pred             ---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC-HHHH---cCCccCCCCHHHhh
Confidence               4568999999999999999999999998653 2222   24565667886553

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=408.46  Aligned_cols=247  Identities=22%  Similarity=0.313  Sum_probs=207.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~--~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...  ...+.+.+|+++++.++| ++|..+..++.+.+..||||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEECCEEEEEEEe
Confidence            5899999999999999999999999999999987643  344568999999999987 5666777777788999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      | +|+|.+++..  +.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.+...... 
T Consensus        99 ~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~-  172 (293)
T d1yhwa1          99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-  172 (293)
T ss_dssp             CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCC-
T ss_pred             cCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeecccccc-
Confidence            9 8899987753  569999999999999999999999999999999999999   47889999999999887543321 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....   .+..+........  .....
T Consensus       173 ------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~~~~--~~~~~  241 (293)
T d1yhwa1         173 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATNGTPEL--QNPEK  241 (293)
T ss_dssp             ------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHHCSCCC--SSGGG
T ss_pred             ------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHHHHhCCCCCC--CCccc
Confidence                  235689999999999999999999999999999999999999998755432   2223332221111  12245


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +++++++||.+||..||++||+++++++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            6899999999999999999999999854

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-54  Score=411.13  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=200.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      +.++|++.+.||+|+||+||+|+++.+++.||||++....   ....+.+|+.+++.++| ++|..+..++.+.+..|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEE
Confidence            4678999999999999999999999999999999886543   23457899999999986 6677777777888999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||| +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+...++++.+||+|||+|+......
T Consensus        86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            9999 7999999875 5679999999999999999999999999999999999999755567899999999998664432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .        ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....   +.+..+.......+.+ .
T Consensus       165 ~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~  232 (307)
T d1a06a_         165 V--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILKAEYEFDSP-Y  232 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHTTCCCCCTT-T
T ss_pred             e--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCCCCCc-c
Confidence            2        22567999999999999999999999999999999999999999875443   4445555555444322 3


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...+|+++.+||.+||..||++||+++++++
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            3567899999999999999999999999866

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=405.57  Aligned_cols=251  Identities=27%  Similarity=0.320  Sum_probs=205.2

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~---~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      -++|++++.||+|+||+||+|+++.+++.||||++....   ..+.+.+|+++++.++| ++|..+..++.+.+..||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccCceeEEEE
Confidence            468999999999999999999999999999999986543   23458999999999987 56777777778899999999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||| +|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.......
T Consensus        83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred             eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCc
Confidence            999 7899998753 4579999999999999999999999999999999999999   4778999999999987654332


Q ss_pred             CCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      ..     .....+||+.|||||++.+..+ +.++|||||||+||||++|+.||.......  ..+..+.......   ..
T Consensus       159 ~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~~---~~  228 (271)
T d1nvra_         159 ER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL---NP  228 (271)
T ss_dssp             EC-----CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTTS---TT
T ss_pred             cc-----cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCC---Cc
Confidence            11     2235689999999999998876 678999999999999999999997644322  2222222222221   12


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...+++++.+||.+||+.||++||+++++++
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3456899999999999999999999998854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=405.91  Aligned_cols=249  Identities=17%  Similarity=0.296  Sum_probs=208.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      +.|++++.||+|+||+||+|+++.+++.||||++....  ..+.+.+|+++++.++| ++|..+..++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCeEEEEEec
Confidence            46999999999999999999999999999999987543  33568999999999987 5677777777888999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      | +|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+.......  
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~--  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ--  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence            9 889999887767789999999999999999999999999999999999999   4788999999999976543211  


Q ss_pred             cccccCCCcccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHH
Q 014527          164 HIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE  238 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (423)
                           ......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.+.+..   +.+.++.......  .
T Consensus       166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~~~~~--~  235 (288)
T d2jfla1         166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKSEPPT--L  235 (288)
T ss_dssp             -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHSCCCC--C
T ss_pred             -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCC--C
Confidence                 122568999999999984     455899999999999999999999999876544   3344444433211  1


Q ss_pred             HhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       239 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....+|+++.+||.+||+.||++|||+++|++
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            122456899999999999999999999998854

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-54  Score=402.69  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=205.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      |-.++|++.+.||+|+||+||+|++   +..||||+++....    .+.+.+|+.++..++|+ +|..+..+. .....+
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~~~~~~-~~~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV-NILLFMGYS-TAPQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCT-TBCCEEEEE-CSSSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCC-CEeeeeEEE-eccEEE
Confidence            4568899999999999999999985   34599999864432    24588999999999874 455565554 345689


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||| +|+|.+++......+++..++.|+.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+....
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC---
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeeccc
Confidence            999999 7899999987667899999999999999999999999999999999999994   789999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      .....     ......||+.|||||++.+.   .++.++|||||||+||||+||+.||.+.....  .....+.......
T Consensus       157 ~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~p  229 (276)
T d1uwha_         157 WSGSH-----QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSP  229 (276)
T ss_dssp             --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCCC
T ss_pred             cCCcc-----cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCCC
Confidence            32211     22356899999999999753   47999999999999999999999998765432  2222233333333


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ........+|+++.+||.+||+.||++|||+++|++.|+.+.+
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            3445556779999999999999999999999999999987754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.4e-53  Score=411.34  Aligned_cols=251  Identities=18%  Similarity=0.260  Sum_probs=213.4

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.....  .+.+.+|+.+++.|+| ++|..+..++.+.+..||||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEEc
Confidence            689999999999999999999999999999999876532  3457899999999986 6677777777889999999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      | +|+|.+++....+.+++..++.|+.||+.||+|||++|||||||||+|||++. +.++.+||+|||+|+.+.....  
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~--  181 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS--  181 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC--
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc--
Confidence            9 88999998655667999999999999999999999999999999999999952 2357899999999987654432  


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhcc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS  243 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (423)
                            .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..   +.+..+.......+ ......
T Consensus       182 ------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~  251 (350)
T d1koaa2         182 ------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWNMD-DSAFSG  251 (350)
T ss_dssp             ------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCSC-CGGGGG
T ss_pred             ------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-cccccC
Confidence                  23568999999999999999999999999999999999999999875433   44555555554433 233456


Q ss_pred             ChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          244 HPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       244 ~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      +++++++||.+||..||++|||+++|++
T Consensus       252 ~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         252 ISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            7899999999999999999999999866

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-53  Score=402.99  Aligned_cols=260  Identities=19%  Similarity=0.283  Sum_probs=213.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      |-.++|++.+.||+|+||+||+|++..+++.||||+++.+. ..+++.+|+++++.++| ++|..+..++.+.+..+|||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC-CCEecCCccEeeCCeeEEEe
Confidence            44578999999999999999999999999999999987654 34568999999999987 66667777777888999999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||| +|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+......
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCC
Confidence            999 78999998753 3568999999999999999999999999999999999999   478899999999998765433


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      ..      ......||+.|+|||++.+..++.++|||||||++|||++|..||......  .+ +.++.......+.   
T Consensus       170 ~~------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~-~~~~i~~~~~~~~---  237 (287)
T d1opja_         170 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQ-VYELLEKDYRMER---  237 (287)
T ss_dssp             SE------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH-HHHHHHTTCCCCC---
T ss_pred             ce------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HH-HHHHHhcCCCCCC---
Confidence            21      122456899999999999999999999999999999999976665432222  12 2223333333332   


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ...+|+++.+||.+||+.||++||++++|++.|+.++++
T Consensus       238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            245689999999999999999999999999998877543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-54  Score=411.55  Aligned_cols=261  Identities=20%  Similarity=0.306  Sum_probs=206.8

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~---~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      +|..++|++++.||+|+||+||+|+++.+++.||+|+++....   ...+.+|+.+++.++| ++|..+..++.+....|
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEE
Confidence            4667899999999999999999999999999999999875432   3458899999999987 56777777777888999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |||||+ +|+|.+++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||+   +.++.+||+|||+|+...
T Consensus        81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred             EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence            999999 7899999875 45799999999999999999999975 99999999999999   478899999999998764


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh-----
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-----  232 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-----  232 (423)
                      ...         ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...............     
T Consensus       157 ~~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  227 (322)
T d1s9ja_         157 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  227 (322)
T ss_dssp             HHT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred             CCc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence            332         125689999999999999999999999999999999999999998644321111000000000     


Q ss_pred             ------------------------------c-CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          233 ------------------------------V-STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       233 ------------------------------~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                                                    . ..+.......++.++.+||.+||..||.+|||++++++  +.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~--Hpf~~~  303 (322)
T d1s9ja_         228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR  303 (322)
T ss_dssp             ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred             cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--CHhhCc
Confidence                                          0 00000000124688999999999999999999999987  455543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-53  Score=401.59  Aligned_cols=263  Identities=18%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~---~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      +..++|++.+.||+|+||+||+|+++.+++   .||||.+......   +.+.+|+++++.|+| ++|..+..++.+.+.
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKSTP  101 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCE
Confidence            445789999999999999999999986654   5889987654433   358899999999976 566677777778889


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||| +|+|.+++....+.+++.+++.|+.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence            99999999 889999888766779999999999999999999999999999999999999   57899999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ........  ........||+.|+|||.+.+..++.++|||||||+||||+| |+.||.+....   +.+..+... ...
T Consensus       179 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~~-~~~  252 (299)
T d1jpaa_         179 EDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQD-YRL  252 (299)
T ss_dssp             -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT-CCC
T ss_pred             cCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-CCC
Confidence            54332211  111223568999999999999999999999999999999998 89999876544   333333332 222


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      +.   ...+|+++.+||.+||+.||++||++.+|++.|+++++.
T Consensus       253 ~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         253 PP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            22   234689999999999999999999999999999988763

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=394.71  Aligned_cols=251  Identities=21%  Similarity=0.246  Sum_probs=200.6

Q ss_pred             CcccCCce-EEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeee--
Q 014527            2 ERIIGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD--   74 (423)
Q Consensus         2 ~~i~~~~y-~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~--   74 (423)
                      +....++| ++.++||+|+||+||+|++..+++.||+|++.....    .+.+.+|+++++.++|++ |..+..++.+  
T Consensus         3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~   81 (270)
T d1t4ha_           3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN-IVRFYDSWESTV   81 (270)
T ss_dssp             EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEEEEES
T ss_pred             CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEeecc
Confidence            33455666 788899999999999999999999999998765432    235789999999998754 5445444332  


Q ss_pred             --CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--cccccccCCceEEeecCCCCcEEEee
Q 014527           75 --GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        75 --~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                        ....|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||+++  |+||||||+|||++  ++++.+||+|
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~D  158 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGD  158 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECC
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEee
Confidence              35679999999 8899998875 457999999999999999999999998  99999999999995  3578999999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC  229 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (423)
                      ||+|+......         .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....  .+.+..+.
T Consensus       159 FGla~~~~~~~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~  226 (270)
T d1t4ha_         159 LGLATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVT  226 (270)
T ss_dssp             TTGGGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHT
T ss_pred             cCcceeccCCc---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHH
Confidence            99997543321         235689999999999876 5999999999999999999999999864432  23333443


Q ss_pred             hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .....   .......++++.+||.+||+.||++|||+++|++
T Consensus       227 ~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         227 SGVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTCCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCC---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            32222   2233456889999999999999999999999865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=397.74  Aligned_cols=247  Identities=22%  Similarity=0.273  Sum_probs=193.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeee--eCCeeEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVL   80 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~--~~~~~~l   80 (423)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++......    +.+.+|+++++.++|++ |..+..+..  .....||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN-IVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTT-BCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCC-EeeEEEEEEeCCCCEEEE
Confidence            6799999999999999999999999999999998765432    34789999999998754 555544333  3556899


Q ss_pred             EEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcC-----cccccccCCceEEeecCCCCcEEEeecc
Q 014527           81 VLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g-----iiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                      ||||| +|+|.+++..   .+..+++..++.++.||+.||+|||++|     ||||||||+|||+   +.++.+||+|||
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG  159 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFG  159 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeecc
Confidence            99999 8899999864   2467999999999999999999999987     9999999999999   478899999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      +|+.+.....       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..   +.+..+...
T Consensus       160 ~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~~  229 (269)
T d2java1         160 LARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIREG  229 (269)
T ss_dssp             HHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHT
T ss_pred             ceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHcC
Confidence            9987654332       123568999999999999999999999999999999999999999875543   344445444


Q ss_pred             hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ....    ....+|+++.+||.+||+.||.+||++++|++
T Consensus       230 ~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 KFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            4322    22456899999999999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=392.79  Aligned_cols=256  Identities=18%  Similarity=0.283  Sum_probs=202.5

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      -..+|++.+.||+|+||+||+|++. +++.||||+++... ..+++.+|+++++.++| ++|..+..++.+.+..++|||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC-CCcccccceeccCCceEEEEE
Confidence            3578999999999999999999986 46789999987654 45569999999999986 667777777777889999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |+ +|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+|+........
T Consensus        81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC-----------
T ss_pred             ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce
Confidence            99 899999988766779999999999999999999999999999999999999   57889999999999876544321


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                            ......||+.|+|||++.+..++.++|||||||++|||+| |.+||......   +.+..+... ...+.+   
T Consensus       158 ------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~~-~~~~~p---  224 (263)
T d1sm2a_         158 ------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG-FRLYKP---  224 (263)
T ss_dssp             -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHHT-CCCCCC---
T ss_pred             ------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHhc-CCCCCc---
Confidence                  1224578999999999999999999999999999999999 56666554332   333333332 222222   


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ...|+++.+||..||+.||++||++++|++.|+++.+
T Consensus       225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            3448899999999999999999999999999998864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=396.34  Aligned_cols=253  Identities=19%  Similarity=0.249  Sum_probs=212.9

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--------~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++....        ..+.+.+|+.+++.|+| ++|..+..++.+..
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~   86 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENKT   86 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence            5678999999999999999999999999999999875432        23458999999999987 56777777788889


Q ss_pred             eeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecC-CCCcEEEeecccee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAK  154 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~-~~~~vkL~DFGla~  154 (423)
                      ..||||||| +|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++..+ ....+||+|||+|+
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            999999999 8899999876 45799999999999999999999999999999999999995322 22369999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .......        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..   +.+..+......
T Consensus       166 ~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~  234 (293)
T d1jksa_         166 KIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNYE  234 (293)
T ss_dssp             ECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCCC
T ss_pred             hcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCC
Confidence            7754332        23567999999999999999999999999999999999999999875443   445555555544


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+ ......+|+++.+||.+||..||++||+++++++
T Consensus       235 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 FE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            44 3334567999999999999999999999998865

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-52  Score=401.32  Aligned_cols=249  Identities=21%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             ceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         8 ~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      .|++++.||+|+||+||+|++..+++.||||++......     +.+.+|+++++.|+| ++|..+..++.+.+..|+||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEECCEEEEEE
Confidence            599999999999999999999999999999998765432     347899999999986 56667777777889999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |||.+++.+.+...++.+++..++.++.||+.||.|||++|||||||||+|||++   .++.+||+|||+|+.....   
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB---
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccccCCC---
Confidence            9995554455555567899999999999999999999999999999999999994   7899999999999765332   


Q ss_pred             CcccccCCCcccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                              ....||+.|||||++.+   ..|+.++|||||||++|||++|..||.+....   +.+..+.........  
T Consensus       169 --------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~--  235 (309)
T d1u5ra_         169 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPALQ--  235 (309)
T ss_dssp             --------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCCCS--
T ss_pred             --------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCC--
Confidence                    24579999999999975   34899999999999999999999999875443   344444444433222  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       ...+|+++.+||.+||+.||++|||+++|++  +.++.+
T Consensus       236 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~  272 (309)
T d1u5ra_         236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR  272 (309)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred             -CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence             2356899999999999999999999999976  445543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.9e-53  Score=409.53  Aligned_cols=252  Identities=23%  Similarity=0.227  Sum_probs=212.5

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.....  ...+.+|+.+++.|+| ++|..+..++.+....|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEE
Confidence            3679999999999999999999999999999999876542  3357889999999976 566677777778899999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      || +|+|.+++......+++.+++.|+.||+.||+|||++|||||||||+|||++. ...+.+||+|||+|+.+..... 
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~-  184 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI-  184 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC-
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc-
Confidence            99 89999887765667999999999999999999999999999999999999942 2467999999999988764432 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+.+..   +.+..+.......+ .....
T Consensus       185 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~  253 (352)
T d1koba_         185 -------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWEFD-EDAFS  253 (352)
T ss_dssp             -------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCCCC-SSTTT
T ss_pred             -------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-ccccc
Confidence                   22567999999999999999999999999999999999999999875543   34445555444333 23345


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+++++.+||.+||+.||.+||+++++++
T Consensus       254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         254 SVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            67999999999999999999999998865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=399.99  Aligned_cols=242  Identities=21%  Similarity=0.314  Sum_probs=208.5

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      |--++|++++.||+|+||.||+|+++.+++.||||+++.     ......+.+|+.+++.++| ++|..+..++.+.+..
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeecccccc
Confidence            334689999999999999999999999999999998763     2345668899999999986 6677787888889999


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |+||||| +|+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+...
T Consensus        81 ~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred             ccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccc
Confidence            9999999 8899998875 5679999999999999999999999999999999999999   578999999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....       ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..   +.+..+.......| 
T Consensus       157 ~~~~~-------~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i~~~~~~~p-  225 (337)
T d1o6la_         157 SDGAT-------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP-  225 (337)
T ss_dssp             CTTCC-------BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred             cCCcc-------cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHHhcCCCCCC-
Confidence            43321       23578999999999999999999999999999999999999999875543   44555655555544 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCC
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPD  265 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt  265 (423)
                          ..+++++++||.+||++||.+||+
T Consensus       226 ----~~~s~~~~dli~~~L~~dP~~R~~  249 (337)
T d1o6la_         226 ----RTLSPEAKSLLAGLLKKDPKQRLG  249 (337)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred             ----ccCCHHHHHHHHhhccCCchhhcc
Confidence                456899999999999999999995

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=402.43  Aligned_cols=255  Identities=20%  Similarity=0.287  Sum_probs=210.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCc-----EEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~-----~vaiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .++|++++.||+|+||+||+|++..+++     .||+|++...   .....+.+|+.++..+.+|++|..+..++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3689999999999999999999876543     6999987543   2344688999999999767888888888888899


Q ss_pred             eEEEEecc-CCCHHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCce
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF  134 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NI  134 (423)
                      .++||||| +|+|.+++....                      ..+++..++.|+.||+.||+|||++|||||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            99999999 899999987533                      2488999999999999999999999999999999999


Q ss_pred             EEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 014527          135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW  213 (423)
Q Consensus       135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf  213 (423)
                      |++   .++.+||+|||+|+.........     ......||+.|||||++.+..++.++|||||||+||||+| |..||
T Consensus       196 ll~---~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         196 LVT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             EEE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccc---cCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            994   78999999999998765543321     1235578999999999999999999999999999999998 89999


Q ss_pred             CCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHH
Q 014527          214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH  274 (423)
Q Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  274 (423)
                      .+....   +.+.++.......+.+   ..+|+++.+||..||+.||++|||+++|++.|.
T Consensus       268 ~~~~~~---~~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         268 PGIPVD---ANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTCCCS---HHHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCHH---HHHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            875443   3334444544443332   345899999999999999999999999998875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=390.19  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=207.0

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      |-.++|++.+.||+|+||+||+|++. +++.||||+++... ..+.+.+|++++..++|+ +|..+..+.. .+..++||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~~~g~~~-~~~~~iv~   86 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-RLVRLYAVVT-QEPIYIIT   86 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEEC-SSSCEEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCC-CEeEEEeeec-cCCeEEEE
Confidence            45679999999999999999999975 57789999987644 445699999999999875 4555555543 45679999


Q ss_pred             ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+......
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCc
Confidence            999 88998876532 3469999999999999999999999999999999999999   578999999999999875433


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCC-CCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSL-PWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......||+.|+|||++.+..++.++|||||||++|||+||.. ||......   +.+..+.. ....+.  
T Consensus       164 ~~------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i~~-~~~~~~--  231 (272)
T d1qpca_         164 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLER-GYRMVR--  231 (272)
T ss_dssp             EE------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT-TCCCCC--
T ss_pred             cc------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh-cCCCCC--
Confidence            21      2235678999999999998899999999999999999999655 45443322   33333332 222222  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       ...+|+++.+||.+||+.||++|||+++|++.|++++..
T Consensus       232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence             245689999999999999999999999999999998864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=392.63  Aligned_cols=258  Identities=21%  Similarity=0.286  Sum_probs=208.9

Q ss_pred             CCceEEece-eeecCceeEEEEEECC--CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeE
Q 014527            6 GVKYKLGRK-IGSGSFGEIFLASHVD--TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         6 ~~~y~i~~~-Lg~G~fg~Vy~a~~~~--~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~   79 (423)
                      .++|.+.+. ||+|+||+||+|.++.  ++..||||+++.....   +.+.+|++++..++|+ +|..+..++. .+..|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~l~g~~~-~~~~~   84 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP-YIVRLIGVCQ-AEALM   84 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEE-SSSEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCC-CEeeEeeeec-cCeEE
Confidence            356888885 9999999999998764  4557999998765433   3588999999999874 5555555554 45689


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      |||||| +|+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+....
T Consensus        85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTT
T ss_pred             EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcccc
Confidence            999999 7899998876567799999999999999999999999999999999999995   788999999999998755


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      .....    .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....   +.+..+.... ..+ 
T Consensus       162 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~~~-~~~-  232 (285)
T d1u59a_         162 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGK-RME-  232 (285)
T ss_dssp             CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTC-CCC-
T ss_pred             ccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC-CCC-
Confidence            43221    12235578999999999999999999999999999999998 99999886544   3333333322 222 


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                        .+..+|+++.+||.+||+.||++||++.+|.+.|+..+..
T Consensus       233 --~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         233 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             --CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              2245699999999999999999999999999999887653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-51  Score=395.34  Aligned_cols=242  Identities=23%  Similarity=0.327  Sum_probs=207.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++.     ....+.+.+|+.+++.++| ++|..+..++.+.+..|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeCCeeeeE
Confidence            579999999999999999999999999999998753     2345568899999999987 5677777778889999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||| |++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+......
T Consensus        83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB
T ss_pred             eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc
Confidence            9999 7788777664 6678999999999999999999999999999999999999   578899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                                ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..   +.+.++.......|    
T Consensus       159 ----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~~~p----  221 (316)
T d1fota_         159 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAELRFP----  221 (316)
T ss_dssp             ----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCCCCCC----
T ss_pred             ----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHHcCCCCCC----
Confidence                      2568999999999999999999999999999999999999999875443   45555665555444    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  271 (423)
                       ..+|+++.++|.+||..||.+|+     ++++|++
T Consensus       222 -~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             35689999999999999999996     7777744

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-52  Score=401.58  Aligned_cols=254  Identities=22%  Similarity=0.347  Sum_probs=214.8

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..     ......+.+|+++++.++| ++|..+..++.+....++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeecccccccccccccc
Confidence            689999999999999999999999999999998753     2344568899999999976 5666777777788899999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+......
T Consensus       120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB
T ss_pred             cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccccc
Confidence            9999 8899888875 4579999999999999999999999999999999999999   578899999999998765432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                                ....||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.   ...+.++.......+    
T Consensus       196 ----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~~~~~~~p----  258 (350)
T d1rdqe_         196 ----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKIVSGKVRFP----  258 (350)
T ss_dssp             ----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC----
T ss_pred             ----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHHHhcCCCCCC----
Confidence                      256899999999999999999999999999999999999999987543   345556666555444    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCC-----ChHHHHHHHHHHHHhcCCCCCcceeceec
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRLFHDLFSREGYDFDFVFDWTIL  293 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~  293 (423)
                       ..+++++.+||.+||..||.+|+     ++++|++          +.|....||..+
T Consensus       259 -~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~----------Hp~f~~~~~~~~  305 (350)
T d1rdqe_         259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAI  305 (350)
T ss_dssp             -TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHH
T ss_pred             -ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc----------CccccCCCHHHH
Confidence             45689999999999999999994     7887754          444455678654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-51  Score=388.06  Aligned_cols=262  Identities=21%  Similarity=0.302  Sum_probs=205.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeEEEeeeeC---
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG---   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~---   75 (423)
                      .+.++|++.+.||+|+||+||+|++..+++.||||+++....     ...+.+|+++++.++|++.+..+..+..+.   
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            467899999999999999999999999999999999875432     224789999999998865555444444333   


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...||||||+ +++|.+++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||++   ..+.++|+|||.+.
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTTCE
T ss_pred             ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhhhh
Confidence            2478999999 7889887765 56799999999999999999999999999999999999994   78899999999987


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      .........    .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..   +.+.++......
T Consensus       160 ~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~~~~~~~  232 (277)
T d1o6ya_         160 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVREDPI  232 (277)
T ss_dssp             ECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCCC
T ss_pred             hhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHHHHHHhcCCC
Confidence            664433211    1233668999999999999999999999999999999999999999875443   333344443333


Q ss_pred             CcHHHhhccChHHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHH
Q 014527          235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLF  277 (423)
Q Consensus       235 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~l~~~L~~~~  277 (423)
                       +.......+|+++.++|.+||+.||++|| ++++|++.|..+.
T Consensus       233 -~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 -PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence             23344567899999999999999999999 8899988777653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=388.94  Aligned_cols=262  Identities=16%  Similarity=0.223  Sum_probs=204.5

Q ss_pred             cccCCceEEeceeeecCceeEEEEEECCCC----cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         3 ~i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~----~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      +|-...|++.+.||+|+||+||+|.+..++    ..||||++......   ..+.+|++++..++| ++|..+..++.+.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEecC
Confidence            566778999999999999999999987654    46999998755433   347899999999986 5666777777788


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...++||||+ ++++.+++......+++..++.++.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+|+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR  158 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhh
Confidence            8899999999 778888887777789999999999999999999999999999999999999   578999999999998


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCC-CCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-QGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf-~~~~~~~~~~~~~~i~~~~~  233 (423)
                      ..........    ......||+.|+|||++.+..++.++|||||||++|||++|..|| .+...   .+.+..+. ...
T Consensus       159 ~~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~~i~-~~~  230 (283)
T d1mqba_         159 VLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAIN-DGF  230 (283)
T ss_dssp             -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH-TTC
T ss_pred             cccCCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH---HHHHHHHh-ccC
Confidence            7654332111    122456899999999999999999999999999999999965555 43332   23333333 233


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..+.+   ..+|.++.+||..||+.||++||++.+|++.|+.+++.
T Consensus       231 ~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 RLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCc---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            33322   34689999999999999999999999999999988753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-51  Score=385.81  Aligned_cols=251  Identities=19%  Similarity=0.172  Sum_probs=213.1

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCeEEEeee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGV   73 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-----------~~~~~E~~~l~~l~~~~~i~~i~~~~~   73 (423)
                      +.++|++.+.||+|+||+||+|++..+++.||||++......           +.+.+|+.+++.|..|+++..+..++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            468999999999999999999999999999999998654321           247899999999997788888888888


Q ss_pred             eCCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccc
Q 014527           74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL  152 (423)
Q Consensus        74 ~~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGl  152 (423)
                      +.+..||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~  156 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF  156 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence            999999999999 8899999976 5679999999999999999999999999999999999999   5889999999999


Q ss_pred             eeeecCCCCCCcccccCCCcccccccccCcccccC------CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHH
Q 014527          153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD  226 (423)
Q Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~  226 (423)
                      |+.+.....        .....||+.|+|||.+.+      ..++.++||||+||+||+|++|+.||.+....   ..+.
T Consensus       157 a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~~~  225 (277)
T d1phka_         157 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR  225 (277)
T ss_dssp             CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred             eeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HHHH
Confidence            988654332        235689999999999863      34688999999999999999999999876543   3444


Q ss_pred             HHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       227 ~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      .+.......+.+ ....+|+++.+||.+||+.||++||++++|++
T Consensus       226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            555555443332 23467999999999999999999999998855

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=402.11  Aligned_cols=259  Identities=19%  Similarity=0.178  Sum_probs=206.2

Q ss_pred             CCceEEec-eeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeee----CCeeEE
Q 014527            6 GVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~-~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~~~~l   80 (423)
                      -++|++.+ .||+|+||.||+|++..+++.||||+++.   ...+.+|+.++.++.+|+++..+..++.+    ....||
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence            36798875 59999999999999999999999999864   45688999998887666777777655443    456899


Q ss_pred             EEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           81 VLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        81 v~e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      ||||| ||+|.+++.... ..+++.+++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||+|+....
T Consensus        87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccC
Confidence            99999 789999997543 4699999999999999999999999999999999999997544567899999999987655


Q ss_pred             CCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHH-HHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK-YDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~~~  237 (423)
                      ...        .....||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+......... ...+.......+.
T Consensus       167 ~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         167 HNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             CCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             CCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            432        2256899999999999999999999999999999999999999987543322221 1122222222222


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      . ....+++++.+||.+||+.||++||++.++++  +.++.
T Consensus       239 ~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~  276 (335)
T d2ozaa1         239 P-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIM  276 (335)
T ss_dssp             T-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHH
T ss_pred             c-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhh
Confidence            2 23456899999999999999999999999866  34554

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=397.43  Aligned_cols=258  Identities=17%  Similarity=0.235  Sum_probs=217.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~-~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      +-++|++++.||+|+||+||+|.++.+++.||||+++..... ..+.+|+++|+.++| ++|..+..++.+.+..|||||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEe
Confidence            347899999999999999999999999999999998765433 347899999999987 567777777788899999999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      || +++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++....... 
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~-  159 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN-  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc-
Confidence            99 78999998765557999999999999999999999999999999999999952 2456899999999987644321 


Q ss_pred             CcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                             .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..   +.+..+.......+. ....
T Consensus       160 -------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~~~-~~~~  228 (321)
T d1tkia_         160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFDE-EAFK  228 (321)
T ss_dssp             -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCCH-HHHT
T ss_pred             -------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCh-hhcc
Confidence                   12557899999999999999999999999999999999999999875443   455566666655543 3345


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      .+++++.+||.+||..||.+||+++++++  +.+++
T Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~  262 (321)
T d1tkia_         229 EISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLK  262 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhc
Confidence            67999999999999999999999999976  45554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-52  Score=385.87  Aligned_cols=252  Identities=18%  Similarity=0.301  Sum_probs=212.1

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      .++|++++.||+|+||+||+|+++ +++.||||+++... ..+.+.+|+.++..++| ++|..+..++.+.+..++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEc
Confidence            578999999999999999999985 67889999987654 45679999999999987 5566676777778889999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      + +|+|.+++......+++..++.++.||++||+|||++||+||||||+|||+   +.++.+||+|||+|+........ 
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce-
Confidence            9 789999887767789999999999999999999999999999999999999   57899999999999876544322 


Q ss_pred             cccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhc
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK  242 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (423)
                           ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....   +....+... ...+.+   .
T Consensus       157 -----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~~~-~~~~~p---~  224 (258)
T d1k2pa_         157 -----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQG-LRLYRP---H  224 (258)
T ss_dssp             -----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHHTT-CCCCCC---T
T ss_pred             -----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHHHhC-CCCCCc---c
Confidence                 2234678999999999999999999999999999999998 89999887654   333334332 222222   3


Q ss_pred             cChHHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q 014527          243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD  275 (423)
Q Consensus       243 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  275 (423)
                      ..|+++.+||.+||+.||++||++++|++.|.+
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            458999999999999999999999999988753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=391.91  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=203.3

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeee-e
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV-D   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~-~   74 (423)
                      |-.++|++++.||+|+||.||+|++..     +++.||||+++.....   ..+.+|..++..+.|++++..+..+.. .
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            345789999999999999999999764     3468999998754432   347788899999988888777755544 4


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL  138 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~  138 (423)
                      ....++||||| +|+|.+++....               ..+++..++.++.||+.||+|||++|||||||||+|||+  
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--  167 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  167 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence            55789999999 899999987532               348999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCch
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLK  217 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG-~~Pf~~~~  217 (423)
                       +.++.+||+|||+|+.........     ......||+.|+|||++.+..++.++|||||||++|||++| ..||.+..
T Consensus       168 -~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         168 -SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             -CGGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -CCCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence             478899999999998765443221     23356899999999999999999999999999999999986 56787654


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..   +.+..........+.   ...+|+++.+||.+||+.||++||++++|++.|+++++.
T Consensus       242 ~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         242 ID---EEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CS---HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH---HHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            33   223333333333322   234589999999999999999999999999999998864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=386.81  Aligned_cols=249  Identities=21%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             ceeeecCceeEEEEEEC--CCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEecc-
Q 014527           13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-   85 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~--~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~~-   85 (423)
                      ++||+|+||+||+|.+.  .+++.||||+++....    .+.+.+|+++++.++|+ +|..+..++. .+..+|||||+ 
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~~~g~~~-~~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP-YIVRMIGICE-AESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCT-TBCCEEEEEE-SSSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCC-CCceEEEEec-cCCEEEEEEcCC
Confidence            46999999999999875  3557899999865432    24588999999999874 5555555553 45678999999 


Q ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCCcc
Q 014527           86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI  165 (423)
Q Consensus        86 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (423)
                      +|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+.+.......  
T Consensus        91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~--  164 (277)
T d1xbba_          91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY--  164 (277)
T ss_dssp             TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE--
T ss_pred             CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccc--
Confidence            8899998875 56799999999999999999999999999999999999994   78999999999998765443221  


Q ss_pred             cccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhhccC
Q 014527          166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH  244 (423)
Q Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (423)
                        .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+...   ....+... ...+.   ...+
T Consensus       165 --~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~~~-~~~~~---p~~~  235 (277)
T d1xbba_         165 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKG-ERMGC---PAGC  235 (277)
T ss_dssp             --EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT-CCCCC---CTTC
T ss_pred             --ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHHcC-CCCCC---Cccc
Confidence              12235578999999999999999999999999999999998 899999865543   33333322 22222   2456


Q ss_pred             hHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       245 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      |+++.+||.+||+.||++||++++|.+.|+..+.
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            9999999999999999999999999999888764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.6e-51  Score=397.01  Aligned_cols=247  Identities=24%  Similarity=0.309  Sum_probs=201.6

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCeEEEeeeeCCeeE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV   79 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~-----~~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~~~~~~~   79 (423)
                      ++|++++.||+|+||.||+|+++.+|+.||||++...     .....+.+|..++..+.  +|++|..+..++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5799999999999999999999999999999987532     23334667766666665  2466777777788889999


Q ss_pred             EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecC
Q 014527           80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD  158 (423)
Q Consensus        80 lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~  158 (423)
                      +||||| +|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||+   +..+.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            999999 8999999876 5679999999999999999999999999999999999999   5789999999999987654


Q ss_pred             CCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcH
Q 014527          159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI  237 (423)
Q Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (423)
                      ...         ....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+............+.....    
T Consensus       160 ~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~----  226 (364)
T d1omwa3         160 KKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----  226 (364)
T ss_dssp             SCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC----
T ss_pred             Ccc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC----
Confidence            332         25589999999999974 5689999999999999999999999987554433333222222222    


Q ss_pred             HHhhccChHHHHHHHHHHhcCCCCCCCC-----hHHHHH
Q 014527          238 EVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR  271 (423)
Q Consensus       238 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~l~~  271 (423)
                       .....+++++.+||.+||..||++||+     +++|++
T Consensus       227 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             223467899999999999999999999     466644

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=391.16  Aligned_cols=246  Identities=23%  Similarity=0.333  Sum_probs=207.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV   81 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv   81 (423)
                      ++|++++.||+|+||+||+|+++.+++.||||++..     ......+..|..++....+|++|..+..++.+.+..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            479999999999999999999999999999999863     334455778888777555567788888888889999999


Q ss_pred             Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        82 ~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      |||+ +|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence            9999 8899998875 5679999999999999999999999999999999999999   578999999999998654433


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHh
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL  240 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~  240 (423)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..   +.+.++.......|    
T Consensus       158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~p----  223 (320)
T d1xjda_         158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP----  223 (320)
T ss_dssp             C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred             c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence            2       123568999999999999999999999999999999999999999875543   44445554444333    


Q ss_pred             hccChHHHHHHHHHHhcCCCCCCCChH-HHHH
Q 014527          241 CKSHPAEFASYFHYCQSLTFDQRPDYG-FLKR  271 (423)
Q Consensus       241 ~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~  271 (423)
                       ..+|+++.+||.+||..||++||++. +|++
T Consensus       224 -~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 -RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             45689999999999999999999985 6643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=382.98  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=200.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~---~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      |-..+|++++.||+|+||+||+|++..++   ..||||.++.....   ..+.+|+++++.++| ++|..+..++. .+.
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENP   81 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEC-SSS
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCe
Confidence            34579999999999999999999987543   46889987654433   348899999999987 44555555543 467


Q ss_pred             eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      .++||||+ +|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheec
Confidence            89999999 8899998887777899999999999999999999999999999999999994   7889999999999876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ......      ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.....   .+..+..... .
T Consensus       159 ~~~~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~~-~  228 (273)
T d1mp8a_         159 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGER-L  228 (273)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCC-C
T ss_pred             cCCcce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC-C
Confidence            543321      1234578999999999999999999999999999999998 899998765543   3333433322 1


Q ss_pred             cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       236 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      +   ....+|+++.+||.+||+.||++||++++|++.|+.+++++
T Consensus       229 ~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         229 P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            2   23466999999999999999999999999999999988654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=384.72  Aligned_cols=241  Identities=23%  Similarity=0.341  Sum_probs=201.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCeEEEeeeeC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYGVDG   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--------~~~~~~~E~~~l~~l~~-~~~i~~i~~~~~~~   75 (423)
                      +.++|++.+.||+|+||+||+|++..+++.||||++....        ...++.+|+.+++.+++ ++++..+..++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            5789999999999999999999999999999999876432        22346799999999984 57788888888889


Q ss_pred             CeeEEEEecc-C-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           76 EDNVLVLDLL-G-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        76 ~~~~lv~e~~-~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      +..++||||+ + +++.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++  .+.+.+||+|||+|
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG  158 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred             CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence            9999999999 3 467777665 56799999999999999999999999999999999999995  34579999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK  232 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (423)
                      +......         .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..         .+....
T Consensus       159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~~~  220 (273)
T d1xwsa_         159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQ  220 (273)
T ss_dssp             EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCC
T ss_pred             eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhhcc
Confidence            8754332         235689999999999987765 678999999999999999999998632         122333


Q ss_pred             cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ...+     ..+|+++.+||.+||..||++|||++++++
T Consensus       221 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 VFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCC-----CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            3322     456999999999999999999999999865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=387.64  Aligned_cols=256  Identities=21%  Similarity=0.288  Sum_probs=202.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCc----EEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~----~vaiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      ..+|++++.||+|+||+||+|++..+|+    .||+|.++..   ...+.+.+|+++++.++| ++|..+..++.+.. .
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~-~   85 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST-V   85 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEESSS-E
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCC-e
Confidence            3569999999999999999999987776    5888877543   234568999999999987 55666666665544 5


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      +++||++ +++|.+.+......+++..++.|+.||+.||+|||++|||||||||+|||++   .++.+||+|||+|+...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceecc
Confidence            5666666 9999999888778899999999999999999999999999999999999994   78899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCc
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP  236 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (423)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+........    +.......+
T Consensus       163 ~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~----~i~~~~~~~  233 (317)
T d1xkka_         163 AEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGERLP  233 (317)
T ss_dssp             TTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH----HHHHTCCCC
T ss_pred             cccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCCCCC
Confidence            433221     1224568999999999999999999999999999999998 899998765443222    222233222


Q ss_pred             HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       237 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      .+   ..+|+++.+||.+||+.||++||++.+|++.|..+..
T Consensus       234 ~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         234 QP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            22   3458999999999999999999999999999887654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=383.67  Aligned_cols=250  Identities=20%  Similarity=0.222  Sum_probs=200.2

Q ss_pred             EeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEe
Q 014527           11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD   83 (423)
Q Consensus        11 i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e   83 (423)
                      .++.||+|+||+||+|+++.+|+.||||+++....       ...+.+|+.+++.++| ++|..+..++.+.+..|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccCCceeehhh
Confidence            46889999999999999999999999998764321       3458899999999987 556667777778889999999


Q ss_pred             ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCCC
Q 014527           84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR  163 (423)
Q Consensus        84 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~  163 (423)
                      |+.+++...+...+..+++..+..++.||+.||+|||++||+||||||+|||+   +..+.+||+|||+|+........ 
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCccc-
Confidence            99777766666556779999999999999999999999999999999999999   58899999999999876543321 


Q ss_pred             cccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh----------
Q 014527          164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------  232 (423)
Q Consensus       164 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------  232 (423)
                            ....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+.+.....          
T Consensus       157 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         157 ------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             ------CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             ------ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence                  2356799999999998754 57999999999999999999999998766554333333222110          


Q ss_pred             ----------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 ----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                ...+........++++.+||.+||..||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                      011223344566889999999999999999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-50  Score=379.39  Aligned_cols=254  Identities=20%  Similarity=0.233  Sum_probs=205.0

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++++.||+|+||+||+|++..+++.||||+++...    ...++.+|+++++.++| ++|..+..++.+....|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccccceeEEE
Confidence            48999999999999999999999999999999886543    34568899999999986 56777777778899999999


Q ss_pred             eccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||+++++.+++... ...+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.......
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence            99988888777543 4569999999999999999999999999999999999999   5788999999999987654332


Q ss_pred             CCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh--------
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------  232 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------  232 (423)
                             ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+.......        
T Consensus       158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence                   223568999999999988766 5889999999999999999999998765433222221111100        


Q ss_pred             -------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 -------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 -------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   ...+.......+++++.+||.+||..||++|||+++|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                         011112233456789999999999999999999999865

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=376.35  Aligned_cols=253  Identities=20%  Similarity=0.285  Sum_probs=201.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee-eCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-~~~~~~lv~   82 (423)
                      |--++|++++.||+|+||.||+|++  .+..||||+++.+...+.+.+|++++++++| ++|..+..++. ..+..++||
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC-TTBCCEEEEECCC--CCEEEE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEecCCcEEEEE
Confidence            3356899999999999999999998  4778999999888878889999999999986 55666655543 445689999


Q ss_pred             ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+++......
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC
Confidence            999 899999986533 358999999999999999999999999999999999999   578999999999998654322


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                                ....+|..|+|||.+.+..++.++|||||||++|||+| |++||......   +.+..+... ...+.  
T Consensus       158 ----------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~~-~~~~~--  221 (262)
T d1byga_         158 ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKG-YKMDA--  221 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTT-CCCCC--
T ss_pred             ----------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcC-CCCCC--
Confidence                      24467899999999999999999999999999999998 78998875544   333344332 22222  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       ...+|+++.+||.+||+.||++||++.+|++.|+.+-+.
T Consensus       222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence             245689999999999999999999999999999887543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=380.47  Aligned_cols=258  Identities=22%  Similarity=0.269  Sum_probs=200.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCC-C--cEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-N--EIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-~--~~vaiKi~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      |-.++|++.+.||+|+||+||+|++... +  ..||||+++...     ..+.+.+|+++++.++| ++|..++.++.+ 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~~~g~~~~-   82 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT-   82 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEee-
Confidence            3456799999999999999999987533 3  368999876432     12458999999999976 556666655544 


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                      ...++||||+ ++++.+.+......+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~  159 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR  159 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCE
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhh
Confidence            4678999999 8899998887777899999999999999999999999999999999999995   67899999999999


Q ss_pred             eecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCchhhhhHHHHHHHHhhhc
Q 014527          155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV  233 (423)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~  233 (423)
                      .........    .......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..   +.+..+.....
T Consensus       160 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i~~~~~  232 (273)
T d1u46a_         160 ALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKIDKEGE  232 (273)
T ss_dssp             ECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTSCC
T ss_pred             hcccCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHHHhCCC
Confidence            875543321    12234567889999999999999999999999999999998 89999876544   34445544444


Q ss_pred             CCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       234 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      ..+.   ...+|+++.+||.+||..||++|||+.+|.+.|.++
T Consensus       233 ~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RLPR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            4332   245689999999999999999999999999888764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=379.12  Aligned_cols=257  Identities=22%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      |-.++|++.+.||+|+||+||+|++..+ +.||||+++... ..+.+.+|+.+++.++|++ |..+..++. .+..++||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~g~~~-~~~~~lv~   90 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVS-EEPIYIVT   90 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEEC-SSSCEEEE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCC-EeEEEEEEe-cCCeEEEE
Confidence            3357899999999999999999998765 569999987654 3456999999999998865 555555553 45689999


Q ss_pred             ecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCC
Q 014527           83 DLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT  160 (423)
Q Consensus        83 e~~-~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (423)
                      ||+ +|+|..++.. ....+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+......
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCC
Confidence            999 7888888754 34569999999999999999999999999999999999999   477899999999998764432


Q ss_pred             CCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCC-CCchhhhhHHHHHHHHhhhcCCcHHH
Q 014527          161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-QGLKAATKKQKYDKICEKKVSTPIEV  239 (423)
Q Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf-~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (423)
                      ..      ......||+.|+|||.+.+..++.++|||||||++|||++|..|| .+...   .+.+..+.. ....+.  
T Consensus       168 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---~~~~~~i~~-~~~~~~--  235 (285)
T d1fmka3         168 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVER-GYRMPC--  235 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT-TCCCCC--
T ss_pred             ce------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHh-cCCCCC--
Confidence            21      123457899999999999999999999999999999999965555 44332   233333332 222232  


Q ss_pred             hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       240 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                       ...+|+++.+||.+||+.||++||++++|++.|++++..
T Consensus       236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence             245689999999999999999999999999998876643

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=377.63  Aligned_cols=256  Identities=20%  Similarity=0.250  Sum_probs=200.2

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCC-CcEEEEEEecCC----CCchhHHHHHHHHHHHc--CCCCCCeEEEeee----
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSG----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGV----   73 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~-~~~vaiKi~~~~----~~~~~~~~E~~~l~~l~--~~~~i~~i~~~~~----   73 (423)
                      ..++|++++.||+|+||+||+|++..+ ++.||||+++..    .....+.+|+.+++.|.  +|+++..+..++.    
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            457999999999999999999999765 677999987532    23446789999998885  3455555544332    


Q ss_pred             -eCCeeEEEEeccCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeecc
Q 014527           74 -DGEDNVLVLDLLGPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG  151 (423)
Q Consensus        74 -~~~~~~lv~e~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFG  151 (423)
                       .....+++||++.+++..+... ....+++..++.++.||+.||+|||++||+||||||+|||+   +..+.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence             2346799999997766655543 34569999999999999999999999999999999999999   578899999999


Q ss_pred             ceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh
Q 014527          152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK  231 (423)
Q Consensus       152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~  231 (423)
                      +++......        ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+......
T Consensus       162 ~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         162 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             hhhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            987644322        223668999999999999999999999999999999999999999886554333333222111


Q ss_pred             -------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 -------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 -------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                         ....+.......+++.+.+||.+||..||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                               1111223344567889999999999999999999999865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=377.25  Aligned_cols=259  Identities=20%  Similarity=0.312  Sum_probs=210.4

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCC-------cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~-------~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      -.++|++++.||+|+||.||+|++..++       ..||||+++.+...   ..+.+|+..+..+.+|++|..+..++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            4579999999999999999999976544       36999998766543   3477899999999777888888888888


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL  138 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~  138 (423)
                      ....++||||+ +|+|.+++....               ..+++.+++.++.||+.||+|||++|||||||||+|||+  
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--  168 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--  168 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--
Confidence            88999999999 899999986432               358999999999999999999999999999999999999  


Q ss_pred             cCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                       +.++.+||+|||+++.........     ......||+.|+|||.+.+..|+.++|||||||++|||++ |..||.+..
T Consensus       169 -~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         169 -TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             -CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence             578899999999998776544322     2335678999999999999999999999999999999998 799998755


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHH
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS  278 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  278 (423)
                      ..   +.+..+. .....+.   ...+|+++.+||.+||+.||++||++.+|++.|+.++.
T Consensus       243 ~~---~~~~~i~-~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         243 VE---ELFKLLK-EGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HH---HHHHHHH-TTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---HHHHHHH-cCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            43   2333332 2332222   24568999999999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-49  Score=377.83  Aligned_cols=262  Identities=21%  Similarity=0.321  Sum_probs=216.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCC
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE   76 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~   76 (423)
                      -.++|++++.||+|+||.||+|++.     .+++.||||+++.....   ..+.+|+.++..+.+|++|..+..++.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3478999999999999999999874     45678999998765433   247899999999987788888888888888


Q ss_pred             eeEEEEecc-CCCHHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEee
Q 014527           77 DNVLVLDLL-GPSLEDLFVYCR-----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL  138 (423)
Q Consensus        77 ~~~lv~e~~-~~sL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~  138 (423)
                      ..++||||| +|+|.+++....                 ..+++..++.++.||+.||+|||++||+||||||+|||++ 
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~-  179 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-  179 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-
Confidence            999999999 889999987532                 2589999999999999999999999999999999999994 


Q ss_pred             cCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCch
Q 014527          139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK  217 (423)
Q Consensus       139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~ellt-G~~Pf~~~~  217 (423)
                        ..+.+||+|||+++........     .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||.+..
T Consensus       180 --~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         180 --HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             --TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             --ccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence              7899999999999876543321     12345689999999999999999999999999999999999 666666544


Q ss_pred             hhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhc
Q 014527          218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE  280 (423)
Q Consensus       218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  280 (423)
                      ..   ..+.++.........+   ..+|+++.+||..||+.||.+||++++|++.|++++.+.
T Consensus       253 ~~---~~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         253 VD---SKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             SS---HHHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HH---HHHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            33   3333444444443332   345899999999999999999999999999999887653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-50  Score=380.43  Aligned_cols=256  Identities=20%  Similarity=0.302  Sum_probs=207.3

Q ss_pred             CCceEEeceeeecCceeEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeeeCCe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED   77 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~-----~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~   77 (423)
                      .++|++++.||+|+||+||+|+++     .+++.||||+++.....   .++.+|+.+++.++|+ ++..+..++.....
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~-niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP-NIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCC-CcccceeeeccCCc
Confidence            367999999999999999999975     35678999998765433   3589999999999874 55556666667888


Q ss_pred             eEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCc
Q 014527           78 NVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN  133 (423)
Q Consensus        78 ~~lv~e~~-~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~N  133 (423)
                      .+++|||+ +++|.+++....                       ..+++..++.|+.||+.||+|||+++||||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            99999999 899999986432                       248899999999999999999999999999999999


Q ss_pred             eEEeecCCCCcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCC-CC
Q 014527          134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS-LP  212 (423)
Q Consensus       134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~-~P  212 (423)
                      ||+   +.++.+||+|||+|+........     .......||+.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus       171 ILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         171 CLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             EEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            999   57889999999999866443221     1223567899999999999999999999999999999999985 67


Q ss_pred             CCCchhhhhHHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHH
Q 014527          213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF  277 (423)
Q Consensus       213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  277 (423)
                      |.+....   +.+..+...... +   ....+|+++.+||..||+.||++|||+.+|++.|+++.
T Consensus       243 ~~~~~~~---e~~~~v~~~~~~-~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         243 YYGMAHE---EVIYYVRDGNIL-A---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTSCHH---HHHHHHHTTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCHH---HHHHHHHcCCCC-C---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            8775443   334444443322 1   22456899999999999999999999999999998763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=377.92  Aligned_cols=260  Identities=18%  Similarity=0.207  Sum_probs=211.1

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECCCCcE--EEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN   78 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~--vaiKi~~~~---~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~   78 (423)
                      |--++|++.+.||+|+||+||+|+++.++..  ||||.+...   ...+.+.+|++++..+.+|++|..+..++.+.+..
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            3347899999999999999999999888764  677766432   23446899999999996668888888888899999


Q ss_pred             EEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCC
Q 014527           79 VLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~  142 (423)
                      ++||||+ +|+|.+++...               ...+++..++.++.||+.||.|||++||+||||||+|||+   +..
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCC
Confidence            9999999 89999998642               2569999999999999999999999999999999999999   578


Q ss_pred             CcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCchhhhh
Q 014527          143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS-LPWQGLKAATK  221 (423)
Q Consensus       143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~-~Pf~~~~~~~~  221 (423)
                      +.+||+|||+|+.......        .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..  
T Consensus       164 ~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--  233 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--  233 (309)
T ss_dssp             GCEEECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred             CceEEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--
Confidence            8999999999986543322        12457899999999999999999999999999999999965 578765433  


Q ss_pred             HHHHHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcC
Q 014527          222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG  281 (423)
Q Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  281 (423)
                       +.+..+... ...+.   ...+|+++.+||.+||+.||++||++++|++.|+.++++..
T Consensus       234 -~~~~~i~~~-~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         234 -ELYEKLPQG-YRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             -HHHHHGGGT-CCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             -HHHHHHHhc-CCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence             344444332 22221   23458999999999999999999999999999999987654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-48  Score=369.89  Aligned_cols=253  Identities=24%  Similarity=0.299  Sum_probs=202.3

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++++.||+|+||+||+|+++ +++.||||++....    ....+.+|+.+++.++| +++..+..++.+.+..+++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccCCceeEEE
Confidence            58999999999999999999985 68899999986543    24568999999999986 56667777777888999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      |++++++...+....+.+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|.........
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence            999888888887767889999999999999999999999999999999999999   57899999999999876544321


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhh---------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK---------  232 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------  232 (423)
                             .....|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+..+....+.......         
T Consensus       157 -------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             -------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence                   22457899999999997654 6999999999999999999999998765443322222211110         


Q ss_pred             ------------cCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       233 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                  ...+.......+++.+.+||.+||+.||++|||++||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        011112233556889999999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=376.60  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=195.7

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeeee-----C
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVD-----G   75 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~~-----~   75 (423)
                      +.++|++++.||+|+||+||+|+++.+|+.||||+++.....    +.+.+|+++|+.++|++.+..+..+...     .
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            679999999999999999999999999999999998754432    3578999999999875544443443322     2


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...|+||||++.+|..+..  ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        96 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             ceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence            2579999999988888775  4579999999999999999999999999999999999999   5889999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhh---
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK---  231 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---  231 (423)
                      .....          ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......   
T Consensus       171 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         171 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence            65433          256799999999999875 4689999999999999999999999876544332222221110   


Q ss_pred             --------------------hcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 --------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 --------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                          ....+.......+++.+.+||.+||..||++|||+++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                0111112223456789999999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-48  Score=375.20  Aligned_cols=258  Identities=21%  Similarity=0.236  Sum_probs=199.0

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEeeee----CCe
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD----GED   77 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~~~----~~~   77 (423)
                      ++.+|++++.||+|+||+||+|++..+++.||||++......   ..+.+|+.+|+.|+|++.+..+..+...    ...
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            358999999999999999999999999999999998754432   3578999999999886555444444322    234


Q ss_pred             eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        78 ~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      .|++|++++++|.+++..  +.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+...
T Consensus        86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred             EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeecc
Confidence            677777779999999864  569999999999999999999999999999999999999   578899999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH-------
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-------  229 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~-------  229 (423)
                      ......    .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+....+.......+.       
T Consensus       161 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         161 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             GGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             CCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            433221    12235679999999999854 457899999999999999999999998755433222221111       


Q ss_pred             ----------------hhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          230 ----------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       230 ----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                      ......+.......+++++.+||.+||..||.+||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                            001112233344566789999999999999999999999865

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=370.75  Aligned_cols=257  Identities=18%  Similarity=0.227  Sum_probs=202.3

Q ss_pred             EEeceeeecCceeEEEEEECCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeEEEee-eeCCeeEEEE
Q 014527           10 KLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVL   82 (423)
Q Consensus        10 ~i~~~Lg~G~fg~Vy~a~~~~~~---~~vaiKi~~~~~~~---~~~~~E~~~l~~l~~~~~i~~i~~~~-~~~~~~~lv~   82 (423)
                      .+.++||+|+||+||+|++..++   ..||||.++.....   .++.+|++++.+++|+ ++..+..+. ......++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP-NVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCT-TBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCC-CEeEEeEEEEecCCceEEEE
Confidence            34678999999999999987643   35899988654332   4589999999999874 455554444 4456889999


Q ss_pred             ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCC
Q 014527           83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT  161 (423)
Q Consensus        83 e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (423)
                      ||| +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+   ++++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccc
Confidence            999 889999888666678899999999999999999999999999999999999   5789999999999987654432


Q ss_pred             CCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCCcHHHhh
Q 014527          162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC  241 (423)
Q Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (423)
                      ...   .......||+.|+|||.+.+..++.++|||||||++|||++|..||.....  ..+....+..... .+.   .
T Consensus       186 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~-~~~---p  256 (311)
T d1r0pa_         186 DSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRR-LLQ---P  256 (311)
T ss_dssp             CCT---TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC-CCC---C
T ss_pred             ccc---eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC-CCC---c
Confidence            221   123356789999999999999999999999999999999998888765322  2223333333322 221   2


Q ss_pred             ccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHh
Q 014527          242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR  279 (423)
Q Consensus       242 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  279 (423)
                      ..+|+++.+||.+||+.||++||++.+|++.|+.+++.
T Consensus       257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            44589999999999999999999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=369.94  Aligned_cols=259  Identities=23%  Similarity=0.256  Sum_probs=199.7

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeEEEeee-------eC
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-------DG   75 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~----~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-------~~   75 (423)
                      ++|++++.||+|+||+||+|++..+|+.||||++....    ....+.+|+++|+.++|++.+..+..+..       ..
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            79999999999999999999999999999999875432    34458899999999998665555544322       24


Q ss_pred             CeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceee
Q 014527           76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK  155 (423)
Q Consensus        76 ~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~  155 (423)
                      ...++||||+.+.+...+......+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA  166 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeee
Confidence            5679999999888887776667789999999999999999999999999999999999999   4788999999999987


Q ss_pred             ecCCCCCCcccccCCCcccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcC
Q 014527          156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS  234 (423)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (423)
                      +........   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.+.......
T Consensus       167 ~~~~~~~~~---~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         167 FSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CCC-----C---CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccccc---ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            654332211   123356899999999999865 5899999999999999999999999876655444444333221110


Q ss_pred             Cc----------------------HHH--hhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          235 TP----------------------IEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       235 ~~----------------------~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                      ..                      ...  .....++++.+||.+||..||++|||++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00                      000  00112567889999999999999999999865

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-48  Score=373.80  Aligned_cols=254  Identities=23%  Similarity=0.259  Sum_probs=195.9

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee-----eCCeeEE
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNVL   80 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~~~~~l   80 (423)
                      .-+|+.+++||+|+||+||+|++..+++.||||++..+..  ...+|+++++.++|++.+..+..+..     +..+.+|
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            3479999999999999999999999999999999876543  34589999999987555444444322     2335789


Q ss_pred             EEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeec
Q 014527           81 VLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR  157 (423)
Q Consensus        81 v~e~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~  157 (423)
                      |||||++++.+.+..   ....+++..++.|+.||+.||+|||++||+||||||+|||++  .+...+||+|||+|+...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhcc
Confidence            999998877666542   345699999999999999999999999999999999999994  233589999999998765


Q ss_pred             CCCCCCcccccCCCcccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhc---
Q 014527          158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV---  233 (423)
Q Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---  233 (423)
                      ....        .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.+......   
T Consensus       175 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         175 RGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  246 (350)
T ss_dssp             TTSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCcc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence            4332        225689999999998875 4689999999999999999999999987654433222222111000   


Q ss_pred             -----------C------Cc-HHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          234 -----------S------TP-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       234 -----------~------~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                 .      .+ ........++++.+||.+||..||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       0      00 01112345789999999999999999999999865

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=368.29  Aligned_cols=257  Identities=20%  Similarity=0.285  Sum_probs=208.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEECC-----CCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeEEEeeeeC
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDG   75 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~~-----~~~~vaiKi~~~~~~~~---~~~~E~~~l~~l~~~~~i~~i~~~~~~~   75 (423)
                      |-.++|++.+.||+|+||+||+|.+..     ++..||||+++......   .+.+|+.+++.++|+ ++..+..++...
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~~~~~~~~~   95 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQG   95 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCT-TBCCEEEEECSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCC-CEeeeeeEEecC
Confidence            445899999999999999999998852     35689999987654433   378999999999874 566666666778


Q ss_pred             CeeEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcE
Q 014527           76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV  145 (423)
Q Consensus        76 ~~~~lv~e~~-~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~v  145 (423)
                      +..++||||+ +|+|.+++....         ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence            8899999999 899999886432         347899999999999999999999999999999999999   588999


Q ss_pred             EEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCchhhhhHHH
Q 014527          146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQK  224 (423)
Q Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG-~~Pf~~~~~~~~~~~  224 (423)
                      ||+|||+|+.........     ......||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+..   +.
T Consensus       173 Kl~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~  244 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV  244 (308)
T ss_dssp             EECCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH
T ss_pred             EEeecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence            999999998765433211     22345789999999999999999999999999999999998 5788775443   44


Q ss_pred             HHHHHhhhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHH
Q 014527          225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL  276 (423)
Q Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  276 (423)
                      +..+...... +.   ...+|+.+.++|..||+.||++||++++|++.|++.
T Consensus       245 ~~~i~~~~~~-~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         245 LRFVMEGGLL-DK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHTTCCC-CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHhCCCC-CC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            4444443322 21   245689999999999999999999999999888754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=367.09  Aligned_cols=267  Identities=23%  Similarity=0.254  Sum_probs=199.6

Q ss_pred             cCCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHH--HHHcCCCCCCeEEEeeeeC----Cee
Q 014527            5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQGGSGIPNIKWYGVDG----EDN   78 (423)
Q Consensus         5 ~~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l--~~l~~~~~i~~i~~~~~~~----~~~   78 (423)
                      +.+.|.+.+.||+|+||+||+|++  +|+.||||+++... .....+|.+++  ..++| ++|..+..++.+.    ...
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~H-pnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCC-CcCcceEEEEEeCCCcceEE
Confidence            357899999999999999999987  68899999986543 33445555544  44555 4455554444432    257


Q ss_pred             EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCcccccccCCceEEeecCCCCcEEEee
Q 014527           79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS--------RGFLHRDIKPDNFLMGLGRKANQVYIID  149 (423)
Q Consensus        79 ~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~giiHrDIKp~NILl~~~~~~~~vkL~D  149 (423)
                      ++||||+ +|+|.+++..  ..+++..++.++.|++.||.|||+        +|||||||||+|||+   +.++.+||+|
T Consensus        77 ~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~D  151 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD  151 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECC
T ss_pred             EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEe
Confidence            9999999 8899999974  469999999999999999999996        599999999999999   5789999999


Q ss_pred             ccceeeecCCCCCCcccccCCCcccccccccCcccccCCC------CCccchHHHHHHHHHHHHhCCCCCCCchh-----
Q 014527          150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRGSLPWQGLKA-----  218 (423)
Q Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~~sDIwSlGvil~elltG~~Pf~~~~~-----  218 (423)
                      ||+++..........   .......||+.|+|||++.+..      ++.++|||||||+||||+||..||.....     
T Consensus       152 FGl~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CTTCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             cCccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            999998765443211   1223568999999999988653      56789999999999999999888743211     


Q ss_pred             -------hhhHHHHHHHHhhhcCCcHHH--hhccChHHHHHHHHHHhcCCCCCCCChHHHHHHHHHHHHhcCCC
Q 014527          219 -------ATKKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGYD  283 (423)
Q Consensus       219 -------~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  283 (423)
                             .........+.......+.+.  .....+..+.+|+.+||+.||++||++.+|++.|+++..++|..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~  302 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK  302 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence                   111122222233333222211  11223567999999999999999999999999999999888753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.9e-47  Score=364.95  Aligned_cols=251  Identities=20%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeee--eCCeeEEEEe
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLD   83 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~--~~~~~~lv~e   83 (423)
                      .++|+++++||+|+||+||+|+++.+++.||||+++.. ...++.+|+.+|+.+.+++++..+..++.  .....++|||
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            46799999999999999999999999999999998753 45678999999999987778888766654  3456899999


Q ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        84 ~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      || +++|..+    .+.+++..++.++.||+.||+|||++||+||||||+|||++  .+++.+||+|||+|+....... 
T Consensus       113 ~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~-  185 (328)
T d3bqca1         113 HVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE-  185 (328)
T ss_dssp             CCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC-
T ss_pred             ecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc-
Confidence            99 6676554    35699999999999999999999999999999999999995  3455799999999987654432 


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhh-hHHHHHHHHhh---------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEK---------  231 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i~~~---------  231 (423)
                             .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||....... ....+..+...         
T Consensus       186 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         186 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             -------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence                   23567899999999988765 7999999999999999999999997643221 11111111110         


Q ss_pred             -hcCC-------------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          232 -KVST-------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       232 -~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                       ....                   ........+++++.+||.+||..||.+|||++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000                   000112345789999999999999999999999865

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=366.26  Aligned_cols=252  Identities=20%  Similarity=0.308  Sum_probs=206.6

Q ss_pred             ccCCceEEeceeeecCceeEEEEEEC---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeEEEeeee
Q 014527            4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVD   74 (423)
Q Consensus         4 i~~~~y~i~~~Lg~G~fg~Vy~a~~~---~~~~~vaiKi~~~~------~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~   74 (423)
                      +--++|++++.||+|+||+||+|++.   .+|+.||||+++..      ...+.+.+|++++++++|+++|..+..+..+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            33477999999999999999999984   46899999987532      2345688999999999999999999888989


Q ss_pred             CCeeEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccce
Q 014527           75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA  153 (423)
Q Consensus        75 ~~~~~lv~e~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla  153 (423)
                      ....+++|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccch
Confidence            99999999999 8899998876 4568899999999999999999999999999999999999   57889999999999


Q ss_pred             eeecCCCCCCcccccCCCcccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHH-h
Q 014527          154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC-E  230 (423)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~-~  230 (423)
                      +.+......      ......|++.|+|||.+.+..  ++.++|||||||+||+|++|+.||.+.........+.+.. .
T Consensus       177 ~~~~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~  250 (322)
T d1vzoa_         177 KEFVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK  250 (322)
T ss_dssp             EECCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred             hhhcccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence            876543322      123567999999999998654  6889999999999999999999998765544433333221 2


Q ss_pred             hhcCCcHHHhhccChHHHHHHHHHHhcCCCCCCCC-----hHHHH
Q 014527          231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLK  270 (423)
Q Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~l~  270 (423)
                      .....     ...+++++.+||.+||..||++||+     +++++
T Consensus       251 ~~~~~-----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil  290 (322)
T d1vzoa_         251 SEPPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK  290 (322)
T ss_dssp             CCCCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred             CCCCC-----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence            22222     2356899999999999999999995     56664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=355.93  Aligned_cols=252  Identities=22%  Similarity=0.273  Sum_probs=202.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEE
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL   82 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~----~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~   82 (423)
                      ++|++++.||+|+||+||+|++..+++.||||+++....    ..++.+|+.+++.++| +++..+..++.+....+++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc-CCEEeeccccccccceeEEe
Confidence            589999999999999999999999999999999865432    3457899999999987 55666777778888999999


Q ss_pred             eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeeecCCCCC
Q 014527           83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN  162 (423)
Q Consensus        83 e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (423)
                      +++.+.+...+....+.+++..+..++.|++.||+|||++||+||||||+|||+   +..+.+||+|||.|+........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCcc
Confidence            999665555566667889999999999999999999999999999999999999   47889999999999887654332


Q ss_pred             CcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC------
Q 014527          163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------  235 (423)
Q Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------  235 (423)
                             .....+++.|+|||.+.+.. ++.++|||||||++|||++|..||......  .+.+.++.......      
T Consensus       158 -------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         158 -------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             -------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCT
T ss_pred             -------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhh
Confidence                   22456788999999988765 699999999999999999999997543322  22222222211111      


Q ss_pred             ------------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 ------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 ------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                        ........+++.+.+||.+||..||.+|||++||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                              111223455789999999999999999999999865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=365.33  Aligned_cols=248  Identities=21%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             CCceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeEEEeee-----eCC
Q 014527            6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV-----DGE   76 (423)
Q Consensus         6 ~~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i~~~~~-----~~~   76 (423)
                      .++|++++.||+|+||+||+|++..+|+.||||++......    ..+.+|+++++.|+|++.+..+..+..     +..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999999999999999998765432    347899999999987655544444432     223


Q ss_pred             eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ..+++|++++++|.+++.  .+++++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhccc
Confidence            456666666999999885  4679999999999999999999999999999999999999   57899999999999765


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHhhhcCC
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST  235 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (423)
                      ....          ....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+   .......
T Consensus       172 ~~~~----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~  238 (348)
T d2gfsa1         172 DDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTP  238 (348)
T ss_dssp             TGGG----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCC
T ss_pred             Cccc----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCC
Confidence            3322          3568999999999987765 689999999999999999999999876544333222   2221111


Q ss_pred             --------------------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          236 --------------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       236 --------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                                ........+++++.+||.+||..||.+|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                                      112223456889999999999999999999999866

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=362.49  Aligned_cols=250  Identities=20%  Similarity=0.239  Sum_probs=187.1

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeE-EEeee-----eCC
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNI-KWYGV-----DGE   76 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~----~~~~~E~~~l~~l~~~~~i~~i-~~~~~-----~~~   76 (423)
                      ++|++++.||+|+||+||+|+++.+|+.||||++......    ..+.+|+.+++.++| ++|..+ ..+..     ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEecccccccCc
Confidence            7899999999999999999999999999999998765432    247899999999986 455454 44322     346


Q ss_pred             eeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEeeccceeee
Q 014527           77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY  156 (423)
Q Consensus        77 ~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~~~  156 (423)
                      ..|+|||||.+++.+.+   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        96 ~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred             eeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhcc
Confidence            78999999988877765   4579999999999999999999999999999999999999   47889999999998876


Q ss_pred             cCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhhhhHHHHHHHHh------
Q 014527          157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------  230 (423)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~------  230 (423)
                      .....        .....+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+.....      
T Consensus       170 ~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         170 GTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence            54332        2356799999999999999999999999999999999999999987554333222211110      


Q ss_pred             -------------hhcCC---------------cHHHhhccChHHHHHHHHHHhcCCCCCCCChHHHHH
Q 014527          231 -------------KKVST---------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR  271 (423)
Q Consensus       231 -------------~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  271 (423)
                                   .....               .........++++.+||.+||..||++|||+++|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                         00000               000011123678999999999999999999999865

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-42  Score=335.52  Aligned_cols=261  Identities=23%  Similarity=0.283  Sum_probs=189.4

Q ss_pred             CCcccC-CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCC----------CCCeE
Q 014527            1 MERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS----------GIPNI   68 (423)
Q Consensus         1 ~~~i~~-~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~-~~~~~~E~~~l~~l~~~~----------~i~~i   68 (423)
                      +|+++. ++|++++.||+|+||+||+|+++.+|+.||||+++.+.. .+.+.+|+++++.+.|.+          ++..+
T Consensus         6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_           6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            356664 679999999999999999999999999999999976532 345788999999987643          34444


Q ss_pred             EEee--eeCCeeEEEEecc--CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh-cCcccccccCCceEEeecCCC
Q 014527           69 KWYG--VDGEDNVLVLDLL--GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKA  142 (423)
Q Consensus        69 ~~~~--~~~~~~~lv~e~~--~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDIKp~NILl~~~~~~  142 (423)
                      ..+.  ......+++|+++  +++....... ....+++..+..++.||+.||+|||+ +||+||||||+|||++..+..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            3333  2445666777766  4444443332 34568999999999999999999998 899999999999999633221


Q ss_pred             ---CcEEEeeccceeeecCCCCCCcccccCCCcccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCchhh
Q 014527          143 ---NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA  219 (423)
Q Consensus       143 ---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDIwSlGvil~elltG~~Pf~~~~~~  219 (423)
                         ..++|+|||.|.......          ....||+.|+|||++.+..++.++|||||||++++|++|+.||......
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~  235 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH  235 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             cccceeeEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence               259999999998654432          2567999999999999999999999999999999999999999754321


Q ss_pred             h---hHHHHHHHHhhhcCCcHHH-------------------------------------hhccChHHHHHHHHHHhcCC
Q 014527          220 T---KKQKYDKICEKKVSTPIEV-------------------------------------LCKSHPAEFASYFHYCQSLT  259 (423)
Q Consensus       220 ~---~~~~~~~i~~~~~~~~~~~-------------------------------------~~~~~~~~l~~li~~cl~~d  259 (423)
                      .   ....+..........+...                                     .....++++.+||.+||..|
T Consensus       236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d  315 (362)
T d1q8ya_         236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD  315 (362)
T ss_dssp             ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred             cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence            1   0111111111000000000                                     01223678999999999999


Q ss_pred             CCCCCChHHHHH
Q 014527          260 FDQRPDYGFLKR  271 (423)
Q Consensus       260 P~~RPt~~~l~~  271 (423)
                      |.+|||++++++
T Consensus       316 P~~Rpta~e~L~  327 (362)
T d1q8ya_         316 PRKRADAGGLVN  327 (362)
T ss_dssp             TTTCBCHHHHHT
T ss_pred             hhHCcCHHHHhc
Confidence            999999999865

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=6.3e-25  Score=193.57  Aligned_cols=163  Identities=17%  Similarity=0.249  Sum_probs=113.9

Q ss_pred             eEEeceeeecCceeEEEEEECCCCcEEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCCCCeE
Q 014527            9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------HPQLLYEAKVYKILQGGSGIPNI   68 (423)
Q Consensus         9 y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~--------------------~~~~~~E~~~l~~l~~~~~i~~i   68 (423)
                      +.++++||+|+||+||+|++. +|+.||||+++....                    ......|...+..+.+.+ ++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA-VPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS-SCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC-cceE
Confidence            568999999999999999985 688999998653211                    011345777788777643 3333


Q ss_pred             EEeeeeCCeeEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCcccccccCCceEEeecCCCCcEEEe
Q 014527           69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII  148 (423)
Q Consensus        69 ~~~~~~~~~~~lv~e~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDIKp~NILl~~~~~~~~vkL~  148 (423)
                      .  ...  ..+++|||+++...       ..++...+..++.||+.+|.|||++||+||||||+|||++    +..++|+
T Consensus        80 ~--~~~--~~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li  144 (191)
T d1zara2          80 Y--AWE--GNAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII  144 (191)
T ss_dssp             E--EEE--TTEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred             E--Eec--CCEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence            3  222  24799999965322       2255667788999999999999999999999999999994    4569999


Q ss_pred             eccceeeecCCCCCCcccccCCCcccccccccCc--c---cccCCCCCccchHHHHHHHH
Q 014527          149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC--N---THLGIEQSRRDDLESLGYVL  203 (423)
Q Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP--E---~~~~~~~s~~sDIwSlGvil  203 (423)
                      |||+|.....+..               ..|...  +   .+....|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999976543221               011110  0   11235678899999976543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.54  E-value=3.1e-07  Score=82.42  Aligned_cols=137  Identities=17%  Similarity=0.192  Sum_probs=91.9

Q ss_pred             CceEEeceeeecCceeEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527            7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus         7 ~~y~i~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~--~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ..|++.+..+.++.+.||++..  .++.++||+.....  ....+.+|...+..|...-.+|.+..++.+.+..++||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            4677777766566689998863  56668888765432  3335789999999998665578888888888889999999


Q ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 014527           85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------  121 (423)
Q Consensus        85 ~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~------------------------------------------  121 (423)
                      + |..+.+...      +......++.+++..|..||+                                          
T Consensus        92 l~G~~~~~~~~------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHTT------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             ccccccccccc------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            9 445433321      111122233444444444442                                          


Q ss_pred             -----------------cCcccccccCCceEEeecCCCCcEEEeecccee
Q 014527          122 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK  154 (423)
Q Consensus       122 -----------------~giiHrDIKp~NILl~~~~~~~~vkL~DFGla~  154 (423)
                                       ..++|+|+.|.|||+.   +++.+-|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~  212 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhcc
Confidence                             1268999999999994   44445699999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.25  E-value=2.6e-06  Score=81.32  Aligned_cols=74  Identities=16%  Similarity=0.191  Sum_probs=49.6

Q ss_pred             eceeeecCceeEEEEEECCCCcEEEEEEecC---------CCCchhHHHHHHHHHHHcCC--CCCCeEEEeeeeCCeeEE
Q 014527           12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENS---------GTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVL   80 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~---------~~~~~~~~~E~~~l~~l~~~--~~i~~i~~~~~~~~~~~l   80 (423)
                      .+.||.|....||++....+++.|+||....         .....+...|++.|..+...  ..+|.+..  .+.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence            4578999999999998877788899995321         11233467799999888643  33555544  46667899


Q ss_pred             EEeccCC
Q 014527           81 VLDLLGP   87 (423)
Q Consensus        81 v~e~~~~   87 (423)
                      |||++++
T Consensus       109 vmE~L~~  115 (392)
T d2pula1         109 VMEDLSH  115 (392)
T ss_dssp             EECCCTT
T ss_pred             EEeccCC
Confidence            9999943

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=7.5e-06  Score=72.62  Aligned_cols=71  Identities=18%  Similarity=0.106  Sum_probs=51.6

Q ss_pred             eeeecC-ceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeEEEeeeeCCeeEEEEeccC
Q 014527           14 KIGSGS-FGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLG   86 (423)
Q Consensus        14 ~Lg~G~-fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~-i~~i~~~~~~~~~~~lv~e~~~   86 (423)
                      .+..|. .+.||++.. .++..+++|+.... ....+..|+..++.|..... +|.+..+..+.+..++||+++.
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            334444 468999874 45666889986554 34568899999998876543 5667777778888999999993

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.39  E-value=0.00024  Score=67.24  Aligned_cols=72  Identities=13%  Similarity=0.125  Sum_probs=53.5

Q ss_pred             eceeeecCceeEEEEEECC-------CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeEEEeeeeCCeeEEEEec
Q 014527           12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL   84 (423)
Q Consensus        12 ~~~Lg~G~fg~Vy~a~~~~-------~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~~~i~~i~~~~~~~~~~~lv~e~   84 (423)
                      ++.|+.|-.-.+|++....       ..+.|++++...........+|..+++.+......|.+..++.    ..+||||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef  122 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY  122 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence            4578878888999998753       2456888987654444557789999999987777788876653    3688999


Q ss_pred             cCC
Q 014527           85 LGP   87 (423)
Q Consensus        85 ~~~   87 (423)
                      +.|
T Consensus       123 i~g  125 (395)
T d1nw1a_         123 IPS  125 (395)
T ss_dssp             CCE
T ss_pred             ecc
Confidence            843

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.12  E-value=0.00077  Score=61.27  Aligned_cols=48  Identities=13%  Similarity=0.179  Sum_probs=31.1

Q ss_pred             ceeeecCceeEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 014527           13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG   62 (423)
Q Consensus        13 ~~Lg~G~fg~Vy~a~~~~~~~~vaiKi~~~~~~~~~~~~E~~~l~~l~~~   62 (423)
                      +.|..|---+.|+++..  +..+++|+.........+..|.+++..|...
T Consensus        24 ~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~   71 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAK   71 (316)
T ss_dssp             EEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred             ecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhhc
Confidence            33456666788998763  3358999987665666788899988888753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.11  E-value=0.002  Score=58.85  Aligned_cols=65  Identities=14%  Similarity=0.097  Sum_probs=44.5

Q ss_pred             eeEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeE-------EEeeeeCCeeEEEEeccCC
Q 014527           21 GEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNI-------KWYGVDGEDNVLVLDLLGP   87 (423)
Q Consensus        21 g~Vy~a~~~~~~~~vaiKi~~~~~-~~~~~~~E~~~l~~l~~~~~i~~i-------~~~~~~~~~~~lv~e~~~~   87 (423)
                      -.||+++. .+|..|++|+.+... ...++..|...+..|.... ++..       ..........+.++++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~g-ipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcC-CCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            48999975 467889999987653 4567889999999987532 2222       1122345667888888843